[
  {
    "page": 1,
    "content": "891\n34.  Atraumatic Tooth Extraction and Socket Grafting, 892\n35.  Bone Substitutes and Membranes, 913\n36.  Particulate Membrane Grafting/Guided Bone Regeneration, 933\n37.  Maxillary Sinus Anatomy, Pathology, and Graft Surgery, 987\n38.  Intraoral Autogenous Bone Grafting, 1054\n39.  Extraoral Bone Grafting for Implant Reconstruction, 1088\n40.  The Use of Botox and Dermal Fillers in Oral Implantology, 1112\nSoft and Hard Tissue \nRehabilitation\nPART VII"
  },
  {
    "page": 2,
    "content": "892\n34\nAtraumatic Tooth Extraction \nand Socket Grafting\nRANDOLPH R. RESNIK AND JON B. SUZUKI\nI\nt is imperative that the implant clinician has a strong under-\nstanding of the extraction socket healing process and options \nfor the socket graft site preservation technique. In most cases \nthe extraction process will initiate a sequence of bony resorptive \nmorphologic changes that negatively alters the alveolar ridge. This \nchapter will discuss the process of atraumatic extraction and a \ndecision process on when no graft is indicated and when to graft \n(i.e., protocol on various bone substitutes, membranes, and heal-\ning periods).\nExtraction Socket Healing\nIn understanding the healing process of the extraction site, the ter-\nminology is often misrepresented (Box 34.1). The process of bone \nrepair occurs when there is injury or conditions of the bone that \ncause incomplete bone volume to form in the residual ridge. The \nmost common conditions that cause bone repair are the absence \nof a labial plate before or as a consequence of tooth extraction. \nOther factors include a bony wall that is less than 1.5 mm thick \n(usually the facial), exudate, gross apical pathology, or excessive \nheat from a dental drill during root extraction.\nThe tooth socket with ﬁve bony walls (i.e., mesial, distal, buc-\ncal, lingual, and apical) will heal by bone regeneration (Fig. 34.1). \nThe process of bone regeneration heals by secondary intention, \nand bone healing in many aspects is similar to secondary intention \nsoft tissue healing. The healing sequence in both hard and soft \ntissue includes inflammation, epithelialization, ﬁbroplasia, and \nremodeling. However, socket healing presents unique microvas-\ncular features and a sequential pattern of bone formation before \nremodeling.\nNumerous authors in the literature have proposed the healing \nsequence and various stages of bone regeneration after a tooth is \nextracted with a healthy surrounding alveolus.\nStage 1: Granulation Stage: After a tooth is extracted, an ini-\ntial clot forms within the socket which consists of a ‘‘coagulum’’ \nof red and white blood cells. At approximately the third day, the \ncoagulum is slowly replaced by highly vascular granulation tissue. \nThe blood clot begins to shrink, and capillaries form sinusoids and \ngranulation tissue, starting from the socket apex and spreading \nlaterally and crestally along the socket walls. Granulation tissue \nreplaces the clot over a 4-to 5-day period.1, 2\nStage 2: Initial Angiogenic Stage: The initial angiogenic stage \nstarts approximately a week after extraction.  This stage develops \nfrom the broken ends of blood vessels in the residual periodon-\ntal ligament covering the cribriform plate. Blood plasma leaks \nfrom the  broken vessels, and immature fibroblasts aggregate at \nthe plasma-rich regions. Fibroplasia begins early in the sequence \nduring the first week as a result of the ingrowth of capillaries and \nfibroblasts. White blood cells kill bacteria and begin to dissolve \nforeign bodies and bone fragments. With few exceptions the \nangiogenesis begins at the bottom of the socket because this area \nis not severely injured during the extraction and has the greatest \nsource of blood vessels.3\nStage 3: Early Bone Formation Stage: This stage starts \napproximately three to four weeks after extraction. The granula-\ntion tissue gradually is replaced by connective tissue (collagen \nfibers, spindle shaped fibroblasts). The capillary activity begins \nthe early phases of trabeculae development.  This capillary activ-\nity is initiated at the socket apex, and trabeculae of woven bone \ngrowth will occur following the formation of blood vessels. Dur-\ning this stage, the cortical bone of the crestal area of the socket \nwill start to resorb, along with the interseptal regions and the \nthinner facial plate.4\nStage 4: Bone Growth Stage: The bone growth stage starts \nat approximately four to six weeks after the extraction. This \nperiod demonstrates the greatest sinusoid formation activity. \nThe forming trabeculae of woven bone first start from the bot-\ntom of the socket after the meshwork of newly formed anasto-\nmosing sinusoidal capillaries. Bone formation is more rapid at \nthis point, creating a three-dimensional lattice pattern of woven \nbone. New bone trabeculae form on the walls and approxi-\nmately two-thirds of the socket is filled at  four – five weeks. \nAt this stage, the center of the socket is primarily composed of \nwoven bone. The more-organized lamellar bone starts to form \nfrom the lining of the socket, moving toward the center. At \napproximately 6 weeks, bone trabeculae almost completely fill \nthe socket.5\nStage 5: Bone Reorganization Stage: The bone reorganization \nstage starts at about 6 weeks after extraction. Usually complete \nepithelial closure of the socket is completed by this time. The pri-\nmary bone trabeculae remodel to form thicker secondary cancel-\nlous bone. This process always begins at the apex of the extraction \nsocket. At approximately 60 days, woven bone has completely \nbridged the defect and at 90 days, woven bone is resorbed by \nosteoclasts which is replaced by lamellar bone. The bridged woven \nbone is usually completely remodeled to lamellar bone by 16"
  },
  {
    "page": 3,
    "content": "893\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nweeks and most osteogenic activity is complete at this time. A new \nperiosteum is established by 180 days.6,7,8\nThe timing for these stages varies among individuals and clin-\nical situations. The number of bony walls around the socket and \nsize of the alveolus greatly influence the regeneration process. \nIn general, larger molar extraction sites (i.e. molar) take lon-\nger to completely form bone compared with smaller-diameter \nanterior sites. Although the period of regeneration for an extrac-\ntion socket is variable, the clinical sign that the socket regenera-\ntion is complete is when the radiographic lamina dura (which \nrepresents the cribriform plate) is no longer present. This heal-\ning period usually takes between  3 to 6 months, dependent on \ntooth size, root number, and extent of trauma during the extrac-\ntion (Fig. 34.2).\nImportance of the Buccal Plate\nOne of the most important factors in the regeneration and repair \nof bone is the buccal plate. The buccal plate of bone is more sus-\nceptible to bone loss. Studies have shown the buccal plate may \nlose up to 56% horizontal bone loss and 30% vertical bone loss \nwithin the first year after extraction.9,10 In addition, when the \nbuccal plate is thicker, the ridge tends to resorb less. The buccal \nplate is also more susceptible to trauma. When iatrogenic buccal \nplate damage occurs, the socket no longer heals by regeneration, \nhowever will heal by repair. This is usually a slower healing process \nand more unpredictable (Fig. 34.3). \nAtraumatic Tooth Extraction\nTheory of Atraumatic Tooth Extraction\nThere exists a full array of reasons teeth are deemed unrestorable; \nperiodontal, endodontic, prosthetic, or orthodontic failures. Once \nthe extraction of a natural tooth is indicated, methods to maintain \nor obtain the surrounding hard and soft tissues are indicated. It is \nthe primary goal of the implant clinician to extract the nonrestor-\nable tooth while minimizing associated trauma and maintaining \nthe hard and soft tissue.\nThe atraumatic tooth extraction technique and socket graft-\ning has become a popular procedure in implant dentistry. The \nprocess of atraumatic tooth extraction and preservation of soft \nand hard tissues begins with the surrounding soft tissue. The \ncells of the inner layer of the periosteum are responsible for \nbone remodeling. When the bone volume is ideal, the peri-\nosteum should be minimally reflected in preservation of the \nblood supply. However, the periosteum can also be a limiting \nfactor in the volume of bone formation. When the periosteum \nis separated from the bone graft by a barrier membrane, more \nvolume of bone is regenerated. The periosteum helps bone \nremodeling or bone repair, but may also limit bone modeling \nand regeneration. \nAtraumatic Tooth Extraction Technique\nMany techniques and protocols exist for removing teeth; however, \nsome basic principles should be applied to all extractions.\nSevering the Connective Tissue Fibers\nThe soft tissue drape surrounding the teeth is affected by the \nreflection of the periosteum and often shrinks to adapt to the \nresidual ridge form. In fact, the soft tissue is more labile to \nthe trauma and reflection of the tissues than the hard tissues. \nTherefore the sulcular and surrounding soft tissue should ide-\nally remain undisturbed during tooth extraction to prevent fur-\nther dimensional loss. The extraction of a natural tooth begins \nwith an incision within the sulcus, preferably with a thin scalpel \nblade or a blunt periotome. The incision should encompass the \nentire tooth (i.e., 360 degrees around the tooth) to sever the \nconnective tissue attachment ﬁbers above the bone (Fig. 34.4). \nThere exist 13 different connective tissue ﬁber groups around \na tooth, of which 6 directly insert into the cementum of the \ntooth above the bone. If these ﬁbers are not severed before the \nextraction, trauma to the soft tissue is imminent. The soft tissue \nmay tear, causing a delay in the healing process and increases \nbleeding (Fig. 34.5). \nMinimizing Soft Tissue Reflection\nThe soft tissue should ideally be minimally reflected, because soft \ntissue retraction and shrinkage during initial healing are more \nevident, especially in the interdental papilla region. Usually a flap \nis raised when the buccal plate is not intact or surgical extrac-\ntion of the tooth is indicated. If a tissue flap needs to be raised, \nan envelope flap (no vertical extension) is used. The vertical \n\t•\t \u0007Bone remodeling—the replacement of old bone tissue by new bone \ntissue; natural phenomena to maintain healthy bone mass\n\t•\t \u0007Bone modeling—adapts bone size and shape to stress or loading\n\t•\t \u0007Bone repair—a physiologic process in which the body facilitates the \nrepair of a bone fracture\n\t•\t \u0007Bone regeneration—requires the use of surgical protocols that enable \nbone growth within deficient sites, using the principles of osteogenesis, \nosteoinduction, and osteoconduction\n\t•\t \u0007Socket restoration versus preservation—difficult to differentiate; \nboth terms are used\n\t\n•\t Bone is restored in the socket (generally for the placement of an implant)\n\t\n•\t \u0007Bone preservation indicates long-term stability of the alveolar ridge\n\t • BOX 34.1\t    \u0007Bone Healing Definitions\n• Fig. 34.1  The treatment plan and protocol for a post-extraction socket \nis dictated by five bony walls: mesial (M), distal (D), buccal (B), lingual (L), \nand apical (A)."
  },
  {
    "page": 4,
    "content": "A\nB\nC\nD\nE\n• Fig. 34.2  The Five Stages of Extraction Site Healing: (A) Granulation Stage: Initial blood clot forms and is \ngradually replaced with granulation tissue, (B) Initial Angiogenic Stage: Blood vessel formation integrates into the \ngraft which starts at approximately one week, (C) Early Bone Formation Stage: At approximately 3-4 weeks, the \ngranulation tissue is replaced by connective tissue.  Woven bone starts to form at apex, (D) Bone Growth Stage: \nGreater woven bone growth continues as the center of the socket is primarily woven bone. Lamellar bone starts \nto form around the apex and lining of the socket, (E) Bone Reorganization Stage: Complete epithelial closure \nis usually complete by week 6. Woven bone is gradually replaced by lamellar and is complete by 16 weeks.\n• Fig. 34.3  The buccal plate is susceptible to fracture during extraction \nbecause the buccal plate is usually thinner than the lingual plate.\n• Fig. 34.4  The extraction of the tooth begins with a scalpel to incise the \nsulcular connective tissue fibers above the bone, which are attached to the \ncementum of the tooth."
  },
  {
    "page": 5,
    "content": "895\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nincisions may compromise the blood supply and may delay the \nhealing of the area. Whenever the periosteum is reflected, the \ncells are injured and need to regenerate before the remodeling \nprocess begins. The cortical bone receives more than 80% of its \narterial blood supply and facilitates 100% of its venous blood \nreturn through the periosteum.11 In some situations reflection of \nthe tissue is necessary such as the use of bone-supported surgical \ntemplates (Fig. 34.6). \nEvaluating the Anatomy of the Tooth to Be Extracted\nThe next step in the atraumatic extraction process is to evalu-\nate the crown and root anatomy. This is especially important \nfor divergent, multirooted teeth. If the roots of the tooth to be \nextracted are divergent, they should be sectioned and removed as \nindividual units, rather than risking fracture of the roots or sur-\nrounding bone (Fig. 34.7). When the roots are fractured, there \nis an increased risk for bone fracture/removal to retrieve them. If \nbone removal around the tooth is necessary (because the tooth \nis fractured or decayed to the bony crest), it ideally should be at \nthe expense of the lingual alveolus, not the more labial bone. The \nbuccal plate of bone is almost always thinner than the lingual \nplate. Another option to reduce trauma when taking out teeth \nis modification of the contact (proximal) areas. When adjacent \nteeth are present the pathway of removal is often obstructed by \nthe position of the adjacent tooth. If the tooth to be extracted \nis not reduced (i.e., mesial and distally), instruments or pressure \nmay chip the enamel (or restoration) of the adjacent tooth and \nmay cause the extraction of the tooth to take an altered pathway \nof removal, which is more likely to fracture the roots, bone, or \nboth (Fig. 34.8). \nAtraumatic Removal of the Tooth\nBasic Principles. Biomechanic concepts have been used to \nextract teeth for thousands of years and date back to the days of \nAristotle (384–322 BCE),12 who described the mechanics of the \nextraction forceps, including the advantages of “two levers acting \nin contrary sense having a single fulcrum.” This was 100 years \nbefore Archimedes reported on the principles of the lever. Pierre \nFauchard13 (1678–1761) is credited with being the pioneer of \nscientiﬁc dentistry and gave speciﬁc instructions for extracting \nteeth using a dental elevator, a “pelican,” or pincers (forceps). \nHe describes loosening the tooth with an elevator, then using \nthe claw of the “pelican” (invented by Chauliac14 in the four-\nteenth century). The pelican handle was positioned both on the \ntooth and on the gum below the tooth while it was rocked back \nand forth (which he called “shaking”) before the extraction. Taft \ndescribed a similar technique using the dental key, which had \n• Fig. 34.5  Illustration depicting the soft tissue attachment to a natural tooth. \nThirteen different fibers insert into the tooth root and if not severed during \nthe atraumatic extraction technique, hard and soft tissue damage will result.\n• Fig. 34.6  When a bone supported and reduction guide is indicated, a \nmore extensive reflection is required for access and seating of the template.\nA\nB\nC\nD\n• Fig. 34.7  Atraumatic Extraction: (A) Mandibular first molar to be extracted, (B) Proximal contacts removed to allow for easier extraction, (C) Sectional of \nroots to minimize trauma, (D) Use of periotome to remove roots."
  },
  {
    "page": 6,
    "content": "896\nPART VII    Soft and Hard Tissue Rehabilitation\nleft and right claws that provided twisting and rocking in both \ndirections.15 This allowed the tooth to be loosened sufﬁciently \nto be pulled from the socket with “pincers” (forceps). Modern \nextraction forceps date from Tomes in 1840, with the develop-\nment of the anatomic forceps, complete with a handle and beak \nto ﬁt the neck of the tooth. \nBiomechanics of Tooth Removal. The principle of the den-\ntal elevator is also not a modern development. Abulkasim (AD \n1050–1122) was the ﬁrst to apply a single lever (elevator) under \nthe tooth to force it from its “bed.” It was improved by Ambroise \nParé in the sixteenth century to lift out the tooth before using the \npelican. Although these biomechanical methods to remove teeth \nare effective, a review of the biomechanical principles is in order to \ndecrease the trauma during the tooth extraction process.\nThe term “simple machine” is often used to describe basic \ndevices that increase the amount of force applied (e.g., the lever, \ninclined plane, wheel, screw, pulley). They each transmit or mod-\nify force or torque. The most common devices used in the extrac-\ntion of teeth include levers and inclined planes.\nThe wedge is technically a moving double inclined plane, \nwhich overcomes a large resistance by applying a relatively \nsmaller force than the load necessary to move an object. The \nmechanical advantage of a wedge depends on the ratio of its \nlength to its thickness. A short wedge with a wide angle moves \nan object faster; however, it requires more force than a long \nwedge with a smaller angle. Dental elevators use the mechanical \nadvantage of a wedge to initiate the luxation of teeth for their \nremoval (Figs. 34.9 and 34.10). \nPeriotomes. Periotomes are usually longer and thinner wedges \ncompared with dental elevators and often are used to begin the atrau-\nmatic extraction process. Periotomes may be used in a similar manner \nfor extraction of intact teeth or removal of retained root fragments.\nTechnique. \n\t1.\t \u0007The long axis of the periotome blade should be inserted into \nthe interproximal region along the root long axis (to protect the \nfacial plate of bone), with the tip of the periotome blade located \nwithin the crest of the alveolar bone. The instrument is then \npushed or tapped with a mallet into the periodontal ligament \nspace along the mesial and distal root, severing the periodontal \nA\nB\n• Fig. 34.8  (A) The maxillary lateral incisor requires extraction. The path-\nway of removal may restrict the extraction or chip an adjacent tooth. (B) \nThe distal portion of the lateral incisor was reduced to allow the tooth to \nmove distal, which allows pressure to the periodontal ligament and bone. \nIn addition, there is less risk for adjacent tooth damage.\n• Fig. 34.9  Improper Extraction Technique: may often lead to retained \nfractured root tips or loss of buccal plate.\nRisk of\nfractured\nbuccal\nplate\n• Fig. 34.10  Conventional extraction forceps often will result in the frac-\nture the buccal plate leading to a compromised future implant site."
  },
  {
    "page": 7,
    "content": "897\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nligament immediately below the alveolar crest and wedging the \ntooth against the opposing cribriform plate (Fig. 34.11A). The \nperiotome should never be used on the facial plate because this \nmay damage the host bone.\n\t2.\t \u0007A period of 10 to 30 seconds is allowed to elapse while the \ninstrument is in place. This allows biomechanical creep to \noccur to the ligament and reduces its strength, and because the \ntooth is pushed against the opposing alveolus, it also will begin \nto expand the bone. This process is much more effective when \nthere is no adjacent tooth contact. Reducing the mesial and \ndistal proximal contacts of the tooth to be extracted not only \ndecreases the risk for damage to the adjacent tooth crown, but \nalso aids in the extraction hopeless tooth.\n\t3.\t \u0007The periotome is then pushed farther down into the periodon-\ntal ligament space toward the root apex, often using a mallet \nand light tapping force. This process continues along the crestal \nthird of the tooth. At the completion of this step the tooth is \noften slightly mobile (Fig. 34.11B).\n\t4.\t \u0007Once the periotome is used as a moving wedge, it may then be \nconverted to a lever (Fig. 34.11C). The blade of the periotome \nis often 3 to 4 mm wide. When the handle is rotated, one side \nof the periotome is applied to the tooth root, the other side to \nthe cribriform plate, and the width of the “wedge” is now the \nlength of a lever, which magniﬁes the rotation force (moment). \nThe rotation of the periotome handle increases both tooth \nmobility and the force against the opposite cortical plate to \nfurther expand it within physiologic limits.\n\t5.\t \u0007A single-rooted tooth is most often tapered. As the periotome \nis tapped further apically toward the cribriform plate, it is \nslightly rotated. Because the socket is tapered, the lateral force \non one side of the tooth is converted to a coronal direction \nforce on the other side and the root is pushed out of the socket. \nAs a result the periotome may now be pushed farther apical, \ntoward the root apex. When time elapses between each force \napplication, the tooth may even slide up and completely out \nof the socket. Additional time and elevation may be required if \nsigniﬁcant tooth mobility is not achieved. \nUse of Conventional Forceps. Traditional dental forceps should \nnot be applied to the tooth until signiﬁcant tooth mobility is \nachieved. Once the wedge and lever action of the dental eleva-\ntor is applied to a tooth, most often dental forceps are used to \nultimately grasp and deliberately rock the tooth back and forth, \nand to rotate it as much as conditions will allow. The combination \nof these tooth movements expands the bony socket and separates \nthe periodontal ligaments. As a consequence the tooth may be \nremoved (Fig. 34.11D). Conventional dental forceps are actually \ntwo ﬁrst-class levers connected with a hinge. The forces applied \nto the forceps handles are the long side of the lever and the beaks \non the tooth are the short side of the lever, with the hinge acting \nas a fulcrum. The force on the handles is magniﬁed to allow the \nA\nC\nB\nD\n• Fig. 34.11  (A) A periotome is inserted along the tooth root on the mesial and pushed (or tapped with a \nmallet) to wedge the tooth against the opposing cribriform plate. A similar process is performed on the \ndistal interpositional region of the tooth root. (B) Once the periotome acts as a wedge and is in place for 10 \nto 30 seconds, it is tapped (with a mallet) farther down along the mesial and distal interproximal root sur-\nface. (C) The periotome is converted into a lever by rotating the handle several degrees, which magnifies \nthe force against the root. The tooth becomes slightly mobile at this stage. (D) A traditional dental forceps \nmay remove the tooth after initial mobility is created by the periotome."
  },
  {
    "page": 8,
    "content": "898\nPART VII    Soft and Hard Tissue Rehabilitation\nbeaks of the forceps to grasp the tooth with great force. None \nof the force on the forceps handles is used to extract the tooth. \nRather, the increased force on the forceps beaks often crushes or \nfractures the tooth. The forceps hold the tooth, and the surgeon’s \nhand, wrist, and arm are used to move and extract the tooth. This \naction would be similar to forcibly pulling a bottle cap off a bottle \nor pulling a nail from a piece of wood using only a pair of pliers. \nAlternative Extraction Forceps. The principles of biomechanics \nare the basis for the development of a different type of dental for-\nceps called Physics Forceps (Golden-Misch Instruments, Detroit, \nMich.). A moment of force in physics represents the magnitude of \nforce applied to a rotational system at a distance from the axis of \nrotation. The principle of moment M is derived from Archimedes’ \ndiscovery of the operating principle of the lever and is deﬁned as\nM = rF\nwhere F is the applied force and r is the distance from the force \napplied to the object. The concept of a moment arm is key to the \noperation of the lever, which is capable of generating mechani-\ncal advantage. This means that the force applied to an object is \naffected by the length of the lever arms. The lever arm is the dis-\ntance from the force input to the fulcrum or from the fulcrum to \nthe force output.\nThe Physics Forceps is a dental extractor that uses ﬁrst-class \nlever mechanics. One beak of the forcep is connected to a “bum-\nper,” which acts as a fulcrum during the extraction. The bumper is \nplaced most often on the facial aspect of the dental alveolus, at or \nabove the mucogingival junction. The second beak of the forcep is \npositioned as low as practical on the tooth root, most often on the \npalatal (lingual) into the gingival sulcus.\nOnce the forcep is in position around the tooth root, no \nsqueezing pressure is applied to the tooth. Instead, the handles, \nonce in position, are rotated as one unit facially for a few degrees \nand stopped for approximately 30-60 seconds (Fig. 34.12). The \ntorque force generated on the tooth, periodontal ligament, and \nbone is related to the length of the handle to the bumper (8 cm), \ndivided by the distance from the bumper to the forceps beak (1 \ncm). As a result a force on the handle connected to the bumper will \nincrease the force on the tooth periodontal ligament and bone by \neight times. No force is required to be placed on the forceps beak, \nB\nA\nC\nD\n• Fig. 34.12  The Physics (Atraumatic) Forceps.  (A) A “bumper” (one beak) is placed on the facial of the \ntooth to be extracted at or below the mucogingival junction. The second beak is placed on the lingual, \nengaging the tooth root. The handles of the forceps act as a lever to rotate (avulse) the tooth from the \nsocket. The bumper is placed below the tooth, usually at or above the mucogingival junction. The beak is \nplaced low on the tooth root in the gingival sulcus. (B) Once the forcep is in position on the tooth root, the \nPhysics Forceps is used as one unit (no squeezing of the handles). A few degrees of rotation to the facial \nplaces moment force on the tooth, which is held for 30 to 60 seconds. (C) Once the tooth releases from \nthe socket, it is removed with a pincer-like device (e.g., pick-ups, extraction forceps, hemostat). (D) After \nremoval of the tooth root, inspection of the root is completed to verify complete removal."
  },
  {
    "page": 9,
    "content": "899\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nwhich is on the tooth. Therefore the tooth does not split, crush, or \nfracture. The 30-60 seconds of constant force cause biomechani-\ncal creep into the bone and periodontal ligament. Once creep has \nexpanded and weakened the periodontal ligament and bone, the \nforceps handle may be slowly rotated another few degrees. This \nusually releases and elevates the tooth a few millimeters from the \nsocket within an additional 10 seconds. At this point the tooth is \nloose and ready to be removed from the socket using any pincer-\nlike device (e.g., pick-ups, an extraction forceps, a hemostat).\nThe extraction of a tooth using the Physics Forceps is similar \nto the removal of a nail from wood with use of a carpenter’s ham-\nmer (instead of pliers). The handle of the hammer is a lever, and \nthe beaks of the hammer ﬁt under the head of a nail (they do not \nsqueeze the head). The hammer head acts as a fulcrum. A rota-\ntional force applied to the hammer handle magniﬁes the force by \nthe length of the handle, and the nail is elevated from the wood. \nUnlike a nail in wood, which is parallel and has friction for its full \nlength, a tooth is tapered. Therefore after it is elevated a few mil-\nlimeters, the periodontal ligament ﬁbers are broken, and the tooth \nmay be easily removed, without additional rotational force. This is \nimportant to note, because further rotational force on the forceps \nmay fracture the facial plate of bone.\nCreep is a phenomenon whereby a material continues to \nchange shape over time under a constant load. In a tooth extrac-\ntion, creep may occur to bone and the periodontal ligament. \nReilly established the creep curve of bone, whereby under a con-\nstant load of 60 MPa, the bone over time responds in three differ-\nent stages.12 The majority of bone changes occur within the ﬁrst \nminute, whereby the initial strain of bone (the change of length \ndivided by the original length) is modiﬁed. The greater the force, \nthe greater the deformation of the bone. This process allows the \ntooth socket to expand and the tooth to exit the socket. A second-\nary creep curve allows the bone to further deform when the force \nis applied for 1 to 5 minutes. The longer the time, the greater the \ndeformation. However, the secondary deformation is only a 10% \nto 20% difference compared with the initial strain over the ﬁrst \nminute. Eventually the bone will fracture if the load is applied \nover a longer time frame, representing creep rupture.\nThe creep curve of the periodontal complex is similar to the \ncreep curve of the bone, whereby the constant load on a tooth \nover time increases the strain and decreases the strength of the \nperiodontal complex. Therefore the clinician should not underes-\ntimate the values of time and constant force to the tooth ligament \nand bone in the extraction process. \nSocket Debridement After Extraction\nOnce the tooth is extracted, the tooth socket should be thoroughly \ndebrided to remove all remnants of the periodontal ligament and \nany other soft tissue debris (e.g., granulation tissue). In addition, all \nﬁbrous tissue from periodontal disease or endodontic origin should \nbe completely removed, because these tissues impair bone formation \nand delay bone healing for extended periods. Bleeding must ideally \nbe present to allow for bone growth factors to enter the site. If bleed-\ning is inadequate, the cribriform plate should be perforated with \neither a periodontal curette or a small carbide bur (i.e., #2 round \nbur) to promote bleeding and potentiate the healing process. Care \nshould be exercised to not fenestrate the buccal or lingual walls and \nFig. 34.15 or penetrate any vital structures (e.g., teeth, nerves, sinus, \nnasal cavity). A serrated curette (i.e., Lucas 86; Salvin Dental) can be \nused to remove the soft tissue and, secondarily, initiates bleeding. If \nlateral ridge augmentation is required, then bone decortication holes \nshould be made over the recipient site to initiate angiogenesis and the \nregional acceleratory phenomenon (RAP) (Figs. 34.13 and 34.14). \nSocket Grafting of the Extraction Site\nSocket-Grafting Technique. Multiple bone graft procedures \nand studies have been evaluated for socket augmentation at the \ntime of extraction. In most cases clinicians use one technique \nfor socket grafting, without regard to the number of walls of \nbone remaining. Therefore rather than using the same technique \nregardless of clinical conditions, when bone repair rather than \nB\nA\n• Fig. 34.13  Postextraction Debridement.  (A) Serrated curette removing debris and soft tissue from \nwithin the socket. (B) Round carbide bure debriding the socket."
  },
  {
    "page": 10,
    "content": "900\nPART VII    Soft and Hard Tissue Rehabilitation\nregeneration is likely, the clinician should provide as many keys to \nbone grafting as possible to increase the socket.\nWhat Type of Bone?. Misch and Dietsh16 have suggested dif-\nferent graft materials and techniques based on the number of \nbony walls that remained after the tooth is removed. A thick ﬁve \nbony wall defect will grow bone with almost any resorbable graft \nmaterial, for example, an alloplast, allograft, or autograft. When \na wall of bone is less than 1.5 mm or a labial plate is missing \n(four bony wall defect), an autograft or freeze-dried bone (FDB) \nwith barrier membrane (BM) and guided bone regeneration \nincreased the predictability of restoring the original bony contour. \nBecker et al.17 evaluated demineralized freeze-dried bone (DFDB) \nalone in extraction sockets, and no evidence of bone formation \nwas observed. It appears DFDB alone may be a poor choice \nfor socket grafting. LeKovic et al.18 compared extractions alone \nwith BM with extractions. At 6 months, crestal bone loss (0.38 \nversus 1.50 mm) and horizontal ridge resorption (−1.31 versus \n−4.56 mm) were found.18 A two or three bony wall defect usually \nwill require the placement of a regenerative material, and autog-\nenous bone or possibly a block graft of cortical autogenous bone \nﬁxated into the host bone position is suggested for one bony wall \ndefect therefore, debridement should be completd with great care \n(Figs 34.16).\nIn the literature there exists no consensus with respect to the \ntype of bone and the ideal membrane. Most studies completed on \nthe type of bone include either allografts or xenografts. Allografts \ninclude demineralized (DFDBA) or mineralized freeze-dried bone \nallograft (FDBA). Because of the remaining calcium and phosphate \nsalts, FDBA tends to resorb much slower and therefore maintains \nspace much better than DFDBA. Xenografts resorb very slow, as \nsome studies have shown them to last more than 44 months.19 \nWhat Type of Membrane?. The indication for the ideal mem-\nbrane is dictated on the presence of a buccal wall. If all walls of \nthe extraction socket are intact, then a fast-acting collagen is used \n(e.g., CollaTape, CollaPlug). If the buccal plate is missing, the \nmembrane must be placed olver the buccal wall and should con-\nsist of a longer-acting material (e.g., longer-acting collagen or \npolytetrafluoroethylene [PTFE]). The advantage of the absorbable \nmembrane (i.e., collagen) is that no reentry is required. The use \nof a dense PTFE attracts bone cells more readily; however, it is \nnonresorbable and needs to be removed.\nThick Five Bony Wall Socket (>1.5 mm). The bone regenera-\ntion process will restore complete morphology and bone volume \nto the residual ridge. This most often occurs when there are ﬁve \nthick bony walls around the extraction site (i.e., all remaining walls \nintact). Most of the keys for predictable bone formation are pres-\nent under these conditions, and the socket often forms bone in \n• Fig. 34.14  Care should be exercised when debriding sockets in the \nmental foramen area because this may cause neurosensory impairment.\n• Fig. 34.15  The proximity of the maxillary posterior teeth to the maxillary \nsinus may lead to perforation of the sinus and possible infectious episodes.\nA\nC\nB\nD\nFive bony wall socket\nNo Graft or Allograft\nFour bony wall socket\nAutograft or RGM and\nbarrier membrane\nTwo to three bony\nwall socket\nGuided Bone Regeneration\n+ Autogenous Bone\nOne bony wall socket\nOnlay block graft of\nautogenous bone\n• Fig. 34.16  The graft materials and techniques for socket grafting are related \nto the remaining number of bony walls. (A) A thick, five-wall bony socket \nmay remain ungrafted or use of an allograft. A thin wall bony socket used an \nallograft and collagen membrane. (B) Four-wall socket requires an allograft \nand a longer-acting membrane. (C, D) A Three-Two- or One wall socket will \nmost likely require autogenous bone, usually in the form of an onlay block."
  },
  {
    "page": 11,
    "content": "901\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nthe extraction socket without loss of width or height. The atrau-\nmatic extraction of a tooth without pathology provides many of the \nkeys necessary for predictable bone regeneration. The extraction \nprocess sets up the regional acceleratory phenomenon (RAP) for \nhealing (which increases the rate of repair and adds bone morpho-\ngenetic protein to the site); the ﬁve bony walls protect the graft \nfrom mobility; the torn blood vessels in the periodontal complex \nleak growth factors into the region (platelet-derived growth fac-\ntor, transforming growth factor); the space is maintained by the \nﬁve walls of the bone; the bony walls provide blood vessels from \nbone into the site; and the defect size is small (i.e., one tooth). As \na result the only key initially missing is soft tissue closure. The soft \ntissue around the extraction site begins to grow over the clot, and \ngranulation tissue of the socket and within 2 to 3 weeks covers the \nextraction site (Fig. 34.17). There exist three treatment options for \na few thick five bony wall socket;\nTreatment Options (Five-Walled) ->1.5 mm)\n\t1.\t \u0007Immediate Placement Implant.\n\t2.\t \u0007No Treatment (Delayed implant Placement). In most thick \nbony wall sockets, bone will regenerate without bone graft \nmaterial added; however, if the buccal plate is less than 1.5 mm, \na socket graft is indicated to minimize collapse of the socket and \nto ensure adequate bone for future implant placement.\n\t3.\t \u0007Socket Grafting: When the extraction socket is grafted, the selec-\ntion of bone graft material is very important. The graft material \nselected should coincide with the normal regeneration process. \nTherefore a material that resorbs too fast (e.g., autogenous bone, \ndemineralized bone) or a material that resorbs too slow (e.g., corti-\ncal mineralized graft, xenograft) is not ideal for use in a five-walled \ndefect. A much better choice would include a mineralized freeze-\ndried graft (cortico-cancellous 50-50) or a 70% mineralized/30% \ndemineralized graft material that will maintain the space. \nFive-Walled Bone-Grafting Technique. After complete socket de-\nbridement the socket is filled with the bone graft material in small \nincrements. The bone graft material is compressed into the socket \nto avoid air spaces (i.e., should have “pushback”). Once the socket \nis completely filled, a collagen plug is hydrated in saline and then \ncut in half and compressed. The collagen is then inserted over the \nbone graft. Another option is cutting a piece of collagen tape (i.e., \nsmall oval piece) and positioning it over the grafted socket. The \ncollagen is placed over the coronal aspect of the socket and the \nreflected tucked under the minimal flap on the buccal and lingual. \nThe tissue is then closed with a crisscross suture. Ideally the suture \ntechnique should include the use of a high-tensile suture material \n(Fig. 34.18 and Box 34.2) similar to vicryl or PTFE. \nThin Five Bony Wall Socket (< 1.5 mm). For thin five bony \nwall sockets, the lack of socket grafting will result in unpredictable \nhealing results.  Therefore, it is recommended that these types of \nsockets be treated with a conventional socket grafting technique \n(# 3 Treatment Option for Thick Five Bony Wall Socket).\nA\nB\nD\nC\nE\nF\n• Fig. 34.17  Five-Walled Socket (< 1.5 mm).  (A) Atraumatic Extraction. (B) Grafting with allograft.  \n(C) Condensation of the graft. (D) Collagen membrane. (E) Final closure. (F) Six-week healing."
  },
  {
    "page": 12,
    "content": "902\nPART VII    Soft and Hard Tissue Rehabilitation\nFour-Wall Bony Socket. Most often in a four-walled defect, the \nbuccal wall is missing. When a labial plate around a socket is miss-\ning, the absence of the wall prevents space maintenance, reduces \nhost bone vascularization, and replaces it with soft tissue vascular-\nization. The facial bone level will never regenerate above the height \nof bone on the facial cortical plate of the tooth. Bone augmenta-\ntion procedures must be used to obtain an ideal volume and con-\ntour of bone. Sockets with a missing lateral wall are signiﬁcantly \ncompromised and heal by repair rather than regeneration.\nWhen conditions of repair instead of regeneration are present, \nsocket grafting for ridge augmentation at the time of extraction \nis indicated.20 Tooth extraction without grafting in four-walled \ndefects will result in residual bone loss from resorption. For exam-\nple, the maxillary anterior region may be reduced 23% in the ﬁrst \n6 months after an extraction and another 11% over the following \n5 years.21 Within 2 years an average of 40% to 60% of the original \nheight and width of bone may be lost with multiple extractions.22\nThe ﬁrst determination after the tooth extraction is complete is \nthe assessment of the thickness of labial and palatal plates of bone \nand their relative height to the ideal volume desires. A curette or \nexplorer may be used with the index finger over the buccal plate. \nIf the buccal plate is missing, it will be easy to detect by tactile \nsensation. When the buccal plate is missing or when it is less than \n1.5 mm thick, a socket graft is indicated. The two techniques of \nchoice include a bone graft or a modiﬁed socket seal surgery (Figs. \n34.19 and 34.26).\nFour-Walled Bone-Grafting Technique. After complete de-\nbridement, a collagen membrane is contoured into a modified “V-\nShape Cone,” where the narrow part is placed on the inner surface \nof the buccal wall. Placing the membrane on the external aspect of \nthe remaining buccal wall may compromise the blood supply and \nhealing. The wider part of the membrane is trimmed to cover the \nsocket opening and extend slightly to the lingual to “tuck” under \nthe lingual marginal tissue. After the membrane is in place, the \nsocket is filled with the bone graft material in small increments. \nThe material is compressed into the socket to avoid air spaces (i.e., \nshould have “pushback”). The suture technique should include the \nuse of a high-tensile suture material. A crisscross suture is recom-\nmended, which encompasses the membrane and graft material. \nThis will prevent the loss of the membrane and will contain the \ngraft material. In some cases the membrane may be sutured to the \ntissue (Fig. 34.20 and Box 34.3).\nNOTE: The membrane should cover only the missing buccal \nwall; the other walls should not have membrane coverage as this \nwill decrease the healing of the area. The goal of the membrane is \nto prevent the soft tissue from repopulating the defect. If a mem-\nbrane is not used, there is a greater chance of the graft particles \nmigrating, resulting in unpredictable results. \nOne, two, and three bony wall sockets. When multiple walls \nof bone are missing, the greater the need for autogenous bone. \nA particulate graft is unpredictable in these situations. Therefore \na donor site is most often used to obtain the autogenous bone: \nmandible (i.e., ramus, symphysis) or maxilla (i.e., tuberosity). In \nsome cases (i.e. three bony wall sockets) a membrane tent screw \nmay be used for space maintenance (Fig. 34.21) via guided bone \nregeneration protocols (GBR). \nObtaining Autogenous Grafting: Secondary Sites\nMandibular Ramus Donor Site: “Scraping Technique”\nWhen autogenous bone is indicated, there exists many possible \nlocations to harvest. One option which is easy, simple, and mini-\nmal morbidity is to obtain autogenous bone is to expose the man-\ndibular ramus and remove bone from the external oblique ridge \nwith double-action rongeurs. The “scrapings” may be placed in a \nsurgical bowl with sterile saline. A second option to obtain smaller \nautogenous chips is to remove a block graft from the lateral ramus. \nRamus block grafts may be taken; however, the blocks need to \nbe reduced into smaller pieces, which is rather time consuming. \nIn addition, a ramus block graft (i.e., veneer graft of the lateral \nramus) has a greater morbidity rate and far greater postoperative \ncomplications (Fig. 34.22). \nThree Treatment Options:\n\t1. \t \u0007Immediate Implant Placement\n\t2. \t \u0007No Socket Graft (delayed implant placement)\n\t3. \t \u0007Socket Graft\nReflection: conservative\nAllograft: cortico-cancellous mineralized allograft or 70% \nmineralized/30%demineralized allograft\nMembrane: regular collagen (∼collagen plug)\nClosure: primary closure is unachievable\nSuture: crisscross suture (polytetrafluoroethylene or Vicryl)\nImmediate implant: fair to good candidate\nProsthesis: Usually an FP-1 fixed prosthesis\n*Thin Five-Walled Socket is treated with option # 3.\n\t• BOX 34.2\t   \u0007Five-Walled  Socket (> 1.5 mm)\nA\nB\n• Fig. 34.18  Five Wall Socket: (A, B) All five walls remaining."
  },
  {
    "page": 13,
    "content": "903\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nMandibular Ramus Donor Site: “Trephine Bur Bone  \nHarvest”\nA more aggressive technique to obtain autogenous bone cores \nfrom the ramus with trephine burs. Trephine burs are end-cutting \nburs that are available in various diameters with the 6- to 8-mm \ntrephine being the most popular to harvest bone from the ramus. \nFor this technique, the ramus has become a more popular site \nin comparison with the symphysis area because of less morbidity. \nOnce the ramus site (i.e., external oblique) is reflected, the tre-\nphine bur is used to harvest the autograft. Half of the trephine bur \nA\nB\n• Fig. 34.19  Four Wall Socket: (A, B) Buccal wall missing.\nA\nB\nD\nC\n• Fig. 34.20  Four-Walled Socket.  (A) Postextraction. (B) Extended collagen membrane. (C) Membrane \nin place. (D) Postsuturing."
  },
  {
    "page": 14,
    "content": "904\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\n• Fig. 34.22  Mandibular Ramus Scraping Technique.  (A) Ramus exposed. (B) Double-action rongeur. (C) \nAutograft stored in sterile saline.\nis placed over the external oblique bony ridge, whereas the other \nhalf is lateral to the bone and above the reflected masseter muscle, \nwhich is elevated off the anterior lateral aspect of the ramus. Strict \nreflection of the soft tissues is warranted. The trephine bur is used \nwith latch type angled surgical drill at 2000-2500 rpm with copi-\nous saline irrigation, 5 to 8 mm deep, making sure it is above and \nlateral to the position of the inferior alveolar nerve, artery, and \nvein. The inferior alveolar canal position may be identified via a \ncone beam computed tomography (CBCT) examination survey.\nAfter the first trephine osteotomy is completed, the second site \nis completed above the half circle created by the ﬁrst osteotomy \nand overlays the circle in the top third, or 3 mm from the top. \nThis is repeated in the bottom third of the initial half circle, 3 mm \nabove the bottom. Three interlacing semicircles are created along \nA\nB\n• Fig. 34.21  (A) 3 - Wall socket - missing lingual and mesial walls, (B) 1 - Wall socket - missing all walls except the apical wall.\nReflection: conservative\nAllograft: cortico-cancellous mineralized allograft or 70% mineralized/30% \ndemineralized allograft\nMembrane: extended collagen or cytoplast (PTFE), (acellular dermis—thin \nbiotype)\nClosure: primary closure is usually unachievable\nSuture: crisscross Suture (PTFE or Vicryl)\nImmediate implant: poor to fair candidate\nProsthesis: Most likely a FP-2 or FP-3 prosthesis\n*Autogenous bone can be used with allograft bone to accelerate healing and \nincrease predictability.\n\t• BOX 34.3\t   \u0007Four-Walled Bony Socket"
  },
  {
    "page": 15,
    "content": "905\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nthe external oblique of the ascending ramus. A large No. 8 round \ncarbide in a straight handpiece then may score the lateral aspect \nof the ramus, corresponding to the depth of the trephine bur \nsemicircle cuts. A chisel or surgical curette then may greenstick \nfracture the donor bone pieces from the ramus. These harvested \npieces are usually an ideal size to use in the graft site, because they \nare approximately 5 × 3 × 5 mm large. A collagen sponge (e.g., \nOraTape, OraPlug) may be placed in the donor site and the tis-\nsues approximated for primary closure. One disadvantage of the \ntrephine ramus technique is the loss of bone from the multiple \nosteotomies of the burs (Fig. 34.23). \nMaxillary Tuberosity Donor Site\nThe tuberosity offers a variable amount of trabecular bone, which \nis dependent on the amount of maxillary bone atrophy and maxil-\nlary sinus pneumatization. This area is convenient and often the \nfirst choice of autogenous donor sites for maxillary sinus graft-\ning23,24; it also may be considered for smaller areas of ridge aug-\nmentation25,26 (Fig. 34.24). The cancellous nature of the bone \nallows it to be molded into an alveolar defect, such as an extraction \nsocket.17 The trabecular graft will more often require the use of a \nbarrier membrane to minimize resorption and stabilize the graft.27 \nThe tuberosity autograft has growth factors for osteoinduction \nand to accelerate blood vessel growth in the host site.\nThe thicker soft tissue in the tuberosity region can mislead the \nassessment of this donor site. The tuberosity should be evaluated \nwith a CBCT survey to determine the maxillary sinus location and \nthe amount of host bone present. The anatomic limitations of this \narea include the maxillary sinus, pterygoid plates, adjacent teeth \nwhen present, and the greater palatine canal.\n The tuberosity technique includes making a vertical incision a \nposteriorly at the lateral aspect of the maxilla and is extended ante-\nriorly across the tuberosity into the molar region. After reflection \nof a mucoperiosteal flap, bone may be harvested from the tuberos-\nity with a rongeur or chisel. Removing the graft with a chisel will \nallow the harvesting of a larger piece of bone. However, the sinus \nmay inadvertently be entered during removal of the graft, with \nresultant oroantral communication. If this is observed at suture \nremoval, the patient is instructed to avoid creating high nasal \nA\nB\nC\nD\n• Fig. 34.23  Ramus Trephine Harvest - (A) 6 mm Trephine bur in latch handpiece, (B, C) Osteotomy per-\nformed over external oblique ridge, (D) Autogenous bone fragments.\n• Fig. 34.24  The maxillary tuberosity region is a common bone donor site for \nbone grafting when trabecular bone is the desired product. Trabecular bone \nhas growth factors for blood vessels and for regeneration of a bone defect."
  },
  {
    "page": 16,
    "content": "906\nPART VII    Soft and Hard Tissue Rehabilitation\npressures and should be placed on antibiotics to prevent infection \nand ensure normal drainage. Most often, the oroantral opening \nwill close on its own (Fig. 34.25). If the oral-antral opening does \nnot close, surgical closure is usually indicated. \nSocket Seal Surgery\nA composite graft socket seal surgery was developed by Misch \net  al.28,29 composed of connective tissue, periosteum, and \ntrabecular bone used to seal a fresh extraction socket. A con-\nnective tissue graft has the advantage over a keratinized graft \nby blending into the surrounding attached gingival regions, \noffering similar color and texture of the epithelium. This is \nmost advantageous in the maxillary anterior region and other \nesthetic areas. The composite graft also contains autogenous \nbone. The major advantage of autologous bone is a more rapid \nand predictable bone formation via osteogenesis. The main dis-\nadvantage is the tuberosity bone resorbs rather fast, therefore \nunpredictable bone growth in quantity may result.\nFirst, a CBCT evaluation should be completed to determine \nif adequate bone is present in the tuberosity location. A 6- to \n10-mm trephine bur corresponding to the extraction site diam-\neter is used in a slow-speed, high-torque handpiece (e.g., 16:1 or \n20:1) to harvest a gingival graft with underlying bone. The most \ncommon site for the intraoral composite graft harvest is the max-\nillary tuberosity region (see Fig. 34.10). The trephine bur will \ndrill through the unreflected, keratinized, attached gingiva and \ninto the bone of the tuberosity region at the prescribed depth \nrelated to the thickness of the tissue and the amount of donor \nbone available. Care should be exerted not to enter the antrum. \nA trephine bur may be used as a lever to greenstick fracture the \nbone core from its base, once it is in position within the bone. A \nMolt elevator may also be used for this purpose. The bone core \n(usually 5–10 mm in height) and the attached soft tissue (about \n3 mm in height) is trimmed of its epithelium with tissue scissors, \nleaving 3 to 6 mm of connective tissue attached to the bone core. \nIf the bone core does not ﬁll the extraction socket completely, a \nmineralized bone graft material (e.g., cortico-cancellous FDBA) \nmay be used in the apical portion of the socket, provided the \nlabial plate is still intact. Because the new bone forms from the \napical portion of the socket, this is the least important region to \naugment.\nIf no bone plate remains in the apical half of the socket, addi-\ntional autogenous bone should be harvested from an additional \nintraoral site to overﬁll the apical half of the socket. The bone of \nthe composite graft (connective tissue attached to periosteum and \nbone) is compressed and ﬁtted into the remaining portion of the \nsocket.\nThe tissue of the composite graft will seal the socket and remain \nabove the surrounding gingiva. A mallet and blunt instrument \nshould be used to lightly tap it into place and compress the bony \ncore to conform to the crestal contour of the socket. The connec-\ntive tissue portion of the graft is then sutured to the surrounding \ngingival tissue with facial and palatal interrupted 4–0 PTFE or \nVicryl sutures (Fig. 34.26). A removable transitional prosthesis \nshould not be permitted to load the tissue during the ﬁrst 6-8 \nweeks after extraction; otherwise the composite graft may become \nmobile and sequestrate.\nThe beneﬁts of the composite graft socket seal surgery tech-\nnique permit the surrounding keratinized gingival tissues to \nmigrate and form a similar color and texture of keratinized tis-\nsue over the socket. The blood supply to the composite graft is \nestablished from the surrounding soft tissue. In addition, because \nautogenous bone is used as the graft in the coronal half of the \nsocket, where the facial bone is most often very thin or absent, \nmore predictable results will occur than if an allograft were used. \nThe transfer of the bone graft with an intact periosteal layer expe-\ndites revascularization and may decrease the healing time.30,31 As a \nresult, reentry may be in 4 to 5 months, and placement of an ideal \nimplant diameter is often made possible.\nUse of Bone Growth Factors in Extraction Site\nBlood Concentrates\nAn option for faster healing and possibly better bone regenera-\ntion is the use of blood concentrates alone or in combination \nwith bone graft material. Many authors have discussed the use of \nblood concentrates in the post-extraction site. Choukroun et al. \ndescribed the use of his second generation platelet concentrate \nplatelet rich fribrin (PRF) with socket grafting.32 PRF is a natu-\nral fibrin biomaterial that allows for greater microvascularization \nand cell migration into the wound.  Growth factors have been \nshown to be  released up to 28 days after placement in extrac-\ntion sites.33 Histologically, the fibrin clot stimulates the extrac-\ntion socket environment for more ideal bone regeneration and \nremodeling.34,35 Rao et al. reported better bone regeneration \nand increased bone density in extraction sites with PRF alone \ncompared to a control group.36 However, the authors advocate \nif PRF is to be used, it is combined with bone graft material, \nwhich has been shown in the literature to facilitate more ideal \nand faster bone regeneration.37\nBone Morphogenic Protein\nThe use of bone morphogenic protein (BMP) has been investi-\ngated with the treatment of post-extraction sockets. BMP’s are \nmembers of a family of proteins that are highly osseoinductive \nand stimulate mesenchymal cells to enhance bone growth.  Fiorel-\nlini et al.38 conducted controlled studies with the use of rhBMP-2 \n(bone morphogenic protein) with acellular collagen sponge in \nextraction sites. They concluded the use of BMP induced signifi-\ncant bone formation for the future placement of dental implants. \nHistologically, the bone was similar to native bone and was load \nbearing.  Rh-BMP is  commercially availability as an osteoinduc-\ntive alloplastic bone graft material (Infuse Bone Graft, Medtronic \nSpinal and Biologics, Memphis, TN, USA).\n• Fig. 34.25  Tuberosity Harvest with Double Action Rongeurs."
  },
  {
    "page": 17,
    "content": "907\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nProvisional Restorations\nIn most cases of socket-grafting site preservation, the patient \nwill require a provisional restoration to maintain esthetics \nand function, and to protect the surgery site. For an interim \nremovable prosthesis the implant clinician should ensure the \nprosthesis is tooth supported (i.e., has vertical stops on the \nadjacent teeth to prevent the partial denture tooth from exert-\ning pressure directly on the tissues around the extractions site), \nand the surface area over the surgical site should be hygienic \nin contour. If a fixed prosthesis is used (e.g., resin bonded \nbridge), the undersurface should not impinge on the tissue \n(Fig. 34.27). \nA\nB\nC\nD\nE\nF\n• Fig. 34.26  (A) The left maxillary central incisor has an absence of facial cortical plate (a four bony wall \ndefect). (B) A trephine bur diameter is selected that corresponds to the size of the extraction site (Bioho-\nrizons, Birmingham, Ala.). (C) The trephine bur performs an osteotomy directly through the keratinized \nattached gingiva and into the tuberosity, and proceeds to the floor of the antrum. (D) The keratinized tis-\nsue, mucosa, periosteum, and bone of the composite graft are removed from the trephine bur. The tissue \nthickness is reduced to 2 to 3 mm above the bone. The surface of the tissue is connective tissue. (E) The \ncomposite graft is inserted into the extraction socket, and a blunt instrument (e.g., mirror handle) and \nmallet taps the composite graft into the socket so that the connective tissue is level with the surrounding \ntissues. (F) Sutures are positioned to maintain the composite graft in place."
  },
  {
    "page": 18,
    "content": "908\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\n• Fig. 34.27  Provisional Restoration.  (A) Postextraction. (B) Overlay temporary bridge (i.e., Snap-On \nSmile). (C) Interim prosthesis inserted placing no pressure on extraction site.\nSocket Graft Healing\nThere exist many variables when determining when a socket graft \nsite is healed for implant placement. Care should be exercised to \nplace the implant only after adequate hard and soft tissue healing \nis obtained. Healing of the hard and soft tissues is determined by \nthe size of the defect, type of graft material, type of bone graft, use \nof a membrane, and blood supply to the area. Usually a healing \ntime ranging from 4 - 8 months is required. Radiographically, usu-\nally when the cribriform plate is not seen on the x-ray, adequate \nhealing is achieved (Fig. 34.28). \nSocket Grafting Contraindications\nInfected Site\nA relative contraindication to the socket-grafting protocol is the \npresence of an acute infection. A tooth demonstrating active infec-\ntion (i.e., exudate or fistula) should be extracted without place-\nment of bone graft material. The patient’s acute infection should \nbe managed by drainage of the infection, lavage of the infected \narea, and the use of systemic antibiotics. The bone grafting may be \ndelayed for a minimum of 8 weeks postextraction to decrease the \npossibility of a graft infection. In addition, this delay will ensure \nbetter tissue quality (i.e., primary closure of the grafted site with \nkeratinized tissue), elevated osteoblast activity, and a newly formed \nwoven bone within the socket. The disadvantage of this surgical \napproach is the need for an additional surgery and a extended total \ntreatment time (Fig. 34.29). \nProximity to Vital Structure (Mental Foramen, \nMandibular Canal)\nIn the mandibular premolar area, 25% to 38% of the time the \nmental foramen is superior to the apex of either of the premolars. \nThe location of the mental foramen is highly variable; however, \nit is most commonly located in the first or second premolar area. \nIf a premolar is extracted, CBCT measurements need to confirm \nadequate bone below the apex. The clinician must be careful in \ndebriding this area because nerve impairment may occur.\n• Fig. 34.28  Healed graft site exhibiting lack of cribriform plate present."
  },
  {
    "page": 19,
    "content": "909\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nIn the mandibular molar area, especially in type 1 nerve loca-\ntions (i.e., mandibular canal close to mandibular teeth apexes), \nafter extraction it is important not to curette or place graft mate-\nrial in close proximity to the nerve canal (Fig. 34.30). In many \ncases, no superior cortical bone is present over the mandibluar \ncanal. \nMaxillary Sinus\nIn the maxillary first molar area, approximately 42% of the max-\nillary roots are located in the sinus proper.39 When the tooth is \nextracted the sinus membrane may be perforated, and an exposure \nmay occur. If grafting is completed, bone graft material may be \nintroduced into the sinus proper, leading to the possibility of acute \nrhinosinusitis or oral-antral fistula formation (Fig. 34.31). \nSocket Graft Complications\nInadequate Fill\nCare should be exercised in filling the entire socket from the apex to \nthe ridge with no voids. This is most often to occur in multirooted \nteeth, especially when root diameter is small. Small increments of graft \nmaterial should be introduced into the socket at a time to avoid inad-\nequate fills. Complications occur when too large of a syringe or too \nmuch volume of material is introduced into the socket and it becomes \ndifficult to condense properly. Amalgam carriers with small amalgam \npluggers can be used to graft smaller sized sockets (Fig. 34.32). \nToo Dense of Socket Fill\nAvoid excessive pressure when condensing the graft material into \nthe socket. Too dense of a particulate graft fill may compromise \nthe vascularity within the socket and final healing (Fig. 34.33). \nUsually when “push-back” of the material occurs, the socket is \ngrafted sufficiently. \nOverfilling the Extraction Socket\nExcess graft material in height placed in the socket may compromise \nthe soft tissue healing over the extraction socket. The graft material \nshould be placed into the socket to the level of the surrounding \nsocket walls. When excess bone is placed into an extraction site, it \nwill usually be slowly lost postoperatively (Fig. 34.34). In addition, \nsoft tissue healing over the extraction site will be delayed. \nLeaving Soft Tissue or Root Fragment\nAfter extraction the tooth and root structure should always be \nevaluated to verify no tissue or root tip is inadvertently left in \nthe socket. Grafting over soft tissue or a root tip will increase the \npossibility of infection, decrease the amount of bone formation, \nand delay the healing process (Fig. 34.35). \nUse of Incorrect Bone Graft Material\nCertain bone substitutes are not ideal for socket grafting. \nSome of these materials include nonresorbable hydroxyapa-\ntite, calcified copolymer alloplast (Bioplant HTR; Bioplant \n• Fig. 34.29  Tooth With Apical Infection.  Care should be exercised in \ngrafting into an infected socket.\nB\nA\n• Fig. 34.30  Neurosensory Impairment (A and B) Socket graft material in close approximation to the man-\ndibular canal. Care should be exercised in type 1 nerve paths."
  },
  {
    "page": 20,
    "content": "A\nB\n• Fig. 34.32  (A and B) Inadequate socket fill (arrows). Graft material should be placed into the extraction \nsockets in small increments so that voids and inadequate fill do not occur.\nA\nB\n• Fig. 34.33  (A) Fill should be completed in small increments to allow for an ideal fill. (B) Adequate density \nis achieved when “pushback” occurs when packing the graft material.\n• Fig. 34.31  Maxillary Sinus Approximation.  Approximately 42% of \nmolar roots are into the sinus floor, leading to possible perforation and \nextrusion of graft material into the sinus. Note the lingual root perforation \ninto the maxillary sinus."
  },
  {
    "page": 21,
    "content": "911\nCHAPTER 34  Atraumatic Tooth Extraction and Socket Grafting\nInc.), and “bioactive” glasses. Most of the alloplasts either \ndo not resorb or resorb slowly with a fibrous encapsulation, \nthereby making them nonideal for subsequent implant place-\nment (Box 34.4). Ideally, the bone graft material should resorb \nat the same rate that bone formation occurs (i.e. mineralized \ncortico-cancellous allograft or 70% mineralized/30% demin-\neralized allograft).\nConclusion\nThe extraction of a natural tooth is one of the most widely per-\nformed procedures completed in dentistry today.  After tooth \nextraction, it is well documented in the literature significant \nmorphologic and dimensional changes occur to the extraction \nsocket. When hard and soft tissue is lost, an increased difficulty \nin implant placement results, which compromises the final pros-\nthetic outcome.  Therefore, it is imperative that extraction sites are \ntreatment predictably to maintain the hard and soft tissue volume. \nMany clinicians treat all sockets the same, with a set treatment \nprotocol to provide for placement of a future implant.  However, \nthe morphology, most specifically the number of remaining bony \nwalls, play a significant role in the amount of resorption after \nextraction.  Therefore, an extraction socket treatment protocol has \nbeen established which is dictated on the number of remaining \nwalls. Each classification involves a different treatment protocol \nwith the goal of maintaining the available bone and regenerating \nbone within the socket area so that ideal implant placement may \nbe completed at a later date. In addition, the clinician must have \na strong understanding of the indications and contraindications \nof socket grafting along with the ideal treatment of associated \ncomplications.\nReferences\n\t 1.\t \u0007Irinakis, T., & Tabesh, M. (2007). Preserving the socket dimensions \nwith bone grafting in single sites: an esthetic surgical approach when \nplanning delayed implant placement. J Oral Implantol. 33(3), 156-\n163.\n\t 2.\t \u0007Ohta Y. Comparative changes in microvasculature and bone during \nhealing of implant and extraction sites. J Oral Implant. 1993;3:184– \n198.\n\t 3.\t \u0007Lin WL, McCulloch CA, Cho MI. Differentiation of periodon-\ntal ligament fibroblasts into osteoblasts during socket healing after \ntooth extraction in the rat. Anat Rec. 1994;240:492–506.\n• Fig. 34.34  Overfilling the Extraction Socket.  Bone should not be grafted above the cortical plate levels. This will result in poor wound healing migration \nof the graft material and incision line opening.\n• Fig. 34.35  Retained Root Tip.  After the extraction, radiographic evi-\ndence should verify no retained roots in the socket.\n\t1. \t \u0007Immediate implant placement (Usually for 5-walled sockets)\n\t2. \t \u0007No Socket Graft - Delayed Implant Placement\n\t\na.\t \u0007Five-walled socket (> 1.5 mm of buccal plate)\n\t\nb.\t Infected site\n\t3. \t Socket graft—five-walled socket (< 1.5 mm of buccal plate)\n\t\n•\t Allograft + CollaTape/CollaPlug\n\t4. \t Socket graft—four-walled socket\n\t\n•\t \u0007Allograft + extended collagen/dense polytetrafluoroethylene membrane\n\t5. \t \u0007Socket graft—one-, two-, three-walled socket\n\t •\t Autograft + allograft\n\t• BOX 34.4\t   \u0007Summary of Post-Extraction Options"
  },
  {
    "page": 22,
    "content": "912\nPART VII    Soft and Hard Tissue Rehabilitation\n\t 4.\t \u0007Araujo MG, Berglundh T, Lindhe J. On the dynamics of periodon-\ntal tissue formation in degree III furcation defects. An experimental \nstudy in dogs. J Clin Periodontol. 1997;24:738–746.\n\t 5.\t \u0007Cardaropoli G, Araujo M, Lindhe J. Dynamics of bone tissue forma-\ntion in tooth extraction sites. An experimental study in dogs. J Clin \nPeriodontol. 2003;30:809–818.\n\t 6.\t \u0007Evian CI, Rosenberg ES, Coslet JG, Corn H. The osteogenic activ-\nity of bone removed from healing extraction sockets in humans. J \nPeriodontol. 1982;53:81–85.\n\t 7.\t \u0007Schropp L, Wenzel A, Kostopoulos L, Karring T. Bone healing and \nsoft tissue contour changes following single-tooth extraction: a clini-\ncal and radiographic 12-month prospective study. Int J Periodontics \nRestorative Dent. 2003;23:313–323.\n\t 8.\t \u0007Cardaropoli G, Araújo M, Lindhe J. Dynamics of bone tissue forma-\ntion in tooth extraction sites: an experimental study in dogs. J Clin \nPeriodontol. 2003;30(9):809–818.\n\t 9.\t \u0007Ohta Y. Comparative changes in microvasculature and bone during \nhealing of implant and extraction sites. J Oral Implant. 1993;3:184–\n198.\n\t10.\t \u0007Araujo MG, Lindhe J. Dimensional ridge alterations following tooth \nextraction. An experimental study in the dog. J Clin Periodontol. \n2005;32(2):212–218.\n\t11.\t \u0007Botticelli D, Berglundh T, Lindhe J. Hard-tissue alterations follow-\ning immediate implant placement in extraction sites. J Clin Peri-\nodontol. 2004;31(10):820–828.\n\t12.\t \u0007Roberts WE, Turley PK, Brezniak N, et al. Bone physiology and \nmetabolism. Calif Dent Assoc J. 1987;15:54–61.\n\t13.\t \u0007Reilly,  DT, Burstein AH. The elastic and ultimate properties of \ncompact bone tissue.  J Biomech. 1975;8(6):393–405.\n\t14.\t \u0007Fauchard P. Le Chirurgien Dentiste, Oú Traité Des Dents. Paris: PJ \nMariette; 1728.\n\t15.\t \u0007Chauliac G. De La Grande Chirurgie. Rouen, France: David du Petit \nval; 1649.\n\t16.\t \u0007Glenner RA, Davis AB, Burns SB. The American Dentist. Missoula. \nMont: Pictorial Histories; 1990.\n\t17.\t \u0007Misch CE, Dietsh F. Bone grafting materials. Implant Dent. \n1993;2:158–167.\n\t18.\t \u0007Becker W, Becker BE, Caffesse R. A comparison of demineralized \nfreeze-dried bone and autologous bone to induce bone formation in \nhuman extraction sockets. J Periodontol. 1994;65:1128–1133.\n\t19.\t \u0007LeKovic V, Keeney EB, Weinlaender M, et al. A bone regeneration \napproach to alveolar ridge maintenance following tooth extraction: \nreport of 10 cases. J Periodontol. 1997;68:563–570.\n\t20.\t \u0007Skoglund A, Hising P, Young C. A clinical and histologic examina-\ntion in humans of the osseous response to implanted natural bone \nmineral. Int J Oral Maxillofac Implants. 1997;12(2):194–199.\n\t21.\t \u0007Misch CE, Dietsh F. Bone grafting materials. Implant Dent. \n1993;2:158–167.\n\t22.\t \u0007Artzi Z, Tal H, Dayan D. Porous bovine bone mineral in healing of \nhuman extraction sockets, part I: histo-morphometric evaluations at \n9 months. J Periodont. 2000;71:1015–1023.\n\t23.\t \u0007McCall RA, Rosenfeld AL. Influence of residual ridge resorption \npatterns on implant ﬁxture placement and tooth position. Int J Peri-\nodontics Restorative Dent. 1991;11:8023.\n\t24.\t \u0007Tatum H. Maxillary and sinus implant reconstruction. Dent Clin \nNorth Am. 1986;30:207–229.\n\t25.\t \u0007Misch CE. Divisions of available bone. In: Misch CE, ed. Contempo-\nrary Implant Dentistry. 2nd ed. St Louis: Mosby; 1993.\n\t26.\t \u0007Misch CM. Comparison of intraoral donor sites for onlay graft-\ning prior to implant placement. Int J Oral Maxillofac Implants. \n1997;12:767–776.\n\t27.\t \u0007ten Bruggenkate CM, Kraaijenhagen HA, van der Kwast WAM, \net al. Autogenous maxillary bone grafts in conjunction with place-\nment of I.T.I. endosseous implants: a preliminary report. Int J Oral \nMaxillofac Surg. 1992;21:81–84.\n\t28.\t \u0007Buser D, Dula K, Belser UC, et al. Localized ridge augmentation \nusing guided bone regeneration. II. Surgical procedure in the man-\ndible. Int J Periodontics Restorative Dent. 1995;15:11–29.\n\t29.\t \u0007Misch CE, Dietsh F, Misch CM. A modiﬁed socket seal surgery: a \ncomposite graft approach. J Oral Implantol. 1999;25:244–250.\n\t30.\t \u0007Tischler M, Misch CE. Extraction site bone grafting in gen-\neral dentistry: review of application and principles. Dent Today. \n2004;23:108–113.\n\t31.\t \u0007Knize D. The influence of periosteum and calcitonin on on-lay bone \ngraft survival. Plast Reconstr Surg. 1974;53:190–199.\n\t32.\t \u0007Zucman P, Mauer P, Berbesson C. The effects of autographs of bone \nand periosteum in recent diaphyseal fractures. J Bone Joint Surg. \n1968;50B:409.\n\t33.\t \u0007Choukroun J, Diss A, Simonpieri A, et al. Plateletrich fibrin (PRF): \na second-generation platelet concentrate. Part IV: clinical effects on \ntissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. \n2006;101:E56–E60.\n\t34.\t \u0007He L, Lin Y, Hu X, Zhang Y, Wu H, et al. A comparative study \nof platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the \neffect of proliferation and differentiation of rat osteoblasts in vitro. \nOral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:707–\n713.\n\t35.\t \u0007Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a \nsecond-generation platelet concentrate. Part II: platelet-related bio-\nlogic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. \n2006;101:E45–E50.\n\t36.\t \u0007Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): \na second-generation platelet concentrate. Part III: leucocyte activa-\ntion: a new feature for platelet concentrates?.\n\t37.\t \u0007Girish Rao S, Bhat P, Nagesh KS, et al. Bone regeneration in extrac-\ntion sockets with autologous platelet rich fibrin gel.  J Maxillofac \nOral Surg. 2013;12(1):11–16.\n\t38.\t \u0007Marx R, Carlson ER, Eichstaedt RM, et  al. Platelet rich plasma \ngrowth factors enhancement for bonegrafts. Oral Surg Oral Med \nOral Pathol Oral Radiol Endod. 1998;85:638–646. doi: 10.10.\n\t39.\t \u0007Fiorellini JP, Howell TH, Cochran D, et al. Randomized study \nevaluating recombinant human bone morphogenetic protein-2 for \nextraction socket augmentation. J Periodontol. 2005;76(4):605–13.\n\t40.\t \u0007Kang SH, Kim BS, Kim Y. Proximity of posterior teeth to the maxil-\nlary sinus and buccal bone thickness: a biometric assessment using \ncone-beam computed tomography.  J Endod. 2015;41(11):1839–\n1846."
  },
  {
    "page": 23,
    "content": "913\n35\nBone Substitutes and \nMembranes\nRALPH POWERS\nS\nince acknowledging titanium as an inert substance capable of \nbinding to bone in humans, implant dentistry has flourished.1,2 \nDr. Per-Ingvar Brånemark is known as the “father of the mod-\nern dental implant” for taking a serendipitous finding in orthopedic \nresearch and applying it to dentistry.3 It took decades for him to \nconvince the medical and dental communities that titanium could \nbe integrated into living tissues, a process he called osseointegration. \nNow dental implants are considered a standard of care and enjoy a \nvery high success rate. Having a reliable implant system is only part \nof the equation. It is well understood that both bone volume and \nbone quality are essential for implant placement and survival.4\nMost dental implants require some type of bone augmentation. \nFor many years autograft (considered the gold standard) was the \nonly material available as a bone void filler, and it still has a place in \nmany applications.5 However, dramatic discoveries in biomaterials \nand improvements in processing, preservation, and packaging have \nmade bone graft substitutes (BGS) available that are safe, effective, \naccessible in sufficient quantities, and suitable for almost all clinical \nsituations. In fact, the global BGS and dental membrane market is \nexpected to grow at a compound annual growth rate of 9.9% per year \nthrough 2025.6 Much of this increase is driven by the large expected \nincrease in dental implant and prosthetics work. The key factors driv-\ning the growth of this market include the growing geriatric popula-\ntion and corresponding dental disorders, rising incidence of tooth \ndecay and edentulism, and the ability for more dental practitioners \nto place implants and provide more complete treatment solutions.\nIt is up to the clinician to create an osseo-adaptive situation \nwhen grafting, that is, having a host site prepared and a patient \nsufficient in health to allow for natural and predictable healing \nafter any type of augmentation procedure. The wise clinician will \nbe familiar with many types of BGS, as well as membranes, and \ntheir properties. The clinician should develop a decision tree for \nevery clinical scenario based on a combination of empirical and \nscientific support. It is hoped the following information will pro-\nvide a basis for understanding the many bone graft and membrane \nmaterials currently available.\nTerminology for Bone Repair and \nRegeneration\nBone remodeling is the ongoing process by which bone is resorbed \nand replaced in a dynamic steady-state process that maintains \nthe health of bone. The process affects the entire skeleton all of \nthe time. Although bone may appear superficially as a static tis-\nsue, it is actually very dynamic, undergoing constant remodeling \nthroughout the life of the vertebrate organism. Bone remodeling \nis triggered by a need for calcium in the extracellular fluid, but it \nalso occurs in response to mechanical stresses (microfracture) on \nthe bone tissue.\nFor the remodeling to occur, appropriate cell signaling occurs \nto trigger osteoclasts to resorb the surface of the bone, followed by \ndeposition of bone by osteoblasts. Together the cells in any given \nparticular region of the bone surface that are responsible for bone \nremodeling are known as the basic multicellular unit (BMU). The \naction of osteoclasts and osteoblasts is synchronized: cells that \nresorb and deposit bone, respectively.\nTo understand bone remodeling, you need to know about three \ncell types found in bone:\n • \u0007Osteoclasts are bone-resorbing cells (-clast means “to break”; \nosteoclasts break down bone). They are large, multinucleate \ncells that form through the fusion of precursor cells. Unlike \nosteoblasts, which are related to fibroblasts and other connec-\ntive tissue cells, osteoclasts are descended from stem cells in the \nbone marrow that also give rise to monocytes (macrophages). \nOne essential feature is the ingrowth of vascular tissue (neovas-\ncularization); this is an essential feature of remodeling in that \nthe new vessels will carry cells and nutrients.\n • \u0007Osteoblasts are bone-forming cells. They are connective tissue \ncells found at the surface of bone. They can be stimulated to \nproliferate and differentiate as osteocytes. They are recruited to \nthe area and form the lining of the newly created tunnel.\n • \u0007Osteocytes are mature bone cells. Osteocytes manufacture type \nI collagen and other substances that make up the bone extra-\ncellular matrix. Osteocytes will be found enclosed in bone7 \n(Fig. 35.1).\nFig. 35.2 includes multiple cells and shows the phases of bone \nremodeling. The group of cells creating the tunnel through the \nbone is the BMU (forming the “cutting cone”). Osteoclasts are \nfollowed by preosteoblasts that adhere to the new wall of the area \nresorbed. As they mature to osteoblasts, they begin to secrete oste-\noid (immature bone matrix) in which they eventually are trapped \nand where they live out the remainder of their existence as osteo-\ncytes. This marks the start of reversal of the resorptive phase. The \nfinal product is the formation of Haversian canals (Fig. 35.3), or \n“osteons,” familiar to all as a normal observation in bone histology."
  },
  {
    "page": 24,
    "content": "914\nPART VII     Soft and Hard Tissue Rehabilitation\nIn infants, bone “turnover” is rapid and may result in a 100% \nnew skeleton within 1 year; in adults, it is approximately 10%.8 \nStatistics of adult bone remodeling are as follows:\n • \u0007Life span of BMU is ∼6 to 9 months.\n • \u0007Speed of BMU is ∼ 25 μm/day.\n • \u0007Bone volume replaced by a single BMU is ∼0.025 mm3.\n • \u0007Life span of osteoclasts is ∼2 weeks.\n • \u0007Life span of osteoblasts is ∼3 weeks.\n • \u0007Interval between successive remodeling events at the same loca-\ntion is ∼2 to 5 years.\n • \u0007Rate of turnover of whole skeleton is ∼10% per year.\nThe 10% per year approximation for the entire skeleton is \nbased on an average 4% turnover per year in cortical bone, which \nrepresents roughly 75% of the entire skeleton, and an average \n28% per year in trabecular (cancellous) bone, which represents \nroughly 25% of the skeleton. As you can see, remodeling occurs \nslowly and continuously.\nBone modeling adapts structure to loading and removes dam-\nage as to maintain bone strength. It involves independent sites of \nresorption and formation that change the size and shape of bones. \nThe stimulus is additional localized stress (as in orthodontic tooth \nmovement and weight training). This is described by Wolff’s law, \nwhich proposes that bone in a healthy person or animal will adapt \nto the loads under which it is placed.9 Modeling occurs at the cel-\nlular level in a fashion similar to that described for remodeling.\nBone repair is a proliferative physiologic process in which the \nbody facilitates the repair of a bone fracture. Repair occurs in \nresponse to trauma (fracture or overuse) and is the result of a com-\nplicated cascade of events.\nBone regeneration is the regrowth of lost tissue. This requires \nthe use of surgical protocols that enable regeneration of the defi-\ncient sites, using the principles of osteogenesis, osteoinduction, \nand osteoconduction (see more detailed definitions later in this \nchapter).\n • \u0007Guided bone regeneration (GBR) refers to alveolar ridge aug-\nmentation or bone redevelopment (for implant placement or \nto preserve the site for fixed or removable bridgework); this \noften requires the presence of a membrane to protect the \ngrafted area and restrict the entrance of unwanted cells. When \na graft is placed into a site (in, for example, a fresh extraction \nsocket), a competition occurs between soft tissue and bone-\nforming cells to fill the surgical site. Soft tissue cells (epithe-\nlial cells and fibroblasts) migrate at a very fast rate compared \nwith bone-formers. A properly chosen and placed membrane \nPreosteoblasts\nOsteoblasts\nLining cells\nOsteocytes\nMonocyte\nOsteoid\nNew bone\nNew bone\nBlood\nvessel\nCapillary\nOsteoclast\nMSC\nMSC\n• Fig. 35.1  The Basics of Bone Remodeling.  Involved are osteoclasts \n(removing old or impaired bone), preosteoblast and osteoblasts (forming \nnew immature bone), and osteocytes trapped within the new bone matrix. \nNone of this can occur without new vasculature to bring in essential cells \nand fluids. Mesenchymal stme cells (MSC) are the precursors to the bone \nforming “blast” cells.\nTime\nCutting\ncone\nClosing\ncone\nReversal\nzone\nDeveloping\nresorption\ncavity\nOsteoclast\nFibroblast\nOsteoblast\nQuiescent\nosteoblast\nBlood\nvessel\nResorption\ncavity\nForming\nosteon\nCompleted\nosteon\n• Fig. 35.2  This is a more advanced look at the basic multicellular unit forming \nthe “cutting cone.” ( Adapted from: Roberts WE Garetto LP, Arbuckle GR et al: \nWhat are the risk factors of osteoporosis? Assessing bone health, J Am Dent \nAssoc 122:59-61, 1991. Source: https://basicmedicalkey.com/functional- \nanatomy-of-the-musculoskeletal-system/)\n• Fig. 35.3  Osteons, or Haversian canals. Evidence that bone remodeling \noccurred in the area."
  },
  {
    "page": 25,
    "content": "915\nCHAPTER 35  Bone Substitutes and Membranes\nwill reduce the competition. Below the membrane, regenera-\ntion occurs. It involves the proliferation of new blood vessels \n(angiogenesis) and the migration of bone-forming cells (osteo-\ngenesis). An initial blood clot will form, which is replaced by \nfibrous bone. This material (called woven bone) is characterized \nby a haphazard organization of collagen and is mechanically \nweak. Later this will be transformed into a better organized, \nload-bearing “lamellar bone” (via normal bone remodeling).10\n • \u0007Guided tissue regeneration (GTR) involves the same techniques \nused in GBR, but for redeveloping (regenerating) lost peri-\nodontal tissues (cementum, periodontal ligament, alveolar \nbone) to retain the natural dentition. Early research in this area \nwas instrumental in the development of the modern mem-\nbrane.11\nThe concept of GBR was described first in 1959 when cell-\nocclusive membranes were employed for spinal fusions.12 The \nterms guided bone regeneration (GBR) and guided tissue regeneration \n(GTR) often are used synonymously and rather inappropriately. \nGTR deals with the regeneration of the supporting periodontal \napparatus, including cementum, periodontal ligament, and alveo-\nlar bone, whereas GBR refers to the promotion of bone formation \nalone. GBR and GTR are based on the same principles that use \nbarrier membranes for space maintenance over a defect, promot-\ning the ingrowth of osteogenic cells and preventing migration of \nundesired cells from the overlying soft tissues into the wound. \nProtection of a blood clot in the defect and exclusion of gingival \nconnective tissue and provision of a secluded space into which \nosteogenic cell from the bone can migrate are essential for a suc-\ncessful outcome. The sequence of bone healing is affected not only \nby invasion of nonosteogenic tissue but more so by the defect size \nand morphology.\nBone preservation indicates long-term stability of the alveolar \nridge. This is a general term for all of the previous terms in this \nsection. \nMechanisms of Bone Repair and \nRegeneration\nFrom the time of Hippocrates it has been known that bone has \nconsiderable potential for regeneration and repair. Nicholas \nSenn,13 a surgeon at Rush Medical College in Chicago, described \nthe utility of antiseptic decalcified bone implants in the treatment \nof osteomyelitis and certain bone deformities. Pierre Lacroix14 \nproposed that there might be a hypothetical substance, osteo-\ngenin, that might initiate bone growth.\nMarshall R. Urist provided the biological basis of bone mor-\nphogenesis. Urist15 made the key discovery that demineralized, \nlyophilized segments of bone induced new bone formation when \nimplanted in muscle pouches in rabbits. This discovery was pub-\nlished in 1965 in Science.15 The term bone morphogenetic protein \n(BMP) first appeared in the scientific literature via the Journal of \nDental Research in 1971.16 Bone morphogenetic (or morphoge-\nneic) proteins are now referred to as BMPs for convenience.\nBone induction is a sequential multistep cascade. The key steps \nin this cascade are chemotaxis, mitosis, and differentiation. Chemo-\ntaxis is movement of a motile cell in a direction corresponding to \na gradient of increasing or decreasing concentration of a particu-\nlar substance (such as a BMP). Mitosis is a type of cell division \nthat results in two daughter cells each having the same number \nand kind of chromosomes as the parent nucleus. This is typical of \nordinary tissue growth. Differentiation is the process by which a \ncell becomes specialized to perform a specific function, as in the \ncase of a bone cell, a blood cell, or a neuron. There are more than \n250 general types of cells in the human body. For bone induction, \nBMPs (uncovered by normal bone remodeling or exposed in the \nmatrix of a properly demineralized graft) signal for chemotaxis of \nbone-forming cells to the bone void. The cells divide to increase \ntheir number and mature to a more specialized form to produce \nnew immature bone material (osteoid). Over time this area is \nremodeled to provide a better structure.\nEarly studies by Hari Reddi unraveled the sequence of events \ninvolved in bone matrix–induced bone morphogenesis. On the \nbasis of this work, it seemed likely that “morphogens” were present \nin the bone matrix. A systematic study, using a battery of bioassays \nfor bone formation, was undertaken to isolate and purify putative \nbone morphogenetic proteins.17 It is well recognized that BMPs \ncan be found in properly prepared demineralized bone products \nin the correct proportion to induce the sequential steps needed for \nbone regeneration. To date, 20 BMPs have been identified.18 Now \nlaboratory-produced recombinant human BMPs (rhBMPs) are \nused in orthopedic applications (rhBMP-2 and rhBMP-7), such \nas spinal fusions and nonunions. rhBMP-2 is U.S. Food and Drug \nAdministration (FDA) approved for some dental use.\nIn general, osteoinduction is the process by which osteogen-\nesis is induced. It is a phenomenon regularly seen in any type of \nbone healing process. Osteoinduction implies the recruitment of \nimmature cells and the stimulation of these cells to develop into \npreosteoblasts. In a bone healing situation such as a fracture the \nmajority of bone healing is dependent on osteoinduction. Osteo-\nconduction means that bone grows on a surface.\nCurrently osteogenesis can occur only with autografts. Examples \nare the use of the rib, grafts from the chin, ascending ramus, ilium, \ntibia, or outer table of the cranium, or from bone collected during \nextraction or other dental procedure. Osteogenesis occurs when \nvital osteoblasts originating from the bone graft material contrib-\nute to new bone growth along with bone growth generated via \nosteoinduction and osteoconduction.19\nOsteoinduction has a rich research history and has been well \nstudied. Osteoinductive materials will recruit the proper bone cells \nto a site, and these cells will form bone. Osteoinduction can pro-\nduce bone where bone is not normally found (ectopic or hetero-\ntropic sites). In fact, the early tests for a material’s osteoinductive \n“potential” were placement of that material into the muscle pouch \nof an animal. An example of a test animal is the “nude” mouse. \nA nude mouse is a laboratory mouse from a strain with a genetic \nmutation that causes a deteriorated or absent thymus, resulting in \nan inhibited immune system because of a greatly reduced num-\nber of T cells. The phenotype (main outward appearance) of the \nmouse is a lack of body hair, which gives it the “nude” nickname. \nThe nude mouse is valuable to research because it can receive \nmany different types of tissue grafts, as it mounts no rejection \nresponse. Therefore if new bone forms in the muscle pouch of a \nnude mouse, it provides evidence of the potential for osteoinduc-\ntivity. Now in vitro tests have been developed to assess potential \nosteoinductivity, although the in vivo animal assay is considered \nthe gold standard.20\nOsteoconduction is the formation of bone on a surface. All \ninert materials possess this characteristic. In bone regeneration, \nhealthy bone must be present adjacent to the site where the graft is \nplaced. Because bone will move from the healthy host site through \nthe grafting material placed in the bone void, this is commonly \nreferred to as “creeping substitution.” Fig. 35.4 illustrates this phe-\nnomenon with a cancellous-based product."
  },
  {
    "page": 26,
    "content": "916\nPART VII     Soft and Hard Tissue Rehabilitation\nIt occurs similarly with a cortical material, but at a slower rate. \nThe rate of creeping substitution is based on the available space \nfor vascular ingrowth. Available space is based on particle spacing \n(if a “powder” type material is used), as well as macroporosity and \nmicroporosity of the material.21\n • \u0007Macroporosity (pore size greater than 100 μm) is usually required \nto facilitate the osteogenesis and angiogenesis. Interconnected \nmacropores are necessary to promote body fluid circulation and \ncell migration to the core of the implant. An example of macro-\nporosity is the normal marrow space formed by trabeculation in \nthe cancellous portion of bone, or the interparticle spacing that \nis created when particulate grafts are placed.\n • \u0007Microporosity (pore size less than 10 μm) has importance, as \ndoes the unique surface properties of microporous scaffolds. \nThese have considerable influence on fluid distribution and \nprotein adsorption. Moreover, capillary force generated by the \nmicroporosity can improve the attachment of bone-related \ncells on the scaffolds surface and even make the cells achieve \npenetration into the micropores smaller than them (Fig. 35.5).\nOsteopromotion involves the enhancement of osteoinduction \nwithout the material possessing osteoinductive properties. As an \nexample, enamel matrix derivative (xenograft based) has been \n1\n2\n3\n4\n• Fig. 35.4  “Creeping substitution.”  This occurs with all materials to \nsome extent because all BGSs are osteoconductive. It requires the pres-\nence of healthy host bone in close proximity to the graft. Neovasculariza-\ntion occurs in cells that will remove/repopulate the space. (Source: https://\npocketdentistry.com/basics-of-bone-grafting-and-graft-materials/ )\nGranules\nMacropore (>100µm)\nMesopore (10 - 100µm)\nMicropore (<10µm)\n• Fig. 35.5  Different Types of Porosity. (Courtesy SigmaGraft Biomaterials, Fullerton, Calif.: http://sigmagraft.\ncom/inteross/ )"
  },
  {
    "page": 27,
    "content": "917\nCHAPTER 35  Bone Substitutes and Membranes\nshown to enhance the osteoinductive effect of demineralized \nfreeze-dried bone allograft (DFDBA) but will not stimulate new \nbone growth alone.22 Platelet-rich plasma and other substances \nderived from the patient’s own blood are also examples. \nIdeal Bone Graft Substitute\nReconstruction of bone defects or preparation of a site for \nimplant placement remains a challenge. On the one hand, \nautografts harbor most features of “ideal” BGS; on the other \nhand, they have a lot of insurmountable disadvantages (higher \nlevel of surgical skill needed, insufficient quantity, second-site \nmorbidity, increased operative time, etc.). An ideal bone graft \nsubstitute should:\n • \u0007be biomechanically stable;\n • \u0007degrade within an appropriate time frame;\n • \u0007exhibit osteoconductive, osteogenic, and osteoinductive prop-\nerties; and\n • \u0007provide a favorable environment for invading blood vessels and \nbone-forming cells.\nEven though osteoconductivity of biomaterials for bone tissue \nengineering (BTE) strategies can be directed by their composi-\ntion, surface character, and internal structure, osteoinductive and \nosteogenic features (discussed later) can be enhanced by the addi-\ntion of osteopromotive materials.23\nHaving the ideal substitute would address only a part of what \nis needed for successful bone regeneration. As illustrated in Fig. \n35.6, the bone healing triad is based on the complex process \ninvolved in tissue repair, wherein the matrix/scaffold (osteocon-\nductive materials), signaling proteins (osteoinductive, located \nwithin the matrix), and tissue-forming cells (osteogenic, osteo-\nclasts and osteoblasts) work in concert to form new tissue (bone) \nin the healthy (osseo-adaptive) host over time. \nIdeal Membrane Material\nGBR is a common technique in implant dentistry for the treat-\nment of bone defects. As discussed earlier, a critical component \nof the GBR procedure is the use of a barrier membrane. These \nmaterials are used to prevent the invasion of cells that are not \nneeded or would interfere with bone formation. The primary \ngoal is selective cell repopulation.24 An ideal barrier membrane \nshould:\n • \u0007Be biologically compatible. There should be no inflammation \nor interaction between the barrier material and the host.\n • \u0007Provide space maintenance. When desired, the membrane \nshould have the ability to prevent defect collapse.\n • \u0007Stabilize the blood clot that forms as part of natural healing. \nThis will allow the regeneration process to progress and reduce \nunwanted tissue integration into the defect.\n • \u0007Provide cell occlusion. This is the primary function of the \nmembrane, but many membranes allow the passage of fluid \nthat may assist in healing.\n • \u0007Have some degree of mechanical strength (based on end-user \nneeds). Strength is needed, and in some cases shape memory is \ndesired.\n • \u0007Resorb predictably, per the end-user requirements. Fortunately, \nmany configurations with varying rates of resorption exist.\n • \u0007Be easy to modify and manipulate.\nAs you will see, there are many types of membranes to choose \nfrom, most of which possess those properties. It is up to the clini-\ncian to choose the barrier membrane that best provides for the \ndesired clinical outcome. \nClassification of Bone Graft Substitutes and \nMembranes\nTransplant refers to the transfer of an organ from one body to \nanother, or from a certain section of the patient’s own body to \nanother area. This procedure is usually performed to replace a \ndamaged or missing organ. Tissues can be transferred from one \nindividual to another, and because they are generally placed to \nencourage the body to heal itself, thus being incorporated into the \nhost, they are considered transplants.\nImplants are medical devices intended to replace a missing body \npart, support a damaged part, or enhance the body in some way. \nTitanium dental implants are a good example. Some research-\ners consider allografts and xenografts (biological material) to be \nimplants because they are nonliving. It is acceptable to call them \neither transplants or implants.\nAutograft (or autotransplantation) is the transplantation of \nfunctioning organs, tissues, or even particular proteins from one \npart of the body to another in the same person. Examples in \nimplant dentistry are grafts from the ascending ramus, chin, or \niliac crest.\nAllograft (or homograft) is the transplantation of cells, tissues, \nor organs to a recipient from a genetically nonidentical donor \nof the same species. It can also be called an allogeneic transplant. \nRelated to this are isografts—a graft of tissue between two indi-\nviduals who are genetically identical (i.e., monozygotic twins). \nDemineralized freeze-dried bone and acellular dermis are exam-\nples used in implant dentistry.\nXenograft (or heterograft) is a tissue graft or organ transplant \nfrom a donor of a different species from the recipient. Bovine \nor porcine sourced materials (cancellous bone or collagen mem-\nbranes) are good examples. An interesting example of xenografts \nis coral-derived materials. These are considered xenografts (as \nopposed to alloplasts) because of their organic nature.\nAlloplast is an inorganic material used as a bone substitute or an \nimplant. Hydroxyapatite (HA) and tricalcium phosphate (TCP) \nmaterials are examples. \nOversight\nA 510(k) is a premarket submission made to the FDA to demon-\nstrate that a medical device is as safe and effective, that is, substan-\ntially equivalent, as a legally marketed device. Once the device is \ndetermined to be substantially equivalent, it can then be marketed \nScaffolds\nAdaptive\nTime\nHost\nMolecules\nCells\nBone\n• Fig. 35.6  The Bone Healing Triad. (Adapted from Murphy CM, O’Brien \nFJ, Little DG, Schindeler A. Cell-scaffold interactions in the bone tissue \nengineering triad. Eur Cell Mater. 2013;26:120-132.)"
  },
  {
    "page": 28,
    "content": "918\nPART VII     Soft and Hard Tissue Rehabilitation\nin the United States. Two years after the Medical Device Amend-\nments of 1976 were enacted, the FDA issued its final draft of the \nmedical device Good Manufacturing Practice (GMP) regulation, \na series of requirements that prescribed the facilities, methods, and \ncontrols to be used in the manufacture, packaging, and storage of \nmedical devices. All 510(k) products must be manufactured under \nGMP, and proof that they are is part of the process for obtaining \napproval. Xenograft and alloplast materials fall under the 501(k) \nrequirements. Products going through the 510(k) pathway can \nhave intended applications or claims.\nAn investigational device exemption (IDE) allows the investiga-\ntional device to be used in a clinical study to collect safety and \neffectiveness data. Clinical studies are most often conducted to \nsupport a premarket approval. Only a small percentage of 510(k)s \nrequire clinical data to support the application. Investigational use \nalso includes clinical evaluation of certain modifications or new \nintended uses of legally marketed devices. All clinical evaluations \nof investigational devices, unless exempt, must have an approved \nIDE before the study is initiated. It is rare that a product intended \nto be used as a BGS or membrane in dentistry requires an IDE \nand premarket approval. If the device does need clinical evaluation \nand has not been cleared for marketing, these are required:\n • \u0007an investigational plan approved by an institutional review \nboard\n • \u0007informed consent from all patients\n • \u0007labeling stating that the device is for investigational use only\n • \u0007monitoring of the study\n • \u0007required records and reports\nGood Clinical Practice refers to the regulations and require-\nments that must be complied with while conducting a clinical \nstudy. These regulations apply to the manufacturers, sponsors, \nclinical investigators, institutional review boards, and the medical \ndevice.\nProducts containing or consisting of human cells or tissues that \nare intended for implantation, transplantation, infusion, or trans-\nfer into a human recipient, and are considered minimally manipu-\nlated, are called human cellular and tissue-based products (HCT/\nPs). HCT/Ps must also be intended for homologous use and can-\nnot be combined with another article (except for water, crystal-\nloids, or a sterilizing, preserving, or storage agent). The product \nmust have no systemic effect and cannot be dependent on the \nmetabolic activity of living cells for the primary function.\nAllograft products are considered medical devices when the \nFDA determines that they have been more than minimally pro-\ncessed. To be considered beyond minimally processed, an original \ncharacteristic of a structural tissue must be altered, and that char-\nacteristic has to be relevant in that it has a potential effect on the \nutility of the tissue for reconstruction, repair, or replacement.\nManufacturers of HCT/Ps (i.e., tissue processors) are required \nby the FDA to comply with Current Good Tissue Practice. This \nincludes proper handling, processing, labeling, and recordkeeping \nprocedures. Under these regulations, tissue banks must screen and \ntest all donors for risk factors and clinical evidence of relevant \ncommunicable disease agents.\nWith the rapid growth of all areas of tissue banking, there has \nbeen an increasing need for accountability and for measures that \nensure that safe, quality tissues are available for clinical use. Qual-\nity improvement can be affected through voluntary standards, \nand most tissue banks have incorporated the achievement of high \nstandards into their goals. The American Association of Tissue \nBanks (AATB) has established comprehensive standards for donor \nscreening, recovery and processing of musculoskeletal, cardiac, \nvascular, and skin tissues, and reproductive cells.25 In addition, \nthe standards contain institutional requirements; descriptions of \nrequired functional components of a tissue bank; requirements \nfor construction and management of records and development of \nprocedures; requirements for informed consent, tissue labeling, \nstorage, and release; expectations for handling adverse outcomes, \ninvestigations, and tissue recalls; requirements for establishment \nof a quality program; specifications for equipment and facilities; \nand guidelines for tissue-dispensing services and tissue distribu-\ntion intermediaries. AATB’s Standards for Tissue Banking are con-\nsulted not only by tissue bankers but also by end-user healthcare \nfacilities, other standard-setting organizations, and regulators \nworldwide. In 2018, more than 100 tissue banks in North Amer-\nica held AATB accreditation. Best practice for checking a tissue \nbank’s accreditation status is to perform an accredited bank search \non the AATB website.26\nThe Joint Commission has standards for storage and issuance \nof tissue for hospitals and ambulatory surgery centers. These \nstandards apply to bone, tendon, fascia, and cartilage, as well as \ncellular tissues of both human and animal (xenograft) origin. The \nstandards address key functions, including the need to develop \nprocedures for tissue acquisition and storage, recordkeeping \nand tracking, and follow-up of adverse events and suspected \nallograft-caused infections, which must be reported to the tis-\nsue bank from which the tissue was obtained. Similar to federal \nregulations and AATB Standards, the minimal record retention \nperiod is specified to be 10 years from the date of transplanta-\ntion, distribution, other disposition, or expiration, whichever is \nlatest.\nFDA authority to create and “enforce regulations necessary \nto prevent the introduction, transmission, or spread of com-\nmunicable diseases between the States or from foreign countries \ninto the States” under Section 361(a) of the U.S. Public Health \nService Act (42 USC 264) applies to human tissue intended for \ntransplantation. Formal enforcement policy and regulations did \nnot exist until December 14, 1993 (codified in 21 CFR Parts 16 \nand 1270), when the “Interim Rule: Human Tissue Intended for \nTransplantation,” which required donor screening, infectious dis-\nease testing, and recordkeeping “to prevent transmission of infec-\ntious diseases through human tissue used in transplantation,” was \nadopted in response to reports of HIV transmission by human \ntissue and of potentially unsafe bone imported into the United \nStates.27\nThese regulations were supplanted by a series of federal reg-\nulations, published in stages, first announced in the Proposed \nApproach to the Regulation of Cellular and Tissue-Based Products \nin March 1997. A final rule, “Human Cells, Tissues, and Cellular \nand Tissue-Based Products: Establishment Registration and List-\ning,” published in January 2001, required organizations that are \nengaged in tissue recovery, donor qualification, tissue processing, \nand/or tissue-related laboratory testing to register as a tissue estab-\nlishment with the FDA. The rule (21 CFR Part 1271) became \neffective for all tissue banks on March 29, 2004.\nA final rule, “Eligibility Determination for Donors of Human \nCells, Tissues, and Cellular and Tissue-Based Products,” published \nMay 25, 2004, set forth donor eligibility requirements, including \nhealth history screening and laboratory testing. Another final rule, \n“Current Good Tissue Practice for Human Cell, Tissue and Cel-\nlular and Tissue-Based Product Establishments; Inspection and \nEnforcement,” published on November 24, 2004, established ele-\nments of good tissue practice, analogous to GMP for blood banks. \nBoth rules became effective May 25, 2005."
  },
  {
    "page": 29,
    "content": "919\nCHAPTER 35  Bone Substitutes and Membranes\nSterility\nSterility will be discussed from the viewpoint of allografts because \nthey are the most difficult to sterilize because of their fragile bio-\nlogic nature and variety.28\nTissue sterilization is defined as the killing or elimination of all \nmicroorganisms from allograft tissue, whereas disinfection refers \nto the removal of microbial contamination. The Association for \nthe Advancement of Medical Instrumentation, a standard-setting \norganization for the medical instrumentation and technology \nindustry, defines sterility assurance level (SAL) as the probabil-\nity that an individual device, dose, or unit is nonsterile (i.e., one \nor more viable microorganisms being present) after it has been \nexposed to a validated sterilization process. Although absolute \nsterility in theory would represent an absence of any pathogen, \nSAL is generally applied only to the level of possible contami-\nnation with bacteria or parasites. In contrast with log reduction \nof viruses determined in assessments of virus reduction methods, \nSAL is an absolute determined by the ability of the method to \neradicate or reduce microorganisms, the susceptibility of organ-\nisms that may be present to the sterilization method applied, and \nthe maximal bioburden that could occur in the initial material. \nFor example, a SAL of 10−6 means that there is less than a 1 in \n1,000,000 chance of a viable microorganism remaining after the \nsterilization procedure. The FDA requires that medical devices be \nsterilized using a method validated to achieve a SAL of 10−6. A \nmedical device derived from or that includes a biological product \ncomponent must also meet a SAL of 10−6 if it is to be labeled \nsterile. A SAL of 10−3, or a 1 in 1000 chance of a viable micro-\norganism being present, is a more achievable goal selected by \nsome processors for aseptically processed tissues if the processor \nhas been unable to validate their process to the more stringent \nSAL of 10−6 level, or if the tissues are unable to withstand the \nharsh treatment needed to achieve a more restrictive SAL without \nan impairment of tissue function. Such tissues may not then be \nlabeled as sterile.\nThe complex physical structures and density of musculoskel-\netal tissues pose challenges for adequate penetration of antimi-\ncrobial agents to eradicate microorganisms. Allografts will not \ntolerate methods usually applied to metal and plastic medical \ndevices because such treatment would impair the mechanical and \nbiologic properties necessary for clinical utility. As an alternative, \nsterilization of tissues has been accomplished by several methods, \nincluding heat, chemicals, ethylene oxide gas, supercritical CO2, \nand gamma or electron beam irradiation. However, not all steril-\nants have adequate tissue penetration. This is particularly the case \nfor gases and liquids. The initial bioburden, which may be high \nin some tissues, must be considered. Some tissues are treated with \nantibiotics in vitro before storage, but this treatment decontami-\nnates only the surface and may be effective against bacteria only.\nA variety of methods, including chemical treatments and irra-\ndiation, has been used to reduce or eliminate pathogens in tissue \nintended for transplantation. The introduction of bone steriliza-\ntion by ethylene oxide gas simplified bone processing and facili-\ntated the widespread use of sterilized air-dried and lyophilized \nbone products. The effects of ethylene oxide treatment on the \nbiomechanical and osteoinductive capacity of bone allografts have \nbeen questioned, although animal studies have yielded incon-\nsistent results. These concerns, combined with those regarding \nthe carcinogenic potential of ethylene oxide and its breakdown \nproducts, have largely led to abandonment of this method in the \nUnited States and the United Kingdom.\nFirst introduced in the 1960s, gamma irradiation of bone is still \nused widely, usually employing a cobalt-60 source. The gamma \nrays penetrate bone effectively and work by generating free radicals, \nwhich may have adverse effects on collagen and limit utility in soft \ntissues unless performed in a controlled dose fashion at ultra-low \ntemperature. The minimal bactericidal level of gamma irradiation is \n10 to 20 kGy (1 kGy = 100,000 rad). Uncontrolled human studies \nhave shown irradiated, calcified, and demineralized bone grafts to be \nclinically effective. Numerous studies have shown that mineralized \nbone allografts irradiated at 25 to 30 kGy are also clinically effec-\ntive, with high success rates reported. In controlled studies the clini-\ncal effectiveness of bone allografts subjected to 25 kGy irradiation \nwas comparable with that of nonirradiated bone grafts, although \ndoses exceeding 25 kGy for cortical bone and 60 kGy for cancellous \nbone have been found to induce cross-linking of collagen and to \nimpair mechanical function in a dose-dependent fashion. There is \nin vitro evidence that high irradiation reduces osteoclast activity and \nincreases osteoblast apoptosis (programmed cell death), and that \nresidual bacterial products induce inflammatory bone resorption \nafter macrophage inactivation. However, the clinical significance of \nthese findings has not been established. Newer processes employ-\ning radioprotectants have preserved bone allograft integrity when \ndoses ≥25 kGy are applied, and controlled-dose methods permit \nsuccessful irradiation at lower doses (see Proprietary Sterilization \nMethods to follow). Irradiated demineralized bone has potential \nosteoinductive activity and has been effective in nonstructural clini-\ncal applications.\nConcerns about pathogen transmission and the limitations of \nirradiation, especially for soft tissues, have prompted improve-\nments in sterilization methods and in the validation of these meth-\nods. A number of proprietary chemical-based processing methods \nhave been developed with aims of effectively penetrating tissues \nand reducing, killing, or inactivating microorganisms and viruses \nwithout unacceptable adverse effects on the tissue’s biomechanical \nproperties. In addition, for use in transplantation, the agents must \neither be able to be effectively removed or be nontoxic. All methods \nin current use are applied only to tissue from donors who have met \nstringent criteria for medical history and behavioral risk assessment \nas well as negative results on infectious disease marker testing.\nProprietary Sterilization Methods\nThe Tutoplast process (Tutogen Medical, Gainesville, Fla.) was \nthe first process to sterilize and preserve tissue without affecting \nbiological or mechanical properties. The process has been in use \nsince the early 1970s for a variety of hard and soft tissues, includ-\ning bone, fascia lata, pericardium, skin, amniotic membrane, and \nsclera. Initially lipids are removed in an ultrasonic acetone bath that \nalso inactivates enveloped viruses and reduces prion activity. Bac-\nteria are destroyed using alternating hyperosmotic saline and puri-\nfied water baths that also wash out cellular debris. Soluble proteins, \nnonenveloped viruses, and bacterial spores are destroyed in mul-\ntiple hydrogen peroxide baths, and a 1N sodium hydroxide treat-\nment further reduces prion infectivity by 6 logs. A final acetone \nwash removes any residual prions and inactivates any remaining \nenveloped viruses. Vacuum extraction dehydrates the tissue before \nthe grafts are shaped and then double-barrier packaged. Terminal \nsterilization using low-dose gamma irradiation yields a SAL of 10−6.\nThe Allowash XG process (LifeNet Health [LNH], Virginia \nBeach, Va.) employs six steps: (1) bioburden control, (2) biobur-\nden assessment, (3) minimization of contamination during pro-\ncessing, (4) rigorous cleaning, (5) disinfection steps, and (6) a final"
  },
  {
    "page": 30,
    "content": "920\nPART VII     Soft and Hard Tissue Rehabilitation\nstep of low-temperature, controlled-dose gamma irradiation. The \nprocess has been validated to achieve a SAL of 10−6. Holtzclaw \net al.29 in 2008 compared the Allowash XG and Tutoplast meth-\nods, and found that each achieved medical-grade sterility with no \neffect on biological or biomechanical properties.\nThe BioCleanse process (Regeneration Technologies, Alachua, \nFla.) uses low-temperature addition of chemical sterilants, such \nas hydrogen peroxide and isopropyl alcohol, which permeate the \ntissue’s inner matrix, followed by pressure variations intended to \ndrive the sterilants into and out of the tissue. Regeneration Tech-\nnologies reports a SAL of 10−6 for soft tissues without adverse \neffects on the initial allograft mechanical properties.\nThe Clearant process (Clearant, Los Angeles, Calif.) is designed \nto avoid the negative effects of gamma irradiation through addi-\ntion of free radical scavengers, using pretreatment dimethyl sulf-\noxide and propylene glycol as radioprotectants. Although the \nprocess subjects tissue to 50 kGy radiation and achieves a SAL of \n10−6 for bacteria, fungi, yeast, and spores, the tissue’s biomechani-\ncal properties are retained.\nThe Musculoskeletal Transplant Foundation (Edison, N.J.) \nuses a series of chemicals, including nonionic detergents, hydro-\ngen peroxide, and alcohol, to treat cortical and cancellous bone \ngrafts. For soft tissues an antibiotic mixture containing gentami-\ncin, amphotericin B, and Primaxin is added and then washed out \nto a nondetectable concentration. The Musculoskeletal Transplant \nFoundation claims a SAL of 10−3 for its products. Incoming tis-\nsues whose bioburden exceeds prescribed parameters are pretreated \nwith low-dose gamma irradiation.\nNovaSterilis (Lansing, N.Y.) has developed a sterilization \ntechnique that uses supercritical carbon dioxide at low tem-\nperatures and relatively low pressures, resulting in transient \nacidification, which is lethal to bacteria and viruses, with good \npenetration reported. However, this technique only recently \nbecame available for clinically available allografts, and data on \nclinical efficacy and retention of allograft mechanical proper-\nties are limited. \nEnd-User Responsibilities\nInformed Consent. The clinician is, as defined by the AATB \nand other organizations, the end-user. As such, the clinician’s \nresponsibility is the safest and most efficacious treatment for his \nor her patient. This begins with a complete understanding of the \ncharacteristics and limitations of any material used in treatment. \nSecond, the patient expectations and concerns must be assessed. \nThis is part of the process of informed consent. It is important that \nproper informed consent is obtained.\nThe Doctrine of Informed Consent30 is based on significant \nhistory:\n • \u0007Schloendorff v. Society of New York Hospital in 1914: An opera-\ntion was performed against the patient’s wishes.\n • \u0007Salgo v. Leland Stanford Jr. University Board of Trustees in 1957: \nThe patient had not been informed of the risks involved with \nthe surgery performed.\n • \u0007Natanson v. Kline in 1960: This verdict established a standard \nthat the risks as understood by a reasonable practitioner must \nbe disclosed.\n • \u0007Canterbury v. Spence in 1972: This verdict required practitio-\nners to disclose the risks that a reasonable patient would want \nto know.\n • \u0007AMA Position Paper on “informed consent” in 1981: This doc-\nument established the “best standards” concerning informed \nconsent in medicine.\nConsent is to reflect all applicable local, state, and federal laws \nand regulations, as well as internal policies and evolving best prac-\ntices. The informed consent discussion has several components31:\n • \u0007the nature of the proposed treatment, including necessity, \nprognosis, time element, and cost;\n • \u0007viable alternatives to the proposed treatment, including what a \nspecialist might offer or the choice of no treatment; and\n • \u0007what are the foreseeable risks, including things likely to occur \nand risks of no treatment?\nWhen obtaining informed consent, the dental professional \nshould:\n • \u0007Use language that is easily understandable.\n • \u0007Provide opportunities for patient questions, such as “What \nmore would you like to know?” or “What are your concerns?”\n • \u0007Assess patient understanding by stating, “If I have not explained \nthe proposed dentistry clearly or if you have difficulty under-\nstanding, please tell me so we can discuss anything you do not \nunderstand.”\nWhen gaining consent for the use of allografts, please use lan-\nguage that does not degrade the spirit of the gift of donation (i.e., \nuse “deceased donor” instead of “cadaver” and “recovered” instead \nof “harvested”). Remember that all tissue is recovered “asepti-\ncally” (not “sterile” and not necessarily in an operating room). \nFor all types of materials (allograft, xenograft, alloplast), proces-\nsors and manufacturers often provide patient education materials \nfor use by the end-user. These do not replace the informed con-\nsent discussion but exist to augment the effort. In addition, most \ncompanies that provide materials have a toll-free number or web-\nsite for answering patient inquiries. Patients’ ability to recollect \nand comprehend treatment information plays a fundamental role \nin their decision making.32 Although patients in general report \nthat they understand information given to them, they may have \nlimited comprehension. Additional media may improve conven-\ntional informed consent processes in dentistry in a meaningful \nway. \nProper Handling of Materials. The end-user is responsible for \nreviewing the “product insert” (also known by other names, e.g., \n“instructions for use,” “package insert”). This document provides \nvaluable information on storage, indications, contraindications, \ntracking, among others. Some materials have been treated with \nchemicals or antibiotics, and this must be listed to avoid allergic \nreactions in their patients.\nMaterials should be inspected on receipt. Are the materials the \nones ordered? Is the packaging intact? Were the materials pro-\ntected from extremes in temperature during shipment? What is \nthe expiration date? If the material appears to be compromised \nin any way, or is not what was expected, the distributor should \nbe notified.\nMaterials should be stored as indicated until time of use. \nIt is imperative that certain material not be frozen or kept in \nareas with extreme heat (both conditions can destroy the char-\nacteristics of some materials). In addition, materials should be \n“logged” or tracked internally at time of receipt, when used on \na patient, or when discarded or returned. All materials bear a \nunique identifier, and it is the responsibility of the end-user \nto have a system for identifying when and where each mate-\nrial is used. In the case of allografts, federal law states that each \nallograft unit have a distinct identifier, and that a system exists \nto track the graft from processor to consignee (and back). This \nmakes it the responsibility of the end-user to track from his or \nher office inventory to the patient, meaning that the unique \nidentifier can be associated with the patient’s unique identifier \n(chart number, etc.).33"
  },
  {
    "page": 31,
    "content": "921\nCHAPTER 35  Bone Substitutes and Membranes\nTracking of xenograft and alloplast, although not always \nrequired, is a good practice. Take the example of a patient who \nexperiences a localized reaction at a site where augmentation \noccurred; allograft bone was mixed with alloplast, and the site was \ncovered with a xenograft membrane. Identification numbers for \neach material would be needed to determine, with the help of the \nindividual processors, the root cause of the localized reaction. In \nthis case, having the information at hand as part of the patient \nsurgical notes would be a great advantage.\nIn the unlikely chance that a recall occurs, it is much easier to \ndetermine patients receiving affected units if that information is \nin a central database or log. Therefore in addition to information \nin the patient’s operative note, it is wise to have a central log where \ngrafts received into inventory are logged (date and time), as well as \ntheir final disposition (used on a patient [and ID of that patient], \nreturned to distributor, discarded, etc., noting date and time). \nExpiration Dates. Materials are not to be used past their expi-\nration date. Disposition should be recorded in the office log, and \nthe material should be discarded in a proper manner. \nMaterial Safety Data Sheets. Material Safety Data Sheets \n(MSDS) are not required for BGSs and membranes. The Occupa-\ntional Safety & Health Administration requires chemical manu-\nfacturers and importers to develop an MSDS for each hazardous \nchemical produced or imported, and these must be provided to a \ndistributor or end-user before or at the time of shipment. “Haz-\nardous” chemicals are defined as any chemical that is a physical or \nhealth hazard. A “physical hazard” is a chemical where scientific \nevidence shows that it is combustible, a compressed gas, explosive, \nflammable, an oxidizer, or unstable (reactive). A “health hazard” \nis a chemical for which statistical evidence exists that shows acute \nor chronic health effects in exposed individuals. BGSs and mem-\nbranes do not pose a physical or health hazard.\nAs always, refer to the Instructions for Use document accom-\npanying any BGS or membrane. This will contain specific infor-\nmation on indications for use, contraindications, precautions, and \npreparation instructions. \n“Single-Patient Use”. All BGSs and membranes, if packaged \nindividually, are designated for single patient use. This means \nthat the material cannot be used for treatment of more than one \npatient. The AATB demands that “Single-Patient Use” appears \non the label of every allograft produced by AATB-accredited tis-\nsue processors. Processors are working with the AATB to ensure \nthat each graft is used for treatment of only one patient, and \nthat each graft can be tracked (personal communication, Jon \nBoyd, Director of Certification and Online Learning, AATB, \nMcLean, Va.). Although the terminology may differ (e.g., “sin-\ngle use”), similar intent exists for xenografts and alloplasts (and \nthis information may appear on a package insert). Consider the \nfollowing:\n • \u0007To reuse a single-use device or material without considering \nthe consequences could expose patients and staff to risks that \noutweigh the perceived benefits.\n • \u0007A device or material designated as “single use” must not be \nreused. It should be used only on an individual patient during \na single procedure and then discarded. It is not intended to be \nreprocessed and used again, even on the same patient.\n • \u0007The reuse of single-use devices can affect their safety, perfor-\nmance, and effectiveness, exposing patients and staff to unnec-\nessary risk.\n • \u0007The reuse of single-use devices has legal implications: Anyone \nwho reprocesses or reuses a device intended by the manufac-\nturer for use on a single occasion bears full responsibility for its \nsafety and effectiveness. \nEnd-User Queries. When in doubt, the end-user should con-\ntact his or her product distributor for additional information. It \nis the responsibility of the distributor to find answers, or to refer \nthe end-user to a subject matter expert, which may include direct \ndiscussion with the manufacturer. In most cases the well-trained \ndistributor representative or customer service representative can \nanswer questions related to manufacture, clinical use, and safety. \nAllograft Source, Processing, and \nDistribution\nAllograft tissue banking has a rich history. The first tissue bank was \nestablished by the U.S. Navy in 1949 by Dr. George Hyatt.34 Hyatt \nwas an orthopedic surgeon at the Naval Medical Center in Bethesda, \nMaryland. The navy program was the first of its kind in the world and \nestablished many of the standards that are followed today (Fig. 35.7). \nDuring the 1950s, the identification of appropriate donor criteria \nfor tissue donation, the development of procurement and processing \nmethods, the establishment of a graft registry and documentation, \nand the clinical evaluation of a variety of tissues were pioneered at \nthis facility. Cryopreservation, freeze-drying, irradiation sterilization \nof tissue, and immunologic principles of tissue transplantation were \ndeveloped during the 50 years of research and development by navy \nscientists. Organ preservation, cadaveric bone marrow recovery, and \nimmunosuppressive protocols were also developed at the Navy Tis-\nsue Bank. The navy was also instrumental in the establishment of \nthe National Marrow Donor Program and the AATB in the United \nStates. Although the Navy Tissue Bank has ceased activity after 50 \nyears of excellence, it should be recognized as the first standard set-\nter for the world community of tissue banks. The first civilian tissue \nbanks were formed by ex-navy surgeons who trained at Bethesda.\nAt this time, all tissue banking in the United States is depen-\ndent on organ procurement organizations (OPOs). The OPOs are \nthe mechanism through which families can elect to donate not \nonly their loved one’s lifesaving organs but also eyes, skin, heart \nvalves, veins, arteries, bone, tendon, ligaments, and other “tissue” \nthat can be used to improve health.\n• Fig. 35.7  Photographs from the first tissue bank, U.S. Navy at Bethesda \nNaval Hospital in Bethesda, Maryland. The picture on the left shows tech-\nnicians at work processing deceased donor material. Out of respect for \nthe donor, processing was done in silence with technicians communicat-\ning nonverbally. The sign on the door translates to “from death, life.” The \nright photograph shows a technician removing frozen grafts from a −80°C \nchest freezer. (From Strong DM. The US Navy Tissue Bank: 50 years on \nthe cutting edge. Cell Tissue Bank. 2000;1:9-16.)"
  },
  {
    "page": 32,
    "content": "922\nPART VII     Soft and Hard Tissue Rehabilitation\nOPOs represent a unique component of health care.35 By \nfederal law, they are the only organizations that can perform \nthe lifesaving mission of recovering organs from deceased \ndonors for transplantation. When the National Organ Trans-\nplant Act was signed into law in 1984, it created the national \nOrgan Procurement and Transplantation Network (OPTN) \nfor matching donor organs to waiting recipients. The OPTN \nboth standardized the process through which organs are \ndonated and shared across the country, and created the system \nof federally designated OPOs throughout the United States \nand its territories. The OPTN includes all OPOs and trans-\nplant centers, and is managed under contract by the United \nNetwork for Organ Sharing located in Richmond, Virginia. \nThere are currently 58 OPOs in the United States, and all are \nnonprofit entities.\nBecause the focus of the OPO is organ donation, tissue recov-\nery and processing are managed by separate entities (tissue, eye, \nskin, heart valves) as designated by each OPO (through a con-\ntract). It is the responsibility of the OPO to make sure every family \nhas the opportunity to fulfill their loved one’s donation wishes.\nTissue processors may use either the OPO or regional recov-\nery programs for the recovery of tissue. All donor suitability \nassessment, recovery, transport, storage, processing, postproduc-\ntion testing, and distribution are the responsibility of the tissue \nprocessor.\nDonor suitability is standardized throughout the United States \nand consists of three parts: initial medical interview with next of \nkin, physical assessment by the recovery team, and laboratory test-\ning for communicable disease. The medical history and history of \npresent illness are critical, and findings result in a high number \nof decisions not to proceed with tissue donation. When a poten-\ntial donor is approved for recovery, they are assigned a unique \nidentifier; this number will be associated with all tissue grafts \nsubsequently produced. Tissue recovery must take place quickly: \nwithin 15 hours from time of asystole, or up to 24 hours from \nasystole if the deceased donor was refrigerated within 12 hours \nof death. Therefore laboratory testing is performed after recovery \nhas occurred. The laboratory assessments not only test for donor \nsuitability (communicable disease and systemic infection), but a \nrepresentative culture from each piece of tissue is tested for micro-\nbiologic contamination via aerobic and anaerobic means at both \nroom and body temperatures. Any biologic contaminant found is \nknown as bioburden.\nRecovery occurs, when possible, in an operating room at the \nhospital of the deceased donor. Many recovery programs and \nOPOs have dedicated recovery facilities, and the donor can be \ntransported there for recovery. Some medical examiner offices \nhave dedicated facilities in cooperation with the local recovery \nprogram or OPO. Recovery is done under aseptic conditions \njust like any surgical procedure. The donor is prepped, draped, \nand recovery occurs in a particular sequence via zones. Each zone \nuses new equipment. Tissue removed is swabbed for culturing, \nwrapped in special materials (impervious to fluids), tagged with \nthe assigned unique identifier, and placed on ice for transport to \nthe tissue processor.\nAfter arriving at the processor, tissue is placed in quarantine \n(−80°C) until all serologic and microbiologic tests are complete. \nIn addition, some donors have autopsies, the results of which must \nbe obtained before processing. A final chart review and additional \ninformation must be assessed and approved before processing into \nusable grafts. The tissue bank medical director has full responsibil-\nity for release of tissue for processing.\nProcessing occurs in clean rooms or laminar flow hoods under \nstrict aseptic conditions. One set of technicians processes one \ndonor at a time—no donor pooling or cross-contamination is \nallowed. Different tissues undergo processing in different ways. \nRegardless of the tissue processor, the end product is the same: \npreparation and preservation of tissue without changing the bio-\nchemical or biological characteristics.\nGrafts (now in quarantine) undergo postproduction review \nand testing (e.g., residual moisture if freeze-dried, residual calcium \nif demineralized) before final “in-package” sterilization (see earlier \nSterility section). Poststerility review occurs (review of dosimetry \nand last look at all processing records) before approval by the \nquality team for release into the “bank” for distribution. Finished \ngrafts are based on surgeon demand. Because the demand in many \ncases outweighs the supply, every effort is taken to maximize the \ndonor gift. The time from receipt of donor tissue to grafts ready to \ndistribute, at most tissue processors, takes approximately 90 days.\nRegarding the “average donor” and the types of grafts produced \nfor dental use, my research shows that two tissue banks provide the \nmajority (>50%) of “full-line” allograft offering to the dental implant \ncommunity. These two are Community Tissue Services (CTS) \nbased in Dayton, Ohio, and LNH in Virginia Beach, Virginia. In \naddition, both offer branded and private label allograft options to \nthe two largest dental implant suppliers in the world (Nobel Biocare \nand Straumann, respectively). Both use similar processing technol-\nogy, and both have a long history of cooperation in tissue banking \n(CTS was founded in 1986, and LNH was founded in 1982). These \ntwo nonprofit organizations are innovative and active as leaders in \nAATB. I queried both processors regarding donors and grafts pro-\nduced for the dental segment in 2017 (personal communication, \nPaul Lehner, Dental Product Manager, CTS, and David Adamson, \nGeneral Manager Dental and Craniomaxillofacial, LNH).\nRegarding donors, it is interesting that if you look at all donors \nreceived, the range is 12 to 80 years old (these are “musculoskel-\netal” donations that can be turned into grafts for a variety of surgical \nspecialties, including dental). An average age cannot be calculated \nbecause the distribution is bimodal, that is, with two different \n“peaks.” One peak occurs from about age 18 to 24 years, and the \nother appears from age 45 to 65 years. About 86.5% of the donors \nwere younger than 70 years, and nearly three of every four donors are \nmale. What is most interesting is that the donor age and gender sta-\ntistics have not changed since the late 2000s (compared with my data \nfrom 2007), except that the number of donors has greatly increased. \nThe increase is due to active donation awareness programs36 and an \nincrease in the number of individuals signing up on the national \ndonor registry—that number is currently 130 million.37 There were \napproximately 30,000 tissue donors in the United States in 2017.\nFinally, all dental allograft processors in the United States are \nAATB accredited. Accreditation is a rigorous program that requires \nadherence to AATB standards, membership in the national organi-\nzation, and periodic inspections. The AATB restricts distribution of \nallografts to hospitals, certain healthcare facilities, dentists, and podia-\ntrists. Distribution intermediaries can receive and store allografts for \nredistribution, but they must follow AATB guidelines, be registered \nwith the FDA, and are subject to state registration(s) and inspection(s). \nXenograft Source, Production, and \nDistribution\nClinicians and researchers have experimented with ways to cor-\nrect skeletal defects in the modern era. Nothing exemplifies this"
  },
  {
    "page": 33,
    "content": "923\nCHAPTER 35  Bone Substitutes and Membranes\nsearch better than the early experiences with xenografts. Orell38 \nin 1937 reported his clinical experiences with the surgical grafting \nof os purum, os novum, and boiled bone. Os purum was ox bone \nprepared by a complicated physicochemical procedure that freed \nthe bone of lipids, connective tissue, and some protein but still \nleft some of the collagen matrix. It was used to fill various skeletal \ndefects, and the author claimed that it was resorbed and replaced \nby host bone in 2 to 3 years.38 In 1956, Forsberg39 used finely \nground, sterile os purum as an implant material for periodontal \nosseous defects. He reported 11 cases and claimed excellent results \nin 1, satisfactory results in 7, and poor results in the remaining 3 \ncases after a postoperative period of up to 12 months.39\nUniversity studies on laboratory-produced anorganic xenograft \nbone began in earnest in the 1950s. Anorganic means that the \norganic portion (∼40% by weight) is totally removed, leaving pure \nHA. Scopp et al.40,41 in the 1960s reported experimental and clinical \nwork with the first commercially available xenogeneic implant mate-\nrial called Boplant (Squibb Pharmaceuticals; this product is no longer \navailable). It was derived from calf bone, and processing consisted of \ndetergent extraction, followed by chloroform and methanol extrac-\ntion to reduce the lipid content, washing with sterile deionized water, \nsterilization by immersions in a liquid sterilizing agent, and finally \nlyophilization and vacuum packaging.40,41 This work was the precur-\nsor to the modern xenograft. Notably, xenografts can be demineral-\nized, freeze-dried, and/or deproteinized, but most distribution is of \na calcified matrix form. To date, sources for xenograft material used \nin dentistry include bovine, porcine, equine, and species of coral. \nIn general, bovine and porcine use cancellous bone. Both materials \nmimic human bone in density, porosity, and calcium content.42-44\nThe best example of xenograft processing and use can be \nseen with anorganic bovine materials such as Bio-Oss (Geistlich \nPharma North America, Inc.).45 The Geistlich Pharma website \nincludes a searchable database for Geistlich Pharma materials and \nassociated clinical studies. Of all of the available BGS materials, \nBio-Oss has the greatest number of published studies. Since its \nbeginnings in 1851 the company has dealt with the processing \nand refining of bone and collagen materials, and up to now they \nhave the most researched biomaterials.\nGeistlich Pharma manufactures its biomaterials in its own \nproduction department at the company’s headquarters in Switzer-\nland. The entire production process is subject to the strictest safety \nstandards and quality checks: from the selection of the raw mate-\nrial suppliers to the delivery of the end products. Safety during \nthe manufacture of the products is guaranteed thanks to extensive \nhygiene measures in a sophisticated zone system with different \nsafety levels and permanent controls.\nGeistlich Bio-Oss is made from the mineral part of bovine \nbone (and is also known as deproteinized bovine bone material). \nThe strictly controlled manufacturing process ensures high quality \nand safety standards by:\n • \u0007a defined origin of the raw material;\n • \u0007a restricted country of origin, for example, Australia, which is \nhistorically and currently free of bovine spongiform encepha-\nlopathy (a prion disease, or “mad cow”);\n • \u0007using selected and certified slaughterhouses;\n • \u0007performing of pre and post mortem health inspection for each \nindividual animal;\n • \u0007restricting source to extremity bone (according to World \nHealth Organization Guidelines on tissue infectivity classified \nas tissues with no detected infectivity or infectious prions), as \nopposed to axial skeleton bones that may be associated with the \nspinal column;\n • \u0007effective inactivation methods with 15-hour treatment at high \ntemperature and cleaning with strong alkaline solutions;\n • \u0007medical-grade sterilization and double sterile packaging; and\n • \u0007official controls by international authorities.\nMany of the controls placed on xenograft production are simi-\nlar to what is seen with allograft. GMP must be followed and \ninternational manufacturers are subject to International Organi-\nzation for Standardization rules.46 International materials coming \nto the United States must obtain FDA clearance, most often via \n510(k) approvals. Distribution of most xenograft materials in den-\ntistry is accomplished through dental supply companies. \nAlloplast Production and Distribution\nThe category of alloplastic implants includes any nonosseous \nmaterial placed into a bony defect for the purpose of stimulating \nrepair or regeneration. It includes a very wide range of materi-\nals, both biologically and nonbiologically derived, and is limited \nonly by the imagination of the investigator and the tolerance of \nliving host tissue. Albee47 in 1920 reviewed the literature to date \nand reported that osmic acid, fibrin, blood, gelatin with lime salts, \nzinc chloride, thyroidin, glacial acetic acid, tincture of iodine, \nadrenaline, extract of hypophysis, copper sulfate, oil of turpentine, \nammonia, lactic acid, silver nitrate solution, alcohol, carbolic acid, \noak bark extract, vaccines, and sera had been used to stimulate \nbone growth without any appreciable success.\nHistorically the oldest known alloplast used in medicine is cal-\ncium sulfate. Calcium sulfate, also known as “gypsum” or “plaster \nof paris,” was first implanted in humans by Dreesman in 1892 as \na void filler of tuberculous osteomyelitis.48\nA great many materials are used today as the basis of alloplasts. \nThese include (but are not limited to): HA (and its many deriva-\ntives), tricalcium phosphates, biphasic configurations, calcium sul-\nfates, bioactive glass (BG), polymer-based materials, and composite \nmaterials.49 In recent years more attention has been placed on \nmacroporosity and microporosity (and interconnectivity of pores), \ninterparticle spacing, mechanical qualities, and rate of resorption.\nAlloplast production follows the guidelines of the pharmaceutical \nindustry. Materials are “manufactured” under GMP, subject to FDA \nand International Organization for Standardization regulations, and \ntheir use is restricted to medical facilities and licensed health profes-\nsionals. Distribution to dental practitioners in the United States is \npredominantly through medical and dental supply companies. \nGraft Descriptions50-60\nAllograft\nMineralized Cortical Particulate. Also known as freeze-dried \nbone allograft (FDBA) (Fig. 35.8), mineralized cortical particulate \ngrafts still contain all of the natural bone components (inorganic \nand organic including BMPs hidden within the bone matrix). \nEven though it is called mineralized, there is no mineral added; \nit is simply “not” demineralized. FDBA is sourced from extrem-\nity bone (femur, tibia, fibula, humerus, radius, ulna, etc.). It can \nbe processed, ground, and sieved to any desired particle range. A \ncommon range is 250 to 1000 μm. Particles smaller than 50 μm \nare quickly removed from the site by macrophages. Some proces-\nsors offer particles up to 3 mm for filling of larger defects. Because \nFDBA still contains its calcified portion, it has mechanical \nstrength. For that reason it is a popular graft material in implant \ndentistry. FDBA is osteoconductive."
  },
  {
    "page": 34,
    "content": "924\nPART VII     Soft and Hard Tissue Rehabilitation\nMineralized Cancellous Particulate. Also known as FDBA, \nmineralized cancellous particulate is made solely from the cancel-\nlous portion of bone. Graft source is the metaphyseal region of \nlong bones. It shares many of the characteristics of mineralized \ncortical particulate but has greater macroporosity because of the \nmarrow space. In addition, the trabecular surface of cancellous is \ncovered with endosteum that, like periosteum, probably plays a \nrole in bone regeneration. Because of the porous nature of cancel-\nlous bone, new vessel growth (in theory) is more rapid through \nthe graft; therefore regeneration will be quicker. Another benefit is \nthat cancellous particles tend to lock together better than equiva-\nlently sized cortical particles, and this will reduce micromotion \nin a graft site. Mineralized cancellous grafts are osteoconductive. \nMineralized Cortical/Cancellous Mix. The mineralized cortical/\ncancellous mix is a combination of the two previous graft types. \nIt can be manufactured in two ways: first is mixing together each \ncomponent 50:50 (v/v), which requires cortical and cancellous \nmaterial from a single donor, which requires additional quality-\ncontrol measures; and the second way is to grind and sieve bone \nfrom the metaphysis of a long bone, which is known as a “natural” \nmix (called corticocancellous) and results in a graft with varying and \nundetermined proportions of cancellous component. Cortical/\ncancellous mix is gaining in popularity because these grafts provide \ngood mechanical support and provide for faster incorporation.\nAccording to information provided by tissue processors CTS and \nLNH (personal communication, Paul Lehner and David Adam-\nson), in 2017 the previous three graft types (combined) accounted \nfor >80% of the total allograft units distributed. In contrast, in \nthe early 1990s  >80% of the grafts distributed were demineralized \ncortical particulate (unpublished data). This shift is directly related \nto the increase in graft use to support implant placement. \nDemineralized Cortical Particulate. Demineralized cortical \nparticulate is also known as DFDBA or demineralized bone matrix \n(DBM). This historically was the first graft produced in great \nnumbers by tissue processors for the periodontal market. Demin-\neralized grafts have osteoinductive potential because processing \nremoves the mineralized portion of the graft, thus exposing the \nnoncollagenous proteins (e.g., BMPs) associated with the collagen \nmatrix. These proteins recruit bone-forming cells to the site, thus \ninducing new bone growth. To be called demineralized, the AATB \nspecifies that residual calcium in the final graft cannot exceed 8% \nby weight. Normal cortical bone, for example, has ∼30% residual \ncalcium. If a graft is over- or under-demineralized, it will not pos-\nsess its full osteoinductive potential. DFDBA is often just called \ndemineralized. The other term, DBM, is reserved for DFDBA that \nis put with a carrier or is packaged in a convenience device such \nas a syringe. When reading market reports, DFDBA is considered \nnonproprietary, made by many processors; DBM is proprietary \nand made by few processors, usually under patent protection. \nBecause DFDBA (and DBM) have their mineral component \nremoved, they have little mechanical strength and often will not \nmaintain space. Both forms, if prepared correctly, are compress-\nible, have osteoinductive potential, and are osteoconductive. \nMineralized Cortical/Demineralized Cortical Combination. \nOne of the newest grafts, mineralized cortical/demineralized cor-\ntical combination (70:30 v/v) takes advantage of the best char-\nacteristics of its components. Unlike DFDBA, this version will \nmaintain space and incorporates quickly compared with mineral-\nized graft forms. It is both osteoconductive and osteoinductive. \nLaminar Bone. Laminar bone is a graft form that was popular \nin the 1990s that has undergone a resurgence. It is made by pre-\nparing cortical sheets (from the diaphysis portion of long bones) \nand demineralizing. This flexible graft not only induces new bone \nto grow but acts as its own membrane. \nIrradiated Cancellous (Vertebral Body). Vertebral bodies pos-\nsess marrow and cancellous with extremely dense trabeculation \n(per Wolff’s law). Cortical particulate, cancellous particulate, \nand block grafts can be produced from vertebral materials. These \nmaterials receive a 25 to 38 kGy gamma irradiation. \nMineralized Cortical and Cancellous Blocks and Cubes. Blocks \nand cubes in almost any dimension can be made from solid sec-\ntions of cortical and cancellous bone. These would be used in \nlarger cases where missing walls must be replaced, among other \ncases. These materials arrive freeze-dried, and clinicians must take \ncare when rehydrating and during fixation. In the freeze-dried \nstate, these grafts are brittle. When properly rehydrated, these \nhave the same biomechanics as natural bone. Most often, fixation \nis by a lag screw method. \nGel, Pastes, and Putties. Gel, pastes, and putties are all made \nwith DBM as the main component with an inert carrier substance. \nThe first such graft came out in the early 1990s and used glycerol \nas a means of dispensing the DBM particles. This was formulated \nfor convenience: the DBM needed no rehydration, there were no \nloose particles to deal with, and the graft was ready to go off the \nshelf. Many gels, pastes, and putties currently exist in the market. \nThere is overlap in the naming of these materials. In general, gel \nmeans very thin (low viscosity), with the possibility of being deliv-\nered via a syringe or other device. Paste is thicker and may lend \nitself to delivery in an open-bore device. Putty is moldable and \ncan be hand-delivered to a site. Many describe it like the modeling \ncompound Play-Doh (Hasbro Corp., Cincinnati, Ohio) used by \nchildren and artists. Putty has additional utility in that it can often \nbe combined with other graft materials (e.g., autograft) or osteo-\npromotive materials. Gels, pastes, and putties also may come in \nvarious formulation. Some have only DBM and a carrier, whereas \nothers have DBM, a mineralized component, and a carrier. These \nmaterials would maintain space much better than a pure demin-\neralized material. \nRib, Mandible, Bone Pins, and Sheets. A variety of additional \nskeletal grafts can be found at different tissue processors. Ribs are \nprocessed by most tissue banks. Mandibles are restricted to a few \nbanks—these being difficult to recover and process. Bone pins \n• Fig. 35.8  This is a common allograft from the ilium. It is shown as a \nreminder that there are only two types of bone—cortical and cancellous—\nfrom which bone grafts are fashioned. Cortical has little macroporosity, \nwhereas cancellous has much. The cancellous portion is made of inter-\nconnecting pores and is created from trabeculae oriented as per Wolff’s \nlaw (form and function). New vessel formation can occur much quicker in \ncancellous bone. (From Sfasciotti GL, Trapani CT, Powers RM. Mandibular \nridge augmentation using a mineralized ilium block: A case letter. J Oral \nImplantol 42(2):215-219, 2016.)"
  },
  {
    "page": 35,
    "content": "925\nCHAPTER 35  Bone Substitutes and Membranes\n(solid cortical) have become more popular in recent years and are \nused much like tenting screws. Cortical sheets are available, but \nnot by all tissue processors. Most tissue banks, if contacted, will \nwork to assist a clinician in finding who has the graft available. \nCell-Based Materials. Osteocel (Nuvasive, Inc., distributed by \nACE Surgical, Brockton, Mass.) is an excellent example of a cell-\nbased material. From a single donor, DFDBA, mineralized cancel-\nlous, and cells from the bone marrow are processed and recombined \ninto this specialized graft. The resulting material is osteoinductive, \nosteoconductive, and osteogenic. Other processors are research-\ning similar solutions, and this is a fast-growing area of tissue \nregeneration. \nPlacental Tissues. The placenta is the source of valuable mem-\nbranes and cells. Human amniotic membrane is the most com-\nmonly used and is derived from the fetal membranes. It consists of \nthe inner amniotic membrane made of single layer of amnion cells \nfixed to collagen-rich mesenchyme. Human amniotic membrane \nhas low immunogenicity, antiinflammatory properties, and can be \nisolated without the sacrifice of human embryos. Amniotic mem-\nbrane has various clinical applications in the field of dermatology, \nophthalmology, ENT (ear, nose, and throat) surgery, orthopedics, \nand dental surgery. \nFascia Lata. Fascia lata is the deep fascia of the thigh. It invests \nthe whole of the thigh but varies in thickness in different parts (the \nsection used for dentistry is around 1 mm thick). Since the 1920s, \nfascia lata from deceased donors has been used in reconstructive \nsurgery. In 1993, Callan55 described cases where freeze-dried fas-\ncia lata was used as a membrane. Although still available from \nmany tissue banks for orthopedic applications, it has largely been \nreplaced by acellular dermis in dental applications. \nPericardium. Pericardium is the membrane enclosing the heart, \nconsisting of an outer fibrous layer and an inner double layer of \nserous membrane. The material resembles fascia lata and can be \nused in a similar fashion. Pericardium is recovered from only heart \nvalve donors; therefore it is in short supply and not processed by \nmost tissue banks. Xenograft pericardium can be substituted (see \nlater discussion). \nAcellular Dermis. Acellular dermal matrix has been used as \na soft tissue replacement since its introduction in 1994. Its first \ndental use was correcting areas with insufficient attached gingiva, \nbut in 1999, Crook56 reported using it as a barrier membrane. \nEven though the material is in high demand, few tissue banks \nproduce acellular dermis because most methods of production are \nproprietary. Acellular dermal matrices are soft tissue matrix grafts \ncreated by a process that results in decellularization but leaves \nthe extracellular matrix intact. It starts with a full-thickness skin \ngraft from a deceased donor. The full-thickness graft is exposed to \nchemicals that remove the epidermis. A secondary step exposes \nthe remaining dermis to chemicals (detergents and endonucleases) \nthat removed the cells and DNA. This is the “decellularization” \nstep that renders the graft acellular. As a result, an immunologic \nresponse in the host is unlikely. Extracellular matrix is preserved, \nas well as biomechanical properties. These materials have found \ngreat use in burns treatment, plastic and reconstructive surgery, \npodiatry, orthopedics, and dentistry. \nXenograft\nParticulate Form. Processing and production considerations \nfor xenograft is similar to what has been described for allograft. \nHowever, cancellous (also known as spongiosa or trabecular \nbone) seems to be the preferred form. Xenograft is most often \ndeproteinized (removing all immunogenic factors) by a variety \nof methods. What is left is a calcified matrix resembling natu-\nral inorganic component (HA) in all ways. Macroporosity and \nmicroporosity are preserved. As discussed previously, both bovine \nand porcine bone resemble human bone from a biochemical and \nbiomechanical perspective. Xenograft particulate is available in \na variety of particle ranges. Because xenograft is pure mineral, it \ndoes resorb slowly and is an excellent material for long-term space \npreservation. \nBlock Form. Solid and porous blocks of xenograft HA can \nbe formed based on desired characteristics. These will function \nto preserve space for much longer than with an allograft. Macro-\nporosity and microporosity can be controlled, as well as surface \ncharacteristics. As a pure HA product the grafts tend to be more \nbrittle than natural bone, so care should be taken when modifying \nshape or using fixation screws. \nPericardium. As mentioned previously, allograft pericardium \nis in short supply. As a result, bovine and porcine pericardium \nsubstitutes have been developed and introduced into the dental \nmarket. Bovine has a greater collagen content than the porcine \nversion. They generally consist of three layers with collagen and \nelastic fibers in an amorphous matrix. Their surface is porous, \nwhich allows for cellular attachment and proliferation, yet has \nan increased density for soft tissue exclusion. Pericardium mem-\nbranes have shown a prolonged resorption in comparison with \ncollagen membranes. \nCollagen-Based Products. Resorbable collagen membranes \n(Fig. 35.9) are manufactured from xenogeneic tendon and skin \nto manage oral wounds such as extraction sockets, for sinus-lift \nprocedures and repairs, and for periodontal or endodontic surger-\nies. They act as scaffolds for bone deposition in GBR, promote \nplatelet aggregation, stabilize clots, and attract fibroblasts, facili-\ntating wound healing. They are designed to resorb within 2 weeks \nto 6 months and are biocompatible, easy to manipulate, and only \nweakly immunogenic. For ease of use, collagen-based products are \navailable in a wide variety of forms such as membranes, plugs, or \ntape. Extended collagen membranes resorb in 4 to 6 months and \nare used for larger bony defects that require longer healing peri-\nods. These membranes are modified by increasing the cross-link \ndensity. \nCoralline Grafts. Madrepore (“stone coral”) and millepora (“fire \ncoral”) are harvested and treated to become “coral-derived gran-\nules” and other types of coralline xenografts. Coral-based materi-\nals are mainly calcium carbonate (and an important proportion \nof fluorides, useful in the context of grafting to promote bone \ndevelopment), whereas natural human bone is made of HA, along \nwith calcium phosphate and carbonate. The coral material is \ntransformed industrially into HA through a hydrothermal pro-\ncess, yielding a nonresorbable xenograft. If the process is omitted, \nthe coralline material remains in its calcium carbonate state for \nbetter resorption of the graft by the natural bone. \nAlloplast\nHydroxyapatite. HA is a commonly used calcium phosphate \nbiomaterial for bone regeneration applications due to having \na composition and structure similar to natural bone mineral. \nHA-based grafts form a chemical bond directly to bone once \nimplanted. Synthetic HA is available and used in various \nforms: (1) porous nonresorbable, (2) solid nonresorbable, and \n(3) resorbable (nonceramic, porous). HA functions as an osteo-\nconductive graft material. These grafts show slow and limited"
  },
  {
    "page": 36,
    "content": "926\nPART VII     Soft and Hard Tissue Rehabilitation\nresorptive potential and generally are dependent on passive \ndissolution in tissue fluid and cell-mediated processes such as \nphagocytosis of particles for resorption. The degradation rate \nof HA depends on the method of ceramic formation, the cal-\ncium/phosphate ratio, crystallographic structure, and porosity. \nThe ability of HA to resorb is also heavily dependent on the \nprocessing temperature. HA grafts synthesized at high temper-\natures are very dense with very limited biodegradability. These \ndense grafts are usually used as inert biocompatible fillers. At \nlower temperatures the particulate HA is porous and undergoes \nslow resorption. \nTricalcium Phosphates. Over the last few years, TCP has been \nused and extensively investigated as a bone substitute. TCP has \ntwo crystallographic forms: α-TCP and β-TCP. β-TCP exhibits \ngood biocompatibility and osteoconductivity, and is used com-\nmonly as a partially resorbable filler allowing replacement with \nnewly formed bone. Resorption of TCP grafts is thought to be \ndependent on dissolution by biological fluids and by presence \nof osteoclast-mediated resorption. In terms of bone regenerative \npotential, β-TCP grafts have been shown to be similar to autog-\nenous bone, FDBA, DFDBA, and collagen sponge. \nBiphasic Configurations. Biphasic configurations refer to grafts \nmade from biphasic calcium phosphate, material composed of HA \nand β-TCP. The combinations are interesting in that the ratio of \nHA to β-TCP can be modified to provide for desired (slow versus \nfast) resorption. Also, by modifying the carrier and the charac-\nteristics of the granules, macroporosity and microporosity can be \naffected. These materials have a long history of use in orthopedics. \nCalcium Sulfate. Calcium sulfate compounds have a compres-\nsive strength greater than that of cancellous bone. Calcium sul-\nfate is usually applied as a barrier material to improve the clinical \noutcomes of periodontal regeneration therapy. When used as a \nbarrier, calcium sulfate materials work as an adjunct with other \ngraft materials. \nBioactive Glass. BG is a wide-open and fast-growing field in \ntissue engineering. BG has been widely studied since the 1970s. \nSince 45S5 BGs were discovered by Hench in 1969, they have \nbeen used for interface bonding of implant, and tissue repair and \nregeneration of bone. Glasses are noncrystalline amorphous solids \nthat are commonly composed of silica-based materials with other \nminor additives. Compared with soda-lime glass (commonly \nused, as in windows or bottles), Bioglass 45S5 (trademarked by \nthe University of Florida) contains less silica and higher amounts \nof calcium and phosphorus. The 45S5 name signifies glass with 45 \nweight % of SiO2 and a 5:1 molar ratio of calcium to phosphorus. \nThis high ratio of calcium to phosphorus promotes formation of \napatite crystals. Lower Ca:P ratios do not bond to bone. Bioglass \n45S5’s specific composition is optimal in biomedical applications \nbecause of its similar composition to that of HA, the mineral com-\nponent of bone.\nThe necessity of finding a material that forms a living bond \nwith tissues led Hench to develop bioglass repair tissues during \nthe Vietnam War. Bioglass offers advantages such as control of \nrate of degradation, excellent osteoconductivity, bioactivity, and \ncapacity to deliver cells, but they present limitations in certain \nmechanical properties, such as low strength, toughness, and reli-\nability. It can chemically bond with host tissue by forming a \nbonelike apatite layer between materials and bone tissue. Ionic \ndissolution products of BG can promote proliferation and differ-\nentiation of osteoblasts by activating a series of genes that regu-\nlate cellular behaviors. The first generation of BG was prepared \nby the melting-quenching method. Although traditional melt-\ning-derived BGs have excellent bioactivity, it was fired at a very \nhigh temperature (>1300°C), so it had a dense structure and \nsmall specific surface area, which limits its application. Com-\npared with the melting-quenching method, the sol-gel method \nis a chemistry-based synthesis route, of which a solution con-\ntaining the compositional precursors undergoes polymer-type \nreactions at room temperature to form a gel. The second genera-\ntion of sol-gel BGs possesses uniform composition, composed \nof numerous nanoparticles with microporous and mesoporous \nstructure, and thus it has high specific surface area. These advan-\ntages grant sol-gel BGs excellent bioactivity. However, up to \nnow, there is no commercial product made of pure sol-gel BG in \nclinical application. \nSynthetic Polymers. Synthetic polymers are discussed later in \nthe Membranes section. \nTitanium Mesh. Guided bone regenerative membranes can \nhelp in treating moderate-to-severe osseous defects, but the inher-\nent physical property of the membrane to collapse toward the \ndefect because of the pressure of the overlying soft tissues (thus \nreducing the space required for regeneration) makes the overall \namount of regenerated bone questionable. The use of titanium \nmesh, which can maintain the space, can be a predictable and \nreliable treatment modality for regenerating and reconstructing a \nseverely deficient alveolar ridge. The main advantages of the tita-\nnium mesh are that it maintains and preserves the space to be \nregenerated without collapsing, and it is flexible and can be bent. \nIt can be shaped and adapted so it can assist bone regeneration \nin non-space-maintaining defects. Due to the presence of holes \nwithin the mesh (Fig. 35.10), it does not interfere with the blood \nsupply directly from the periosteum to the underlying tissues and \nbone-grafting material. It is also completely biocompatible to oral \ntissues. Titanium mesh performs dual duty as a bone replacement \nand a barrier product. \nMembranes\nGTR and GBR membranes can be found in every graft source cat-\negory previously listed. Each can be viewed as being either “resorb-\nable” or “nonresorbable” based on whether the membrane can be \nleft in the surgical site. There are advantages and disadvantages to \neach, and it is up to the clinician to understand where each type \nwill have applicability.\n• Fig. 35.9  Collagen Membrane.  Collagen materials come in a variety of \nshapes and vary in their resorption time. (Courtesy Humanus Dental AB, \nMalmö, Sweden: https://www.humanusdental.com/conform-resorbable-\ncollagen-membrane-1520-mm)"
  },
  {
    "page": 37,
    "content": "927\nCHAPTER 35  Bone Substitutes and Membranes\nResorbable Membranes. There are three types of biologically \nresorbable (degradable) membranes: (1) polyglycolide synthetic \ncopolymers, (2) collagen, and (3) calcium sulfate.\nThe most commonly used biodegradable synthetic polymers \nfor three-dimensional scaffolds in tissue engineering are saturated \npoly(α-hydroxy esters), including poly(lactic acid) (PLA) and \npoly(glycolic acid) (PGA), as well as poly(lactic-coglycolide) copo-\nlymers. The chemical properties of these polymers allow hydro-\nlytic degradation through deesterification. Once degraded, the \nmonomeric components of each polymer are removed by natural \npathways. PGA is converted to metabolites or eliminated by other \nmechanisms, and PLA can be cleared through the tricarboxylic \nacid cycle. Due to these properties, PLA and PGA have been used \nin biomedical products and devices, such as degradable sutures, \nwhich have been approved by the FDA. Their properties can be \nhighly modified through each product’s final material design, sur-\nface topography, and porosity. In addition, dissolution rates can be \ncontrolled with resorption occurring in weeks to months.\nCollagen membranes, as well as all resorbable membranes, do \nnot normally require a second surgery for retrieval. Patients appre-\nciate the elimination of a second surgery, in addition to less mor-\nbidity. Collagen is the principal component of connective tissue \nand provides structural support for tissues throughout the body. \nCollagen is a hemostatic agent. It possesses the ability to stimu-\nlate platelet attachment and to enhance fibrin linkage, which may \nassist initial clot formation and stabilization, leading to enhanced \nregeneration. In addition, collagen is chemotactic for fibroblasts. \nCollagen membranes are easy to manipulate and adapt nicely to \nthe alveolar topography. Although collagen is a weak immunogen, \nit is very well tolerated by patients.\nCalcium sulfate with its long use in medicine provides an inex-\npensive solution in a variety of clinical situations. As previously \ndiscussed, when used as a resorbable barrier, calcium sulfate mate-\nrials work as an adjunct with other graft materials. \nNonresorbable Membranes. Materials such as cellulose acetate \nlaboratory filters (Millipore; Merck KGaA, Darmstadt, Germany, \noperating as MilliporeSigma in the United States), silicone sheets, \nand expanded polytetrafluoroethylene (e-PTFE) laboratory filters \nwere the first nonresorbable biomaterials used for investigating \nbarrier membranes for regenerative therapy. Although these mate-\nrials demonstrated some therapeutic potential, limitations such as \ninability to integrate with surrounding tissue, brittleness, and the \nneed to remove them after a certain period were observed. The \nfunction of nondegradable (nonresorbable) membranes is tem-\nporary, as they maintain their structural integrity on placement \nand are later retrieved via surgery. Although this gives the clinician \ngreater control over the length of time the membrane will remain \nin place, the retrieval procedure increases the risk for surgical site \nmorbidity and leaves the regenerated tissues susceptible to damage \nand postsurgery bacterial contamination. However, in situations \nsuch as alveolar ridge augmentation before placement of dental \nimplants, it may be desirable for the membrane to retain its func-\ntional characteristics long enough for adequate healing to occur, \nand then be removed. Hence in specific situations a nonresorbable \nmembrane provides more predictable performance.\ne-PTFE was originally developed in 1969, and it became the \nstandard for bone regeneration in the early 1990s. The e-PTFE \nmembrane was sintered (sintering is the process of compacting \nand forming a solid mass of material by heat or pressure without \nmelting it to the point of liquefaction), and it had pores between \n5 and 20 μm in the structure of the material. The most popular \ncommercial type of e-PTFE was Gore-Tex (W.L. Gore & Associ-\nates, Newark, Del.). The e-PTFE membrane acts as a mechani-\ncal hindrance. Fibroblasts and other connective tissue cells are \nprevented from entering the bone defect so that the presumably \nslower migrating cells with osteogenic potential are allowed to \nrepopulate the defect.\nIn time, clinicians discovered that e-PFTE exposed to the \noral cavity resulted in migration of microorganisms through the \nhighly porous membrane. With an average pore size of 5 to 20 \nμm and the diameter of pathogenic bacteria generally less than \n10 μm, migration of microorganisms through the highly porous \ne-PTFE membrane at exposure was a common complication. A \nhigh-density polytetrafluoroethylene (d-PTFE) membrane with \na nominal pore size of less than 0.3 μm was developed (Cyto-\nplast; Osteogenics Biomedical, Lubbock, Tex.) to address this \nproblem. The increased efficacy of d-PTFE membranes in GTR \nhas been proved with animal and human studies. Even when the \nmembrane is exposed to the oral cavity, bacteria is excluded by \nthe membrane, whereas oxygen diffusion and transfusion of small \nmolecules across the membrane is still possible. Thus the d-PTFE \nmembranes can result in good bone regeneration even after expo-\nsure. Because the larger pore size of e-PTFE membranes allows \ntight soft tissue attachment, it usually requires sharp dissection at \nmembrane removal. On the contrary, removal of d-PTFE is sim-\nplified because of lack of tissue ingrowth into the surface structure. \nIn 1995, Bartee58 reported that the use of d-PTFE is particularly \nuseful when primary closure is impossible without tension, such as \nalveolar ridge preservation, large bone defects, and the placement \nof implants immediately after extraction. In those cases d-PTFE \nmembranes can be left exposed, and thus preserve soft tissue and \nthe position of the mucogingival junction. \nComparing Bone Graft Substitutes and \nMembrane Characteristics\nWhen comparing bone graft substitutes and membrane character-\nistics, the choices are many. Fortunately there are suppliers who \nhave developed regenerative portfolios that offer a “full range” of \nchoices, allowing the clinician latitude in providing their patient \nwith the best treatment. Fig. 35.11 illustrates a small sample of \navailable material diversity from one such supplier.\n• Fig. 35.10  Titanium Mesh.  This can be used in place of a bone graft \nsubstitute when severe defects are encountered. The material acts as its \nown membrane. (Courtesy Salvin Dental)"
  },
  {
    "page": 38,
    "content": "928\nPART VII     Soft and Hard Tissue Rehabilitation\nThe clinician is faced with a wide variety of materials in the \nmarket. Many appear to be similar, whereas many others appear \nto be markedly superior or inferior. As pointed out in this chapter, \nthere are but a few product categories. The products in all catego-\nries are made under the strictest of regulations. Industry strives to \nprovide safe and effective grafts for all surgical specialties.\nInformation on any graft type is easy to find thanks to the \nWorld Wide Web. The end-user has a responsibility to keep up to \ndate on materials and techniques. Companies supplying the spe-\ncialty of implant dentistry have expanded their regenerative port-\nfolios and gained the technical knowledge to support the doctor \nin making grafting choices. This ensures the best treatment option \nfor every patient.\nThe following tables are provided as a quick summary of materials \ncovered in this chapter. Table 35.1 examines the materials regulated as \nHCT/Ps (donated human tissue). Table 35.2 lists the materials that \nare on the market via the 510(k) route (xenografts and alloplasts). \nLooking to the Future\nIn the area of hard tissue replacement, significant advancements \nare being made related to milled “custom” graft materials. Most of \nthe strides are a result of improvements in scanning, tomography, \nand manufacturing technologies. Also, advances in cell culture \nand the ability to create three-dimensional print scaffolds from \nbiologic materials provide unlimited opportunities for both hard \nand soft tissues. Soft tissue augmentation shows promise in several \nareas, mainly from improved understanding in the area of wound \nhealing and improved manufacturing. Cell-based grafts will play a \nbig part in regeneration.\nMilling of “custom” blocks is currently available.61 Patient selec-\ntion is a great part of the success and at the time of this writ-\ning, only dental surgeons who have received special training on \nthe technique can use the service. Fabrication requires cone beam \ncomputed tomography and a tissue processor with the ability to \nmill bone using computer-aided design and computer-aided man-\nufacturing (Fig. 35.12). The technology originated in Europe, is \nnow available in the United States, and resultant grafts:\n • \u0007are sourced from processed human allograft;\n • \u0007are composed of natural mineralized collagen (normal trabecu-\nlar bone);\n • \u0007have 65% to 80% macroporosity, pore size 100 to 1800 μm \n(mean 600 to 900 μm);\n • \u0007can be produced to a maximum size: 23 × 13 × 13 mm;\n • \u0007show fast graft incorporation and complete remodeling poten-\ntial;\n • \u0007possess no antigenicity;\n • \u0007result in no donor site morbidity;\n • \u0007heal/integrate in 5 to 6 months;\n • \u0007can be stored at ambient temperature for long periods; and\n • \u0007are safe and sterile.\nCell culture technology is one of the fastest-growing areas of \nregenerative innovation.62 It is part of BTE, the specific field of tis-\nsue engineering that mainly focuses on enhancing bone regenera-\ntion and repair by creating substitutes to traditional bone-grafting \nmaterials. BTE started about three decades ago and has witnessed \ntremendous growth ever since. Bone serves as a paradigm for gen-\neral principles in tissue engineering because of its high regenerative \npotential compared with other tissues in the body. Classic BTE \nparadigm includes the following three key components: biomate-\nrials to provide a scaffold for new tissue growth, cells, and signal-\ning molecules. It is quite possible that components can be made \nfrom different classes of materials (e.g., a xenograft combined with \nan alloplast), thus taking advantage of the best properties of each.\nScaffolds can be either acellular or cellular on implantation \nwithin this model. In the former, the architecture and geometry \npromote the recruitment of local stem cell and or/osteoprogenitor \ncells, which could be possible with attachment motifs and chemi-\ncal “smart” cues placed within the scaffold architecture. On the \nother hand, the latter strategy involves implantation of a scaffold \ncombined with stem cell and or/osteoprogenitor cells, which can \nbe incorporated by two methods: (1) cell seeding into a “prefab-\nricated” scaffold, a commonly applied tissue engineering strategy; \nand (2) cell encapsulation during scaffold fabrication made of \nhydrogel polymer matrix, based on the immobilization of cells \nwithin a semipermeable membrane. This technique protects cells \nfrom the immune system and permits uniform cell distribution \nwithin the construct.63\n• Fig. 35.11  Today’s clinician has many products to choose from. (Courtesy Salvin Dental)"
  },
  {
    "page": 39,
    "content": "929\nCHAPTER 35  Bone Substitutes and Membranes\n  \u0007Allograft-Derived Materials\nHCT/P Products\nFunction\nSpace Maintaining\nMode\nTime to Remodel\nMineralized cortical\nBGS particulate\nYes\nOsteoconductive\n6 months\nMineralized cancellous\nBGS particulate\nYes\nOsteoconductive\n<6 months\nMineralized cortical/cancellous mix\nBGS particulate\nYes\nOsteoconductive\n<6 months\nDemineralized cortical\nBGS particulate\nNo\nOsteoconductive/osteoinductive\n4–5 months\nMineralized cortical/demineralized \ncortical mix\nBGS particulate\nYes\nOsteoconductive/osteoinductive\n4–5 months\nLaminar bone\nBGS structural\nN/A\nOsteoconductive/osteoinductive\n4–5 months\nDBM gel, putty, paste\nBGS particulate\nVaries\nOsteoconductive/osteoinductive\nVaries\nMineralized block, cube, rib, man-\ndible, pins\nBGS structural\nYes\nOsteoconductive\nSlow\nCell-based material\nBGS particulate\nYes\nOsteoconductive/osteoinductive/osteogenic?\nVaries\nPlacental tissue\nMembrane\nN/A\nResorbable\nFast\nFascia lata\nMembrane\nN/A\nResorbable\n4–6 months\nPericardium\nMembrane\nN/A\nResorbable\n4–6 months\nAcellular dermis\nMembrane\nN/A\nResorbable\n4–6 months\nBGS, Bone graft substitutes; DBM, demineralized bone matrix; N/A, not applicable.\n   \nTABLE \n35.1\n  \u0007Xenograft- and Alloplast-Derived Materials [510(k) Regulated]\n510(k) Products\nFunction\nSpace Maintaining\nMode\nTime to Remodel\nXenograft mineralized \ncancellous\nBGS particulate\nYes\nOsteoconductive\nSlow\nXenograft mineralized \ncancellous block\nBGS structural\nYes\nOsteoconductive\nSlow\nXenograft pericardium\nMembrane\nN/A\nResorbable\n4–6 months\nXenograft collagen forms\nMembrane\nN/A\nResorbable\nVaries, weeks to months\nCoralline based\nBGS particulate\nYes\nOsteoconductive\nSlow to medium\nHydroxyapatite\nBGS particulate and structural\nYes\nOsteoconductive\nVaries (generally slow)\nTricalcium phosphates\nBGS particulate\nYes\nOsteoconductive\nVaries (generally fast)\nBiphasic (hydroxyapatite + \ntricalcium phosphate)\nBGS particulate\nYes\nOsteoconductive\nVaries (can be controlled by \nratio of mix\nCalcium sulfate\nBGS (additive) and membrane\nYes\nOsteoconductive (resorbable \nwhen used as membrane)\nFast\nBioactive glass\nBGS (mainly as particulate)\nYes\nOsteoconductive\nVaries (generally slow)\nSynthetic polymers\nMembrane\nN/A\nResorbable and nonresorbable \nforms\nVaries based on composition\nTitanium mesh\nBGS (in severe cases) and \nmembrane\nMaintains space\nNonresorbable\nNever resorbs\nBGS, Bone graft substitutes; N/A, not applicable.\n   \nTABLE \n35.2"
  },
  {
    "page": 40,
    "content": "930\nPART VII     Soft and Hard Tissue Rehabilitation\nRegarding BTE created scaffolds, the following characteristics \nare desired:\n • \u0007hydrophilicity, roughness, and surface topography\n • \u0007porosity, pore size, and interconnectivity\n • \u0007mechanical strength close to native tissues and a predictable \ndegradation rate (5 to 6 months is desired for dental use)\n • \u0007biocompatible and bioactive\n • \u0007ability to bind and release drugs or chemicals that can affect the \nhealing microenvironment\nMuch work remains in this area, but the technologies show \ngreat promise.\nSoft tissue grafts and membranes will benefit from a better \nunderstanding of clinical need. Manufacturers now know that \ncollagen-based membranes can be modified by cross-linking to \naffect the rate of resorption. In addition, collagen-based materials \ncan be preformed in molds to increase utility in cases with extreme \nanatomic variations. Thickness can be modified to produce “dead \nsoft” materials that lack any memory and adhere perfectly to local \nanatomy. Naturally, research is going on with all material types for \nmembranes that can be left “predictably” exposed to the oral cav-\nity in cases where primary closure cannot be achieved. Much work \nwith d-PTFE has already occurred in this area.64\nRowe et  al.65 in 2016 discussed work with electrospinning. \nThis is a process by which microfibers/nanofibers can be formed \nfrom a viscous polymer solution exposed to an electric field. \nAlthough widely used in tissue engineering applications, biocom-\npatible PLA and poly(ε-caprolactone) electrospun meshes have \ndisplayed properties that might enable its application as a GTR/\nGBR membrane. In initial tests it performed better than a current \ncommercially available product.\nControllable osteoinduction maintained in the original defect area is \nthe key to precise bone repair. In 2018, Ma et al.66 reported on research \ninvolving the development of a dual-sided (“Janus”) membrane that \nacts as a membrane on one side and is osteoinductive on the other.\nAllografts (acellular dermis, fascia lata, and pericardium) are \nconstantly being modified. The main focus for the future will be \nprocessing innovations resulting in consistency of thickness, ste-\nrility of the product (to a SAL 10−6—not all products are at this \ndesired level), and an increase in the length of time materials can \nbe stored at ambient temperature. Acellular dermis will be highly \nstudied because of its unique makeup and utility in many surgi-\ncal disciplines. A unique reticular dermis is already available that \nretains architectural elements (open structure), mechanical prop-\nerties (elasticity, organized collagen, and elastin), and key matrix \nproteins to support physiologic cellular responses during regen-\nerative remodeling.67 Of course a great deal of attention is being \ngiven to placental-based materials (chorion and amnion), with \nmany products being marketed at the time of this writing.\nCell-based products for use in dentistry are currently available.68 \nThese feature (generally) three components: demineralized corti-\ncal bone, mineralized cancellous bone, and marrow cells; therefore \nthese products mimic the biologic profile of autograft (osteoin-\nductive, osteoconductive, and osteogenic). Currently these prod-\nucts require special shipping and storage at ultracold temperatures \n(not usually available in the typical dental office). Future efforts \nwith these grafts will be to create shipping solutions that can act \nas short-term storage for those offices without ultralow-tempera-\nture freezers or the ability to store at lower temperatures for short \nperiods. In addition, ways to increase the number and viability \nof bone-forming cells are being studied. Cell-based grafts are the \nmost difficult of all BGS materials to produce because each com-\nponent must come from a single donor, and processing must occur \nquickly to protect the viability of the osteogenic component. \nSummary\nBone graft substitutes and membranes make up a significant \nportion of the dental implant market. Most patients who need \nimplant therapy will need either an autograft or a substitute. The \nindustries and regulatory bodies responsible for the manufacture \nof these materials, and instruments and technologies that augment \ntheir use, have reached a high level of maturity. Patient safety and \ngraft performance are the focus of industry while always striving \nfor improvement. Patients are active participants in their own \ntreatment, and the most appropriate grafting decisions can be \nmade collaboratively through the informed consent process.\nThe use of autografts, allografts, xenografts, or alloplasts, alone \nor in combination, should be based on the individual’s systemic \nhealing capacity, the osteogenic potential of the recipient site, time \navailable for graft maturation, and the patient’s expectations. Cli-\nnicians have a responsibility to their patients to understand the \nmany products available for use in GBR. It must also be under-\nstood that no one ideal BGS or membrane exists.\nAlthough product comparisons may seem difficult, the pro-\ncess is made easier by realizing the best patient outcome. Each \ngraft class has characteristics unique to that group, and it is up \nto the end-user to evaluate each characteristic against patient \nneeds. Also, the end-user has a responsibility to handle and use \neach material as intended to protect his or her patients and staff.\nWhat has been presented in this chapter covers the basics of \nBGS and membranes. The next 10 to 15 years will see dramatic \nchanges in biomaterials and techniques, and will provide the clini-\ncians even more options for successful implant treatment.\nAcknowledgments\nThe author thanks Paul Lehner, David Adamson, Karen Colella, \nWilliam Simmons, Greg Slayton, and Jonathan Boyd for their \ntechnical assistance and their dedication to the dental specialty. \nHe also expresses his appreciation to the employees of CTS, LNH, \nSalvin Dental Specialties, and the AATB. They have been friends \nand mentors for many years.\n• Fig. 35.12  A custom solution created from cone beam computed \ntomography and computer-aided design/computer-aided manufacturing \nmilling (botiss.com)."
  },
  {
    "page": 41,
    "content": "931\nCHAPTER 35  Bone Substitutes and Membranes\nReferences\n 1. \u0007Leventhal GS. Titanium, a metal for surgery. J Bone Joint Surg Am. \n1951;33-A(2):473–474.\n\t 2.\t \u0007Brånemark PI, Hansson BO, Adell R, et al. Osseointegrated implants \nin the treatment of the edentulous jaw. Experience from a 10-year \nperiod. Scand J Plast Reconstr Surg Suppl. 1977;16:1–132.\n\t 3.\t \u0007Dr. Brånemark, father of modern dental implant, dies at 85. \nhttps://www.ada.org/sitecore/content/home-ada/publications/ada-\nnews/2015-archive/january/dr-branemark-father-of-modern-dental-\nimplant-dies-at-85#.WuCOuw1S4-8.email. Accessed May 30, 2018.\n 4. \u0007Chrcanovic BR, Albrektsson T, Wennerberg A. Bone quality \nand quantity and dental implant failure: a systematic review and \nmeta-analysis. Int J Prosthodont. 2017;30(3):219–237. https://doi \n.org/10.11607/ijp.5142.\n 5. \u0007Misch CM. Autogenous bone: is it still the gold standard? Implant Dent. \n2010;19(5):361. https://doi.org/10.1097/ID.0b013e3181f8115b.\n\t 6.\t Global Dental Membrane and Bone Graft Substitute Market Dynamics \n2018: Industry Analysis, Competitors Size & Share, Trends, Demand, \nGlobal Research to 2025 – Healthcare News. https://journalhealthcare.\ncom/156676/global-dental-membrane-and-bone-graft-substitute-mar-\nket-dynamics-2018-industry-analysis-competitors-size-share-trends-\ndemand-global-research-to-2025/. Accessed May 30, 2018.\n 7. \u0007Bone Remodeling. https://courses.washington.edu/conj/bess/bone/\nbone2.html. Accessed May 30, 2018.\n\t 8.\t \u0007Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphom-\netry: standardization of nomenclature, symbols, and units. Report \nof the ASBMR Histomorphometry Nomenclature Committee. \nJ Bone Miner Res. 1987;2(6):595–610. https://doi.org/10.1002/\njbmr.5650020617.\n\t 9.\t \u0007Wolff J. Concerning the interrelationship between form and func-\ntion of the individual parts of the organism. By Julius Wolff, 1900. \nClin Orthop. 1988;(228):2–11.\n\t10.\t \u0007Khojasteh A, Kheiri L, Motamedian SR, Khoshkam V. Guided bone \nregeneration for the reconstruction of alveolar bone defects. Ann \nMaxillofac Surg. 2017;7(2):263–277. https://doi.org/10.4103/ams \n.ams_76_17.\n\t11.\t \u0007Nyman S, Gottlow J, Karring T, Lindhe J. The regenerative poten-\ntial of the periodontal ligament. An experimental study in the mon-\nkey. J Clin Periodontol. 1982;9(3):257–265.\n 12. \u0007Hurley LA, Stinchfield FE, Bassett AL, Lyon WH. The role of \nsoft tissues in osteogenesis. An experimental study of canine spine \nfusions. J Bone Joint Surg Am. 1959;41-A:1243–1254.\n\t13.\t \u0007Senn on the healing of aseptic bone cavities by implantation of anti-\nseptic decalcified bone. Ann Surg. 1889;10(5):352–368.\n 14. \u0007Lacroix P. Recent investigations on the growth of bone. Nature. \n1945;156:576–577.\n\t15.\t \u0007Urist M. Bone: formation by autoinduction. Science. 1965;150: \n893–899.\n\t16.\t \u0007Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res. \n1971;50(6):1392–1406. https://doi.org/10.1177/0022034571050\n0060601.\n 17. \u0007Reddi H. Bone morphogenetic proteins. Adv Dent Res. 1995;9(suppl \n3):13. https://doi.org/10.1177/0895937495009003S0401.\n\t18.\t \u0007Sheikh Z, Javaid MA, Hamdan N, et al. Bone regeneration using \nbone morphogenetic proteins and various biomaterial carriers. \nMater Basel Switz. 2015;8(4):1778–1816. https://doi.org/10.3390/\nma8041778.\n\t19.\t \u0007Wozney JM. The bone morphogenetic protein family and osteogene-\nsis. Mol Reprod Dev. 1992;32(2):160–167. https://doi.org/10.1002/\nmrd.1080320212.\n\t20.\t \u0007Edwards JT, Diegmann MH, Scarborough NL. Osteoinduction of \nhuman demineralized bone: characterization in a rat model. Clin \nOrthop. 1998;357:219–228.\n\t21.\t \u0007Zhang K, Fan Y, Dunne N, Li X. Effect of microporosity on scaf-\nfolds for bone tissue engineering. Regen Biomater. 2018;5(2): \n115–124. https://doi.org/10.1093/rb/rby001.\n\t22.\t \u0007Boyan BD, Weesner TC, Lohmann CH, et al. Porcine fetal enamel \nmatrix derivative enhances bone formation induced by demineralized \nfreeze dried bone allograft in vivo. J Periodontol. 2000;71(8):1278–\n1286. https://doi.org/10.1902/jop.2000.71.8.1278.\n\t23.\t \u0007Janicki P, Schmidmaier G. What should be the characteristics of the \nideal bone graft substitute? Combining scaffolds with growth fac-\ntors and/or stem cells. Injury. 2011;42(suppl 2):S77–81. https://doi \n.org/10.1016/j.injury.2011.06.014.\n 24. \u0007Rakhmatia YD, Ayukawa Y, Furuhashi A, Koyano K. Current barrier \nmembranes: titanium mesh and other membranes for guided bone \nregeneration in dental applications. J Prosthodont Res. 2013;57(1): \n3–14. https://doi.org/10.1016/j.jpor.2012.12.001.\n\t25.\t \u0007American Association of Tissue Banks. Standards for Tissue Banking. \n14th ed. McLean, VA: AATB; 2016.\n\t26.\t \u0007Accredited Bank Search. https://www.aatb.org/?q=content/accredited-\nbank-search.\n 27. \u0007CFR—Code of Federal Regulations Title 21. https://www.accessdata \n.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=1271. \nAccessed May 30, 2018.\n 28. \u0007Powers R, Linden J. Tissue Banking. In: Rossi’s Principles of Transfusion \nMedicine. 5th ed. West Sussex, UK: Wiley-Blackwell; 2016.\n 29. \u0007Holtzclaw D, Toscano N, Eisenlohr L, Callan D. The safety of \nbone allografts used in dentistry: a review. J Am Dent Assoc 1939. \n2008;139(9):1192–1199.\n\t30.\t \u0007Green D, McKenzie R. Nuances of informed consent: the paradigm \nof regional anesthesia. Hosp Spec Surg. 2007;3(1):115–118. https://\ndoi.org/10.1007/s11420-006-9035-y.\n\t31.\t \u0007Watterson D. Informed consent and informed refusal in den-\ntistry. https://www.rdhmag.com/articles/print/volume-32/issue-9/ \nfeatures/informed-consent-and-informed-refusal.html.\n 32. \u0007Moreira NCF, Pachêco-Pereira C, Keenan L, et al. Informed con-\nsent comprehension and recollection in adult dental patients: a sys-\ntematic review. J Am Dent Assoc 1939. 2016;147(8):605–619.e7. \nhttps://doi:10.1016/j.adaj.2016.03.004.\n\t33.\t \u0007Strong DM, Shinozaki N. Coding and traceability for cells, tissues \nand organs for transplantation. Cell Tissue Bank. 2010;11(4):305–\n323. https://doi.org/10.1007/s10561-010-9179-3.\n\t34.\t \u0007Strong DM. The US Navy Tissue Bank: 50 years on the cutting \nedge. Cell Tissue Bank. 2000;1(1):9–16. https://doi.org/10.102\n3/A:1010151928461.\n 35. \u0007About OPOs. AOPO. http://www.aopo.org/about-opos/. Accessed \nMay 29, 2018.\n 36. \u0007Donate Life America: Organ, Eye, and Tissue Donation Registra-\ntion. Donate Life America. https://www.donatelife.net/. Accessed \nMay 29, 2018.\n 37. \u0007Organ Donation, Organ Donor Registry | organdonor.gov. https://\norgandonor.gov/index.html. Accessed May 29, 2018.\n 38. \u0007Orell S. Surgical bone grafting with “os purum,” “os novum,” and \n“boiled bone. J Bone Joint Surg. 1937;19:873.\n\t39.\t \u0007Forsberg H. Transplantatin of os purum and bone chips in the surgi-\ncal treatment of periodontal disease (preliminary report). Acta Odont \nScandinav. 1956;13:235.\n\t40.\t \u0007Scopp IW, Kassouny DY, Morgan FH. Bovine bone (Boplant). \nJ Periodontol. 1966;37(5):400–407.\n\t41.\t \u0007Scopp I, Morgan J, Dooner J, et al. Bovine Bone (Boplant) implants \nfor infrabony oral lesions. Periodontics. 1966;4:169–176.\n\t42.\t \u0007Pietrzak WS, Ali SN, Chitturi D, et al. BMP depletion occurs \nduring prolonged acid demineralization of bone: characteriza-\ntion and implications for graft preparation. Cell Tissue Bank. \n2011;12(2):81–88. \nhttps://doi.org/10.1007/s10561-009-\n9168-6.\n\t43.\t \u0007Pietrzak WS, Woodell-May J. The composition of human cortical \nallograft bone derived from FDA/AATB-screened donors. J Cranio-\nfac Surg. 2005;16(4):579–585.\n\t44.\t \u0007Aerssens J, Boonen S, Lowet G, Dequeker J. Interspecies differences \nin bone composition, density, and quality: potential implications for \nin vivo bone research. Endocrinology. 1998;139(2):663–670. https://\ndoi.org/10.1210/endo.139.2.5751."
  },
  {
    "page": 42,
    "content": "932\nPART VII     Soft and Hard Tissue Rehabilitation\n\t45.\t \u0007America GPN. Geistlich Biomaterials - USA Pharma. https://www \n.geistlich-na.com/en-us/.\n 46. \u0007ISO - International Organization for Standardization. https://www \n.iso.org/home.html. Accessed May 30, 2018.\n\t47.\t \u0007Albee FH. Studies in bone growth: triple calcium phosphate as a \nstimulus to osteogenesis. Ann Surg. 1920;71(1):32–39.\n 48. \u0007Peltier LF, Bickel EY, Lillo R, Thein MS. The use of plaster of paris \nto fill defects in bone. Ann Surg. 1957;146(1):61–69.\n 49. \u0007Campana V, Milano G, Pagano E, et al. Bone substitutes in ortho-\npaedic surgery: from basic science to clinical practice. J Mater Sci \nMater Med. 2014;25(10):2445–2461. https://doi.org/10.1007/\ns10856-014-5240-2.\n\t50.\t \u0007Samsell B, Moore M, Bertasi G, et al. Are bone allografts safe and \neffective for today’s dental practitioners? Dentistry. 2014;4(9):1–6. \nhttps://doi.org/10.4172/2161-1122.1000260.\n 51. \u0007Liu J, Kerns DG. Mechanisms of guided bone regeneration: a review. \nOpen Dent J. 2014;8:56–65. https://doi.org/10.2174/18742106014\n08010056.\n\t52.\t \u0007Sheikh Z, Hamdan N, Ikeda Y, et al. Natural graft tissues and syn-\nthetic biomaterials for periodontal and alveolar bone reconstruc-\ntive applications: a review. Biomater Res. 2017;21:9. https://doi \n.org/10.1186/s40824-017-0095-5.\n\t53.\t \u0007Tomlin EM, Nelson SJ, Rossmann JA. Ridge preservation for \nimplant therapy: a review of the literature. Open Dent J. 2014;8:66–\n76. https://doi.org/10.2174/1874210601408010066.\n 54. \u0007Mohan R, Bajaj A, Gundappa M. Human amnion membrane: \npotential applications in oral and periodontal field. J Int Soc Prev \nCommunity Dent. 2017;7(1):15–21. https://doi.org/10.4103/jispcd.\nJISPCD_359_16.\n 55. \u0007Callan DP. Guided tissue regeneration without a stage 2 surgical \nprocedure. Int J Periodontics Restorative Dent. 1993;13(2):172–179.\n 56. \u0007Crook K. GBR and sinus augmentation using autogenous and DFDB \nAllograft and Alloderm as the barrier. N M Dent J. 1999;50(2): \n24–26.\n\t57.\t \u0007Almazrooa SA, Noonan V, Woo S-B. Resorbable collagen mem-\nbranes: histopathologic features. Oral Surg Oral Med Oral Pathol \nOral Radiol. 2014;118(2):236–240. https://doi.org/10.1016/j \n.oooo.2014.04.006.\n\t58.\t \u0007Bartee BK. The use of high-density polytetrafluoroethylene mem-\nbrane to treat osseous defects: clinical reports. Implant Dent. \n1995;4(1):21–26.\n\t59.\t \u0007Gentile P, Chiono V, Carmagnola I, Hatton PV. An overview of \npoly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tis-\nsue engineering. Int J Mol Sci. 2014;15(3):3640–3659. https://doi \n.org/10.3390/ijms15033640.\n 60. \u0007Chen J, Zeng L, Chen X, et al. Preparation and characterization \nof bioactive glass tablets and evaluation of bioactivity and cyto-\ntoxicity in  vitro. Bioact Mater. 2018;3(3):315–321. https://doi \n.org/10.1016/j.bioactmat.2017.11.004.\n 61. \u0007Otto S, Kleye C, Burian E, et al. Custom-milled individual allo-\ngeneic bone grafts for alveolar cleft osteoplasty-A technical note. \nJ Craniomaxillofac Surg. 2017;45(12):1955–1961. https://doi \n.org/10.1016/j.jcms.2017.09.011.\n 62. \u0007Oryan A, Alidadi S, Moshiri A, et al. Bone regenerative medicine: \nclassic options, novel strategies, and future directions. J Orthop Surg. \n2014;9(1):18. https://doi.org/10.1186/1749-799X-9-18.\n\t63.\t \u0007Asa’ad F, Pagni G, Pilipchuk SP, et  al. 3D-printed scaffolds and \nbiomaterials: review of alveolar bone augmentation and periodon-\ntal regeneration applications. Int J Dent. 2016:1239842. https://doi \n.org/10.1155/2016/1239842.\n\t64.\t \u0007Barboza EP, Stutz B, Ferreira VF, Carvalho W. Guided bone \nregeneration using nonexpanded polytetrafluoroethylene mem-\nbranes in preparation for dental implant placements—a report of \n420 cases. Implant Dent. 2010;19(1):2–7. https://doi.org/10.1097/\nID.0b013e3181cda72c.\n 65. \u0007Rowe MJ, Kamocki K, Pankajakshan D, et al. Dimensionally stable \nand bioactive membrane for guided bone regeneration: an in vitro \nstudy. J Biomed Mater Res B Appl Biomater. 2016;104(3):594–605. \nhttps://doi.org/10.1002/jbm.b.33430.\n\t66.\t \u0007Ma B, Han J, Zhang S, et al. Hydroxyapatite nanobelt/polylactic \nacid Janus membrane with osteoinduction/barrier dual functions for \nprecise bone defect repair. Acta Biomater. 2018;71:108–117. https://\ndoi.org/10.1016/j.actbio.2018.02.033.\n\t67.\t \u0007Dasgupta A, Orgill D, Galiano RD, et al. A novel reticular dermal \ngraft leverages architectural and biological properties to support \nwound repair. Plast Reconstr Surg Glob Open. 2016;4(10). https://\ndoi.org/10.1097/GOX.0000000000001065.\n\t68.\t \u0007Maksoud M. Stem cell bone allografts in maxillary sinus and ridge \naugmentation, report of a case. J Dent Oral Biol. 2016;1(1):1–4."
  },
  {
    "page": 43,
    "content": "933\n36\nParticulate Membrane grafting/\nGuided Bone Regeneration\nC. STEPHEN CALDWELL\nT\nhe field of restorative dentistry has been through a para-\ndigm shift in recent years that has completely changed \ntreatment planning and the prospects for reconstruction \nof severely compromised dental cases. The use of dental implants \nin most treatment plans today offers the possibility of restorative \nsuccess using fixed prostheses in many situations that would have \npreviously been impossible. Meeting the demands and expecta-\ntions of our enthusiastic patient population requires the multidis-\nciplined implant team to perform at new and challenging levels of \nsophistication. As we attempt to restore these progressively more \ndifficult cases, the severely compromised bony ridge defects that \nwe encounter will continue to challenge team members to develop \nnew and predictable grafting techniques (Fig. 36.1).\nThe goal of any dental implant procedure is to restore the patient \nto optimal form, function, and esthetics. Through the combined \nefforts of a great number of clinicians and researchers, guidelines \nhave been established in regard to proper implant numbers and \npositioning based on possible prosthetic designs. The patient’s \nexisting bone volume often makes the proper placement and posi-\ntioning of implants difficult, if not impossible. Ideal treatment \nplanning in implant dentistry often requires the correction of sig-\nnificant alveolar ridge defects in regions where dental implants are \nindicated to support critical prostheses. Alveolar ridge defects are \ncaused by a variety of factors including developmental anomalies, \ntrauma, and most commonly, tooth extraction. After tooth loss a \npredictable resorptive process of the alveolar bone occurs in both \na horizontal and a vertical dimension1 (Fig. 36.2).\nThe loss of alveolar bone can pose a challenge both from the \nperspective of supporting a conventional removable prosthesis \nor placement of dental implants in an ideal position for func-\ntional and esthetic results. Before development of effective bone-\ngrafting techniques, implants were placed in regions where there \nwas available bony support, often leaving the restorative dentist \nwith the task of restoring an implant in a less than ideal position \nwithin the arch. The success of implant dentistry today has been \nlargely related to the advent of bone augmentation techniques \nthat allow regeneration of an ideal ridge form and placement of \nimplants in their ideal functional and esthetic positions2–6 (Fig. \n36.3).\nThe augmentation of bone volumes through grafting is an \neffective, but technique-sensitive process. It requires meticulous \nsurgical skill, practice, and knowledge to become proficient in \ncreating predictable bone growth before implant placement. \nComplications are plentiful in this discipline, leading to treat-\nment delays, patient and provider frustration, as well as possible \nneurosensory, vascular, and infectious issues. The dental implant \nsurgeon must have a firm understanding of the limitations \nencountered in various bone-grafting techniques to develop \nappropriate treatment plans. Clinicians must be able to not only \nprevent complications during the procedure, but also properly \naddress complications related to these issues should they arise \n(Box 36.1).\nIndications for Bone Grafting\nThe presence of an adequate volume of available bone is one of \nthe most important prerequisites for predictable implant place-\nment and osseointegration. Although loss in bone volume may \nresult from trauma, bone deficiency is most frequently due to the \nnormal physiologic process that occurs after tooth loss or extrac-\ntion. Studies have shown that resultant bone resorption after tooth \nremoval can be approximately 1.5 to 2 mm vertically and 3.8 mm \nin the horizontal plane within 6 months.7,8\nCurrently, bone regeneration procedures are widely accepted \nas a viable option for the treatment of edentulous deficiencies to \nbe restored with an implant-supported prosthesis. Implant clini-\ncians have a wide range of bone-grafting materials and procedures \nat their disposal. For years the gold standard in bone regenera-\ntion has been the use of autogenous (autograft) bone because \nof its inherent osteoconductive, osteoinductive, and osteogenic \nproperties (Box 36.2). Because autogenous bone is composed of \nthe patient’s own tissue, there is a reduction in the likelihood of \nimmunoreactions and possible infectious transmission. However, \nautogenous bone grafting has disadvantages, including the need \nfor a secondary surgical site, a potential increase in pain and dis-\ncomfort, bone-harvesting quantity restrictions, increased costs, \nand longer surgical procedures. Studies have shown that only \n61% of patients accept grafting with autogenous bone.9 Methods"
  },
  {
    "page": 44,
    "content": "934\nPART VII    Soft and Hard Tissue Rehabilitation\nthat minimize the inconvenience related to autogenous bone har-\nvests allow the surgical team the opportunity to use the boost of \nautogenous grafts without putting their patients through excessive \ndiscomfort. As tempting as it may be, the lack of incorporation \nof at least some autogenous bone in a large ridge augmentation \n(> 3 mm) can ultimately change the density of the final graft, \nits resistance to unpredictable remodeling, the overall ability to \nregenerate vertical volume, and to some degree the width of a \nA\nB\nC\nD\n• Fig. 36.1  Careful planning and surgical execution can provide patients with the opportunity to replace \ntheir missing teeth with restorations that are not only functional, but also esthetically pleasing. (A Preopera-\ntive CBCT Cross-section of severely compromised central incisor B) Cross-section of the same site after \ncompleting a large ridge augmentation. (C and D) Final restorations in the anterior graft site.\n• Fig. 36.2  The progressive resorption of the bony ridge after an extraction leads to a situation that com-\npromises all aspects of the restorative process. As resorption advances, less bone is available for implant \nplacement, thus compromising the final result."
  },
  {
    "page": 45,
    "content": "935\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nlarge horizontal graft site. Therefore ideally 50% autogenous bone \nshould be used in vertical regeneration cases and in large-volume \nhorizontal grafts.\nSuccess in any implant prosthesis requires the implants to be \nplaced in positions that provide ideal esthetics, function, comfort, \nand support. To be successful in the development of a favorable \nprosthesis, the number and positions of implants in an edentulous \nspace must be determined with a careful analysis of the relationship \nbetween the restorative prosthesis and the forces that will be exerted \non the final prosthesis. This is then combined with the functional \nand esthetic aspects of the case, ultimately dictating the relationship \nbetween the implants, bone, and opposing forces. All of these factors \nmust be considered in planning support for a prosthesis that func-\ntions well while maintaining the bone volume around its implant \nabutments. Clinicians too often try to bypass the grafting process, \neither to save time or because they are not experienced in advanced \ngrafting techniques. Insufficient bone in recipient sites leads to place-\nment of implants with inadequate diameters, shorter lengths, insuf-\nficient numbers, or less than ideal angulations. Compromises such \nas these can eventually lead to significant damage around an implant \nand the prosthesis it supports. Due to the fact that resorption and \nremodeling occur in every edentulous site, the need for adjunctive \nbone grafting must be considered and is often vital for a successful \noutcome.\nFailure to recognize the need for bone grafting leads to \nnumerous treatment issues, ranging from esthetic complica-\ntions to implant and prosthetic failure. Placing implants of \nsuboptimal sizes or in less than ideal numbers to bypass the \ngrafting process is a compromise that often leads to force-\nrelated failures of implant components, failure of the prosthe-\nsis itself, or accompanied bone loss. Ultimately, prosthetic and \nimplant morbidities may result. A multidisciplinary approach \nshould be taken to assess the optimal prosthetic solution for \nthe patient, based on the patient’s wishes, available bone, and \nother factors. After a prosthetic plan has been established, the \nclinician should begin planning the implant positions required \nto execute the prosthetic option. Once the sites for the spe-\ncific implants have been determined, the associated regions are \nevaluated for bony foundational support in that specific site. \nIf inadequate bone is available to successfully place an implant \nin a key location for the prosthesis, grafting should then be \nincluded in the treatment plan to build the appropriate bone \nvolumes (Fig. 36.4). \nCellular Bone Regeneration Process\nThe cellular development of bone in a deficient site involves a \ndelicate process that occurs over an extended period. This series \nof steps can be easily disrupted by cellular ingrowth, micromove-\nment, infection, or bacterial contamination. Therefore the process \nof guided bone regeneration (GBR) is always carried out in a pro-\ntected space where the natural step-by-step process of bone devel-\nopment can occur. The first phase of this regeneration process \ninvolves the recruitment of osteoblast precursors and growth fac-\ntors to the recipient area. This is accomplished primarily through \nthe existing bony recipient bed, its vasculature, and the graft mate-\nrial (i.e., autograft, allograft, xenograft). The second phase of the \nprocess is the resorption/deposition process. Host osteoprogeni-\ntor cells will infiltrate the graft within 7 days, and resorption and \ndeposition will occur via creeping substitution and osteoconduc-\ntion. The osteoblast precursors differentiate into mature osteo-\nblasts under the influence of osteoinductors and synthesize new \nbone during the first weeks. Growth factors involved in the bone \nformation process act on fibroblast and osteoblast proliferation, \nextracellular matrix deposition, mesenchymal cell differentiation, \nand vascular proliferation (Fig. 36.5 and Box 36.3). \n• Fig. 36.3  Loss of Soft and Hard Tissue. After tooth loss, bone loss \noccurs with respect to the prosthesis position. As the bone resorbs, the \nvertical and horizontal soft tissue support around teeth and implants dis-\nappears. This results in the exposure of the failing implant body, together \nwith a future nonesthetic implant prosthesis.\n\t•\t \u0007Alveolar ridge width\n\t•\t \u0007Alveolar ridge height\n\t•\t \u0007Alveolar ridge angulation\n\t•\t \u0007Available restorative space\n\t•\t \u0007Maxillary/Mandibular alveolar ridge relationship\n\t•\t \u0007Proximity to vital structures\n\t•\t \u0007Bony undercuts/defects\n\t•\t \u0007Maxillary Sinus pneumatization\n\t•\t \u0007Available autogenous donor sites\n\t • BOX 36.1\t    \u0007Hard Tissue Considerations With Implant \nTreatment Planning\n1.  Osteogenic Grafts\n\t•\t \u0007Osteogenic bone grafts originate from autogenous origin and are \ncomprised of live, viable cells capable of differentiation and formation of \nbone. \n2.  Osteoinductive Grafts\n\t•\t \u0007Osteoinductive grafting materials provide a biological stimulus (proteins \nand growth factors) that induce the progression of mesenchymal stem \ncells and other osteoprogenitor cells toward osteoblast lineage. \n3.  Osteoconductive Grafts\n\t•\t \u0007Osteoconduction is the process that allows the bone graft to be \nconducive to forming bone, thereby acting as scaffolding for bone \ngrowth.\n\t• BOX 36.2\t   \u0007Biologic Bone Healing Classification"
  },
  {
    "page": 46,
    "content": "936\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\nD\nE\n• Fig. 36.4  Malpositioned Implants. (A) Implants placed in compromised bone sites result in a compro-\nmised final prosthesis. (B and C) Implants positioned too far facially will increase prosthesis morbidity and \ncompromise esthetics. (D and E) Implants positioned too far lingual will result in an overcontoured prosthe-\nsis, but also will place the implants at a biomechanical disadvantage.\n• Fig. 36.5  Guided bone regeneration combines the science of bone regeneration with the management \nof space maintenance for development of planned bony configurations. With the use of bone screws and \na barrier membrane, bone regeneration may take place."
  },
  {
    "page": 47,
    "content": "937\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nTreatment Planning in the Compromised \nEdentulous Ridge\nTreatment planning for implant-supported restorations in \nedentulous spaces requires a clear understanding of the resorp-\ntive patterns of bone loss. As a ridge resorbs, available bone for \nsupport of dental implants disappears, preventing placement of \nimplants in key locations for restorative success. After tooth loss \nthe initial pattern of bone resorption starts with loss of the lateral \n(buccal) aspect of the ridge, eventually leading to a decrease in \nvertical ridge height. As this resorptive process occurs, the posi-\ntion of implant-supported restorations can change substantially \nsecondary to the new interarch relationship between the maxilla \nand the mandible. For instance, the loss of maxillary posterior \nteeth with the accompanied loss of the buccal bony ridge width \nwill often lead to development of a posterior crossbite. This is \ncompounded as the mandible deteriorates into a division C or \nD ridge, resorbing until the remaining mandibular basal bone \nis actually positioned laterally, away from the remaining maxil-\nlary bone. Treatment planning must combine final restorative \nloading of implants in a manner that will not place unreason-\nable forces on the implant-bone interface leading to excessive \nbone remodeling and implant failure. The current ability of the \nimplant team to regenerate bone in critical sites has increased the \npredictability of final prostheses and in doing so has reduced the \nnumber of implant failures (Fig. 36.6).\nEdentulous Site Assessment\nThe treatment planning process begins with a reasonable assess-\nment of the extent of the bony deficiency and the capacity of a \nregenerative procedure to create adequate support for implants in \ntheir ideal positions for comfort, esthetics, function, and support. \nAs the extent of bone regeneration is evaluated, care must be taken \nin the beginning stages to identify the expected positions of each \nrestoration or prosthesis using accurate restorative wax-ups. Evalu-\nation of the relationship between the required restorative positions \nand the bony deficiency will then provide insight into the volume \nand shape of the bone that will need to be regenerated. At this \nBone Remodeling—the natural phenomena in which old bone is \ncontinually replaced with new bone. This balanced process is critical for \nmaintenance of healthy bone mass.\nBone Modeling—these changes in size and shape of bone in a region are \nadaptations in response to stress or loading forces directed to the bone.\nBone Repair—the physiologic process in which the body facilitates the \nrepair of a bone fracture.\nBone Regeneration—the development of new bone growth in deficient \nsites using surgical protocols that apply the principles of osteogenesis, \nosteoinduction, and osteoconduction for directed bone growth.\nGuided Bone Regeneration (GBR): technique to reconstruct alveolar bone \ndeficiencies via the use of a barrier membrane to exclude epithelial cells \nand allow slower-growing cells to form bone.\nGuided Tissue Regeneration (GTR): technique to regenerate lost \nperiodontal structures via the use of a barrier membrane to exclude \nepithelial or connective tissue ingrowth.\n\t• BOX 36.3\t   \u0007Bone Healing and Grafting Definitions\nA\nB\nC\nD\n• Fig. 36.6  Resorptive Pattern in Posterior Mandible. (A) The normal bony contours in a coronal view of the \nmaxillary and mandibular arches. (B) The initial resorption of bone in the mandibular arch from Division A to \nDivision B. (C) As bone resorbs further (Division B to Division C), the resultant mandibular position is more \nlingually (medially) inclined in comparison with the maxillary arch. Further loss in the lower arch leaves the \nremaining bone in a more lateral position than the maxillary arch. (D) Often when bone resorbs, the posi-\ntion of the implant is compromised, as can be seen by the cross-sectional image depicting a perforation."
  },
  {
    "page": 48,
    "content": "938\nPART VII    Soft and Hard Tissue Rehabilitation\nstage the most predictable surgical approach and bone graft mate-\nrial (e.g., autograft, allograft, xenograft) is selected to ensure ade-\nquate bone support can be developed for ideal implant placement.\nIn site assessment treatment planning, complications often \nresult when the clinician fails to understand the relationship \nbetween the limitations of various regenerative grafting tech-\nniques and the predictable development of the required bone \ncontours and bone volume needed for overall restorative suc-\ncess. It is not possible to treat every bony defect with simple \nor limited techniques that a clinician learns early in his or her \nlearning curve. This discipline requires a variety of approaches \nto meet the reality of advanced bone resorption, and as the \nsurgeon gains experience, correct application of techniques will \nlead to predictable outcomes. When the incorrect technique \nis used, inadequate bone volume will be regenerated, leading \nto either compromised restorative results or a potential fail-\nure of the prosthesis. These problems not only compromise the \nlocal grafting site, but they can also destroy bone around sur-\nrounding teeth, creating a worse situation than was originally \nencountered (Fig. 36.7).\nA\nB\nC\nD\nE\n• Fig. 36.7  (A) Maxillary left lateral and canine implants were placed in a poorly executed bone graft site, \nleading to a devastating esthetic situation. (B) Because of the malpositioned implants, a removable partial \ndenture was placed to hide the implant position. (C) Maxillary left lateral incisor replacement resulted in a \ndefect after two unsuccessful attempts to graft a missing facial cortical plate. (D) The loss of the cortical \nbone raised the defect to the level of the apices of the adjacent teeth. (E) The only remaining bone is found \nalong the palatal cortical plate."
  },
  {
    "page": 49,
    "content": "939\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nIn an ideal setting, prevention of ridge resorption starts with aware-\nness of ridge preservation and limiting bone loss before major ridge \ndefects occur. This starts with atraumatic extraction techniques, aggres-\nsive socket grafting, and communication among the members of the \nimplant team in respect to the need for timely preservation of the \nridge. The longer the patient remains without an implant in an extrac-\ntion site, the greater the chance that adjunctive grafting procedures will \nbe necessary. Use of effective grafting materials is critical for successful \nresults. For patients with long-term edentulism, the surgeon needs to \nbe fully aware of the patterns of bone resorption to understand the \ncurrent underlying bony architecture and to correctly choose a grafting \nprotocol that will build the correct volume for the intended prosthesis. \nThis working knowledge of ridge resorption and expertise in the use \nof effective diagnostic imaging to accurately assess bone volumes gives \nthe clinician the opportunity to correctly organize a reasonable and \npredictable implant treatment plan (Fig. 36.8).\nThe use of cone beam computed tomographic (CBCT) imaging, \ntogether with proper diagnostic digital or cast models, allows the cli-\nnician to create a clear prosthetic plan. The restorative wax-up can \neasily be interlaced into computed tomographic (CT) imaging soft-\nware for assessment of the bone volumes needed for proper implant \nsupport in key positions. This whole process has been advanced with \ndigital scans and virtual crowns/implants. The digital plans, once inte-\ngrated into CBCT images, allow the team to visualize the relation-\nships between bone volume and restorative components. Once the \ndimensions and volume of the graft have been determined, proper \napplication of bone-grafting techniques and materials is necessary \nto ensure that the intended volume can be achieved. At this point \nthe patient should be educated on the details of the regenerative pro-\ncedures and a timeline of treatment. Advanced grafting procedures \ndelay completion of the final prosthesis, and patients should be aware \nof the extent of the inconveniences that will need to be tolerated dur-\ning this surgical sequence (Fig. 36.9, Fig. 36.10). \n1\nDivision B\n2. Small diameter\nOsteoplasty\n3\nGraft\n• Fig. 36.8  Treatment Planning Decision Tree. In a Division B ridge, \nvarious treatment options are possible, including osteoplasty, Division \nB implants, or bone grafting. However, each treatment plan has advan-\ntages and disadvantages that should be taken into consideration with \nrespect to the final prosthesis (e.g., type 1 fixed prosthesis [FP-1], FP-2, \nor FP-3).\nA\nB\nC\n• Fig. 36.9  (A) Use of three-dimensional imaging allows the implant team the opportunity to visualize the \nrelationship between the osteotomy and the surrounding bone and teeth. (B) Examination of cone beam \ncomputed tomography cross sections allows assessment of proposed implant sites and their relationship \nto available bone. In this case there is not enough bone to support an implant without additional grafting in \nthe site. (C) The absence of adequate buccal bony support indicates the need to regenerate at least 5mm of \nbone. Bone around this coronal 5mm of the implant is critical for functional support during loading."
  },
  {
    "page": 50,
    "content": "940\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\nD\nE\n• Fig. 36.10  (A) Planning a case in three-dimensional software starts with incorporation of the restorative \nwax-up into the cone beam computed tomographic image. (B) Implants are then introduced in posi-\ntions that will support the crowns in their required restorative positions. (C and D) As the cross sections \nare evaluated in this particular case, it is apparent that there is not enough ridge width for placement of \nimplants in the existing bone. This preliminary view indicates that augmentation of the ridge will be neces-\nsary for proper implant alignment and support. (E) Evaluation of the actual bony ridge at the time of surgery \nconfirms the previous digital assessment of the bony deficiency."
  },
  {
    "page": 51,
    "content": "941\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nBony Defect Morphology Considerations and \nClassification\nOne of the most difficult components of bone augmentation \ntreatment planning is learning how to predict the amount of bone \nthat will actually be required to develop the proper foundational \nsupport that the restorative treatment plan requires. Evaluation \nof the clinical situation, review of two-dimensional radiographs, \nassessment of models with restorative wax-ups, and information \nfrom CBCT all play a role in determining where bone will be \nrequired and how much bone will be needed to successfully graft \nthe site. The concept of determining graft volume is even more \nimportant when autogenous bone is incorporated into the regen-\nerative process. The location of an autogenous bone harvest often \ndetermines how much volume of bone can be retrieved. The chin \nand ramus are the primary sites for significant donor volumes used \nin block grafting, but these sites can provide only a limited volume \nof bone. If these local donor sites are inadequate, bone can be \ntaken at the apex of many osteotomy sites. In addition, the use of \na Piezosurgery unit and bone scrapers may be utilized to harvest \ncortical shavings. (Fig. 36.11)\nIn cases where a previous procedure fails to properly develop \nadequate bone volumes for ideal implant positioning, reflection of \ntissue over the grafted site will reveal inadequate bony support for \nthe intended implant size and position. At this time, critical deci-\nsions must be made to prevent the chance of compromising the \noverall case success because of this shortfall. The easiest solution is \nto stop and regraft the site, but this causes inconvenience for the \npatient, embarrassment for the surgeon, and an overall increase in \nthe treatment time and expense. The alternative is to either ignore \nthe deficiency, placing the implant in a deficient site or attempt-\ning supplemental grafting around the exposed implant sur-\nfaces. Implant placement in compromised sites without grafting \nultimately limits the implant size or forces improper positioning of \nthe implant in the alternative position. This option then leads to a \ncompromised result and incurs unnecessary risk for future failure. \nFor more experienced surgeons, simultaneous implant placement \nwith additional grafting can be attempted, but this is limited to \ncases where the surrounding basal bone allows proper implant \npositioning application of grafting principles. (Fig. 36.12), \n(Fig. 36.13).\nBony Defect Classification\nDetermining if an edentulous site will require augmentation \nshould start with an initial assessment of the bony defect. \nCareful review of the topography of the recipient site includes \nreview of the bone levels on adjacent teeth, bony protuberances, \nthe depth of the actual defect itself, variations in the vertical \nheight of the remaining walls of the ridge, and the condition of \nthe surrounding soft tissue. A successful graft depends on the \npassage of various cellular components from the surrounding \nrecipient site’s bony walls and vascular components into the \ndeveloping graft site. The larger the distance from these bony \nsurfaces to the peripheral graft components, the greater is the \nchallenge for the various cells to migrate to the outer limits of \nthe particulate graft. The surrounding prominent bony con-\ntours also provide additional support and protection for the \ngraft particles, limiting micromovement that usually results in \ncompromised bone growth. These fixed bony surfaces can also \nhelp with containment of graft particles and eventual support \nof membranes. Depending on the morphology and topography \nof the defect, the clinician may determine the difficulty and \npotential success of augmentation procedures. The following \nclassification system is based on the bony contours of the defi-\ncient area.\n• Fig. 36.11  This series of cross sections was prepared from a mandible showing a patient who has a very \nthin overall ridge width throughout the anterior and posterior regions. As this case is considered for aug-\nmentation, concern should be directed to the potential for graft failure because of the overall discrepancy \nbetween the thin basal bone width and the required width for implant positioning."
  },
  {
    "page": 52,
    "content": "942\nPART VII    Soft and Hard Tissue Rehabilitation\nBone Defect Classification\n\t1.\t \u0007Depression\n\t2.\t \u0007Concavity\n\t3.\t \u0007Trough\n\t4.\t \u0007Elevation/Prominence\n\t5.\t \u0007Vertical (Height)\n\t6.\t \u0007Buccal & Lingual Cortical Destruction\n\t7.\t \u0007Complex/Multi-Dimensional\n(Fig. 36.14), (Fig. 36.15).\nDepression\nA simple depression in a potential implant site is a bony defect \nmeasuring less than 3.0 mm. If these types of defects are left \nuntreated, they can contribute to either a ridge dehiscence or \na fenestration when an implant is placed in the region. These \ndepressed areas are usually grafted at the time of implant \nplacement and they do not require the use of extensive space \nmaintenance techniques. When a depression is noted, it can \nA\nB\nC\nD\nE\nF\n• Fig. 36.12  Osseous Defects. (A) When evaluating osseous defects, the three-dimensional relationship of bone \nloss versus adjacent tooth positioning is crucial. (B) Severe vertical resorption requires regeneration to avoid \ncomplications with support, esthetics, and poor healing. (C) The position of the adjacent teeth and roots should \nbe evaluated to determine the prognosis of an implant-related restoration. (D) Defects that destroy both the \nfacial and palatal cortical plates limit the choice of regenerative procedures that can be used. (E and F) When \nthere is a sharp declining ridge adjacent to a natural tooth, placement of an implant 1.5 mm away creates a \nfailing situation beginning at time of the initial implant placement. As time passes, both the tooth and the implant \nwill be compromised. Positioning the implant away from the natural tooth can limit this proximity problem; how-\never, the implant body position will be too apical, which affects the esthetics and biomechanics."
  },
  {
    "page": 53,
    "content": "943\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nA\nB\n• Fig. 36.13  Cone Beam Computed Tomography (CBCT) Evaluation of Osseous Defects. (A) The use \nof interactive treatment planning should be completed to determine any possible bony deficiencies. (B) \nThree-dimensional CBCT can be used to obtain a better ideal of the bone morphology.\nA\nB\n• Fig. 36.14  (A) Evaluation of the clinical appearance of an edentulous space can easily mislead clinicians \nwith respect to the underlying bony contours. (B) Flap reflection reveals a severely resorbed facial aspect \nof the edentulous ridge.\nB\nA\n• Fig. 36.15  (A) Facial and palatal ridge resorption with coronal and apical defects. This will require facial \nand palatal regeneration. (B) Severe facial resorption with some remaining palatal bony cortical plate."
  },
  {
    "page": 54,
    "content": "944\nPART VII    Soft and Hard Tissue Rehabilitation\nbe covered with a layer of allograft material and covered with \na collagen membrane. Long-term isolation of the particles is \nnot as critical in these situations as compared to larger defects \nwhere fibrous in-growth can be catastrophic. Depression type \nbony defects are the most predictable types of grafts and \nadvanced surgical expertise is not as critical as in other defect \ntypes. \nConcavity\nThe concave shaped ridge defect has a significant horizontal \ndepression or bony defect in the middle of the ridge that exceeds \n3.0 mm in overall depth. These defects have reasonable remnants \nof bone surrounding the site that can be used for graft support, \ncontainment of particles, and delivery of an adequate supply of \ncells for angiogenesis. Regeneration in these sites is relatively \npredictable and most of the implant support will still be pro-\nvided by the surrounding autogenous bone. A concave defect \nwill require adequate space maintenance for the development of \nsignificant horizontal bony growth requiring the use of a static \nsupport system (e.g. bone screws, a titanium supported mem-\nbrane) that is maintained for at least 5 months. (Fig. 36.16A, \nFig. 36.16B). \nTrough\nSevere ridge defects may on occasion destroy the ridge to the depth \nof the lingual/palatal cortical plate. These are most commonly \nseen in single tooth defects, especially after a traumatic extraction. \nThe resulting defect provides clearly defined lateral walls of bone \nformed by the roots of the adjacent teeth and most of these sites \nalso have an apical wall of bone that approximates the prior apex \nof the tooth. Although these are deep and involved defects, they \nprovide protection for the graft components through their actual \nconfiguration. Fixation of tenting screws in the middle of these \ndefects assures maintenance of the needed space for regeneration. \nThe presence of four actual bony walls provides a ready source \nof cellular components and the resulting regenerative potential is \nexcellent. Therefore, grafting in these defects can be completed \nmore predictably than a wide and exposed concave defect that \nrequires complex vertical support for development of graft depth, \nprotection from removeable prostheses, and general exposure to \nmicromovement (Fig. 36.17). \nElevation/Prominence\nWhen ridge defects extend across the span of several teeth, the \ntopography of the lateral and vertical surfaces of potential graft sites \ncan vary significantly. A horizontal concavity or isolated depression \nin a recipient site can be complicated by adjacent elevated promi-\nnences of cortical bone. The maxillary cuspid region would be a \ntypical site where the original tooth extended beyond the surround-\ning basal bone. The loss of the cortical plate on an adjacent premolar \nwould be a distinct contrast to the prominent cortical support over \na cuspid. Other examples would be changes in the overall facial con-\ntours created by malpositioned teeth. Situations like this also can \ndevelop as various teeth are lost over an extended period of time and \nthe resulting loss of ridge support emphasizes the facial contours of \nthe remaining compromised teeth. Grafting around these promi-\nnent regions does not require much support in the elevated area, but \ngood space maintenance is needed directly adjacent to the elevated \nportion of the recipient site (Fig. 36.18). \nVertical (Height)\nAccurate assessment of the vertical ridge height in a potential aug-\nmentation site is critical from a treatment planning standpoint. \nAs the vertical defect height is increased, the crown-implant ratio \nbecomes problematic with respect to esthetics and biomechani-\ncal factors. Regeneration of vertical height is a complex grafting \nprocedure and that is usually reserved for clinicians with advanced \nexperience and skills in complex soft tissue manipulation. A true \nvertical defect is in essence a through and through defect with \nthe loss of both cortical plates. These defects will require that the \nconcept of space maintenance be moved into a 3rd dimensional \nskill. A thin sharp-edged ridge top is usually present, with two \ndense cortical surfaces approximating each another with little to \nno medullary component between them. The resulting surface \narea requiring regeneration involves the palatal/lingual aspect, the \nvertical height defect region, and the highly resorbed facial/buccal \nportion of the ridge. The limiting factor with these types of defects \nis the level of the bone on the interproximal aspect of the adjacent \nA\nB\n• Fig. 36.16  (A). Concave Ridge Defect: This ridge has multiple contours to the generalized horizontal \ndefect. There is an angular coronal defect at the top of the ridge, as well as a serious apical defect that \nleaves a large region that will need to be regenerated. (B). This Concave defect requires significant support \nfor the membrane to regenerate adequate bone in the deeper portions."
  },
  {
    "page": 55,
    "content": "945\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nB\nC\nA\n• Fig. 36.17  Trough Defect Type: (A) 3D CBCT image demonstrating the loss of interproximal bone. This \nwill greatly limit development of adequate height of the interproximal papilla in the final restoration. (B and \nC) Three-dimensional and clinical images of severe horizontal defect with loss of bone on adjacent teeth. \nThere is still fairly good vertical height of the palatal cortical plate.\n• Fig. 36.18  This ridge defect has a complex nature to its topography. \nThe prominent portions of the facial aspect of the ridge will help with sup-\nport and regenerative components to the more compromised adjacent \nareas. Careful evaluation of the remaining surfaces demonstrate examples \nof other defect types.\nMM\nII\nIII\nIV\nV\nVI\n25\n20\n15\n10\n5\nAnterior Mandible\n• Fig. 36.19  Vertical Ridge Defect Type: Lower anterior complex ridge defect \nwith serious vertical component that destroyed both the facial and lingual \ncortical plates. The precipitous vertical drop in bone height from the inter-\nproximal tooth bone to the base of the defect requires correction of the verti-\ncal defect for reasonable implant placement and esthetics. Placement of an \nimplant in the middle of the depressed region would still involve a horizontal \ndeficiency. Preservation of the bone levels on the adjacent teeth is a priority."
  },
  {
    "page": 56,
    "content": "946\nPART VII    Soft and Hard Tissue Rehabilitation\nteeth. Clinicians must understand that it is not possible to raise a \nridge higher than the adjacent bony level. In complex cases, this \nlimitation can often require removal of an adjacent tooth to pro-\nvide a higher adjacent interproximal height for potential vertical \ndevelopment. This is most often seen in anterior areas of the max-\nilla and mandible where the aesthetic demands of a case require as \nmuch vertical regeneration as possible (Fig. 36.19). \nBuccal/Lingual (Palatal)\nRidge assessment must include a three-dimensional review of the \nbony resorption on the lingual/palatal aspects as well as on the \nfacial and vertical regions. Severe ridge defects can often include a \nsignificant lingual/palatal component that moves the regenerative \nprocedure into a complex surgical category. The most common \nsite for a true “Hour Glass” ridge defect is in the anterior portion \nof the maxilla or mandible. Unfortunately, these sites are techni-\ncally challenging with respect to tissue release, space maintenance, \nand graft containment. In general, the palatal tissue is very thick \nand dense, limiting any significant stretching or expansion of tis-\nsue over a graft and membrane. For example, the lingual tissue in \nthe mandible is paper-thin and procedures to release and extend \nlingual tissue over a graft has a potential for button-holing a flap \nor for potential complications in the region of vessels, salivary \ncomponents, and muscle attachments. Fixation of tenting screws \nin palatal defects requires extensive reflection of the palatal tissue \nand accurate anchorage of the membrane beyond the borders of \nthe bony defect. Membrane fixation on the lingual aspect of the \nmandible is a delicate process and awareness of the vital structures \nif critical. Regeneration in these sites is limited to clinicians with \nextensive surgical and bone grafting experience (Fig. 36.20 A, B). \nComplex/Multi-Dimensional\nComplex ridge defects are made up of a combination of the con-\nfigurations described above. These sites will more than likely have \ndeep horizontal destruction that is combined with at least one \nvertical component. These type of defects vary from a severe single \ntooth site to a complete section of a quadrant. It is the recognition \nof the complexity of these situations that is critical for success. The \nsheer volume of bone that needs to be regenerated can only be \ndetermined with advanced integration of 3D Imaging and CBCT \nsurveys. The restorative requirements then dictate the actual loca-\ntions for implant support and subsequently the areas where spe-\ncific volumes of bone will be need to be regenerated. At that point, \nthe specific technique can be chosen by its potential for devel-\nopment of large volumes of bone. These cases require harvesting \nsignificant volumes of autogenous bone and use of isolating mem-\nbranes capable of separating the developing graft sites from soft \ntissue infiltration. Complex cases should be avoided until a clini-\ncian has extensive experience in development of bone in each of \nthe basic situations described above (Fig. 36.21). \nA\nB\n• Fig. 36.20  Hour-glass Ridge Defect: The images in examples (A) and \n(B) demonstrate the destruction of the facial and palatal cortical plates. \nRegeneration in these sites will require growth in both dimensions. Failure \nto regenerate the palatal portion of the site will lead to facial positioning of \nthe implant and most likely, a facial bony deficiency.\nA\nB\n• Fig. 36.21  Complex Ridge Defect: The images in (A) and (B) demonstrate the severity of bone loss that \ncan occur over time and in highly destructive situations. These defects require advanced training and \nexperience for predictable grafting success."
  },
  {
    "page": 57,
    "content": "947\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nSoft Tissue Considerations\nPatient-to-patient comparisons of the soft tissue drape surround-\ning the natural teeth often demonstrate significant differences in \ncolor, surface consistency, tissue thickness, and overall esthetics. \nThis is emphasized when a very thin and friable tissue drape sur-\nrounds an anterior tooth. Differentiation of patients into either a \n“thick biotype” or a “thin biotype” is a critical tool that should be \nused during routine restorative care and anterior implant–related \ntreatment planning. Cook et al.10 demonstrated the simplest way to \ndetermine a patient’s tissue biotype is through the evaluation of the \nvisibility of a periodontal probe in the sulcus of an anterior tooth. A \npatient with a thick biotype will not show any translucence of the \nprobe through the sulcular tissue. In contrast, a thin biotype will \nallow visualization of the coloration of a probe through the sulcular \ntissue.10\nA patient with a thick biotype has tissue with a robust pink \nstippled appearance. This dense tissue drape forms a thick layer \nof tissue that is very forgiving when dental restorations are placed \naround natural teeth and when dental implants are involved. The \nthin biotype patient, however, presents a much more difficult \nchallenge. These patients often have a thinner labial plate thick-\nness, a narrower keratinized tissue width, and a greater distance \nfrom the cement-enamel junction to the initial alveolar crest. This \ndelicate layer of tissue is so thin that the periodontal probe can be \nvisualized when it is lightly placed in the sulcus. Patients with a \nthin biotype are also more prone to tissue recession, complicating \nthe predictability of restorative esthetics around anterior teeth. As \nteeth migrate out of position or rotate in the arch, the prominence \nof the roots can increase, complicating the soft tissue situation \neven more. Thin layers of tissue around the maxillary anterior \nteeth require meticulous planning to hide underlying crown mar-\ngins (Box 36.4 and Fig. 36.22).\nPatient biotype and bony architecture must be considered early in \nall implant treatment planning to avoid a variety of issues that become \nvery complex compared with similar situations around natural teeth. \nThis early planning allows the surgical team the opportunity to incor-\nporate tissue grafting into each surgical stage, allowing deficiencies to \nbe avoided or to at least be minimized. These problems can be sig-\nnificantly complicated when major bone grafting has been completed \nin the region, resulting in elevation of the mucogingival junction \nand repositioning of the mucosa into the zone surrounding implant \nrestorative margins. The tissue thickness in postoperative graft sites is \noften very thin, and development of an adequate emergence profile \nfor crowns requires development of at least 3 mm of keratinized tis-\nsue thickness over the top of the implant body prior to restoring the \nimplant. Restorative dentists often find it difficult to mask the dark \ntones in the coronal portions of natural teeth with endodontic-related \ncolor changes. This problem is compounded in a patient with a thin \nbiotype as the color passes through the thin facial bone and thin tis-\nsue consistency. This problem with translucence is a reoccurring issue \nwith implant restorations. Problems related to the translucence of the \ndark hue of the implant body and the abutment through thin tis-\nsue can significantly complicate the esthetics surrounding the final \nrestoration.11 A patient with a thick biotype and thick facial cortical \n\t•\t \u0007Gingival biotype\n\t•\t \u0007Width of keratinized tissue\n\t•\t \u0007Soft tissue thickness\n\t•\t \u0007Vestibular depth\n\t•\t \u0007Smile Line\n\t•\t \u0007Frenum attachments\n\t• BOX 36.4\t   \u0007Soft Tissue Evaluate and Assessment \nConsiderations\nA\nD\nE\nB\nC\n• Fig. 36.22  (A) Thin biotype exhibiting metal show-through. Tissue biotype can be defined by the trans-\nlucence of a probe through the sulcus. (B) Thick biotype yellow probe (i.e., no-show through). (C) Thick \nbiotype with dark probe (i.e., no show-through). (D) Intermediate biotype with visible probe through sulcular \ntissue (i.e., show-through). (E) Thin biotype with probe (i.e., show-through)."
  },
  {
    "page": 58,
    "content": "948\nPART VII    Soft and Hard Tissue Rehabilitation\nbone makes an ideal implant patient when restorations are placed and \nminor deficiencies can be hidden behind the thickened tissue mass. A \npatient with a thin biotype does not usually have a robust facial bone \nthickness, and any remodeling changes in facial bone density or thick-\nness can greatly alter the restorative esthetics (Fig. 36.23).\nAdditional problems related to tissue thickness develop in \nimplant cases as time passes and bony changes occur around \nthe implant body. Esthetics around an implant restoration \noften change because there is an active bone remodeling pro-\ncess around implants that often results in a loss of facial cor-\ntical thickness. This can be a serious problem if an implant is \nplaced in a site with very thin facial bone or in a site where the \nquality of bone lateral to the implant resorbs as the prosthesis is \nloaded and the functional forces are centered on the coronal 5 \nmm of the implant body. If recession or slight bone loss occurs, \nthe facial aspect of the implant can be exposed, creating a dark \nhue that shows through the overlying tissue and contributes to a \npoor esthetic situation.\nAs anterior immediate implants are considered, recommenda-\ntions for the actual location of the implant in the socket have changed \nsignificantly as resorptive patterns in immediate implants have been \nstudied over time. An immediate implant currently should be placed \nsignificantly palatal to the facial cortical plate to allow for bone \nremodeling. This paradigm shift has occurred over time as the rec-\nommendations for implant diameters in anterior spaces have steadily \ndecreased to accommodate for these changes in facial bone thickness \nand complications related to color translucence through the soft tis-\nsue. Current recommendations specify that the facial aspect of the \nimplant body should be placed at least 3 mm palatal to the inner edge \nof the facial cortical plate. Additional authors currently recommend \ngrafting on the facial aspect of anterior immediate implant sites with \nbovine particulate grafts and connective tissue graft to minimize long-\nterm changes.\nWhen a clinician is preoperatively aware of a problem related to \ntissue biotype, it is possible to plan ahead procedurally to maintain \nor possibly change the biotype, leading to optimal esthetic out-\ncomes. Patients with a very thin biotype can be evaluated for intra-\noperative supplementation using connective tissue grafts and facial \nbone grafts to create a more forgiving tissue drape over the implant \nsite. Because thicker cortical bone volumes promote thicker bio-\ntypes, the bony architecture and soft tissue drape may be modi-\nfied in an esthetic zone before implant placement and restoration. \nAdvance planning also provides the implant team an opportunity \nto inform the patient about these issues and to point out potential \nesthetic complications before commencing treatment. Any com-\npromise in a patient’s expectations must be addressed, especially if \nthe patient is not interested in grafting to modify the tissue type.\nImplant restorative care in thin biotypes often requires tis-\nsue augmentation as the case ages to create a thick, dense layer of \nfibrous tissue over the implant body and any deficiencies involving \nthe adjacent natural teeth. Connective grafting procedures are read-\nily available to increase the thickness of the tissue drape in situations \nsuch as this. Subepithelial connective grafting procedures may use \npalatal connective tissue, dense connective tissue from the maxillary \ntuberosity, or acellular dermal matrix (i.e., OrACELL [Salvin Den-\ntal Specialties], AlloDerm [BioHorizons IPH, Inc.], PerioDerm) \nas the source of donor tissue. A thick layer of connective tissue is \ninserted into the deficient regions with tunneling procedures, allow-\ning the repositioned tissue flap to provide the blood supply to the \ndeveloping graft site. The use of the subepithelial approach allows \nthe implant clinician to produce a final tissue tone and color that \nmatches the adjacent natural tissue (Fig. 36.24A, B and C).\nA\nB\nC\n• Fig. 36.23  Tissue Biotypes. (A and B) Thick biotype. (C) Thin biotype."
  },
  {
    "page": 59,
    "content": "949\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nLarge edentulous regions in the posterior portions of both arches \noften have little, if any, remaining keratinized tissue. These deficient \nregions can be augmented “before” the bone grafting procedure using \n“free tissue grafting techniques.” In these cases, the epithelial layer of \nthe palate is used as the source of the donor tissue. This usually creates \nlarge zones of thicker keratinized tissue with a distinct pinkish white \ncolor, duplicating the color of the tissue where the graft was harvested. \nThis dense tissue is not always acceptable from an esthetic standpoint \nwhen it is placed in the anterior maxilla. Some of this color issue can \nbe reduced by taking the graft from the posterior portion of the vault \nof the palate, away from the rugae found in the anterior palate. Use of \nthinner palatal grafts can also limit some of these annoying color issues. \nIt is still important to keep in mind that the actual “thickness of the \ntissue” is important in the development of an emergence profile for the \nfinal restorations. At least 3 mm of tissue thickness is needed for not \nonly this emergence pattern but is also important from the standpoint \nof implant health as the implant is restored and maintained.\nThe importance of the depth of soft tissue above the platform \nheight has been described by Linkevicius et al.12 in respect to \nmaintenance of crestal bone height. Implants with less than 3 \nmm of tissue height over an implant were shown to be suscep-\ntible to crestal bone loss. The authors compared both regular \nroot form implant and platform switch designs, and all implants \nwere shown to be susceptible to this specific soft tissue related \nbone loss.12\nMost anterior treatment plans involving major bone-grafting \ntoday incorporate the addition of layers of connective tissue, \nallograft, or bovine graft particles with membrane coverage to \nlimit excessive bone remodeling in these critical regions. These \nconcepts are critical in “immediate implant” cases, where many \ncases require both soft tissue and hard tissue supplementation.\nAugmentation and implant treatment planning should include \na careful assessment of any frenum attachments that could inter-\nfere with the grafting process. Grafting in regions where there \nis still a highly placed frenum can be compromised during \nthe healing phase when remnants of the frenum place tension on the \nclosed incision line, contributing to incision line opening. The maxil-\nlary frenum should routinely be removed if it appears to be prob-\nlematic for future tissue health. The lower frenum and lateral frenum \nattachments can create a similar tension effect, but the routine perios-\nteal release incision in these graft sites usually eliminates this particular \nproblem in most cases (Fig. 36.25). \nGuided Bone Regeneration Protocol\nRegeneration of bone in a specified area requires that a protected zone \nbe created where the development process can be completed with-\nout interference. Block grafting and other approaches have previously \nbeen described for development of significant amounts of bone regen-\neration in appropriate sites. This chapter describes various protocols \nthat use the principle of “space maintenance and tissue exclusion” for \ndefined bone development. One of the most important components \nof the GBR process is space maintenance via the use of barrier mem-\nbranes. Dahlin et al.13 and many other authors have described the \nA\nC\nB\n• Fig. 36.24  Soft Tissue Augmentation over the facial aspect of an implant site with “grey tone” to the \noverlying soft tissue. (A). Grey coloration over the facial of the implant site. (B) A connective tissue graft is \ndrawn into a tunnel prepared over the facial of the implant site. (C). The final restoration in place following \nthe successful grafting procedure."
  },
  {
    "page": 60,
    "content": "950\nPART VII    Soft and Hard Tissue Rehabilitation\ndevelopment of new bone growth using membranes that contained \ngrafts materials, allowing only neighboring bone or bone marrow cells \nto migrate into the bony defect, without ingrowth of competing soft \ntissue cells from the overlying mucosa.\nIn general, membranes are used in GBR procedures to act as \nbiological and mechanical barriers, preventing the invasion of \nnon–bone-forming cells (e.g., epithelial cells), whereas slower-\nmigrating bone-forming cells are drawn into the defect sites.14 \nAs bone defects heal over time, there is a competition between \nsoft tissue ingrowth and slower action bone-forming cells that are \ntrying to migrate into the area. Soft tissue cells tend to migrate at \na much faster rate than bone-forming cells and if left unchecked, \nthey will infiltrate the developing site. Therefore the primary goal \nof barrier membranes is to allow for selective cell repopulation \nand to guide the proliferation of various tissues during the heal-\ning process.15 Below the protective membrane, the regeneration \nprocess proceeds with angiogenesis and migration of osteogenic \ncells into the site. This initial blood clot is replaced by woven \nbone after vascular ingrowth, and later is transformed into load-\nbearing lamellar bone. This ultimately assists in the support of \nhard and soft tissue regeneration.16 If a barrier membrane is not \nused, the bony defect will fill in with soft tissue, resulting in \ncompromised bone growth (Boxes 36.5 and 36.6).\nIn the following guided bone regeneration protocol, there \nexists nine distinct steps for successful and predictable outcomes;\n\t1.\t \u0007Incision and Flap Design\n\t2.\t \u0007Flap Reflection\n\t3.\t \u0007Removal of Residual Soft Tissue\n\t4.\t \u0007Recipient Bed Preparation\n\t5.\t \u0007Tissue Release\n\t6.\t \u0007Membrane Placement\n\t7.\t \u0007Space Maintenance\n\t8.\t \u0007Bone Graft Placement\n\t9.\t \u0007Closure\nStep 1: Incision and Flap Design\nIncision design is one of the keys to a predictable regenera-\ntive result. Ideal incision designs provide complete access to \nthe surgical site without compromising the integrity of the \nA\nB\nD\nC\n• Fig. 36.25  (A) High frenum attachment. (B to D) Removal of frenum and placement of healing abutment.\nPrimary closure\nAngiogenesis for necessary blood supply and undifferentiated \nmesenchymal cells\nSpace maintenance/creation to facilitate adequate space for bone ingrowth\nStability of wound to induce blood clot formation\n\t• BOX 36.5\t   \u0007“PASS” Principles for Predictable Bone \nRegeneration69\nWoven bone = 60–100 μm/day\nLamellar bone = 1 μm/day\nFibrous tissue = 1000 μm/day (1 mm/day)\n\t• BOX 36.6\t   \u0007Growth Rates of Soft Tissue Versus Hard \nTissue"
  },
  {
    "page": 61,
    "content": "951\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nsurrounding tissue. As the incision is planned the anatomy of \nthe adjacent papilla must be considered to prevent any dam-\nage that will compromise the esthetics and function of the tis-\nsue postoperatively. The patient’s biotype and the amount of \nkeratinized tissue is always reviewed, and any deficiencies in \nattached tissue must be accounted for in the incision design. \nThe incision must be planned in a way that keeps incision lines \naway from critical regions where graft particles or blocks could \nbecome exposed. Observation of sound surgical principles in \npreparation of incisions is critical for maintenance of the blood \nsupply to all of the involved tissues. Wide-based incisions are \nalways important to prevent interruptions in the vascular sup-\nply to the flap.\nFailure to properly plan the incision design of a flap during \ngrafting can pose numerous issues, mainly related to incision line \nopening postoperatively. Incision line opening exposes the regen-\neration site to an influx of oral pathogens, soft tissue ingrowth, \nand loss of the graft materials that were intended to be isolated \nduring the maturation process (Fig. 36.26A, B and C and Box \n36.7).\nThe coronal incision is usually placed on the crest of the \nridge, favoring a location closer to the palatal aspect if pos-\nsible. It is important that the scalpel make a continuous full-\nthickness cut through the tissue and the periosteum, ending on \nthe actual bone. Incisions that are irregular and leave regions of \nattached tissue and periosteum will lead to maceration of the \nflap as it is reflected. This shredding of tissue also compromises \nthe periosteal layer that is the primary source for blood to the \nunderlying bone. A survey of the available keratinized tissue \nmust be completed before making an incision. In regions of \nbountiful attached tissue, the surgeon can use his discretion \nin the location of the incision through the keratinized regions. \nIn regions where the keratinized tissue is limited, the incision \nshould at least “split” the distance between the two edges of \nthe keratinized tissue. It is always best to try to keep incision \nlines away from areas that are key to regenerative volume and \nprotection (Fig. 36.27A,B, C, D).\nWhen possible, the papillae should be preserved while inci-\nsions are prepared. If there is a good papilla adjacent to a graft \nsite, the incision should be designed to avoid involvement of \nthe papilla or it should be moved to the adjacent interproxi-\nmal space. If the papilla is absent or is flat, the incision can \nbe directed to the root approximating the graft or it can be \nmoved to the adjacent space. It should be kept in mind that \nregeneration of a compromised interproximal papilla is still \none of the most difficult endeavors in soft tissue surgery today. \nAn incision in the middle of an anterior space of a “thin bio-\ntype” patient can either permanently scar the region or can \ncompletely destroy the papilla form and esthetics in the final \nrestoration.\nThe positioning of vertical releasing incisions is one of the most \nimportant parts of the incision. A broad-based releasing incision \nshould be prepared to maintain the blood supply to the flap and \nto allow elevation, retraction, repositioning, and suturing without \ntension. It should be kept in mind that most graft sites have a \ncompromised soft tissue component that becomes a greater issue \nas the complexity of the underlying architecture increases. Most \nof these sites have a minimal keratinized band of tissue at the \ncrest of the ridge, tapering quickly to the mobile mucosa of the \nvestibule. Full-thickness vertical release incisions should generally \nbe planned to extend to the apical portion of mucogingival junc-\ntion. In larger bone graft sites the vertical release will often extend \ndeeper into the vestibule to help with complete release of the flap \nA\nB\nC\n• Fig. 36.26  Incision Design. (A) Ideal crestal incision when adequate \nattached tissue is present. (B) Crestal or more lingually placed incision \nthat preserves the limited amount of keratinized tissue. (C) Crestal full-arch \nincision designed to preserve the limited facial zone of keratinized tissue.\n\t•\t \u0007Consideration of tissue biotype as incision is planned\n\t•\t \u0007Maintain ideal papilla forms and levels\n\t•\t \u0007Preservation and utilization of keratinized tissue in region\n\t•\t \u0007Maintain the integrity of the full-thickness flap during reflection\n\t•\t \u0007Design of lateral releasing incisions in locations that minimize exposure \nof graft particles\n\t•\t \u0007Maintaining wide-based incisions to provide adequate blood supply to \nflap\n\t• BOX 36.7\t   \u0007Principle Concepts to Be Practiced in \nGrafting Incisions"
  },
  {
    "page": 62,
    "content": "952\nPART VII    Soft and Hard Tissue Rehabilitation\nduring a tension-free closure. The location of vertical releases \nshould be moved away from the most critical zones of the graft, \nlimiting encroachment of the incision closure on the bulk of the \ngraft particles and membrane margin. This is very important in \ncases where the barrier membrane is nonresorbable and exposure \nof a margin of the membrane can contribute to graft failure. In \nthose cases, it is best to completely move the release to a com-\npletely different interproximal space. Properly placed incisions \nwill position the margins of the flap over host bone instead of the \ngraft particles and the membrane (Figs. 36.28 A and B). Vertical \nincisions have been related to scar formation in the surgical sites \nafter healing. Most scars are related to irregular incisions and poor \nadaptation of the wound edges at the time of suturing.\nThe goal of any implant treatment plan would be placement of \nrestorations in the middle of a zone of attached keratinized tissue \nthat is at least 3 mm thick from the level of the platform of the \nimplant to the margin of the tissue surrounding the implant. Few \nresorbed ridges have an abundance of keratinized, and in most \nsituations the surgeon will need to incorporate development of \na thick tissue zone that will provide an emergence profile for the \nrestoration and protection of the implant-bone interface. As the \nincision is prepared, the keratinized tissue dictates the path of the \nA\nB\nC\nD\n• Fig. 36.27  Design for Papilla Preservation. (A and B) Ridge incision, making sure to “score” the bone to \nobtain full-thickness flap; (C and D) incision continued to include a vertical release.\nA\nB\n• Fig. 36.28  Papilla-Sparing Incision. (A) Initial incision. (B) Full-thickness reflection."
  },
  {
    "page": 63,
    "content": "953\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nincision line and often determines how easily the wound will be to \nclose and to withstand the strain on the incision line during heal-\ning. If adequate attached tissue is not present, soft tissue grafting \nshould be completed either before the augmentation procedure, as \na portion of the grafting protocol, or after the implants are placed. \nTissue development options include autogenous free tissue grafts, \nautologous connective tissue grafts, acellular dermal matrix (Allo-\nDerm, OrACELL), or combinations of Mucograft and soft tissue \ngrafts. In addition, when inadequate keratinized tissue is present, \nthe incision should be placed toward the lingual portion of the \nremaining keratinized tissue, preserving as much attached tissue \non the facial as possible. This allows for greater resistance to mus-\ncle pull and will decrease incision line opening (Fig. 36.29 A and \nB) (Fig. 36. 30). \nStep 2: Flap Reflection and Site Preparation\nFull-Thickness Reflection\nElevation of the tissue to expose the recipient site requires reflection \nof a full-thickness mucoperiosteal flap. This should be completed in \nan uninterrupted release of the flap that includes the surface mucosa, \nsubmucosa, and periosteum. This initial release is accomplished with \nan angled curette or a scalpel that is used to score the bone, ensuring \ncomplete penetration through the tissue layers and the periosteum. \nAs the tissue is reflected, the underlying bone should be “scraped” \nwith the curette or periosteal elevator in a side-to-side motion. It is \nimportant to confirm at this stage that the complete flap has been \nfreed from the bone and that it is freely drawing away from the bony \nsurface. Partial-thickness reflection leads to tissue trauma or shred-\nding of the flap itself. Tissue that has been compromised in this man-\nner results in slower healing and a higher morbidity. When using a \nperiosteal elevator (i.e., 2–4 Molt) for this flap release, the edge should \nalways rest on the bone to prevent tearing through of the tissue flap.\nThe tissue thickness on the lingual aspect of the mandible is \nvery thin and friable. This tissue can be easily torn during reflec-\ntion of the flap and manipulation of the tissue during the graft-\ning procedures. Resulting “buttonhole” openings compromise the \nblood supply to the surrounding tissue that is needed for coverage \nover the graft site, leading to compromised results postoperatively. \nTearing or buttonholing the lingual flap may also expose the graft \nsite and increase the possibility of margin necrosis coronal to the \ntear. This exposure may lead to a total graft failure (Fig. 36.31 A \nand B).\nIf the lingual flap is torn during the procedure, it can some-\ntimes be repaired using 5–0 chromic suture, approximating the \nedges of the tear and preventing tension on the weak site. It is rec-\nommended to use a collagen membrane below these fenestrations \nto assist with healing and to isolate the graft materials. Mainte-\nnance of the blood supply to the tissue flap is important, requiring \nthat all tension on the flap be minimized.\nA flap covering a graft that does not have complete release of \npressure on the two margins of the flap will often pull open dur-\ning the healing process (incision line opening). Tension on the flap \ncompromises the blood supply to the tissue along the suture line \nthat is under pressure. This pressure leads to necrosis and even-\ntual separation of the two edges of the flap closure. Once this has \noccurred the flap cannot be sutured back into place, and the graft \nsite is open for contamination and tissue ingrowth. The success of \nbone grafting is largely dependent on the maintenance of space \nfor bone development and isolation of the graft particles during \nthe slow process of osteogenesis. Soft tissue ingrowth, bacterial \ncontamination, and migration of graft particles predictably com-\npromise regenerative results.\nA\nB\n• Fig. 36.29  Alternative Release Incisions. (A) The vertical releasing incision is often moved laterally to the \nadjacent papilla space to obtain adequate access. This will minimize incision line opening when larger graft \nvolumes are obtained. (B) Extending the incision to an adjacent tooth also minimizes the possibility of the \nincision over top of the graft site.\n• Fig. 36.30  Poorly Placed Release Incision. The incision should be posi-\ntioned away from the graft site and also be more lateral to obtain a more \nbroad-based flap design."
  },
  {
    "page": 64,
    "content": "954\nPART VII    Soft and Hard Tissue Rehabilitation\nThe typical graft site requires that the overlying flap be released \nenough for extension of the flap at least 5 mm beyond the edge of \nthe adjacent margin for a tension-free flap closure. The only way \nto achieve this free flap release is complete release of the periosteal \nlayer, allowing the elastic fibers of the underlying flap to stretch as \nthe flap is drawn over the graft site. \nStep 3: Removal of Residual Soft Tissue and \nPathology\nBefore bone grafting, all evidence of soft tissue remnants should \nbe eradicated. Soft tissue fibers left on the recipient site can limit \nproper attachment of the newly regenerated bone to the underly-\ning basal layer. These fibrous tissue remnants are the same tissue \nthat the barrier membrane is attempting to exclude from the site. \nEarly fibrous tissue growth in the wound simply bypasses that crit-\nical barrier and starts fresh tissue development right in the center \nof the graft site (Fig. 36.32 A and B). \nStep 4: Recipient Bed Preparation\nPreparation of the recipient site for an augmentation is very \nimportant in the development of a healthy ridge. The recipient \nsite is usually covered with a dense layer of cortical bone that \ndoes not easily provide a blood supply to a developing graft. The \nprocess of decortication of the recipient base is used to open \nmultiple pathways through this thick layer of bone. These pilot \nholes create an open pathway to the underlying trabecular bone \nwhere blood flow into the graft site will increase revasculariza-\ntion (angiogenesis) and introduce bone growth factors into the \ngraft site.17 The decortication is usually accomplished with the \nuse of cross-cut fissure burs or small, round burs that are used \nto perforate the cortical plate. Copious amounts of chilled saline \nshould be used to prevent thermal trauma (Fig. 36.33 A and B).\nThe decortication process initiates the regional acceleratory \nphenomenon, which describes the cellular stimulating technique \nused to accelerate the healing rate of a graft site. In this process, \nbone decortication is used as a “noxious stimulus,” and it has been \nshown that the healing rate of a graft site can be increased 2 to \n10 times the normal healing rate by initiating the regional accel-\neratory phenomenon (RAP).18 This acceleration is accomplished \nby the introduction of platelets to the area that ultimately release \ngrowth factors including platelet-derived growth factor (PDGF) \nand transforming growth factor (TGF). Ultimately the decortica-\ntion process will lead to better integration of the graft to the host \nbone. \nA\nB\n• Fig. 36.31  Lingual Flap Design and Exposure. (A) The lingual should be reflected to expose the entire \nlingual surface; however, care must be exercised not to tear the flap. Perforating or a buttonhole in the flap \nwill compromise the graft site. (B) If this occurs, it is very difficult to mend the tear, potentially compromis-\ning the closure of the graft site or predisposing the region to incision line opening over the healing graft. \nIncision line opening leads to an increased morbidity of the graft site.\nA\nB\n• Fig. 36.32  (A and B) Removal of fibrous/soft tissue with course barrel bur."
  },
  {
    "page": 65,
    "content": "955\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nStep 5: Tissue Release\nSuccessful augmentation procedures require maintenance of an \nintact tissue closure along the incision line during the healing pro-\ncess. One of the most common surgical complications that clini-\ncians will experience early in their learning curve is incision line \nopening. The failure of maintaining this tissue union is directly \nrelated to an inadequate release of tension on the tissue flap as it \nis stretched over the widened graft space. Clinicians will find that \nit is highly unlikely to pull a tissue flap over any sizable graft site \nwithout first altering the integrity of the flap itself.\nThe most important concept in augmentation procedures is \ntotal membrane coverage of grafting materials from the time of \nmembrane placement to completion of the graft maturation pro-\ncess. Success is directly related to the overall management of the \nsoft tissue flap during flap closure. A successful case starts with \nthe incision and continues with proper flap reflection of an intact \nperiosteal layer, proper membrane positioning, and completion \nwith a tension-free flap closure.\nTissue Release Technique\nExamination of the exposed inner surface of a reflected flap will \nreveal a smooth, shiny layer of the periosteum. The periosteum is \ncomposed of a thin, firm layer of dense tissue that has no elastic \nfibers. This binding layer limits any significant elongation of the \nflap as it is stretched over a graft site. A shallow incision through \nthe dense tissue “releases” the tight band of pressure on the under-\nlying tissue flap. The tissue directly below the periosteum is pri-\nmarily composed of elastic-type fibers, and once the periosteum \nhas been released, the entire flap can be stretched. This simple \nreleasing incision ultimately allows tension-free closure over the \ngraft site (Fig. 36.34 A B and C) site (Fig. 36.35 A and B). \nStep 6: Membrane Selection and Placement\nBarrier membranes are generally used in guided bone regen-\neration procedures to act as biological and mechanical barriers \nagainst the invasion of fibrous tissue into the developing graft \nsite. The membrane also will allow for the migration of the \nslower-migrating bone-forming cells into the defect sites During \nthe bone regeneration process, there is a competition between \nsoft-tissue and bone-forming cells to invade the surgical site. In \ngeneral, soft-tissue cells migrate at a much faster rate than bone-\nforming cells. Therefore, the primary goal of barrier membranes \nis to allow for selective cell repopulation and to guide the pro-\nliferation of various cells during the healing process. Below the \nprotection of the membrane, the regeneration process is allowed \nto continue unchecked with early angiogenesis and migration of \nosteogenic cells. The initial blood clot is replaced by woven bone \nafter vascular ingrowth, which later is transformed into load-\nbearing lamellar bone. This will ultimately support the hard- and \nsoft-tissue regeneration. If a barrier membrane is not utilized, \nlack of isolated space maintenance will result in soft-tissue inte-\ngration and compromised bone growth.\nTypes of Membranes\nMembranes are typically classified as resorbable or nonresorbable. \nNonresorbable membranes have included titanium foils, expanded \npolytetrafluoroethylene (e-PTFE), and dense polytetrafluoroeth-\nylene (d-PTFE) with or without titanium reinforcement. Resorb-\nable membranes are typically made of polyesters (e.g., polyglycolic \nacid, polylactic acid) or tissue-derived collagens (e.g., AlloDerm \nGBR, Pericardium, Ossix Plus). Non-resorbable membranes are \nbio-inert materials and require a second surgical procedure for \nremoval after bone regeneration is complete. Resorbable mem-\nbranes are naturally biodegradable and have varying resorption \nrates. However, all membranes, non-resorbable or resorbable, dif-\nfer in their biomaterial and physical characteristics. These varied \ncharacteristics can often be associated with advantages and disad-\nvantages in various clinical situations (Box 36.8).\nNon-Resorbable Membranes. Non-resorbable membranes \nexhibit excellent biocompatibility, superior mechanical strength, \nincreased rigidity, and generally achieve more favorable space \nmaintenance than unsupported resorbable membranes. How-\never, wound dehiscence is more common with non-resorbable \nmembranes, and these membranes have the disadvantage of the \nneed for a second surgery. This second procedure can result in an \nincreased morbidity, higher costs, and over-all patient discomfort. \nThe most common types of non-resorbable membranes include \npolytetrafluoroethylene (PTFE) and titanium mesh.\n\ta.\t \u0007Expanded PTFE membranes — The expanded PTFE mem-\nbrane (e-PTFE) was the first type of membrane used in implant \ndentistry and was the gold standard for bone regeneration in \nthe 1990s. The e-PTFE membrane was advantageous as it pre-\nvented fibroblasts and connective-tissue cells from invading the \nB\nA\n• Fig. 36.33  Host Site Decortication. (A) The host site is prepared with \na tapered cross-cut fissure bur (e.g., 169 L) to initiate angiogenesis. (B) \nThe decortication must be deep enough to initiate bleeding, thus allowing \nblood vessels into the area (i.e., angiogenesis)."
  },
  {
    "page": 66,
    "content": "956\nPART VII    Soft and Hard Tissue Rehabilitation\nbone defect, yet they allowed the osteogenic cells to repopu-\nlate the graft area. The most common e-PTFE membrane in \nimplant dentistry was GORE-TEX® (W.L. Gore & Associates, \nInc.; Flagstaff, Ariz.).\nThe two sides of e-PTFE membranes were composed of dif-\nferent layers. One side was approximately 1 mm thick with 90 \npercent porosity, which impeded the growth of epithelium; The \nother side was approximately 0.15 mm thick with 30 percent \nA\nB\nC\n• Fig. 36.34  Tissue Release Procedure. (A) Adequate flap release around bone graft sites is the most criti-\ncal step for tension-free flap closure and predictable graft success. (B) A single shallow incision through \nthe periosteum is prepared inside the flap while maintaining tension from elevating the flap. (C) The clear \nseparation of the periosteal edges as the flap is extended and the elastic fibers allow the flap to stretch \n(i.e., tension-free).\nA\nB\n• Fig. 36.35  Extended Periosteal Release Procedures. (A) The incision may be extended on the mesial \nand distal aspect of the graft site to allow increased mobility of the flap when it is extended. (B) After blunt \ndissection of the periosteal release with scissors (i.e., scissors should be parallel to the flap), the flap can \nbe freely extended over the graft site. This release must be completed until the flap can be repositioned at \nleast 5 mm beyond the lingual aspect of the graft site."
  },
  {
    "page": 67,
    "content": "957\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nporosity, which provided space for new bone growth and lim-\nited fibrous tissue ingrowth.19\nThe e-PTFE membranes had a high incidence of exposure, thereby \nresulting in an increased infection rate because of the ingrowth of bac-\nteria into the highly porous structure. Additionally, the porous struc-\nture, with an approximate pore size of 5–20 micrometers, allowed for \nsoft-tissue ingrowth, leading to increased difficulty in removal.\n\tb.\t \u0007High-density PTFE membranes — Because of the associated \ncomplications of e-PTFE membranes, a higher density material — \nless than 0.3 microns — was developed in the early 1990s under the \nname Cytoplast™ (Osteogenics Biomedical; Lubbock, Texas). This \nhigh-density PTFE (also termed dense PTFE or d-PTFE) has been \nshown to have a lower risk of bacterial colonization in comparison \nto e-PTFE membranes, therefore resulting in fewer infections. \nThe high density and small pore size of the membrane prevents \npassage of bacteria through the membrane, while allowing oxygen \ndiffusion and passage of small molecules. Because of the lack of tis-\nsue ingrowth into the 0.3 micron pores, d-PTFE membranes are \nmuch easier to remove. Clinical use of d-PTFE has demonstrated \nthat localized membrane exposure does not always dictate failure \nof the developing graft. If the d-PTFE membrane can be main-\ntained for at least 6 weeks, removal at that time or later will often \nbe followed with development of a reasonable bony ridge. \n(Fig. 36.36).\n\tc.\t \u0007Titanium-reinforced PTFE membranes — The addition of \na Titanium strut to a PTFE membrane allows the membrane \nto be shaped into a form that will develop bone in the con-\ntour and volume required by the restorative plan. These types \nof membranes are especially useful in the treatment of large os-\nseous defects where varied thicknesses of bone are dictated by \nan irregular recipient topography. Studies of GBR procedures \nusing titanium-reinforced nonresorbable membranes have \nshown great success with horizontal and vertical alveolar ridge \naugmentation because of their ability to maintain space, mini-\nmize graft mobility, and exclude soft tissue ingrowth.20–24 (Fig. \n36.37 ) (Fig. 36.38).\n\td.\t \u0007Titanium Mesh Titanium mesh is a non-resorbable barrier \nthat has been shown to be effective in maintaining space with-\nout collapsing. Titanium foils are flexible and can be bent and \nmanipulated to mold around a bony defect. Titanium mesh \nhas demonstrated predictable biocompatibility and features \nholes within the mesh that allow for maintenance of the blood \nsupply from the periosteum. The primary disadvantage of tita-\nnium mesh is related to an increased incidence of wound dehis-\ncence’s and overall difficulty in maintaining soft-tissue coverage \nduring the lengthy healing process. Exposure of the mesh may \nlead to an increased rate of infection and patient discomfort, \nleading to early removal of the mesh. \nResorbable Membranes. Resorbable membranes exhibit the \nadvantage of no second-stage surgery for removal, thus decreas-\ning discomfort and morbidity to the patient. However, the draw-\nbacks of collagen include an unpredictable resorption time, which \nmay adversely affect the amount of bone formation. Resorbable \nmembranes derived from xenogeneic collagen for use in GBR pro-\ncedures are the most popular membranes utilized in implant den-\ntistry today. The various types of resorbable membranes include \ncollagen, pericardium, and acellular dermal matrix.\nResorbable collagen membranes consist of either type I or type III \ncollagen from bovine or porcine origin. Collagen membranes are easy \n\t1.\t \u0007Tissue compatibility — Ideally, the membrane should be biocompatible, \nresulting in no inflammation or interaction between the membrane and \nthe host tissue that could lead to wound dehiscence or a local infection.\n\t2.\t \u0007Space maintenance — The membrane should have a generally firm \nconsistency to help maintain the regenerative space and to prevent loss \nof the defined ridge shape required by the restorative plan.\n\t3.\t \u0007Stabilization of the blood clot — The membrane should provide \nstabilization of the blood clot, allowing the regeneration process to \nprogress and reducing connective tissue integration into the defect.\n\t4.\t \u0007Cell Occlusiveness — The porosity of the membrane should prevent \nfibrous tissue from invading the graft site. A larger pore size may \ninhibit bone formation by allowing the in-growth of faster-growing \nsoft tissue cells. When the pore size is too small, limited cell migration \ninhibits collagen deposition and ultimately contributes to poor graft \ndevelopment.\n\t5.\t \u0007Mechanical Strength — The membrane should have high durability \nand mechanical strength to protect the blood clot and resist passage of \nunwanted cells and bacteria. This same material strength is important \nwhen the membrane is tacked to the apical portion of the recipient site. \nA fragile membrane can easily tear around the fixation tack, releasing \nthe anchorage of the membrane.\n\t6.\t \u0007Predictable resorption rate — The resorption time of the membrane \nshould coincide with the regeneration rate of bone tissue. The continued \npresence of the membrane is dependent on the location of the graft, the \navailable vascularity in the region, and the quantity of graft material.\n\t7.\t \u0007Easy to modify and manipulate — The membrane should be capable \nof size and shape alteration while maintaining adequate stiffness to \nprevent collapse into the graft site.\n\t• BOX 36.8\t   \u0007Ideal Barrier Membrane Characteristics\n• Fig. 36.36  D-PTFE membrane with titanium reinforcement depicting \nspace maintenance principle, which allows  for angiogenesis and the bone \nregeneration to progress. (Image adapted from Osteogenic Biomedical).\n• Fig. 36.37  Polytetrafluoroethylene (d-PTFE) Membrane. Clinical view of \nd-PTFE membrane."
  },
  {
    "page": 68,
    "content": "958\nPART VII    Soft and Hard Tissue Rehabilitation\nto manipulate and have favorable effects on coagulation and wound \nhealing, variable cross-linking, low antigenicity and high tensile \nstrength.25 Additionally, they inhibit epithelial cells, promote the \nattachment of connective-tissue cells, and increase platelet aggre-\ngation, which leads to wound stabilization and increased healing.\nCollagen constitutes over 50 percent of the proteins in the \nhuman body. As the collagen membrane is degraded through enzy-\nmatic reactions, the process resembles normal tissue turnover.26–33 \nToday, most collagen membranes are derived from allogenic or \nxenogeneic sources, which have become popular in implant den-\ntistry. They act as scaffolding for osteoconduction, increase plate-\nlet aggregation and stability of clots, and allow for the attraction \nof fibroblasts for healing. Collagen membranes are manufactured \nwith a variable resorption rate, which occurs through inflamma-\ntory cell biodegradation. The resorption rate is altered via the \nmanufacturing process by the amount of cross-linking.\nCollagen barriers are available in various forms:\n\ta.\t \u0007Collagen tape / plugs are mainly used to control bleeding \nand maintain the blood clot within extraction sites. Collagen \ntape/plugs are usually a soft, pliable, sponge-like material that \nrapidly absorbs blood, thereby creating an artificial clot. The \ncollagen allows aggregation of platelets, which results in the \ndegranulation and release of bone-growth factors. Collagen \ntape/plugs have a resorption time of approximately 10–14 days \nare not indicated for guided bone regeneration procedures.\n\tb.\t \u0007Regular collagen membranes resorb in three to four months \nand are mainly used in guided bone regeneration for small- to \nmedium-size bony defects. Ideally, primary closure is recom-\nmended to decrease graft morbidity.\n\td.\t \u0007Extended collagen membranes resorb in four to six months \nand are used for larger bony defects that require longer heal-\ning periods. These membranes are modified by increasing the \ncross-link density. Cross-linked collagen membranes are most \ncommonly used in guided bone regeneration procedures for \nlarger bony defects requiring longer healing time and graft con-\ntainment.\n\te.\t \u0007Pericardium Membranes are most commonly of either bovine or \nporcine origin, with bovine having a greater collagen content. They \ngenerally consist of three layers with collagen and elastic fibers in \nan amorphous matrix. Their surface is porous, which allows for \ncellular attachment and proliferation, yet has an increased density \nfor soft-tissue exclusion. (Fig. 36.39 A, B, and C).\n\tf.\t \u0007Acellular Dermal Matrix (ADM) is a biocompatible \nhuman (allograft) connective-tissue matrix derived through \na process of removing all cells within the dermis. Because \nof the cells being removed during the manufacturing pro-\ncess, no viruses may be transmitted. Additionally, because \nof the acellular nature of this membrane, no inflammatory \nreactions or rejection will occur. The inert allograft, when \nused as a membrane, acts as an architectural framework that \nallows for fibroblast migration and vascularization. Allo-\nDerm is an acellular dermal matrix originally developed \nin 1994 to be used as a skin allograft for burn patients.34 \nIt has been used in the medical and dental literature as an \nallograft for various procedures because of its ability to \nrapidly vascularize and to increase soft tissue thickness. In \nthe dental literature, AlloDerm has been successfully used \nfor root coverage, thickening of soft tissues, and GBR.35,36 \nAlloDerm GBR is a thinner version (thickness ranges from \n0.5 to 0.9 mm) of the original AlloDerm product (thickness \nranges from 0.9–1.6 mm), specifically designed for GBR. \nAlloDerm GBR has been successfully used as a barrier mem-\nbrane and has also been shown to significantly increase soft \ntissue thickness by 45% and 73% from baseline at 6 and 9 \nmonths, respectively (baseline 0.55 ± 0.16 mm to 0.80 ± \n0.26 mm at 6 months and 0.95 ± 0.28 mm at 9 months; \nP < 0.0033), when used as a barrier membrane for GBR of \nhorizontal alveolar ridge deficiencies.37,43 (Fig. 36.40 A, B, \nand C). \nSizing and Positioning of Membranes\nThe selection of the membrane type is one of the most impor-\ntant aspects of bone regeneration protocol. The choice of a specific \ntype of barrier membrane is directly related to the ultimate success \nof the regenerative process. With numerous resorbable and non-\nresorbable membranes available, each one has specific properties \nthat either help or hinder the isolation properties of the proce-\ndure. These properties relate ultimately to the workability of the \nmaterial and the longevity of its protection of the underlying graft \nparticles.\nThe size of the membrane must be large enough to com-\npletely cover the entire graft site after the bulk of the graft \nhas been placed in the recipient site. As the membrane is then \nstretched over the graft, it must be wide enough and long \nenough to guarantee that all of the graft particles will be iso-\nlated from any soft tissue or bacterial ingrowth. Experience \nindicates that the minimum membrane will be 20 × 20 mm \nand in almost all large graft sites, use of a 20 × 40 mm mem-\nbrane will be needed. Attempting to piecemeal two or three \nsmall membranes together is not only difficult, but also intro-\nduces another variable into the concept of graft isolation over \nan extended time frame. The most efficient way to trim and \nshape a large piece of dermal matrix or connective tissue is to \nwet a tongue depressor in saline and then use this as a “cutting \nboard” for the membrane (Fig. 36.41).\nPositioning of membranes around teeth is very critical to reduce \ncomplications. The use of d-PTFE requires a minimum of 2 mm \nbetween the edge of the membrane and the side of an adjacent \nroot surface. d-PTFE membranes with titanium struts should be \ntrimmed in a manner that prevents a lateral extension of the strut \n• Fig. 36.38  Polytetrafluoroethylene (PTFE) Membrane: Clinical image \ndepicting dense PTFE membrane prior to modification of the 2mm free \nzone adjacent to each tooth (Photo courtesy of Dr. John Hamrick)."
  },
  {
    "page": 69,
    "content": "959\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nin the region of the coronal aspect of the graft site. Titanium struts \nthat are positioned close to the interproximal root surfaces will often \nlead to membrane exposure and a compromised graft volume in \nthe region. Newer d-PTFE membranes are designed to keep these \nlateral extensions located away from these critical regions. Specific \nelimination of all sharp edges or rough margins is critical in the \nelimination of membrane perforation through thin regions of the \noverlying flap. GBR techniques using titanium mesh require 2 mm \nof clearance from the root of a tooth because of similar issues.\nWhen using resorbable membranes around teeth, the 2-mm \nrule is not a critical factor, and resorbable membranes can be \nplaced directly against the roots of the adjacent teeth without \ncausing a membrane failure. Acellular dermal matrix does not \nneed to be separated from root surfaces, keeping in mind that this \nsame membrane is used in routine periodontal procedures for root \ncoverage. The only complication with placing resorbable mem-\nbranes directly against natural roots is related to primary wound \nclosure in the root proximity. Membranes must be smooth, and \nthey should allow the overlying flap to be adapted evenly around \nthe neck of a tooth root. \nInitial Placement of Membrane\nAfter preparation of the recipient site, the barrier membrane \nmay be initially fixated. The initial fixation may be completed \neither apically or on the lingual aspect of the ridge. Fixation of \nthe membrane before placing the particulate graft assures that \nthe membrane will not shift after the bulk of the graft has been \nplaced and that it defines the apical extent of the graft itself. \nIn situations where tacks cannot be used the membrane can be \nfixed both apically and palatally/lingually with sutures. It should \nbe kept in mind that definition of this space is established by \nthe membrane. If the thickness of the graft narrows as the graft \nextends toward the apex of the regenerative site, the thickness \nof the bony support of the implant itself will also be reduced. \nIn that instance an apical fenestration often occurs, introducing \none of a number of variables that can complicate the predictabil-\nity of an implant over time (Figs. 36.42 and 36.43. \nStep 7: Space Maintenance\nAside from the soft tissue exclusion and clot stability, space main-\ntenance is key to the success of the GBR process. The creation \nand continued unmoving support of the graft “space” can be \naccomplished with membranes supported by tenting screws/pins, \ntitanium-reinforced membranes, molded titanium mesh, block \ngrafts, dental implants, or the bulk of particulate graft mate-\nrial.44–48 Most of the new techniques in GBR protocols require \nspecific support of this area where bone is needed. Simply filling \nthe defect space with bone particles has been shown to greatly \nlimit the final bone volumes, and definition of the actual shape of \nthe ridge is really not predictable. As this protected “free zone” is \ndefined, possibilities of successful development of new bone have \nbeen greatly improved.\nA\nB\nC\n• Fig. 36.39  Pericardium Membrane. (A) Fixation of membrane. (B) Autogenous bone being placed under \ntent screws. (C) Final veneer graft of allograft bone."
  },
  {
    "page": 70,
    "content": "960\nPART VII    Soft and Hard Tissue Rehabilitation\nSpace Maintenance Options\n\t1.\t \u0007d-PTFE integrated with titanium struts\n\t2.\t \u0007Titanium Mesh\n\t3.\t \u0007Tent Screws \nTent Screw Technique\nTo support the membrane support and prevent collapse of the \ngraft in most particulate membrane techniques, tenting screws \nare used. The principle of tenting screws utilizes the “head” of \nthe screw for vertical and horizontal support. This support system \nliterally creates the surface countour of the membrane and bone \ngraft material, which allows for the bone regeneration process to \nproceed in a predictable manner.\nSize of Fixation Screws. Bone fixation screws on the market \ntoday are generally non-resorbable screws that either have threads \nfrom the head to the tip of the screw or a smooth neck with 3 mm \nof thread design at the tip of the screw.47,48,50,51 Use of resorbable \nscrews has been described, and this possibility gives the surgeon \nthe option to avoid a reentry procedure to remove the fixation \nscrews.41 As the variety of fixation screws is explored, choices of \nscrews with large-head diameters are preferred. The wide head is \nimportant with this technique because the primary purpose of \nthe screw is to support the membrane during the complete bone \nmaturation process. If the head of the screw perforates through \nthe membrane, the vertical support will be lost and the particulate \ngraft is subject to pressure and micromovement. When support is \nlost, the final volume and consistency of the matured ridge will \nbe altered.\nUse of narrow-diameter (small) screw heads that are used in \nblock grafting procedures was found to periodically result in com-\npromised and decreased bone growth. Most likely, the membrane \nwill lose its vertical support after the small screw head perforates \nthrough the membrane.\nIdeally, bone fixation screws with a shaft diameter of 1.5 mm \nare recommended instead of thicker screws because it decreases the \n• Fig. 36.41  Modification of membrane to encompass defect using a #15 \nblade.\nA\nB\nC\n• Fig. 36.40  Collagen Membranes. (A) Bone screws placed in defect area. (B) Collagen membrane \nhydrated and fixated with tacks. (C) Site grafted and membrane positioned over graft."
  },
  {
    "page": 71,
    "content": "961\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\noverall post-grafting bone volume when larger-diameter screw shafts \nare used. Most screws today are self-threading and are easily inserted \ninto decortication holes. The most common length of tent screws is \napproximately 6 mm, however the clinician should anticipate screw \nlengths of 10 -12 mm for larger osseous defects (Fig. 36.44). \nTent Screw Numbers. The amount of support required to \nmaintain the spatial dimensions of the graft site determine the \nnumber and positioning of these screws. Screws are anchored \nin the recipient site as needed to form a dome over the graft \nsite that replicates the height of bone needed for ideal implant \nplacement. Ultimately the tenting screws act as “tent poles” \nto support the membrane, decrease graft mobility, and relieve \nexternal pressure on the graft.49 Placement of simple mem-\nbranes over graft materials without defining space maintenance \nwill usually lead to variable postoperative bone volumes and \noften deficient bony support on the facial and lingual aspect \nof the coronal aspects of the implant platform (i.e., membrane \ncollapse) (Fig. 36.45). \nTent Screw Positioning. The positioning of the screws should \nbe planned in a manner that will result in a dome shape that is \nformed by the “heads of the screws” matching the required con-\ntour of the final ridge form. The use of multiple screws in this \ntechnique creates very specific ridge forms that cannot be attained \nwith unsupported membranes. Screws are placed 3 to 4 mm apart \nto allow solid bone formation between the screws. Basically, the \nnumber and position of tent screws is directly related to the size \nand the required contour of the bone graft.\nClinical situations where screws have been placed too close \ntogether periodically demonstrate weaker zones of bone forma-\ntion which may result in difficult implant positioning. This can be \nimportant because lateral forces are placed on mature bone graft \nsites during implant osteotomy preparation and implant place-\nment. Postoperative bony ridges using this specific technique have \nbeen found to easily tolerate the lateral forces of bone spreaders \nand wide body implants without any significant problems related \nto flaking or granular bony ridge forms. The only problem encoun-\ntered with respect to screw positioning has been related to screw \npositions that were too close to the crest of the ridge. In these situ-\nations, an osteotomy diameter can encroach on the unfilled screw \nhole and the thin fragment of bone can become detached (Figs. \n36.46 A, B, C, and D) (Figs. 36.47 A, B, C, and D).\nCare should also be exercised in placing tent screws in approxi-\nmation to adjacent teeth. The location and trajectory of adjacent \ntooth roots should be determined to prevent screw placement into \na tooth root. Ideally, post-operative radiographs should be taken \nto verify ideal positioning in relation to tooth roots. \nStep 8: Bone Graft Placement\nThe success of a bone graft is very dependent on the proper appli-\ncation of the basic principles of bone development. This has been \nemphasized as surgeons attempt to regenerate large bony defects \nthat require development of a viable graft that can be far from the \nrecipient bone, where all of the regenerative components originate. \nC\nB\nA\n• Fig. 36.42  Membrane Placement in Proximity to Teeth. (A) Titanium-reinforced membrane. (B) Extended \ncollagen membrane. (C) Acellular matrix."
  },
  {
    "page": 72,
    "content": "962\nPART VII    Soft and Hard Tissue Rehabilitation\nThis is even more important in vertical regeneration because the \ngraft particles contact the host bone only at the base of the defect, \nand the other three sides of the graft are totally separated from \nthis natural source of cells for angiogenesis and cellular ingrowth.\nPrior to placement of the graft material, the recipient site should \nbe free of soft tissue remnants, bone decorticated, and initial fixa-\ntion of the membrane should be completed. When placing graft \nmaterial into a bony defect, ideally a systematic layered approach \nshould be utilized consisting of three layers which is dependent on \nthe size and location of the graft site.\nLayer # 1: Autograft (Optional)\nThe first layer of the guided bone regeneration graft is comprised \nof autogenous bone. Autogenous bone is usually indicated in any \nbony defect which requires horizontal bone growth of greater than \n3 mm or in all cases of vertical regeneration. Autogenous bone \nharvesting today is typically harvested from any exposed region of \ncortical/cancellous bone present in the oral cavity. In the maxilla, \ndonor sites are often available apical to most implant sites and in \nthe tuberosity area. In the mandible, in the lateral aspect of the \nramus provides a bountiful source of cortical bone which may be \nharvested via numerous techniques.\nRamus Graft Harvest\nIncision and Reflection. The incision for harvesting a graft \nin the ramus region starts at the level of the occlusal plane and \nproceeds down the external oblique ridge a short distance until it \nextends medially to the distal buccal aspect of the second molar or \nthat same region if the area is edentulous. The incision continues \nanteriorly, following the crest of the ridge or following the sulcus \nto the distal aspect of the first molar or premolar, where a vertical \nrelease is usually prepared. The incision should always be located \nlateral to the retromolar pad to avoid any possible damage to the \nlingual nerve. The flap is reflected laterally to expose the cortical \nbone distal to the terminal molar and a minimal exposure of the \nlateral aspect of the ramus. \nRamus Harvesting Techniques. To harvest cortical bone from \nthe ramus, numerous techniques are available;\nLateral Ramus Block: A cortical block may be harvested from \nthe ramus and broken into smaller cortical particles. The amount \nof surface area obtained from smaller particles is much greater \nthan what could be obtained by fixating an entire harvested block. \nThe harvested block is processed by breaking the block into small \npieces using double-action rongeurs. Use of large particles is not \nrecommended, and complete destruction of the block with a bone \nmill has also not produced the results found with reasonable sized \nparticles. The preparation of dense cortical bone has always pre-\nsented a challenge in block grafting when an irregularly surfaced \ncortical graft needs to be trimmed and reshaped for adaptation in \na graft site. In the case of particulate grafting, the complete piece \nof cortical bone must be broken into small pieces before it can be \nused. Control of the graft particles during this process is critical \nbecause loose particles can be easily lost or contaminated as the \ngraft is processed. Autogenous bone harvests are challenging, and \nloss of critical bone particles or blocks can cause unnecessary time \ndelays and patient discomfort if additional bone needs to be har-\nvested to replace a contaminated block.\nThe particulate grafting technique described in this chapter \nrequires that a piece of a cortical block be completely broken \nup into small particles that are then packed into irregular bony \ndefects. These small particles tend to “shoot out” of the rongeurs \nif they are not carefully contained. The best way to eliminate the \nloss of these cortical particles is to fill a clear, shallow glass beaker \nor bowl with saline. The block is then submerged in the saline, and \ndouble-action rongeurs are used to break it up into the particle \nsize needed for the procedure. The saline slows escaping particles \nin the same manner that water slows the movement of a bullet that \nis fired into water. The bone is typically broken up into 1 × 2 mm \nparticles for placement in the graft site. (Figs. 36.48).\nScraping Technique: Another option of obtaining autogenous \nbone is removing cortical bone chips from the external oblique \nridge. A double action rongeur may be used to remove small frag-\nments from the exposed bone. The scrapings may be placed into a \nsterile surgical bowl with sterile saline. Another option of obtain-\ning cortical chips is with the use of specific manufactured “scrap-\ners”, which not only harvest the bone, but also collect it within \nthe scraper device. And lastly, piezosurgery units may be used with \ndedicated scraper tips. (Fig. 36.49).\nTrephine Technique: The use of trephine burs (i.e. cylindrical \nend-cutting burs) have been advocated to harvest bone from the \nramus area. These end-cutting burs that are available in various \ndiameters, with the 6–8 mm trephine being the most popular for \nA\nResorbed ridge/\nHorizontal and vertical deficiency\nBony socket with all walls\nE. Urban mattress design closure\nTitanium supporting struts\nSoft tissue\nParticulate graft\nparticles\nParticulate graft particles\nPTFE\nmembrane\nResorbable\nmembrane/\nNo vertical\nsupport\nB\n• Fig. 36.43  Resorbable vs. Non-resorbable membrane (A)This figure rep-\nresents a nonresorbable dense polytetrafluoroethylene (d-PTFE) barrier \nmembrane (provided by Osteogenics Biomedical) that has titanium sup-\nporting struts to prevent collapse into the regenerative space fill the under-\nlying space with a bony matrix that can be replaced with viable bone as \nthe regenerative process is completed. (B) This figure demonstrates the \nuse of a resorbable barrier membrane with no supporting components. In \nthis situation the membrane functions as a protective layer that prevents \ningrowth of soft tissue into the underlying space. Membranes should gen-\nerally be elevated above the ridge deficiency with screws or titanium to \nprevent collapse into the space or shifting of the graft particles."
  },
  {
    "page": 73,
    "content": "963\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nharvesting bone from the ramus. One half of the trephine bur is \nplaced over the external oblique bony ridge, while the other half is \nlateral to the bone and above the reflected masseter muscle, which \nis elevated off the anterior lateral aspect of the ramus. The trephine \nbur is used with an angled surgical drill at 2,000 rpm with copious \nsaline irrigation, to a depth of approximately 5–8 mm, making \nsure the cuts are above and lateral to the position of the inferior \nalveolar nerve (IAN), artery and vein. The IAN position should be \nidentified via a CBCT exam survey. \nRamus Recipient Site Closure. After removing the harvested \ndonor bone the donor site is filled with a double layer of collagen \ntape before closing the wound with a combination of interrupted \nand mattress sutures. This closure is monitored as each suture is tied \nto confirm that there is no flap tension. The use of Vicryl or Teflon \n(Cytoplast) sutures is recommended to allow the implant clinician the \nopportunity to remove the sutures when he or she feels the wound \nhas adequately healed. Due to the nature of soft tissue in the ramus \nregion, overlapping tissue margins can contribute not only to post-\noperative opening of wounds, but also to a lengthy recovery process. \nAdditional Harvest Sites. Maxillary Tuberosity Donor Site: \nThe maxillary tuberosity offers a variable amount of trabecular \nbone, which is dependent on the extent of maxillary bone atro-\nphy and maxillary sinus pneumatization. The cancellous nature \nof the bone allows it to be molded into the extraction socket. The \ntuberosity should be evaluated with a CBCT survey to determine \nthe maxillary sinus location and the amount of host bone present.\nTori: The use of cortical bone harvested from lingual tori has \nbeen shown to produce excellent results. This is dense cortical bone, \nand large amounts of bone can be harvested from the typical lin-\ngual donor site. The use of Piezosurgery techniques allows the tori \nto be separated from the mandible without the threat of injury to \nunderlying anatomic regions. There has been no noted difference \nA\nB\n• Fig. 36.44  Tent Screw Size (A) Older generation tent screws of various diameters and head size, (B) \nNewer tent screws with larger, convex head which allow for more ideal space maintenance.\nA\nB\n• Fig. 36.45  (A). Tent screws used to stabilize membrane to achieve desired contour. (B) Postoperative \nresults of bone growth to ideal contours."
  },
  {
    "page": 74,
    "content": "A\nB\nC\nD\n• Fig. 36.47  (A-D) The screws have been used in these varied surfaced defects to define a smooth final \nridge contour that will allow implant placements in proper locations specified by the restorative wax-up.\nA\nC\nD\nB\n• Fig. 36.46  (A to D) Screw placement literally determines the final contours of the augmented graft site. \nThe screw head should never be placed higher than the level of the adjacent interproximal bone. When \nlarge head screws are used on the buccal aspect, the uppermost edge should be angled slightly to prevent \nits sharp edge from perforating the membrane. The best location for the largest diameter screw heads is \nlower down in the graft site where lateral support is needed."
  },
  {
    "page": 75,
    "content": "in the final graft quality when tori were used as the donor source in \nregeneration cases (Fig. 36.50). \nPlacement of Layer # 1. The small autograft chips or small par-\nticulate pieces are placed directly on the host bone surrounding \nthe bone screws. Because of the extensive nature of grafts requir-\ning autogenous bone, at least 50% of the graft volume should be \nmade up of this autogenous bone, with allograft compromising \nthe second layer. Graft particles are transferred from the bowl to \nthe graft site with cotton forceps or a Molt curette. A bone or \namalgam plugger with a small end can be used to manipulate the \nparticles between the various screws. This process fills most of the \ndefect and voids, regardless of the topography of the recipient site. \nIt should be kept in mind that the volume of this graft is clearly \ndefined by the levels of the heads of the bone screws. The screws \nhave been positioned in a manner that defines the outermost bor-\nders of the desired bony ridge, corresponding to the requirements \nof the restorative plan and the needed sites for implant placement \n(Fig. 36.51). \nParticulate Graft Material Options. There are many optional \ntechniques and materials for use in regenerative graft procedures. \nSuccessful application of these techniques requires that the clini-\ncian have a comprehensive understanding of the various types of \nbone grafts and bone substitutes available, and the inherent advan-\ntages and disadvantages of each material. The ideal characteristics \nof a bone substitute include biocompatibility, low incidence of \ninfection and immunogenicity, predictable maintenance of space \nover time, and the ability to be replaced entirely with new, viable \nbone growth. To comprehend the concept of bone regeneration \nand to select the ideal bone graft material, the implant clinician \nshould have a strong understanding of bone biology.\nAllograft Bone. Allogenic bone is harvested from an indi-\nvidual of the same species and transplanted to a genetically dif-\nferent individual. Allografts are considered to be one of the best \nsources for supplementation of an autograft or as an alternative \nto an autograft. Allografts are available in many different prepa-\nrations, with the most common being FDBA and demineralized \nFDBA (DFDBA). Although their biological properties vary, they \nA\nB\nC\nD\n• Fig. 36.48  Ramus Autograft Harvest With Piezosurgery Unit. (A) Piezo cuts made in ramus bone. (B) \nBlock removed. (C) Harvested block. (D) Block bone made into particulate chips.\nA\nB\n• Fig. 36.49  Alternative Bone Scraper. (A) Disposable bone scraper. (B) \nHarvested bone inside scraper."
  },
  {
    "page": 76,
    "content": "966\nPART VII    Soft and Hard Tissue Rehabilitation\n• Fig. 36.50  Tori Bone Harvest: (A) Tori Exposure  (B) Harvested Tori.\nA\nB\nC\nD\n• Fig. 36.51  Delivery of bone particulate around the tenting screws: (A) Autogenous cortical particles have \nbeen placed around the screws on each side of the defect. The allograft application has been started in the \ncenter region and it will then be placed over the autogenous particles. (B) Autogenous bone particles have \nbeen placed around the fixation screws and the screw lengths are visible in the adjacent region where graft \nhas not been positioned yet. (C) The allograft is placed over the autogenous bone on the right side before \nthe layers are started on the opposite side. (D). The particulate has been placed over the entire recipient \nsite and the membrane is ready to be drawn over the entire region.\ngenerally exhibit osteoconductive qualities with reduced osteoin-\nductive properties found in DFDBA. FDBA and DFDBA offer \nthe advantage of decreased patient morbidity secondary to the \nelimination of the need for a second surgical site.\nAllografts undergo extensive and rigorous processing proce-\ndures. First, allografts are processed by freeze-drying the graft at \napproximately −15°C to −20°C, allowing for easier handling and \na decreased antigenicity. The main drawbacks of freeze-dried bone \ninclude the potential risk for cross-infection and the possibility of \nimmunologic reactions because of its protein content. The possibil-\nity of disease transmission cannot be completely eliminated; how-\never, there are no documented cases of disease transmission related"
  },
  {
    "page": 77,
    "content": "967\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nto the use of allografts in dentistry after completion of more than 1 \nmillion cases in a 25-year period.57 In addition, allografts have been \nrelated to variations in sample quality related to age and the health \nvariations of the donor. These variations in the regenerative proper-\nties of a specific sample indicate the possible importance of using \na sample from a single donor rather than a donor pool. Allografts \nare primarily osteoconductive materials, with some reduced osteo-\ninductive properties in demineralized bone matrix preparations.\nTypes of Allografts. The most common allografts used in \nimplant dentistry have varying characteristics. For example:\n\t•\t \u0007DFDBA is osteoconductive and osteoinductive. The material con-\nsists of highly processed bone with at least 40% of the mineral \ncontent of the bone matrix being removed by 0.5 to 0.6 M hydro-\nchloric acid until the calcium content is reduced to less than 2%.58 \nThis allows for increased availability of matrix-associated BMPs or \ngrowth factors that allow the graft to become osteoinductive.\n\t•\t \u0007FDBA is an allogenic bone that does not undergo the demin-\neralization process. Also referred to as “mineralized” because \nthe mineral content has not been reduced, FDBA has the \nsame BMP content in its organic matrix. However, it does \nnot have the same osteoinductive capability as DFDBA. \nFDBA has been shown to be a better scaffold for osteocon-\nduction than DFDBA, which allows for superior space main-\ntenance.59 Eventually osteoclasts break down the mineral \ncontent of FDBA until demineralization occurs, inducing \nnew bone formation and a prolonged protein release. \nParticle Form and Size. The allograft particle form and size \ncontribute to the predictability of bone regeneration.\n\t•\t \u0007Ideal particle form: Allografts are available in three particle \nforms: cortical, cancellous, and cortico-cancellous. Cortical \nallografts are associated with an increased density and greater \nspace maintenance properties, subsequently allowing a slower \nresorption rate. Cancellous chips are advantageous because \nthey allow for osteoconductive scaffolding and deposition of \nosteoblasts while also allowing a faster resorption rate. The \ncortico-cancellous mixture allows for the benefits of both can-\ncellous and cortical bone.\n\t•\t \u0007Ideal particle size: The particle size of the allograft material \nis very important in the bone regeneration process, because a \nparticle size that is too small (less than 125 μm) leads to fast \nresorption with inconsistent bone formation. A larger particle \nsize (greater than 1000 μm) restricts resorption and may be \nsequestered or result in delayed healing. Studies have shown \nan ideal particle size for predictable bone regeneration to be \napproximately 250 to 1000 μm.60 \nXenografts. Xenografts are bone grafts originating from a dif-\nferent species. Most commonly, xenografts are derived from \nbovine (cattle) origins, with less common sources including equine \n(horses) and porcine (pigs). The most common xenografts are natu-\nral hydroxyapatite (HA) derived from animal bone and anorganic \nbone matrix produced from bovine sources. Xenogenic bone grafts \nexhibit excellent osteoconductive properties and act as a scaffold for \nnewly deposited bone. Although xenografts are available in greater \nsupply than allograft materials, they have been shown to exhibit \nelevated inflammatory responses, along with a slow and inconsis-\ntent resorption process. Consideration must also be given to the \nrisk for cross-contamination with bovine spongiform encephalopa-\nthy or porcine endogenous retroviruses. Unfortunately it has been \nshown to be difficult to adequately screen xenografts for the pos-\nsibility of a viral presence61 (Fig. 36. 52). \nAlloplasts. Because of the remote possibility of disease trans-\nmission from allografts and xenografts, some in the literature have \nadvocated alternative bone substitute options. Alloplasts, which \nare synthetic, are a biocompatible option for the implant clini-\ncian. Alloplasts have the advantage of relatively no immunogenic \nresponses, and there is no risk for disease transmission. These \nmaterials have been shown to be osteoconductive, with an inter-\nconnecting pore system that serves as a scaffold for the migration \nof bone-forming cells.62 Unfortunately many alloplastic grafts do \nnot allow the graft material to be replaced with vital bone cells, \nwhich results in nonvital bone at the implant interface.\nTypes of Alloplasts. A wide range of synthetic materials for \nallografts have been developed, such as synthetic HA, β-tricalcium \nphosphate, calcium-phosphate cements, and glass ceramics.\n\t•\t \u0007HA is the basic component of inorganic bone and exhibits a \nsimilar chemical composition to natural bone. HA is most com-\nmonly processed from natural reef coral skeletons or homoge-\nnized calcium-phosphate powder. It is not only biocompatible \nand osteoconductive, but also has excellent space-maintaining \nqualities. However, synthetic HA has shown unpredictable and \nslow degradation after approximately 1 to 2 years.63\n\t•\t \u0007Tricalcium phosphate has a calcium-to-phosphate ratio of 1.5, \nwhich is much lower than HA and results in less compressive \nstrength. Calcium phosphates resorb 10 to 20 times faster than \nHA, and their macroscopic mechanical properties are inadequate \nfor load-bearing surfaces because of their inherent brittleness. \nBecause of the fast biodegradation rate, this bone can be unpre-\ndictable and is not consistent with adequate bone deposition.\n\t•\t \u0007Carbonate apatite with collagen has been shown to resemble \nbone more than any other calcium phosphate available. The \ninorganic content of bone contains approximately 7% carbon-\nate by weight.64 Studies have shown that carbonate apatite \nexhibits a more controlled resorptive pattern, as well as excel-\nlent osteoconductivity and biocompatibility.65 When carbon-\nate apatite is combined with collagen, the biological stability \nand strength are increased, which allows the scaffolds to act as \na delivery vehicle for growth factors and living cells for bone \nformation.66 Scanning electron microscopy studies have shown \nthat the highly porous and interconnected structure ensures a \nbiological environment that is conducive to cell attachment, \nproliferation, angiogenesis, and tissue growth.67\n\t•\t \u0007Bioactive glasses are ceramic substitutes that are reinforced by \noxides—sodium oxide, calcium oxide, phosphorus pentoxide, \nand silicon dioxide—and exhibit questionable mechanical \nstrength. They are absorbable and have no risk for disease trans-\nmission or immune responses. The bioactive ceramics exhibit \nimproved mechanical properties relative to bioactive glass, but \nthey are still brittle enough to fracture when subjected to cyclic \nloading. To improve their resistance to fracture, methods of \nincorporating stainless-steel and zirconia ﬁbers have been per-\nformed. Studies have shown questionable efﬁcacy of bioactive \nglasses with respect to osteoconduction qualities and the ability \nto bond to tissues (bioactivity).68 \nLayer # 2 Summary. The second layer of the graft is ideally \nmade up of particulate allograft that is placed over the top of the \nautograft (i.e. or 100% allograft for smaller defects < 3 mm). The \nallograft should veneer over the screw heads, however care should \nbe exercise to not “overfill” the graft site. The recommended \nallograft bone type is either 70% mineralized / 30% demineral-\nized or a cortical/cancellous mixture of mineralized bone. It is \nhighly recommended that the ridge be overdeveloped rather than \nunderdeveloped. Excessive overfilling of the graft site may lead to \ndifficult tissue closure and increases the possibility of incision line \nopening."
  },
  {
    "page": 78,
    "content": "968\nPART VII    Soft and Hard Tissue Rehabilitation\nLayer # 3: Final Implant Placement\nAfter the graft material (Layers # 1 and # 2) is ideally positioned, \nthe membrane (previously fixated apically or lingually) is stretched \nover the graft site. The membrane should be of sufficient size to \ntotally encompass the entire graft. The goal of the membrane fixa-\ntion is to not allow any movement, which could negatively affect \nthe wound healing. In most cases, the final fixation is on the pala-\ntal aspect of the ridge with two tacks. Additional fixation can be \nused as needed in large graft sites to limit membrane movement. \nBone Growth Factors\nBone growth factors can be a significant part of the bone-grafting \nprocess as they may enhance the formation and mineralization of \nbone. In addition, bone growth factors may induce undifferenti-\nated mesenchymal cells to differentiate into bone cells that trigger a \ncascade of intracellular reactions for the release of additional bone \ngrowth and cell-enhancing factors. These growth factors actually \nbind to specific receptors on the surface of target cells directing a \nmore timely healing process. More than 50 known growth factors \nhave been identified and categorized according to their specific \ncontributions to the functions in bone healing. The two most \ncommon bone growth factor techniques utilize blood concen-\ntrates and recombinant human Bone Morphogenetic Protein-2.\nBlood Concentrates. Most blood concentrates used in implant \ndentistry today are direct derivatives of platelets. The platelet, also \ncalled a thrombocyte, are blood cells that are primarily involved \nin the blood clotting process. A unique secondary function of a \nplatelet is to release a wide range of growth factors that enhance \ncollagen production, cell mitosis, blood vessel growth, cell recruit-\nment, and cell differentiation.69\nThe two most utilized and studied platelet concentrates in \nimplant dentistry today are platelet-rich plasma (PRP) and plate-\nlet-rich fibrin (PRF). The first-generation blood concentrate, \nplatelet-rich plasma, was first introduced by Marx in 1998. His \nstudies showed bone maturity to be twice as effective with the use \nof PRP in grafted sites, and the addition of PRP increased bone \ndensity up to 30% in healed sites.70\nA second-generation blood substitute, platelet-rich fibrin, was \nfirst described by Choukroun in 2001. This concentrate has been \nshown to exhibit a much simpler processing protocol in compari-\nson to PRP. PRF is very effective in the release of important growth \nfactors present in platelets, such as platelet-derived growth factor \n(PDGF), transforming growth factor beta (TGF-ß), insulin-like \ngrowth factor (IGF), fibroblast growth factor (FGF), and epithelial \ngrowth factor (EGF). 71 (Box 36.9) Multiple clinical studies have \nshown increased soft tissue healing, enhanced healing of grafted \nbone, promotion of angiogenesis, and faster wound healing.72–74\nThe internal organization make-up of platelet rich fibrin \nis rather unique as it contains three adhesive molecules (fibrin, \nfibronectin, and vitronectin) that result in a highly elastic, matri-\ncial mesh architecture. This complex three-dimensional struc-\nture allows for a longer release of growth factors. As the platelets \ndegranulate, a sustained release of growth factors may range from \na time period of one to four weeks.75\nD\nC\nA\nB\n• Fig. 36.52  There can be very substantial variations in the density of matured graft sites, depending on \nwhat type of graft was used initially. The delayed turn-over of bovine particulate can greatly affect the den-\nsity when an implant is placed before the complete substitution cycle has been completed. (A) PepGen15. \n(B) OsteoGraf 300/FDBA. (C) 90% autogenous/FDBA. (D) Mix of autogenous/bovine/FDBA."
  },
  {
    "page": 79,
    "content": "969\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nPRF is an autologous fibrin matrix that incorporates platelets, \nleukocytes, cytokines, and circulating stem cells that are gradually \nreleased to accelerate physiologic healing. It is easily obtained and \ndoes not require any biochemical blood handling.52 After drawing \nblood and placing in a centrifuge for 12 minutes, the coagula-\ntion cascade will be triggered. The end result is a fibrin clot in the \nmiddle layer, situated between the acellular platelet-poor plasma \nand the red blood cells. When this fibrin clot (PRF) is used as a \nmembrane, it will help isolate and protect the wound while serv-\ning as a matrix to accelerate healing. When the PRF is mixed with \nthe graft material (allograft), the fibrin clot acts as a biological \nconnector between all of the elements of the graft, while also act-\ning as a matrix that initiates angiogenesis, stem cell accumulation, \nand migration of osteoprogenitor cells to the graft. Thus the syn-\nergistic effects of the fibrin matrix and growth factors allow for \nthe enhanced healing of the hard and soft tissues. Studies have \nshown that PRF with freeze-dried bone allograft (FDBA) heals \nfaster than FDBA alone.53\nThe second-generation blood concentrate platelet rich fibrin \n(PRF) has been shown to be advantageous in comparison to plate-\nlet rich plasma (PRP):\n\t•\t \u0007Is naturally polymerized and requires no chemical use\n\t•\t \u0007Requires a conventional, single spin centrifuge\n\t•\t \u0007Has a slower release of growth factors\n\t•\t \u0007Is more efficient with cell migration and proliferation\n\t•\t \u0007More advantageous fibrin network that stores cytokines and \ngrowth factors\n\t•\t \u0007Better healing properties\n\t•\t \u0007Less disposables required resulting in less expense\nPlatelet Rich Fibrin Uses. With bone augmentation proce-\ndures, PRF may be used as either a membrane or added to the \nparticulate bone grafting material. Studies have shown that PRF is \nadvantageous in healing during regenerative procedures either as a \nmembrane or when added to particulate bone.76 Because the PRF \nmembrane resorbs rather fast (∼ 7 days), it is not the most ideal \nmembrane to be used to prevent soft tissue invasion. Therefore, \nusually the PRF membrane is placed over the primary membrane \n(e.g. collagen) to aid in hard and soft tissue healing (Figs. 36.53). \nRecombinant human bone morphogenetic protein-2. \nRecombinant human bone morphogenetic proteins (rhBMPs) \nare a group of sequentially arranged amino acids and polypeptides \nthat are osteoinductive proteins, acting to initiate, stimulate, and \namplify bone morphogenesis. BMPs stimulate mesenchymal stem \ncells to induce bone formation via differentiation to osteoblasts, \nwhich form and mineralize new bone. BMP-2 has been purified, \nsequenced, and cloned, and is marketed as rhBMP-2 (recombi-\nnant human bone morphogenetic protein-2; Infuse; Medtronic, \nInc., Minneapolis, Minn.). Infuse bone graft consists of two com-\nponents: a 1.5 mg/mL concentration of rhBMP-2 and an absorb-\nable collagen sponge. Studies have shown rhBMP-2 with titanium \nmesh to be an effective treatment for augmentation of the deficient \nbony ridge before implant placement.54 The new bone formed by \nrhBMP-2 has been shown to be similar to native bone and can with-\nstand the stresses of implant placement and prosthetic function.55 \nStep 9: Closure\nThe final closure of the bone graft site is one of the most important \nsteps of the grafting process. Ideally, a tension-free flap adaptation is \nthe key to predictable results. If a poor suturing technique is used, \nincision line opening may result, which significantly increases the \nmorbidity of the procedure. Therefore, meticulous principles should \nbe adhered to with respect to a tension-free flap, ideal suture tech-\nnique, and the close post-operative evaluation of the surgical site.\nThe type of suture selected should include a high tensile strength \nmaterial. The most common suture materials used today include \nvicryl (absorbable) or PTFE (nonmabsorbable). The primary prin-\nciple of wound closure in GBR cases is attaining a completely \n“tension-free” closure over the submerged graft. Specific attention \nmust be directed to proper approximation of the margins of the \nflap to confirm there is no overlapping of the tissue flaps.\nUsually the combination of horizontal mattress and inter-\nrupted sutures are used to close these graft sites. One of the pri-\nmary advantages of using the horizontal mattress sutures is the \nability to “evert” the tissue margins. By everting the margins of \nthe flap outward, the connective tissue layers will be approximated \nagainst each other. A flap closure that “overlaps” two flaps is actu-\nally placing the connective tissue layer of the first flap over the epi-\nthelial layer of the adjacent flap. This type of poor approximation \nleads to at best a weak suture line and most often an open margin \npostoperatively. Additional interrupted sutures may be used to \napproximate all edges of the wound. The vertical incisions may be \nclosed with 5-0 Chromic, as they may greatly reduce the post-op \nformation of tissue scars.\n(Fig. 36. 54). (Fig. 36.55 A, B, and C) (Fig. 36. 56). \nPostoperative Treatment\nProvisional Restoration\nThe successful maturation of a bone graft site requires that the \narea be completely protected from micromovement of the iso-\nlating membrane and the underlying graft material. A success-\nful graft is totally dependent on blood clot adhesion, capillary \ningrowth, and the introduction of associated growth factors for \npredictable healing. It has been estimated that micromovement \nof 25 μm over a graft site can decrease the final graft volume \nas much as 40%. Therefore, disruption of any kind will consis-\ntently yield compromised results in mature graft development, if \nnot full graft failure.\nThe most common source of daily pressure on a site occurs when the \npatient’s transitional appliance has contact with the surface of the graft \nsite. If possible, a fixed bonded transitional bridge should be placed over \nthe graft site because it totally prevents contact with the underlying graft \nsite. If this is not possible and the patient insists on a temporary prosthe-\nsis, plans for a carefully constructed removable partial denture should \nbe formulated. A transitional prosthesis (flipper or removable partial \n\t1.\t \u0007Platelet-derived growth factor (PDGF)\n- Stimulates fibroblast mitogenesis and collagen synthesis\n\t2.\t \u0007Transforming growth factor beta (TGF-ß)\n- Enhances wound healing via endothelial angiogenesis\n\t3.\t \u0007Insulin-like growth factors (IGF)\n- Enhances rate and quality of wound healing via bone matrix formation \nand cell replication\n\t4.\t \u0007Epithelial growth factor (EGF)\n- Increases angiogenesis and epithelial mitogenesis\n\t5.\t \u0007Fibroblast growth factor (FGF)\n- Increases angiogenesis, epithelialization, and fibroblasts\n\t6.\t \u0007Vascular Endothelial Growth Factor (VEGF)\n- Increases endothelial growth factor and angiogenesis\n\t• BOX 36.9\t   \u0007Growth Factors Released by Platelets"
  },
  {
    "page": 80,
    "content": "970\nPART VII    Soft and Hard Tissue Rehabilitation\ndenture) must be modified to eliminate any significant contact with \nthe graft site. If a removable prosthesis is absolutely necessary, all buccal \nflanges should be removed, and if possible, the acrylic should be altered \nto create regions of support on the lingual surfaces of the adjacent teeth. \nOcclusal rests should be used, or in cases where this is not possible, \nthere must be good adaptation of the prosthesis to direct the forces to \nalternative stress-bearing areas (i.e., tissue areas away from the graft site \nthat take the pressure off the graft site).\nEssix appliances allow temporary replacement of teeth in narrow \nspan regions, allowing long-term prostheses to be fabricated after \nthe initial healing process has been completed. However, the Essix \nappliance does have disadvantages related to esthetics, fracture, \nwear issues, and discoloration. The Snap-On Smile appliance (Den-\nMat Holdings, LLC) has been used successfully over longer-span \nedentulous regions with more pleasant esthetics that and increases \npatient acceptance (Figs. 36.57) (Fig. 36. 58) (Fig. 36.59). \nDevelopment of Ideal Bone Density in \nRegeneration Sites\nThe sole purpose of ridge augmentation and bone grafting is to \ndevelop a dense, stable volume of bony support for implants of \nappropriate sizes and numbers that are placed in the locations \nspecified by the restorative plan. The quality and density of the \nfinal graft development are important because a weak and granu-\nlar implant osteotomy site is more susceptible to crumbling dur-\ning implant insertion. These granular ridges can also resorb when \nthe implant is loaded and stress is placed on the coronal aspect \nof the implant-bone interface. As clinicians plan augmentation \nprocedures, they must understand the limitations of the materials \nthat they are using and the techniques that are going to be used. \n• Fig. 36.54  Bone Graft Suturing. Polytetrafluoroethylene (PTFE) sutures \nover ridge with minimal tension from the vertical release incisions.\nA\nB\nC\nD\n• Fig. 36.53  (A) PRF used as a secondary membrane over the primary membrane, (B) PRF may be added \nto the graft material, (C) Sticky Bone, (D) Platelet Poor Plasma may be used to hydrate the primary (col-\nlagen) membrane"
  },
  {
    "page": 81,
    "content": "971\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nMisch56 created a system of bone densities for implants, rang-\ning from D1 (hardest) to D4 (softest/most porous). These divi-\nsions encompass the acceptable ranges for the placement and rigid \nfixation of implants. Successful regeneration procedures develop \na final osteotomy site that provides adequate bone volume in a \ndense, firm, manageable form that has a large number of vital \nbone cells that will easily integrate with the titanium implant \nbody.\nSuccess in bone grafting requires a thorough knowledge of the \nvariety of grafting materials that are available and their capacity to \nbe readily replaced with vital bone on a timely basis. The ultimate \ngoal is a clear understanding of the concepts of osteoinduction \nand osteoconduction, which is critical for predictable grafting suc-\ncess. It is easy in the incorporation of regeneration into a practice \nroutine to simply open a bottle of bone for use in a surgical pro-\ncedure, instead of preparing to open a second site for a cortical \nbone harvest. Unfortunately, the characteristics of different types \nof bone graft vary greatly and in the long term this can signifi-\ncantly affect the volume and quality of the regenerated bone. It is \nvitally important that the clinician have a strong understanding \nA\nB\nC\n• Fig. 36.55  (A, B, C) Polytetrafluoroethylene sutures over ridge with minimal tension from the vertical \nrelease incisions.\nA\nB\n• Fig. 36.56  Alternative Lingual Suture Membrane Fixation. (A) Tack placed in palatal cortical plate with \nsuture started through the palatal flap, passing below the flap and back through the membrane. (B) The \nsuture is then passed back from beneath the flap and out again."
  },
  {
    "page": 82,
    "content": "A\nC\nB\n• Fig. 36.57  Interim Prosthesis Modification. (A and B) The buccal flange and the grafted area should be \nmodified to remove any possible pressure areas. (C) Post adjusted prosthesis showing minimal flange and \nridge area relieved.\nA\nB\nC\nD\n• Fig. 36.58  Interim Prosthesis-Related Pressure. (A) Fixation screw exposed with associated bone loss \n(B) caused by interim prostheses with protrusion placing pressure on graft. (C) Essix appliances allow \ntemporary replacement of teeth in narrow span regions. However, the Essix appliances do have disadvan-\ntages in respect to limited esthetics, fractures, and discoloration. If adjusted properly, it will not allow any \npressure on the graft site. (D) Essix appliance with added acrylic that encompasses the soft tissue defect \nand potentially may place undue pressure on the grafted area."
  },
  {
    "page": 83,
    "content": "973\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nand foundation of the use and indications of the available bone \ngrafting materials (Box 36.10). \nGraft Maturation Healing Times\nAs time frames for graft maturation are considered, it must be kept \nin mind that this whole approach to grafting is a “substitution” pro-\ncess where the grafted bone is eventually going to be replaced with \nnewly developed natural bone. For adequate healing the graft must \nbe given sufficient time to resorb and for new bone to be regener-\nated in its place. This process varies considerably as different graft \ntypes are considered. A common issue with clinicians early in their \nlearning curve is trying to use a “fixed” healing time period for all \nparticulate grafts.\nIdeally many factors must be taken into consideration when \ndetermining the healing time. One of the most important \nfactors is the number of remaining walls of bone that surround \nthe recipient site. In general the larger the number of walls sur-\nrounding the graft, the shorter the healing time. The second fac-\ntor is the use of autogenous bone within the graft. The more \nautogenous bone used, the shorter is the healing time. The \nquantity of allograft is a significant factor because the greater the \namount of allograft, the longer the required healing period. This \nis directly tied to the time needed for adequate angiogenesis. The \ntype of bone used is also significant with the healing time: autog-\nenous (fast), allograft (moderate), xenograft (slow), and alloplast \n(slow to unpredictable bone turnover). Lastly, systemic diseases \nsuch as diabetes, hyperparathyroidism, thyrotoxicosis, osteoma-\nlacia, osteoporosis, and Paget’s disease may all affect the healing \nresponse. (Box 36.11)\nIn summary, it is always best to err on the side of safety and \nallow for more bone healing time. For most cases involving graft \nsites composed entirely of allograft, 6 to 8 months is recommended \nwhen graft volumes are less than 4 mm in dimension. In similar \nsites with larger graft volumes (>4 mm), 6 to 10 months is highly \nrecommended. Premature reentry into the graft may initiate many \ncomplications. In cases of poor or delayed healing, the quality of \nbone will be very weak and granular, similar to D5 bone. This type \nof bone is very soft and prone to overpreparation, ultimately result-\ning in a poor bone-implant contact. If this situation is encountered, \nthe surgical implant placement protocol should be altered with \nunderpreparation of the osteotomy, osseodensification techniques \nA\nB\nC\n• Fig. 36.59  Alternative Interim Prosthesis. (A) Large grafting site. (B) Final \nclosure of ridge augmentation. (C) Placement of Snap-On Smile over the \nclosed graft site to protect augmentation site during the healing process.\n\t1.\t \u0007Autogenous Grafts: a graft removed from one anatomic location and \nplaced in another location in the same individual\nDonor sites: tuberosity, ramus, symphysis, iliac crest, etc. (coagulum, \nparticulate, block grafts)\nIndications: used as the 1st layer in GBR procedures which require > 3 \nmm of bone growth (horizontal) or vertical bone growth\n\t2.\t \u0007Allograft: grafts taken from the same species—human cadaver\n\t\na.\t \u0007Osteoinductive Allografts: grafting materials that provide a \nbiological stimulus (proteins and growth factors) that induce the \nprogression of mesenchymal stem cells and other osteoprogenitor \nlineage. (Example: Demineralized Freeze Dried Bone Allograft \n{DFDBA})\n\t\nb.\t \u0007Osteoconductive Allografts: relatively inert filling materials that \nintegrate with new forming bone. Osteoconduction is the process \nthat permits osteogenesis when cells already committed to bone \nformation are also present in a closed environment.\n(Example: Mineralized Freeze-Dried Bone Allograft {FDBA})\nIndications: used as 2nd layer for grafts > 3 mm or as sole grafting \nmaterial for grafts < 3 mm\nOptions: 1. 70% FDBA / 30 DFDBA\n2. 100% FDBA (Cortico-Cancellous)\n\t3.\t \u0007Xenograft: osteoconductive graft from another species\n(Examples: Bovine {Bio-Oss, Bio-Oss porcine, and equine)\nIndications: rarely used in GBR protocols\n\t4.\t \u0007Alloplast: osteoconductive—a chemically or naturally derived \nnonanimal material\n(Examples: Hydroxyapatite, Bioglass, calcium sulfate)\nIndications: rarely used in GBR protocols\n\t5.\t \u0007Biologics: cell-based therapies, growth factors, and osteoconductive \nmatrices, that clinically enhance bone regeneration\n(Example: Emdogain, recombinant human bone morphogenetic \nprotein-2, platelet-rich plasma, platelet-rich fibrin)\nIndications: elective use, however highly recommended in larger graft \ncases\n\t• BOX 36.10\t   \u0007GBR Bone-Grafting Options"
  },
  {
    "page": 84,
    "content": "974\nPART VII    Soft and Hard Tissue Rehabilitation\nand/or the use of osteotomes. The concepts of ridge remodeling \nafter loading should be seriously considered, and placement of \nadditional layers of xenograft with membrane coverage should be \nused. Overall, patience in graft maturation is critically important. \nBone-Grafting Complications\nIncisive Canal Involvement in Regeneration Sites\nImplant restorations in the anterior maxillary region present one \nof the most difficult challenges in dentistry today. The combina-\ntion of esthetic demands, biomechanical/functional issues, and \nphonetic challenges require implant placement in ideal positions. \nThe incisive foramen is the exit point of the nasopalatine canal, \nwhere the terminal branch of the descending palatine artery and \nnasopalatine nerve pass into the oral cavity. The proximity of the \nincisive foramen and the path of the canal must be evaluated in \nall maxillary incisor implant treatment plans because there can be \nsignificant variations in the size, position, and angulation of the \nnasopalatine canal and the exiting foramen. As the bone around \nthe maxillary central incisors resorbs, the zone of available bony \nsupport moves palatally, frequently encroaching on the incisive \nforamen.\nDefining the dimensions and pathway of the nasopalatine canal \nwith CBCT imaging allows the surgeon to decide whether implants \ncan be placed within the required restorative space or whether aug-\nmentation will be needed for ideal placement. This is particularly \nimportant in cases involving immediate implants because the lin-\ngual angulation of the immediate implant osteotomy could poten-\ntially fenestrate into the incisive canal. A fenestration in the side of \nan osteotomy allows neural/fibrous tissue invasion into the oste-\notomy, retarding bone growth and rigid fixation of the implant.\nAxial CBCT images provide the most accurate view of the \nsize, shape, and location of the canal in respect to the possible \nimplant sites. Use of CBCT cross sections and three-dimensional \nimages can also help determine the positions and dimensions of \nthis important anatomic variant. The clinician must be aware of \na possible widening of the canal above the level of the foramen, \ncreating a fenestration between the canal and the osteotomy in the \nmore apical regions of the osteotomy. As the cross sections of the \nCBCT are reviewed, the possible presence of a nasopalatine cyst \nshould be ruled out, and edentulous arches should be reviewed \nfor an enlarged foraminal dimension, as is often noted. The posi-\ntions of implants in central incisor regions where the foramen is \ninvolved should be adjusted distally where an FP-1 restoration \ndoes not require a specific placement. This slight adjustment dis-\ntally prevents fenestration on the mesiopalatal line angle, where \nthis deficiency most likely will occur.\nSevere bone resorption on the facial aspect of the maxilla \nreduces the ridge thickness to surprising extents, often leaving \nonly a thin ridge that is positioned well to the palatal aspect of \nthe required location for a central incisor implant. It should be \nkept in mind that a line between the cingula of the two cus-\npids passes directly over the incisal foramen. Subsequently, if an \nimplant is placed this far palatally, the emergence profile will \noriginate at a significantly proclined angle and the complete res-\ntoration will be palatally positioned. Cases such as this require \nthat the seriously deficient ridge be regenerated before implant \nplacement.\nRegions that are determined to be deficient will require facial \naugmentation using techniques that are capable of generating suf-\nficient lateral/vertical bone volume for proper implant placement \nand restorative success. Cases where the implant can be moved \nslightly in a distal direction can sometimes prevent the need for \nmajor augmentation. Another option in a FP-3, RP-4, or RP-5 \ncase is the obliteration and grafting of the nasopalatine canal, \nwhich can aid in providing significant bone volume for implant \nplacement into vital bone and potentially creating a better ridge \nconsistency on maturation. (Fig. 36.60) \nReleasing the Tissue Flap From Underlying \nTenting Screws\nFlap reflection is a basic procedure that is common in all surgi-\ncal applications. Correct tissue manipulation allows the flap to be \nreleased and reflected without tearing or damaging the underly-\ning periosteal layer. The use of bone fixation screws in particulate \ngrafting techniques creates a complicated situation for flap reflec-\ntion because the fibrous tissue layer of the periosteum surrounds \nthe head of the screw and any exposed portion of the neck of the \nscrew. As the flap is reflected away from a screw insertion site, this \nfibrous layer must be released before the flap can continue to be \ndrawn away from the region.\nThis binding attachment cannot be easily drawn over the screw \nheads, and there is a potential to create perforations or tears in the flap \nas it is released. Flap reflection in this situation starts with a simple full-\nthickness crestal incision that is prepared over the graft site. Flap release \nis initiated with a sharp curette that is used to release the flap and to \nreflect the periosteum, scraping side to side until the full flap can be \nelevated. As the flap is released, the bone fixation screws must be freed \nfrom the thick layer of fibrous tissue that adheres to the screw head. A \n#12 scalpel maybe used to sever the fibrous layer over the screw, and \na sharp curette is then used to continue the flap release until another \nscrew is encountered. Once the flap has been completely released, the \nfixation screws are accessible for removal before placing the implants \n(Fig. 36.61). \nExposure of the Bone Fixation Screw During the \nHealing Process\nBone fixation screws in regeneration sites sometimes become \nexposed during the healing process, potentially leading to bacte-\nrial invasion around the neck of the screw. Careful attention to \nthe time lines of the screw exposure and the type of regenera-\ntive process is important in these situations. It is not uncommon \nfor the tissue covering the heads of the fixation screws to become \nvery thin. This paper-thin tissue allows the color and contour \nof the screw heads to be visible and palpable. This is of no sig-\nnificant concern, and the only precaution is directed to relief of \nany removeable appliance that could be placing pressure on the \n\t1.\t \u0007Remaining number of bony walls\n\t2.\t \u0007Use or exclusion of autogenous bone\n\t3.\t \u0007Type of allograft material\n\t4.\t \u0007Particle size of allograft material\n\t5.\t \u0007Amount of blood supply at graft site\n\t6.\t \u0007Use of bone growth factors\n\t7.\t \u0007Presence of systemic diseases\n\t8.\t \u0007Lifestyle issues (smoking, alcohol)\n\t9.\t \u0007Post-operative complications\n\t• BOX 36.11\t   \u0007Factors That Affect the Healing Time of \nParticulate Grafts"
  },
  {
    "page": 85,
    "content": "975\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nalready tender and thin tissue. If at any time the actual head per-\nforates through the tissue, it should be considered for removal.\nExposure of fixation screws in particulate grafting occurs \nwhen the head of the screw works its way through the overly-\ning membrane and eventually perforates through the thin layer of \nthe mucosa that covers the graft site. This typically happens when \nthe screw head has a thin diameter that perforates through the \nmembrane and eventually through the tissue. Particulate grafting \ntechniques use these fixation screws to support the membrane and \nto define the shape of the desired bony contours. The use of a \nscrew with a “wide head” is found to be important for predictable \nresults. The type of membrane used for graft isolation also makes \na significant difference when perforation of the screw through the \nmembrane is a concern. Acellular dermal matrix and pericardium \ntend to be very resistant to membrane perforation during the heal-\ning process, whereas collagen membranes are soft when moistened \nand tend to perforate and tear if strain is placed on the hydrated \nmembrane. Perforation of a membrane allows the ingress of for-\neign matter and fibrous soft tissue cells into the graft site, causing \na disruption in the bone regeneration process. If the head of the \nA\nB\n• Fig 36.60  Incisive Canal Approximation (A) Two implants in # 8 and # 9 positions after significant bone \naugmentation, note that even with augmentation, implant placement impinging on incisive canal, (B) After \nextensive maxillary grafting, anatomical limitations of the incisive canal contraindicates implant placement.\nA\nC\nD\nB\n• Fig. 36.61  Bone Screw Removal. (A and B) The flap has been completely released and the fixation \nscrews are accessible for removal (before placing the implants). (C and D) Bone must be removed from \ninside the screws before attempting removal with either a 12 blade or periodontal scaler."
  },
  {
    "page": 86,
    "content": "976\nPART VII    Soft and Hard Tissue Rehabilitation\nscrew pushes through the soft tissue and is exposed, bacterial con-\ntamination may result, potentially leading to graft infection and \npossible failure.\nThe head of the bone fixation screws should have a wide and \nsmooth diameter that provides enough surface area to support the \nmembrane and to limit abrasion against the overlying mucosal layer. \nA small head will tend to work its way through a membrane when it \nis placed under tension or where a delicate membrane is being used. \nThe typical bone fixation screw has a diameter of 1.5 mm, and the \nhead of the screw should be as wide as possible. Newer generations of \nfixation screws have been designed specifically for membrane graft-\ning, and they provide a very wide surface area for even support of a \nmembrane. These larger heads also support such a large surface that \nthe actual number of fixation screws can be reduced significantly.\nExposed screw heads should be maintained with chlorhexidine \nrinses until the surrounding soft tissue has healed. It is recom-\nmended that the screws in particulate techniques be removed at \nthis time to eliminate the possibility of contamination of the graft \nthrough the opening around the shaft of the screw. If the screw is \npreventing pressure on the graft in respect to the use of a remov-\nable prosthesis, retention of the screw could be considered. Under \nno circumstances should efforts be made to cover the screw by \nrepositioning the soft tissue (Fig. 36.62). \nIncision Line Opening in Bone-Grafting Sites\nMaintenance of complete soft tissue coverage over healing bone-\ngrafting sites is one of the most important principles that must be \nobserved for predictable grafting success. Any time that the heal-\ning graft site is exposed to the oral flora during the healing process, \nthere will be some type of compromised change in the final graft \nsite volume and in its overall integrity. Incision line opening with \ncompromised graft results can often be a major limiting factor in \nsuccessful implant placement.\nIncision line opening can compromise even the most care-\nfully planned regeneration site, and most of these graft sites will \nrequire additional grafting at a later time if an actual complication \ndevelops. An open incision line introduces numerous potential \ncomplications into the healing process. First, the introduction of \nmicroorganisms into a graft site through an open incision can lead \nto an infection in the healing graft site. Exposure of the graft par-\nticles and the presence of purulence is an indication of impending \nfailure of the graft. The infection reduces the pH in the graft site, \ncausing a breakdown of the graft particles and eventually com-\npromising the resulting ridge volume. Second, an open incision \nline may allow exposure and breakdown of the barrier membrane, \ncontributing to fibrous tissue ingrowth into the graft site. Lastly, \nthere exists a potential for particulate graft materials to escape the \ngraft site, resulting in an inadequate bone volume in the final pro-\nposed implant site.\nThe most important concept in maintaining incision line \nintegrity is consistent tension-free wound closure. This protective \nseal can be most effectively managed from the standpoint of over-\nall flap management throughout the surgical procedure. A clini-\ncian’s experience in manipulation of soft tissue affects this aspect \nof bone regeneration more than any other part of bone regen-\neration surgery. As the clinician gains more experience in delicate \ntissue management and begins to understand the maintenance of \na tension-free flap closure, problems with graft and membrane \nexposure will become an uncommon occurrence.\nAll regeneration sites require that the overlying tissue flap be \nstretched over the wide bulk of the graft at the completion of the \nprocedure. Unfortunately there is a finite distance that a tissue \nflap can be freely stretched, and at this point the wound closure \nis placed under tension. Even though pressure can be exerted on \nthe stiches to force closure of the wound, the incision line is put \nunder an unreasonable amount of stress. The continual tension \nand pressure will eventually lead to necrosis of the tissue around \nthe sutures, leading to an open incision postoperatively.\nThe inner surface of a reflected flap is lined with the periosteum: \na thin, dense binding layer of tissue that cannot be stretched. The \ntissue directly below the periosteum is very loose mobile tissue full \nof elastic fibers. This disparity in tissue types can predictably be \nneutralized with a shallow incision through the dense periosteal \nlayer. This “tissue release” is accomplished by preparing a clear and \ncontinuous releasing incision through the periosteum, exposing \nthe underlying elastic layers of tissue that can then be released \nfor expansion of the flap over the enlarged graft site. As this inci-\nsion perforates the periosteal layer, the two edges clearly separate, \nallowing the elastic tissue below the periosteum to stretch. A sharp \npair of Metzenbaum scissors is then placed into the space below \nthe periosteum, and as the scissor tips are opened, the tissue easily \nreleases and the edges separate further. This is repeated until the \ncomplete flap is stretched over the graft site and 5 mm beyond the \nopposite flap margin.\nIn the event of an incision line opening, the patient should be \nplaced on a frequent monitoring protocol to observe the status of \nthe graft material and any grafting hardware present. The oral micro-\nflora must be managed with the use of daily chlorhexidine rinses. \nThe clinician must not attempt to suture the site again because \nhealing margins along incision lines feature tissue that cannot, at \nthat time, support the pressure of another suture under tension \n(Figs. 36.63 and 36.64). \nHigh Mucogingival Junction Following Ridge \nAugmentation\nMajor ridge augmentation requires that the soft tissue flap be \nstretched over the enlarged graft site. Through the process of \nextending this tissue laterally over a large and bulky graft, the \nmucogingival junction is elevated to a level that often surrounds \nthe abutment with mucosa. Various approaches are available to \nprevent or repair this deficiency of keratinized tissue, but the \naddition of pre-surgical procedures to an already involved series of \nsurgical appointments often prevents implant teams from coping \nwith this situation.\nThe simplified approach is to place a very wide autologous \ntissue graft from the palate over the mucosal region prior to the \nactual augmentation procedure. The main complaint about this \napproach is the fact that palatal grafts like this have a whiter color \nafter the graft is placed and it really does not match the thin and \npink color of anterior restorative sites. Those grafts are better indi-\ncated for use in posterior regions.\nThe best method available in this situation was described by Dr. \nEsteban Urban who recommends releasing the loose mucosal tis-\nsue with a split thickness flap, leaving the underlying periosteum \nand fibrous tissue intact. The released mucosal flap is sutured api-\ncally with multiple 5-0 Chromic sutures, creating an exposed zone \nof exposed tissue from the top of the ridge to the newly sutured \ntissue. A thin strip of palatal tissue is removed, and it is sutured \nalong the apical suture line to fixate the repositioned tissue. This \ntechnique will ultimately prevent relapse of the mucosal tissue \nlevel. A large piece of mucograft (i.e. resorbable collagen matrix - \nGeistlich Mucograft®) is placed over the exposed periosteum and"
  },
  {
    "page": 87,
    "content": "977\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nsutured with chromic sutures. This arrangement of tissue, muco-\ngraft, and tissue graft create a predictable zone of keratinized tissue \non the facial aspect of the implant restoration and the addition of \nthe mucograft basically eliminates any discomfort related to the \nrepositioning of the mucosal flap. (Fig. 36.65 A, B, C, D, and E) \nGraft Infection\nGraft materials resorb rapidly at a lower pH condition, with HA \ncrystals dissolving at pH 5.5 or less. Infectious environments may \ncontain a pH of 2 or less, which can cause the rapid dissolution of \na graft. Infection may be caused by lack of aseptic surgical tech-\nnique, incision line opening, or infection from adjacent dental \nsources. The presence of a localized infection in a bone graft will \ncause dissolution of the graft material, contributing to graft fail-\nure. The severity of this failure can vary depending on the duration \nof the infection and the onset of the contamination.\nThe use of proper surgical technique is vital in the preven-\ntion of surgical contamination. Preoperative antibiotic regi-\nmens, chlorhexidine scrubs, and aseptic technique will limit \nbacterial contamination at the time of surgery. Proper suture \ntechnique and flap design are grafting fundamentals that \nC\nD\nF\nE\nA\nB\n• Fig. 36.62  Membrane Tent Screws. (A) Larger screw heads are more likely to grow bone than smaller \nscrew heads. Note the lack of bone around the small-headed screw on the far right side of the photo. (B) \nWide-head bone screw. (C) Tent screws are available in various width shanks and lengths. (D) As the graft \nheals and the membrane resorbs, the head of the fixation screws are often visible through the thin mucosa \ncovering the healing graft site. This is not a complication, and no special treatment is necessary. (E) Screw \nperforation through thin tissue. (F) Screw removal before implant placement."
  },
  {
    "page": 88,
    "content": "A\nB\nC\n• Fig. 36.63  Membrane Exposure. (A) Acellular dermis exposure. (B) Collagen membrane exposure. (C) \nDense polytetrafluoroethylene exposure through buccal mucosa and residual ridge. All membrane expo-\nsures should be maintained as long as possible.\nA\nB\nC\n• Fig. 36.64  Membrane Exposure. (A) Two weeks after surgery. (B) Three weeks after surgery. (C) By keep-\ning the area clean with chlorhexidine, at 5 weeks postoperative closure is obtained."
  },
  {
    "page": 89,
    "content": "979\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nprevent incision line opening that can also expose the graft \nto the oral microflora. Lastly, the clinician should ensure that \nall space maintenance components (nonresorbable membranes, \ntitanium mesh, tenting screws) are free from sharp edges that \nmay perforate the mucosa postoperatively, allowing the ingress \nof bacteria into the graft.\nPostoperative examinations must be routinely scheduled, \nespecially during the initial stages of wound healing. The patient \nmust be instructed in hygiene techniques that minimize strain \non the incision line, and postoperative chlorhexidine rinses can \nbe used to manage the bacterial microflora. If incision line open-\ning occurs, the patient must be placed on a chlorhexidine rins-\ning protocol to keep the graft site clean until the granulation is \ncomplete. If the patient experiences purulence from the site or \ngeneral malaise, antibiotic protocols must be commenced imme-\ndiately. Nonresorbable membranes should be maintained for at \nleast 6 weeks unless the site becomes infected. If this occurs, the \nmembrane should be removed before the situation advances. \nA\nB\nC\nD\nE\n• Fig. 36.65  High mucosal attachment in the restorative space of the prosthesis: (A). Note the elevated \nmucogingival junction, particularly on the distal implant. (B). Free Tissue harvest. (C). Split thickness release of \nthe mucosa, with apical fixation using 5 0 Chromic sutures. (D). Fixation of the free tissue graft at the depth of \nthe newly defined vestibule. The exposed tissue between the tissue graft and the top of the ridge is covered \nwith “Mucograft”. (E). Three week post operative image is graft site with new zone of keratinized attachment."
  },
  {
    "page": 90,
    "content": "980\nPART VII    Soft and Hard Tissue Rehabilitation\nUltrasonic Piezosurgery-Related Tissue Injury\nThe use of ultrasound technology in dentistry first began in the 1950s, \nand newer Piezosurgery units have been developed using low-frequency \nultrasound (10–60 kHz) for the selective cutting of bone. Traditional \nbone drilling with motorized drills is easily available to clinicians; how-\never, cutting bone with a drill can generate excessive amounts of heat \nin dense bone, potentially damaging the surrounding tissue. A surgical \ndrill that comes in contact with blood vessels, nerves, or sinus mem-\nbranes can also cut or damage adjacent vital structures. The use of Piezo-\nsurgery in implant surgery has been a welcome alternative to motorized \ndrills in many applications. At the lower ultrasonic frequencies used for \nPiezosurgery, surgical inserts cut through hard, mineralized bone but \ndo not damage the surrounding soft tissue or generate high amounts of \nheat. Piezosurgery has been especially useful in implant surgery, where \nbone must be cut in close proximity to a nerve or blood vessel.\nAs Piezosurgery has been performed, it has been reported by \npractitioners that the inserts should not be allowed to function \nwhile in direct contact with the soft tissue flap. Earlier surgical \nunits were reported to “heat up the insert tip” during use, and irri-\ntations or burns on the soft tissue flap were sometimes detected. \nThis altered tissue issue has not been evident in updated Piezosur-\ngery units, but careful attention must be directed to protection \nof surrounding soft tissue during ultrasonic insert use. Instruc-\ntors describe this as an abrasive phenomenon caused by the rapid \nultrasonic movement of the tip against the soft tissue. Care must \nbe taken to keep the tissue flap away from the ultrasonic inserts.\nDevelopment of any abrasive or burn-type lesion should be \ntreated symptomatically, just as any other oral burn or abrasive \nlesion would be treated. If there are any signs of more serious dam-\nage, more involved treatment may require appropriate referrals for \nwound care (Figs. 36.66 A, B, and C  and 36.67). \nSummary\nTo satisfy the ideal goals of implant dentistry, the hard and soft \ntissues need to be present in ideal volume and quality. After \ntooth loss, the resorption of the alveolar process occurs so often \nthat augmentation procedures are often necessary to restore the \nhard and soft tissues. This becomes especially significant when \nthe edentulous areas are in the esthetic zone. Augmentation \nprocedures not only enhance the final esthetic result, but also \nwill make a more predictable biomechanical foundation to \nminimize possible complications. In implant dentistry today, \nthere exist a vast array or procedures and protocols to augment \ndeficient implants sites. This chapter presented an overview of \nthe indications for guided bone regeneration techniques along \nwith a classification of differing ridge morphology that will \nallow the clinician to understand the predict ability and diffi-\nculty based on the bony ridge deficiency. The following images \ndemonstrate the regenerative potential of current approaches to \nbone augmentation. Jensen and Terheyden78 in 2009 reviewed \n108 articles and concluded that the mean average of particu-\nlate grafting with a membrane was 2.6mm and 24.4% required \nadditional grafting post operatively. As the concept of “Space \nMaintenance” has been explored over recent years, techniques \nand barrier materials have improved significantly, changing the \nability of surgeons to regenerate ridge defects. The following \ncases are examples of the ability of these techniques to regen-\nerate large amounts of bone in critical regions. These are not \na few “rare cases” that have been cherry picked for this publi-\ncation. Careful application of the principles described in this \nchapter have demonstrated similar results on a very predictable \nbasis (Box 36.12 and Figs. 36.68-36.72).\nA\nB\nC\n• Fig. 36.66  Piezoelectric Handpiece Trauma. (A and B) The shaft of the handpiece (A) and the insert (B) \nshould not be allowed to contact the soft tissue because soft tissue burns or trauma may result. (C) Ideal \nposition of handpiece and insert with no contact to adjacent tissues."
  },
  {
    "page": 91,
    "content": "981\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nA\nB\n• Fig. 36.67  Ideal Retraction. (A) The piezoelectric inserts are separated from the surrounding soft tissue \nwith “Pritchard retractors” and wide flap access. (B) Two retractors retract the tissue, whereas the piezo \ninsert prepares the bone.\nStep 1: Incision\n\ta.\t \u0007Position—ideally bisect the attached tissue; if compromised keratinized \ntissue, incision should be made more to the lingual\n\tb.\t \u0007Broad based—release incisions should always be broad based to \nmaintain adequate blood supply to allow for ideal healing\n\tc.\t \u0007Papilla sparing—when possible around adjacent natural teeth, incisions \nshould be made maintaining the papilla; this reduces the chance of \naltering or losing the papilla and the development of a “black triangle” \nStep 2: Reflection\nA full-thickness reflection is recommended. The amount of reflection is related \nto development of adequate exposure to the graft site for placement of bone \ngrafts and barrier membranes. It is also important in preparation of the site for \ntension-free primary closure. \nStep 3: Removal of Recipient Site Soft Tissue\nIt is imperative that all soft tissue is removed from the recipient site because \nsoft tissue remnants will prevent bone formation. This may be accomplished in \nvarious ways including: (1) hand instrument removal, (2) small round burs (#8 \ncarbide), or (3) laboratory straight handpiece burs (carbide, diamond). \nStep 4: Decortication\nThe recipient site should be decorticated to increase bleeding (angiogenesis) \nand to allow bone growth factors to enter the area, enhancing bone formation. \nWhen decorticated, bleeding must be visible through the decortication sites. \nCross-cut fissure burs or small, round burs may be used to perforate the \ncortical plate. \nStep 5: Tissue Release\nIt is imperative the tissue is prepared prior to graft placement to prevent \ndisruption of the graft material. Therefore, the flap is prepared to minimize any \ntension on the incision line. Ideally, the facial flap should extend a minimum of 5 \nmm over the lingual flap. There are two techniques which include (1) periosteal \nrelease - # 15 blade, and (2) blunt dissection – Metzunbaum scissors. \nStep 6: Membrane Placement\n\ta.\t \u0007Membrane selection—the type of membrane will depend on the shape \nand volume of bone required, the predictability of soft tissue closure \n(resorbable vs. nonresorbable), and the experience of the surgeon.\n\tb.\t \u0007Hydration—most membranes will need to be hydrated to allow for \nproper placement and to minimize the possibility of poor closure\n\tc.\t \u0007Fixation—the membrane should be apically fixated with tacks or sutures \nto minimize movement. Usually the facial/buccal tacks are placed before \ngrafting. This initial stabilization of the membrane allows the site to \nremain undisturbed after graft placement. It is highly recommended to \nfix the membrane on the lingual/palatal aspect with tacks or sutures.\n\td.\t \u0007Adequate periosteal release over the graft site—the tissue should be \nreleased enough for the flap to be stretched freely, allowing tension-free \nclosure. Ideally the facial flap should extend a minimum of 5 mm beyond \nthe lingual flap. \nStep 7: Space Maintenance\nFor predicatble bone growth, the space must be maintained to allow the \nbone grafting material to heal undisturbed. Placement of a support \nsystem (tenting screws, polytetrafluoroethylene (PTFE) membrane with \ntitanium, titanium mesh) must be used. Collapse of the graft site will \nresult in compromised bone growth. \nStep 8: Graft Material Placement\n\ta.\t \u0007Autogenous: Usually, autogenous bone is recommended when bone \ngrowth of greater than 3 mm is required. When indicated, autograft \nshould be the first layer (against the host bone). The autograft shavings \nshould cover the complete recipient bed below the screws.\n\t• BOX 36.12\t   \u0007Guided Bone Regeneration Protocol\nContinued"
  },
  {
    "page": 92,
    "content": "• BOX 36.12\t   \u0007Guided Bone Regeneration Protocol—cont’d\n\tb.\t \u0007Allograft: The allograft should be placed as the second layer in larger \nbone graft cases (> 3 mm). For smaller graft cases, 100% allograft may \nbe used (i.e. 70% FDBA / 30 DFDBA or\n100% FDBA Cortico-Cancellous). The particulate bone should be densely \npacked to avoid air spaces which tend to harbor bacteria.\n\t•\t \u0007After the bone graft is placed, the membrane is drawn completely over \nthe graft material with 2 to 3 mm of overlap over native bone to limit \nexposure of the particulate during the healing process. The membrane \nshould be fixated (on the free end) with tacks or sutures. In situations \nwhere the membrane cannot be fixated, it can be tucked under the \nlingual flap and the coronal surface can be included in the closure \nsutures to limit movement. If platelet-rich fibrin or platelet-rich plasma \nis being used, it should be placed over the membrane (in between the \ntissue and membrane). \nStep 9: Closure\n\ta.\t \u0007Suture selection: The most ideal sutures for tissue closure are Vicryl \n(resorbable) or PTFE (Cytoplast, nonresorbable). The PTFE suture allows \nadjustment of the suture tension as the knot is being tied, and results in \nminimal inflammation around a healing incision line.\n\tb.\t \u0007Primary sutures: the crest or ridge area should be closed first with a \ntension-free suture line. Mattress sutures should be placed at intervals \nthat distribute the pressure on the incision over a large surface area. \nMattress suture evert the tissue flaps, thereby decreasing the possibility \nof incision line opening. Interrupted sutures may be used between the \nmattress sutures. A common mistake is to close the vertical releasing \nincisions first, thereby placing tension on the crestal suture line.\n\tc.\t \u0007Secondary sutures: After the crestal area has been closed, the releasing \nincisions may be closed passively. Care should be exercised not to place \ntoo much tension on the releasing flaps, thereny limiting tension on the \ncrestal sutures.\nA\nC\nB\n• Fig. 36.68  (A – C) Posterior mandible augmentation for horizontal regeneration using autogenous , min-\neralized freeze-dried bone allograft, and GBR acellular dermis membrane."
  },
  {
    "page": 93,
    "content": "983\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nA\nB\nC\n• Fig. 36.69  Advanced Vertical & Horizontal defect with loss of facial and palatal cortical plates following \nthe loss of two implants. (A) Flap reflection showing the severe destruction caused by two failed implants. \n(B) The final ridge form following ridge augmentation with autogenous bone and allograft/acellular dermis, \n(C) Final Prosthesis\nA\nB\n• Fig. 36.70  Maxillary Anterior Horizontal Augmentation; (A) Exposed defect, note the papilla saving inci-\nsion design, (B) Post-op bone augmentation healing."
  },
  {
    "page": 94,
    "content": "A\nB\nC\n• Fig. 36.71  Maxillary Anterior Augmentation (A). Anterior regeneration using space maintenance for site \ndevelopment. (Autogenous bone, FDBA and Acellular dermis). (B). Post-augmentation ridge form\nA\nB\n• Fig. 36.72  Vertical Ridge Augmentation (A) Pre-op, (B) Post-op."
  },
  {
    "page": 95,
    "content": "985\nCHAPTER 36  Particulate Membrane grafting/Guided Bone Regeneration\nReferences\n\t 1.\t \u0007Schropp L, Wenzel A, Kostopoulos L, Karring T. Bone healing and \nsoft tissue contour changes following single-tooth extraction: a clini-\ncal and radiographic 12-month prospective study. Int J Periodontics \nRestorative Den. 2003;23:313–323.\n\t 2.\t \u0007Clementini M, Morlupi A, Canullo L, et  al. Success rate of dental \nimplants inserted in horizontal and vertical guided bone regenerated \nareas: a systematic review. Int J Oral Maxillofac Surg. 2012;41:847–852.\n\t 3.\t \u0007Hammerle CH, Jung RE, Feloutzis A. A systematic review of the \nsurvival of implants in bone sites augmented with barrier mem-\nbranes (guided bone regeneration) in partially edentulous patients. J \nClin Periodontol. 2002;29(3):226–231, discussion 232–223.\n\t 4.\t \u0007McAllister BS, Haghighat K. Bone augmentation techniques. J Peri-\nodontol. 2007;78:377–396.\n\t 5.\t \u0007Jensen SS, Terheyden H. Bone augmentation procedures in local-\nized defects in the alveolar ridge: clinical results with different bone \ngrafts and bone-substitute materials. Int J Oral Maxillofac Implants. \n2009;24:218–236.\n\t 6.\t \u0007Nevins M, Mellonig JT. The advantages of localized ridge augmen-\ntation prior to implant placement: a staged event. Int J Periodontics \nRestorative Den. 1994;14:96–111.\n\t 7.\t \u0007Liu J, Kerns DG. Mechanisms of guided bone regeneration: a review. \nOpen Dent J. 2014;8:56–65.\n\t 8.\t \u0007Van der Weijden F, Dell’Acqua F, Slot DE. Alveolar bone dimen-\nsional changes of post-extraction sockets in humans: a systematic \nreview. J Clin Periodontol. 2009;36(12):1048–1058.\n\t 9.\t \u0007Hof M, Tepper G, Semo B, Arnhart C, Watzek G, Pommer B. \nPatients’ perspectives on dental implant and bone graft surgery: \nquestionnaire-based interview survey. Clin Oral Implants Res. \n2014;25(1):42–45.\n\t10.\t \u0007Cook DR, Mealey BL, Verrett RG, et al. Relationship between clini-\ncal periodontal biotype and labial plate thickness: an in vivo study. \nInt J Periodontics Restorative Dent. 2011;31(4).\n\t11.\t \u0007Ryan CD, Mealey BL, Verrett RG, et al. Relationship between clini-\ncal periodontal biotype and labial plate thickness: an in vivo study. \nInt J Periodontics Restorative Dent. 2011;31(4):344–354.\n\t12.\t \u0007Linkevicius T, Apse P, Grybauskas S, Puisys A. Influence of thin \nmucosal tissues on crestal bone stability around implants with \nplatform switching: a 1-year pilot study. J Oral Maxillofac Surg. \n2010;68(9):2272–2277.\n\t13.\t \u0007Dahlin C, Buser D, Dahlin C, Schenk R, eds. Guided Bone Regen-\neration in Implant Dentistry. Chicago. IL: Quintessence Publ; 1994. \nScientific Background of guided bone regeneration.\n\t14.\t \u0007Chou AH, LeGeros RZ, Chen Z, Li Y. Antibacterial effect of zinc \nphosphate mineralized guided bone regeneration membranes. \nImplant Dent. 2007;16(1):89–100.\n\t15.\t \u0007Nishibori M, Betts NJ, Salama H, Listgarten MA. Short-term heal-\ning of autogenous and allogeneic bone grafts after sinus augmenta-\ntion: a report of 2 cases. J Periodontol. 1994;65(10):958–966.\n\t16.\t \u0007Pitaru S, Tal H, Soldinger M, Grosskopf A, Noff M. Partial regen-\neration of periodontal tissues using collagen barriers. Initial observa-\ntions in the canine. J Periodontol. 1988;59(6):380–386.\n\t17.\t \u0007Fiorellini JP, Buser D, Riley E, et al. Effect on bone healing of bone \nmorphogenetic protein placed in combination with endosseous \nimplants: a pilot study in beagle dogs. Int J Periodontics Restorative \nDent. 2001;21:41–47.\n\t18.\t \u0007Melcher AH, Accurs GE. Osteogenic capacity of periosteal and \nosteoperiosteal flaps elevated from the parietal bone of the rat. Arch \nOral Biol. 1971;16:573–580.\n\t19.\t \u0007Zhang Y, Zhang X, Shi B, Miron RJ. Membranes for guided tis-\nsue and bone regeneration. Annals of Oral & Maxillofacial Surg. \n2013;1(1):10.\n\t20.\t \u0007Pellegrini G, Pagni G, Rasperini G. Surgical approaches based on biolog-\nical objectives: GTR versus GBR Techniques. Int J Dent. 2013:521–547.\n\t21.\t \u0007Dahlin C, Linde A, Gottlow J, Nyman S. Healing of bone defects by \nguided tissue regeneration. Plast Reconstr Surg. 1988;81:672–676.\n\t22.\t \u0007Buser D, Dula K, Hirt HP, Schenk RK. Lateral ridge augmentation \nusing autografts and barrier membranes: a clinical study with 40 par-\ntially edentulous patients. J Oral Maxillofac Surg. 1996;54:420–432, \ndiscussion 432–423.\n\t23.\t \u0007Chiapasco M, Abati S, Romeo E, Vogel G. Clinical outcome of \nautogenous bone blocks or guided bone regeneration with e-PTFE \nmembranes for the reconstruction of narrow edentulous ridges. Clin \nOral Implants Res. 1999;10:278–288.\n\t24.\t \u0007Simion M, Dahlin C, Rocchietta I, et al. Vertical ridge augmen-\ntation with guided bone regeneration in association with dental \nimplants: an experimental study in dogs. Clin Oral Implants Res. \n2007;18:86–94.\n\t25.\t \u0007Pocket Dentistry [internet]. Barrier Membranes for Guided Bone \nRegeneration. [updated 2015 Jan 5; cited 2017 Dec 28]. Avail-\nable from: https://pocketdentistry.com/3-barrier-membranes-for-\nguided-bone-regeneration/#end_en139.\n\t26.\t \u0007Rispoli L, Fontana F, Beretta M, Poggio CE, Maiorana C. Sur-\ngery guidelines for barrier membranes in guided bone regeneration \n(GBR). J Otolaryngol Rhinol. 2015;1(2):1–8.\n\t27.\t \u0007Buser D, Dula K, Hess D, et al. Localized ridge augmentation with \nautografts and barrier membranes. Periodontol. 1999;2000:151–\n163. 19.\n\t28.\t \u0007Trombelli L, Farina R, Marzola A, et al. GBR and autogenous corti-\ncal bone particulate by bone scraper for alveolar ridge augmentation: \na 2-case report. Int J Oral Maxillofac Implants. 2008;23:111–116.\n\t29.\t \u0007Simion M, Baldoni M, Rassi P, Zaffe D. A comparative study of the \neffectiveness of e-PTFE membranes with and without early expo-\nsure during the healing period. Int J Periodontics Restorative Dent. \n1994;14(2).\n\t30.\t \u0007Machtei EE. The effect of membrane exposure on the outcome of \nregenerative procedures in humans: a meta-analysis. J Periodontol. \n2001;72(4):512–516.\n\t31.\t \u0007Bartee BK, Carr JA. Evaluation of a high-density polytetrafl uoro-\nethylene (n-PTFE) membrane as a barrier material to facilitate \nguided bone regeneration in the rat mandible. J Oral Implantol. \n1995;21(2):88–95.\n\t32.\t \u0007Fontana F, Santoro F, Maiorana C, et al. Clinical and histologic \nevaluation of allogeneic bone matrix versus autogenous bone chips \nassociated with titanium-reinforced e-PTFE membrane for vertical \nridge augmentation: a prospective pilot study. Int J Oral Maxillofac \nImplants. 2008;23(6).\n\t33.\t \u0007Buser D, Dula K, Belser U, et al. Localized ridge augmentation using \nguided bone regeneration. 1. Surgical procedure in the maxilla. Int J \nPeriodontics Restorative Den. 1993;13:29–45.\n\t34.\t \u0007Feuille F, Knapp CI, Brunsvold MA, Mellonig JT. Clinical and his-\ntologic evaluation of bone-replacement grafts in the treatment of \nlocalized alveolar ridge defects. Part 1: mineralized freeze-dried bone \nallograft. Int J Periodontics Restorative Den. 2003;23:29–35.\n\t35.\t \u0007Sterio TW, Katancik JA, Blanchard SB, et al. A prospective, mul-\nticenter study of bovine pericardium membrane with cancellous \nparticulate allograft for localized alveolar ridge augmentation. Int J \nPeriodontics Restorative Den. 2013;33:499–507.\n\t36.\t \u0007Fowler EB, Breault LG, Rebitski G. Ridge preservation utilizing \nan acellular dermal allograft and demineralized freeze-dried bone \nallograft: Part II. Immediate endosseous implant placement. J Peri-\nodontol. 2000;71:1360–1364.\n\t37.\t \u0007Wainwright DJ. Use of an acellular allograft dermal matrix \n(AlloDerm) in the management of full-thickness burns. Burns. \n1995;21:243–248.\n\t38.\t \u0007Pocket Dentistry. Barrier membranes for guided bone regeneration. \n[updated 2015 Jan 5; cited 2017 Dec 28]. https://pocketdentistry.\ncom/3-barrier-membranes-for-guided-bone-regeneration/#end_\nen139.\n\t39.\t \u0007Luitaud C, Laﬂamme C, Semlali A, et al. Development of an engi-\nneering autologous palatal mucosa-like tissue for potential clinical \napplications. J Biomed Mater Res B Appl Biomater. 2007;83(2):554–\n561."
  },
  {
    "page": 96,
    "content": "986\nPART VII    Soft and Hard Tissue Rehabilitation\n\t40.\t \u0007Yamada M, Kubo K, Ueno T, et al. Alleviation of commercial col-\nlagen sponge- and membrane-induced apoptosis and dysfunction in \ncultured osteoblasts by an amino acid derivative. Int J Oral Maxil-\nlofac Implants. 2010;25(5):939–946.\n\t41.\t \u0007Rispoli L, Fontana F, Beretta M, Poggio CE, Maiorana C. Sur-\ngery guidelines for barrier membranes in guided bone regeneration \n(GBR). J Otolaryngol Rhinol. 2015;1(2):1–8.\n\t42.\t \u0007Rothamel D, Schwarz F, Sager M, Herten M, Sculean A, Becker \nJ. Biodegradation of differently cross-linked collagen mem-\nbranes: an experimental study in the rat. Clin Oral Implants Res. \n2005;16(3):369–378.\n\t43.\t \u0007Schwarz F, Rothamel D, Herten M, et al. Immunohistochemical \ncharacterization of guided bone regeneration at a dehiscence-type \ndefect using different barrier membranes: an experimental study in \ndogs. Clin Oral Implants Res. 2008;19(4):402–415.\n\t44.\t \u0007McAllister BS, Haghighat K. Bone augmentation techniques. J Peri-\nodontol. 2007;78:377–396.\n\t45.\t \u0007Griffin TJ, Cheung WS, Hirayama H. Hard and soft tissue aug-\nmentation in implant therapy using acellular dermal matrix. Int J \nPeriodontics Restorative Dent. 2004;24:352–361.\n\t46.\t \u0007Polimeni G, Koo KT, Qahash M, et al. Prognostic factors for alveo-\nlar regeneration: effect of a space-providing biomaterial on guided \ntissue regeneration. J Clin Periodontol. 2004;31:725–729.\n\t47.\t \u0007Le B, Burstein J, Sedghizadeh PP. Cortical tenting grafting tech-\nnique in the severely atrophic alveolar ridge for implant site prepara-\ntion. Implant Dent. 2008;17:40–50.\n\t48.\t \u0007Le B, Rohrer MD, Prasad HS. Screw “tent-pole” grafting technique \nfor reconstruction of large vertical alveolar ridge defects using human \nmineralized allograft for implant site preparation. J Oral Maxillofac \nSurg. 2010;68:428–435.\n\t49.\t \u0007Caldwell GR, Mealy BL. A prospective study: alveolar ridge aug-\nmentation using tenting screws, acellular dermal matrix and \ncombination particulate grafts. A Thesis for Master of Science in \nPeriodontics—The University of Texas Health Science Center at San \nAntonio Graduate School of Biomedical Sciences. May 2013\n\t50.\t \u0007Hempton TJ, Fugazzotto PA. Ridge augmentation utilizing guided \ntissue regeneration, titanium screws, freeze-dried bone, and trical-\ncium phosphate: clinical report. Implant Dent. 1994;3:35–37.\n\t51.\t \u0007Simon BI, Chiang TF, Drew HJ. Alternative to the gold standard for \nalveolar ridge augmentation: tenting screw technology. Quintessence \nInt. 2010;41:379–386.\n\t52.\t \u0007Choukroun J, et al. Platelet-rich fibrin (PRF): a second-generation \nplatelet concentrate. Part IV: clinical effects on tissue healing. Oral \nSurg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(3):e56–\ne60.\n\t53.\t \u0007Choukroun J, et al. Platelet-rich fibrin (PRF): a second-generation \nplatelet concentrate. Part V: histologic evaluations of PRF effects \non bone allograft maturation in sinus lift. Oral Surg Oral Med Oral \nPathol Oral Radiol Endod. 2006;101(3):299–303.\n\t54.\t \u0007Misch CM. Bone augmentation of the atrophic posterior mandi-\nble for dental implants using rhBMP-2 and titanium mesh: clini-\ncal technique and early results. Int J Periodontics Restorative Dent. \n2010;31(6):581–589.\n\t55.\t \u0007Boyne PJ, Lilly LC, Marx RE, et al. De novo bone induction by \nrecombinant human bone morphogenetic protein-2 (rhBMP-2) \nin maxillary sinus floor augmen- tation. J Oral Maxillofac Surg. \n2005;63:1693–1707.\n\t56.\t \u0007Misch CE. Bone density: a key determinant for treatment planning. \nIn: Contemporary Implant Dentistry. St. Louis: Mosby; 2008:130–146.\n\t57.\t \u0007Sanz M, Vignoletti F. Key aspects on the use of bone substi-\ntutes for bone regeneration of edentulous ridges. Dent Mater. \n2015;31(6):640–647.\n\t58.\t \u0007Boyce T, Edwards J, Scarborough N. Allograft bone: the inﬂuence \nof processing on safety and performance. Orthop Clin North Am. \n1999;30(4):571–581.\n\t59.\t \u0007Piattelli A, Scarano A, Corigliano M, Piattelli M. Comparison of \nbone regeneration with the use of mineralized and demineralized \nfreeze-dried bone allografts: a histological and histochemical study \nin man. Biomaterials. 1996;17(11):1127–1131.\n\t60.\t \u0007Shapoff CA, Bowers GM, Levy B, Mellonig JT, Yukna RA. The \neffect of particle size on the osteogenic activity of composite grafts of \nallogeneic freeze-dried bone and autogenous marrow. J Periodontol. \n1980;51(11):625–630.\n\t61.\t \u0007Jacobsen G, Easter D. Allograft vs. Xenograft: Practical Considerations \nfor Biologic Scaffolds. Musculoskeletal Transplant Foundation; 2008.\n\t62.\t \u0007Barrack RL. Bone graft extenders, substitutes, and osteogenic pro-\nteins. J Arthroplasty. 2005;20(4 2):94–97.\n\t63.\t \u0007Esposito M, Grusonvin MG, Rees J, et al. Effectiveness of sinus lift \nprocedures for dental implant rehabilitation: a Cochrane systematic \nreview. Eur J Oral Implantol. 2010;3(1):7–26.\n\t64.\t \u0007LeGeros RZ. Calcium phosphates in oral biology and medicine. \nMonogr Oral Sci. 1991;15:1–201.\n\t65.\t \u0007Suh H, Park JC, Han DW, Lee DH, Han CD. A bone replaceable \nartificial bone substitute: cytotoxicity, cell adhesion, proliferation, \nand alkaline phosphatase activity. Artif Organs. 2001;25(1):14–21.\n\t66.\t \u0007Peter M, Binulal NS, Nair SV, Selvamurugan N, Tamura H, Jaya-\nkumar R. Novel biodegradable chitosan-gelatin/nano-bioactive glass \nceramic composite scaffolds for alveolar bone tissue engineering. \nChem Eng J. 2010;158(2):353–361.\n\t67.\t \u0007Salim S, Ariani MD. In vitro and in vivo evaluation of carbonate \napatite-collagen scaffolds with some cytokines for bone tissue engi-\nneering. J Indian Prosthodont Soc. 2015;15(4):349–355.\n\t68.\t \u0007Chan C, Thompson I, Robinson P, Wilson J, Hench L. Evaluation \nof Bioglass/dextran composite as a bone graft substitute. Int J Oral \nMaxillofac Surg. 2002;31(1):73–77.\n\t69.\t \u0007Wang H, Boyapati L. “PASS” principles for predictable bone regen-\neration. Implant Dent. 2006;15(1):8–17. \n\t70.\t \u0007Kiran NK, Mukunda KS, Tilak Raj TN. Platelet concentrates: a \npromising innovation in dentistry. J Dent Sci Res. 2011;2:50–61.\n\t71.\t \u0007Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, \nGeorgeff KR. Platelet-rich plasma: growth factor enhancement for \nbone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. \n1998;85(6):638–646.\n\t72.\t \u0007Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin (PRF): \na second-generation platelet concentrate. Part IV: clinical effects on \ntissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. \n2006;101(3):e56–e60.\n\t73.\t \u0007Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin (PRF): \na second-generation platelet concentrate. Part IV: clinical effects on \ntissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. \n2006;101:56–60.\n\t74.\t \u0007Kang YH, Jeon SH, Park JY, et al. Platelet-rich fibrin is a Bioscaffold \nand reservoir of growth factors for tissue regeneration. Tissue Eng \nPart A. 2011;17:349–359.\n\t75.\t \u0007Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): \na second-generation platelet concentrate. Part I: technological con-\ncepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol \nEndod. 2006;101:e37–e44.\n\t76.\t \u0007Kobayashi E, Flückiger L, Fujioka Kobayashi M. Comparative \nrelease of growth factors from PRP, PRF, and advanced-PRF. Clin \nOral Investig. 2016;20(9):2353–2360.\n\t77.\t \u0007Montanari M, Callea M, Yavuz I, Maglione M. A new biological \napproach to guided bone and tissue regeneration. Case Reports. 2013 \n(2013): bcr2012008240.\n\t78.\t \u0007Storgard JS, Hendrik T. Bone augmentation procedures in localized \ndefects in the alveolar ridge: clinical results with different bone grafts \nand bone-substitute materials. In: Database of Abstracts of Reviews of \nEffects (DARE): Quality-assessed Reviews [Internet]. UK: Centre for \nReviews and Dissemination; 2009."
  },
  {
    "page": 97,
    "content": "987\n37\nMaxillary Sinus Anatomy, \nPathology, and Graft \nSurgery\nRANDOLPH R. RESNIK AND CARL E. MISCH\nT\nhe posterior maxilla has been described as one of the most \nchallenging and complex intraoral regions that confronts \nthe implant clinician. There exist many treatment planning \nand patient factors that contribute to these problems in this area, \nwhich in many cases require the clinician to have additional train-\ning and an increased skill set:\n• Poor bone density\n• Compromised available bone\n• Increased pneumatization of the maxillary sinus\n• Increased crown height space\n• Ridge position shifts toward lingual (medial)\n• Difficult access because of anatomic location\n• Increased biting force\n• Requirement of wider diameter implants and increased number\nBefore discussing the various treatment options of the pos-\nterior maxilla, it is imperative that the implant clinician have a \nstrong foundation for maxillary sinus anatomy, anatomic variants, \npathology, and a comprehensive understanding of the various \ntreatment approaches.\nMaxillary Sinus Anatomy\nThe maxillary sinuses were first illustrated and described by Leonardo \nDa Vinci in 1489 and later documented by the English anatomist \nNathaniel Highmore in 1651.1 The maxillary sinus, or antrum of \nHighmore, lies within the body of the maxillary bone and is the larg-\nest and first to develop of the paranasal sinuses (Fig. 37.1). Adult max-\nillary sinuses are pyramid-shaped, air-filled cavities that are bordered \nby the nasal cavity. There is much debate about the actual function \nof the maxillary sinus. Possible theorized roles of the sinus include \nweight reduction of the skull, phonetic resonance, participation of \nwarming humidification of inspired air, and olfaction. A biomechani-\ncal adaptation of the maxillary sinus directs forces away from the orbit \nand cranial cavity when a force is delivered to the midface.\nDevelopment and Expansion of the Maxillary \nSinus\nA primary pneumatization occurs at approximately 3 months of \nfetal development by an outpouching of the nasal mucosa within \nthe ethmoid infundibulum. At that time, the maxillary sinus is a \nbud situated at the infralateral surface of the ethmoid infundibu-\nlum between the upper and middle meatus. Prenatally, a second-\nary pneumatization occurs. At birth, the sinus is still an oblong \ngroove on the mesial side of the maxilla just above the germ of the \nfirst deciduous molar.2\nAt birth, the sinus cavities are filled with fluid. Postnatally and \nuntil the child is 3 months old the growth of the maxillary sinus is \nclosely related to the pressure exerted by the eye on the orbit floor, \nthe tension of the superficial musculature on the maxilla, and \nthe forming dentition. As the skull matures, these three elements \ninfluence its three-dimensional (3D) development. At 5 months, \nthe sinus appears as a triangular area medial to the infraorbital \nforamen.3\nDuring the child’s first year, the maxillary sinus expands lat-\nerally underneath the infraorbital canal, which is protected by \na thin bony ridge. The antrum grows apically and progressively \nreplaces the space formerly occupied by the developing dentition. \nThe growth in height is best reflected by the relative position of \nthe sinus floor. At 12 years of age, pneumatization extends to the \nplane of the lateral orbital wall, and the sinus floor is level with \nthe floor of the nose. During later years, pneumatization spreads \ninferiorly as the permanent teeth erupt. The adult sinus has a vol-\nume of approximately 15 mL (34 mm height x 33 length x 23 mm \nwidth). The main development of the antrum occurs as the per-\nmanent dentition erupts and pneumatization extends throughout \nthe body of the maxilla and the maxillary process of the zygomatic \nbone. Extension into the alveolar process lowers the floor of the \nsinus approximately 5 mm. Anteroposteriorly, the sinus expansion \ncorresponds to the growth of the midface and is completed only \nwith the eruption of the third permanent molars when the young \nperson is about 16 to 18 years of age.4\nIn the adult, the sinus is pyramid shaped with consisting of four \nbony walls, the base of which faces the lateral nasal wall and the \napex of which extends toward the zygomatic bone (Fig. 37.2). The \nfloor of the maxillary sinus cavity is reinforced by bony or mem-\nbranous septa, joining the medial or lateral walls with oblique or \ntransverse buttress-like webs. They develop as a result of genetics \nand stress transfer within the bone over the roots of teeth. These \nhave the appearance of reinforcement webs in a wooden boat and"
  },
  {
    "page": 98,
    "content": "988\nPART VII    Soft and Hard Tissue Rehabilitation\nrarely divide the antrum into separate compartments. These ele-\nments are present from the canine to the molar region and tend to \ndisappear in the maxilla of the long-term edentulous patient when \nstresses to the bone are reduced. Karmody found that the most \ncommon oblique septum is located in the superior anterior corner \nof the sinus or infraorbital recess (which may expand anteriorly to \nthe nasolacrimal duct).5 The medial wall is juxtaposed with the \nmiddle and inferior meatus.\nAlthough the maxillary sinus maintains its overall size while \nthe teeth are present, an expansion phenomenon of the maxil-\nlary sinus occurs with the loss of posterior teeth.6 The antrum \nexpands in both inferior and lateral dimensions. This expansion \nmay even invade the canine eminence region and proceed to the \nlateral piriform rim of the nose. The dimension of available bone \nheight of the posterior maxilla is greatly reduced as a result of dual \nresorption from the crest of the ridge and pneumatization of the \nsinus after the loss of teeth. The sinus expansion is more rapid than \nthe crestal bone height changes. As a result of the inferior sinus \nexpansion, the amount of available bone in the posterior maxilla \ngreatly decreases in height (Fig. 37.3). The maxillary sinus tends \nto enlarge with age, as well as with edentulism, which further \n1\n1\n2\n3\n4\n• Fig. 37.1  Maxillary sinus (1) is the largest of the four paranasal sinuses. \nThe initial maxillary sinus formation is completed at age 16 to 18 years. 2, \nFrontal sinus; 3, ethmoid sinus; 4, sphenoid sinus.\nOrbit\nMiddle\nmeatus\nMaxillary\nsinus\nat birth\nMaxillary\nsinus\nevolution\nTooth\nSphenoethmoidal sinus\nFrontal\nsinus\nCrista\ngalli\nSuperior\nmeatus\nFrontonasal\ndura\nNasal\nseptum\nNasal\nfossa\nInferior\nmeatus\n• Fig. 37.2  Maxillary sinus begins to form in the fetus and by 5 months is the size of a pea, under the \neye, and close to the ostium for drainage. By 16 years of age, the maxillary sinus has four thin, bony walls \naround it. The superior wall separates it from the floor of the orbit. The medial wall contains the ostium to \ndrain the sinus and separates it from the nasal fossa. The lateral wall forms the maxillary bone below the \nzygomatic arch. The floor of the antrum rests above the roots of the teeth."
  },
  {
    "page": 99,
    "content": "989\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\ndecreases the amount of available bone. In addition to the dimin-\nished quantity, bone in the posterior maxilla often is softer and of \npoorer quality. Radiographs typically reveal sparse trabeculations, \nand the tactile experience of drilling in this bone resembles a Sty-\nrofoam type of material (D4 Bone).\nAfter normal sinus expansion, with periodontal disease and tooth \nloss increasing the bone loss, inadequate bone will result between \nthe alveolar ridge crest and the floor of the maxillary sinus. In most \ncases, bone quantity will be compromised for implant placement. \nThe limited available bone is compounded by a decrease in bone \ndensity and the shifting of the residual ridge in a medial direction. \nTherefore this area of the maxilla is often reported with an increased \nincidence of implant malpositioning and morbidity. \nBone Resorption Process\nThe maxilla generally has a thinner cortical plate facially compared \nwith any region of the mandible, and very minimal cortical bone is \npresent on the ridge. In addition, the trabecular bone in the posterior \nmaxilla is finer (less dense) than other dentate regions. When maxil-\nlary posterior teeth are lost, an initial decrease in bone width at the \nexpense of the labial bony plate results. The width of the posterior \nmaxilla has been shown to decrease at a more rapid rate than in any \nother region of the jaws.7 The resorption phenomenon is accelerated \nby the loss of vascularization of the alveolar bone and the existing \nfine trabecular bone type. However, because the initial residual ridge \nis inherently wide in the posterior maxilla, even with a significant \ndecrease in the width of the ridge, adequate-diameter root-form \nimplants (∼5mm) usually can be placed. However, as the resorp-\ntion process continues, the residual ridge continues to progressively \nshift toward the palate until the ridge is significantly resorbed into a \nmedially positioned narrower bone volume.8 This results in the buc-\ncal cusp and central fossa of the final restoration being cantilevered \nfacially to satisfy esthetic requirements at the expense of biomechan-\nics in the moderate to severe atrophic ridges. This cantilevered part \nof the prosthesis is usually in the form of a ridge lap pontic area, \nwhich in most cases results in hygiene difficulties. \nResultant Poor Bone Density\nIn general, the bone quality is poorest in the posterior max-\nilla, compared with any other intraoral region.9 A literature \nreview of clinical studies reveals that the poorest bone density \nmay decrease implant loading survival by an average of 16%, \nand it has been reported as low as 40%.10 The cause of these \nfailures is related to several factors. Bone strength is directly \nrelated to its density, and the poor-density bone of this region \nis often 5 to 10 times weaker, compared with bone found in the \nanterior mandible. Bone densities directly influence the bone-\nto-implant contact percentage (BIC), which accounts for the \nforce transmission to the bone. The BIC is least in D4 bone, \nand the stress patterns in this bone migrate farther toward the \napex of the implant (Fig. 37.4). As a result, bone loss is more \npronounced and also occurs along the implant body, rather \nthan only crestally, as in other denser bone conditions. D4 \nbone also exhibits the greatest biomechanical elastic modulus \ndifference compared with titanium under load.11 Earlier stud-\nies and surgical protocols did not take into consideration the \npoor BIC in this area.\nIn the posterior maxilla, the deficient osseous structures and \nan absence of cortical plate on the crest of the ridge is often \nobserved, which further compromises the initial implant stabil-\nity at the time of insertion. The labial cortical plate is thin, and \nthe ridge is often wide. As a result, the lateral cortical BIC to sta-\nbilize the implant is often insignificant. The implant placement \nprotocol often uses bone compression (osseodensification) rather \nthan bone extraction (removal) to create the implant osteotomy \nto compensate for these deficiencies. If the surgical protocol is \nnot modified, the initial healing of an implant in D4 bone will \nbe compromised. \n1\n2\n3\n3\n3\n4\nA\nB\n• Fig. 37.3  (A) The fourth expansion phenomenon of the maxillary sinus occurs with the loss of the poste-\nrior teeth. The anterior portion of the sinus may expand to the piriform rim of the nose. The inferior expan-\nsion may approach the crest of the ridge. 1, Maxillary sinus; 2, frontal sinus; 3, ethmoid sinus; 4, sphenoid \nsinus. (B) Coronal section of the posterior region of the edentulous human maxilla. Note expansion of \nthe sinus floor inferiorly far below the level of the floor of the nose. The alveolar ridge bone is markedly \natrophied, whereas the ridge submucosa has become fibrotic. Stained with Rescorcin Fuchsin stain and \ncounterstained with Ban Gieson. (Courtesy Mohamed Sharawy, Augusta, Georgia.)"
  },
  {
    "page": 100,
    "content": "990\nPART VII    Soft and Hard Tissue Rehabilitation\nBony Walls\nThe maxillary sinus features six bony walls, each of which contain \nimportant anatomic structures that play a significant role in the \ntreatment of the maxillary posterior region. The implant clinician \nmust have a strong understanding and foundation of the bony \nwalls associated with the posterior maxilla in the preoperative \nassessment before surgical procedures (Fig. 37.5)\nAnterior Wall\nThe anterior wall of the maxillary sinus consists of thin, compact \nbone extending from the orbital rim to just above the apex of \nthe cuspid. With the loss of the canine, the anterior wall of the \nantrum may approximate the crest of the residual ridge. Within \nthe anterior wall and approximately 6 to 7 mm below the orbital \nrim, with anatomic variants as far as 14 mm from the orbital rim, \nis the infraorbital foramen (Fig. 37.6A). The infraorbital nerve \nruns along the roof of the sinus and exits through the foramen. \nThe infraorbital blood vessels and nerves lie directly on the supe-\nrior wall of the maxillary sinus and within the sinus mucosa.\nTenderness to pressure over the infraorbital foramen or redness \nof the overlying skin may indicate inflammation of the sinus mem-\nbrane from infection or trauma, which may contraindicate graft \nsurgery until resolution. In patients exhibiting anatomic variants \nof the infraorbital foramen, neurosensory impairment may occur \nduring retraction of this area, leading to neurapraxia type injuries. \nThe use of worn, sharp-edged retractors should be avoided when \nreflecting tissue superiorly in this area to avoid potential injuries. \nWithin the anterior wall of the sinus, the thinnest part is the \ncanine fossa, which is directly above the canine tooth. The anterior \nwall of the maxillary sinus may also serve as surgical access during \nCaldwell-Luc procedures to treat a preexisting or post–sinus graft, \npathologic condition. \nSuperior Wall\nThe superior wall of the maxillary sinus coincides with the thin \ninferior orbital floor. The orbital floor slants inferiorly in a medio-\nlateral direction and is convex into the sinus cavity.\nA bony ridge is usually present in this wall that houses the infra-\norbital canal, which contains the infraorbital nerve and associated \nblood vessels. Dehiscence of the bony chamber may be present, \nresulting in direct contact between the infraorbital structures and \nthe sinus mucosa.\nOcular symptoms may result from infections or tumors in the \nsuperior aspects of the sinus region and may include proptosis \n(bulging of the eye) and diplopia (double vision). When these \nproblems occur, the patient is closely supervised, and a medical \nconsult is advised to decrease the risk of severe complications that \nmay result from the spread of infection in a superior direction. \nSuperior-spreading infections may lead to significant ocular prob-\nlems or brain abscesses. As a result, when ocular or cerebral symp-\ntoms appear, aggressive therapy to decrease the spread of infection \nis indicated. Overpacking the maxillary sinus with bone graft \nmaterial during a sinus graft may result in pressure against the \nsuperior wall if a sinus infection develops (see Fig. 37.6B). \nPosterior Wall\nThe posterior wall of the maxillary sinus corresponds to the \npterygomaxillary region, which separates the antrum from the \ninfratemporal fossa. The posterior wall usually has several vital \nstructures in the region of the pterygomaxillary fossa, including \nthe internal maxillary artery, pterygoid plexus, sphenopalatine \nganglion, and greater palatine nerve. The posterior wall should \nalways be identified radiographically because when the wall is not \npresent, a pathologic condition (including neoplasms) is to be sus-\npected (see Fig. 37.6C).\nCommon donor sites to obtain autogenous bone for sinus aug-\nmentation procedures include the tuberosity area. Special consid-\neration should be taken for the posterior extent of the tuberosity \nremoval. Aggressive tuberosity removal may lead to bleeding in \nthe infratemporal fossa (pterygoid plexus), resulting in life-threat-\nening situations.\nIt should be noted that pterygoid implants placed through \nthe posterior sinus wall and into this region may approach vital \nstructures, including the maxillary artery. A blind surgical tech-\nnique to place a pterygoid implant through the posterior wall may \nhave increased surgical risk. However, they are of benefit primarily \n• Fig. 37.4  Bone–implant contact percent is often reduced in the posterior \nmaxilla because the quality of bone is poorer than other regions of the \nmouth. This histologic slide depicts the numerous areas of no bone con-\ntact at the implant interface.\n• Fig. 37.5  Maxillary sinus is comprised of six walls that contain significant \nanatomic and vital structures, which are important in the placement of \nimplants. 1, Lateral, 2, anterior, 3, medial, 4, posterior, 5, inferior, 6, superior."
  },
  {
    "page": 101,
    "content": "991\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nwhen third or fourth molars are needed for prosthetic reconstruc-\ntion or sinus grafts are contraindicated and available bone poste-\nrior to the antrum is present. \nMedial Wall\nThe medial wall of the antrum coincides with the lateral wall of \nthe nasal cavity and is the most complex of the various walls of the \nsinus. On the nasal aspect, the lower section of the medial wall \nparallels the lower meatus and floor of the nasal fossa; the upper \naspect corresponds to the middle meatus. The medial wall is usu-\nally vertical and smooth on the antral side (see Fig. 37.6D).\nThe main drainage avenue of the maxillary sinus is through the \nmaxillary ostium. The primary ostium is located in the superior \naspect of the sinus medial wall and drains its secretions via the \nethmoid infundibulum through the hiatus semilunaris into the \nmiddle meatus of the nasal cavity. The infundibulum is approxi-\nmately 5 to 10 mm long and drains via ciliary action in a superior \nand medial direction. The ostium diameter averages 2.4 mm in \nhealth; however, pathologic conditions may alter the size to vary \nfrom 1 to 17 mm.12\nThe maxillary ostium and infundibulum are part of the ante-\nrior ethmoid middle meatal complex, the region through which \nA\nB\nC\nE\nF\nD\n• Fig. 37.6  Six bony walls of the maxillary sinus. (A) Anterior. (B) Superior. (C) Posterior. (D) Medial. (E) \nLateral. (F) Inferior."
  },
  {
    "page": 102,
    "content": "992\nPART VII    Soft and Hard Tissue Rehabilitation\nthe frontal and maxillary sinuses drain, which is primarily respon-\nsible for mucociliary clearance of the sinuses to the nasopharynx. \nAs a result, obstruction in one or more areas of the complex will \nusually result in rhinosinusitis or lead to morbidity of the graft or \nimplant. Patency of the maxillary ostium is most crucial preop-\neratively and postoperatively during maxillary graft sinus surgery \nto prevent infection and morbidity of the graft. Evaluating the \npatency of the ostium via cone beam computerized tomography \n(CBCT) is easily accomplished with evaluation of serial cross-\nsectional images. The patency of the ostium must be ascertained \nbefore surgery to prevent or minimize postoperative complica-\ntions. This is easily verified via coronal or cross-sectional images \non CBCT surveys. Of utmost importance when performing \nany procedure involving the maxillary sinus, the patency of the \nostium must be maintained throughout the postoperative period. \nIf ostium patency is compromised, increased morbidity of the \nimplant or graft will occur because the mucociliary action of the \nmaxillary sinus will be compromised.\nSmaller, accessory or secondary ostia may be present that are \nusually located in the middle meatus posterior to the main ostium. \nThese additional ostia are most likely the result of chronic sinus \ninflammation and mucous membrane breakdown. They are pres-\nent in approximately 30% of patients, ranging from a fraction \nof a millimeter to 0.5 cm, and are commonly found within the \nmembranous fontanelles of the lateral nasal wall.13 Fontanelles are \nusually classified either as anterior fontanelles (AFs) or posterior \nfontanelles (PFs) and are termed by their relation to the uncinated \nprocess. These weak areas in the sinus wall are sometimes used to \ncreate additional openings into the sinus for treatment of chronic \nsinus infections. Primary and secondary ostia may, on occasion, \ncombine and form a large ostium within the infundibulum. \nLateral Wall\nThe lateral wall of the maxillary sinus forms the posterior max-\nilla and the zygomatic process. This wall varies greatly in thick-\nness from several millimeters in dentate patients to less than 1 \nmm in an edentulous patient. A CBCT examination will reveal \nthe osseous thickness of the lateral wall, which is crucial in defin-\ning the osteotomy location and preparation technique. Patients \nexhibiting increased parafunction forces will have thicker lateral \nwalls (see Fig. 37.6E). The lateral wall thickness of the maxilla \nhas been noted to be extremely variable, with some cases being \nnonexistent. This will lead to an increased possibility of membrane \nperforation, even occurring on reflection. In contrast, the lateral \nwall may be very thick, which is usually seen with patients that \nexhibit parafunction and have just recently lost the posterior teeth. \nIn these situations, lateral wall sinus grafting becomes very dif-\nficult because of the cortical thickness. The lateral wall houses the \nintraosseous anastomosis of the infraorbital and posterior superior \nalveolar artery, which may lead to a bleeding complication because \nthis area is the site for osteotomy preparation of the lateral wall \nsinus graft procedure. \nInferior Wall\nThe inferior wall or floor of the maxillary sinus is in close relation-\nship with the apices of the maxillary molars and premolars. The \nteeth usually are separated from the sinus mucosa by a thin layer \nof bone; however, on occasion, teeth may perforate the floor of the \nsinus and be in direct contact with the sinus lining. Studies have \nshown that the first molar has the most common dehiscent tooth \nroot, occurring up to approximately 30% to 40% of the time.14 \nIn dentate patients the sinus floor is approximately at the level of \nthe nasal floor. In the edentulous posterior maxilla the sinus floor \nis often 1 cm below the level of the nasal floor (see Fig. 37.6F).\nRadiographically, the sinus inferior floor morphology is easily \nseen via 3D imaging. The floor is rarely flat and smooth; the pres-\nence of irregularities and septa should be determined and their \nexact locations noted. Irregular floors are most often seen after \nteeth are extracted, leaving residual bony crests that increase risk \nof perforation because of the difficulty in membrane reflection. \nIn some cases, the bony crests are not even seen on the CBCT \nevaluation.\nComplete or incomplete bony septa may exist on the floor \nin a vertical or horizontal plane. Approximately 30% of dentate \nmaxillae have septa, with three-fourths appearing in the premo-\nlar region. Complete septa separating the sinus into compart-\nments are very rare, occurring in only 1.0% to 2.5% of maxillary \nsinuses.15 The presence of septa complicate lateral wall sinus graft \nprocedures, which leads to an increased likelihood of membrane \nperforation. \nOstiomeatal Complex\nThe ostiomeatal unit is composed of the maxillary ostium, eth-\nmoid infundibulum, anterior ethmoid cells, hiatus semilunaris, \nand the frontal recess, which encompasses the area of the middle \nmeatus. This common channel allows for air flow and mucociliary \ndrainage of the frontal, maxillary, and anterior ethmoid sinuses. \nBlockage in this area leads to impaired drainage of the maxil-\nlary, frontal, and ethmoid sinuses, which may result in rhinosi-\nnusitis and postoperative complications after implant or grafting \nprocedures.\nRadiographic identification of the ostiomeatal complex and \nrelated structures must be evaluated to prevent potential postopera-\ntive complications. Pathology or variations within the ostiomeatal \ncomplex may lead to postoperative sinus graft morbidity or implant \ncomplications caused by compromised mucociliary drainage (alter-\nation of normal sinus physiology) of the maxillary sinus. \nBlood Supply and Sensory Innervation\nThe vascular supply in the maxillary sinus is a vital part of the \nhealing and regeneration of bone after a sinus graft and healing \nof a dental implant. The blood supply to the maxillary sinus is \nderived from the maxillary artery, which emanates from the exter-\nnal carotid artery. The maxillary artery supplies the bone sur-\nrounding the sinus cavity and also the sinus membrane. Branches \nof the maxillary artery, which most often include the posterior \nsuperior alveolar artery and infraorbital artery, form endosseous \nand extraosseous anastomoses that encompass the maxillary sinus. \nThe formation of the endosseous and extraosseous anastomoses in \nthe maxillary sinus is termed the double arterial arcade. Studies \nhave shown vascularization of postgraft material to depend on the \nintraosseous and extraosseous anastomoses, along with the blood \nvessels of the Schneiderian membrane, which is supplied by the \nposterior superior alveolar artery and the infraorbital artery along \nthe lateral wall.16\nThere exist different factors that alter the vascularization in this \narea. With increasing age, the number and size of blood vessels \nin the maxilla decrease. As bone resorption increases, the cortical \nbone becomes thin, resulting in less vascularization. As the lateral \nwall becomes thinner, the blood supply to the lateral wall and lat-\neral aspect of the bone graft comes primarily from the periosteum, \nresulting in a compromised vascularization to the region."
  },
  {
    "page": 103,
    "content": "993\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nExtraosseous Anastomosis\nThe extraosseous anastomosis is found in approximately 44% of \nthe population and is usually in close approximation to the peri-\nosteum of the lateral wall.\nThe extraosseous anastomosis is superior to the endosseous \nunit, which is approximately 15 to 20 mm from the dentate alveo-\nlar crest. To minimize vascular trauma to the extraosseous anasto-\nmosis, surgical and anatomic considerations should be addressed. \nIdeally, vertical incisions should be made as short as possible to \ndecrease the possibility of blood vessel damage. It is crucial to gain \nadequate access to the lateral aspect of the maxilla, and the perios-\nteum should be reflected full thickness with great care. Haphazard \nreflection may lead to severing or damage to the anastomosis, with \nresultant postoperative edema. Severing of the extraosseous anas-\ntomosis may result in significant increased bleeding during the \nsurgical procedure. This intraoperative complication may give rise \nto impaired visibility for the clinician, along with increased sur-\ngery duration. Additionally, postoperative complications such as \npain, edema, and ecchymosis may result from the severing of these \nblood vessels. If trauma to these vessels occurs, direct pressure or \nthe use of electrocautery may be used. However, electrocautery may \npotentially cause membrane damage or necrosis. If severe bleed-\ning occurs, curved Kelly hemostats are used to clamp the bleeding \nvessel, followed by ligature placement. A slowly resorbable suture \nwith high tensile strength such as Vicryl is recommended. \nIntraosseous Anastomosis\nThe intraosseous anastomosis is found within the lateral wall of the \nsinus, which supplies the lateral wall and the sinus membrane. In \nan edentulous maxilla with posterior vertical bone loss, the endos-\nseous anastomosis may be 5 to 10 mm from the edentulous ridge. \nThe endosseous artery has been shown to be observed on CBCT \nscans in approximately one-half of the patients requiring a sinus \ngraft.17 However, anatomic cadaver studies have shown the preva-\nlence to be 100%.17 In 82% of cases, the most common anatomic \nlocation was observed between the canine and second premolar \nregion.18 However, with a long-term edentulous patient with a thin \nlateral wall, the artery may be atrophied and almost nonexistent.\nSurgical, radiographic, and anatomic considerations should be \naddressed to minimize trauma to these blood vessels. The CBCT \nradiographic identification is extremely important in identifying \nthese blood vessels before surgery so preparation may be made. \nRadiographically, smaller anastomoses will not be seen if the pixel \nsize (∼1.0 mm) is less than one-half the size of the anastomosis \nvessel. Studies have shown that the use of a 0.3 or 0.4 CBCT pixel \nsize for radiographic evaluation will most likely show the smaller \nanastomoses.19\nStudies have shown that in 20% of lateral wall osteoto-\nmies significant bleeding complications may occur,20 mainly \nbecause the anastomosis is greater than 1.0 mm in diameter. \nIt has been shown that vessels larger than 1.0 mm are more \nproblematic and associated with significant bleeding, whereas \nsmaller vessels (<1.0 mm) are usually insignificant and easily \nmanaged (Fig. 37.7; Box 37.1).\nIn most cases, bleeding is a minor complication and of short \nduration; however, in some instances it may be significant and \ndifficult to manage. To control bleeding, there are many possible \ntreatments: (1) the patient should be repositioned into an upright \nA\nC\nInfraorbital\nartery\nMaxillary artery\nPosterior\nsuperior artery\nIntraosseous\nbranch of PSA\nD\nB\n• Fig. 37.7  Blood supply of the maxillary sinus. (A) Extraosseous and intraosseous anastomosis, which \nis made up of the infraorbital and posterior superior artery. (B) Cross-sectional cone beam computerized \ntomography image depicting intraosseous anastomosis (arrow). (C) Intraosseous notch (arrow) containing \nthe intraosseous anastomosis, which comprises the posterior superior artery and infraorbital artery. (D) Pos-\nterior lateral nasal artery location in the medial wall of the maxillary sinus. PSA, Posterior Superior Artery."
  },
  {
    "page": 104,
    "content": "994\nPART VII    Soft and Hard Tissue Rehabilitation\nposition and pressure applied with a surgical gauze; (2) electrocau-\ntery may be used, although this may lead to membrane necrosis and \nperforation, with possible migration of graft material; (3) a second \nwindow may be made proximal to the bleeding source to gain access \nto the bleeding vessel, especially if location cannot be obtained from \nthe original window; and (4) cutting the bone and vessel with a \nhigh-speed diamond with no irrigation (which cauterizes the vessel). \nPosterior Lateral Nasal Artery\nA posterior lateral nasal artery (branch of the sphenopalatine \nartery that also rises from the maxillary artery) supplies the medial \naspect of the sinus cavity. The medial and posterior walls of the \nmaxillary sinus mucosa receive their blood supply from the poste-\nrior lateral nasal artery.\nDuring sinus graft surgery the clinician may be in close \napproximation to this artery when elevating the membrane off the \nmedial wall. Care should be exercised to minimize trauma to this \narea because aggressive reflection of the membrane may result in \ntrauma to the blood vessel or perforation into the nasal cavity.\nTrauma to this artery may cause significant bleeding in the \nsinus proper and also within the nasal cavity. Because the medial \nsinus wall is very thin (usually one-half the thickness of the lateral \nwall), aggressive membrane reflection may result in trauma, lead-\ning to bleeding issues. \nSphenopalatine/Infraorbital Arteries\nThe sphenopalatine artery is also a branch of the maxillary artery and \nenters the nasal cavity through the sphenopalatine foramen, which is \nnear the posterior portion of the superior meatus of the nose.\nAs the sphenopalatine artery exits the foramen, it branches into \nthe posterior lateral nasal artery and the posterior septal artery.21 \nAdditionally, the infraorbital artery enters the maxillary sinus via the \ninfraorbital fissure in the roof of the sinus and ascends cranially into \nthe orbital cavity. Because of the anatomic locations of these blood \nvessels, it is rarely a concern with respect to sinus graft surgery.\nThe sphenopalatine and infraorbital blood vessels are usually \nnot problematic for bleeding complications during lateral-approach \nsinus elevation surgery because of their anatomic locations. How-\never, incorrect incision locations and aggressive reflection may \ndamage the blood vessels. If bleeding does occur, it is usually easily \ncontrolled with pressure and local hemostatic agents. \nMaxillary Sinus Mucosa\nThe epithelial lining of the maxillary sinus is a continuation of the \nnasal mucosa and is classified as a pseudostratified, ciliated colum-\nnar epithelium, which is also called the respiratory epithelium.\nThe epithelial lining of the maxillary sinus is much thinner \nand contains fewer blood vessels than the nasal epithelium. This \naccounts for the membrane’s pale color and bluish hue. Five pri-\nmary cell types exist in this tissue: (1) ciliated columnar epithelial \ncells, (2) nonciliated columnar cells, (3) basal cells, (4) goblet cells, \nand (5) seromucinous cells. The ciliated cells contain approxi-\nmately 50 to 200 cilia per cell. In a healthy maxillary sinus the \ncilia cells assist in clearing mucus from the sinus and into the naso-\npharynx. The nonciliated cells compose the apical aspect of the \nmembrane, contain microvilli, and serve to increase surface area. \nThese cells have been theorized to facilitate humidification and \nwarming of inspired air. The basal cell’s function is similar to that \nof a stem cell that can differentiate as needed. The goblet cells in \nthe maxillary sinus produce glycoproteins that are responsible for \nthe viscosity and elasticity of the mucus produced. The maxillary \nsinus contains the highest concentration of goblet cells compared \nwith the other paranasal sinuses. The maxillary sinus membrane \nalso exhibits few elastic fibers attached to the bone (no tenacious \nattachment is usually present), which simplifies elevation of this \ntissue from the bone during grafting procedures. The thickness \nof the sinus mucosa in health varies, but it is generally 0.3 to 0.8 \nmm.22 In smokers, it varies from very thin and almost nonexistent \nto very thick, with a squamous type of epithelium.\nRadiographically, normal, healthy paranasal sinuses reveal a \ncompletely radiolucent (dark) maxillary sinus. Any radiopaque \n(whitish) area within the sinus cavity is abnormal, and a patho-\nlogic condition should be suspected. The normal sinus membrane \nis radiographically invisible, whereas any inflammation or thick-\nening of this structure will be radiopaque. The density of the dis-\neased tissue or fluid accumulation will be proportional to varying \ndegrees of gray values.\nMaintaining the integrity of the sinus membrane is crucial in \ndecreasing postoperative complications, including loss of graft \nmaterial and the possibility of infection.\nMany factors may alter the physiology of the sinus mucosa, \nsuch as viruses, bacteria, and foreign bodies (implants). Care \nshould be taken to minimize membrane perforations during sur-\ngery. If perforations occur, appropriate repair treatment protocols \nshould be followed. \nMaxillary Sinus Mucociliary Clearance\nNormal mucociliary flow is crucial to maintaining the healthy \nphysiology of the maxillary sinus. In a healthy sinus an adequate \nsystem of mucus production, clearance, and drainage is maintained. \nThe key to normal sinus physiology is the proper function of the \ncilia, which is the main component of the mucociliary transport \nsystem. The cilia move contaminants toward the natural ostium and \nthen to the nasopharynx. The cilia of the columnar epithelium beat \ntoward the ostium at approximately 15 cycles per minute, with a \nstiff stroke through the serous layer, reaching into the mucoid layer. \nThey recover with a limp reverse stroke within the serous layer. This \nmechanism slowly propels the mucoid layer toward the ostium at a \nrate of 9 mm per minute and into the middle meatus of the nose.22\nIn health, mucoid fluid is transported toward the ostium of \nthe maxillary sinus and drains into the nasal cavity, eliminating \ninhaled small particles and microorganisms. This mucociliary \ntransport system is an active transport system that relies heavily \non oxygen. The amount of oxygen absorbed from the blood is not \nadequate to maintain this drainage system; additional oxygen has \nto be absorbed from the air in the sinus. This is why the patency of \nthe ostium is crucial in maintaining the normal transport system.\n• Endosseous anastomosis (within the lateral wall of sinus)\n-supplies lateral wall and sinus membrane\n \n1. Posterior superior alveolar artery\n \n2. Infraorbital artery\n • \u0007Extraosseous anastomosis (within periosteum)\n-supplies sinus mucous membranes\n \n1. Posterior superior alveolar artery\n \n2. Infraorbital artery\n • Posterior lateral nasal artery (medial and posterior wall)\n-supplies medial and posterior walls of maxillary sinus\n\t • BOX 37.1\t     \u0007Arterial Supply to Posterior Maxilla \n(Double Arterial Arcade)"
  },
  {
    "page": 105,
    "content": "995\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nVarious elements may decrease the number of cilia and slow \ntheir beating efficiency. Viral infections, pollution, allergic reac-\ntions, and certain medications may affect the cilia in this way. \nGenetic disorders (e.g., dyskinetic cilia syndrome) and factors \nsuch as long-standing dehydration, anticholinergic medications \nand antihistamines, cigarette smoke, and chemical toxins also can \naffect ciliary action23 (Fig. 37.8).\nAn alteration in the sinus ostium patency or the quality \nof secretions can lead to disruption in ciliary action, which \nmay result in rhinosinusitis. For clearance to be maintained, \nadequate ventilation is necessary. Ventilation and drainage are \ndependent on the ostiomeatal unit, which is the main sinus \nopening. Ciliary movements of ciliated epithelial cells dictate \nclearance of the maxillary sinus. It is important to maintain \nthe patency of the maxillary ostium and the ostiomeatal com-\nplex in the postoperative period to minimize the possibility of \ncomplications.\nThe physiologic mucociliary transport system may be com-\npromised by abnormalities in the cilia, which include a decrease \nin overall ciliary number and poor coordination of their move-\nment. This altered physiology may result in an increased mor-\nbidity of implant placement or bone graft healing. Therefore it \nis crucial that the mucociliary drainage mechanism be main-\ntained throughout the postoperative treatment period. This \nis most likely accomplished with good surgical technique, \nevaluation and treatment of prior drainage issues, and strict \nadherence to the use of pharmacologic agents (e.g., antibiotics, \ncorticosteroids). \nOrganisms trapped on mucus\nMucus movement\nOstium\nOuter layer\nof mucus\nPericiliary\nserous fluid\nPseudostratified\ncolumnar\nepithelial cell\nMucous gland\nCilia\nGoblet cell\nBasal cell\nAir\nGel phase\nPropulsion\nAqueous phase\nRecovery\nEpithelium\nA\nB\nC\nD\n• Fig. 37.8  Maxillary sinus membrane (Schneiderian Membrane). (A) The pseudostratified columnar epi-\nthelium cells have 50 to 200 cilia per cell that beat toward the ostium to help clear 1 L of mucus from \ngoblet and mucous glands each day from the sinus. In health, the mucous has two layers: a bottom serous \nlayer and top mucoid layer. The cilia beat with a stiff stroke in the mucoid layer toward the ostium and a \nrelaxed recovery stroke within the serous layer. (B) Cross-sectional image depicting an inflamed Schnei-\nderian membrane. If the sinus membrane is of normal thickness, it will not be visible on a radiograph. (C) \nClinical image depicting the thinness of the lateral wall and show through (dark blue) of the Schneiderian \nmembrane. (D) Bluish hue of the membrane after lateral wall window preparation."
  },
  {
    "page": 106,
    "content": "996\nPART VII    Soft and Hard Tissue Rehabilitation\nMaxillary Sinus Bacterial Flora\nThere is much debate on the bacterial flora of the maxillary sinus. \nMaxillary sinuses have been considered to be generally sterile in \nhealth; however, bacteria can colonize within the sinus without \nproducing symptoms. In theory, the mechanism by which a ster-\nile environment is maintained includes the mucociliary clearance \nsystem, immune system, and the production of nitric oxide within \nthe sinus cavity. In recent endoscopic studies, normal sinuses were \nshown to be nonsterile, with 62.3% exhibiting bacterial coloniza-\ntion. The most common bacteria cultured were Streptococcus viri-\ndans, Staphylococcus epidermidis, and S. pneumoniae.24 The culture \nfindings for secretions in acute maxillary sinusitis yielded high \nnumbers of leukocytes, S. pneumoniae, or S. pyogenes, with Hae-\nmophilus influenzae being recovered from the purulent exudates \nwith lower numbers of staphylococci. Other reports have indicated \nthe bacterial flora of the maxillary sinus consists of nonhemolytic \nand alpha hemolytic streptococci, as well as Neisseria spp. Addi-\ntional microorganisms identifiable in various quantities belong to \nstaphylococci, Haemophilus spp., pneumococci, Mycoplasma spp., \nand Bacteroides spp. This is important to note because the sinus \ngraft procedure often violates the sinus mucosa, and bacteria may \ncontaminate the graft site, leading to postoperative complications.\nThe implant clinician must understand the importance of reduc-\ning the bacterial count and possible microorganisms that may initiate \ninfections in the maxillary sinus. A strict aseptic technique should be \nadhered to during any surgical procedures that invade the maxillary \nsinus proper. This will minimize the possibility of bacterial coloniza-\ntion within the graft, which may lead to increased morbidity. The \ntype of bacteria inhabiting the sinus is very important because it \ndictates what antibiotic is prescribed preoperatively, postoperatively, \nand therapeutically in case of infection. The most common bacteria \npresent in the sinus must be susceptible to the specific antibiotic to \nprevent infection and decrease the morbidity of the graft. The antibi-\notic selected should not be the clinician’s “favorite”; instead it should \nbe the most ideal antibiotic, which is specific for the involved bac-\nteria. Ideally, Augmentin (875/125 mg) has been shown to be most \neffective antibiotic for bacterial infections in the maxillary sinus. \nMaxillary Sinus: Clinical Assessment\nTo establish adequate osseous morphology for the placement of \nendosteal implants in the resorbed maxillary posterior region, \nvarious grafting techniques have been developed to increase bone \nvolume. In 1987 Misch25 developed four different categories for \nthe treatment of the posterior maxilla (termed subantral [SA]) as \nSA-1 through SA-4 and was later modified and updated by Resnik \nin 2017 (Fig. 37.9). The SA-1 posterior maxilla allows implant \nplacement inferior to the sinus cavity, without penetration into \nA\nB\nC\nD\n• Fig. 37.9  Subantral augmentation classification. (A) SA-1: implant placement that does not extend into \nthe maxillary sinus proper. (B) SA-2: implant placement that elevates the sinus membrane approximately \n1 to 2 mm without bone grafting. (C) SA-3: implant placement and simultaneous bone grafting by either a \ncrestal or lateral-wall approach. (D) SA-4: lateral wall sinus augmentation with delayed implant placement."
  },
  {
    "page": 107,
    "content": "997\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nthe sinus proper. Because the sinus floor is not altered, a preexist-\ning sinus pathology or anatomic variant will be less likely to affect \nthe healing process. As such, if the patient has a preexisting maxil-\nlary sinus condition or develops a sinus infection after implant \nplacement, then implants are not at risk of becoming contami-\nnated. However, the SA-2 to SA-4 surgical procedures do alter the \nsinus membrane and sinus floor. With these treatment options, \na thorough preoperative evaluation is completed to rule out any \nexisting pathologic condition in the maxillary sinus. In this way, \nthe risk of possible mucus or bacteria contaminating the graft and \ncreating a bacterial smear layer on the implant is reduced. There-\nfore the possibility of impaired bone formation during healing is \nreduced. In addition, because of the proximity of the maxillary \nsinus to numerous vital structures, postoperative complications \ncan be very severe and even life-threatening.\nPathologic conditions associated with the paranasal sinuses are \ncommon ailments and afflict more than 31 million people each \nyear. Approximately 16 million people will seek medical assistance \nrelated to sinusitis; yet sinusitis is one of the most commonly \noverlooked diseases in clinical practice. Potential infection in the \nregion of the sinuses may result in severe complications. Infections \nin this area have been reported to result in sinusitis, orbital celluli-\ntis, meningitis, osteomyelitis, and cavernous sinus thrombosis. In \nfact, paranasal sinus infection accounts for approximately 5% to \n10% of all brain abscesses reported each year.26\nA physical examination of the maxillary sinus evaluates the \nmiddle third of the face for the presence of asymmetry, deformity, \nswelling, erythema, ecchymosis, hematoma, or facial tenderness \n(Table 37.1). Nasal congestion or obstruction, prevalent nasal dis-\ncharge, epistaxis (bleeding from the nose), anosmia (the loss of the \nsense of smell), and/or halitosis (bad breath) are noted.\nThe clinical examination for maxillary rhinosinusitis concerns the \nregions surrounding the maxillary antrum. The examination is con-\nducted to assess each wall surrounding the maxillary sinus separately. \nThe infraorbital foramen on the facial wall of the antrum is palpated \nthrough the soft tissue of the cheeks or intraorally to determine whether \ntenderness or discomfort is present. The intraoral examination assesses \nthe floor of the antrum by alveolar ulceration, expansion, tenderness, \nparesthesia, and oroantral fistulae. The eyes are examined to evaluate \nthe superior wall of the sinus for proptosis, pupillary level, lack of eye \nmovement, and diplopia. The nasal fluids may be used to evaluate the \nmedial wall of the sinus by asking the patient to blow the nose in a \nwaxed paper. The mucus should be clear and thin in nature. A yellow \nor greenish tint or thickened discharge indicates infection. Infected \nmaxillary sinuses typically are symptomatic, which can exhibit exudate \nin the middle meatus and may be inspected with a nasal speculum \nand headlight (rhinoscopy) through the nares. The methods of exami-\nnation of the infected maxillary sinus may include transillumination, \nnasoendoscopy, bacteriology, cytology, fiberoptic antroscopy, and radi-\nography CBCT, or magnetic resonance imaging [MRI]). \nMaxillary Sinus Radiographic Evaluation\nVarious radiographic techniques have been used in implant dentistry \nto evaluate the maxillary posterior region. In the early days of oral \nimplantology, evaluation of this area was limited to 2-dimensional \n(2D) radiographs. However, these types of radiographs have inher-\nent disadvantages that are affected by magnification and distortion, \nwhich leads to errors in diagnosis and treatment planning. Currently, \nthis anatomic area is evaluated mainly by the use of 3D radiographic \ntechniques (CBCT) or medical CT because they have become more \naccurate and efficient, with a significant reduced radiation.\nCone Beam Computerized Tomography\nCBCT surveys have allowed the implant clinician to evaluate \nanatomic structures, anatomic variants, and pathologies more \naccurately. Many software programs are available that allow \ncombining 3D images with computer software and allow an \naccurate assessment of the maxillary sinus. Because visualization \nof the maxillary sinus and surrounding structures are crucial for \nthe proper diagnosis and treatment planning, it is highly sug-\ngested the implant clinician utilize CBCT anytime procedures \ninvolve the maxillary sinus.\nPresently, no radiographic modality provides more information \nabout the paranasal sinuses than CBCT. This type of radiography \nprovides much more detailed information about the anatomy and \npathologic condition of the sinuses compared with 2D radiog-\nraphy. Studies have concluded that CBCT is the best option for \nviewing the surrounding osseous structures and pathologic condi-\ntion in the maxillary sinuses.27,28\nThe maxillary sinus can be evaluated with most CBCT images, \nincluding reformatted axial, panoramic, cross-sectional, sagittal, and \n3D images. Most physicians use the coronal radiographs to evaluate the \nparanasal sinuses. The implant clinician must have a clear understand-\ning of the CBCT radiographic anatomy and the pathologic conditions \nassociated with the posterior maxilla and maxillary sinus regions. \nNormal Anatomy\nMaxillary Sinus Membrane (Schneiderian \nMembrane)\nA CBCT scan of normal, healthy paranasal sinuses reveals a com-\npletely radiolucent (dark) maxillary sinus. Any radiopaque (whit-\nish) area within the sinus cavity is abnormal, and a pathologic \ncondition should be suspected. The normal sinus membrane is \nradiographically invisible, whereas any inflammation or thicken-\ning of this structure will be radiopaque. The density of the dis-\neased tissue or fluid accumulation will be proportional to varying \ndegrees of gray values. \n  \u0007Preoperative and Postoperative Physical \nExamination\nSite\nSigns of Infection\nInferior wall\nBulge in hard palate, ill-fitting den-\nture, loose teeth, hypesthesia or \nnonvital teeth, bleeding, palatal \nerosion, oroantral fistula\nMedial wall\nNasal obstruction, nasal discharge, \nepistaxis, cacosmia, visible mass \nin nostril\nAnterior wall\nSwelling, pain, skin changes\nPosterior wall\nMidface pain, hypesthesia of one-\nhalf of face, loss of function of \nlower cranial nerves\nSuperior wall\nDiplopia (double vision), proptosis \n(eye bulging out), chemosis, pain \nor hypesthesia, decreased visual \nacuity\n   \nTABLE \n37.1"
  },
  {
    "page": 108,
    "content": "998\nPART VII    Soft and Hard Tissue Rehabilitation\nOstiomeatal Complex\nThe ostiomeatal unit is composed of the maxillary ostium, eth-\nmoid infundibulum, anterior ethmoid cells, and the frontal recess. \nThe main drainage avenue of the maxillary sinus is through the \nostium. The maxillary ostium is bounded superiorly by the eth-\nmoid sinuses and inferiorly by the uncinate process. The uncinate \nprocess is a bony knifelike projection that is attached inferiorly to \nthe inferior turbinate and posteriorly has a free margin. Drainage \ncontinues through the ostium into the infundibulum, which is a \nnarrow passageway leading into the middle meatus. The middle \nmeatus is the radiolucent space bounded by the middle and infe-\nrior turbinates. \nNasal Cavity\nWithin the nasal cavity, three nasal turbinates or conchae (supe-\nrior, middle, and inferior) exist and are small downward projec-\ntions of bone. Between the turbinates is a space or recess termed \na meatus. The respiratory epithelium covers the turbinates and \nmeatus and warms, moistens, and cleans the air that is respirated \ninto the lungs.\nThe nasal septum is the bony partition that creates a barrier \nbetween the right and left sides of the nasal cavity. Obstructions \nwithin any aspect of the nasal system predispose the area to patho-\nlogic conditions (Fig. 37.10). \nMaxillary Sinus: Anatomical Variants\nNumerous anatomic variants arise that can predispose a patient \nto postsurgical complications. When these conditions are noted, \na pharmacologic protocol may need to be altered and/or implants \nmay be placed after the sinus graft has matured, rather than pre-\ndisposing them to an increased risk by inserting them at the same \ntime as the sinus graft. As stated previously, patency of the ostium \nis paramount to maintain drainage. Preexisting skeletal and bony \nabnormalities of the ostiomeatal complex may compromise the \npatency of the maxillary ostium, thereby, predisposing patients to \nmaxillary rhinosinusitis.\nParadoxical middle turbinate\nDeflected\nucinate\nprocess\nPolyps\nNon-patent\nostium\nMucous\nretention cyst\nBig nose\nvariant\nDeviated\nseptum\nConcha\nbullosa\nHiatus\nSemilunaris\nInfundibulum\nOsteomeatal\ncomplex\nUncinate\nprocess\nMiddle\nmeatus\nMaxillary\nsinus\nOstium\nMaxillary\nsinus\nMiddle turbinate\nInferior meatus\nInferior turbinate\nNasal septum\nEye\nEthmoid\nsinus\nEthmoid\nbulla\nFrontal\nsinus\nA\nB\n• Fig. 37.10  (A) Normal paranasal anatomy. (B) Paranasal pathology and anatomic variants."
  },
  {
    "page": 109,
    "content": "999\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nNasal Septum Deviation\nA nasal septum deviation is a very common anatomic variant, occur-\nring in as much as 70% of the population older than 14 years. This \nbony variant in extremes may cause obstruction of the ostiomeatal \nunit, which results in inflammation from air turbulence, causing \nincreased mucosal drying and particle deposition. If the deviation \nis long-standing, then atrophy of the middle turbinate may occur, \nresulting in narrowing of the ostiomeatal complex (Fig. 37.11).29\nTimmenga and colleagues30 evaluated 45 patients who received \n85 sinus grafts with endoscopy postsurgery. Of the 45 patients, \nfive were found to have sinusitis postsurgery; all five of those \npatients had a nasal deviation or oversized turbinate. Therefore \nwhen these conditions are observed, consideration should be given \nto not place the implant at the same time as the sinus graft, and \nthe recommended preoperative and postoperative pharmacologic \nprotocol is especially warranted. \nMiddle Turbinate Variants\nThe middle turbinate plays a significant role in proper drainage of \nthe maxillary sinus. A concha bullosa is a pneumatization within \nthe middle turbinate and may occlude the ostiomeatal complex, \ncompromising adequate drainage. This variant is seen in approxi-\nmately 4% to 15% of the population (Fig. 37.12).31 Another vari-\nant in this anatomic structure is a paradoxically curved middle \nturbinate, which presents a concavity toward the septum, decreas-\ning the size of the meatus. This also predisposes the patient to a \nhigher incidence of sinus disease. \nUncinate Process Variants\nThe uncinate process is a projection of the ethmoid bone which is \nlocated in the wall of the lateral nasal cavity. This bony process is an \nimportant anatomic structure in the patency of the ostium. A deflected \nuncinate process (either laterally or medially) can narrow the ethmoid \ninfundibulum, affecting the ostiomeatal complex. Perforations may \nalso be present within the uncinate process, leading to communication \nbetween the nasal cavity and ethmoid infundibulum. In addition, the \nuncinate process may be pneumatized. Although this is rare, it may \ncompromise adequate clearance and drainage of the maxillary sinus. \nSupplemental Ostia\nA supplemental ostium or secondary ostia may occur between the \nmaxillary sinus and the middle meatus, which is often found in \nthe posterior fontanelles (PF). This may be found in approximately \n18% to 30% of individuals. Because these secondary openings are \nusually located posterior and inferior to the natural ostium, they \nmay predispose the patient to sinusitis by the recirculation of \ninfected secretions from the primary meatus back into the sinus cav-\nity. On occasion, these secondary ostia may be encountered during \nthe elevation of the medial wall of the antrum before placement of \nthe sinus graft. When observed, a piece of collagen is placed over the \nsite to prevent graft material from entering the nasal cavity. \nMaxillary Hypoplasia\nHypoplasia of the maxillary sinus may be a direct result from \ntrauma, infection, surgical intervention, or irradiation to the max-\nilla during the development of the maxillary bone. These condi-\ntions interrupt the maxillary growth center, producing a smaller \nthan normal maxilla. A malformed and positioned uncinate \nprocess is associated with this disorder, leading to chronic sinus \ndrainage problems. Most often, these patients have adequate bone \n• Fig. 37.11  Nasal septum deviation is a common variant. Extreme cases \nmay obstruct the ostiomeatal unit and increase the risk of sinusitis after a \nsinus graft.\nMT\nIT\nA\nB\n• Fig. 37.12  (A) Nasal cavity anatomy: inferior turbinate (IT), middle turbi-\nnate (MT), inferior meatus (red arrow), middle meatus (yellow arrow). Note \nthe paradoxical middle turbinate. (B) Coronal image depicting concha bul-\nlosa (arrow) and deviated septum."
  },
  {
    "page": 110,
    "content": "1000 PART VII    Soft and Hard Tissue Rehabilitation\nheight for endosteal implant placement, and a sinus graft is not \nrequired to gain vertical height (Fig. 37.13)\nInferior Turbinate and Meatus Pneumatization  \n(Big-Nose Variant)\nMisch had observed, on rare occasion, that the inferior third of \nthe nasal cavity pneumatizes within the maxilla and resides over \nthe alveolar residual ridge. An evaluation of 550 computerized \ntomography (CT) scans of complete or partially edentulous maxil-\nlae found this condition in 18 patients (3% incidence). When the \npatient has this condition, the maxillary sinus is lateral to the eden-\ntulous ridge. When inadequate bone height is present below this \nstructure, a sinus graft does not increase available bone height for an \nimplant. This condition is difficult to observe on a two-dimensional \npanoramic radiograph. If unaware, then the implant can be placed \ninto the nasal cavity above the residual ridge and even penetrate the \ninferior turbinate. A sinus graft is contraindicated with this patient \ncondition because the sinus is lateral to the position of the implants. \nInstead, in most cases an onlay graft is required to increase bone \nheight (Fig. 37.14). \nMaxillary Sinus Pathology\nA pre-existing, pathologic, maxillary sinus condition may be a rela-\ntive or absolute contraindication for many procedures that will alter \nthe sinus floor before or in conjunction with sinus grafting and/or \nimplant insertion. The risk of postoperative infection is elevated and \nmay compromise the health of the implant and the patient. There-\nfore pathologic conditions, either preoperative or postoperative, of a \nmaxillary sinus should be evaluated, diagnosed, and treated.\nPathologic conditions of the maxillary sinus may be divided \ninto four categories: (1) inflammatory lesions, (2) cystic lesions, \n(3) neoplasms, and (4) antroliths and foreign bodies. Studies have \nshown that 20% to 45% of the asymptomatic population has a sub-\nclinical pathologic condition in the maxillary sinus. The author has \nevaluated approximately 2000 prospective candidates for maxillary \nsinus augmentation procedures at the Misch International Implant \nInstitute for signs of pathology. The results concluded 38.7% of \nasymptomatic patients had maxillary sinus pathologic conditions \non CBCT scan evaluation. Manji and colleagues evaluated 275 \npatients and concluded that 45.1% were classified as exhibiting \nsinus pathology (i.e., 56.5% had mucosal thickening (≥5 mm), \n28.2% with polypoidal thickening, 8.9% partial opacification and/\nor air/fluid level, and 6.5% complete opacification).32 Because of \nthis increased incidence, it is highly recommended that a thorough \nradiographic evaluation be completed on all prospective sinus eleva-\ntion patients.\nInflammatory Disease\nInflammatory conditions can affect the maxillary sinus from \nodontogenic and nonodontogenic causes.\nOdontogenic Rhinosinusitis (Periapical Mucositis)\nOdontogenic sinusitis describes a type of sinus disease in which \nradiographic, microbiologic, and/or clinical evidence indicates it is of \na dental origin (i.e., from a tooth). The close proximity of the roots \nof the maxillary posterior teeth to the floor of the sinus suggest any \ninflammatory changes in the periodontium or surrounding alveolar \nbone may result in pathologic conditions in the maxillary sinus.\nEtiology. Odontogenic sinusitis is usually the result of an \ninfected tooth (e.g., periapical abscess, cyst, granuloma, periodontal \ndisease) that causes an expansile lesion within the floor of the sinus. \nPeriapical inflammation has been shown to be capable of affect-\ning the sinus mucosa, with and without perforation of the cortical \nbone of the sinus floor. Infection and inflammatory mediators are \ncapable of spreading directly or via bone marrow, blood vessels, \nand lymphatics to the maxillary sinus, causing an inflammatory \nresponse.33 Additional etiologic factors include sinus perforations \nduring extractions and foreign bodies (e.g., gutta-percha, root tips, \namalgam). Odontogenic rhinosinusitis is often polymicrobial, with \nanaerobic streptococci, Bacteroides spp., Proteus spp., and coliform \nbacilli involved. Studies have shown 10% to 40% of all rhinosinus-\nitis sinusitis cases may have an underlying dental pathology.34,35 \nRadiographic Appearance. The radiographic evaluation of \npatients with odontogenic sinusitis will most commonly dem-\nonstrate a unilateral maxillary sinusitis. A unilateral maxillary \nodontogenic sinusitis is often overlooked on CBCT scans because \nthey are frequently asymptomatic. Involvement of the ostiome-\natal complex may result in extension to adjacent paranasal sinuses \n(e.g., ethmoid, frontal, sphenoid), ranging from 27% to 60% \namong patients with odontogenic sinusitis.36 Odontogenic sinus-\nitis has been shown to exhibit bilateral involvement in 20% of \n• Fig. 37.14  Inferior meatus pneumatization (big nose variant). Cone beam \ncomputerized tomographic panoramic image depicting the abnormally \nlarge nasal cavity extending into the molar area.\n• Fig. 37.13  Maxillary hypoplasia. Coronal cone beam computerized \ntomographic view of an abnormally small sized maxillary sinus"
  },
  {
    "page": 111,
    "content": "1001\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\npatients. In some cases, a slight thickening of the sinus membrane \nmay be present adjacent to the offending tooth.37 Usually the \nradiographic appearance will be a radiopaque band that follows \nthe contours of the sinus floor. \nDifferential Diagnosis. Odontogenic sinusitis may be confused \nwith acute rhinosinusitis sinusitis; however, acute rhinosinusitis is \nalmost always symptomatic. Mild mucosal thickening from a non-\nodontogenic origin (e.g., smoking, allergy) may also show similar \nradiographic signs. However, the nonodontogenic origin may be \nconfirmed from lack of radiographic evidence of a diseased or pain-\nful tooth. \nTreatment. Before any type of sinus augmentation or implant \nplacement into the sinus, the tooth or teeth involved should be \ntreated periodontally, endodontically, or extracted. After intraoral \nsoft tissue healing and resolution of the pathologic condition (i.e., \na minimum of 6 weeks), the bone graft and/or implant may be \nperformed with minimal morbidity. The removal of unhealthy \nteeth decreases sinus membrane thickening, but most of the time \nit does not completely resolve it. In addition, epithelial metaplasia \nwith the ciliated mucosa changing to simple cuboidal and strati-\nfied squamous keratinized tissue may result. Therefore, depend-\ning on the severity, in some cases the mucosal thickness may \nremain because of the change in epithelia structure and metaplasia \nchanges6 (Fig. 37.15). \nMild Mucosal Thickening (Nonodontogenic)\nSinus membrane thickening has been shown to be present in \napproximately 46.7% of patients, with equal distribution between \nhealthy and unhealthy natural teeth.38 The most common area for \nthe mucosal thickening has been shown to be in the midsagittal \nsinus region, which is adjacent to the first and second molars. In \nthe literature, it is accepted that mucosal thickening greater than 2 \nmm is considered a pathologic sinus membrane.39-42\nEtiology. Local odontogenic issues, such as periapical pathol-\nogy, periodontal disease, and the health of the adjacent dentition, \nhave been shown to be the etiologic factor in the inflammatory \nresponse to the sinus membrane in approximately 50% of cases.43 \nHowever, nonodontogenic factors such as smoking,44 allergies, \nsinus congestion, mold, and air pollution may aggravate the sinus \nmucosa, resulting in mild thickening. Chronic inflammatory con-\nditions may result in altered bacterial flora, along with mucociliary \nclearance and cilia changes. \nRadiographic Appearance. On a CBCT image, usually thick-\nened mucosa will appear as a radiopaque widened membrane. \nThickened mucosa can easily be seen when evaluating axial images. \nTreatment. Usually no treatment is necessary because mild \nmucosal thickening is asymptomatic. Studies have shown that \nslight mucosal thickening allows for sinus grafting procedures to \nbe completed with a decreased incidence of membrane perfora-\ntion (Fig. 37.16). \nAcute Rhinosinusitis\nA nonodontogenic pathologic condition may also result in inflam-\nmation in the form of sinusitis. The most common type of sinus-\nitis is acute rhinosinusitis (i.e., sinusitis symptoms of less than \n3 months). The signs and symptoms of acute rhinosinusitis are \nrather nonspecific, making it difficult to differentiate from the \ncommon cold, influenza type of symptoms, and allergic rhinitis. \nHowever, the most common symptoms include purulent nasal \ndischarge, facial pain and tenderness, nasal congestion, and pos-\nsible fever.\nAcute maxillary rhinosinusitis results in 22 to 25 million \npatient visits to a physician in the United States each year, with \na direct or indirect cost of $6 billion. Although four paranasal \nsinuses exist in the skull, the most common involved in rhinosi-\nnusitis are the maxillary and frontal sinuses.45\nEtiology. An inflammatory process that extends from the \nnasal cavity after a viral upper respiratory infection often causes \nacute maxillary sinusitis. Microbiological cultures have shown the \nmost common pathogens causing acute rhinosinusitis are S. pneu-\nmoniae, H. influenzae, and Moraxella catarrhalis. These pathogens \ninclude approximately 20% to 27% β-lactamase–resistant bacte-\nria. S. aureus has also been cited, with the microbiology of acute \nrhinosinusitis. However, this pathogen is usually only seen in nos-\nocomial (hospital-induced) sinusitis and is unlikely to be seen in \nan elective sinus graft patient.\nThe most important factor in the pathogenesis of acute rhinosi-\nnusitis is the patency of the maxillary ostium.46,47 Local predispos-\ning causes of sinusitis include inflammation and edema associated \nwith a viral upper respiratory tract infection or allergic rhinitis. \nAs a consequence, mucous production within the sinus may \nbe abnormal in quality or quantity, along with a compromised \n• Fig. 37.15  Odontogenic rhinosinusitis. Cone beam computerized tomo-\ngraphic panoramic view showing molar roots extending into the maxillary \nsinus, resulting in inflammation of the sinus membrane. Note the com-\nmunication between the maxillary molar roots and the maxillary sinuses.\n• Fig. 37.16  Mild mucosal thickening. Three-dimensional axial view show-\ning bilateral mucosal thickening (gray area surrounding the bony walls of \nthe maxillary sinus)."
  },
  {
    "page": 112,
    "content": "1002\nPART VII    Soft and Hard Tissue Rehabilitation\nmucociliary transport. In an occluded ostium, an accumulation of \ninflammatory cells, bacteria, and mucus exists. Phagocytosis of the \nbacteria is impaired with immunoglobulin (Ig)-dependent activi-\nties decreased by the low concentration of IgA, IgG, and IgM \nfound in infected secretions.\nThe oxygen tension inside the maxillary sinus has significant \neffects on pathologic conditions. When the oxygen tension in the \nsinus is altered, resultant sinusitis occurs. Growth of anaerobic and \nfacultative organisms proliferate in this environment.48 Many fac-\ntors may alter the normal oxygen tension within the sinuses. A \ndirect correlation exists between the ostium size and the oxygen \ntension in the sinus. In patients with recurrent episodes of sinus-\nitis, oxygen tension is often reduced, even when infection is not \npresent. As a consequence, a history of recurrent acute rhinosinus-\nitis is relevant to determine whether a bone graft or dental implant \nmay be at increased risk of morbidity. \nRadiographic Appearance. The radiographic hallmark in \nacute rhinosinusitis is the appearance of an air-fluid level. A line of \ndemarcation will be present between the fluid and the air within \nthe maxillary sinus. If the patient is radiographically positioned \nsupine, then the fluid will accumulate in the posterior area; if the \npatient is upright during the imaging survey, the fluid will be seen \non the floor and horizontal in nature. Additional radiographic \nsigns include smooth, thickened mucosa of the sinus, with pos-\nsible opacification. In severe cases, the sinus cavity may fill com-\npletely with supportive exudates, which gives the appearance of a \ncompletely opacified sinus. With these characteristics, the terms \npyocele and empyema have been applied. \nTreatment. Because acute rhinosinusitis is one of the most \ncommon health problems today, patients having sinus grafting \nprocedures should be well screened for a past history and cur-\nrent symptoms. Even though acute rhinosinusitis is a self-limiting \ndisease, a symptomatic patient should be treated and cleared by \ntheir physician before any grafting procedures. These patients are \nalso more prone to postoperative rhinosinusitis. As a result, a sinus \ngraft is performed and given a longer healing period before place-\nment of an implant. In addition, the suggested antibiotic coverage \nmay be altered and extended, both before and after the sinus graft \nprocedure (Fig. 37.17). \nChronic Rhinosinusitis\nChronic rhinosinusitis is a term used for a sinusitis that does not \nresolve in 3 months and also has recurrent episodes. It is the most \ncommon chronic disease in the United States, affecting approxi-\nmately 37 million people. Symptoms of chronic rhinosinusitis \nare associated with periodic episodes of purulent nasal discharge, \nnasal congestion, and facial pain.\nEtiology. As maxillary rhinosinusitis progresses from the acute \nphase to the chronic phase, anaerobic bacteria become the predomi-\nnant pathogens. The microbiology of chronic rhinosinusitis is very \ndifficult to determine because of the inability to acquire accurate \ncultures. Studies have shown that possible bacteria include Bacte-\nroides spp., anaerobic gram-positive cocci, Fusobacterium spp., and \naerobic organisms (Streptococcus spp., Haemophilus spp., Staphylo-\ncoccus spp.).49 A Mayo Clinic study showed that in 96% of patients \nwith chronic rhinosinusitis, active fungal growth was present.50 \nRadiographic Appearance. Chronic rhinosinusitis may \nappear radiographically as thickened sinus mucosa, complete \nopacification of the antrum, and/or sclerotic changes in the sinus \nwalls (which give the appearance of denser cortical bone in the \nlateral walls). \nTreatment. Medical evaluation and clearance by an experi-\nenced physician in sinus pathology (e.g., otolaryngologist [ENT]) \nis highly recommended for patients with chronic maxillary rhi-\nnosinusitis before any sinus grafting, because significant bacterial \nresistance and fungal growth is highly probable. Fungal infections \nare often difficult to treat and control, and serious complications \nmay result in postoperative sinus graft patients. In many chronic \nrhinosinusitis patients, a sterile and nonpathologic sinus is dif-\nficult to obtain, contraindicating (absolute) sinus grafting and/or \nimplants. \nAllergic Rhinosinusitis\nEtiology. Allergic sinusitis is a local response within the maxil-\nlary sinus caused by an irritating allergen in the upper respiratory \ntract. Therefore allergens may be a cause of acute or chronic rhi-\nnosinusitis. This category of sinusitis may be the most common \nform, with 15% to 56% of patients undergoing endoscopy for \nsinusitis showing evidence of allergy. Allergic rhinosinusitis often \nleads to chronic sinusitis in 15% to 60% of patients.51 The sinus \nmucosa frequently becomes irregular or lobulated, with resultant \npolyp formation. \nRadiographic Appearance. Polyp formation related to allergic \nsinusitis is usually characterized by multiple, smooth, rounded, \nradiopaque shadows on the walls of the maxillary sinus. Most \ncommonly, polyps initially are located near the ostium and are \neasily observed on a CBCT scan. In advanced cases, ostium occlu-\nsion, along with displacement or destruction of the sinus walls, \nmay be present with a radiographic image of a completely opaci-\nfied sinus. \nTreatment. When patients have a history of allergic rhinosinus-\nitis, special attention must be given to a patent ostium, bacterial \nresistance, and close postoperative supervision. Polyps, if enlarged \nor too numerous, may be required to be removed before the sinus \nB\nA\n• Fig. 37.17  Acute rhinosinusitis. (A and B) Flat radiopaque (gray) line within the maxillary sinus, which is \ntermed an air-fluid level and consistent with acute rhinosinusitis."
  },
  {
    "page": 113,
    "content": "1003\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\ngraft. This may be performed through an anterior Caldwell-Luc \napproach or by an endoscopic procedure via the maxillary ostium.\nAllergic sinusitis patients often have a greater risk of complica-\ntions related to an increase in allergen production. Because sinus \ngrafting is an elective procedure, the time of year for the surgery \nmay be altered to decrease the postoperative infection risk. For \nexample, if hay fever or a grass allergy is related to the patient’s \nsinusitis, then the sinus graft surgery should be performed in the \nseason or seasons that have least risk to aggravate the sinus mucosa \n(i.e., winter or fall). In severe cases of polyposis, any procedure \nviolating the sinus proper may be an absolute contraindication \n(Fig. 37.18). \nFungal Rhinosinusitis (Eosinophilic Fungal Rhinosinusitis)\nGranulomatous rhinosinusitis is a very serious (and often over-\nlooked) disorder within the maxillary sinus. Patients who exhibit \nsigns of fungal rhinosinusitis may indicate an extensive history of \nantibiotic use, chronic exposure to mold or fungus in the envi-\nronment, or history of immunosuppression. Fungal rhinosinusitis \nhas been categorized into five types: acute necrotizing (fulmi-\nnant), chronic invasive, chronic granulomatous invasive, fungal \nhall (sinus mycetoma), and allergic. The first three types are clas-\nsified as tissue-invasive and the last two are noninvasive fungal \nrhinosinusitis.52\nEtiology. Fungal infections are usually caused by aspergillosis, \nmucormycosis, or histoplasmosis. Chronic rhinosinusitis patients \nshould always be evaluated for granulomatous conditions because \na high percentage of fungal growth exists in this patient popula-\ntion. Of concern in these patients is eosinophils are activated that \nrelease major basic protein (MBP) into the mucus, which attacks \nand destroys the fungus. However, this may result in the mem-\nbrane being irritated and possibly irreversibly damaged, which \nallows bacteria to proliferate. Three possible clinical signs may \ndifferentiate fungal rhinosinusitis from acute or chronic rhino-\nsinusitis; however, a positive diagnosis requires mycological and \nhistologic studies.53\n1. No response to antibiotic therapy\n2.\t \u0007Soft tissue changes in sinus associated with thickened reactive \nbone, with localized areas of osteomyelitis\n3. \u0007Association of inflammatory sinus disease that involves the \nnasal fossa and facial soft tissue \nRadiographic Appearance. Granulomatous rhinosinusitis \nis extremely variable and may appear radiographically as mild \nthickening (less common) to complete opacification (more com-\nmon) of the sinus. The majority of sinuses show complete opaci-\nfication with hyperdense areas.54 Extension beyond the maxillary \nsinus to other sinuses is common and expansion and erosion of a \nsinus wall may be present. \nTreatment. Patients with a history or current knowledge of \nfungal rhinosinusitis should be referred to their physician or an \nENT for treatment and surgical clearance (i.e., in most cases clear-\nance will not be given because fungal rhinosinusitis is rarely cur-\nable). Treatment usually involves debridement and therapy with \nan antifungal agent, such as amphotericin B (Fig. 37.19). \nCystic Lesions\nCystic type lesions are a common occurrence in the maxillary \nsinus. They may vary from microscopic lesions to large, destruc-\ntive, expansile pathologic conditions. Cystic lesions may include \npseudocysts, retention cysts, primary mucoceles, and postopera-\ntive maxillary cysts.\nPseudocysts (Mucous Retention Cyst)\nThe most common cysts in the maxillary sinus are mucous reten-\ntion cysts. After much controversy, in 1984, Gardner55 distin-\nguished these cysts into two categories: (1) pseudocysts and (2) \nA\nB\n• Fig. 37.18  Allergic rhinosinusitis. (A) Bilateral polypoid inflammation consistent with allergic rhinosinusitis. (B) Polyp removal on a patient \nwith chronic allergic rhinosinusitis. Unfortunately the polyps have a high incidence of recurrence, and in many cases this contradicts implant \ntreatment.\n• Fig. 37.19  Fungal rhinosinusitis. Coronal cone beam computerized \ntomographic image of fungal rhinosinusitis, which has the radiographic \nappearance of an opacified sinus with localized highly densified areas."
  },
  {
    "page": 114,
    "content": "1004 PART VII    Soft and Hard Tissue Rehabilitation\nretention cysts. Pseudocysts are more common and of much \ngreater concern during sinus graft surgery, compared with reten-\ntion cysts. Pseudocysts recur in approximately 30% of patients \nand are often unassociated with sinus symptoms. As a conse-\nquence, many physicians do not treat this condition. However, \nwhen their size is larger (approximately >10 mm in diameter), \npseudocysts may occlude the maxillary ostium during a sinus graft \nprocedure and increase the risk of postoperative infections. Stud-\nies have shown successful bone graft and implant placement in \nmaxillary sinuses with pseudocysts.56\nEtiology\nA pseudocyst is caused by an accumulation of fluid beneath the peri-\nosteum of the sinus mucosa. This elevates the mucosa away from the \nfloor of the sinus, giving rise to a dome-shaped lesion. Pseudocysts \nhave also been termed mucosal cysts, serous cysts, and nonsecreting \ncysts. Pseudocysts are not true cysts because they lack an epithelial \nlining; however, they are surrounded by fibrous connective tissue.57 \nThe cause of the fluid is thought to result from sinus mucosa bacte-\nrial toxins or from odontogenic causes (Fig. 37.20). \nRadiographic Appearance\nPseudocysts are depicted radiographically as smooth, homog-\nenous, dome-shaped, round to ovoid, well-defined radiopaci-\nties. Pseudocysts do not have a corticated (radiopaque) marginal \nperimeter and almost always located on the floor of the sinus cav-\nity. In some cases, pseudocysts may encompass the entire maxillary \nsinus, making diagnosis difficult because it may be radiographi-\ncally similar to rhinosinusitis. \nTreatment\nPseudocysts are not a contraindication for sinus graft surgery, unless \ntheir approximate size increases the possibility of occluding the \nmaxillary ostium. If a large pseudocyst (i.e., greater than 8 mm) is \npresent, then the elevation of the membrane during a sinus graft \nmay raise the cyst to occlude the ostium. In addition, on elevation \nor placement of the grafting material, the cyst may be perforated, \nallowing fluid within the cyst to contaminate the graft. Large cysts \nof this nature should be drained and allowed to heal before or in \nconjunction with sinus elevation surgery. Most often, an ENT phy-\nsician should evaluate to determine any intervention. If a pseudo-\ncyst is less than 8 mm, then less concern is needed and the fluid \nmay be drained in conjunction with sinus grafting, depending on \nthe surgeon’s experience in the treatment of this condition. Caution \nshould be exercised to prevent membrane perforation. A strict recall \nevaluation of this area during the follow-up period of the sinus graft \nsurgery is in order because reoccurrence of pseudocysts is common. \nRetention Cysts\nRetention cysts may be located on the sinus floor, near the ostium, \nor within antral polyps. Because they contain an epithelial lining, \nresearchers consider them to be mucous secretory cysts and “true” \ncysts. Retention cysts are often microscopic in size.\nEtiology\nRetention cysts result from partial blockage of seromucinous \ngland ducts located within the connective tissue underlying the \nsinus epithelium. As the secretions collect, they expand the duct, \nproducing a cyst that is encompassed by respiratory or cuboidal \nepithelium. They may be caused by sinus infections, allergies, or \nodontogenic reasons. \nRadiographic Appearance\nRetention cysts are usually very small and not seen clinically or \nradiographically. In rare instances, they may achieve adequate size \nto be seen in a CT image and may resemble the appearance of a \nsmall pseudocyst. \nTreatment\nNo treatment for retention cysts exist before or in conjunction \nwith a sinus graft and/or implant insertion. \nFluid\nA\nB\n• Fig. 37.20  Pseudocyst. (A) Diagram showing fluid accumulation underneath the membrane. (B) Radio-\ngraph showing the dome-shaped characteristics of a pseudocyst."
  },
  {
    "page": 115,
    "content": "1005\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nPrimary Maxillary Sinus Mucocele\nA primary mucocele is a cystic, expansile, destructive lesion that \nmay include painful swelling of the cheek, displacement of teeth, \nnasal obstruction, and possible ocular symptoms.58 The primary \nmucocele is more commonly found in the ethmoid sinus (45.5%) \nversus the maxillary sinus (18.3%).59\nEtiology\nThe primary mucocele arises from blockage of the maxillary \nostium by fibrous connective tissue. Because of the compromised \ndrainage, the mucosa expands and herniates through the antral \nwalls. This mucocele is classified as a cyst because it is lined by \nantral epithelium, which contains mucin. \nRadiographic Appearance\nIn the early stages, the primary mucocele involves the entire sinus \nand appears as an opacified sinus. As the cyst enlarges, the walls \nbecome thin and eventually perforate. In the late stages, destruc-\ntion of one or more surrounding sinus walls is evident. \nTreatment\nSurgical removal of this cyst is indicated prior to any bone aug-\nmentation procedures (Fig. 37.21). \nSecondary Maxillary Sinus Mucocele \n(Postoperative Maxillary Cyst)\nA postoperative maxillary cyst of the maxillary sinus is a cystic \nlesion that usually develops secondary to a previous trauma or \nsurgical procedure in the sinus cavity. It also has been termed a \nsurgical ciliated cyst, postoperative maxillary sinus mucocele, \nor a secondary mucocele.60-62 Secondary mucoceles occur most \ncommonly in the maxillary sinus (86%) versus the ethmoid sinus \n(7.1%).59\nEtiology\nA postoperative maxillary cyst is a direct result of trauma or past \nhistory of surgery within the maxillary sinus. The cyst is derived \nfrom the antral epithelium and mucosal remnants that previ-\nously were entrapped within the prior surgical site. This separated \nmucosa results in an epithelium-lined cavity in which mucin is \nsecreted. The antrum becomes divided by a fibrous septum in \nwhich one part drains normally, whereas the other part is com-\nposed of the mucocele. It is relatively rare in the United States; \nhowever, it constitutes approximately 24% of all cysts in Japan. \nAt least three reported cases exist of a postoperative maxillary cyst \nforming after a sinus graft procedure, including one by the author \nof this chapter.63 \nRadiographic Appearance\nThe cyst radiographically presents as a well-defined radiolucency \ncircumscribed by sclerosis. The lesion is usually spherical in the \nearly stages, with no bone destruction. As it progresses, the sinus \nwall becomes thin and eventually perforates. In later stages, it will \nappear as two separated anatomic compartments. \nTreatment\nSurgical ciliated cysts should be enucleated before any bone aug-\nmentation procedures. If observed after the sinus graft, then the \ncysts should be enucleated and regrafted in the site (Fig. 37.22) \nNeoplasms\nEtiology\nPrimary malignant tumors within the maxillary sinus are usually \ncaused by squamous cell carcinomas or adenocarcinomas. Signs \nand symptoms of malignant disease are related to the surround-\ning sinus wall that the tumor invades and includes swelling in the \ncheek area, pain, anesthesia or paresthesia of the infraorbital nerve \n(e.g., anterior wall), and visual disturbances (e.g., superior wall). \nThese tumors in the sinus are usually nonspecific and give a variety \nFluid\nA\nB\n• Fig. 37.21  Primary maxillary sinus mucocele. (A) Diagram showing expansive nature of a primary maxil-\nlary sinus mucocele. (B) Radiograph showing the initial stage of complete opacification and later stages \nincluding expansion of the bony plates."
  },
  {
    "page": 116,
    "content": "1006 PART VII    Soft and Hard Tissue Rehabilitation\nof consequences, including opacified sinuses; soft tissue masses in \nthe sinus; and sclerosis, erosion, or destruction of the walls of the \nsinus. Sixty percent of squamous cell carcinomas of the parana-\nsal sinuses are located in the maxillary sinus, usually in the lower \none-half of the antrum. Clinical signs in the oral cavity reflect the \nexpansion of the tumor and an increased mobility of the involved \nteeth. Invasion of the infratemporal fossa is also possible.1 \nRadiographic Appearance\nRadiographic signs of neoplasms may include various-sized radi-\nopaque masses, complete opacification, or bony wall changes. A \nlack of a posterior wall on a panoramic radiograph should be a \nsign of possible neoplasm (Fig. 37.23). \nTreatment\nAny signs or symptoms of a lesion of this type should be immedi-\nately referred for medical consultation. Sinus graft surgery is abso-\nlutely contraindicated while this condition exists. \nAntroliths and Foreign Bodies\nMaxillary sinus antroliths are the result of complete or partial \nencrustation of a foreign body. These masses found within the \nmaxillary sinus originate from a central nidus, which can be \nendogenous or exogenous.64\nEtiology\nThe majority of endogenous sources are from dental origin, \nincluding retained roots, root canal sealer, fractured dental instru-\nments, and dental implants. Additionally, bone spicules, blood, \nand mucus have been reported to cause antroliths.65 Reports in \nthe literature of exogenous sources include paper, cigarettes, snuff, \nand glue.66 Although most antroliths are asymptomatic, they \noften are associated with sinusitis. \nRadiographic Appearance\nThe radiographic appearance of a maxillary antrolith resembles \neither the central nidus (e.g., retained root) or appears as a radi-\nopaque, calcified mass within the maxillary sinus (Fig. 37.24). \nDifferential Diagnosis\nBecause the calcified antrolith is composed of calcium phosphate \n(CaPO4), calcium carbonate salts, water, and organic material, it \nwill be considerably more radiopaque than an inflammatory or \ncystic lesion.67 The central nidus of the antrolith is similar to its \nusual radiographic appearance. \nFluid\nB\nA\nC\nD\n• Fig. 37.22  Secondary maxillary sinus mucocele. (A) Diagram showing cystic nature of a secondary \nmucocele, which divides the sinus into two compartments. (B) Radiograph of blade implant with well-\ndefined radiolucency around the implant. (C) Blade implant removed with associated pathology. (D) Histol-\nogy revealing a secondary maxillary sinus mucocele."
  },
  {
    "page": 117,
    "content": "1007\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nTreatment\nBefore sinus augmentation and implant placement, the antrolith \nshould be surgically removed. If sinusitis exists, then the sinus cav-\nity should be allowed to heal completely before sinus augmen-\ntation procedures. A nonsymptomatic condition may have the \nantrolith removed and sinus graft performed at the same surgery, \nonly if the sinus membrane is not compromised. \nMiscellaneous Factors That Affect the Health \nof the Maxillary Sinus\nSmoking\nThe use of tobacco is one of the main factors that may lead to \nan increased morbidity after sinus graft procedures. Smoking is \nknown to be associated with an increased susceptibility to aller-\ngies and infections because it interferes with ciliary function and \nsecretory immunity of the nasorespiratory tract. In the maxillary \nsinus, this may have direct effects on both immune exclusion and \nsuppression because IgA and IgM responses are reduced, whereas \nIgE responses are increased. Smoking is believed to interfere \nwith bone graft healing because it reduces local blood flow by \nincreasing peripheral resistance and causing an increased platelet \naggregation. By-product chemicals of smoking, such as hydrogen \ncyanide and carbon monoxide, have been shown to inhibit wound \nhealing, as does nicotine, which inhibits cellular proliferation. \nTobacco may interfere directly with osteoblastic function, and \nstrong evidence exists of decreased bone formation in smokers. \nIn addition, smokers have a significant reduction of bone mineral \ncontent. Bone mineral density can be reduced two to six times \nin a chronic smoker. Overall, smoking may contribute to poor \navailable bone quality and poor healing capacity resulting from \nvascular and osteoblastic dysfunction.68\nThere exist many clinical studies with smoking and sinus \ngraft procedures. Klokkevold evaluated the success rate of dental \nimplants placed in the posterior maxilla; it showed a 7% greater \nfailure rate compared with nonsmokers.69 Lindquist showed that \nsmokers can also suffer detrimental effects around successfully \nintegrated maxillary implants, with a significantly greater bleed-\ning index, greater mean peri-implant pocket depth, more frequent \nperi-implant inflammation, and radiographically greater mesial \nand distal bone loss.70 Olson and colleagues found an association \nbetween dental implants placed in augmented maxillary sinuses \nand history of smoking.71 Widmark reported a higher failure rate \nin smokers after rehabilitation of severely resorbed maxillae with \nand without bone graft.72 Schwartz-Arad and colleagues evaluated \n212 implants in the posterior maxilla, resulting in a 95.5% success \nrate with nine failures. Of the nine failures, five were in patients \nthat smoked.73\nIn summary, smoking is not an absolute contraindication for \nsinus graft procedures. However, patients should be instructed to \ncease smoking before and after sinus graft procedures because of \nthe literature-based studies showing a higher risk of wound dehis-\ncence, graft infection and/or resorption, and a reduced probability \nof osseointegration. It is recommended, however, that if a decision \nto proceed with surgery has been made, then patients refrain from \nsmoking at least 15 days before surgery (i.e., the time it takes for \nnicotine to clear systemically) and 4 to 6 weeks after surgery. More-\nover, smokers should sign a detailed informed consent in which \nrisks connected to smoking are clearly defined and explained. \nRelative and Absolute Contraindication to \nMaxillary Sinus Graft Procedures\nIn general contraindications for implant surgery also apply to \nsinus graft procedures. However, additional specific and local \nconditions may exist that increase morbidity. Several conditions \nrelated to the maxillary sinus are a concern, but they are not neces-\nsarily contraindications to the sinus graft procedure. The implant \nclinician, after evaluation of the CBCT scan and evaluation of the \nmaxillary sinus, will in some cases need further medical evalua-\ntion before proceeding with procedures that may invade the sinus \nproper. There exists a wide variation in the severity of the possible \npathologic conditions that may be present in the maxillary sinus. \nFor example, a patient may have a mild deviated septum. Because \nit does not affect the mucociliary clearance of the maxillary sinus \n• Fig. 37.23  Axial contrast-enhanced computerized tomography (bone \nwindow) shows almost complete radiopacification of the right maxillary \nsinus by squamous cell carcinoma. There is destruction of the walls of \nthe sinus and an air-fluid interface in the left sinus. (From Koenig LJ, et al. \nDiagnostic Imaging: Oral and Maxillofacial. 2nd ed. Philadelphia, PA: Else-\nvier; 2017.)\n• Fig. 37.24  Antroliths. Any object left in the sinus will calcify and is termed \nan antrolith. Antroliths usually will result in mucociliary clearance issues."
  },
  {
    "page": 118,
    "content": "1008\nPART VII    Soft and Hard Tissue Rehabilitation\nand there is no associated pathology, no medical consultation \nby an ENT is warranted. However, if a deviated septum is pres-\nent and severe, resulting in a nonpatent ostium, an ENT referral \nwould be highly recommended.\nA list of relative and absolute contraindications is listed in \nBoxes 37.2 and 37.3. \nReduction of Sinus Graft Complications\nEven though sinus graft procedures have high success rates, these \nprocedures tend to have a higher risk of infection than implant \nplacement surgery because the patient is predisposed to infec-\ntions originating from the oral surgical procedure (i.e., intraoral \ninfection originating from the surgical site) or from the sinus \ngraft procedure (i.e., infection within the sinus proper). There-\nfore a surgical environment that includes a strict aseptic technique \nincluding intraoral and extraoral scrubbing with chlorhexidine, \nscrubbing and draping the patient, and gowning the doctor and \nassistant should be considered in addition to sterile gloves and \nsterile instruments. The risk of postoperative sinus infection is \ngenerally less than 5% when these procedures and a preoperative \nand postoperative pharmacologic regimen are used.73,74\nProphylactic Medications\nSystemic Antimicrobial Medications\nThe risks of bacterial contamination before and after sinus graft \nprocedures are much different than routine implant surgical pro-\ncedures. Therefore the pharmacologic protocol for sinus graft pro-\ncedures should be effective against the organisms in this surgical \nsite. The recommended pharmacologic regimen includes a pro-\nphylactic antibiotic, anti-inflammatory medications, and antimi-\ncrobial rinses.\nCompared with routine dental implant surgery, sinus augmen-\ntation has a greater chance of morbidity because of the possible \nadditional routes of infection. Bacterial invasion may originate \nfrom different sources such as (1) intraoral surgery, (2) bone graft \nmaterial, and (3) bacteria from the sinus cavity. Additionally, it \nhas been well documented that the inclusion of foreign bodies \n(e.g., implants, autografts, allografts) increases infection rates.75,76 \nBecause a greater chance of infection and morbidity exists with this \ntype of surgical procedure, a strict antibiotic protocol is of benefit. \nAntibiotic medications have been shown to significantly reduce the \nnumber of sinus graft or implant failures caused by infection.77\nFollowing the principles of prophylactic antibiotic administra-\ntion, the antibiotic should be effective against the bacteria most \nlikely to cause infection. The most likely contaminating organisms \nafter intraoral surgery are primarily streptococci, anaerobic gram-\npositive cocci, and anaerobic gram-negative rods. S. pneumoniae, H. \ninfluenzae, and M. catarrhalis are the three most common patho-\ngens found within the maxillary sinus that may lead to acute sinus \ninfections.78 S. aureus is not common with acute episodes; however, \nit has been shown to have a significant role in causing chronic rhi-\nnosinusitis disease, along with anaerobic bacteria. The organisms \nassociated with infection in general oral surgical procedures include \nα-hemolytic streptococci and S. viridans.79 Therefore a pharmaco-\nlogic protocol should be effective against these organisms.\nWhen evaluating various classes of antibiotic medications used \nfor treatment of maxillary sinus infections, the antibiotic class \nof choice is the β-lactam antibiotic drugs. With the wide range \nof possible routes of bacterial invasion and types of bacteria, the \nantibiotic drug must be broad spectrum to account for all these \npossibilities. However, bacterial resistance has become a signifi-\ncant problem in the treatment of these pathogens. Bacterial resis-\ntance is initiated by two common mechanisms: (1) production of \nantibiotic-inactivating enzymes (S. aureus, H. influenzae, and M. \ncatarrhalis) and (2) alteration in target site (S. pneumoniae). Stud-\nies have shown the following resistance (i.e., β-lactamase produc-\ntion) results80:\nH.influenzae: 36.8%\nM.catarrhalis: 98%\nS.pneumoniae: 28.6%\nBecause of the high rate of bacterial resistance, amoxicillin (the \ndrug of choice for many years) is no longer recommended for anti-\nbiotic prophylaxis for the sinus graft surgery. Instead, amoxicillin-\nclavulanate (Augmentin) is used because the addition of clavulanic \nacid enhances amoxicillin’s activity against the β-lactamase–pro-\nducing strains of bacteria.\nThe patient with a history of nonanaphylactic allergic reaction \nto penicillin may take cefuroxime axetil (Ceftin) as an alterna-\ntive.81 Ceftin is a second-generation cephalosporin that possesses \ngood potency, efficiency, and strong activity against resistant S. \npneumoniae and H. influenzae. If a patient has a true history of \nanaphylactic reaction to penicillin, recurrent sinus infections, or \nNo referral\n1. Mild mucosal thickening\n2. Small cyst (<8 mm)\n3. History of mild Sinusitis with no radiographic evidence of pathology\nReferral recommendation\n1. Air-fluid Level \n2. Cyst (~ >8 mm)\n3. Primary/secondary mucocele\n4. Polyps\n5. Opacified sinus\n6. Chronic sinusitis (MRSA, fungal)\n7. Bony wall expansion /destruction\n8. Previous trauma\n8. Foreign body in sinus\n10. Early learning curve\nENT, Ear, nose, and throat (otolaryngologist); MRSA, methicillin-resistant Staphylococcus aureus.\n\t • BOX 37.3\t      \u0007Medical Consultation: Otolaryngologist \n(ENT)\nRelative contraindications:\n1. \u0007Limited anatomic/structural impairments of the sinus or nasal walls that \nare correctable (i.e., deviated septum)\n2. Inflammatory/infectious processes that are treatable\n3. Foreign bodies\n4. Oroantral fistulas\nAbsolute contraindications:\n1. \u0007Anatomic/structural impairments of the sinus or nasal walls that are \nnoncorrectable.\n2. \u0007Inflammatory/infectious processes that cannot be resolved (i.e., chronic \nrhinosinusitis)\n3. Fungal or granulomatous diseases of the nasosinus.\n4. Benign/malignant neoplasms of the nasosinus.\n\t • BOX 37.2\t  \t  \u0007Absolute versus Relative \nContraindications"
  },
  {
    "page": 119,
    "content": "1009\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\na recent history of antibiotic use, then doxycycline may be used. \nIn the past, the quinolone class of antibiotics (e.g., Levaquin, \nAvelox) have been used with excellent success because they exhibit \nsuperior activity against most types of involved bacteria. However, \nrecently the Food and Drug Administration (FDA) has recom-\nmended the adverse effect of tendon damage does not warrant its \nroutine use anymore.\nMaximum effectiveness of prophylactic antibiotic drugs occurs \nwhen the antibiotic is in adequate concentrations in the tissue \nbefore bacterial invasion is initiated. Because the sinus mucosa has \nlimited blood supply when infection and inflammation is pres-\nent, poor antibiotic blood levels are achieved. Therefore to combat \npossible bacterial invasion from the sinus surgery, antibiotic medi-\ncations should be administered at least 1 full day (24 hours) before \nsurgery and extended for approximately 5 days after surgery. \nLocal Antibiotic Medications\nThe antibiotic concentration within a blood clot of the sinus \ngraft depends on the systemic blood titer. After the clot stabilizes, \nfurther antibiotic drugs do not enter the area until revasculariza-\ntion.82 The bone graft is a dead space with minimum blood supply \nand absence of protection by the host’s cellular defense mecha-\nnisms. This leaves the graft prone to infections that would nor-\nmally be eliminated by either the host defenses or the antibiotic. \nThe osteogenic induction of autografts and allografts is greatly \nretarded when contaminated with infectious bacteria.83 To ensure \nadequate antibiotic levels in an SA graft, it is recommended to add \nantibiotic to the graft mixture.84,85 This local antibiotic may pro-\ntect the graft from early contamination and infection. Numerous \nstudies have shown that an antibiotic added to graft material has \nno deleterious effects on bone growth. Antibiotic drugs such as \npenicillin, cephalosporin, and clindamycin, even in high concen-\ntrations, have not been found to be destructive to bone-inductive \nproteins.86\nThe locally delivered antibiotic should have efficacy against \nthe most likely organisms encountered. Because the incidence of \nallergy is so high with β-lactam antibiotic drugs, the parenteral \nform of cefazolin (Ancef) is recommended. If there exists a true \nallergy to penicillin (i.e., anaphylactic), then Cleocin may be used \nas an alternative. Orally administered capsules and tablets should \nnot be used within the graft because they contain fillers that inter-\nfere with bone regeneration.\nClinical experience indicates that less risk of infection exists \nwhen preoperative and postoperative antibiotic drugs are used \nboth orally and in the graft. Because infection considerably \nimpairs bone formation for patients undergoing sinus graft pro-\ncedures, oral antibiotic coverage is continued for approximately 5 \ndays after the surgery. Recommended antibiotic drugs are shown \nin Box 37.4. \nOral Antimicrobial Rinse\nAn additional antimicrobial medication used with respect to sinus \naugmentation surgery is chlorhexidine gluconate. This category of \nantimicrobial rinse has been shown to successfully decrease infec-\ntious episodes and minimizes postoperative complications from \nthe incision line.87 Gentle oral rinses of chlorhexidine gluconate \n0.12% should be used twice daily for 2 weeks after surgery or until \nthe incision line is completely healed.88 \nGlucocorticoid Medications\nSinus augmentation surgery usually results in increased post-\noperative inflammation. Therefore a pharmacologic regimen \nis recommended to decrease postoperative edema. Glucocor-\nticoids have been well documented to decrease inflammation \nof the soft tissue and minimize postoperative pain, swelling, \nand incision line opening. In addition, the clinical manifesta-\ntions of surgery on the sinus mucosa also can be decreased by \nuse of a glucocorticoid medication.89 Therefore the usual surgi-\ncal protocol for most implant surgeries, including sinus grafts, \nincludes a short-term dose of dexamethasone (Decadron) (Box \n37.5). To ensure patency of the ostium and minimize inflam-\nmation in the sinus before surgery, steroid medications are ini-\ntiated 1 full day before surgery. This medication should also be \nextended 2 days postoperatively because edema peaks at 2 to 3 \ndays postsurgery. \nDecongestant Medications\nSympathomimetic drugs that influence α-adrenergic receptors \nhave been used as therapeutic agents for the decongestion of \nmucous membranes. Both systemic and topical decongestant \nmedications are useful in reopening a blocked sinus ostium and \nfacilitating drainage. Oxymetazoline 0.05% (Afrin or Vicks \nNasal Spray) and phenylephrine 1% are useful topical deconges-\ntant medications. The vasoconstrictor action of oxymetazoline \nlasts approximately 5 to 8 hours, which is preferred compared \nwith 1 hour for phenylephrine. However, decongestant drugs \nhave many disadvantages. Topical decongestant drugs can cause \na rebound phenomenon and the development of rhinitis medi-\ncamentosa if used more than 3 to 4 days. The effectiveness of the \ntopical decongestant is markedly enhanced by proper position of \nthe patient’s head during administration of the drug. It should \nSystemic Antibiotic Prophylaxis\n1. \u0007Augmentin (amoxicillin-clavulanic acid) (825 mg/125 mg), one tablet bid \nstarting 1 day before surgery and 5 days after surgery \nNon-anaphylactic allergy to penicillin\n2. Ceftin (cefuroxime axetil) (500 mg), , one tablet bid starting 1 day before \nsurgery and 5 days after surgery \nAnaphylactic allergy to penicillin\n3. Doxycycline (100 mg), one tablet bid starting 1 day before surgery and 5 \ndays after surgery \nLocal Antibiotic in Graft\n1. Ancef (Cefazolin 1 gm): Dilute with 2 mL saline (500 mg/mL)\na. 0.2 mL or 100 mg: add to collagen membrane\nb. 0.8 mL or 400 mg: add to graft material\n2. Clindamycin 150 mg/1 mL\na. 0.2 mL or 30 mg: add to collagen membrane\nb. 0.8 mL or 120 mg: add to graft material\nbid, Twice a day.\n\t• BOX 37.4\t     \u0007Recommended Prophylactic Antibiotic \nDrugs for Sinus Grafting Procedures\nDexamethasone (4 mg) × 6 tablets\n• Two tablets (8 mg) in the morning, the day before surgery\n• Two tablets (8 mg) in the morning of surgery\n• One tablet (4 mg) in the morning, the day after surgery\n• One tablet (4 mg) in the morning, the second day after surgery\n\t • BOX 37.5\t \t\u0007  Glucocorticoid Protocol"
  },
  {
    "page": 120,
    "content": "1010\nPART VII    Soft and Hard Tissue Rehabilitation\nalso be noted that the pulse amplitude and blood flow in the \nsinus mucosa is reduced with decongestant drugs, such as oxy-\nmetazoline. This may, in turn, decrease the defense mechanism \nwithin the tissues.90\nAs a consequence of the medical and local risks of deconges-\ntant medications, the modified sinus graft pharmacologic proto-\ncol no longer recommends the prophylactic use of decongestant \nmedications. \nAnalgesic Medications\nIn most cases, sinus graft procedures usually require very mini-\nmal postoperative analgesic coverage. If a narcotic is required, \nany analgesic combination containing codeine, such as Tyle-\nnol 3, is prescribed postoperatively because codeine is a potent \nantitussive, and coughing may place additional pressure on \nthe sinus membrane and introduce bacteria into the graft. The \npatient is instructed to cough (if necessary) with the mouth \nopen so excessive air pressure does not occur through the \nostium. \nCryotherapy\nWith sinus elevation procedures, postoperative inflammation in \nthe posterior maxilla is very common because of the extent of tis-\nsue reflection. Because postoperative swelling can adversely affect \nthe incision line, measures should be taken to minimize this con-\ndition. Application of cold dressings and cold oral liquids, along \nwith elevation of the head and limited activity for 2 to 3 days, \nwill help minimize the swelling. The applied cold dressing and \nliquids will cause vasoconstriction of the capillary vessels, reduc-\ning the flow of blood and lymph, resulting in a lower degree of \nswelling. Ice or cold dressings should only be used for the first 24 \nto 48 hours. After 2 to 3 days, heat may be applied to the region \nto increase blood and lymph flow, which helps to clear the area \nof the inflammatory consequences. This also assists in the reduc-\ntion of ecchymosis that may have occurred from the bleeding \nand tissue reflection. \nAseptic Technique\nBecause of the extent of tissue reflection, technique sensitivity \nof sinus surgery, and need for asepsis, oral or conscious seda-\ntion is usually recommended for sinus graft procedures. After \nsedation and adequate infiltration anesthesia (i.e., posterior \nand middle alveolar nerve, greater palatine nerve) are obtained, \nthe patient is prepared for surgery. Preparation of the surgi-\ncal site is important in sinus manipulation surgery to reduce \ncontamination by the patient’s own normal flora. The oral cav-\nity cannot become a sterile environment for surgery. However, \nintraoral preparation before surgery may significantly reduce \nthe bacterial count in the mouth. Studies reveal a significant \nreduction in bacteremia during extractions and implant sur-\ngery complications after preparation with antiseptic mouth \nrinse.89,90\nIodophor compounds (Betadine) are a most effective anti-\nseptic. However, because the iodine is complexed with organic \nsurface-active agents, it has been shown to inhibit the osteoinduc-\ntion of allograft bone. Therefore the use of 0.12% chlorhexidine \ngluconate (Peridex) scrub and rinse is most often used as intraoral \npreparation of the surgical site requiring a bone graft. Extraoral \npresurgical scrubbing of the skin should also be performed with \nchlorhexidine antiseptics prior to surgery. \nSurgical Treatment of the Maxillary Sinus: \nHistory\nIn the early 1970s, Tatum began to augment the posterior maxilla \nwith autogenous rib bone to produce adequate vertical bone for \nimplant support.91,92 He found that onlay grafts below the exist-\ning alveolar crest would decrease the posterior intradental height \nsignificantly, yet very little bone for endosteal implants would be \ngained. Therefore in 1974 Tatum developed a modified Caldwell-\nLuc procedure for sinus augmentation (SA) grafting. The crest of \nthe maxilla was infractured to elevate the maxillary sinus mem-\nbrane. Autogenous bone was then added in the area previously \noccupied by the inferior third of the sinus. Endosteal implants \nwere inserted in this grafted bone after approximately 6 months. \nImplants were then loaded with final prostheses after an additional \n6 months.\nIn 1975 Tatum developed a lateral-approach surgical technique \nto elevate the sinus membrane and place implants simultaneously. \nThe implant system used was a one-piece ceramic implant, and \na permucosal post was required during the healing period. Early \nceramic implants were not designed adequately for this procedure, \nand results with the technique were unpredictable. In 1981 Tatum \ndeveloped a submerged titanium implant for use in the posterior \nmaxilla and achieved predictable results.\nFrom 1974 to 1979, the primary graft material for sinus \ngrafts was autologous bone. In 1980 Tatum55,93 further \nexpanded the application of the SA augmentation technique \nwith a lateral maxillary approach and the use of synthetic bone. \nThe same year, Boyne and James first reported on the sinus \ngraft technique using autogenous bone for SA grafts.60 Most of \nthe publications in the 1980s were anecdotal or based on very \nsmall sample sizes. \nTreatment Classifications for the Posterior \nMaxilla\nIn 1984, Misch61 organized a treatment approach to the posterior \nmaxilla based on the amount of bone below the antrum, and in \n1986 he expanded the treatment approach to include the available \nbone width that was related to implant design. In 1987 Misch \nincluded the technique of the sinus floor elevation through the \nimplant osteotomy before implant placement.62 He reported on \n170 sinus graft cases, with two complications and an uneventful \nresolution.\nIn the Misch SA classification, the treatment modality is \ndependent on the available bone height between the floor of the \nantrum and the crest of the residual ridge in the region of the \nideal implant locations. The SA protocol also suggested a surgi-\ncal approach, bone graft material, and a time table for healing \nbefore prosthetic reconstruction. In 1995 Misch94 modified his \n1987 classifications to include the lateral dimension of the sinus \ncavity; this dimension was used to modify the healing period pro-\ntocol because smaller width sinuses (0–10 mm) form bone faster \nthan larger width (>15 mm) sinuses. The Division A–width ridge \nwas also increased to 6 mm to permit more bone to encompass \nthe implant on each side. In 2017 Resnik modified the Misch \nclassification to include alternative treatment options with short \nimplants, crestal grafting approaches, and treatment plan modi-\nfications based on force-related factors, which are detailed in Box \n37.6 (Figs. 37.25–37.28)."
  },
  {
    "page": 121,
    "content": "1011\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nSurgical Technique\nSubantral Option One: Conventional Implant \nPlacement\nThe first Misch SA treatment option, SA-1, occurs when suffi-\ncient bone height is available to permit the placement of endosteal \nimplants following the usual surgical protocol, with no maxillary \nsinus involvement. Because the quality of bone in the posterior max-\nilla often is D3 or D4 bone, bone compaction or osseodensification \nto prepare the implant site is common. This technique permits a \nmore rigid initial insertion of the implant and also increases the BIC.\nRequired Bone Dimensions\nIn the abundant bone volume (Division A),the minimum ideal \nbone height for the SA-1 is related to the associated force fac-\ntors. Under favorable conditions, a minimum of 8 mm of bone \nis required from the crest of the ridge to the inferior floor of \nthe sinus for the placement of an 8-mm implant. The literature \nhas concluded that short implants (8 mm) have been shown \nto be successful in the posterior maxilla. If multiple implants \nare placed, then ideally the implants should be splinted for \nforce distribution. For unfavorable conditions, greater than \n10 mm of bone is required in height to allow for placement \nof an implant so it does not invade the maxillary sinus. This \nwill allow an implant of 10 mm in length to be placed that \nwill allow for a greater insertion torque and BIC. Therefore the \nimplant will be less likely to have force-related effects that may \ncause micromovement during the healing phase and poorer \nhealing (Fig. 37.29).\nBecause the maxillary sinus proper is not invaded during an \nSA-1 approach, it is less critical if preexisting pathology in the \nsinus is present. However, if pathology is present that warrants \nmedical referral, then this should be completed before any implant \nplacement. Therefore in general the sinus pathologic contraindi-\ncations for sinus graft surgery do not apply for implant insertion \nwhen adequate bone is present below the sinus for implants of \nadequate size to support the load of the prosthesis. Although a \ncommon axiom in implant dentistry is to remain 2 mm or more \nfrom an opposing landmark, this is not necessary in the SA region.\nNarrower bone volume patients (Division B) in SA-1 may \nbe treated with osteoplasty or augmentation to increase the \nwidth of bone. The insertion of smaller surface area implants (as \nsmall-diameter root-form implants) are not suggested because \nthe forces are greater in the posterior regions of the mouth, and \nthe bone density is less than in most regions. In addition, the \nnarrow ridge is often more medial than the central fossa of the \nmandibular teeth and will result in an offset load on the res-\ntoration, which will increase the strain to the bone. However, \nmultiple narrow diameter implants may be placed to support \none tooth (i.e., two narrow diameter implants to support one \nmolar).\nOsteoplasty in the SA-1 posterior maxilla may change the SA \ncategory if the height of the remaining bone is sufficient to allow \nfor adequate bone postosteoplasty. Augmentation for width may \nbe accomplished with bone spreading, membrane grafting, or \nautogenous grafts. Larger diameter implants are often required in \nthe molar region, and bone spreading to place wider implants is \nthe most common approach when the bone density is poor. If \nless than 2.5 mm of width is available in the posterior edentu-\nlous region (C–w), then the most predictable treatment option is \nto increase width using onlay autogenous bone grafts. After graft \nmaturation the area is reevaluated to determine the proper treat-\nment plan classification.\nEndosteal implants in the SA-1 category are left to heal in a \nnonfunctional environment for approximately 4 to 8 months \n(depending on bone density and force factors) before the abut-\nment post(s) are added for prosthodontic reconstruction. Care \nis taken to ensure that the implants are not traumatized during \nthe initial healing period. Progressive loading during the pros-\nthetic phases of the treatment is suggested in D3 or D4 bone \n(Box 37.7). \nFavorable Conditions\n• \u0007Good quality of bone (D2/D3 bone) with the presence of cortical bone \npresent\n• \u0007Minimal occlusal force factors\n• No parafunction\n• Ideal crown/implant ratio \nUnfavorable Conditions\n• Poor quality of bone (D3/D4 bone) with no cortical bone present\n• Increased occlusal force factors\n• Parafunctional forces present\n• Poor crown/implant ratio\n\t• BOX 37.6\t    \u0007Force-Related Factors\nB\nA\n• Fig. 37.25  Bone quality. (A) Thick cortical bone and a dense cancellous bone, which is consistent with a \nD2 type of bone, (B) No cortical bone present, with very fine trabecular bone, which is usually consistent \nwith D4 bone and mainly found in the posterior maxilla."
  },
  {
    "page": 122,
    "content": "1012\nPART VII    Soft and Hard Tissue Rehabilitation\nSubantral Option Two: Sinus Lift and \nSimultaneous Implant Placement\nThe second SA option in the Misch SA classification, SA-2, is \nselected when the intended implant length is 1 to 2 mm greater \nthan the vertical bone present (Fig. 37.30). In this technique, 1 \nto 2 mm may be achieved via elevating the sinus membrane with-\nout bone grafting. Tatum95 originally developed this technique \nin 1970, and Misch96 first published it in 1987. Summers97 \npublished a similar procedure in 1994, 24 years after Tatum’s \nfirst presentation.\nBecause the SA-2 surgical approach modifies the floor of the \nmaxillary sinus, a preexisting pathologic condition of the sinus \nshould not be present because it may affect the implant site by \nretrograde infection.\nThis technique is reserved for 8 to 10 mm of host bone below \nthe sinus in which an implant is placed via an osteotome tech-\nnique that elevates the membrane approximately 1 to 2 mm with \nthe use of no grafting. Ideally, an 8-mm implant is used with cau-\ntion in these cases.\nRationale\nIn some situations, a longer implant may be required for pros-\nthetic support and initial fixation. Worth and Stoneman98 have \nreported a comparable phenomenon of bone growth under an \nelevated sinus membrane called a “halo formation”. They observed \nthe natural elevation of the sinus membrane around teeth with \nperiapical disease. The elevation of the membrane resulted in new \nbone formation once the tooth infection was eliminated. In an \narticle by Palma and colleagues99 the elevation of the sinus mem-\nbrane in implant insertion, with or without a graft material below \nthe mucosa, gave similar results in primates regarding implant \nstability or BIC after healing. As a result of the autologous bone \npresent above the apical portion of the implant with an SA-2 tech-\nnique, and the sinus floor fracture (which increases the regional \naccelerated phenomenon of bone repair and formation), new \nbone formation over the implant apex is predictable. \nIncision and Reflection\nIn an edentulous posterior maxilla, a full-thickness incision is made \non the crest of the edentulous ridge from the tuberosity to the distal \nof the canine region. A vertical, lateral relief incision is made at its \ndistal and anterior extension of the crestal incision for approximately \n5 mm. If minimal attached tissue exists on the crest of the ridge, \nwhich is more often observed in the premolar region, then the pri-\nmary incision is made more palatal to place more keratinized tissue \non the facial aspect. When teeth are present in the region, the crestal \nincision extends at least one tooth beyond the edentulous site. If one \ntooth is missing, the reflection is similar to a single-tooth replace-\nment option, and even a direct (flapless technique) may be used.\nA full-thickness palatal flap is first reflected because the palatal \ndense cortical plate facilitates soft tissue reflection. Special atten-\ntion is given to avoid the pathway of the greater palatine artery or \nto remain completely subperiosteal so that this structure remains \n• Fig. 37.26  Force factors. The posterior maxilla is very susceptible to \nforce-related issues because of strong muscles such as the temporalis \n(green) and masseter (red).\n• Fig. 37.27  Parafunction. Forces are significantly increased in patients \nwho exhibit parafunction. In this radiograph, the prominent antegonial \nnotch is consistent with parafunctional forces and masseter hypertrophy.\nA\nB\n• Fig. 37.28  Crown/implant ratio. The maxillary posterior region often is confronted with a an increased \ninterocclusal space because of the vertical and horizontal bone resorption. (A) Three-dimensional image \nshowing the apical positioning of implants caused by vertical bone resorption. (B) Cone beam computer-\nized tomography interactive treatment planning evaluating the increased crown height space."
  },
  {
    "page": 123,
    "content": "1013\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nwithin the soft tissue. The labial mucosa is reflected off the eden-\ntulous ridge, rather than elevating the tissue from the bone. The \ncrest should not be used to leverage the tissue because the ridge may \nhave minimal cortical bone and a perforation may result. This could \nresult in damage to the residual ridge or possibly even penetrate the \nsinus or nasal cavity. Once the tissue is reflected, the width of the \navailable bone is evaluated to ensure that it is greater than 6-7 mm \nwide and allows the placement of Division A root-form implants. \nOsteotomy and Sinus Elevation (SA-2)\nThe endosteal implant osteotomy is prepared as determined by the \ndensity of bone protocol, which is usually D3 or D4 bone. The \ndepth of the osteotomy is approximately 1 to 2 mm short of the \nfloor of the antrum. When in doubt of the height dimension, the \nosteotomy should err on a shorter length. The implant osteotomy \nis prepared to the appropriate final diameter, short of the antral \nfloor, by approximately 1 mm.\nA flat-end or cupped-shape osteotome is selected for the infrac-\nture of the sinus floor. Usually in D3 bone, an osteotome of the \nsame diameter as the final osteotomy is selected. In D4 bone, an \nosteotomy one to two sizes smaller than the final implant size maybe \nused, performing an osseodensification technique. The osteotome is \ninserted and tapped firmly in 0.5- to 1.0-mm increments beyond \nthe osteotomy until reaching its final vertical position, up to 2 \nmm beyond the prepared implant osteotomy. A slow elevation of \nthe sinus floor is less likely to tear the sinus mucosa. This surgical \napproach compresses the bone below the antrum, causes a green-\nstick-type fracture in the antral floor, and slowly elevates the unpre-\npared bone and sinus membrane over the broad-based osteotome. If \nthe osteotome cannot proceed to the desired osteotomy depth after \ntapping, then it is removed and the osteotomy is prepared again \nwith rotary drills an additional 1 mm in depth. The osteotome is \nthen reinserted to attempt the greenstick fracture of the antral floor.\nCare should be exercised when removing the osteotomes \nfrom the osteotomy site. The osteotome should never be luxated \nbecause this will increase the width of the final osteotomy, leading \nto less insertion torque. Once the osteotome prepares the implant \nsite, the implant may then be threaded into the osteotomy and \nextended up to 2 mm above the floor of the sinus. The implant \nis slowly threaded into position so the membrane is less likely to \ntear as it is elevated. The apical portion of the implant engages \nthe more dense bone on the cortical floor, ideally with bone over \nthe apex, and an intact sinus membrane. The implant may extend \n0 to 2 mm beyond the sinus floor, and the 1 mm of compressed \nbone covering over the implant apex results in as much as a 3-mm \nelevation of the sinus mucosa (Fig. 37.31). Ideally, the implant \ndesign should include a convex apex with no apical openings as \nthis design will be less likely to cause a membrane perforation. \nModified SA2 Techniques\nRosen and associates100,101 developed a modification to the SA-2 \ntreatment approach for use at the time of an extraction of a maxil-\nlary molar. The technique is indicated when the maxillary molar is \nextracted, the surrounding walls of bone are intact, and no periapi-\ncal pathologic condition is present. The crest of the ridge to the \nantral floor should be 7 mm or more in height. Once the tooth is \nextracted and the surrounding bony walls confirmed, a modifica-\ntion of the SA-2 technique is in order. A 5- to 6-mm trephine bur \nis used in the center of the extraction site and prepares the bone 1 \nto 2 mm below the antral floor. A 5- to 6-mm-diameter, flat-ended \nor cup-shaped osteotome and mallet intrudes the core of bone 2 \nmm above the sinus floor, creating 9 mm or more of vertical bone. \nA socket graft may be used within the extraction socket but is not \npushed into the surgical space of the sinus because it may perforate \nthe sinus mucosa. After 4 months, an implant may be inserted.\nSome authors have used the SA-2 sinus lift procedure to gain \nmore than 2 mm of implant vertical height. However, these \nblind surgical techniques increase the risk of sinus membrane \nperforation.\nThe success of the intact sinus membrane lift cannot be con-\nfirmed before or at the time of implant placement. Attempts to \n“feel” the elevation of the membrane from within an 8-mm-deep \nimplant osteotomy may cause tearing of the sinus lining.\nAttempting to elevate the sinus mucosa more than 2 mm \nthrough an implant osteotomy 3 to 4 mm wide and 8 mm deep \nis not predictable. Reiser and colleagues102 reported that when \nthe sinus elevation was 4 to 8 mm in cadavers, almost 25% \nresulted in sinus perforation. The implant osteotomy sinus floor \nB\nA\n• Fig. 37.29  SA-1 (A and B) Treatment plan which includes implant placement below the maxillary sinus proper.\n• \u0007Favorable conditions: >8 mm host bone (implant approximately 8 mm \nin length or greater)\n• \u0007Unfavorable conditions: >10 mm host bone (implant approximately 10 \nmm in length or greater)\n\t • BOX 37.7\t     \u0007SA-1 Requirements"
  },
  {
    "page": 124,
    "content": "1014\nPART VII    Soft and Hard Tissue Rehabilitation\ntechnique is often attempted because of the perceived ease of \nsurgery of an SA-2 technique versus a lateral-wall or transcrestal \napproach. \nComplications\nIf a sinus membrane perforation occurred during the initial \nimplant placement procedure, then bone height growth is less \nlikely to occur. This is the primary reason why only 0 to 2 mm \nof additional bone height is attempted with this technique. How-\never, even when membrane perforation occurs and/or no bone \ngrows around the apical end of the implant, the SA-2 technique \nis of benefit because the apical end of the implant is surrounded \nby denser bone. This enhances rigid fixation during healing and \nincreases BIC, leading to improved loading conditions. If inad-\nequate bone is formed around the apical portion of an implant, \nthen a progressive-loading protocol for D4 bone is suggested dur-\ning prosthetic reconstruction (Box 37.8). \nSubantral Option Three: Sinus Graft with \nImmediate Endosteal Implant Placement\nThe third approach to the maxillary posterior edentulous region, \nSA-3, is indicated when at least 5 mm of vertical bone and suf-\nficient width are present between the antral floor and the crest of \nthe residual ridge in the area of the intended prosthesis abutment \n(Fig. 37.32).\nA residual height of 5 mm for the SA-3 category has been \nselected for two main reasons: (1) this height (in adequate bone \nB\nA\n• Fig. 37.31  (A) SA-3 crestal. Treatment plan that includes implant insertion with bone grafting via the \ncrestal (osteotomy) approach gaining approximately 3 to 4 mm of height. (B) Lateral wall. Treatment plan \nthat includes implant insertion with bone grafting via the lateral-wall approach gaining more than 4 mm of \nheight (i.e., amount of height is determined by size of lateral wall).\n• Favorable conditions: (>8 mm host bone, ideally 10-mm implant)\n• Unfavorable conditions: (>10 mm host bone, ideally 12-mm implant)\n\t • BOX 37.8\t    \u0007 SA-2 Requirements\nA\nB\n• Fig. 37.30  SA-2. (A) Radiograph depicting an SA-2 (maxillary second premolar) and SA-1 (maxillary first \nmolar). (B) SA-2 implant that includes implant insertion with penetration into the maxillary sinus proper 1 \nto 2 mm without bone grafting."
  },
  {
    "page": 125,
    "content": "1015\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nwidth and quality) can be considered sufficient to allow primary \nstability of implants placed at the same time as the sinus graft pro-\ncedure, and (2) because of the amount of residual bone (5mm), \ngreater blood supply is present, which allows for more predictable \nand faster healing.\nAnesthesia\nInfiltration anesthesia has been used with success for sinus graft \nsurgeries in the past; however, more profound regional anesthesia \nis achieved by blocking the secondary division of the maxillary \nnerve (V2). The sinus graft surgery often requires the reflection \nof the soft tissue extending to the zygomatic process. In addition, \nseveral branches of the maxillary division of the fifth cranial nerve \ninnervate the sinus mucosa. As such, a V2 block is advantageous \nfor patient comfort, and this achieves anesthesia of the hemimax-\nilla, side of the nose, cheek, lip, and sinus area.\nTwo options exist for V2 block anesthesia: (1) high and within \nthe pterygomaxillary tissue behind the posterior wall of the max-\nilla or (2) at the depth of approximately 1 inch with a long-gauge \nneedle within the greater palatine foramen (Fig. 37.33). The first \nmethod is easier to perform but may injure the pterygoid plexus \nor the maxillary artery and result in hematoma, or it may fail to \nreach the proper landmark. With the second option, it is more \ndifficult to locate the foramen and negotiate up the canal. It \nmay also injure the greater palatine artery or nerve. Too deep an \nadministration with a greater palatine approach may result in the \npenetration of the orbit floor. Possible sequelae include periorbital \nswelling and proptosis, diplopia, retrobulbar block with dilated \npupil, corneal anesthesia, motionless eye, retrobulbar hemorrhage, \nand optic nerve block with transient loss of vision. However, the \nsuccess rate is greater, and the clinical risks appear minimal. There-\nfore most often, the first attempt for block anesthesia is within the \ngreater palatine foramen; if unsuccessful, then the high posterior \napproach is used. Prevention of these complications is ensured by \nreduction of the needle depth measurement for smaller patients \nand the strict application of the technique. Proper angulation \nduring soft tissue penetration prevents possible entrance into the \nnasal cavity through the medial wall of the pterygopalatal fossa.\nInfiltration anesthesia is first administered to the posterior \nand middle alveolar nerve and greater palatine nerve. Scrubbing, \ngowning, and draping of the patient is next. Then after the infil-\ntration is effective, the V2 block is administered. A long-acting \nanesthetic such as bupivacaine 0.5% (Marcaine) is preferred. \nBlock anesthesia with these agents is longer acting than infiltra-\ntion in the maxilla.103\nThe greater palatine foramen is found using an open-bore \ninstrument (i.e., the handle of a mouth mirror with the mirror \nportion removed). Pressure is applied with this instrument along \nthe palatal tissue, at the union of the residual ridge and hard pal-\nate, in the region of the second molar. Most often, the open-bore \nhandle will feel and recede into the foramen. Slight pressure for \na few seconds then marks the tissue over the opening of the fora-\nmen. A long, 1.5 inch needle is introduced into the foramen \nfrom the opposite side of the mouth and negotiates the canal for \napproximately 1 inch. \nSurgical Approaches\nThere exist two options for grafting the sinus along with simulta-\nneous implant placement.\nA\nB\n• Fig. 37.33  Anesthesia, V2 block. (A) Greater palatine foramen approach through the greater palatine \nforamen located 1 cm medial and adjacent to the second molar teeth. (B) Cotton swab may be pressed at \nthe junction of the hard palate and the maxillary alveolar process until it falls into the foramen depression. \nThe needle is advanced perpendicular until bone is contacted slowly at an angle of 45 degrees to the long \naxis of the hard palate.\n• Fig. 37.32  SA-4. Treatment plan that includes bone grafting via the \nlateral-wall approach with no implant placement. Implant placement is \ndelayed according to the healing of the sinus graft sites."
  },
  {
    "page": 126,
    "content": "1016\nPART VII    Soft and Hard Tissue Rehabilitation\nLateral Wall. A Tatum lateral maxillary wall approach is per-\nformed by performing an osteotomy over the lateral wall of the \nmaxillary sinus, infracturing the window, elevating the sinus \nmembrane and window, grafting to the medial wall, and then \nplacing the implant (SA-3).\nIncision and Reflection. A crestal incision is made on the pal-\natal aspect of the maxillary posterior edentulous ridge from the \ntuberosity to one tooth anterior to the anterior wall of the maxil-\nlary sinus, leaving at least 2 mm of attached tissue on the facial \naspect of the incision. Because ridge resorption occurs toward the \nmidline at the expense of the buccal dimension, the incision is \nmade with awareness of the greater palatal artery, which proceeds \nclose to the crest of the ridge in the severely atrophic maxilla. If \nbleeding from the palatal flap occurs, then a hemostat may be used \nto constrict the blood vessels distal to the bleeding, pressure may \nbe applied over the greater palatine foramen with a blunt instru-\nment, or electrocoagulation at the bleeding site may be used.\nA vertical relief incision is made on the distal of the incision to \nenhance surgical access to the maxillary tuberosity. A broad-base \nanterior vertical relief incision is also made at least 10 mm anterior \nto the anterior vertical wall of the sinus. This may result in the \nincision being made over the distal aspect of the first bicuspid or \ncanine. The facial soft tissue flap is designed, following general \nprinciples, with a base wider than the crest to ensure proper blood \nsupply. The palatal portion of the flap is first reflected, followed by \nthe facial crestal tissue, which is reflected off the crest.\nThe facial full-thickness mucoperiosteal flap is reflected to \nexpose the complete lateral wall of the maxilla and a portion of \nthe zygoma. The facial flap should be reflected to provide com-\nplete vision and access to the maxillary lateral wall. The superior \naspect of the flap should never approach the infraorbital fora-\nmen because aggressive reflection of the facial flap may cause a \nneuropraxia type of nerve impairment and damage to this nerve \nstructure. The reflected labial tissue can be sutured to the cheek \nmucosa, carefully avoiding the parotid duct. All fibrous and soft \ntissue should be removed from the lateral-wall access site to avoid \nsoft tissue contamination of the bone graft. Entrapping soft tissue \nwithin the sinus may lead to formation of a secondary mucocele \nor surgical ciliated cyst. A moist 4 x 4 gauze or a 2-4 molt with a \nscraping motion easily removes this tissue (Fig. 37.34). \nAccess Window. The overall design of the lateral-access window \nis determined after the review of the CBCT scan, which helps \ndetermine the thickness of the lateral wall of the antrum, the posi-\ntion of the antral floor from the crest of the ridge, the posterior \nof the anterior wall in relationship to the teeth (if present), the \npresence of septa on the floor and/or walls of the sinus, and any \nassociated pathology within the maxillary sinus.\nThe outline of the Tatum lateral-access window is scored on the \nbone with a rotary handpiece under copious cooled sterile saline. It \nis often easier to perform this step at 50,000 rpm (1:1 handpiece), \nbut it is possible even at 2000 rpm, depending on the lateral-wall \nbone thickness. There exist multiple techniques to score the sinus \nwindow: (1) carbide bur (No. 6 or No. 8), (2) diamond bur, (3) \nbone removal burs (e.g., Dask bur), or (4) Piezosurgery units. With \nexperience, the first bur is usually a No. 8 round carbide, which \nscratches the bone and designs the overall window dimension. This \nbur is followed with a No. 8 round diamond, which “polishes” away \nthe bone within the groove made by the carbide bur. A No. 8 round \ndiamond bur for the entire process is of benefit for an early learning \ncurve because carbide burs “chatter” more and may tear the sinus \nmembrane if the bur inadvertently comes in contact with it.\nThe inferior score line of the rectangular access window on the \nlateral maxilla is placed approximately 1 to 2 mm above the level \nof the antral floor (i.e., which in an SA-3 is >5 mm from the crest). \nIf the inferior score line is made at or below the level of the antral \nfloor, then infracture of the lateral wall will be impossible because \nthe score line will be over host bone. If the inferior score line is \nmade too high (>4 mm) above the sinus floor, then a ledge above \nthe sinus floor will result in a blind dissection of the membrane on \nthe floor, which may also lead to perforation.\nThe most superior aspect of the lateral-access window should \nbe approximately 2-3 mm above the planned implant length (i.e., \n12-mm implant would require the window to be 15 mm from the \nridge crest). A soft tissue retractor placed above the superior mar-\ngin of the lateral-access window (i.e., always maintained on bone, \nnot soft tissue) helps retract the facial flap and prevents the retrac-\ntor’s inadvertent slip into the access window, which may damage \nthe underlying membrane of the sinus.\nThe anterior vertical line of the access window is scored \napproximately 1 to 2 mm from the anterior sinus border. The \nA\nB\n• Fig. 37.34  Incision/reflection. Full-thickness reflection is necessary to expose the lateral wall. (A) For a \nsingle-tooth sinus augmentation, usually the incision extends one tooth on each side of the edentulous \nsite. (B) For a large SA4 edentulous area, the anterior incision must extend 5-10 mm anterior to the anterior \nwall (approximately distal of cuspid) and posteriorly to the tuberosity."
  },
  {
    "page": 127,
    "content": "1017\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\ndistal vertical line should be made approximately 5 mm distal to \nthe most posterior planned implant site (i.e., this will allow for \nadequate space if the implant position is changed more distally). \nIf the patient is fully edentulous, the distal vertical line should be \nmade approximately 5 mm distal to the first molar position. If the \nsinus access window outline is difficult to determine in relation \nto the sinus cavity, then it should err over the antrum rather than \nover the bone around this structure.\nIn general, a larger access window offers many advantages, includ-\ning easier access, less stress on the membrane during initial elevation, \nand ease of additional membrane elevation with instruments because \nof the direct access that facilitates graft placement. The corners of the \naccess window should always be rounded, not right or acute angles. \nIf the corner angles are too sharp, then membrane perforation may \noccur from the use of a surgical curette at the corner or during the \ninfracture of the lateral wall. Once the lateral-access window is delin-\neated, the rotary bur continues to scratch the outline with a paint-\nbrush stroke approach under cooled sterile saline irrigation, until a \nbluish hue is observed below the bur or hemorrhage from the site \nis observed. The expansion of the maxillary sinus after tooth loss \npushes the arteries of the membrane to the outside of the structure \nand just below the surrounding bone. Therefore either the bluish hue \nof the membrane or bleeding in the area are signs of approaching the \nsinus membrane. This observation should be achieved circumferen-\ntially around the access window. The access window should not be \noverprepared in depth because direct contact with the membrane \nwith rotary burs may cause a perforation (Fig. 37.35).\nComplications\nEndosseous Anastomosis. It should be noted that the largest blood \nvessel in the lateral wall is from an endosseous anastomosis from \nthe posterior superior alveolar and the infraorbital artery. How-\never, when the lateral wall is very thin in the edentulous patient, \nthe anastomosis will atrophy and become nonexistent. The anas-\ntomosis has been shown to be located approximately 15 to 20 mm \nfrom the alveolar crest.\nThe horizontal lines of the access window should ideally not be \npositioned directly over this structure. The vertical lines of the access \nwindow often cut through the artery. Because the blood supply may \nbe from either direction, both vertical access lines may have bleeding. \nThis is rarely a concern for vision or blood loss during the procedure. \nIf intraosseous bleeding is a problem, then the high-speed diamond \nused to score the window may be used without irrigation and polish \nthe bleeding site, which cauterizes the vessel from the heat on the \nbony wall. Electrocautery may also be used on this vessel, if neces-\nsary. A hemostat maybe used; however, care should be exercised to \navoid fracturing the lateral wall and/or perforating the sinus mucosa. \nElevating the head and a surgical sponge applied to the site for a few \nminutes also aides in the control of hemorrhage. \nSinus Membrane Elevation. The first step in elevating the win-\ndow is to ensure that the lateral window is completely “free” from \nthe host bone. A flat-ended metal punch (or mirror handle) and \nmallet may be used to gently infracture the lateral-access window \nfrom the surrounding bone while still attached to the thin sinus \nmembrane. The flat-ended punch is first positioned in the center \nof the window. If light tapping does not greenstick fracture the \nbone, then the flat-ended punch is placed along the periphery of \nthe access window and tapped again. If the window does not sepa-\nrate easily, then the punch is rotated so that only an edge comes \nin contact with the scored line. This decreases the surface area of \nthe punch against the score line of the window and increases the \nA\nD\nE\nB\nC\n• Fig. 37.35  Window preparation. (A) Window osteotomy should be made just through the cortical bone. \n(B) Initially, an outline form should be completed with a round carbide (No. 8), (C) Final preparation should \nbe completed through the cortical bone with a round diamond (No. 8). (D and E) Osteotomy is complete \nwhen the window is free 360°."
  },
  {
    "page": 128,
    "content": "1018\nPART VII    Soft and Hard Tissue Rehabilitation\nstress against the bone. Another light tap with the mallet will most \nlikely cause greenstick fracture of the bone along the scored line. \nIf this still does not free the window, then further scoring of the \nbone with the handpiece and diamond bur is indicated, and the \ntapping procedure is repeated.\nA short-bladed soft tissue curette designed with two right-angle \nbends is introduced along the margin of the window (i.e., Sal-\nvin Sinus Curette No. 1). The curved portion is placed against \nthe window, whereas the sharp edge is placed between the sinus \nmembrane and the margin of the inner wall of the antrum for \na depth of 2 to 4  mm. The curette should always stay on the \nbone and be used in a scraping motion. If any sharp edges of bone \nremain on the bone’s margin, then they may be flicked off with \nthe curette. The curette is slid along the bone margin 360 degrees \naround the access window. This ensures the release of the mem-\nbrane from the surrounding walls of the sinus without tearing \nfrom the sharp bony access margins. The sinus membrane may \nbe elevated from the antral walls easily because it has few elastic \nfibers and is not attached to the cortical wall. Specially designed \nand shaped curettes are available to facilitate this surgical maneu-\nver. A larger curved periosteal or sinus membrane elevator is then \nintroduced through the lateral-access window along the inferior \nborder (i.e., Salvin Sinus Curette No. 2). Once again, the curved \nportion is placed against the window, and the sharp margin of the \ncurette is dragged along the floor of the antrum while elevating \nthe sinus membrane. The curette should always be maintained on \nthe bony floor to avoid a membrane perforation. The curette is \nnever blindly placed into the access window. The implant clinician \nshould see and/or feel the curette against the antral floor or sinus \nwalls at all times. Once the mucosa on the antral floor is elevated, \nthe lateral, distal, and medial wall of the sinus is addressed. The \ncurette is pushed against the bone that easily reflects the mem-\nbrane. The sinus membrane is inspected for perforations or open-\nings into the antrum proper.\nIt is easier to gain direct vision and access to the distal por-\ntions of the antrum than the anterior portions when the sinus area \nexpands beyond the access window. Therefore whenever the peri-\nosteal elevator or curette cannot stay against the bone with good \naccess in the anterior area, the access window should be increased \nin size toward the anterior. A Kerrison rongeur or a second win-\ndow similar to the initial score-and-fracture technique may be \nused to expand the size of the access window.\nThe periosteal elevators and curettes further reflect the membrane \noff the anterior vertical wall, floor, and medial vertical wall. It is bet-\nter to err on the high side to ensure that ideal implant height may \nbe placed without compromise (i.e., always maintaining a patent \nostium). The lateral-access window is positioned as part of the supe-\nrior wall of the graft site, once in final position. The SA space has the \noriginal sinus floor as the base; the posterior antral wall, medial antral \nwall, and anterior antral wall as its sides; and the lateral-access window \nand elevated sinus mucosa as its superior wall (Figs. 37.36 and 37.37). \nSinus Graft: Layered Approach. \nTop Layer: Collagen and Antibiotic. A resorbable collagen \nmembrane (Oratape) soaked with a parental form of antibiotic \n(Ancef 0.2 mL) is then prepared (Box 37.9). The collagen and \nantibiotic are placed onto the elevated antral floor region and \nattach to the sinus mucosa on the superior part of the graft site. \nThe collagen is a carrier for the antibiotic to decrease the risk of \npostoperative infection. In addition, in case of membrane tearing \nor separation of the sinus mucosa (with or without the awareness \nof the clinician), the collagen membrane seals the opening (Fig. \n37.38). It is imperative that a portion of the membrane be left \nA\nC\nD\nB\n• Fig. 37.36  Sinus membrane reflection. (A) Membrane reflection starts on the floor, (B) is extended to the \nanterior wall, (C) extended to the posterior, (D) and then to the superior. Curette should always be main-\ntained on the bone to prevent perforation."
  },
  {
    "page": 129,
    "content": "1019\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\noutside of the sinus, preventing “intrusion” of the entire mem-\nbrane into the sinus during bone placement.\nSecond Layer: Sinus Graft Materials. The second layer of \nthe sinus graft layered approach is the most abundant and con-\nsists of the allograft bone grafting material. Many materials have \nbeen proposed in single or combination mixes, including min-\neralized and demineralized freeze-dried bone,104,105 β-tricalcium \nphosphate (β-TCP),106 xenograft hydroxyapatite (HA) (bovine \nanorganic bone), and calcium carbonates (bioactive glass).107 In \naddition, more recent research has focused on combining “tradi-\ntional” bone substitutes with bone growth factors.108 Each graft \nmaterial used in the sinus graft technique presents a similar, yet \ndistinct, biological approach to the healing process.\nWhat Type of Graft Material? Autogenous bone for years has been \nconsidered the gold standard of grafting material. Tatum first de-\nveloped and reported the use of autogenous bone for sinus grafts \nin the 1970s, and Boyne109,110 and James first published the in-\nformation in 1980. In primates (Macaca fascicularis), Misch111,112 \nfound the use of iliac crest or tail bone in sinus grafts produced \nbone slightly denser than typical in the region, as evidenced from \nhistology sections harvested at the reentry procedure. Similar find-\nings have been observed during case series studies, with patients \nundergoing sinus grafts with autologous bone from the iliac crest \nor intraoral donor sites.113\nIt is interesting to note that sinus grafts in the literature that \nhave used 100% autogenous bone have lower success rates than \nsinus grafts with synthetic substitutes (e.g., Del Fabbro and col-\nleagues114 reported 87.70% versus 95.98%).115 Many additional \nstudies have concluded that 100% autogenous bone results in less \nbone formation that a composite type of graft. Hallman and col-\nleagues showed that sinuses grafted with 100% xenograft com-\npared with 100% autogenous exhibited greater healing and higher \nimplant survival rates.116 Froum and colleagues reported that if \n20% autogenous bone was added to other bone substitutes, a \ngreater mean vital bone formation was found.117\nDemineralized freeze-dried bone (DFDB) has been shown \nto be osteoinductive, which is capable of inducing undifferenti-\nated mesenchymal cells to form osteoblasts. The mechanism for \nthis process appears to relate to the bone morphogenic protein \n(BMP) found primarily in cortical bone. In animal and human \nstudies, DFDB allograft (DFDBA) powder used alone in sinus \ngrafts did not provide satisfactory results. Bone was present but \nnot in sufficient volume as the graft material originally placed. \nSpeculation exists that the material resorbs more rapidly than \nthe bone formation process, resulting in less bone formation. \nIn addition, studies have shown that DFDB, when placed into \nan area of low-oxygen tension (hypoxic or hypocellular tissue), \nresults in fibrous or cartilage tissue rather than bone.118 Other \nauthors have observed similar conclusions on the poor perfor-\nmance of DFDB used alone in animal and human studies.119At \nthe Sinus Graft Consensus Conference,14 high success rates were \nreported for all materials and combinations, with the exception \nof DFDB when used alone.\nMineralized freeze-dried bone allografts (FDBAs) are an allo-\ngenic bone that does not undergo the demineralization process. \nFDBA has the same BMP content in its organic matrix; however, \nit does not have the same osteoinductive capability as DFDBA. \nFDBA has been shown to be a better scaffold (osteoconduction) \nthan DFDBA, which allows for superior space maintenance.120 \nEventually, osteoclasts breakdown the mineral content of FDBA \nuntil demineralization occurs, inducing new bone formation and \na prolonged protein release.\nCammack and colleagues examined mineralized and deminer-\nalized freeze dried allograft used in sinus augmentation procedures \nand found no statistical significance between the two bone sub-\nstitutes. A histomorphometric study by Froum and colleagues121 \nat 26 to 32 weeks after grafting evaluated mineralized cancel-\nlous bone allograft (MCBA) and anorganic bovine bone material \n(ABBM) for sinus augmentation. Bilateral sinus grafts, one filled \nwith MCBA and the other with ABBM, were compared. The aver-\nage vital bone content of the MCBA was 28.25%, compared with \nthe ABBM of only 12.44%. Therefore mineralized corticocancel-\nlous bone of approximately 250 to 1000 μm is advantageous for \nA\nB\n• Fig. 37.37  Window elevation. (A and B) The window should not be “intruded” but elevated. When com-\nplete, the lateral wall will be at 90 degrees and the medial bone exposed (green arrow).\n1. Top layer (superior)\na. Collagen membrane\nb. Local antibiotic (Ancef)\n2. Middle layer (intermediate)\na. 70% mineralized freeze-dried bone allograft\nb. 30% demineralized freeze-dried bone allograft\nc. Platelet-rich fibrin from 10 mL of whole blood\nd. Antibiotic (Ancef 500 mg/mL)\n3. Bottom layer (inferior)\na. Autogenous bone, tuberosity*\n*Dependent on the amount of host bone present\n\t• BOX 37.9\t    \u0007Sinus Graft Layered Technique"
  },
  {
    "page": 130,
    "content": "1020\nPART VII    Soft and Hard Tissue Rehabilitation\nbone graft material because it fulfills space maintenance require-\nments and allows for cell migration.122\nAllograft bone material is available in three particle forms: \ncortical, cancellous, and corticocancellous. Cortical allografts are \nassociated with an increased density and greater space maintenance \nproperties, which allow for slower resorption. Cancellous chips are \nadvantageous because they allow for osteoconductive scaffolding \nand deposition of osteoblasts while being faster resorbing. Ideally, \nthe use of corticocancellous bone is advantageous because it allows \nfor both the benefits of cancellous and cortical bone to be used in \nthe grafting process.\nThe ideal particle size of the allograft material is very important \nin the bone regeneration process because too small (<125 μm) \nparticle size leads to fast resorption, with an inconsistent bone \nformation. A larger particle size (>1000 μm) restricts resorption \nand may be sequestered or result in delayed healing. Studies have \nshown an ideal particle size for predictable bone regeneration to be \napproximately 250 to 1000 μm.123\nIn addition to the mineralized bone, bone graft factors in the \nform of platelet-rich fibrin may be used. Whole blood is drawn \n(approximately 10 ml) from the patient and placed into a cen-\ntrifuge for 10 to 15 minutes at 3000 rpm. The blood is sepa-\nrated by the centrifuge into three layers: (1) red blood cells, (2) \nplatelet-rich fibrin (PRF), and (3) platelet-poor plasma (PPM). \nThe PRF layer contains many growth factors that are involved in \nthe cascade of bone mineralization.124 The PRF is added to the \nbone substitutes, along with a local antibiotic to be added into \nthe sinus proper. A parenteral form of antibiotic is used rather \nthan a tablet form because oral antibiotic drugs often have fillers \nin the product that are not osteoconductive. The most common \nantibiotic is Ancef 500 mg/mL, and 0.8 mL of solution is added \nto the graft (Fig. 37.39). \nA\nB\n• Fig. 37.39  Middle layer. The middle layer consists of allograft (i.e., 70% mineralized, 30% demineralized) \nplus antibiotic. (A) Allograft syringed into the sinus proper. (B) Packing of the sinus with a packer.\nB\nA\n• Fig. 37.38  Top layer. (A and B) Fast-resorbing collagen (e.g., Collatape) is used with antibiotic as the top \nlayer. The collagen membrane should be positioned to the medial wall and with a small segment exposed \noutside the superior aspect of the window. A longer acting collagen may be used if a known membrane \nperforation is present."
  },
  {
    "page": 131,
    "content": "1021\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nSummary: 2nd Layer. The second layer of the lateral-wall sinus \ngraft will consist of the following:\n 1.  a. 70% mineralized FDBA, 30% demineralized DFDBA\nOR\n \nb. Mineralized FDBA: (Corticocancellous)\n \n• Particle Size  = 250–100 μm\n \n• Approximately 250–1000 μm\n 2. PRF\n 3. Local antibiotic (Ancef)\nThese materials are mixed in a surgical bowl and filled into a bone \ngrafting syringe or 1 cc hypodermic syringe. When placing the graft \nmaterial, insert the syringe into the sinus proper in approximation to \nthe medial wall and material is extruded as the syringe is removed. \nThe grafting material should be deposited in an anterior and inferior \ndirection. This will ensure material raises the lateral window instead of \nintrusion toward the medial wall. Intrusion will lead to lack of bone \nformation near the medial wall and may affect implant placement \nand post-sinus mucociliary function. By extruding the material in the \nanterior direction, bone graft material will be placed into the anterior \nsegment of the sinus incorporating graft material in contact with the \nanterior wall and increasing blood supply for healing. The material \nshould be condensed with a serrated packer, and packing pressure \nshould be firm but not excessive. Inadequate pressure will result in air-\nspaces, which may predispose the graft to future infection. Excessive \ncondensation may lead to perforation of the membrane and extrusion \nof material into the sinus proper.\nBottom Layer \nRegional Acceleratory Phenomenon. The third or bottom layer will \nconsist of multiple steps to enhance bone growth. First, especially \nif little bleeding is present from the sinus floor and the anterior \nwall, a sharp instrument (e.g., scaler, curette) is used to scratch \nthe bone. This trauma will initiate the regional acceleratory phe-\nnomenon (RAP), which introduces more growth factors into the \nsite and starts the angiogenesis process. The blood vessels allow \nmigration of osteoclasts and osteoblasts that resorb and replace the \ngraft with live, viable bone. In addition, the blood vessels provide \nblood supply to the autologous bone portion of the graft, which \nis required for initial osteogenesis. The medial wall should not be \nscratched because it is very thin and perforation may occur. \nAutogenous Bone. The second part of the third layer is the use \nof autogenous bone. Osteogenic material is capable of producing \nbone, even in the absence of local undifferentiated mesenchymal \ncells. Autogenous bone predictably exhibits this activity in the si-\nnus graft. Misch has performed reentry of more than 1500 sinus \ngrafts (at implant placement) accompanied by more than 50 hu-\nman histologic sections and 18 primate sinus grafts and histology. \nA consistent histologic and clinical finding is that bone grows into \nthe augmentation region from the surrounding walls of the max-\nillary antrum in which the sinus membrane was elevated.125 In \nother words, the bone growth came from the surrounding walls \nof bone, similar to an extraction socket. The last regions to form \nbone are usually the center of the lateral-access window and the \nregion under the elevated sinus membrane. In fact, no new bone \nat time intervals up to 12 months was found to grow immediately \nunder the sinus membrane.\nThe most common harvest site for the lateral-wall approach is \nthe maxillary tuberosity on the same side of the patient that the \nsinus is being augmented. In this way, an additional surgical site \nis not required, which decreases morbidity to the patient. Addi-\ntional sources of bone to be added to the graft site may be any bone \nfragments from implant osteotomy sites, bone cores over the roots \nof anterior teeth, sinus exostoses, and cores from the mandibular \nsymphysis or ramus region. The autogenous bone is placed on the \noriginal bony floor in the area most indicated for implant insertion. \nA blood supply from the host bone can be established earlier to this \ngrafted bone and maintains the viability of the transplanted bone \ncells and the osteogenic potential of the transplanted bone growth \nfactors. Autogenous bone represents an important component of the \nsinus graft, and is of more importance in an SA-4 approach com-\npared with an SA-3, which has more host bone present (Fig. 37.40).\nThe harvest of the tuberosity bone is initiated with the expo-\nsure of the tuberosity bone; however, care should be exercised to \nnot extend the incision to the hamular notch area because this \nmay result in potential bleeding episodes. Once there is full-thick-\nness reflection of the tuberosity bone, double-action rongeurs may \nremove small pieces of the mainly cancellous bone. The tuberos-\nity bone is usually soft and therefore is compressed to form more \ncells per volume. Usually, rotary burs or bone chisels are not \nrecommended because this reduces the amount of bone grafted \nand increases the possibility of perforation into the sinus proper. \nAdditional autogenous bone may be harvested intraorally or extra-\norally, as indicated on a case-by-case basis (Fig. 37.41).\nThe autogenous bone is then placed on the floor by making \nsmall spaces with a curette within the allograft material. Ideally, \na space should be made to the medial wall because it is advanta-\ngeous for autograft chips to be placed in approximation to the \nmedial wall. After placement of the autogenous bone, the grafted \narea is veneered with the allograft material to fill any voids that \nare present. \nImplant Insertion. A review of the literature by Del Fabbro \nand colleages126 notes success rates of implants placed at the same \ntime as the graft have a survival rate of 92.17%, whereas a delayed \nimplant insertion has a survival rate of 92.93%. The 5 to 10 mm \nof initial bone height in an SA-3 posterior maxilla, the cortical \nbone on the residual crest, and the cortical-like bone on the origi-\nnal antral floor may stabilize an implant that is inserted at the \ntime of the graft and permit its rigid fixation. Therefore when the \nconditions are ideal for the SA-3 sinus graft, the implant may be \ninserted at the same appointment. When inserting implants into \nan SA-3 sinus graft, the sinus should always be completely filled \nprior to implant placement. Attempting to graft after implant \ninsertion is very difficult and will lead to voids. When preparing \nthe osteotomy into the grafted sinus, a finger rest should be main-\ntained so that control of the handpiece is maintained upon perfo-\nration into the sinus. Care should be exercised to not extend the \nosteotomy into the grafted material. This will result in dispersion \nof the graft material. Penetration though the inferior floor should \nonly be approximately 1 mm, as there will be no resistance from \nthe graft material when placing the implant. In most cases, the \nosteotomy will be underprepared to allow for osseodensification \n(D4 bone). Implant placement is more accurate when inserted \nwith a handpiece (Figs. 37.42 and 37.44).\nThe advantage of the SA-3 technique is the decreased treat-\nment time because the implant and sinus graft are completed at \nthe same time. In addition, there exist several disadvantages of \nimmediate implant placement compared with delaying implant \nplacement (i.e., SA-4 approach):\n 1. \u0007The individual rate of healing of the graft may be assessed dur-\ning the healing period, while the implant osteotomy is being \nprepared and the implant inserted. The healing time for the \nimplant is no longer arbitrary, but it is more patient specific.\n\t2.\t \u0007Under ideal conditions, postoperative sinus graft infections occur \nin approximately 3% to 5% of patients, which is greater than \nthe percentage for implant placement surgery or intraoral onlay"
  },
  {
    "page": 132,
    "content": "B\nA\n• Fig. 37.41  Bottom layer. The bottom layer consists of any autogenous bone obtained because the \nimportance of autogenous bone is inversely proportional to the amount of host bone present. (A) harvested \nbone placed into window. (B) Final bone packing of autogenous bone.\nA\nB\nC\n• Fig. 37.42  SA-3 implant placement. (A) After lateral-wall sinus grafting, the osteotomy is completed, usu-\nally after the initial surgical drill, osteotomes are used to widen the osteotomy. (B) Implant placement into \ngraft material. (C) Final veneer grafting over implant site.\nA\nB\nC\n• Fig. 37.40  Autogenous bone harvest. (A) Usually because of access, the maxillary tuberosity is the most \nideal location for autogenous harvest. (B) Harvest can be completed with a double-action rongeur. (C) Usu-\nally large autogenous pieces may be obtained without penetration into the maxillary sinus."
  },
  {
    "page": 133,
    "content": "1023\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nbone grafts. If the sinus graft becomes infected with an implant \nin place, then a bacterial smear layer may develop on the implant \nand make future bone contact with the implant less predictable. \nThe infection is also more difficult to treat when the implants \nare in place and may result in greater resorption of the graft as a \nconsequence. If the infection cannot be adequately treated, then \nthe graft and implant must be removed. Therefore a decreased \nrisk of losing the graft and implant exists if a postoperative infec-\ntion occurs with a delayed implant insertion. Some reports in the \nliterature indicate a slightly higher failure rate of implants when \ninserted simultaneously compared with a delayed approach.\n\t3.\t \u0007Blood vessels within the graft are required to form and remodel \nbone. An implant in the middle of the sinus graft does not provide \na source of blood vessels. It may even impair the vascular supply.\n 4. \u0007Bone width augmentation may be indicated in conjunction \nwith sinus grafts to restore proper maxillomandibular ridge \nrelationships and/or increase the implant diameter in the molar \nregion. Augmentation may be performed simultaneously with \nthe sinus graft. As a result, larger diameter implants may be \nplaced with the delayed technique.\n 5. \u0007The bone in the sinus graft is denser with the delayed implant \nplacement. As such, implant angulation and position may be \nimproved because it is not dictated by existing anatomic limita-\ntions at the time of the sinus graft.\n 6. \u0007The clinician may access the sinus graft before implant inser-\ntion. On occasion, the sinus graft underfills a region, and the \nlack of awareness of the condition during implant insertion at \nthe same time results in an implant placed in the sinus proper, \nrather than the graft site.\n\t7.\t \u0007On reentry to a sinus graft, it is not unusual to observe a crater-\nlike formation in the center of the lateral-access window, with \nsoft tissue invagination. If the implant is already in place, then \nit may be difficult to remove the soft tissue and assess its pre-\ncise extent. When soft tissue is present at a delayed implant \ninsertion, the region is curetted and replaced with a bone graft \nbefore implant placement. The healing time for the implant is \nrelated to the developing bone assessed at the delayed surgery, \nnot an arbitrary period that may be, on occasion, too brief. \nMembranes. After implant placement, a thin layer of graft mate-\nrial may be veneered over teh lateral access opening. A resorbable \nmembrane (e.g., Collatape) is then placed over the lateral-access \nwindow (Fig. 37.43). A membrane will delay the invasion of fibrous \ntissue into the graft and will enhance the repair of the lateral bony \nwall. A nonresorbable membrane should not be used because reen-\ntry would be required and the possibility of postoperative sinus \ninfection will increase. A bacterial smear layer may accumulate in \nthe nonresorbable material and contribute to the infection process. \nRarely will a resorbable membrane become infected.\nA\nB\n• Fig. 37.43  Membrane. (A) Collagen membrane positioning over the lateral window (i.e., may use platelet-\nrich fibrin over collagen). (B) Final suturing of surgical site.\nA\nB\n• Fig. 37.44  SA-3 lateral wall. (A) The sinus should always be grafted before implant placement (B) because \ngrafting is difficult to complete after implant is placed (i.e., cannot graft on medial aspect of implant)."
  },
  {
    "page": 134,
    "content": "1024\nPART VII    Soft and Hard Tissue Rehabilitation\nPRF may be used as a double membrane by placement over \nthe lateral collagen membrane to increase the amount of growth \nfactors for bone formation and to increase the growth factors \nfor tissue healing. If inadequate PRF is available because it was \nused in the second layer of the graft, then PPP may be used \nbecause platelets are present but in lower quantities. Froum \nand colleagues127 evaluated sinus grafts with barrier mem-\nbranes over the lateral-access wall compared with no barrier \nmembrane. All sinus graft combinations in the study demon-\nstrated higher vital bone percentage on the cores when a bar-\nrier membrane was used. Misch observed a higher vital bone \npercentage even when collagen was used over the lateral-access \nsite compared with no collagen. Tarnow and colleagues com-\npleted a split-mouth design study with bilateral sinus grafts, \nwith or without covering the lateral window with a membrane. \nHistologic samples revealed a higher percentage of bone with a \nmembrane (25.5%) compared with no membrane (19.9%).128 \nSoft Tissue Closure. The soft tissues and periosteum should be \nreapproximated for primary closure without tension, with care \nto eliminate graft particles in the incision line. Because of the \naccess window grafting, along with the double layer membrane, \nit is often necessary to stretch the tissue to allow for tension-free \nclosure. Therefore the facial flap must often be expanded, which \nusually can be completed by periosteal release incisions. A tissue \npickup holds the facial flap to the height of the mucogingival tis-\nsues junction. The flap is then elevated, and a No. 15 blade is \nused to incise the tissue 1 mm deep through the periosteum above \nthe mucoperiosteum. Tissue scissors are then introduced into the \nincision parallel to the facial flap at a depth of 3 to 5 mm. A \nblunt dissection under the flap releases the periosteum and muscle \nattachments to the base of the facial flap. The flap may then be \nadvanced over the graft site to the palatal tissues.\nIt should be noted that horizontal vascular anastomoses are \nlocated lateral to the maxilla, within the soft tissue (extraosse-\nous anastomosis), and approximately 20 mm above the crest of \nthe ridge. A blunt dissection does not violate these vessels. No \ntension should exist on the facial flap with primary closure of \nthe site. Interrupted horizontal mattress or a continuous suture \n(3-0 polyglycolic acid [PGA]) may be placed. Suturing is more \ncritical with this procedure than with many other implant place-\nments. Incision line opening may contribute to infection, con-\ntamination, or loss of graft materials. The borders and flange of \nan overlaying soft tissue–borne denture or partial denture are \naggressively relieved to eliminate pressure against the lateral wall \nof the maxilla.\nCrestal Approach. The second option for an SA-3 sinus \naugmentation and implant placement is the use of the crestal \napproach. This approach has become more popular for reducing \ncomplications from lateral-wall sinus augmentation procedures. \nThe crestal approach sinus augmentation uses an osteotome to \nbreak through the floor and then graft below the sinus membrane. \nThe following are the five steps used in the procedure:\n   \nStep 1: A conventional full-thickness flap with crestal incision is \ncompleted to gain access to the bony ridge. A pilot drill is used \nto perform the initial osteotomy 1 to 2 mm short of the sinus \nfloor. The exact measurement of the available bone is com-\npleted via CBCT images. Incrementally larger surgical drills or \nosteotomes should be used to widen the osteotomy, at least one \ndrill short of the final implant width.\nStep 2: A small diameter osteotome is inserted into the prepared \nsite to compress the sinus floor using a surgical mallet. A slight \n“give” will occur when the bone is breached. A periapical radio-\ngraph may be taken to verify positioning. Incremental wider \nosteotomes are inserted to expand and to obtain vertical expan-\nsion of the bone height to accommodate the implant diameter.\nStep 3: After the last osteotome is used, bone graft material is slow-\nly introduced into the osteotomy site. First, a PRF coagulant \nmaybe placed into the osteotomy site. This will allow for en-\nhanced soft tissue healing via penetration through the collagen \nmembrane to increase bone growth. Second, collagen is tapped \ninto position to elevate the membrane. A small piece of collagen \n(i.e., approximately 1½ larger than the osteotomy hole) is placed \ninto the osteotomy site, with the last osteotome. The collagen \nwill act as a buffer between the bone graft material and the sinus \nmembrane. The collagen is less likely to perforate the membrane.\nStep 4: The graft material is slowly introduced into the sinus oste-\notomy with a bone graft spoon or an amalgam carrier. The si-\nnus floor is then elevated by repeated increments of bone graft \nmaterial and placed into position with an osteotome.\nStep 5: Once the osteotomy is widened and sinus membrane is \nelevated to the desired height, the implant may be inserted.\n   \nThis SA-3 crestal technique has the advantage of surgical sim-\nplicity, which decreases possible surgical morbidity. The main \ndisadvantage of this technique is the unknown perforation of the \nsinus membrane. Ideally, the sinus membrane integrity should be \nmaintained during the procedure. The limitations of this technique \ninclude elevating the membrane approximately 3 to 4 mm. If greater \nheight is required, the lateral-wall approach may be used (Figs. 37.45 \nand 37.46; Box 37.10). \nSubantral Option Four: Sinus Graft Healing and \nExtended Delay of Implant Insertion\nIn the fourth option for implant treatment of the posterior max-\nilla, SA-4, the SA region for future endosteal implant insertion is \nfirst augmented, then after sufficient healing, implant placement is \ncompleted. This option is indicated when less than 5 mm remains \nbetween the residual crest of bone and the floor of the maxillary \nsinus (Fig. 37.47). In addition, if an SA-3 approach is warranted \nbecause only 5 mm of bone is present, but pathology is present, it is \noften advantageous to complete an SA-4 technique. The SA-4 cor-\nresponds to a larger antrum and minimal host bone on the lateral, \nanterior, and distal regions of the graft because the antrum gener-\nally has expanded more aggressively into these regions. The inad-\nequate vertical bone in these conditions decreases the predictable \nplacement of an implant at the same time as the sinus graft, and \nless recipient bone exists to act as a vascular bed for the graft. In \naddition, in most cases, less autologous bone exists in the tuberosity \nfor harvesting, and fewer septa or webs will exist in the sinus (and \ntypically exhibit longer mediodistal and wider lateromedial dimen-\nsions). Therefore the fewer bony walls, less favorable vascular bed, \nminimal local autologous bone, and larger graft volume all mandate \na longer healing period and slightly altered surgical approach.\nThe Tatum lateral-wall approach for sinus graft is performed as \nin the previous SA-3 procedure without the implant insertion (Fig. \n37.48). Most SA-4 regions provide better surgical access than their \nSA-3 counterparts because the antrum floor is closer to the crest, \ncompared with the SA-3 posterior maxilla. However, in Division \nD maxillae, it is usually necessary to expose the lateral maxilla and \nthe zygomatic arch. The access window in the severely atrophic \nmaxilla may even be designed in the zygomatic arch. In general, \nthe medial wall of the sinus membrane is elevated approximately"
  },
  {
    "page": 135,
    "content": "1025\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\n12 mm from the crest so that adequate height is available for future \nendosteal implant placement. The combination of graft materi-\nals used and their placement are identical to the SA-3 technique \nlateral-wall approach. However, because less autogenous bone is \noften harvested from the tuberosity, an additional harvest site may \nbe required, most often above the roots of the maxillary premolars \nor from the mandible (i.e., ascending ramus).\nThe width of the host site for most edentulous posterior maxillae \nis Division A. However, when Division C–w to D exists, a mem-\nbrane or onlay graft for width is indicated. When the graft cannot \nbe secured to the host bone, it is often better to perform the sinus \ngraft 6 to 9 months prior to the autogenous graft for width. After \nthe graft maturation, the implants may be inserted (Box 37.11).\nVascular Healing of Graft\nHealing of the sinus graft takes place by several vascular routes, \nincluding the endosseous vascular anastomosis and the vasculature \nof the sinus membrane from the sphenopalatine artery. In mildly \nresorbed ridges, the host bone receives its blood supply from both \ncentromedullary and mucoperiosteal vessels. However, as age \nand the resorption process increases, the bone gradually becomes \ntotally dependent on the mucoperiosteum for the blood supply. \nThe periphery of the graft is mainly supplied by vessels of the sinus \nmembrane and by intraosseous vascular bundles. The central por-\ntions of the graft receive blood from collateral branches of the \nendosseous anastomosis. The extraosseous vascular anastomosis \nmay enter the graft from the lateral-access window.\nMany local variables are related to sinus graft maturation, \nincluding healing time, the volume of the SA graft, the distance \nfrom the lateral to medial wall (small, average, or large), and the \namount of autologous bone in the multilayered approach, all of \nwhich relate to the speed and amount of new bone formation.\nThe time of evaluation of the sinus graft is perhaps the great-\nest variable of all. Froum and colleagues129,130 evaluated a sinus \ngraft from the same patient at 4 months, 6 months, 12 months, \nand 20 months. The amount of new bone continuously increased, \ncompared with the amount of graft material in the antrum. In \naddition, the additional time allowed the graft to mature into a \nload bearing type of bone. In summary, the more time that elapsed \nfrom sinus graft to implant loading, the more vital bone was avail-\nable to support the occlusal load.\nThe type of bone graft material used in the sinus graft may affect \nthe rate of bone formation. Bone formation is fastest and most com-\nplete within the first 4 to 6 months with autogenous bone, followed \nby the combination of autogenous bone, porous HA, and DFDB \n(6–10 months); alloplasts only (i.e., TCP) may take 24 months to \nA\nB\nC\nD\nE\nPRF\nCollagen\nPRF\nCollagen\nBone graft\nPRF\nCollagen\nBone graft\n• Fig. 37.45  Crestal approach. (A) Step 1: Initial osteotomy short of sinus floor. (B) Osteotome used to widen \nosteotomy. (C) Platelet-rich fibrin and collagen membrane placement. (D) Allograft material placement.  \n(E) implant placement."
  },
  {
    "page": 136,
    "content": "1026\nPART VII    Soft and Hard Tissue Rehabilitation\nform bone. The time required before implant insertion for SA-4 or \nimplant uncovery is dependent on the volume of the sinus graft. \nMost healed sinus augmentations (i.e., especially SA-4) will be the \nD4 type of bone; therefore osseodensification surgical approach and \nprogressive bone loading techniques should be strictly followed. \nPostoperative Instructions\nThe postoperative instructions are similar to those for most oral \nsurgical procedures. Rest, ice, pressure, and elevation of the head \nare particularly important. Strict adherence to the pharmaco-\nlogic protocol as mentioned previously is vital to decrease postop \nmorbidity is of major importance. Although smoking is not an \nabsolute contraindication for sinus grafting, smoking during the \nhealing period may negatively affect the healing and increase the \npossibility of postoperative infections.\nBlowing the nose and/or creating negative pressure while \nsucking through a straw or cigarettes should also be eliminated \nfor the 2 weeks after surgery. Block and Kent131 reported on a \npatient who lost the entire sinus graft 2 days after surgery from \nA\nB\nC\nD\nE\nF\nG\nH\nI\n• Fig. 37.46  Crestal approach. (A) Initial osteotomy completed via fully guided template 1 mm short of the \nsinus floor, (B) Sequential osteotomes are used to infracture sinus floor, (C) Placement of PRF plug, (D) \nCollagen membrane placed over osteotomy site, (E) Osteotome used to elevate collagen membrane, (F) \nBone allograft placed into osteotomy site in increments, (G) Osteotomes elevate graft material, (H) Implant \nplacement, (I) Final implant with graft material.\n• Favorable conditions: (>5 mm host bone, Implant size < 4mm greater \nthan host bone)\n• Unfavorable conditions: (>8 mm host bone, Implant size < 4mm \ngreater than host bone)\n\t• BOX 37.10\t    \u0007SA-3 (Crestal Approach) Requirements"
  },
  {
    "page": 137,
    "content": "1027\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nblowing the nose. Sneezing, if it occurs, should be done with the \nmouth open to relieve pressure within the sinus. Swelling of the \nregion is common, but pain is usually less severe than after ante-\nrior implants in an edentulous mandible. In addition, the patient \nshould be warned against lifting and pulling on the lip to observe \nthe surgical site or during oral hygiene procedures to reduce the \nrisk of incision line opening. The patient should be notified that \nsmall bone particles or synthetic bone found in the mouth or \nexpelled from the nose with bleeding is not unusual (Box 37.12). \nImplant Insertion\nThe implant surgery at reentry after successful sinus grafts is simi-\nlar to SA-1, with a few exceptions. The periosteal flap on the lat-\neral side is elevated to directly allow inspection of the previous \naccess window of the sinus graft. The previous access window may \nappear completely healed with bone, soft and filled with loose \ngraft material, or with cone-shaped fibrous tissue in-growth (with \nthe base of the cone toward the lateral wall).\nA\nD\nE\nF\nB\nC\n• Fig. 37.47  SA-4. (A) Membrane elevation starting on the floor of the sinus. (B and C) Membrane is \nreflected to the medial wall. (D) First layer (superior) is collagen with antibiotic. (E) Second layer (middle) \nallograft bone. (F) Third layer (floor), which is comprised of autogenous bone.\nB\nA\n• Fig. 37.48  SA-4. Bone placement (A) placement with a 1-cc syringe. (B) Bone packer is used until “push-\nback” is obtained.\n• Favorable or unfavorable conditions: <5 mm host bone\n\t• BOX 37.11\t    \u0007SA-4 Requirements"
  },
  {
    "page": 138,
    "content": "1028\nPART VII    Soft and Hard Tissue Rehabilitation\nIf the graft site on the lateral-access wall appears clinically as bone, \nthen the implant osteotomy and placement follow the approach des-\nignated by the bone density. If soft tissue has proliferated into the \naccess window from the lateral-tissue region, then it is curetted and \nremoved. The region is again packed to a firm consistency with autol-\nogous bone from the previously augmented tuberosity and mineral-\nized freeze-dried bone. The implant osteotomy may then be prepared \nand the implant placed a the D4 bone protocol. Additional time (6 \nmonths or more) is allowed until the stage II implant uncovery is \nperformed and progressive bone loading is used during prosthetic \nreconstruction. The time interval for stage II uncovery and prosthetic \nprocedures after implant insertion of a sinus graft is dependent on \nthe density of bone at the reentry of implant placement. The crest of \nthe ridge and the original antral floor may be the only cortical bone \nin the region for implant fixation. The most common bone density \nobserved for a sinus graft reentry is D3 or D4. Most often, mineral-\nized bone graft (or xenograft) material in the sinus graft has not con-\nverted to bone. The tactile sense and the CBCT evaluation interpret \nthe mineralized graft material as a denser bone type; therefore a tactile \nor radiographic D3 bone may actually be D4-like bone. It is prudent \nto wait longer (rather than shorter) for implant uncovery. An SA-4 \nsinus graft has a recommended healing time at least 4 to 6 months for \nimplant insertion and another 4 to 8 months for implant uncovery. \nTherefore the overall graft maturity time is 4 to 10 months for SA-3, \nand SA-4 healing time is 8 to 14 months before prosthetic reconstruc-\ntion. Progressive loading after uncovery is most important when the \nbone is particularly soft and less dense. Inadequate bone formation \nafter the sinus graft healing period of SA-4 surgery is a possible, but \nuncommon, complication. \nIntraoperative Complications Related to \nSinus Graft Surgery\nMembrane Perforations\nThe most common complication during sinus graft surgery is tear-\ning or creation of an opening in the sinus membrane (Box 37.13). \nThis has several causes, which include a preexisting perforation, \ntearing during scoring of the lateral window, existing or previous \npathologic condition, and elevation of the membrane from the \nbony walls. According to studies, membrane perforations occur \nabout 10% to 34% of the time. It has been reported with a higher \nfrequency in smokers. If membrane perforation occurs more often \nthan this, then the clinician should give consideration to alter or \nreevaluate the surgical technique used in sinus grafting.\nSinus membrane perforation usually does not affect the sinus \ngraft. However, in a report of the Sinus Consensus Conference, \nanalysis of failed sinus grafts found 48% (79 of 164 failures) were \nattributed to sinus membrane perforations.130 In an endoscopic \nevaluation after sinus grafts, macrolaceration of the sinus mem-\nbrane resulted in a typical sinusitis appearance, even when clini-\ncal conditions of infection were not present.132 Once the tear or \nperforation is identified, the continuation of the sinus elevation \nprocedure is modified. The sinus membrane should be elevated \noff the bony walls of the antrum, despite the mucosal tear. If a \nportion of the membrane is not elevated away from a sinus wall, \nthen the graft material will be placed on top of the membrane, \npreventing the bone graft from incorporating with the bony wall.\nThe perforation of the sinus membrane should be sealed to pre-\nvent contamination of the graft from the mucus and contents of \nthe sinus proper and to prevent the graft material from extruding \ninto the sinus proper. When graft materials enter the sinus proper, \nthey may become sources for infection or may migrate and close \noff the ostium to the nasal cavity and create an environment for \nan infection.\nNumerous studies have shown a very low probability of sinus \ninfections after perforations in the sinus membrane. Jensen and \ncolleagues133 reported that graft maturation occurred and no sinus \ninfections were observed despite a 35% incidence of sinus perfora-\ntion during the procedure in 98 patients.\nThe surgical correction of a small perforation is initiated by \nelevating the sinus mucosal regions distal from the opening. Once \nthe tissues are elevated away from the opening, the membrane ele-\nvation with a sinus curette should approach the tear from all sides \nso that the torn region may be elevated without increasing the \nopening size. The antral membrane elevation technique decreases \nthe overall size of the antrum, thus “folding” the membrane over \non itself and resulting in closure of the perforation. A piece of \nresorbable collagen membrane (e.g., Collatape) is placed over the \nopening to ensure continuity of the sinus mucosa before the sinus \nbone graft is placed. The collagen will stick to the membrane and \nseal the SA space from the sinus proper.\nIf the sinus membrane tear is larger than 6 mm and cannot be \nclosed off with the circumelevation approach, then a resorbable \ncollagen membrane with a longer resorption cycle (e.g., Renovix, \nBioMend), may be used to seal the opening.\nThe remaining sinus mucosa is first elevated as described pre-\nviously. A piece of collagen matrix is cut to cover the sinus tear \nopening and overlap the margins more than 5 mm. It should be \nnoted that when a sinus tear occurs, it is sealed with a dry col-\nlagen membrane so that it may be rotated into the lateral-access \nopening, gently lifted to the mucosal tissue around the opening, \nand allowed to stick to the mucosa. Once the opening is sealed, \nthe sinus graft procedure may be completed in routine fashion. \nHowever, care should be taken when packing the sinus with graft \nmaterial. After a perforation, the graft is easily pushed through \nthe collagen-sealed opening and into the sinus proper. The graft \nmaterial is then gently inserted and pushed toward the sinus floor \nand sides but not toward the top of the graft. A sinus perforation \nmay cause an increased risk of short-term complications. A greater \nbacterial penetration risk exists into the graft material through \n1. Do not blow your nose.\n2. Do not smoke or use smokeless tobacco.\n3. Do not take in liquids through a straw.\n4. Do not lift or pull on lip to look at sutures (stitches).\n5. \u0007If you must sneeze, then do so with your mouth open to avoid any \nunnecessary pressure on the sinus area.\n6. Take your medication as directed.\n7. \u0007You may be aware of small granules in your mouth for 2 to 3 days after \nsurgery.\n8. \u0007Bleeding from the nostril may be present for the first 24 hours after surgery.\n\t• BOX 37.12\t    \u0007Sinus Graft Postoperative Instructions\n• Small (<2 mm) fast-resorbing collagen (e.g., Collatape, Oratape)\n• Medium (2–4 mm) regular collagen (e.g., OraMem)\n• Large (>4 mm) longer acting collagen (e.g., Renovix, OraMem Extend)\n\t• BOX 37.13\t    \u0007Membrane Perforations"
  },
  {
    "page": 139,
    "content": "1029\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nthe torn membrane. In addition, mucus may invade the graft and \naffect the amount of bone formation. Graft material may leak \nthrough the tear into the sinus proper, migrate to and through \nthe ostium, and be eliminated through the nose or obstruct the \nostium and prevent the normal sinus drainage. Ostium obstruc-\ntion is also possible from swelling of the membrane related to the \nsurgery. These conditions increase the risk of infection. However, \ndespite these potential complications, the risk of the infection is \nlow (less than 5%); therefore the sinus graft surgery should con-\ntinue, and the patient should be monitored postoperatively for \nappropriate treatment (Figs. 37.49 and 37.50). \nAntral Septa\nAntral septa (i.e., also termed buttresses, webs, and struts) are \nthe most common osseous anatomic variants seen in the maxil-\nlary sinus. Underwood,134 an anatomist, first described maxillary \nsinus septa in 1910. He postulated that the cause of these bony \nprojections derived from three different periods of tooth develop-\nment and eruption. Krennmair and colleagues135 further classified \nthese structures into two groups: primary structures, which are a \nresult of the development of the maxilla, and secondary struc-\ntures, which arise from the pneumatization of the sinus floor after \ntooth loss.\nMisch136 postulated that septa might be bone reinforcement \npillars from parafunction when the teeth were present. He noticed \nthese structures occur more often in SA-3 sinuses and after a \nshorter history of tooth loss. Long-term edentulous sites and SA-4 \nsinuses have fewer septa. The prevalence of septa has been reported \nto be in the range of 33% of the maxillary sinuses in the den-\ntate patient and as high as 22% in the edentulous patient.137 The \nsepta may be complete or incomplete on the floor, depending on \nwhether they divide the bottom of the sinus into compartments. \nThe septa may also be incomplete from the lateral wall or, the \nmedial wall, or it should extend from the floor.\nThe shape of an incomplete maxillary sinus septum often \nresembles an inverted gothic arch that arises from the inferior or \nlateral walls of the sinus. In rare instances, they may divide the \nsinus into two compartments that radiate from the medial wall \ntoward the lateral wall.\nThe most common location of septa in the maxillary sinus has \nbeen reported to be in the middle (second bicuspid–first molar) \nregion of the sinus cavity. CBCT scan studies have shown that 41% \nof septa are seen in the middle region, followed by the posterior \nregion (35%) and the anterior region (24%). For diagnosis and \nevaluation of septa, CBCT scans are the most accurate method of \nradiographic evaluation.138 Panoramic radiography has been shown \nto be very inaccurate, with a high incidence of faulty diagnoses.\nSinus septa may create added difficulty at the time of surgery. \nMaxillary septa can prevent adequate access and visualization to \nthe sinus floor; therefore inadequate or incomplete sinus graft-\ning is possible. These dense projections complicate the surgery in \nseveral ways. After scoring the lateral-access window in the usual \nfashion, the lateral-access window may not greenstick fracture \nand rotate into its medial position. The strut reinforcement is also \nmore likely to tear the membrane during the releasing of the access \nwindow. The sinus membrane is often torn at the apex of the but-\ntress during sinus membrane manipulation because difficulty \nexists in elevating the membrane over the sharp edge of the web, \nand the curette easily tears the membrane at this position. How-\never, because septa are mainly composed of cortical bone, immedi-\nate implant placement may engage this dense bone, allowing for \nstrong intermediate fixation. Moreover, septa allow for faster bone \nformation because they act as an additional wall of bone for blood \nvessels to grow into the graft.\nManagement of Septa Based on Location\nThe use of CBCT radiographs before sinus graft surgery permits the \nsurgeon to observe and plan the necessary modifications to the sinus \ngraft procedure as a result of the septa. The modification to the sur-\ngery is variable depending on its location. The septa may be in the \nanterior, middle, or distal compartment of the antrum. When the \nseptum is found in the anterior section, the lateral-access window is \ndivided into sections: one in front of the septa and another distal to \n• Fig. 37.49  Maxillary sinus perforation from window outline osteotomy.\nA\nB\n• Fig. 37.50  Perforation repair. (A and B) Extended collagen membrane fixated on the superior aspect of \nthe sinus cavity."
  },
  {
    "page": 140,
    "content": "1030\nPART VII    Soft and Hard Tissue Rehabilitation\nthe structure. This permits the release of each section of the lateral \nwall after tapping with a blunt instrument. The elevation of each \nreleased section permits investigation into the exact location of the \nsepta and to continue the mucosal elevation.\nThe mucosal tissue may often be elevated from the lateral \nwalls above the septa. The curette may then slide down the side \nwalls and release the mucosa from the bottom half of the sep-\ntum on each side. The sinus curette should then approach the \ncrest of the buttress from both directions, up to its sharp apex. \nThis permits elevation of the tissue over the web region without \ntearing the membrane. When the strut is located in the middle \nregion of the sinus, it is more difficult to make two separate \naccess windows within the direct vision of the clinician. As a \nresult, one access window is made in front of the septa. The sinus \ncurette then proceeds up the anterior aspect of the web, toward \nits apex. The curette then slides toward the lateral wall and above \nthe septal apex. The curette may then slide over the crest of the \nseptum approximately 1 to 2 mm. A firm, pulling action frac-\ntures the apex of the septum. Repeated similar curette actions \ncan fracture the web off the floor. Once the septum is separated \noff the floor, the curette may proceed more distal along the floor \nand walls. When the septum is in the posterior compartment \nof the sinus, it is often distal to the last implant site. When this \noccurs, the posterior septum is treated as the posterior wall of \nthe sinus. The sinus membrane manipulation and sinus graft are \nplaced up against and anterior to the posterior septum (Figs. \n37.51–37.53). \nBleeding\nBleeding from the lateral-approach sinus elevation surgery is rare; \nhowever, it has the potential to be troublesome. Three main arte-\nrial vessels should be of concern with the lateral-approach sinus \naugmentation. Because of the intraosseous and extraosseous anas-\ntomoses that are formed by the infraorbital and posterior superior \nalveolar arteries, intraoperative bleeding complications of the lat-\neral wall may occur. The soft tissue vertical-release incisions of the \nfacial flap in a resorbed maxilla may sever the extraosseous anas-\ntomoses. The extraosseous anastomosis on average is located 23 \nmm from the crest of the dentate ridge; however, in the resorbed \nmaxilla, it may be within 10 mm of the crest. When this artery \nis severed, significant bleeding has been observed. These vessels \noriginate from the maxillary artery and have no bony landmark to \ncompress the vessel. Therefore vertical release incisions in the soft \ntissue should be kept to a minimum height with delicate reflec-\ntion of the periosteum. Hemostats are usually difficult to place \non the facial flap to arrest the bleeding. Significant pressure at the \nposterior border of the maxilla and elevation of the head to reduce \nthe blood pressure to the vessels usually stops this bleeding. The \nelevation of the head may reduce nasal mucosal blood flow by \n38%.139,140\nThe vertical component of the lateral-access wall for the sinus \ngraft often severs the intraosseous anastomoses of the posterior \nalveolar artery and infraorbital artery, which is on average approxi-\nmately 15 to 20 mm from the crest of a dentate ridge. Methods to \nlimit this bleeding, which is far less of a risk, have been addressed \nand include cauterization by the handpiece and diamond bur \nwithout water, electrocautery, or pressure on a surgical sponge \nwhile the head is elevated (Fig. 37.54).\nThe third artery of which the implant surgeon should be cau-\ntious is the posterior lateral nasal artery. This artery is a branch of \nthe sphenopalatine artery that is located within the medial wall of \nthe antrum. As it courses anteriorly, it anastomoses with terminal \nbranches of the facial artery and ethmoidal arteries. A significant \nbleeding complication may arise if this vessel is severed during \nelevation of the membrane off the thin medial wall.\nEpistaxis (active bleeding from the nose) is a common disorder; \nhowever, it has been reported that 6% of patients who experience \nthis in the general population require medical treatment to con-\ntrol and stop the hemorrhage because it lasts longer than 1 hour. \nTreatment options to treat epitasis include nasal packing, electro-\ncautery, and the use of vasoconstrictive drugs. Vessel ligation and/\nor endoscopic surgery are necessary on rare occasions.\nThe most common site (90%) of nasal bleeding is from a \nplexus of vessels at the anteroinferior aspect of the nasal septum \nand the anterior nasal cavity (which is anterior to the sinus cav-\nity and within the anterior projection of the nose). The posterior \nnasal cavity accounts for 5% to 10% of epitasis events and is \nin the region of the sinus graft. If the orbital wall of the sinus \nis perforated, or if an opening into the nares is already present \nfrom a previous event, then the sinus curette may enter the nares \nand cause bleeding. The arteries involved in this site are com-\nposed of branches of the sphenopalatine and descending pallia-\ntive arteries, which are branches of the internal maxillary artery. \nThe posterior half of the inferior turbinate has a venous network \ncalled the Woodruff plexus. Lavage of the nares with warm saline \nand oxymetazoline decongestant sprays provides excellent vaso-\nconstrictive activity to treat the condition. A cotton roll with \nsilver nitrate or lidocaine with 1:50,000 epinephrine may also \nbe effective.\nBleeding from the nose may also be observed after sinus graft \nsurgery. Placing a cotton roll, coated with petroleum jelly with \ndental floss tied to one end, within the nares may obtund nose \nbleeding after the surgery. After 5 minutes the dental floss is gently \npulled and removes the cotton roll. The head is also elevated, and \nice is applied to the bridge of the nose. If bleeding cannot be con-\ntrolled, then reentry into the graft site and endoscopic ligation by \nan ENT surgeon may be required (Figs. 37.55 and 37.56). \nShort-Term Postoperative Complications\nShort-term complications are defined as those that occur within \nthe first few months after surgery.\nIncision Line Opening\nIncision line opening is uncommon for this procedure because \nthe crestal incision is in attached gingiva and usually is at least \n5 mm away from the lateral-access window. Routinely, the soft \ntissue requires release before primary approximation and sutur-\ning. Because a collagen membrane is placed over the window, the \nsoft tissue will usually not approximate without tension unless the \nsurgeon expands the facial flap by releasing the periosteum above \nthe mucogingival junction (where the tissue becomes thicker). \nIncision line opening occurs more commonly when lateral-ridge \naugmentation is performed at the same time as sinus graft surgery, \nor when implants are placed above the residual crest and covered \nwith the soft tissue. It may also occur when a soft tissue–supported \nprosthesis compresses the surgical area during function before \nsuture removal.\nThe consequences of incision line opening are delayed healing, \nleaking of the graft into the oral cavity, and increased risk of infec-\ntion. However, if the incision line failure is not related to a lateral \nonlay graft and is only on the crest of the ridge and away from the"
  },
  {
    "page": 141,
    "content": "1031\nA\nB\nC\nD\nE\nF\nG\nH\nI\nJ\nK\nL\n• Fig. 37.51  Large septum in center of sinus. (a) Septum. (B) Window made anterior to septum. (C) Membrane \nis elevated off of floor. (D–G) Membrane is exposed anteriorly, posteriorly and to the medial wall. (H) Posterior \nwindow is outlined. (I–L) Membrane exposed on second window allowing for grafting around the septum."
  },
  {
    "page": 142,
    "content": "1032\nPART VII    Soft and Hard Tissue Rehabilitation\nsinus access window, then the posterior crestal area is allowed to \nheal by secondary intention. During this time, a soft tissue–borne \nprosthesis should be aggressively relieved, with no reline mate-\nrial in contact with the ridge. If incision line opening includes \na portion of a nonresorbable membrane (i.e., for lateral-ridge \naugmentation), then the membrane should be cleaned at least \ntwice daily with an oral rinses of chlorhexidine. \nNerve Impairment\nThe infraorbital nerve is of concern in sinus elevation surgery \nbecause of its anatomic position. This nerve enters the orbit via the \ninferior orbital fissure and continues anteriorly. It lies in a groove \nin the orbital floor (which is also the maxillary sinus superior wall) \nbefore exiting the infraorbital foramen. The infraorbital nerve \nexits the foramen approximately 6.1 to 7.2 mm from the orbital \nrim. Note that anatomic variants have been reported to include \ndehiscence and malpositioned infraorbital foramina, along with \nthe nerve transversing the lumen of the maxillary sinus rather \nthan coursing through the bone within the sinus ceiling (orbital \nfloor). Malpositioned nerves have been reported as far as 14 mm \nfrom the orbital rim in some individuals. In the severely atrophic \nmaxilla, the infraorbital neurovascular structures exiting the fora-\nmen may be close to the intraoral residual ridge and should be \navoided when performing sinus graft procedures to minimize pos-\nsible nerve impairment. This is of particular concern on soft tissue \nreflection and the bone preparation of the superior aspect of the \nwindow. Special considerations should be taken during reflection \nof the superior flap, and sharp-ended retractors should be avoided. \nUsually, those most at risk have a small cranial base (i.e., elderly \nfemales).\nComplication\nBecause the infraorbital nerve is responsible for sensory innerva-\ntions to the skin of the molar region between the inferior bor-\nder of the orbit and the upper lip, iatrogenic injury to this vital \nstructure can result in significant neurosensory deficits of this ana-\ntomic area. Most often the nerve is not severed, and a neuropraxia \nresults. Even though this injury is sensory and there is no motor \ndeficit, patients usually have a difficult time adapting to this neu-\nrosensory impairment (Fig. 37.57). \nManagement\nIf an infraorbital nerve impairment occurs, the implant clinician \nshould immediately follow the clinical and pharmacologic neuro-\nsensory impairment protocol. \nA\nB\n• Fig. 37.53  Septum in posterior part of sinus. (A) Maxillary septum found on the floor in the posterior of \nthe sinus. (B) An access window and curette elevates the mucosa anterior to the septum. The posterior \nsepta is used as a posterior wall to contain the graft material.\nA\nB\n• Fig. 37.52  Clinical image of septum. (A) Two windows bisecting the sep-\ntum. (B) Both windows reflected exposing the septum."
  },
  {
    "page": 143,
    "content": "1033\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nRevision Surgery\nWhen failure or compromise of the sinus graft occurs, reentry \nprocedures are sometimes required to correct deficits. Failed or \ncompromised sinus grafts result in altered soft and hard tissue \ncharacteristics, mainly the formation of adhesions of the Schnei-\nderian membrane to the buccal flap. This results in difficulty with \nreflecting the buccal flap during the reentry procedure. Stud-\nies have shown that separation of the adhesions from the sinus \nmucosa led to a 47% perforation rate. In addition, it has been \nshown that altered characteristics of the Schneiderian membrane \nresult in a nonflexible thick fibrotic membrane. In some cases, in \nwhich voids are present but have difficult access, regrafting proce-\ndures may need to be accomplished via a closed approach through \nthe osteotomy site.101\nTreatment Implications\nBecause of access issues, along with the higher perforation rate and \nfibrotic changes in the Schneiderian membrane, patients need to \nbe informed of a higher postoperative complication rate involving \nquestionable reentry bone growth and implant success. If reentry \nis necessary, usually bony adhesions and bony fenestrations of the \nlateral walls will be present.\nThe combination of fibrotic changes of the Schneiderian \nmembrane, increased chance of perforation, and altered sinus \nphysiology lead to a high complication rate. The continuation \nof the sinus mucosa and oral mucosa make reentry revision sur-\ngery problematic and difficult. This will require the separation \nof the oral and sinus mucosa to gain access to the sinus proper \n(Fig. 37.58). \nA\nB\n• Fig. 37.54  Intraosseous anastomosis. (A) Significant bleed from anastomosis (B) controlled by crushing \nbony area in which bleeding originated.\nA\nB\n• Fig. 37.55  Nasal bleeding. (A) Nasal bleeding immediately postop (B) usually may be controlled by gauze \npressure packs."
  },
  {
    "page": 144,
    "content": "1034\nPART VII    Soft and Hard Tissue Rehabilitation\nEdema\nBecause of the extent of tissue reflection and manipulation, sinus \ngraft surgery often results in significant edema. The resultant post-\noperative swelling can adversely affect the incision line, leading to \ngreater morbidity.\nPrevention\nThe use of good surgical technique that involves careful reflection \nand retraction will decrease the amount of postoperative edema. \nThe greater the surgery duration, the greater is the chance of \nedema. Caution should be used to decrease the amount of surgical \nduration and should not exceed the patient’s tolerance. To mini-\nmize edema, corticosteroid use is used 1 day before and 2 days \nafter surgery. This short-term prophylactic steroid use will allow \nfor adequate blood levels to combat edema, which usually will \npeak at 48 to 72 hours. Dexamethasone is the ideal drug of choice \nbecause of its high antiinflammatory potency. \nCryotherapy\nApplication of an ice pack, along with elevation of the head and \nlimited activity for 2 to 3 days, will help minimize the post-\noperative swelling. This cryotherapy will cause vasoconstriction \nof the capillary vessels, reducing the flow of blood and lymph \nand resulting in a lower degree of swelling. Ice or cold dressings \nshould only be used for the first 24 to 48 hours. After 2 to 3 \ndays, heat (moist) may be applied to the region to increase blood \nand lymph flow to help clear the area of the inflammatory conse-\nquences. This will also help reduce the possibility of ecchymosis \nthat may result. \nEcchymosis\nSinus graft surgery also increases the possibility of bruising or \necchymosis. Because of the extent of reflection, bone preparation, \n• Fig. 37.56  Bleeding control. Bleeding may be controlled by electrocautery.\nA\nC\nB\nV2\n16.02mm\nV2\n• Fig. 37.57  Nerve impairment. (A) Infraorbital foramen anatomic variants that are close to the residual \nridge. (B) V2 sensory impairment. (C) Special broad-based retractor which minimizes trauma to the infra-\norbital nerve."
  },
  {
    "page": 145,
    "content": "1035\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nand the highly vascular surgical area, ecchymosis will occur more \noften with this procedure compared with other implant related \nsurgeries.\nEtiology\nThe etiology of ecchymosis includes the following: blood vessels \nrupture → red blood cells die and release hemoglobin → macro-\nphages degrade hemoglobin via phagocytosis → production of \nbilirubin (bluish-red) → bilirubin is broken down to hemosiderin \n(golden-brown). \nPrevention\nIn most cases, ecchymosis will not be able to be completely pre-\nvented; however, the goal should be to minimize the extent of \nbruising. Additionally, good surgical technique, shorter surgical \nduration, the avoidance of anticoagulant analgesics, and postop-\nerative cryotherapy all aid in the control of this phenomenon. \nPatients should always be informed of the possibility of ecchymo-\nsis. This is easily accomplished by having it be part of the postop-\nerative instructions (Fig. 37.59). \nPain\nMinimal discomfort and pain is usually associated with sinus graft \nsurgery. However, if narcotics are indicated, any analgesic combi-\nnation containing codeine, such as Tylenol 3, is prescribed post-\noperatively because codeine is a potent antitussive, and coughing \nmay place additional pressure on the sinus membrane and intro-\nduce bacteria into the graft. The patient is instructed to cough (if \nnecessary) with the mouth open to minimize possible air pressure \nchanges within the sinus cavity. \nOroantral Fistulae\nOroantral fistulae may develop postoperatively, especially if the \npatient has a history of past sinus pathology or infection. Small \noroantral fistulae (<5 mm) usually will close spontaneously after \ntreatment with systemic antibiotic drugs and daily rinses with \nchlorhexidine. However, larger fistulae (>5 mm) will normally \nrequire additional surgical intervention (Fig. 37.60). Larger \nfistulae are associated with an epithelialized tract, which is the \nresult of the fusion of the sinus membrane mucosa to the oral \nepithelium. When this occurs, patients will most likely complain \nof fluids entering the nasal cavity on eating or drinking. Caution \nshould be exercised in using the Valsalva maneuver (i.e., nose \nblowing test) to confirm the presence of an oroantral fistula at \nthe time of surgery. The patient is asked to pinch their nostrils \ntogether to occlude the nose. The patient blows gently to see if \nair escapes into the oral cavity via the sinus. This is not recom-\nmended because this test may create an opening or make a small \nopening larger. The Valsalva maneuver may be used postopera-\ntively to diagnose a suspected communication.\nManagement\nClosure of oroantral fistulae can be accomplished by using broad-\nbased lingual or facially rotated flaps (Figs. 37.61 and 37.62). Buc-\ncal flaps to close the fistula may be more difficult after a sinus graft \nbecause of the location of the graft site. In addition, the buccal \ntissue is very thin, and rotated or expanded buccal flaps usually \nresult in loss of vestibular depth. Before the initiation of the flap \ndesign, the soft tissue around the fistula is excised and the sinus \nfloor curetted to ensure direct bone contact. A tension-free rotated \nA\nB\n• Fig. 37.58  Revision surgery. (A) Postoperative infections often result in \nthe sinus and nasal epithelium being continuous, (B) Reentry into sinus \nrequires incising the tissue to separate the oral and nasal epithelium.\n• Fig. 37.59  Postoperative edema and ecchymosis. One of the most \ncommon postoperative complications is edema and ecchymosis, which \noften may extend into the mandible and neck area."
  },
  {
    "page": 146,
    "content": "1036\nPART VII    Soft and Hard Tissue Rehabilitation\nflap is then made for complete covering of the communication. \nFor oroantral closure after sinus graft procedures, a lingual flap is \nrecommended because of the abundance of keratinized mucosa \nwith an adequate blood supply. Flap designs include island flaps, \n“tongue-shaped” flaps, or rotational and advanced flaps, depend-\ning on the size of the exposure. A key to closing the oroantral \nopening is the dissection of the buccal flap lateral to the fistula. An \nincision that extends 15 mm anterior and posterior to the fistula \nis of benefit. The fistula then has an elliptical incision on each \nside of the opening. The core of tissue and the fistulous tract are \nexcised. The facial flap is undermined and expanded well into the \ntissues of the cheek. The palatal aspect of the incision is adjacent to \nthe tongue-shaped flap. Placement of the incision for the pedicle \nflap should be split thickness and take into account the location \nand depth of the greater palatine artery. Once the attached palatal \npedicle graft is rotated to the lateral and attached to the facial \nflap, horizontal mattress sutures are placed to invert the flap to \nachieve a watertight seal. Sutures with high tensile strength (Vic-\nryl) should be used and allowed to remain in place for at least 2 \nweeks (Fig. 37.63). \nPost-Operative Infection\nWhen evaluating postsurgical infectious complications after sinus \ngraft procedures, the implant clinician must differentiate the \ntype, location, and etiology of the infectious episode. The infec-\ntion may originate within the graft site or may originate in the \nmaxillary sinus proper. It could also be a combination of both \n(Table 37.2). Very few studies have evaluated these different pro-\ncesses. Postsurgically, there exist many reports with varying results \n(approximately 0%–27%) on the incidence of infection leading \nto acute rhinosinusitis.141 Postoperative infections after sinus graft \nsurgery may result from the following:\n • Acute rhinosinusitis: infection within the sinus proper\n • Graft site: infection within the graft area\n • \u0007Combination infection: from acute rhinosinusitis and ­graft \nsite\nGraft Site Infections\nEtiology of Graft Site Infection\nThe graft site may become infected from many sources: (1) preex-\nisting site bacteria, (2) bacterial contamination of the surgical site, \n(3) graft material, (4) surgical technique, (5) bacterial contami-\nnation from acute rhinosinusitis, (6) lack of systemic and local \nprophylactic antibiotics, and (7) systemic, mediation, or lifestyle \nfactors (Fig. 37.64).\nAdditionally, studies have shown a direct correlation between \nan increased infection rate with simultaneous implant placement \nand with simultaneous ridge augmentation.\nOne such study showed that simultaneous ridge grafting \nincreased the infection rate significantly (15.3%) versus sinus graft-\ning alone (3%).142 Most often, the infection begins more than 1 \nweek after surgery, although it may begin as soon as 3 days later. \nDiagnosis\nThe most common sign of graft site infection is swelling, pain, \ndehiscence, or exudate near or including the grafting surgical \nsite. Patients may complain of poor taste and loss of graft par-\nticles in their mouth. Incision line opening is a common sequa-\nlae with exudate discharge. Graft site infections usually occur \nwithin days to weeks of the surgery and are less common as a late \ninfection. Initially, the infection may start as a graft site infection \n(localized to the graft), which then leads to an acute maxillary \nrhinosinusitis (Fig. 37.65). \nTreatment\nAlthough the incidence of infection after the procedure is usu-\nally low, the damaging consequences on osteogenesis and the \npossibility of serious complications require that any infection be \naggressively treated. In case of postoperative infection, it is recom-\nmended that the clinician perform a thorough examination of the \narea by palpation, percussion, and visual inspection to identify \nthe area primarily affected. Infection will usually follow the path \nof least resistance and is observed by changes in specific anatomic \nsites to which it spreads.143\nEarly, aggressive treatment is crucial for graft site infections \nto prevent the loss of graft or extension of the infection into the \nsinus proper, causing an acute rhinosinusitis or spread of infec-\ntion to other vital areas. Initially, systemic antibiotics along with \nantimicrobial rinses should be used. If infection persists, debride-\nment and drainage should be completed, along with the use of \nsterile saline and chlorhexidine. A Penrose drain may also be \nused in cases that do not respond to systemic antibiotics. In some \ninstances, oroantral fistulae result after infection cessation (see the \nsection “Oroantral Fistulae”).\nAntibiotic treatment in the maxillary sinus, both prophylacti-\ncally and therapeutically, is much different than for most oral sur-\ngical procedures. When selecting antibiotic medications for sinus \ninfections, a variety of factors must be evaluated. These include \nthe most common type of pathogens involved, antimicrobial resis-\ntance, pharmacokinetic and pharmacodynamic properties, and \nA\nB\n• Fig. 37.60  Oroantral fistula: (A) Postoperative fistula resulting from poor \nwound healing. (B) Radiograph showing communication between the \nsinus and oral cavity."
  },
  {
    "page": 147,
    "content": "1037\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nB\nA\nC\nD\nE\n• Fig. 37.61  Oroantral fistula repair. (A) oroantral fistula, (B) flap extension for tension-free closure, (C) \nExtended collagen membrane, (D) Membrane positioned, (E) Lateral sliding flap to obtain primary closure."
  },
  {
    "page": 148,
    "content": "1038\nPART VII    Soft and Hard Tissue Rehabilitation\nthe tissue (sinus) penetration of the various antibiotic drugs. The \nantibiotic medication of choice should be effective against respira-\ntory and oral pathogens while exhibiting known activity against \nresistant strains of the common pathogens. Two such factors are \nused when evaluating sinus antibiotic medications: (1) the mini-\nmum inhibitory concentration (MIC) and (2) the concentration \nof antibiotic drugs penetrating inflamed diseased sinus tissue. The \nMIC is the lowest concentration of the antimicrobial agent that \nresults in the inhibition of growth of a microorganism. The MIC \nis usually expressed by MIC 50 or MIC 90, meaning that 50% \nor 90% of the microbial isolates are inhibited, respectively. Previ-\nous studies and treatment modalities used amoxicillin as the first \ndrug of choice. However, with the increasing prevalence of peni-\ncillinase- and β-lactamase–producing strains of H. influenzae and \nM. catarrhalis, along with penicillin-resistant strains of S. pneu-\nmoniae, other alternative antibiotic drugs should be selected.\nβ-Lactam Medications. The most common β-lactam antibi-\notic drugs used in the treatment of rhinosinusitis and graft site \ninfections are penicillin (amoxicillin, Augmentin) and cephalo-\nsporin (Ceftin, Vantin). Amoxicillin has been the drug of choice \nfor years to combat the bacterial strains associated with rhinosi-\nnusitis and infections in the oral cavity. However, its effectiveness \nhas been questioned recently because of the high percentage of \nβ-lactamase–producing bacteria and penicillin-resistant S. pneu-\nmoniae. Augmentin (amoxicillin-clavulanate) has the added \nadvantage of activity against β-lactamase bacteria. It has been \nassociated with a high incidence of gastrointestinal side effects. \nHowever, with the dosing regimen (twice a day [bid]), these com-\nplications have been significantly decreased. Two recommended \ncephalosporin medications have also been suggested to treat rhi-\nnosinusitis: cefuroxime axetil (Ceftin) and cefpodoxime proxetil \n(Vantin). Other cephalosporin drugs fail to achieve adequate sinus \nfluid levels against the causative pathogens. Ceftin and Vantin \nhave good potency and efficacy, while exhibiting strong activity \nagainst resistant S. pneumoniae and H. influenzae. \nMacrolide Medications. Macrolide drugs are bacteriostatic \nagents that include erythromycin, clarithromycin (Biaxin), and \nazithromycin (Zithromax). Macrolide medications have good \nactivity against susceptible pneumococci; however, with the \nincreasing rate of macrolide resistance, their use in combating \nsinus pathogens is becoming associated with a high likelihood of \nclinical failure. These antibiotic drugs are very active against M. \ncatarrhalis, although their activity on H. influenzae is question-\nable. These antibiotic medications are not suggested to treat post-\noperative sinus infections. \nLincosamide Medications. Clindamycin (Cleocin) is the \nprimary lincosamide drug used in clinical practice today that \nis considered to be bacteriostatic. However, in high concen-\ntrations, bactericidal activity may be present. Clindamycin \nis mainly used for the treatment of gram-positive aerobes \nand anaerobes. With acute sinus disease, clindamycin is \nusually not indicated because it exhibits no activity against \nA\nB\nC\n• Fig. 37.62  Membrane-assisted closure of oroantral communications. (A) Oroantral fistula in the right \nmaxillary alveolar process in the region of the missing first molar, which is to be closed with subperiosteal \nplacement of alloplastic material such as gold or titanium foil or a resorbable collagen membrane. Facial \nand palatal mucoperiosteal flaps are developed. Extension of the flaps along the gingival sulcus one or \ntwo teeth anterior and posterior allows some stretching of the flap to facilitate advancement for closure \nover the defect. The fistulous tract is excised. Osseous margins must be exposed 360 degrees around \nthe bony defect to allow placement of the membrane beneath the mucoperiosteal flaps. The flap is sup-\nported on all sides by underlying bone. (B) Closure. Ideally, the flaps can be approximated over the defect. \nIn some cases, a small gap between the flaps will heal over the membrane by secondary intention. Even if \nthe intraoral mucosa does not heal primarily, the sinus lining usually heals and closes, and the membrane \nis then exfoliated or resorbed, and mucosal healing progresses. (C) Cross-section of membrane closure \ntechnique. Buccal and palatal mucoperiosteal flaps are elevated to expose osseous defect and large area \nof underlying alveolar bone around the oroantral communication. The membrane overlaps all the margins \nof the defect, and the facial and palatal flaps are sutured over the membrane. (From Hupp JR, et al. Con-\ntemporary Oral and Maxillofacial Surgery. 5th ed. St Louis, MO: Elsevier; 2009.)"
  },
  {
    "page": 149,
    "content": "1039\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nH. influenzae and M. catarrhalis. This drug may be used in \nchronic sinus conditions because anaerobic organisms play a \nmuch larger role in the disease process. \nTetracycline-Derived Medications. Doxycycline (Vibramy-\ncin) is a bacteriostatic agent with adequate activity against peni-\ncillin-susceptible pneumococci and M. catarrhalis. This drug does \nnot exhibit any activity against penicillin-resistant bacteria and is \nnot effective against H. influenzae. However, doxycycline may be \nused as an alternative antibiotic for the treatment of acute rhino-\nsinusitis infections. \nSulfonamide Medications. The most common sulfonamide \ndrug, trimethoprim-sulfamethoxazole (Bactrim) is bacteriostatic. \nRecently a high rate of resistance to these drugs has been seen \nwith S. pneumoniae, H. influenzae, M. catarrhalis, and other sinus \npathogens. This drug should not be considered to treat postopera-\ntive infections unless a culture and sensitivity test has been per-\nformed and susceptibility is shown. \nMetronidazole Medication. Metronidazole is the most impor-\ntant member of the nitroimidazole group. It is bactericidal and is \neffective against gram-positive and gram-negative anaerobic bac-\nteria. Its main use would be in the treatment of chronic sinus (not \nacute) conditions. The medication should be used with another \nantibiotic drug to be effective against aerobic bacteria.\nAntibiotic Conclusion. In the evaluation of different antibi-\notic drugs used for the treatment of pathologic conditions of the \nsinus, meticulous analysis of the activity against the most com-\nmon pathogens must be evaluated. With all of the antibiotic med-\nications evaluated, amoxicillin-clavulanate, and cefuroxime axetil \nA\nB\nC\n• Fig. 37.63  Postsinus graft infection. (A) Preoperative radiograph. (B) Postoperative sinus augmentation. \n(C) 4-week postop with graft site infection and acute rhinosinusitis."
  },
  {
    "page": 150,
    "content": "1040 PART VII    Soft and Hard Tissue Rehabilitation\nshow excellent MIC 90 blood levels against the most common \npathogens associated with sinus infections. \nDecongestant Medications. Recent recommendations in the \nmedical literature state that nasal decongestants (sympathomimetic \ndrugs) should not be used except in severe cases of congestion and \ninfection. Nasal decongestants have been shown to impair blood \nflow, decreasing antibiotic levels to the site. Additionally, it may \ncause a rebound phenomenon and the development of rhinitis \nmedicamentosa. This rebound phenomenon has been theorized to \noccur as a negative feedback vasodilation after repeated introduc-\ntions of the sympathomimetic (vasoconstricting) drug. \nSaline Rinses. An important treatment for the patient with the \npresence of acute rhinosinusitis and graft infections is the use of \nsaline rinses with a bulb syringe or a squeeze bottle in the nos-\ntril used to lavage the sinus through the ostium. The nasal saline \nrinse has a long history for treatment of sinonasal disease. Hyper-\ntonic and isotonic saline rinses have proven to be effective against \nchronic rhinosinusitis. These techniques of nasal irrigation have \nbeen evaluated, with the best option of a positive-pressure irriga-\ntion using a squeeze bottle that delivers a gentle stream of saline \nto the nasal cavity (NeilMed’s Sinus Rinse; NeilMed Pharmaceu-\nticals Inc.). The syringe or squeeze bottle should not seal the nasal \n  \u0007Types of Postoperative Sinus Infections\nAcute Rhinosinusitis\nGraft Site Infection\nCombination\nEtiology\n • Preexisting pathology\n • Nonpatent ostium\n • Anatomic variants\n • Graft overfill\n • Postsurgery physiologic alteration\n • Spread of infection from graft site\n • History of chronic rhinosinusitis\n • Preexisting odontogenic or allergic rhinosinusitis\n • Preexisting pathology\n • Oral pathogen contamination\n • Untreated periodontitis\n • Perforation\n • Lack of asepsis\n • Long duration surgery\n • Simultaneous ridge augmentation\n • Simultaneous implant placement\n • Lack of prophylactic medication\n • Lack of local graft antibiotics\n • Systemic diseases, smoking/alcohol\nPrimary site could \nbe sinus proper or \ngraft site\nBacteria\nAerobic gram-positive cocci (Streptococcus pneumoniae)\nAerobic gram-negative rods (Haemophilus influenzae) \n(Staphylococcus epidermidis, Streptococcus viridans, \nBranhamella catarrhalis)\nAerobic gram-positive cocci (S. viridans)\nAerobic gram-positive cocci (Staphylococcus \naureus)\nAerobic gram-negative rods (Bacteroides)\nAerobic gram-positive cocci (peptostreptococcus)\nAny combination of \npathogens\nPrevention\nCBCT:\nConfirmation of ostium patency\nConfirmation of no pathology or anatomic variants\nProphylactic medications\nProphylactic medication\nGood surgical technique\nAseptic technique\nShort surgical duration\nNo membrane perforation\nAny combination of \npreventive mea-\nsures\nSymptoms\nMild:\nFacial pain/edema\nCongestion\nNasal drip/blockage\nCough\nSevere:\nSignificant facial pain/edema\nFever\nHeadache\nProptosis/diplopia\nMalaise\nSite pain/edema\nIncision line opening\nExudate\nBad taste\nBleeding\nIntraoral swelling\nAny combination of \nsymptoms\nIdeal antibi-\notic\nβ-Lactam\nβ-Lactam\nLincosamide\nβ-Lactam\nInitial treat-\nment\nAntibiotic:\n1. Augmentin\n2. Ceftin\nNasal saline\nAntibiotic:\n1. Augmentin\n2. Clindamycin\nChlorhexidine\nAntibiotic:\n1. Augmentin\n2. Ceftin\nNasal saline/rinse\nSecondary \ntreatment\nReferral, especially if cerebral/ocular symptoms\nDebridement/irrigation\nPossible culture\nDebridement\nPossible culture\nReferral, especially \nif cerebral/ocular \nsymptoms\nCBCT, Cone beam computerized tomography.\n   \nTABLE \n37.2"
  },
  {
    "page": 151,
    "content": "1041\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nopening because this may force bacteria up toward the ethmoidal \nsinus. Instead, a gentle lavage with sterile saline rinses the sinus \nand flushes out the mucus and exudate. Ideally, the head is placed \ndown and forward so that the saline can reach the ostium in the \nsuperior and anterior portion of the sinus. The course of therapy \nshould continue for at least 7 days.144 Another option is the Neti \nPot, which is very common among chronic rhinosinusitis patients \n(Fig. 37.66). \nAcute Rhinosinusitis Infections\nEtiology of Acute Rhinosinusitis\nThere are two causes of acute maxillary rhinosinusitis after sinus \ngraft surgery: (1) preexisting maxillary sinus pathology or (2) \nprogression of sinus graft surgery to involve the maxillary sinus \nproper (Fig. 37.67). \nDiagnosis\nMaxillary rhinosinusitis is a complication that arises when the \npatient postoperatively complains of any of the following symp-\ntoms: (mild) headache, pain, or tenderness in the area of the \nmaxillary sinus; rhinorrhea; or (severe) fever, headache, or ocular \nsymptoms. Studies have supported the fact that patients who had \npredisposing factors for rhinosinusitis were more at risk of devel-\noping postoperative transient rhinosinusitis.\nThe wide range of reported percentages (3%–20%) may be \nthe result of different methods used for diagnosis (i.e., clinical, \nradiographic, endoscopic). Cases of maxillary sinusitis after dental \nimplant surgery have rarely been reported in the dental literature. \nHowever, recently in the medical literature, numerous cases of \nminor to severe complications after sinus surgery have been docu-\nmented. Although very infrequent, severe infections may lead to \nmore severe complications, such as orbital cellulitis, optic neuri-\ntis, cavernous sinus thrombosis, epidural and subdural infection, \nmeningitis, cerebritis, blindness, osteomyelitis, and, although \nrare, brain abscess and death.145 \nTreatment\nIf infection occurs postoperatively, treatment must be aggres-\nsive because of the possible complications that may arise to close \nanatomic structures. Systemic antibiotic therapy is the first line \nof treatment, along with close observation of symptoms. Recent \nmedical literature discourages the use of systemic decongestants \nand highly recommends the use of saline lavage and rinses. Sys-\ntemic decongestants have been shown to impair site antibiotic \ndelivery and also have a high degree of rebound effect (rhinitis \nmedicamentosa).\nIf symptoms are not alleviated with antibiotic and deconges-\ntant medications, possible referral to the patient’s physician or \nENT is warranted. Emergency consultation should be considered \nif the patient complains of a severe headache that is not relieved by \nmild analgesics, as well as persistent or high fever, lethargy, visual \nimpairment, or orbital swelling.\nThe authors highly recommend that a professional association \nwith an ENT be obtained. Because the possible morbidity of these \ninfections and causative pathogen is not easily determined, referral \nis sometimes needed. Additionally, if mild sinus symptoms per-\nsist or signs of severe infection are present, immediate referral is \nrecommended. Resolution of these conditions has been accom-\nplished with the use of antibiotic drugs, endoscopic treatment, or \nCaldwell- Luc procedures (Fig. 37.68). \nCombination (Graft Site Infections/Acute \nRhinosinusitis)\nEtiology\nThe etiology of a combination infection can either be initiated \nfrom the graft site or the sinus proper. \nDiagnosis\nThe diagnosis for a combination type infection can parallel a com-\nbination of graft site symptoms and/or acute rhinosinusitis. \nTreatment\nThe treatment of a combination type infection should include the \nuse of a β-lactam antibiotic (e.g., Augmentin) followed by the use \nof debridement and nasal saline rinses. If ocular or cerebral symp-\ntoms persist, or the patient does not respond to antibiotic treat-\nment, referral is recommended.\nThe most current, comprehensive study on the treatment \nof sinus disease involves guidelines established by the Sinus \nand Allergy Health Partnership, Centers for Disease Control \nand Prevention, and the FDA in 2000. With this information \nas a guide, the following recommendations for antibiotic use \nin the treatment of infections after sinus graft are suggested \n(Box 37.14). \nSpread of Infection\nBecause of the anatomic and topographic location of the maxillary \nsinus, infections from oral or sinus pathogens may spread quickly \nto adjacent sites.\nSinus-related pathologic conditions are the most common \ncause of orbital infection, accounting for 60% to 84% of cases. \nBecause of the seriousness of ocular infections, early diagnosis and \naggressive treatment is paramount.\nVarious routes may predispose this area to infection from the \nmaxillary sinus and include the following:\n 1. \u0007The venous plexus of the maxillary sinus drains through the \nposterior wall into the deep facial vein, through the pterygoid \nplexus, and finally into the cavernous sinus.\n 2. \u0007Veins also perforate the osseous roof of the maxillary sinus, \nentering the orbit through the superior and inferior ophthal-\nmic vein. These veins also are connected to the pterygoid plexus \nand cavernous sinus.\n• Fig. 37.64  Graft site infection showing exudate and incision line opening."
  },
  {
    "page": 152,
    "content": "1042\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\nD\nE\n• Fig. 37.65  Postgraft infection. (A) Cone beam computerized tomographic (CBCT) coronal image show-\ning implant with associated infection. (B) Axial CBCT image showing a completely opacified sinus. (C) \nIntraoral view of draining fistula tracts (green arrows). (D) Incision and drainage. (E) Exudate and infected \ntissue removal."
  },
  {
    "page": 153,
    "content": "1043\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\n 3. \u0007Additionally, numerous veins perforate the anterior wall that \ndrain into the superior ophthalmic vein and into the cavernous \nsinus. From the cavernous sinus, drainage through the deep \nmiddle cerebral vein communicates with the white substance \nof the brain’s superficial venous system.\nBecause of the elaborate maxillocerebral venous anastomo-\nses, spread of infection from the maxillary sinus may result \nin possible sequelae such as brain abscesses, intraorbital \nabscesses, orbital cellulitis, cavernous sinus thrombosis, and \nosteomyelitis. \nImplant Penetration Into the Sinus\nBränemark and colleagues146 reported on animal histologic stud-\nies and 44 clinical cases of implants penetrating the maxillary \nsinus. They reported success rates comparable to other maxillary \nimplants, and no postoperative signs or symptoms were found \nwith these implants. An animal study by Boyne147 led to the same \nconclusion. The assumption was that direct connection between \nhard and soft tissues to the integrated implant created a barrier to \nthe migration of microorganisms. However, it should be noted \nthese animals do not have the same incidence of maxillary sinusitis \ncomparable to humans.\nIt is possible that an implant that penetrates the sinus floor \nmay contribute to a source of periodic sinusitis because a bacterial \n• Fig. 37.66  Neti Pot. Used for nasal irrigation resulting in flushing out the \nnasal passages.\nA\nB\n• Fig. 37.67  Culture and sensitivity. In some cases of rhinosinusitis, a cul-\nture and sensitivity test may be administered. (A) Swab sealed and sent to \nlaboratory for culture and sensitivity testing.(B) Culture swab placed into \nthe infected site.\nA\nB\n• Fig. 37.68  Functional endoscopic sinus surgery (FESS). (A) FESS scope. \n(B) Surgical placement of FESS."
  },
  {
    "page": 154,
    "content": "1044\nPART VII    Soft and Hard Tissue Rehabilitation\nsmear layer would be difficult to remove through regular phago-\ncytic activity. When this is suspected, removal of the implant or \nan apicoectomy of the implant apex, from a lateral-access window, \nmay be of benefit (Fig. 37.69). \nOverfilling of the Sinus\nThe goal of the sinus graft is to obtain sufficient vertical height \nof bone to place endosteal implants with long-term success. The \nmaximum length requirement of an implant with adequate sur-\nface of design is rarely more than 15 mm, and as a result, the goal \nof the initial sinus graft is to obtain at least 16 mm of vertical \nbone from the crest of the ridge. This usually means the bot-\ntom one-half of the sinus is filled with graft material because \nmost sinuses approximate 35 mm in height. A CBCT scan of \nthe sinus before surgery may be used to estimate the amount of \ngraft material required for the ideal volume of sinus graft mate-\nrial. Care should be given to the amount of graft material placed \ninto the sinus. Overfilling the sinus can result in blockage of the \nostium, especially if membrane inflammation or the presence of \na thickened sinus mucosa exists.\nThe majority of sinus graft overfills do not have postopera-\ntive complications. If, however, a postoperative sinus infection \noccurs without initial resolution, reentry and removal of a por-\ntion of the graft and changing the antibiotic protocol may be \nappropriate (Fig. 37.70). \nPostoperative Cone Beam Computerized \nTomographic Mucosal Thickening (False \nPositive for Infection)\nImmediate postoperative radiographs may reveal significant muco-\nsal thickening within the sinus. The clinician should not determine \nthis to be infection unless the previously mentioned signs of infec-\ntion are noted. Normally, elevation of the sinus mucosa and bone \ngrafting does alter the overall maxillary sinus environment by reduc-\ning the size of the sinus and repositioning the mucociliary transport \nsystem. In spite of this, only short-term clearance impairment exists, \nresulting in only subclinical effects on the sinus physiology. How-\never, in cases of preoperative sinusitis histories, elevation surgery \nmay predispose a patient to sinus-related complications. It has been \nshown that these procedures do alter the microbial environment. \nStudies reveal at 3 months after surgery, positive sinus cultures were \npresent compared with cultures taken for the same patients pre-\noperatively. However, after 9 months the cultures were similar to \nthe preelevation results. The key is maintenance of the ostiomeatal \nopening between the maxillary sinus and the nasal cavity. \nMigration of Implants\nIn 1995 the first case of a displaced (migrated) implant into the \nmaxillary sinus was documented. Since then, an increased number \nof reports are coming to light, documenting an ever-increasing \nproblem. Reports have shown that implants migrating from the \nmaxillary sinus have been found in the sphenoid sinus, ethmoid \nsinus, orbit, nasal cavity, and anterior cranial base.\nEtiology\nThe etiology of implant displacement or migration from the \nmaxillary sinus includes many possibilities. The timing of \n• Fig. 37.69  Implant penetration into sinus. Coronal image showing \nimplant placement into maxillary sinus leading to a completely opacified \nmaxillary sinus.\nMild Infection\nSymptoms\n • Purulent and nonpurulent nasal drip\n • Nasal blockage\n \n• Facial pain and pressure\n \n• Intraoral and extraoral swelling\n • Cough \nTreatment\n 1. \u0007Amoxicillin-clavulanate (Augmentin) 825 mg/125 mg (1 tablet bid for 10 days)\n \na. \u0007If nonanaphylactic allergy to amoxicillin:  \ncefuroxime axetil (500 mg) 1 tablet bid for 10 days\n \nb. \u0007True anaphylactic allergy to amoxicillin:  \ndoxycycline (100 mg) 1 tablet bid for 10 days\n 2. Nasal saline rinses \nModerate to Severe Infection\nSymptoms\n • Mild infections symptoms\n • Severe headache\n • High persistent fever (>102.5°F)\n \n• Periorbital swelling\n \n• Ocular symptoms (diplopia, proptosis)\n \n• Altered mental status\n • Infraorbital hyperesthesia \nTreatment\n 1. Immediate physician referral (emergency room or ENT Physician)\nBid, Twice daily; ENT, ear, nose, and throat (physician).\n\t• BOX 37.14\t    \u0007Infection Treatment Summary \n(Combination)"
  },
  {
    "page": 155,
    "content": "1045\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nimplants ending up in the maxillary sinus proper varies from \nintraoperative displacement to migration years later. Many etio-\nlogic factors have been suggested, according to the timing (early \nversus late) (Table 37.3). \nPrevention\nFor early migration/displacement complications, most likely the \ncause is surgical error or incorrect treatment planning. When \nevaluating late migration/placement complications, the majority \nof issues are a direct result of postoperative prosthetic errors (too \nearly loading) or factors that are precipitated by lack of integration \nor minimal bone at the implant interface. \nManagement\nThe management of displaced or migrated implants into the max-\nillary sinus should be treated with urgency. Leaving implants in \nthe maxillary sinus may lead to acute rhinosinusitis complications. \nAdditionally, implants left in the maxillary may become calcified \n(antrolith) or become displaced into other anatomic areas (e.g., \nsinuses, orbit, nasal cavity, brain).\nThe patients should be referred as soon as possible for removal \nvia a Caldwell-Luc approach or endoscopy (functional endoscopic \nsinus surgery [FESS]) (Figs. 37.71–37.77). \nPostoperative Fungal Infection\nFungal infection after sinus bone grafting is rarely reported; how-\never, with the increased number of sinus graft procedures being \nperformed, inevitably more will be reported in the literature. Fun-\ngal sinusitis is a destructive, invasive disease that is mostly caused \nby Aspergillus. Aspergillus spp. is a fungus of the Ascomycetes class, \nwhich is one of the most commonly encountered in the human \nenvironment. In the diagnosis of fungal sinusitis, there exist two \nforms: noninvasive and invasive. The invasive form is rare and \nis almost always associated with immunocompromised patients. \nErosion and osseous destruction occurs that may be fatal. How-\never, this form has not been associated with dental implants or \nsinus graft surgery.\nCase studies have shown postoperative complications after \nsinus graft surgery148 and overextension of root canal filling \ninvolving the noninvasive form. This type of fungus growth is also \ntermed fungus balls or aspergilloma and is associated with immu-\nnocompetent patients.\nDiagnosis\nUsually, the patient will present with clinical symptoms of frontal \nheadache, orbicular pain, nasal congestion, and bleeding, with signs \nof chronic rhinosinusitis. Radiographically, a distinctly increased \nsoft tissue density mass (radiopacity) is seen on CBCT scans. \nManagement\nReferral to an ENT for evaluation and confirmation of diagnosis. \nUsually, treatment involves surgical removal via Caldwell-Luc or \nFESS techniques because systemic antimycotic drugs are ineffective. \nSummary\nIn the past, implant treatment in the posterior maxilla was reported \nas the least predictable region for implant survival. Causes cited \ninclude inadequate bone height, poor bone density, and high \nocclusal forces. Past implant modalities attempted to avoid this \nregion, with procedures such as excessive cantilevers from anterior \nimplants or excess numbers of pontics when implants are placed \nanterior and posterior to the antrum.\nA\nB\n• Fig. 37.70  Overfilling of the sinus. (A) Cone beam computerized tomographic coronal scan image depict-\ning excess graft material occluding the maxillary ostium. (B) Significant overfill of maxillary sinus leading to \nan acute rhinosinusitis.\n  \u0007Migration of Dental Implants\nEarly\nLate\n• Poor initial stability\n• \u0007Overpreparation of osteotomy \nsite\n• Poor quality of bone\n• No crestal cortical bone\n• \u0007Implant placement into sinus \nwithout bone graft\n• Incorrect treatment planning\n• Surgical inexperience\n• Untreated antral preparation\n• Postoperative sinus infection\n• Immediate placement implants\n• Too early loading\n• \u0007Changes in intranasal or \nintrasinus pressure\n• Peri-implantitis\n• Autoimmune reaction\n   \nTABLE \n37.3"
  },
  {
    "page": 156,
    "content": "1046\nPART VII    Soft and Hard Tissue Rehabilitation\nThe maxillary sinus may be elevated and SA bone regener-\nated to improve available bone height. Tatum began to develop \nthese techniques as early as the mid-1970s.3 Misch149 developed \nfour options for treatment of the posterior maxilla in 1984 based \non the height of bone between the floor of the antrum and the \ncrest of the residual bone. These options were further modified \nto reflect the width of available bone, once adequate height was \nobtained. Root-form implants of adequate size are indicated in \nthe posterior maxilla. The higher forces and less dense bone often \nrequire larger diameter implants.\nIt is the observation of the authors, using the sinus graft pro-\ncedures described in this chapter for more than 30 years, in clini-\ncal practice, universities, and private implant institutes, that the \nsinus graft procedure is more than 97% effective. This region \nof the mouth predictably grows more bone in height than any \nother intraoral region. However, an organized approach needs to \nbe completed with respect to patient selection, pathology evalu-\nation, pharmacologic management, and surgical and prosthetic \nprotocol to increase success and decrease potential morbidity of \nthe procedures.\nA\nB\nC\n• Fig. 37.71  Migrated implants into maxillary sinus. (A and B) Implants displaced into maxillary sinus. (C) \nImplant obstructing the maxillary ostium.\n• Fig. 37.72  Migrated implant into nasal cavity. Implant that was displaced \ninto the maxillary sinus and eventually eroded through the medial wall of \nsinus into the nasal cavity."
  },
  {
    "page": 157,
    "content": "1047\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nA\nB\nC\nD\n• Fig. 37.73  Migrated implants. (A) Ethmoid sinus. (B–D) Migrated implant into sphenoid sinus. (A, From \nHaben M, Balys R, Frenkiel S. Dental implant migration into the ethmoid sinus. J Otolaryngol. 2003;32:342–\n344, 2003; B–D, From Felisati G, Lozza P, Chiapasco M, et al. Endoscopic removal of an unusual foreign \nbody in the sphenoid sinus: an oral implant. Clin Oral Implants Res. 2007;18:776–780.)"
  },
  {
    "page": 158,
    "content": "1048\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\n• Fig. 37.74  (A and B) Migrated implants into the orbital area. (From Griffa A, Viterbo S, Boffano P. Endoscopic-\nassisted removal of an intraorbital dislocated dental implant. Clin Oral Implants Res. 2010;21:778–780.)\n• Fig. 37.75  Migrated implants anterior cranial base. (From Cascone P, et al. A dental implant in the anterior \ncranial fossae. Int J Oral Maxillofac Surg. 2010;39:92–93.)"
  },
  {
    "page": 159,
    "content": "1049\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\nA\nB\n• Fig. 37.76  Etiology of displaced/migrated implants. (A) Implant placement into maxillary sinus without \nbone grafting. (B) Implant placement into sites with poor bone density, therefore compromised primary \nstability.\nA\nC\nD\nB\n• Fig. 37.77  (A) Panoramic radiograph depicting migrated dental implant in the right sinus. (B) Coronal \nimage showing implant in the maxillary ostium area. (C) Functional endoscopic sinus surgery (FESS) \napproach to retrieve implant. (D) Removal of implant from sinus cavity. (From Chiapasco M, Felisati G, \nMaccari A, et al. The management of complications following displacement of oral implants in the para-\nnasal sinuses: a multicenter clinical report and proposed treatment protocols. Int J Oral Maxillofac Surg. \n2009;38(12):1273–1278.)"
  },
  {
    "page": 160,
    "content": "1050\nPART VII    Soft and Hard Tissue Rehabilitation\nReferences\n 1. \u0007Blitzer A, Lawson W, Friedman WH, eds. Surgery of the Paranasal \nSinuses. Philadelphia: WB Saunders; 1985.\n 2. \u0007Lang J, ed. Clinical Anatomy of the Nose, Nasal Cavity and Paranasal \nSinuses. New York: Thieme; 1989.\n 3. \u0007Anon JB, Rontal M, Zinreich SJ. Anatomy of the Paranasal Sinuses. \nNew York: Thieme; 1996.\n 4. \u0007Stammberger H. History of rhinology: anatomy of the paranasal \nsinuses. Rhinology. 1989;27:197–210.\n 5. \u0007Karmody CS, Carter B, Vincent ME. Developmental anomalies of \nthe maxillary sinus. Trans Am Acad Ophthalmol Otol. 1977;84:723–\n728.\n 6. \u0007Hinni ML, McCaffrey TV, Kasperbauer JL. Early mucosal \nchanges in experimental sinusitis. Otolaryngol Head Neck Surg. \n1993;107:537.\n 7. \u0007Pietrokovski J. The bony residual ridge in man. J Prosthet Dent. \n1975;34:456–462.\n 8. \u0007Misch CE. Divisions of available bone in implant dentistry. Int J \nOral Implantol. 1990;7:9–17.\n 9. \u0007Misch CE. Bone character: second vital implant criterion. Dent \nToday. 1988;7:39–40.\n 10. \u0007Goodacre JC, Bernal G, Rungcharassaeng K, et al. Clinical com-\nplications with implants and implant prostheses. J Prosthet Dent. \n2003;2:121–132.\n 11. \u0007Misch CE, Qu Z, Bidez MW. Mechanical properties of trabecu-\nlar bone in the human mandible: implications for dental implants \ntreatment planning and surgical placement. J Oral Maxillofac Surg. \n1999;57:700–706.\n 12. \u0007Misch CE. C Ontemporary Implant Dentistry. 3rd ed. St Louis: \nMosby; 2008.\n 13. \u0007Rice DH, Schaefer SD. E Ndoscopic Paranasal Sinus Surgery. 3rd ed. \nPhiladelphia: Lippincott Williams & Wilkins; 2003.\n 14. \u0007Kilic C, Kamburoglu K, Yuksel SP, Ozen T. An assessment of the \nrelationship between the maxillary sinus floor and the maxillary \nposterior teeth root tips using dental cone-beam computerized \ntomography. Eur J Dent. 2010;4(4):462.\n 15. \u0007Ulm CW, Solaur P, Krennmar G, et al. Incidence and suggested \nsurgical management of septa in sinus lift procedures. Int J Oral \nMaxillofac Implants. 1995;10:462–465.\n 16. \u0007Traxler H, Windisch A, Geyerhofer U, et al. Arterial blood supply \nof the maxillary sinus. Clin Anat. 1999;12(6):417–421.\n 17. \u0007Elian N, Wallace S, Cho SC, et al. Distribution of the maxillary \nartery as it relates to sinus floor augmentation. Int J Oral Maxillofac \nImplants. 2005;20:784–787.\n 18. \u0007Nicolielo LFP, Van Dessel J, Jacobs R, et al. Presurgical CBCT \nassessment of maxillary neurovascularization in relation to maxil-\nlary sinus augmentation procedures and posterior implant place-\nment. Surg Radiol Anat. 2014;36(9):915–924.\n 19. \u0007Apostolakis D, Bissoon AK. Radiographic evaluation of the supe-\nrior alveolar canal: Measurements of its diameter and of its position \nin relation to the maxillary sinus floor: a cone beam computerized \ntomography study. Clin Oral Implants Res. 2014;25:553–559.\n 20. \u0007Zijderveld SA, van den Bergh JP, Schulten EA, ten Bruggenkate \nCM. Anatomical and surgical findings and complications in 100 \nconsecutive maxillary sinus floor elevation procedures. J Oral Max-\nillofac Surg. 2008;66:1426–1438.\n 21. \u0007Solar P, Geyerhofer U, Traxler H. Blood supply to the maxil-\nlary sinus relevant to sinus floor elevation procedures. Clin Oral \nImplants Res. 1999;10:34–44.\n 22. \u0007Morgensen C, Tos M. Quantitative histology of the maxillary \nsinus. Rhinology. 1977;15:129.\n\t23.\t \u0007Scadding GK, Lund VJ, Darby YC. The effect of long-term antibi-\notic therapy upon ciliary beat frequence in chronic rhinosinusitis. J \nLaryngol Otol. 1995;109:24–26.\n 24. \u0007Jiang RS, Liang KL, Jang JW. Bacteriology of endoscopically nor-\nmal maxillary sinuses. J Larynogol Otol. 1999;113:825–828.\n 25. \u0007Misch CE. Maxillary sinus augmentation for endosteal implants: \norganized alternative treatment plans. Int J Oral Implantol. \n1987;4:49–58.\n 26. \u0007American Academy of Otolaryngology—Head and Neck Surgery. \nFact sheet: 20 questions about your sinuses. Available at: http://\nwww.entnet.org/healthinfo/sinus/sinus_questions.cfm. \nAccessed \nOctober 7, 2007.\n 27. \u0007Zinreich SJ, Kennedy DW, Rosenbaum AE, et  al. Paranasal \nsinuses: CT imaging requirements for endoscopic surgery. Radiol-\nogy. 1987;163:769–775.\n 28. \u0007McGowan DA, Baxter PW, James J. The Maxillary Sinus and its \nDental Implications. Oxford: Butterworth-Heinemann; 1993.\n 29. \u0007Bolger WE, Butzin CA, Parsons DS. Paranasal sinus bony anatomic \nvariations and mucosal abnormalities: CT analysis for endoscopic \nsurgery. The Laryngoscope. 1991;101:56–64.\n 30. \u0007Timmenga MN, Marius N. Maxillary Sinus Floor Elevation Sur-\ngery: Effects on Maxillary Sinus Performance [doctoral DisserTation]. \nGroningen, The Netherlands: University of Groningen; 2003.\n 31. \u0007McKenzie M. Manual of Diseases of the Nose and Throat. London: \nChurchill Livingstone; 1980.\n 32. \u0007Manji A, Faucher J, Resnik RR. Suzuki JB Prevalence of maxillary \nsinus pathology in patients considered for sinus augmentation proce-\ndures for dental implants. Implant Dent. 2013;22(4):428–435.\n\t33.\t \u0007Maxillary BW. Sinusitis of dental origin. Am J Orthod Oral Surg. \n1943;29:133–151.\n 34. \u0007Melen I, Lindahl L, Andreasson L, Rundcrantz H. Chronic maxil-\nlary sinusitis: Definition, diagnosis and relation to dental infections \nand nasal polyposis. Acta Otolaryngol (Stockh). 1986;101:320–327 \n([PubMed]).\n 35. \u0007Puglisi S, Privitera S, Maiolino L, et  al. Bacteriological findings \nand antimicrobial resistance in odontogenic and non‐odontogenic \nchronic maxillary sinusitis. J Medical Microbiology. 2011;60:1353–\n1359.\n 36. \u0007Saibene AM, Pipolo GC, Lozza P, et  al. Redefining boundar-\nies in odontogenic sinusitis: a retrospective evaluation of extra-\nmaxillary involvement in 315 patients. Int Forum Allergy Rhinol. \n2014;4:1020–1023.\n 37. \u0007Saibene AM, Vassena C, Pipolo C, et al. Odontogenic and rhino-\ngenic chronic sinusitis: a modern microbiological comparison. Int \nForum Allergy Rhinol. 2015;6:41–45.\n 38. \u0007Block MS, Dastoury K. Prevalence of sinus membrane thickening \nand association with unhealthy teeth: a retrospective review of 831 \nconsecutive patients with 1,662 cone-beam scans. J Oral Maxillofa-\ncial Surg. 2014;72(12):2454–2460.\n 39. \u0007Bornstein MM, Wasmer J, Sendi P, et  al. Characteristics and \ndimensions of the schneiderian membrane and apical bone in max-\nillary molars referred for apical surgery: a comparative radiographic \nanalysis using limited cone beam computed tomography. J Endod. \n2012;38:51.\n 40. \u0007Janner SF, Caversaccio MD, Dubach P, et al. Characteristics and \ndimensions of the schneiderian membrane: a radiographic analy-\nsis using cone beam computed tomography in patients referred for \ndental implant surgery in the posterior maxilla. Clin Oral Implants \nRes. 2011;22:1446.\n 41. \u0007Maillet M, Bowles WR, McClanahan SL, et al. Cone-beam com-\nputed tomography evaluation of maxillary sinusitis. J Endod. \n2011;37:753.\n 42. \u0007Pazera P, Bornstein MM, Pazera A, et al. Incidental maxillary sinus \nfindings in orthodontic patients: a radiographic analysis using \ncone-beam computed tomography (CBCT). Orthod Craniofac Res. \n2011;14:17.\n 43. \u0007Rege IC, Sousa TO, Leles CR, et al. Occurrence of maxillary sinus \nabnormalities detected by cone beam CT in asymptomatic patients. \nBMC Oral Health. 2012;12:30.\n 44. \u0007Bascom R, Kesavanathan J, Fitzgerald TK, et al. Sidestream tobacco \nsmoke exposure acutely alters human nasal mucociliary clearance. \nEnviron Health Perspect. 1995;103:1026."
  },
  {
    "page": 161,
    "content": "1051\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\n 45. \u0007American Academy of Otolaryngology—Head and Neck Surgery. \nFact sheet: 20 questions about your sinuses. Available at: http://\nwww.entnet.org/healthinfo/sinus/sinus_questions.cfm. \nAccessed \nOctober 7, 2007.\n 46. \u0007Daley DL, Sande M. The runny nose infection of the paranasal \nsinuses. Infect Dis Clin North Am. 1988;2:131.\n 47. \u0007Zinreich SJ, Messerklinger W, Drettner B. The obstruction of the \nmaxillary ostium. Rhinology. 1967;5:100–104.\n 48. \u0007Aust R, Drettner B. Oxygen tension in the human maxillary sinus \nunder normal and pathological conditions. Acta Otolaryngol. \n1974;78:264.\n 49. \u0007Bolzer WE, Kennedy DW. Changing concepts in chronic sinusitis. \nHosp Pract. 1992;27:20.\n 50. \u0007Ponikau JU, Sherris DA, Kern EB. The diagnosis and incidence of \nallergic fungal sinusitis. Mayo Clin Proc. 1999;74:877–884.\n 51. \u0007Beninger MS, Mickleson SA. Functional endoscopic sinus surgery, \nmorbidity and early results. Henry Ford Hosp Med J. 1990;38:5.\n 52. \u0007Chakrabarti A, Das A, Panda NK. Overview of fungal rhinosinus-\nitis. Indian J Otolaryngol Head Neck Surg. 2004;56(4):251–258.\n 53. \u0007Dufour X, Kauffmann-Lacroix C, Ferrie JC, et al. Paranasal sinus \nfungus ball: epidemiology, clinical features and diagnosis. A ret-\nrospective analysis of 173 cases from a single medical center in \nFrance, 1989-2002. Med Mycol. 2006;44:61–67.\n 54. \u0007Mukherji SK, Figueroa RE, Ginsberg LE, et  al. Allergic fungal \nsinusitis: CT findings. Radiology. 1998;207(2):417–422.\n 55. \u0007Gardner, David G. “Pseudocysts and retention cysts of the maxillary \nsinus.” Oral surgery, oral medicine, oral pathology. 1984;58(5):561–\n567.\n 56. \u0007Oh JH, An X, Jeong SM, Choi BH. Crestal Sinus augmenta-\ntion in the presence of an antral pseudocyst. Implant Dent. \n2017;26(6):951–955.\n 57. \u0007Harar RP, Chadha NK, Rogers G. Are maxillary mucosal cysts \na manifestation of inflammatory sinus disease? J Laryngol Otol. \n2007;121(8):751–754.\n 58. \u0007Kudo K, et al. Clinicopathological study of postoperative maxillary \ncysts. J Jpn Stomatol Soc. 1972;21:250–257.\n 59. \u0007Lee KC, Lee NH. Comparison of clinical characteristics between \nprimary and secondary paranasal mucoceles. Yonsei Med J. \n2010;51(5):735–739.\n 60. \u0007Boyne PJ, James RA. Grafting of the maxillary sinus floor with \nautogenous marrow and bone. J Oral Surg. 1980;38:613–616.\n 61. \u0007Misch CE. Divisions of available bone. Contemporary implant \n­dentistry. 1993;1:125–128.\n 62. \u0007Misch CE. Treatment planning for the edentulous posterior max-\nilla. In: Misch CE, ed. Contemporary Implant Dentistry. 2nd ed. St \nLouis: Mosby; 1999.\n 63. \u0007Misch CM, Misch CE, Resnik RR, Ismail YH, Appel B. Post-\noperative maxillary cyst associated with a maxillary sinus eleva-\ntion procedure: a case report. J Oral Implantol. 1991;17(4): \n432–437.\n 64. \u0007Blaschke FF, Brady FA. The maxillary antrolith. Oral Surg Oral \nMed Oral Pathol. 1979;48:187–191.\n 65. \u0007Evans J. Maxillary antrolith: a case report. Br J Oral Surg. \n1975;13:73–77.\n 66. \u0007Crist RF, Johnson RI. Antrolith: report of case. J Oral Surg. \n1972;30:694–695.\n 67. \u0007Karges MA, Eversol LR, Poindexter BJ. Report of case and review \nof literature. J Oral Surg. 1971;29:812–814.\n 68. \u0007Levin L, Schwartz-Arad D. The effect of cigarette smoking on den-\ntal implants and related surgery. Implant Dent. 2005;4:357–361.\n 69. \u0007Klokkevold PR, Ham TJ. How do smoking, diabetes and peri-\nodontitis affect outcomes of implant treatment? Int J Oral Maxil-\nlofac Implants. 2007;22:173–202.\n 70. \u0007Lindquist LW, Carlsson GE, Jemt T. Association between marginal \nbone loss around osseointegrated mandibular implants and smok-\ning habits: a 10-year follow-up study. J Dent Res. 1997;10:1667–\n1674.\n 71. \u0007Olson JW, Dent CD, Morris HF, Ochi S. Long-term assessment \n(5 to 71 months) of endosseous dental implants placed in the aug-\nmented maxillary sinus. Ann Periodontol. 2000;5:152–156.\n 72. \u0007Widmark G, Andersson B, Carlsson GE, Lindvall AM, Ivanoff CJ. \nRehabilitation of patients with severely resorbed maxillae by means \nof implants with or without bone grafts: a 3- to 5-year follow-up \nclinical report. Int J Oral Maxillofac Implants. 2001;16:73–79.\n 73. \u0007Schwartz‐Arad D, Herzberg R, Dolev E. The prevalence of surgi-\ncal complications of the sinus graft procedure and their impact on \nimplant survival. J Periodontol. 2004;75(4):511–516.\n 74. \u0007Barone A, Santini S, Sbordone L, et al. A clinical study of the out-\ncomes and complications associated with maxillary sinus augmen-\ntation. Int J Oral Maxillofac Implants. 2006;21:81–85.\n 75. \u0007Peterson LJ. Antibiotic prophylaxis against wound infections in oral \nand maxillofacial surgery. J Oral Maxillofac Surg. 1990;48:617–\n620.\n 76. \u0007Olson M, O’Connor M, Schwartz ML. Surgical wounds infection: \na 5 year prospective study of 10,193 wounds at the Minneapolis VA \nMedical Center. Ann Surg. 1984;199:253.\n 77. \u0007Dent CD, Olson JW, Farish SE, et al. The influence of preoperative \nantibiotics on success of endosseous implants up to and including \nstage II surgery: a study of 2641 implants. J Oral Maxillofac Surg. \n1997;55(suppl 115):19–24.\n 78. \u0007Lebowitz AS. Antimicrobic therapy in rhinologic infection. In: \nGoldsmith J, ed. The Principles and Practice of Rhinology. New York: \nJohn Wiley & Sons; 1987.\n 79. \u0007Mulliken JB, Glowacki J, Kaban LB, et al. Use of demineralized \nallogenic bone I implants for the correction of maxillocraniofacial \ndeformities. Ann Surg. 1981;194:366–372.\n 80. \u0007Jacobs MR, Felmingham D, Appelbaum PC, et al. The Alexan-\nder Project 1998-2000: susceptibility of pathogens isolated from \ncommunity-acquired respiratory tract infection to commonly used \nantimicrobial agents. J Antimicrob Chemother. 2003;52:229–246.\n 81. \u0007Snydor A, Gwaltney J, Cachetto DM, et al. Comparative evalu-\nation of cefuroxime axetil and cefaclor for treatment of acute \nbacterial maxillary sinusitis. Arch Otolaryngol Head Neck Surg. \n1989;115:1430.\n 82. \u0007Gallagher DM, Epker BN. Infection following intraoral surgical \ncorrection of dentofacial deformities: a review of 140 consecutive \ncases. J Oral Surg. 1980;38:117–120.\n 83. \u0007Urist MR, Silverman BF, Buring K, et al. The bone induction prin-\nciple. Clin Orthop Relat Res. 1967;53:243–283.\n 84. \u0007Mabry TW, Yukna RA, Sepe WW. Freeze-dried bone allografts \ncombined with tetracycline in the treatment of juvenile periodonti-\ntis. J Periodontol. 1985;56:74–81.\n 85. \u0007Beardmore AA, Brooks DE, Wenke JC, et al. Effectiveness of local \nantibiotic delivery with an osteoinductive and osteoconductive \nbone-graft substitute. J Bone Joint Surg Am. 2005;87:107–112.\n 86. \u0007Petri WH. Osteogenic activity of antibiotic-supplemented bone \nallografts in the Guinea pig. J Oral Maxillofac Surg. 1984;42:631–\n636.\n 87. \u0007Lambert PM, Morris H, Ochi S. The influence of 0.12% chlorhexi-\ndine digluconate rinses on the incidence of infectious complica-\ntions and implant success. J Oral Maxillofac Surg. 1997;55(suppl \n5):25–30.\n 88. \u0007Ragno JR, Szkutnik AJ. Evaluation of 0.12% chlorhexidine rinse \non the prevention of alveolar osteitis. Oral Surg Oral Med Oral \nPathol. 1991;72:524–526.\n 89. \u0007Falck B, Svanholm H, Aust R. The effect of xylometazoline on the \nmucosa of human maxillary sinus. Rhinology. 1990;28:239–477.\n 90. \u0007Ragno JR, Szkutnik AJ. Evaluation of 0.12% chlorhexidine rinse \non the prevention of alveolar osteitis. Oral Surg Oral Med Oral \nPathol. 1991;72:524–526.\n 91. \u0007Tatum OH. Lecture Presented at Alabama Implant Study Group. Bir-\nmingham: Ala; 1977.\n 92. \u0007Tatum OH. Maxillary and sinus implant reconstruction. Dent Clin \nNorth Am. 1986;30:107–119."
  },
  {
    "page": 162,
    "content": "1052\nPART VII    Soft and Hard Tissue Rehabilitation\n 93. \u0007Tatum Jr OH, Lebowitz MS, Tatum CA, et al. Sinus augmenta-\ntion: rationale, development, long term results. N Y State Dent J. \n1993;59:43–48.\n 94. \u0007Misch CE. Divisions of available bone in implant dentistry. Int J \nOral Implantol. 1990;7:9–17.\n 95. \u0007Tatum H Jr. Maxillary and sinus reconstructions. Dent Clin North \nAm. 1986;30:207–229.\n 96. \u0007Misch Carl E. Contemporary implant dentistry. Implant Dentistry. \n1999;8(1):90.\n 97. \u0007Summers RB. Maxillary implant surgery: the osteotome technique. \nCompend Cont Educ Dent. 1994;15:152–162.\n 98. \u0007Worth HM, Stoneman DQ. Radiographic interpretation of antral \nmucosal changes due to localized dental infection. J Can Dent \nAssoc. 1972;38:111.\n 99. \u0007Palma VC, Magro-Filho O, de Oliveria JA, et al. Bone reformation \nand implant integration following maxillary sinus membrane eleva-\ntion: an experimental study in primates. Clin Implant Dent Relat \nRes. 2006;8:11–24.\n 100. \u0007Rosen Paul S, Robert Summers, Jose R. Mellado, Leslie M. Salkin, \nRichard H. Shanaman, Manuel H. Marks, Paul A. ­Fugazzotto. The \nbone-added osteotome sinus floor elevation technique: multicenter \nretrospective report of consecutively treated patients. International \nJournal of Oral and Maxillofacial Implants. 1999;14(6):853–858.\n 101. \u0007Mardinger O, Moses O, Chaushu G, et al. Challenges associated \nwith reentry maxillary sinus augmentation. Oral Surg Oral Med \nOral Pathol Oral Radiol Endod. 2010;110(3):287–291.\n 102. \u0007Reiser GM, Rabinovitz Z, Bruno J, et al. Evaluation of maxillary \nsinus membrane response following elevation with the crestal osteo-\ntome technique in human cadavers. Int J Oral Maxillofac Implants. \n2001;16:833–840.\n 103. \u0007Malamed SF. Techniques of maxillary anesthesia. In: Malamed S, \ned. Handbook of Local Anesthesia. 3rd ed. St Louis: Mosby; 1990.\n 104. \u0007Whittaker JM, James RA, Lozada J, et al. Histological response and \nclInical Evaluation of Heterograft and Allograft Materials in the Eleva-\ntion of the Maxillary Sinus of the Preparation of Endosteal Implant \nSites.\n 105. \u0007Hurzeler MB, Quinones CR, Kirsch A, et al. Maxillary sinus aug-\nmentation using different grafting materials and dental implants in \nmonkeys, part III. Clin Oral Implants Res. 1997;8:401–411.\n 106. \u0007Nishibori M, Betts NJ, Salama H, et  al. Short term healing of \nautogenous and allergenic bone grafts after sinus augmentation—a \nreport of 2 cases. J Periodontol. 1994;65:958–966.\n 107. \u0007Furusawa T, Mizunuma K. Osteoconductive properties and \nefficacy of resorbable bioactive glass as a bone grafting material. \nImplant Dent. 1997;6:93–101.\n 108. \u0007Wiltfang J, Schiegel KA, Schultze-Mosgau S, et al. Sinus floor aug-\nmentation with beta-tricalciumphosphate (beta-TCP): does plate-\nlet-rich plasma promote its osseous integration and degradation. \nClin Oral Implants Res. 2003;12:213–218.\n 109. \u0007BOYNE Philip J. Grafting of the maxillary sinus floor with autog-\nenous marrow and bone. J. Oral Surg. 1980;38:613–616.\n 110. \u0007Tatum Jr OH. Sinus Augmentation. Statistical evaluation of. \n1993;15:1979–1994.\n 111. \u0007Misch CE, Dietsh F. Subantral augmentation in Macaca fascicu-\nlaris—pilot study, Am Acad implant dent 40th Mtg Abs. J Oral \nImplantol. 1991;17:340.\n 112. \u0007Misch CE. Maxillary sinus left with subantral augmentation. In: \nMisch CE, ed. Contemporary Implant Dentistry. St Louis: Mosby; \n1993.\n 113. \u0007Moy PK, Lundgren S, Holmes RE. Maxillary sinus augmentation: \nhistomorphometric analysis of graft materials for maxillary sinus \nfloor augmentation. J Oral Maxillofac Surg. 1993;51:857–862.\n 114. \u0007Del Fabbro M, Testori T, Francetti L, et al. Systematic review of \nsurvival rates for implants placed in the grafted maxillary sinus. Int \nJ Periodontics Restorative Dent. 2004;24:565–577.\n 115. \u0007Tidwell JK, Blijdorp PA, Stoelinga PJW, et al. Composite grafting \nof the maxillary sinus for placement of endosteal implants. Int J \nOral Maxillofac Surg. 1992;21:204–209.\n 116. \u0007Hallman M, Sennerby L, Lundgren S. A clinical and histologic eval-\nuation of implant integration in the posterior maxilla after sinus floor \naugmentation with autogenous bone, bovine hydroxyapatite, or a \n20:80 mixture. Int J Oral Maxillofac Implants. 2002;17(5):635–643.\n 117. \u0007Froum SJ, Tarnow DP, Wallace SS, et al. Sinus floor elevation using \nanorganic bovine bone matrix (OsteoGraf/N) with and without \nautogenous bone: a clinical, histologic, radiographic, and histo-\nmorphometric analysis-part 2 of an ongoing prospective study. Int \nJ Periodontics Restorative Dent. 1998;18(6):528–543.\n 118. \u0007Loukota RA, Isaksson SG, Linner EL, et al. A technique for insert-\ning endosseous implants in the atrophic maxilla in a single stage \nprocedure. Br J Oral Maxillofac Surg. 1992;30:46–49.\n 119. \u0007Nishibori M, Betts NJ, Salama H, et  al. Short term healing of \nautogenous and allergenic bone grafts after sinus augmentation—a \nreport of 2 cases. J Periodontol. 1994;65:958–966.\n 120. \u0007Piattelli A, Scarano A, Corigliano M, Piattelli M. Comparison of \nbone regeneration with the use of mineralized and demineralized \nfreeze-dried bone allografts: a histological and histochemical study \nin man. Biomaterials. 1996;17:1127–1131.\n 121. \u0007Froum SJ, Wallace SS, Elian N, et  al. Comparison of mineral-\nized cancellous bone allograft (Puros) and anorganic bovine bone \nmatrix (Bio-Oss) for sinus augmentation: histomorphometry at \n26 to 32 weeks after grafting. Int J Periodontics Restorative Dent. \n2006;26:543–551.\n 122. \u0007Cammack GV, Nevins M, Clem D3, Hatch JP, Mellonig JT. His-\ntologic evaluation of mineralized and demineralized freeze-dried \nbone allograft for ridge and sinus augmentations. Int J Periodontics \nRestorative Dent. 2005;25(3):231–237.\n 123. \u0007Block MS, Finger I, Lytle R. Human mineralized bone in extrac-\ntion sites before implant placement: Preliminary results. J Am Dent \nAss. 2002;133(12):1631–1638.\n 124. \u0007Nevins M, Kirker Head C, et al. Bone formation in the goat maxil-\nlary sinus induced by absorbable collagen sponge implants impreg-\nnated with recombinant human bone morphogenetic protein-2. Int \nJ Periodontics Restorative Dent. 1996;16:9–19.\n 125. \u0007Vlassis JM, Hurzeler MB, Quinones CR. Sinus lift augmenta-\ntion to facilitate placement of non submerged implants—a clini-\ncal and histological report. Pract Periodontics Aesthet Dent. 1993;5: \n15–23.\n 126. \u0007Del Fabbro M, Testori T, Francetti L, et al. Systematic review of \nsurvival rates for implants placed in the grafted maxillary sinus. Int \nJ Periodontics Restorative Dent. 2004;24:565–577.\n 127. \u0007Froum SJ, Wallace SS, Elian N, et  al. Comparison of mineral-\nized cancellous bone allograft (Puros) and anorganic bovine bone \nmatrix (Bio-Oss) for sinus augmentation: histomorphometry at \n26 to 32 weeks after grafting. Int J Periodontics Restorative Dent. \n2006;26:543–551.\n 128. \u0007Tarnow DP, Wallace SS, Froum SJ, et  al. Histologic and clini-\ncal comparison of bilateral sinus floor elevations with and with-\nout barrier membrane placement in 12 patients: part 3 of an \nongoing prospective study. Int J Periodontics Restorative Dent. \n2000;20(2):117–125.\n 129. \u0007Froum SJ, Wallace SS, Tarnow DP, Cho SC. Effect of platelet-rich \nplasma on bone growth and osseointegration in human maxillary \nsinus grafts: three bilateral case reports. International Journal of \nPeriodontics and Restorative Dentistry. 2002;22(1):45–54.\n 130. \u0007Jensen OT, Leonard BS, Block MS, et  al. Report of the sinus \nConsensus Conference of 1996. Int J Oral Maxillofac Implants. \n1998;13(suppl):11–30.\n 131. \u0007Block MS, Kent JN. Maxillary sinus grafting for totally and par-\ntially edentulous patients. J Am Dent Assoc. 1993;124:139.\n 132. \u0007Aimetti M, Romagnoli R, Ricci G, et  al. The effect of mac-\nrolacerations and microlacerations of the sinus membrane as \ndetermined by endoscopy. Int J Periodontics Restorative Dent. \n2001;21:581–589.\n 133. \u0007Jensen J, Sindet-Petersen S, Oliver AJ. Varying treatment strategies \nfor reconstruction of maxillary atrophy with implants: results in 98 \npatients. J Oral Maxillofac Surg. 1994;52:210–216."
  },
  {
    "page": 163,
    "content": "1053\nCHAPTER 37  Maxillary Sinus Anatomy, Pathology, and Graft Surgery\n 134. \u0007Underwood Arthur S. An inquiry into the anatomy and pathol-\nogy of the maxillary sinus. Journal of anatomy and physiology. \n1910;44(4):354.\n 135. \u0007Krennmair G, Ulm CW, Lugmayr H, et al. The incidence, location \nand height of maxillary sinus septa in the edentulous and dentate \nmaxilla. J Oral Maxillofac Surg. 1999;57:667–671.\n 136. \u0007Misch CE. Dental Implant Prosthetics. St. Louis. Mosby Inc. \n2005;211:223.\n 137. \u0007Kim MJ, Jung UW, Kim CS, et al. Maxillary sinus septa: preva-\nlence, height, location and morphology: a reformatted computed \ntomography scan analysis. J Periodontol. 2006;77:903–908.\n 138. \u0007Lee WJ, Lee SJ, Kim HS. Analysis of location and prevalence of \nmaxillary sinus septa. Journal of periodontal & implant science. \n2010;40(2):56–60.\n 139. \u0007Gurr P, Callahan V, Baldwin D. Laser-Doppler blood flowmetry \nmeasurement of nasal mucosa blood flow after injection of the \ngreater palatine canal. J Layngol Otol. 1996;110:124–128.\n 140. \u0007Flanagan D. Arterial supply of maxillary sinus and potential for \nbleeding complication during lateral approach sinus elevation. \nImplant Dent. 2005;14:336–339.\n 141. \u0007Guerrero JS. Lateral window sinus augmentation: complica-\ntions and outcomes of 101 consecutive procedures. Implant Dent. \n2015;24(3):354–361.\n 142. \u0007Barone A, Santini S, Sbordone L, et al. A clinical study of the out-\ncomes and complications associated with maxillary sinus augmen-\ntation. Int J Oral Maxillofac Implants. 2006;21(1):81–85.\n 143. \u0007Sandler NA, Johns FR, Braun TW. Advanc structures in the man-\nagement of acute and chronic sinusitis. J Oral Maxillofac Surg. \n1996;54:1005–1013.\n 144. \u0007Olson DEL, Rosgon BM, Hilsinger RL. Radiographic comparison \nof three nasal saline irrigation. The Laryngoscope. 2002;112:1394–\n1398.\n 145. \u0007Smith D, Goycollea M, Meyerhoff WL. Fulminant odontogenic \nsinusitis. Ear Nose Throat J. 1979;58:411.\n 146. \u0007Brånemark PI, Adell R, Albrektsson T, et al. An experimental and \nclinical study of osseointegrated implants penetrating the nasal cav-\nity and maxillary sinus. J Oral Maxillofac Surg. 1984;42:497–505.\n 147. \u0007Boyne PJ. Analysis of performance of root form endosseous \nimplants placed in the maxillary sinus. J Long Term Eff Med \nImplants. 1993;3(2):143–159.\n 148. \u0007Sohn DS, Lee JK, Shin HI, et al. Fungal infection as a complication \nof sinus bone grafting and implants: a case report. Oral Surg Oral \nMed Oral Pathol Oral Radiol Endod. 1993;107(3):375–380.\n 149. \u0007Misch Carl E. Contemporary implant dentistry. 2nd edition. Saint \nLouis: Mosby; 1999."
  },
  {
    "page": 164,
    "content": "1054\n38\nIntraoral Autogenous Bone \nGrafting\nC. STEPHEN CALDWELL AND CARL E. MISCH\nT\nreatment plans in implant dentistry in the past used existing \nbone volume to determine the location and type of implant \nand restorations were adapted to accommodate irregulari-\nties related to implant locations. In abundant bone (Division A), \nendosseous root form implants were inserted; in bone of moderate \nwidth (Division B), blade implants were placed; and in inadequate \nheight of bone (Division C−h), subperiosteal implants were the \ntreatment of choice.\nTreatment planning has dramatically changed. The final pros-\nthesis type and design is first determined, followed by determin-\ning the ideal implant positions, numbers, and sizes. The available \nbone is often inadequate to provide the foundation required for a \npredictable treatment plan. As a consequence, bone grafting has \nbecome a more frequent solution for achieving long-term success.\nIn addition to the biomechanical and functional needs signifi-\ncant esthetic considerations need to be included in planning a case. \nBone grafting is often indicated to allow placement of an implant \nin the proper location for an ideal esthetic result. In addition, \nthe soft tissue drape often requires enhancement in the esthetic \nzone as the bone foundation sets the tone for the soft tissue drape. \nTherefore when ideal crown contours (FP-1) and soft tissue are \ndesired, bone augmentation is an important aspect of the treat-\nment plan. As a result of biomechanical-based foundations and \nesthetic desires, a primary diagnostic consideration for implant \nprostheses is the available bone in the edentulous span. The place-\nment of endosteal dental implants requires adequate bone volume \nat the desired locations for ideal prosthetic support. With insuf-\nficient bone volume, several surgical techniques may be used to \nreconstruct the deficient ridge in preparation for implant place-\nment, including bone spreading (ridge splitting), bone growth \nfactors, particulate grafting (allograft, xenograft, alloplast), and \nautogenous grafting (intraoral or extraoral donor sites).\nThe number of key factors present and the geometry of a bony \ndefect are important considerations in the selection of a modal-\nity for ridge augmentation.1 In general the fewer the number of \nremaining bony walls, the greater is the need for osteopromotive \ntechniques. Although allografts and guided bone regeneration \ntechniques have been used predictably in slight-to-moderate bone \nregeneration (primarily for inadequate width in the horizontal \ndimension), these methods have limitations and have been found \nto produce less favorable results in the treatment of larger bone \ndeficiencies.2-13 Ideally the most predictable bone graft mate-\nrial possesses osteoconductive, osteoinductive, and osteogenic \nproperties. The only type of bone-grafting material that maintains \nall three of these regenerative properties is autogenous (autolo-\ngous) bone. Therefore autologous cortical/trabecular bone grafts \nmay be considered and have been proved to be highly success-\nful for the repair of moderate-to-severe alveolar atrophy and bone \ndefects (Fig. 38.1).14-28\nHistory of Autogenous Bone Grafts\nThe use of iliac crest autologous bone blocks with osteointegrated \nimplants was initially described by Brånemark et al.29 and is now \nan accepted procedure in oral and maxillofacial rehabilitation. \nAlthough the iliac crest is often used in oral and maxillofacial \nreconstruction with dental implants,30-34 there are many disad-\nvantages related to harvesting bone from the ilium. The surgery \nis far more aggressive than intraoral techniques and it must be \nperformed in a hospital setting under general anesthesia. This ulti-\nmately will increase patient cost, and complications from the sur-\ngery, such as neurosensory and gait disturbances are increased.35 \nAs an alternative to the iliac crest, there are multiple autogenous \ndonor graft sites that originate intraorally; these include the man-\ndibular symphysis, mandibular ramus, and maxillary tuberosity.\nIn the literature the mandibular symphysis was one of the first \nintraoral donor sites reported. Early case reports described its use \nin the repair of intraoral birth defects, such as cleft palates.36,37 In \n1992 Misch et al.38 expanded the indications for use of the man-\ndibular symphysis and ramus block bone grafts with endosteal \ndental implants. In the repair of localized alveolar defects of the \njaws, bone grafts harvested from the intraoral sites known to offer \nseveral advantages.20,38-41 The main advantage of intraoral versus \nextraoral donor grafts is their convenient surgical access and lower \nmorbidity. The proximity of donor and recipient sites can reduce \noperative and anesthesia time, making them ideal for outpatient \nimplant surgery. In addition, patients report minimal donor site \ndiscomfort compared with bone harvested from the iliac crest or \nother extraoral donor sites.19,20,38-45 Bone harvested from the max-\nillofacial region appears to have inherent biological advantages in \nbone graft augmentation. This may be attributed to the embryo-\nlogic origin of the donor bone.43,46-51 The majority of bones in the \nhuman skeleton are of endochondral origin (from a cartilaginous \nprecursor). With the exception of alveolar bone and the man-\ndibular condyles, the maxilla and body of the mandible develop \nintramembranously.52 It has been demonstrated that membranous"
  },
  {
    "page": 165,
    "content": "1055\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nbone grafts show less resorption in comparison with endochon-\ndral bone grafts.46,47,49,53-56 Although cancellous grafts revascular-\nize more rapidly than cortical grafts,14 cortical membranous grafts \nrevascularize more rapidly than endochondral bone grafts, with \na thicker cancellous component.48,57 Early revascularization of \nmembranous bone grafts results in an improved maintenance of \ngraft volume.48,56-58 It is also theorized that bone of ectomesen-\nchymal origin, such as the mandible, has a better potential for \nincorporation in the maxillofacial region because of a biochemical \nsimilarity in the protocollagen of the donor and recipient bone.59 \nMore recent research suggests that grafted bone independent from \nits embryogenic origin will mimic the properties of the recipient \nbone.60 The inductive capacity of cortical grafts is explained by \ntheir higher concentration of bone morphogenetic proteins.60-62 \nBone from the maxillofacial skeleton contains increased concen-\ntrations of growth factors, which may lead to a greater capacity for \nbone repair and graft retention.63 Another hypothesis is that the \nimproved survival of craniofacial bone grafts is simply caused by \ntheir three-dimensional structure.64,65 Because these grafts have a \nthicker cortical volume, they resorb at a slower rate.53,54,57,66 In \nbone graft reconstruction, an emphasis has been placed on the \ntransplantation of viable osteoprogenitor cells from cancellous \nmarrow grafts, because the majority of osteoblasts are present in \ncancellous bone.18 However, because of significant graft resorp-\ntion associated with cancellous block grafts from endochondral \ndonor bone, they are not the primary donor bone in reconstruc-\ntion of mandibular discontinuity defects and ridge augmentation \nfor soft tissue–supported prostheses.16,18,55-57,67,68 In contrast, cor-\nticocancellous block grafts harvested from the ilium have greater \nbone volume compared with particulate cancellous grafts.57 When \nendosteal implants are surgically placed in corticocancellous bone, \nit has been observed that bone resorption is slower. This may be \nbecause of the microarchitecture of the bone graft (i.e., cortical \ncompared with cancellous).\nCortical bone harvested from the mandible exhibits slower \ngraft resorption and excellent graft incorporation into the host \nbone compared with cancellous bone grafts.57 This is due to the \nvast amounts of osteocytes, growth factors, and bone morphoge-\nnetic protein contained in cortical bone. This facilitates angio-\ngenesis and osteoblast migration into the graft site.69-72 It has \nalso been shown that the dense structure of the cortical grafts \noffers improved implant stability and interfacial stress transmis-\nsion on implant loading.73-75 When used in block bone grafting, \nthe results have been consistent, with excellent graft stabil-\nity.19-23,25,26,38-45,76-91 Mandibular block bone grafts may be har-\nvested from the residual ridge, symphysis, body, and ascending \nramus (Fig. 38.2). \nPreoperative Evaluation of Recipient Site\nA preoperative, comprehensive evaluation of the host graft site \nis extremely important. The implant clinician must identify \nany esthetic concerns, the graft dimensions needed to recon-\nstruct the osseous deficiency or zone of atrophy, the soft and \nhard tissue topography, and the periodontal and endodontic \nhealth of the adjacent teeth.38,92,93 The host site should ideally \nbe evaluated in width, height, and length. In general the most \npredictable bone augmentation sites require only the width \ndimension and extend for one tooth. This provides mesiodistal \nand apical walls of host bone. A one-tooth span provides ease \nA\nB\n• Fig. 38.1  Autogenous Bone Grafting: (A) Clinical image depicting block \ngrafting to a large defect in the maxillary left central and incisor area. (B) \nPost-graft healing allows for ideal placement’s of dental implants.\nA\nB\n• Fig. 38.2  (A) The symphysis block graft is usually harvested approxi-\nmately 5 mm below the roots of the anterior teeth and extends to the \nlingual plate. (B) The symphysis and ramus region are two of the most \npopular sites that are harvested for intraoral defects."
  },
  {
    "page": 166,
    "content": "of soft tissue manipulation and minimal risk for incision line \nopening. The least predictable bone graft sites are more than \nfour teeth in length and require more than 5 mm of height and \nwidth of bone (Fig. 38.3).\nThe implant clinician must always take into consideration the \nfinal prosthesis in the treatment planning of osseous defects. When \nan FP-1 prosthesis is the treatment of choice, the adjacent teeth \nnext to the host graft site should ideally have bone on the roots to \na level within 2 mm of the cement-enamel junction. When a bone \ngraft is placed adjacent to a tooth root (rather than bone), the graft \nmost often resorbs to the level of the existing bone on the adjacent \ntooth root. Therefore in a one-intratooth defect, a line drawn from \neach bone level on the adjacent roots is the maximum bone height \nthat can be predictably expected.\nIn selection of the donor bone for a graft site the graft recipi-\nent site needs to be evaluated in terms of width and height graft \nrequirements. When greater than 4 mm of donor bone graft width \nis required (C−w bone volume), the mandibular symphysis is the \npreferable donor site because of the corticocancellous nature of \nthe graft. When donor graft requirements are less than 4 mm in \nwidth, the ascending ramus of the mandible should be considered \n(Division B to B−w bone volume). When considering atrophy in \nthe vertical dimension, the symphysis of the mandible is a good \nsource of bone because of the greater volume of bone that can be \nacquired.\nAn accurate radiographic assessment is imperative for com-\nplete assessment of the osseous defect. Ideally preoperative \nimaging studies should include a cone beam computed tomo-\ngraphic (CBCT) scan because they have become the standard \nof care in preoperative implant surgical planning and in the \nevaluation of the recipient and donor sites.94-96 Mounted study \ncasts on a semiadjustable articulator of the patient’s jaws allow \nthe implant team to fully evaluate the anatomy of the jaws \nand teeth that cannot be fully appreciated while examining the \noral cavity. In addition to mounted study models, a diagnos-\ntic wax-up of the reconstructed jaw and dentition will help to \ndetermine graft dimensions such as width, height, and implant \npositioning in relation to the opposing dentition. From this \ninformation, surgical templates may be fabricated with respect \nto the ideal implant position in relation to the position of the \nfinal prosthesis (Fig. 38.4).38,41,94,95\nPreparation of Recipient Site\nThe recipient graft site should be clinically evaluated before \nbone harvesting is initiated. This assessment allows the clinician \nto obtain accurate graft dimensions that are required to recon-\nstruct osseous defects or zones of atrophy in preparation for future \nimplant placement. Soft tissue incisions to expose the recipient \nsite are made within attached keratinized tissue. In an edentulous \nridge the soft tissue incision is made slightly lingual to the gingival \ncrest to reduce the risk for incision lines opening from jaw move-\nment and postsurgical edema. When harvesting a monocortical \nblock of bone, vertical releasing incisions are made anterior and \nposterior to the crestal incision line to provide good visualization \nof the surgical site and ease of graft harvest, and to avoid tearing \nof the soft tissue flap. The soft tissue reflection of the flap distal to \nthe graft site may be a full- or split-thickness reflection to facilitate \nsoft tissue healing and reduce incision line opening (Figs. 38.5 \nand 38.6). \nSelection of Intraoral Donor Site\nAfter the recipient site has been reviewed, the selection of the \ndonor site can be determined. The severity of the defect basically \ndetermines if this graft can be taken from the ramus or in major \ndefects, from the mandibular symphysis.  In minor defects where \ncancellous bone is applicable, bone form the maxillary tuberosity \ncan be considered.  It is always preferable to use autogenous bone \nas the graft material in this type of case.\nMandibular Symphysis Donor Site\nAnatomy\nThe mandibular symphysis describes the area in the midline of \nthe mandible where the two lateral halves of the mandible fuse \nat an early period of life. The median ridge divides and encloses \nthe triangular eminence or mental protuberance. The base of the \nprotuberance is depressed in the center and is raised on either side \nto form the mental tubercle. The most inferior aspect of the man-\ndibular symphysis is termed the “menton,” and this area serves as \nthe origin of the geniohyoid and genioglossus muscles (Fig. 38.7). \nBecause the average interforaminal distance is greater than 4 cm, \nthe symphysis is ideal for recipient sites that require large intra-\noral grafts. In general the symphysis has proven to be a good graft \nchoice for graft reconstruction cases that require graft sizes of four \nor more teeth, especially when both vertical and horizontal defi-\nciencies are present. \nA\nB\n• Fig. 38.3  Clinical evaluation of the underlying bone is often misleading. \n(A) Clinical evaluation of edentulous site. (B) After mucoperiosteal flap, tis-\nsue is reflected to reveal significant bony defect.\n1056\nPART VII    Soft and Hard Tissue Rehabilitation"
  },
  {
    "page": 167,
    "content": "A\nB\nC\n• Fig. 38.4  Cone Beam Computed Tomographic Evaluation of Edentulous Space.  (A) Three-dimen-\nsional image of edentulous site showing compromised width. (B) Cross section of compromised bone. (C) \nCross section showing accurate height and width measurements.\nA\nB\n• Fig. 38.5  Papilla-Sparing Incision.  (A) Broad-based incision maintaining the papilla. (B) Full reflection \nrevealing the bony defect that will dictate the donor site graft."
  },
  {
    "page": 168,
    "content": "1058\nPART VII    Soft and Hard Tissue Rehabilitation\nRadiographic Evaluation\nAs part of the treatment planning process, CBCT imaging stud-\nies are recommended to evaluate the symphysis to determine the \nanatomic bone morphology, which includes the approximate \nlength of the mandibular teeth, the distance between the mental \nforamina, and the vertical height of bone between the root apices \nand the inferior border of the mandible. CBCT imaging allows \ncomprehensive three-dimensional visualization of the graft site, \navoidance of unwanted complications, especially violation of the \nfloor of the mouth with its highly vascular structures (e.g., sub-\nlingual and submental arteries). CBCT imaging is superior to \nplain film radiographs (e.g., panoramic) because it can provide \nthe clinician with anatomic information in three dimensions \nthat are not available on two-dimensional films. However, intra-\noperative periapical radiographs may be used to ascertain the \napical location of the incisor teeth to prevent injury to the roots \nof the anterior teeth.\nIt is imperative to determine the buccal-lingual dimension of \navailable bone throughout the symphysis area. Great care should \nbe exercised to avoid hourglass mandibles because perforation of \nthe lingual plate may lead to fracture or damage to blood vessels. \nThe width of the mandible in the midline is usually the greatest \ndimension and decreases toward the mental foramen area. Man-\ndibular symphysis width is several millimeters narrower in the \nregion of the premolar and canines, compared with the midline \n(Fig. 38.8).\nThe average dimension of the anterior mandible between \nthe mental foramina is approximately 44 mm, with African \nAmerican males having the greatest distance, followed by white \nmales, and African American females.97 It is recommended that \nall osteotomy cuts remain a minimum of 5 mm from the ante-\nrior aspect of the mental foramen to avoid injury to the mental \nneurovascular bundle and mental nerve. In a study by Monta-\nzem et al.,98 dentate cadaver mandibular blocks were harvested \nfrom the mandibular symphysis to evaluate the maximum bone \nquantity without causing damage to the mental nerve. When \ntwo symmetric blocks were measured from each site, the average \nwas 21 × 10 × 7 mm, the largest was 25 × 13 × 9 mm, and the \nsmallest measured 21 × 6.5 × 6 mm.98 Therefore the mandibular \nsymphysis is an ideal donor site for harvesting cortico-cancellous \nblocks (Fig. 38.9). \nAnesthesia\nThe anterior symphyseal region of the mandible is innervated by \nthe mandibular branch of the fifth cranial nerve (V3) and cervi-\ncal nerves from C-3 and C-4. Bilateral dental or Akinosi (closed-\nmouth) blocks with lidocaine 2% (1:100,000 epinephrine) and \nMarcaine 0.5% (1:200,000 epinephrine) can be used to obtain V3 \ninnervation anesthesia. Infiltration anesthesia is then performed \nanterior and inferior to the mental foramen and in the midline at \nthe base of the mental protuberance. \nIncision and Reflection\nSurgical access to the symphysis is accomplished using crestal \nor vestibular incisions. When incisor teeth are present, a ves-\ntibular approach is recommended as reflection of the soft tissue \naround the anterior teeth may result in tissue recession and \nroot exposure soft tissue healing.99 In addition, a vestibular \nincision is less traumatic and results in reduced postopera-\ntive discomfort. However, the vestibular incision will usually \nresult in more intraoperative bleeding and the highest risk for \nincision line opening, but the least risk for soft tissue changes \naround the teeth and root exposure after healing. It also creates \nmuch simpler access to the symphysis area and allows for easier \nsuturing of the incision line. Limiting the distal extent of the \nvestibular incision to the canine tooth area (i.e., mesial of the \ncanine) will reduce the incidence of mental nerve neurosensory \nimpairment.38,39,44 When there is a high mucogingival junc-\ntion (MGJ) or high muscle attachments, a sulcular incision \nmay be indicated because a vestibular incision would have a \nhigher incidence of incision line opening. In addition, sulcular \nincisions are advantageous when less than 4 mm of keratin-\nized gingival height is found around the lower anterior teeth \nbecause incision line opening is a greater risk. This is often seen \nwhen the mentalis muscle is large and parafunctional forces in \nthis region exist. The sulcular incision carries the least risk for \nincision line opening after healing but has an increased risk for \nroot exposure. The sulcular approach is also the most time con-\nsuming approach from the standpoint of suturing (Fig. 38.10).\nUsing a scalpel or electrocautery, an incision is made through \nthe mucosa and periosteum down to the symphysis bone between \nthe bilateral canine teeth. Using a periosteal elevator, the soft tis-\nsue flap is reflected (full-thickness) off of the anterior mandible. \nFull-thickness reflection is required so that no soft tissue remains \non the donor bone that could interfere with healing (Figs. 38.11 \nand 38.12).\nTo avoid ptosis of the chin, it is recommended that soft tis-\nsue dissection to the inferior border of the mandible be avoided. \nThis limited reflection prevents complete reflection of the mentalis \nmuscle from its lower attachment to the bone. \n• Fig. 38.6  Larger trapezoid flap exposing large undercuts on facial and \nlingual.\nMental \nprotuberance\nMental \ntubercle\n• Fig. 38.7  Mandibular symphysis anatomy showing the mental protuber-\nance and the mental tubercle."
  },
  {
    "page": 169,
    "content": "1059\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nA\nB\nC\n• Fig. 38.8  Cone Beam Computed Tomography Evaluation.  (A) It is very important not to solely treat-\nment plan the anterior mandible via the two-dimensional or three-dimensional panoramic image. (B) Three-\ndimensional image depicting hourglass anatomy. (C) Cross section showing severe undercuts.\n• Fig. 38.9  The average interforaminal distance between the mental foramen is greater than 44 mm, and \naccurate measurements should be determined before graft harvesting."
  },
  {
    "page": 170,
    "content": "1060 PART VII    Soft and Hard Tissue Rehabilitation\nDonor Site Osteotomy Harvest\nAfter the symphysis is exposed, the osteotomy for the graft har-\nvest is planned. The dimensions of the block bone graft are deter-\nmined by the size of the host bone defect. The osteotomies may \nbe performed with a surgical fissure bur (557, 702—straight 1:1 \nhandpiece), oscillating saw, or Piezotome unit. In general the \nPiezosurgery unit allows more efficient and bone-saving osteot-\nomy cuts (Fig. 38.13).\nPiezotome surgery (Acteon Corp.) is a technology that uses a \nmodulated ultrasonic frequency to cut or sever mineralized tis-\nsue. This ultrasonic surgery technique uses microoscillations (i.e., \n60–200 m/sec at 25–29 kHz) to cut hard tissue, without damag-\ning soft tissue. With this type of surgical modality, precision cuts \ncan be prepared and greater bone graft quantities can be harvested \non a predictable basis. In addition, visibility is improved because \na cavitation effect is created from the irrigation/cooling solution \nthat is used. Numerous studies have shown the ultrasonic bone \ncutting technique to be more favorable than conventional rotary \ninstruments.100\nA\nB\nC\n• Fig. 38.10  (A) Sulcular incisions are usually made in the anterior mandible \nfor a symphysis harvest when the keratinized tissue is less than 4 mm in \nheight or when a heavier musculature is observed. (B) The incision extends \ndistal to the canines, and a vertical release incision is made anterior and \nabove the height of the mental foramen. A full-thickness mucoperiosteal \nflap reflection exposes the symphysis for the harvest. (C) A sulcular inci-\nsion has less risk for postoperative incision line opening; however, there is \na greater risk for root exposure after healing.\nA\nB\nC\n• Fig. 38.11  (A) A vestibular incision is made 5 to 10 mm below the muco-\ngingival junction when 4 to 9 mm of keratinized tissue height is observed \non the facial of the mandibular anterior teeth. (B) The incision extends to \nthe distal of the canines, and a vertical release incision is made for approxi-\nmately 10 mm (above the height of the mental foramen). A full-thickness \nmucoperiosteal reflection exposes the mandibular symphysis. (C) Vestibu-\nlar incisions often heal with scar formation."
  },
  {
    "page": 171,
    "content": "1061\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nThe harvesting of the symphysis block includes four different \nosteotomy cuts: (1) superior, (2) inferior, (3) right vertical, and (4) \nleft vertical (Figs. 38.14 and 38.15).\nSuperior Cut. The superior bone cut is usually made first and \nis dictated by the location of the mandibular incisor and canine \nteeth. To avoid root injury of the incisor teeth, when harvesting \nblocks of bone from the symphysis, it is recommended to remain \na minimum of 5 mm apical to the apices of the incisor and canine \nteeth. Usually the canine teeth are much longer than the incisor \nteeth (i.e., incisors: ∼12–14 mm, canines: ∼16 mm).101 The angu-\nlation of the superior cut is slightly converging (i.e., with respect \nto the lingual plate) because this will minimize injury to the tooth \nroots and allow for easier removal of the bone. The depth of the \nosteotomy should always be through the labial cortex; however, \nit should never be extended lingually to the lingual cortical plate \n(Fig. 38.16). \nInferior Cut. The inferior bone cut is often the most difficult \nto perform because access is always difficult and challenging. Care \nshould be exercised not to compromise the inferior border of the \nmandible because this may cause iatrogenic fracture of the sym-\nphysis area and possibly create a discontinuity defect. The horizon-\ntal inferior osteotomy should be at least 5 mm or more superior to \nthe inferior border of the mandible, and the lingual cortical plate \nshould be preserved so that the lingual plate does not fracture off \nduring the harvest. \nVertical Cuts. Bilateral vertical cuts are made to connect the hori-\nzontal superior and inferior cuts.  The location of these cuts must be \nat a minimum 5 mm anterior to each mental foramen. The presence \nof an anterior loop should always be evaluated and when present, \nproper modification to the location of the cuts should be adjusted. As \nthe horizontal and vertical cuts are connected, care should be taken \nto make sure all four cuts are completely through the cortical plates \nand that they each connect with the adjacent cut. Small islands of \nintact bone can prevent the block from freely being removed from \nthe donor site. (Fig. 38.17). \nBlock Removal\nBlock removal from the symphysis is usually completed with a \nstraight/curved bone chisel and mallet or a Potts elevator. The \nchisel/elevator is usually placed in one of the vertical cut areas, \nand an elevated force is applied to verify movement of the block. \nIf no movement of the block is present, the osteotomies may be \ndeepened slightly and reverification that all cuts are continuous. \nThe chisel can be used with the mallet; however, the mandible \nshould be stabilized to prevent any damage to the temporoman-\ndibular joint. Ideally the patient should maintain his or her teeth \nin maximum intercuspation.\nAfter block removal, cancellous bone may be available (i.e., \ndetermined by CBCT cross-sections) to harvest to supplement \n• Fig. 38.12  When there exists an abundant amount of attached keratin-\nized tissue on the facial aspect of the mandibular anterior teeth, an incision \nin the keratinized tissue is of benefit. The incision is made to the distal of \nthe canines. In this case a midline vertical incision was made, because the \nsymphysis harvest was limited in size.\nPiezotome\nBur\nBur\nBur\nA\nB\nC\nD\nE\nPiezotome\nPiezotome\n• Fig. 38.13  Piezotome (Acteon) versus Bur.  (A) Piezotome surgical unit. (B) Surgical image showing the \nsuperior osteotomy cut with the Piezotome. (C) Cadaver study showing a more ideal osteotomy with a Piezo-\ntome surgery unit in comparison with a bur. (D and E) Harvested block comparing the Piezotome and bur."
  },
  {
    "page": 172,
    "content": "1062\nPART VII    Soft and Hard Tissue Rehabilitation\nany voids in the block graft. Bone curettes of varying sizes will \nallow for the available cancellous bone to be removed from the \ndonor site.102 Care must be exercised not to perforate the lingual \ncortical plate. In some cases, because of the size of the block or the \nacute angle of the symphysis, the block outline may require sec-\ntioning into two sections. This will allow for easier block removal \nbecause two blocks of bone can be harvested from the symphysis \ninstead of one large block of bone. Another option is to maintain \na section of bone in the midline of the symphysis because this \nwill decrease the risk for altering the postoperative appearance of \nthe chin, especially when the patient has a prominent chin point. \nAfter the bone block is harvested, the defect can be filled with a \nparticulate graft material (e.g., microporous hydroxyapatite and \na collagen membrane) to minimize the possibility of a defect and \nto help to restore the contour of the mandible (Fig. 38.18; Boxes \n38.1 and 38.2). \nClosure\nIf a vestibular incision is used, a two-layered soft tissue closure is \nrecommended for suturing. The periosteum is first closed with \nresorbable suture (e.g., 4–0 or 5–0 Vicryl), as well as the men-\ntalis muscle and vestibular mucosa. This is followed by the outer \ntissue closure with a high tensile strength suture material (e.g., \nVicryl, PTFE). To allow for ease of closure, the patient should \nbite into the centric occlusion, which also decreases tension on \nthe flap. Postoperative pressure dressings in the form of pressure \n5 mm\n5 mm\n5 mm\n10 mm\nB\nA\n• Fig. 38.14  (A) The guidelines for the symphysis block harvest are usually 5 mm from each mental fora-\nmen, 5 mm below the roots of the anterior teeth, and 5 mm from the inferior border of the mandible. (B) \nThe superior osteotomy for the bone block is made 5 mm from the apex of the mandibular anterior teeth. \nThe block margin slopes down in the canine region because of the longer roots.\nA\nB\nC\n• Fig. 38.15  (A) Cone beam computed tomography cross section in midline showing buccal and lin-\ngual contours. (B) Osteotomy cuts should not be perpendicular to the outer buccal plate because block \nremoval will be difficult. (C) Osteotomy cuts should converge toward the lingual to allow for easier removal."
  },
  {
    "page": 173,
    "content": "1063\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nA\nB\n• Fig. 38.17  Symphysis Graft Outline.  (A) Outline too close to mental \nforamen and apical regions of the teeth. (B) Ideal outline with ideal space \nfrom the mental foramen and teeth roots.\nA\nB\n• Fig. 38.16  (A) When in doubt on the location of the superior cut, a radiopaque material may be placed in \nthe osteotomy and evaluated radiographically. (B) The radiograph reveals the initial osteotomy is too close \nto the canine root and should be 6 mm more apical in this region.\n• Fig. 38.18  In some cases, involving large blocks, the bone should be \nsectioned in half to allow for easier removal.\nIndications\n • Horizontal and vertical ridge augmentation\n • Thicker graft required (corticocancellous)\n • Maximum: 0.7 × 1.5 × 6 cm \nAdvantages\n • Easy access\n • Can obtain large amount of cancellous bone\n • Usually a corticocancellous graft \nDisadvantages\n • Altered sensation of mandibular anterior teeth\n • Inferior alveolar nerve damage\n • Patient cosmetic concerns\n • More challenging closure\n • Greater possibility of incision dehiscence\n\t • BOX 38.1\t    \u0007Symphysis Bone Graft"
  },
  {
    "page": 174,
    "content": "1064\nPART VII    Soft and Hard Tissue Rehabilitation\ntapes placed over the skin of the chin can reduce the development \nof hematoma formation, incision line dehiscence, and infection \n(Figs. 38.19 and 38.20). \nAlternative Symphysis Procedures\nIf a large monocortical bone block is not indicated, circular-\nshaped bone cores ranging from 4 to 10 mm in diameter may be \nharvested with a trephine bur for use in alveolar augmentation.103 \nTrephine burs of varying diameters can remove bone cores of dif-\nferent lengths down to the lingual cortex of the mandible. A Molt \ncurette or other instrument is then used to recover the bone core. \nIt is critical that the bone cores be fixated and immobilized dur-\ning the healing phase to avoid nonunion of the bone core to the \nnative host mandible. After 4 to 6 months of bone healing, dental \nimplants can usually be surgically placed into the grafted bone. \nAfter an additional 3-month healing period, the implants may be \nprosthetically restored. \nMandibular Ramus Donor Site\nA second intraoral autogenous donor graft site that may be \nused is the mandibular ramus. The mandibular ramus has many \nadvantages as a potential donor site. This area allows sufficient \namounts of bone to be harvested for graft reconstruction and \nprovides easy access to the ascending ramus, patient discomfort \nis less compared with the symphysis graft, and there is reduced \nrisk for neurosensory disturbances from injury to the infe-\nrior alveolar neurovascular bundle. The primary disadvantage \nwith the use of ramus grafts is that access may be difficult in \nsome cases and the quantity of bone is limited (i.e., mainly in \nwidth).\nAnatomy\nThe mandibular ramus is the second largest part of the man-\ndible (i.e., mandibular body is the largest), and it extends cra-\nnially from the angle of the mandible and away from the body \nat approximately 110 degrees. The ramus is quadrilaterally \nshaped and is made up of two surfaces, four borders, and two \nprocesses.\nAnatomic Surfaces: \n\t1.\t \u0007Lateral surface: It is relatively flat and is defined by the internal \nand external oblique ridges, and the Masseter muscle attach-\nment encompasses much of the surface.\n\t2.\t \u0007Medial surface: The medial surface includes the entrance to \nthe mandibular foramen and the inferior alveolar vessels and \nnerve. The lingula is the surrounding prominent ridge that \ngives attachment to the sphenomandibular ligament. The \nmylohyoid groove runs obliquely downward and forward, and \nis the location for mylohyoid vessels and nerve. The internal \npterygoid inserts behind the mylohyoid groove. \nAnatomic Borders: \n\t1.\t \u0007Inferior border: The lower border is a thicker part of the \nmandible, which is continuous with the inferior border of \nthe mandible. The lower border junctions with the posterior \nIncision: vestibular—depending on access, slightly apical to mucogingival \njunction from mesial of cuspid to mesial of cuspid; an alternative \nincision is a sulcular incision\nSuperior: 5 mm below apices of anterior teeth\nInferior: 5 mm superior to the inferior border of mandible\nVertical: 5 mm anterior to mental foramen\nBone harvest: chisel and mallet, or Potts elevator\n\t• BOX 38.2\t   \u0007Symphysis Graft Osteotomy Technique\nA\nB\nC\n• Fig. 38.19  Vestibular Closure.  (A) Use of a “two layer” closure in a chin \ngraft site limits excess tension on the healing wound as the mentalis mus-\ncle is flexed. The mentalis can be sutured to its remnants if they are visible \nor it can be anchored with sutures that pass from the muscle, through \nthe interproximal tissue, around an incisor, and back through the adjacent \ninterproximal papilla to then draw the muscle to its proper level. This is \ncompleted on both sides of the symphysis. (B) A second suture line is \nused to approximate the mucosal layer of the vestibule. Assuring that there \nis not any tension on the sutured wound. (C) Post operative photo showing \na matured vestibular block graft donor site."
  },
  {
    "page": 175,
    "content": "1065\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nA\nC\nE\nB\nD\nF\n• Fig. 38.20  (A) The inferior osteotomy is planned and is usually 5 mm above the inferior border of the \nmandible when a harvest is primarily for an increased width of bone. (B) A fissure bur may be used to con-\nnect the dots of the planned bone block. (C) The block is usually designed to be harvested in two pieces. \n(D) After an osteotome is used to ensure the osteotomy is made up to the lingual plate, the chisel is angled \nto shear the one block from this landmark. (E) The second bone block is easier to harvest because the \nbone chisel can slide along the lingual plate with direct access. (F) The bone blocks are positioned in key \nimplant regions, with at least two fixation screws. \nborder at the angle of the mandible (gonial angle). The mas-\nseter muscle attaches laterally, and the internal pterygoid \nattaches medially.\n\t2.\t \u0007Anterior border: It is continuous with the oblique line and is \nthin at the crest.\n\t3.\t \u0007Posterior border: It is thicker and is covered by the parotid \ngland.\n\t4.\t \u0007Superior border: This is a thin bone that makes up two pro-\ncesses, the coronoid and condylar. The mandibular notch is a \ndeep concavity that separates the two processes."
  },
  {
    "page": 176,
    "content": "1066\nPART VII    Soft and Hard Tissue Rehabilitation\nM\nK\nI\nG\nH\nJ\nL\nN\n• Fig. 38.20, cont’d  (G) The bone blocks are recontoured in situ to smooth the edges, which might per-\nforate the soft tissue flaps. (H) Additional particulate bone may be harvested from the symphysis with a \nrongeur or trephine bur. (I) The particulate bone is placed between the blocks and in any voids between \nthe host bone and blocks. (J) A reentry into the host site after 5 months. (K) The block grafts usually exhibit \nless resorption compared with the particulate graft (in the center). (L) A drill guide is used to position the \nimplants into the graft site. (M) Four implants are positioned in the grafted site. (N) After 4 months of healing \nthe abutments are inserted and the prosthesis may be fabricated."
  },
  {
    "page": 177,
    "content": "1067\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nAnatomic Processes: \n\t1.\t \u0007Coronoid process: This is a thin, triangular eminence that \nallows attachment to the masseter and temporalis muscle.\n\t2.\t \u0007Condylar process: The condylar process ends with the condyle, \nwhich is the articular surface for articulation with the articular \ndisk of the temporomandibular joint (Fig. 38.21). \nRadiographic Evaluation\nClinical evaluation of the ascending ramus is ideally evaluated via \nCBCT technology. With the various CBCT views available to \nevaluate the ramus area, the amount of bone available for grafting, \nalong with the location of the inferior alveolar nerve canal, may \nbe determined. The anteroposterior length of the external oblique \nand prosthetic “buccal shelf” ranges from no presence from the \nthird to first molar, to a dominant projection lateral to the body \nof the mandible. An index finger may be placed on the external \noblique ridge of the ascending ramus and lateral aspect of the \nmandible. Often a ledge is palpable lateral to the second molar \nregion and begins to disappear at the medial of the first molar. The \nwider the “ledge” lateral to the molars or body of an edentulous \nmandible, the wider the ramus block bone that can be harvested. \nSome mandibles have almost no “buccal shelf,” whereas others are \nvery significant (i.e., ∼7 mm). Most often the buccal shelf disap-\npears at the mid-first molar region to the anterior and to the third \nmolar region on the posterior aspect. The ramus length is variable, \nwith the most common vertical limit below the coronoid process, \nbecause this structure is so very thin that a block section would \nremove the entire segment. When determining the location of the \ngraft site, there exist three anatomic variables that require clinical \nand radiographic evaluation.\n\t1.\t \u0007The first variable includes the buccal-lingual mandibular canal \nposition. Although the buccolingual position of the mandibu-\nlar canal is variable within the body of the mandible, the dis-\ntance from the canal to the medial aspect of the buccal cortical \nplate (medullary bone thickness) has been found to be greatest \nat the distal half of the first molar.104 Therefore when larger \ngrafts are planned, the anterior vertical bone cut may be made \nin this area. The vertical bone cuts are progressively deepened \nuntil bleeding from the underlying cancellous bone is vis-\nible, which will allow for a safe distance from the mandibular \ncanal.105,106\n\t2.\t \u0007The second variable is the distance from the external oblique and \nramus to the inferior alveolar canal. The mean anteroposterior \nwidth of the ramus is 30.5 mm, with the mandibular foramen \nlocated about two-thirds of the distance from the anterior bor-\nder.105 A CBCT scan is ideally used to assess and evaluate these \nbony dimensions. The lingula on the medial ramus is the entry \npoint of the inferior alveolar nerve, and its location is variable. \nIt may be at the occlusal plane (most often), above the occlusal \nplane, or below the occlusal plane. The lingula may be in the \nanterior third of the ramus, the middle third, or the distal third \nof the width of the ramus. As a general rule the higher and \nfarther forward the lingula, the closer the inferior alveolar canal \nis adjacent to the external oblique ridge. As a result the ramus \nblock harvest must be located lateral to the inferior alveolar \ncanal and is usually less than 3 mm thick. The lower and more \ndistal the lingual is in the ramus on the CBCT, the lower the \ninferior alveolar canal is to the external oblique. As a result the \nramus block may be as much as 6 mm in width.\n\t3.\t \u0007The third variable is the width of the posterior ramus. In gen-\neral, females have a thinner ramus body and width compared \nwith males. Because of these anatomic variables, a rectangular \nblock of cortical bone 3 to 6 mm in thickness may be har-\nvested from the ramus.106 The length of the rectangular graft \nmay range from 1 to 3.5 cm, and the height approximately 1 \ncm.20,44,107 Such anatomic dimensions may correct width defi-\nciencies involving a span of three to four teeth.\nAlthough use of the coronoid process as an autologous graft \nhas been reported,108-110 the amount of bone for ridge augmen-\ntation is negligible considering the potential postoperative dis-\nability of a coronoidectomy.111,112 However, such anatomic size \nand shape may be used as a veneer graft to gain additional ridge \nwidth. The anatomic proximity makes the ramus well suited for \naugmentation to the posterior mandible inadequate in width \n(Fig. 38.22).42 \nIncision and Reflection\nThe surgical procedure to harvest a block bone graft from \nthe ramus is similar to performing a sagittal split ramus oste-\notomy.106,113-119 With a scalpel, an incision is initiated on the \nmidcrest of the ridge in the posterior edentulous patient, begin-\nning at the base of the retromolar pad. Caution should always \nbe exercised to avoid the retromolar pad in the incision design \nbecause this may result in neurosensory impairment issues (i.e., \nparesthesia, anesthesia, or dysphasia caused by injury of the lin-\ngual nerve, the chorda tympani nerve, and a sympathetic branch \nof the parasympathetic nerve to the submandibular gland with \nthe lingual nerve).\nInitiating the incision on the ascending ramus no higher than \nthe level of the occlusal plane minimizes the possibility of severing \nthe buccal artery or exposing the buccal fat pad.106 The incision \ncontinues anteriorly into the buccal sulcus of the molar teeth or \nposterior ridge area. When making the incision in this area, often \na minor bleeding issue may result. At the height of the occlusal \nplane, the buccal artery crosses the ascending ramus of the man-\ndible. The maxillary artery traverses anteriorly and laterally to the \nretromolar pad. If severed, profuse bleeding is observed, which is \nusually treated with hemostats to clamp the vessel on the lingual \naspect of the incision.\nA mucoperiosteal flap is reflected from the mandibular \nbody, exposing the lateral aspect of the ramus. The attachment \nof the buccinator muscle is observed first. A periosteal elevator \nis placed medial to this structure and directly on the bone of \nthe external oblique and along the ramus. The flap is elevated \nMandible\nBone graft\nsites\n• Fig. 38.21  The ramus and posterior body may be used as a bone block \nharvest site."
  },
  {
    "page": 178,
    "content": "A\nB\nC\n• Fig. 38.22  Ramus Bone Graft.  (A) Outline of four major osteotomy cuts. (B) Translucent outline of donor \nsite and its relationship to the inferior alveolar canal. (C) Cross-sectional view of graft site.\nsuperiorly along the external oblique ridge. After the facial flap \nis reflected the incision in the midramus may be extended to \nthe attachment of the temporalis muscle. The periosteal ele-\nvator slides along the ramus 15 mm deep, down the ramus \ntoward the first premolar region, and identifies the mental fora-\nmen. The host site is reflected and prepared for receiving the \nblock graft (Fig. 38.23). \nDonor Site Osteotomy Harvest\nSuperior Cut. The width of the ramus and the external oblique \nlateral of the mandibular body are identified. A straight handpiece \nand a small, round drill (No. 2–4) or a thin flat insert on a Piezo-\nsurgery unit punctures the bone 3 to 6 mm (i.e., dependent on the \nbony thickness as per the CBCT survey) from the lateral aspect \nof the ramus and external oblique for the superior cut. The holes \nshould allow at least 3 mm of bone on the lingual of the ramus \nand 2 mm of bone adjacent to the molar teeth (when present). \nThe length of the graft is determined, as dictated by the host site \n(previously reflected and prepared). The penetrating holes, just \nthrough the cortical bone, are then connected with a fissure bur \n(No. 557 surgical length) or Piezosurgery unit. The depth of the \nosteotomy should ideally be greater than 2 mm above the man-\ndibular canal (Fig. 38.24). \nVertical Cuts. The anterior vertical cut may then be made \nand begins in relation to the existence and width of the buccal \nshelf (extend oblique ridge) of the mandible. Usually the mid-\nfirst molar is in the position of the anterior vertical cut. After the \nvertical osteotomy approximates the position of the inferior alveo-\nlar nerve, the osteotomy is limited to the thickness of the buccal \ncortical plate, usually 2 to 3 mm in thickness. The osteotomy is \nprogressively deepened until bleeding bone from the osteotomy \nis observed. The anterior osteotomy is usually 10 to 12 mm in \nlength. The posterior osteotomy is then completed, which is usu-\nally above and lateral to the inferior alveolar nerve (in front of \nthe lingula on the lingual of the ramus). The posterior osteotomy \nmay be full thickness through the cortical plate to the horizontal \nosteotomy. Because the mandibular canal in this region is usually \ninferior or posterior, the osteotomy is made through the entire \ndepth of the cortex (Figs. 38.25 and 38.26). \nInferior Cuts. The inferior osteotomy will connect the poste-\nrior, and anterior vertical cuts may be performed with an oscillat-\ning saw, large, round bur (No. 8) in a straight handpiece, or a right \nangled insert with a Piezosurgery unit. This cut is usually the most \ndifficult because access and visibility are limited. With the inferior \ncut a shallower cut is made into the cortex to create a line of frac-\nture. This inferior cut with a drill should not be made completely \nthrough the cortex, because it may be located in close proximity \nto the mandibular canal. The piezosurgery tip allows preparation \nof a more defined cut and it does not have the danger of damaging \nthe nerve if it happens to come in contact with any vital structure.\nIdeally the superior, anterior, and posterior vertical, and \ninferior cuts should be made continuous so ease of harvesting \nis accomplished. A thin chisel is gently tapped along the entire \nlength of the external oblique osteotomy, taking care to parallel \nthe lateral surface of the ramus to avoid inadvertent injury to the \ninferior alveolar nerve. A wider wedge chisel or Potts elevator may \nthen be inserted and levered to pry the bone block segment free \nand complete the greenstick fracture of the graft from the ramus. \nAfter removal of the block, any sharp edges around the ramus are \nsmoothed with a bur or file. A hemostatic dressing (collagen, gela-\ntin sponge, oxidized cellulose) may be placed into the donor area, \nand closure of the site may be completed after fixation of the graft \nto the receptor site (Boxes 38.3 and 38.4). \nAlternative Ramus Procedures\nAn alternative option from obtaining a ramus block is the harvest-\ning of bone cores with trephine burs. The cores can be fixated if \nlarge enough or ground down to small particulate pieces that can \n1068\nPART VII    Soft and Hard Tissue Rehabilitation"
  },
  {
    "page": 179,
    "content": "A\nC\nD\nB\nG\nH\nF\nE\n• Fig. 38.23  (A) The ramus site is the first option for a block graft, especially when the posterior mandible \nrequires augmentation. The incision in an edentulous posterior mandible starts at the retromolar pad and \ncontinues to the first premolar. (B) After the full-thickness posterior mucoperiosteal flap is reflected, the \nincision is extended lateral to the retromolar pad and directly over the bone of the ascending ramus to the \nheight of the occlusal plane. (C) The facial flap is reflected, and the attachment of the buccinator muscle \nis identified. (D) A periosteal elevator slides along the lateral aspect of the ramus, under the masseter \nmuscle, for a depth of 15 mm. The incision is extended along the ascending ramus when the donor block \nrequires additional length. (E) Ramus retractors are shaped to retract the masseter and curved to allow the \npreparation of the block at the inferior margin. (F) The facial flap is advanced. Metzenbaum tissue scissors \nare used in a blunt dissection to create the submucosal space. (G) The host site is prepared for the graft \nwith small holes through the cortical plate, 3 to 5 mm apart. (H) The host site is prepared with a round bur \nto create a wall of bone at the apical region of the graft."
  },
  {
    "page": 180,
    "content": "1070\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\n• Fig. 38.24  Superior Osteotomy Cuts.  (A) Too close to the lateral border, which would result in too thin \nof a graft. (B) Ideal position that allows for a wider graft.\nA\nPotential donor\nsite\nB\nComplete cut\nthrough cortex\nC\n• Fig. 38.25  (A) The ramus donor site is lateral to the molars (buccal shelf region) and extends up the \nascending ramus. (B) The ramus donor site uses the outer cortical bone of the ramus and posterior body \nof the mandible. (C) The top portion of the ramus donor block (green line) is usually above and lateral to the \nposition of the inferior alveolar nerve complex."
  },
  {
    "page": 181,
    "content": "1071\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nbe used with a membrane graft. Small bone chisels can be used to \nremove the bone cores. It is hard to collect large volumes of bone \nusing a trephine and harvesting of blocks is probably better suited \nfor most involved graft sites (Figs. 38.27 and 38.28). \nTuberosity Donor Site\nThe maxillary tuberosity has been shown to be a viable intraoral \ndonor source for autogenous bone and a source of osteoprogenitor \ncells.77,120 The tuberosity bone, although variable in the amount of \nbone that can be harvested, has been shown to be advantageous in \nmaxillary sinus grafting and ridge augmentation procedures. The \ncancellous nature of this bone allows it to be shaped and molded. \nIndications\n • Horizontal and vertical ridge augmentation\n • Three to four tooth edentulous sites (maximum size = 3 × 5 cm) \nAdvantages\n • Allows for largest average surface area of intraoral grafts\n • No esthetic concerns\n • Decreased pain and discomfort\n • Decreased chance of incision dehiscence \nDisadvantages\n • Inferior alveolar and lingual nerve injury\n • Access may be difficult\n • Trismus\n\t• BOX 38.3\t   \u0007Ramus Graft\nA\nB\nC\nD\n• Fig. 38.26  (A) The anterior vertical cut is made with a straight handpiece and a fissure bur or oscillating saw. \nThe position is often at the mid-first molar region. The cuts 5 mm above the inferior alveolar nerve (IAN) com-\nplex are full thickness. (B) The posterior vertical cut is often above and lateral to the lingual and IAN, and there-\nfore may be made full thickness along the lateral ramus to the superior block margin. The width of the bone \nblock on the superior margin is designed with a small, round bur and ranges from 3 to 6 mm in width from the \nlateral border. (C) The superior osteotomy is made through the cortical bone and may extend to within 5 mm \nof the posterior IAN. The horizontal dimension of the ramus block determines the width of the donor site and \nis related to the amount of bone needed and the anatomy of the donor site. (D) A fissure bur connects the \npilot holes of the horizontal cut. This cut is through the cortical plate and may proceed to 2 mm above the IAN.\nIncision:\nInitiates at the level of the occlusal plane in the ascending ramus \n(medial to the external oblique ridge)\nExtends anteriorly, avoiding the retromolar pad\nSuperior: on external oblique ridge along anterior border of the mandibular \nramus (approximately one-third width of the mandible)\nAnterior: distal half of the first molar\nPosterior: superior aspect of the external oblique ridge (level of occlusal \nplane)\nInferior: ∼10 mm in height\n\t• BOX 38.4\t   \u0007Ramus Graft Osteotomy Technique"
  },
  {
    "page": 182,
    "content": "1072\nPART VII    Soft and Hard Tissue Rehabilitation\nTuberosity grafts may be used as a particulate graft, or in some \ncases a block graft (Fig. 38.29).\nAnatomy\nThe maxillary tuberosity is defined as the bone at the lower \npart of the infratemporal surface of the maxilla. It is a rounded \neminence that is especially prominent after growth of the third \nmolars. The quality of bone in the maxillary tuberosity is usually \nconsidered a very poor type of bone, usually a D4 bone with \nfine trabeculae and minimal to no cortical bone. The thicker \nsoft tissue in the tuberosity area can be extremely misleading, \nwhich frequently results in a misrepresentation of the amount of \navailable bone. The anatomic limitations of this area include the \nmaxillary sinus, pterygoid plates, adjacent teeth when present, \nand the greater palatine canal. \n• Fig. 38.27  The ramus is exposed and bone cores are obtained via tre-\nphine burs.\nA\nB\nC\nD\nE\n• Fig. 38.28  (A) Autogenous ramus harvest block. (B) Harvested cortical ramus block. (C) Block stored in \nsterile saline. (D) Block reduced to particulate fragments. (E) Particulate fragments placed in the donor site. \n(From Caldwell CS. Bone grafting complications. In: Resnik RR, Misch CE, eds. Misch’s Avoiding Compli-\ncations in Oral Implantology. St. Louis, MO: Elsevier; 2018.)\n• Fig. 38.29  Cone beam computed tomographic panoramic view depict-\ning a significant amount of tuberosity bone available for grafting."
  },
  {
    "page": 183,
    "content": "1073\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nRadiographic Analysis\nIdeally a CBCT examination will reveal the quantity of bone \npresent below the sinus. It is imperative to make an accurate \nassessment of the bone quantity because exposing the maxillary \nsinus after graft removal may lead to increased complications \n(Fig. 38.30). \nIncision and Reflection\nThe incision to expose the maxillary tuberosity consists of a \ncrestal incision and a posterior vertical release (45 degrees) from \nthe posterior part of the tuberosity. The incision should never \nextend onto the lingual contour of the posterior tuberosity or \ninto the hamular notch area because this area is associated with \nan increased possibility of bleeding episodes. It is important to \nincise to the bone because in some cases the tissue can be very \nthick. \nDonor Site Osteotomy Harvest\nAfter reflection of a mucoperiosteal flap the bone may be har-\nvested from the tuberosity with a double-action rongeur or \nchisel. Removing the graft with a chisel will allow the harvest-\ning of a larger piece of bone; however, a greater chance of per-\nforation into the maxillary sinus is possible (Fig. 38.31; Boxes \n38.5 and 38.6). \nA\nB\n• Fig. 38.30  Cone Beam Computed Tomographic Cross Section.  (A) Significant amount of bone for graft-\ning. (B) Minimal amount of bone present that would likely result in a communication with the maxillary sinus.\nA\nB\n• Fig. 38.31  Tuberosity Harvest.  (A) Bone removed from tuberosity with a double-action rongeur. (B) \nTuberosity bone cores after harvest."
  },
  {
    "page": 184,
    "content": "1074\nPART VII    Soft and Hard Tissue Rehabilitation\nBlock Graft Preparation\nFixation of the Block Graft\nOnce the monocortical block of bone has been harvested, the \nrecipient site is ready to receive the graft. It cannot be overstressed \nthat for successful graft survival at the recipient site, complete soft \ntissue coverage must be present that is passive and tension free. \nIf the soft tissue flap has extensive tension, the incision lines will \nopen, resulting in graft exposure and eventual infection of the \ngraft that will result in loss of the bone graft.\nSoft Tissue Preparation\nThe soft tissue dissection beyond the graft recipient site will help \nto avoid soft tissue incision line opening and graft exposure. With \nmost bone grafts, soft tissue closure may be challenging. Misch \ndeveloped a submucosal space technique that helps in overcoming \nthis potential complication. The technique reflects a full-thick-\nness flap over the graft site and at least 5 mm above the height of \nthe MGJ. The periosteum and soft tissues 5 mm above the MGJ \nremain on the bone and are not reflected. The facial flap is then \nlifted 3 to 5 mm above the depth of the MGJ and using a scalpel, \nan incision through the periosteum 1 to 2 mm deep and parallel \nto the crestal incision extends over and beyond the vertical releas-\ning incision. After the incision is made through the periosteum, \npointed tissue scissors (i.e., Metzenbaum scissors) may be intro-\nduced into the periosteal incision for 10 to 15 mm or more, paral-\nlel to the surface mucosa, with the blades of the scissors closed, \nso the facial flap thickness is 3 to 5 mm. The tissue scissors are \nthen opened with blunt dissection, which allows the muscles to \nbe separated from the flap and creates a submucosal space. With \nthe periosteum, tissues and muscles attached to the bone are on \none side, and a 3- to 5-mm-thick facial flap is on the other side.\nWith this technique the facial flap may now advance the depth \nof the submucosal space 10 mm or more. This technique greatly \nincreases the ability to advance the soft tissue flap over a large \nblock graft. The advantage of the submucosal space technique is \nthat a split-thickness flap is created and maintains the muscles on \nthe periosteum, which is attached to the bone above the contours \nof the host site. Because the muscle attachments are the primary \nsource of vascularization to the periosteum and host bone, vascu-\nlarity remains undisturbed. Muscle healing is a primary cause of \nflap retraction and incision line opening. Because the muscles are \nno longer attached to the facial flap and the flap may be advanced \nmore than 10 mm, there is no tension on the incision line, which \nreduces the risk for incision line opening. One complication of \nthe soft tissue procedures to improve graft coverage is the loss of \nvestibular depth. The reduced vestibular depth is rarely an esthetic \nconcern, and when the restoration is implant retained, the pros-\nthesis does not rely on a valve seal for primary retention (as in a \ncomplete denture). Advancement of the facial flap for graft cover-\nage may also result in a reduction in keratinized mucosa over the \nfacial aspect of the gingival crest. In some cases, soft tissue or acel-\nlular dermis grafts may be necessary, or the attached mucosa may \nbe repositioned facially at the stage II implant uncovery surgery \n(Fig. 38.32). \nPreparation of the Recipient Site\nThe next step in graft reconstruction is preparation of the lateral \nand crestal surfaces of the host and grafted bone using a small-\ndiameter drill equal to or smaller than the drill size of bone screws \nused to fixate the donor bone (i.e., ∼1.4-mm diameter). The ratio-\nnale for this procedure is to facilitate angiogenesis at the graft site.\nDrill perforations are 3 to 5 mm apart in the entire area of \nthe graft and host site. Perforations are created under copious \namounts of saline and penetrate both the facial and lingual plates \nof bone in the region of the graft, especially when augmenta-\ntion is desired on both sides of the residual ridge. This procedure \nincreases the availability of osteogenic cells, accelerates revascu-\nlarization, increases the regional acceleratory phenomenon, and \nimproves graft union96,121,122 (Figs. 38.33 and 38.34). \nFixation of the Block Graft\nAfter the block of bone has been harvested, it can be stored in ster-\nile saline solution or immediately fixated to the host bone. Mini-\nmal time should elapse before placement of the block on the host \nbone.123,124 When placing the bone graft onto the host bone, the \ncancellous portion of the graft should be in contact with the host \nbone.81,125,126 Because the graft should passively rest on the host \nbone, the host bone and harvested block of bone need to be con-\ntoured before graft fixation.127,128 The edges of the block of bone \ncan be smoothed with a small, round bur to create a fine, smooth \nsurface that blends in with the surface of the host bone when fix-\nated with rigid fixation screws. Particulate cancellous bone can \nthen be used to fill in any voids between the host bone and har-\nvested block of bone.\nWhen preparing the harvested block of bone, the drill holes \non the surface of the block graft are slightly larger than the diam-\neter of the rigid fixation screws. This permits the rigid fixation \nscrews to compress the block graft directly up against the host \nbone while the screw is threaded completely through both corti-\nces (Fig. 38.35). The outer thread of the fixation screw is usually \n1.4 to 2.0 mm in diameter, with a V-shaped thread design. This \nallows the screw to thread into the host bone during fixation of \nthe graft to the host bone, and removal of the screw at the time of \nimplant placement 4 to 6 months after the graft has remodeled to \nIndications\n • Socket grafting, sinus augmentation, small bony defects\n • Approximately 1–3 mL \nAdvantages\n • Allows for largest average surface area of intraoral grafts\n • No esthetic concerns\n • Decreased pain and discomfort\n • Decreased chance of incision dehiscence \nDisadvantages\n • Entry into maxillary sinus\n • Oral-antral fistula\n • Bleeding (posterior-superior alveolar, pterygoid plexus)\n • Hematoma\n\t• BOX 38.5\t   \u0007Tuberosity Bone Graft\nIncision: midcrestal incision from first molar to posterior extent of ridge \n(short of hamular notch)\nBone harvest: double-action rongeur, chisel and mallet, Piezosurgery\n\t• BOX 38.6\t   \u0007Tuberosity Graft Osteotomy Technique"
  },
  {
    "page": 185,
    "content": "1075\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nthe jaw. The head of the fixation screw should be 2.2 mm or more \nin diameter and flat so that it can compress the donor block graft \nagainst the host bone.\nA lag fixation screw design should not be used. A lag screw \ndesign has smooth metal for 5 to 10 mm below the screw head, \nand the apical half of the screw has threads. When the screw is \nplaced through the block of bone and host bone, the technique \nis effective in rigidly fixating the block of bone to the host bone \n(Fig. 38.36). However, when the screw is removed before implant \nplacement, it has been observed that newly regenerated osseous \ntissue has formed around the smooth portion of the lag screw. This \nmay present problems in removal of the lag screw. While remov-\ning the lag screw, the surgeon may have to tap the graft while the \nscrew is being removed. This could lead to loosening of the bone \ngraft from the host bone.\nThere are many rigid fixation screw kits that can be used in \nbone graft procedures available to the clinician. It is recom-\nmended that the clinician use self-tapping threaded screws with \nthe tip of the screw pointed and not blunt, to allow penetration \ninto bone. Screw kits come in a variety of screw diameter sizes. \nThe two most commonly used to rigidly fixate the block of bone \nto the host bone are 2.0- and 1.6-mm-diameter screws. After \nthe bone graft has been harvested the next step is stabilizing the \ngraft passively to the host bone and rigidly fixating the graft with \nthe use of rigid fixation screws, plates, or stainless-steel wires. If \nusing rigid fixation screws, two or more screws are required to \nfixate the graft to the host bone that avoids movement. When \nusing only a single rigid fixation screw, the block of bone may \nnot be rigidly fixated to the host bone. If the graft is not rigidly \nfixated to the host bone, the graft may rotate and move, which \nwill lead to a fibrous union.\nThe screws are ideally secured to both the facial and the lingual \ncortical plates. Therefore with bicortical stabilization the osteot-\nomy screw holes must penetrate both facial and lingual cortices. \nIn most cases the host site will need to be altered to allow a passive \nfit for the graft. This is easily accomplished with a small, round \ncarbide (No. 6, No. 8). In addition, the block may be altered with \na pear-shaped carbide because the block should have no sharp \nedges. After recontouring, the donor block of bone is slightly \nrecessed into the host bone 1 to 2 mm, and there should exist no \nmicromovement. With completion of the bone graft procedure, \nthe soft tissues are reapproximated and closed with sutures. After \na graft healing period of 4 to 6 months, dental implants may be \nplaced into the graft site. \nMembranes and Block Grafts\nThe use of membranes over autogenous block grafts is controver-\nsial in the literature. Chaushu et al.129 reported soft tissue com-\nplications, including membrane exposure (42 [30.7%] of 137), \nincision line opening (41 [30%] of 137), and perforation of the \nmucosa over the grafted bone (19 [14%] of 137). Infection of the \ngrafted site occurred in 18 (13%) of 137 bone grafts. Gielkens \net al.130 conducted a metaanalysis to investigate the effects of bar-\nrier membranes on onlay autogenous grafts. They concluded after \na vast systemic review that the available studies are too weak to \nsupport the use of membranes. Therefore at this time there are \ninsufficient data to support the use or nonuse of barrier mem-\nbranes with respect to bone resorption.\nA\nB\nC\nD\n• Fig. 38.32  Tissue Preparation for Tension-Free Closure.(A and B) Periosteal release technique with \na scalpel. (C and D) Blunt dissection that stretches the periosteum with the use of blunted scissors."
  },
  {
    "page": 186,
    "content": "1076\nPART VII    Soft and Hard Tissue Rehabilitation\n Maturation and Integration of Block Grafts\nIn most cases, a radiographic survey (e.g. periapical, bite-\nwings, CBCT) is obtained to evaluate healing approximately \n3–4 months after the initial surgery.  In conjunction with the \nradiographic assessment, a clinical examination should be used \nto evaluate the changes in the grafted ridge contour as well as \nthe tiassue health.  Once healing is complete, tissue reflection \naccess is obtained to remove any bone screws and allow for ideal \nimplant placement. The autogenous graft should be evaluated \nfor any mobility, which usually is indicative of bone graft failure. \n(Fig. 38.37, Fig. 38.38). \nComparison of Intraoral Bone-Grafting \nDonor Sites\nA comparison of intraoral donor sites for onlay grafting before \nimplant placement was reported by Misch.44 The volume of the sym-\nphyseal donor grafts was almost twice as great as ramus sites (1.74 \nversus 0.9 cm3). The ramus was primarily a cortical graft, whereas \nthe symphysis block was cortical/trabecular. However, the ramus \nand symphysis donor sites have similar success rates. Aloy-Prósper \net al.131 in a systemic review showed the success and survival rates \nof implants placed into vertical and horizontal defect ridges treated \nwith intraoral block grafts. They concluded that placing implants \ninto block grafts versus native bone had similar success rates.\nA\nB\n• Fig. 38.33  Soft Tissue Removal.  (A) Soft tissue removed with a sharp \nperiosteal elevator. (B) Course carbide in a 1:1 straight handpiece.\nA\nB\n• Fig. 38.34  Recipient Site Decortication.  (A) Decortication holes that \ninitiate angiogenesis to heal the graft. (B) Must have bleeding through the \ndecortication holes for the growth factor release.\n• Fig. 38.35  A lag screw approach is used to fixate the block. The screw \nslides through the block, and the screw head is larger than the hole in the \nblock."
  },
  {
    "page": 187,
    "content": "1077\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nClavero et al.120 compared the morbidity and amount of com-\nplications with ramus and symphysis donor sites. They deter-\nmined although the symphysis has better accessibility, the ramus \ndonor site allows for a greater amount of harvested bone, with \nhigher bone density and more cortical content, together with \nfewer complications.\nGultekin et al.132 studied the difference in bone loss between \nautogenous block grafts and guided bone regeneration (GBR). \nThey concluded that both the block graft group and GBR group \nprovided sufficient volume of bone for implant placement. How-\never, the GBR group did show greater bone resorption in com-\nparison with the autografts.\nYates et al.133 compared the harvested volume of the ramus ver-\nsus the symphysis and also the associated morbidity. They deter-\nmined that the ramus can provide the greatest volume of bone and \nsignificantly less morbidity in comparison with symphysis bone \ngrafting (Table 38.1). \nPostoperative Care and Instructions\nAn increase in incision line opening has been associated with post-\noperative smoking and diabetes in patients with autografts.26,134 \nPatients should stop smoking at least 3 days before surgery and at \na minimum until the incision line has healed. It is imperative that \nthe graft be immobilized during healing and there exists no exter-\nnal pressure on the graft. Removable soft tissue–borne prostheses \nshould not be worn or should be adjusted to prevent graft loading. \nThe flange area of a removable prosthesis should be completely \nremoved, and the edentulous ridge area is generously relieved, \nwhich requires the patient to use denture adhesive for prosthesis \nretention. However, the denture adhesive should not be placed \nover the incision line. The patient is instructed to use the provi-\nsional removable prosthesis for cosmetic appearance only rather \nthan function.\nCareful postoperative follow-up is necessary to inspect the bone \ngraft region and eliminate pressure areas from an overlying pros-\nthesis. More favorable provisional solutions are tooth-borne fixed \nor removable partial dentures, resin-bonded bridges, or denture \nteeth bonded to the adjacent dentition.135 The use of transitional \nimplants to support a fixed-interim prosthesis during the healing \nphase may be considered for patients less tolerant of removable \nprovisional restorations.136,137 \nComplications\nSymphysis Graft Complications\nIncision Line Opening\nMany factors predispose the symphysis donor site to incision \nline opening. If a vestibular incision is used, a two-layered suture \ntechnique is recommended. A suture with a high tensile strength \nshould be used (e.g., Vicryl, PTFE) to maintain the integrity of \nthe incision line. The patient should be instructed not to pull on \nthe lower lip to evaluate the surgical site because this will increase \nthe chances of incision dehiscence. Misch138 determined that \n• Fig. 38.36  The screw should fixate each bone block. The screws should \nengage the lingual plate of the host site.\n  \u0007Comparison of Intraoral Donor Sites\nCriteria\nSymphysis\nRamus\nTuberosity\nSurgical access\nGood\nFair to good\nFair to good\nPatient cosmetic concern\nHigh\nLow\nLow\nGraft shape\nThick\nThin veneer\nThin to thick\nGraft morphology\nCortico-cancellous\nCortical\nCancellous\nGraft size (cm)\n5–15\n5–10\n∼5\nGraft resorption\nMinimal\nMinimal\nModerate\nHealed bone quality\nD1, D2\nD1, D2\nD3, D4\nDonor Site Complications\nPostoperative pain/edema\nModerate\nMinimal\nMinimal\nNeurosensory: teeth\nCommon (temporary)\nUncommon\nUncommon\nNeurosensory: tissue\nUncommon (temporary)\nUncommon\nUncommon\nIncision dehiscence\nOccasional (vestibular)\nUncommon\nUncommon\n   \nTABLE \n38.1"
  },
  {
    "page": 188,
    "content": "1078\nPART VII    Soft and Hard Tissue Rehabilitation\ndehiscence of the donor site occurred in 10.7% of anterior man-\ndibles because of function of the mentalis muscle, and no incision \nline opening was found in the posterior mandible or ramus donor \nsites. \nNeurosensory Impairment\nNeurosensory deficits of the third branch of the trigeminal \nnerve are rare in association with symphysis grafts. However, \nit is a common sequela to have neurosensory changes in the \nmandibular anterior teeth. Because the second terminal branch \nof the inferior alveolar nerve (incisive branch) terminates in \nthe anterior mandibular area, it is not uncommon to sever this \nsection of the nerve during osteotomy preparation. However, \nbecause the incisive nerve is only a sensory nerve to the inci-\nsor teeth, this usually results in only a “dullness” in sensation. \nHoppenreijs et al.139,140 showed a negative pulpal response in \n16% of patients after a symphysis graft, with total resolution \nin 6 to 12 months.\nUsually a neurosensory impairment of the mandibular ante-\nrior teeth does not result in a painful sensation, but it is disrup-\ntive, causing patients to generally describe the incisors as having \na “woody feeling.” This series of complications can usually be \navoided by refraining from aggressive harvesting of medullary \nbone surrounding the donor site.\nStudies have shown the incidence of neuropraxia after the har-\nvesting of block grafts from the ramus versus the symphysis. After \n18 months, more than 50% of the patients with harvest sites in \nthe symphysis still had altered sensation. None of the patients in \nthe ramus donor group reported any symptoms at 18 months.141\nThe superior portion of the harvest site should be prepared at \nleast 5 mm below the level of the incisor root tips to prevent a \nneurosensory impairment. Care must be taken to avoid the longer \nroots of the cuspids as each end of the harvest pattern is prepared. \nAggressive harvesting of the medullary portion of the symphysis \nshould be minimized in the superior aspects if possible to limit \ndamage to neural pathways through the region. Most importantly, \ncomplete patient education must be conducted “before” the sur-\ngery informing the patient about potential sensory changes that \ncould occur. The patient should be aware that he or she could \nfeel a dullness or “woody” feeling of the mandibular anterior teeth \nafter surgery. This can be temporary or a permanent condition, \nbut it has never been described as a particularly annoying feeling. \nRarely is there an indication for endodontic therapy, as the vitality \nof the teeth returns to normal. \nBleeding Episodes\nWhen a cortical graft and the surrounding medullary bone are \nharvested in the symphyseal region, the underlying neurovascu-\nlar components are often compromised. These disruptions to the \nnerves and blood vessels may be accompanied by possible signifi-\ncant bleeding immediately after the graft harvest.\nA\nB\n• Fig. 38.37  (A). Two blocks of cortical bone have been fixated on the \nlateral aspect of the posterior mandibular ridge with fixation screws. Med-\nullary particulate has been used to fill the voids around the block grafts. (B). \nThe mineralized block grafts after five months of healing. Note the smooth \nsurface of the final graft and the nature of the intertwined recipient site and \nthe grafted blocks.\nB\nA\n• Fig. 38.38  (A). This 3 D image shows the severe bony defect resulting \nfrom removal of a blade implant. This vertical defect extends to the level of \nthe mandibular canal. (B). Five month postop matured block graft site that \nwas supplemented with particulate around the remaining defects. Note \nthe density of the final bony structure."
  },
  {
    "page": 189,
    "content": "1079\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nThe incisive nerve is the second terminal branch of the inferior \nalveolar nerve that provides innervation to the mandibular teeth. \nThe incisive nerve path between the mental foramina has been \nknown to be a safe zone for bone harvesting because of the lack \nof vital structures that can be affected by grafts taken from this \nregion. A thorough understanding of the neurologic and vascular \nanatomy in this region is critical for the prevention of complica-\ntions during and after surgery in the symphyseal region. Aggres-\nsive graft harvesting in this area may give rise to a lingual plate \nperforation, which leads to possible significant bleeding issues and \nairway management complications.\nThe sublingual arteries may also cause significant bleeding if \nthe lingual plate is perforated. The incisive neurovascular bundle \nis found to join other vascular structures in the midsymphyseal \nregion. The genioglossus muscle attaches to the genial tubercle in \nthe midline, and the sublingual artery courses through the lingual \nforamen at the genial tubercle. The lingual artery is approximately \n1 to 2 mm in diameter, and cross-sectional views clearly show its \nanastomosis with the incisive canal at this point.\nThe preparation of a grafting osteotomy in the midline can \npotentially resect these blood vessels if they fall in the path of \nthe vertical preparation. If this occurs, the sectioned extension \nof the lingual artery can prolapse back into the floor of the \nmouth. The severed vessel may release arterial blood flow in the \nsublingual space, potentially raising the tongue to a point that \ncompromises the airway. Immediate emergency intervention to \nmaintain the airway is critical, and in some cases this requires \nuse of a tracheostomy until the blood flow has been controlled \n(Fig. 38.39). \nPtosis\nOne of the main patient concerns when confronted with the pros-\npect of symphysis grafting is a change in facial or soft tissue appear-\nance. The idea of having a permanent bony chin defect or ptosis \ncontributes to a patient’s apprehension regarding this procedure.\nThe main concern of patients after a symphysis graft is a post-\noperative change in the soft tissue contour of the chin. In the liter-\nature there exists no evidence of a statistically significant incidence \nof dehiscence or chin ptosis after a symphysis graft. To minimize \nthe possibility of ptosis, avoid degloving the mentalis muscle by \nmaintaining the facial and inferior aspects of the mandible and \nthe lingual aspect of the inferior border of the mandible during \nflap refection. In addition, to prevent lower lip height reduction \nand vermilion zone inversion, the integrity of the periosteum to \nthe inferior reflection should not be deeper than one-third of the \ntotal distance from the vermilion border to the MGJ. An extraoral \nbandage or pressure dressing may be used postoperatively for sup-\nport and to help with compression of the wound. \nRamus Graft Complications\nNeurosensory Deficit\nPatients have also shown less concern with bone removal from \nthe ramus area, and augmentation of this donor site is unneces-\nsary. Although vestibular incision dehiscence has occurred with \nsymphysis grafts, it is usually not a common occurrence in the \nramus donor site. Patients are less able to discern neurosensory \ndisturbances in the posterior buccal soft tissues compared with \nthe lower lip and chin. Although the incision along the exter-\nnal oblique ridge may injure the long buccal nerve, reports of \npostoperative neurosensory deficit in the buccal mucosa are less \nfrequent and will most likely go unnoticed by the patient.142,143 \nIn contrast with the teeth superior to the symphysis donor site, \npatients have reported minimal altered sensation in their molar \nteeth.44,144\nDamage to the inferior alveolar neurovascular bundle could \nalso occur during harvesting of the graft in the ramus area of \nthe mandible. When using bone chisels or elevators, the instru-\nments must parallel the lateral surface of the ramus to avoid a \nnerve impairment. If the inferior ramus cut is below the level of \nthe inferior alveolar canal, graft separation should not be com-\npleted until it can be verified that the neurovascular bundle is not \ntrapped within the graft. Although nerve injury to the inferior \nalveolar nerve is low, patients should be aware of this risk during \nthe consultation before surgery.\nOn occasion the inferior alveolar nerve is identified and directly \nobserved when the block graft is removed from the ramus. When \nthis occurs, dexamethasone (Decadron) 4 mg (1 cc) may be placed \nB\nA\n• Fig. 38.39  (A) Cross-sectional image depicts fractured symphyseal plate from poor patient selection of a \nsymphysis graft. (B) Axial view. (From Cordaro L, Rossini C, Mijiritsky E. Fracture and displacement of lingual \ncortical plate of mandibular symphysis following bone harvesting: case report. Implant Dent. 2004;13:202-206.)"
  },
  {
    "page": 190,
    "content": "1080\nPART VII    Soft and Hard Tissue Rehabilitation\ndirectly on the nerve for 30 seconds to reduce inflammation and \nedema. A second dose of 4 mg (1 cc) then is applied for an addi-\ntional 30 seconds. A collagen sponge may be placed over the site, \nbut hydroxyapatite or graft material is not indicated (Figs. 38.40 \nand 38.41). \nBone Graft Complications\nIncision Line Opening in Bone-Grafting Sites\nMaintenance of complete soft tissue coverage over healing bone-\ngrafting sites is one of the most important principles that must be \nobserved for predictable grafting success.\nAnytime that the healing graft site is exposed to the oral flora \nduring the healing process, there will be some type of compro-\nmised change in the final graft site volume and in its overall integ-\nrity. Incision line opening with compromised graft results can \noften be a major limiting factor in successful implant placement.\nIncision line opening can compromise even the most care-\nfully planned regeneration site, and most of these graft sites will \nrequire additional grafting at a later time if an actual compli-\ncation develops. An open incision line introduces numerous \npotential complications into the healing process. First, the intro-\nduction of microorganisms into a graft site through an open \nincision leads to an infection in the healing graft site. Exposure \nof the block graft and accompanied graft particles accompanied \nby the presence of purulence is an indication of impending fail-\nure of the graft. The infection reduces the pH in the graft site, \ncausing a breakdown of the graft and eventually compromising \nthe resulting ridge volume. Second, an open incision line may \nallow exposure and breakdown of any barrier membranes, con-\ntributing to fibrous tissue ingrowth into the graft site. Lastly, \nthere exists a potential for particulate graft materials that have \nbeen packed around the circumference of the block to escape the \ngraft site, resulting in an inadequate bone volume in the final \nproposed implant site.145\nTension-free tissue coverage is the most critical variable in pre-\nventing incision line opening. A clinician’s experience in manipu-\nlation of soft tissue affects this aspect of bone regeneration more \nthan any other part of bone regeneration surgery. As the clini-\ncian gains more experience in delicate tissue management and \nbegins to understand the maintenance of a tension-free flap clo-\nsure, problems with graft and membrane exposure will become an \nuncommon occurrence.\nThe inner surface of a reflected flap is lined with the perios-\nteum: a thin, dense layer of tissue that cannot be stretched. It is \nimpossible to stretch the soft tissue flap over a graft site without \nfirst severing this layer of tissue. This “tissue release” is accom-\nplished by preparing a clear and continuous releasing incision \nthrough the periosteum, exposing the underlying elastic layers of \ntissue that can then be released for expansion of the flap over the \nenlarged graft site. As this incision perforates the periosteal layer, \nthe two edges clearly separate, allowing the elastic tissue below the \nperiosteum to stretch. A sharp pair of Metzenbaum scissors is then \nplaced into the space below the periosteum, and as the scissor tips \nare opened, the tissue easily releases and the edges separate farther. \nThis is repeated until the complete flap is stretched over the graft \nsite and 5 mm beyond the opposite flap margin.\nIn the event of an incision line opening, the patient should be \nplaced on a frequent monitoring protocol to observe the status \nA\nB\n• Fig. 38.40  (A) On occasion the inferior alveolar nerve complex can be identified after the block is \nremoved. (B) When this occurs, dexamethasone (Decadron) 4 mg (1 cc) may be used directly on the nerve \nto reduce inflammation.\n• Fig. 38.41  Large donor graft site leading to exposure of the inferior \nalveolar nerve (arrow) with associated neurosensory impairment. (From \nCaldwell CS. Bone grafting complications. In: Resnik RR, Misch CE, \neds. Misch’s Avoiding Complications in Oral Implantology. St Louis, MO: \n­Elsevier; 2018.)"
  },
  {
    "page": 191,
    "content": "1081\nCHAPTER 38  Intraoral Autogenous Bone Grafting\nof the graft material and any grafting hardware present. The oral \nmicroflora must be managed with the use of daily chlorhexidine \nrinses. The clinician must not attempt to suture the site again \nbecause healing margins along incision lines feature tissue that \ncannot, at that time, support the pressure of another suture under \ntension.\nIf graft dehiscence occurs, the wound should be allowed to \nheal by secondary intention. Resuturing an incision line open-\ning is rarely successful and will usually result in a larger dehis-\ncence. The block graft may be recontoured with a diamond bur \nto reduce the bulk of exposed bone. The bone above the margins \nof the surrounding tissue is ground off, which also removes the \nbiofilm. This procedure is repeated every 2 to 4 weeks until the site \nis closed (Figs. 38.42 and 38.43). \nMobility of the Block\nMobility of an autogenous graft during the healing process will \nalmost always result in a graft failure. Mobility of the block pre-\nvents proper integration of the newly forming bone, and even-\ntually it will lead to soft tissue invasion between the block and \nthe recipient site. Rigid fixation of the block graft to the recipi-\nent bone site is critical for success in the regenerative process. \nAlthough regeneration with block grafting is related to the con-\ncept of “barrier by bulk,” micromovement will often contrib-\nute to a weak bond between the cortical graft and the recipient \nsite. This will potentially cause the block to separate from the \nridge as pressure is placed on the interface between the native \nbone and the integrated block as a result of the implant being \ninserted into the osteotomy. The most common cause for graft \nmobility is insufficient fixation or pressure from a prosthesis \npostoperatively.\nInitial fixation of a block graft must be attained when the block \nis originally placed in the recipient site. Any movement of the \nblock during the healing process will disrupt the formation of a \nstable clot around the migrating cells, and a loose block will not \nintegrate into the host bone. Ideally two fixation screws should be \nused in every block graft, eliminating any micromovement of the \nblock during the healing process.\nThe recipient site should be prepared for close approximation \nof the surface of the block graft to the recipient site. The block \nshould be inlaid into the recipient site, and particles of medul-\nlary bone or allograft should be packed around the circumference, \nfilling any discrepancies. The temporary prosthesis should be \nadjusted to prevent any contact with the graft site, and the buccal \nflange should be removed on any removable appliance to limit \nmicromovement.\nFixation screws should be engaged into the underlying bone \nenough to provide rigid support of the graft. A longer shaft on \nA\nB\n• Fig. 38.43  Consequences of Resuturing an Incision Line Opening.  (A) \nIncision line opening 2 weeks after surgery and treated with resuturing. (B) \nSix weeks postresuturing showing significant incision line opening.\nA\nB\n• Fig. 38.42  (A) Incision line opening or block dehiscence is a complication of block bone grafts. (B) The \nsoft tissue should not be resutured over the graft that dehisces during the first few months. Instead, the \nblock is recontoured so the bone above the tissue margins is removed. The area is left to heal by second-\nary intention."
  },
  {
    "page": 192,
    "content": "1082\nPART VII    Soft and Hard Tissue Rehabilitation\nthe supporting screw may be necessary to obtain ridge fixation \nin soft bone. The screws should have a self-threading tip, and the \npreparation hole should be prepared deep enough to prevent the \nshaft of the screw from bottoming out in dense cortical bone. \nExcess insertion pressure on a screw passing into very dense bone \nwithout adequate depth preparation can contribute to the head \nof the screw snapping off during its insertion. Most updated fixa-\ntion screws have a pointed self-threading screw tip that helps with \nscrew insertion.\nIf micromovement of the block graft occurs during sur-\ngery, the block should be removed and the screws should be \nreplaced with longer or wider fixation screws. If the move-\nment occurs during the healing phase, the block should be \nmonitored carefully; however, most likely it will need to be \nremoved (Fig. 38.44). \nSoft Tissue Irritation From an Overextended \nFixation Screw\nBone fixation screws are routinely placed in the bony ridge for \nvarious reasons during implant-related surgery. It is not uncom-\nmon to discover the end of a screw extending beyond the lingual \nor palatal cortical plate. When this occurs, there is a potential \nfor the overextended screw to cause discomfort. Overextended \nscrews can be a source of irritation to the thin soft tissue on \nthe lingual aspect of the mandible. The movement of the thin \nmucosa and tongue against the sharp point of the screw can \ncause quite a bit of discomfort. This is not usually an issue in \nthe maxilla, where the thicker nature of the palatal tissue acts as \na protective buffer.\nTo prevent this complication, screw placement should be \nfollowed by both a visual inspection of the opposing surface \nof cortical bone and a digital review of any potential problems \nareas that will need correction. The only way to treat an over-\nextended screw involves reflection of a flap to provide access for \nremoval of the overextension or removal of the complete screw. \nScrew removal is not usually a reasonable solution because that \nwould require reflection of the tissue overlying the maturing \ngraft site and disruption of the graft as the screw is removed \n(Fig. 38.45). \nImplant Placement\nBecause mandibular donor grafts exhibit minimal resorption, \npredictable gains in bone volume allow implant placement in \nmost planned sites. A staged treatment plan with implant place-\nment after graft healing is the preferred method of reconstruc-\ntion. Reports on simultaneous implant insertion during bone \ngraft placement have revealed complications, such as block \ngraft fracture, wound dehiscence with exposure of implants and \ngraft, and a higher implant failure rate compared with a staged \napproach.38-40,46,55,146 In addition, diminished bone contact has \nbeen found around titanium implants placed simultaneously with \nautologous grafts.12,30,85,147 A staged surgery permits implant \nplacement for ideal prosthetic alignment without the concern \nof graft fixation or remodeling. Staging the implant placement \nalso provides an improved vascularity of the transplanted bone as \nthe exposed surface area is increased and unimpeded by an inert \nbiomaterial.53,148 It also allows for any unanticipated increase in \ngraft resorption and should provide a more stable foundation. \nThe implant-bone interface should be improved, because the \nimplant surface is in close contact with the already incorporated \nbone graft. Autologous bone grafts offer an improved quality \nof bone at earlier healing times compared with allogeneic bone \ngrafts or guided bone regeneration techniques.38,58,87,149-151 The \ndensity of healed block mandibular bone grafts has been found \nto be D1 to D2 regardless of the original quality of the recipient \nsite.38,44,58 An appropriate drilling sequence for dense bone and \nA\nB\nC\n• Fig. 38.44  Prevention of Graft Mobility.  (A) Two screws need to be \nplaced to prevent micromovement during healing. (B) The donor site \nneeds to be prepared to minimize “rocking” of the graft when fixated. (C) \nBlock graft securely fits into host site. (From Caldwell CS. Bone grafting \ncomplications. In: Resnik RR, Misch CE, eds. Misch’s Avoiding Complica-\ntions in Oral Implantology. St Louis, MO: Elsevier; 2018.)"
  },
  {
    "page": 193,
    "content": "1083\nCHAPTER 38  Intraoral Autogenous Bone Grafting\ntapping may be necessary for atraumatic implant placement. The \nimplant surgery activates bone formation and induces interfacial \nremodeling with bone maintenance, even in unloaded condi-\ntions.152,153 After integration a progressive bone loading of the \nimplants is recommended.154 Additional graft resorption after \nimplant insertion has not been noted radiographically on loaded \ncases.155-158 \nSummary\nAutologous bone grafts are the only type of graft material that heals \nvia osteogenesis, osteoinduction, and osteoconduction. Bone har-\nvested from the maxillofacial region offers several advantages in the \nreconstruction of the residual ridge for implant placement. Intra-\noral donor sites require only one operational field, which decreases \nA\nD\nB\nC\n• Fig. 38.45  Screw Overextension.  (A) When screw extends through the lingual plate (arrow), this will \noften result in pain and discomfort for the patient. (B) Preoperative evaluation for fixation screw. (C) Ideally \nthe fixation screw should exhibit bicortical stabilization, and the length measurements may be determined \nvia cone beam computed tomographic measurements. (D) The protruding tip of this fixation screw has \nbeen visualized. (From Caldwell CS. Bone grafting complications. In: Resnik RR, Misch CE, eds. Misch’s \nAvoiding Complications in Oral Implantology. St. Louis, MO: Elsevier; 2018.)"
  },
  {
    "page": 194,
    "content": "1084\nPART VII    Soft and Hard Tissue Rehabilitation\nthe surgical and anesthetic time. Larger block bone grafts may be \nharvested from the mandibular symphysis, body, or ramus area. \nParticulate autograft may be harvested from the maxillary tuber-\nosity, extraosseous tori, ridge osteoplasty, extraction sites, implant \nosteotomy, and bone collection devices. These grafts require a short \nhealing period and exhibit minimal resorption, while maintaining \ntheir dense quality. The morbidity of graft harvest is low, and com-\nplications usually result in only temporary debilitation. The use of \nthese techniques allows the placement of implants in ideal positions \nfor optimal esthetics and functional support.\nReferences\n\t 1.\t \u0007Misch CE, Dietsh F. Bone grafting materials in implant dentistry. \nImplant Dent. 1993;2:158–167.\n\t 2.\t \u0007Buser D, Bragger U, Lang NP, et al. Regeneration and enlargement \nof jaw bone using guided tissue regeneration. Clin Oral Implant Res. \n1990;1:22–32.\n\t 3.\t \u0007Lekholm U, Becker W, Dahlin C, et al. The role of early vs. late \nremoval of GTAM membranes on bone formation around oral \nimplants placed in immediate extraction sockets: an experimental \nstudy in dogs. Clin Oral Implant Res. 1993;4:121–129.\n\t 4.\t \u0007Palmer RM, Floyd PD, Palmer PJ, et al. Healing of implant dehis-\ncence defects with and without expanded polytetrafluoroethylene \nmembranes: a controlled clinical and histological study. Clin Oral \nImplant Res. 1994;5:98–104.\n\t 5.\t \u0007Jovanovic SA, Schenk RK, Orsini M, et al. Supracrestal bone for-\nmation around dental implants: an experimental dog study. Int J \nOral Maxillofac Implants. 1995;10:23–31.\n\t 6.\t \u0007Pinholt EM, Haanaes HR, Donath K, et  al. Titanium implant \ninsertion into dog alveolar ridges augmented by allogenic material. \nClin Oral Implant Res. 1994;5:213–219.\n\t 7.\t \u0007Becker W, Lekholm U, Dahlin C, et al. The effect of clinical load-\ning on bone regenerated by GTAM barriers: a study in dogs. Int J \nOral Maxillofac Implants. 1994;9:305–313.\n\t 8.\t \u0007Lang NP, Hammerle CHF, Bragger U, et al. Guided tissue regen-\neration in jawbone defects prior to implant placement. Clin Oral \nImplant Res. 1994;5:92–97.\n\t 9.\t \u0007Simion M, Baldoni M, Rossi P, et  al. A comparative study of \nthe effectiveness of e-PTFE membranes with and without early \nexposure during the healing period. Int J Periodont Rest Dent. \n1994;14:167–180.\n\t10.\t \u0007Simion M, Trisi P, Piatelli A. Vertical ridge augmentation using a \nmembrane technique associated with osseointe-grated implants. Int \nJ Periodont Rest Dent. 1994;14:497–511.\n\t11.\t \u0007Fritz ME, Malmquist J, Koth D, et al. The use of guided bone \nregeneration to fill large mandibular defects in monkeys: a pilot \nstudy. Int J Oral Maxillofac Implants. 1994;9:644–652.\n\t12.\t \u0007Becker W, Schenk R, Higuchi K, et al. Variations in bone regen-\neration adjacent to implants augmented with barrier membranes \nalone or with demineralized freeze-dried bone or autologous grafts: \na study in dogs. Int J Oral Maxillofac Implants. 1995;10:143–154.\n\t13.\t \u0007Caplanis N, Sigurdsson TJ, Rohrer MD, et al. Effect of allogeneic, \nfreeze-dried, demineralized bone matrix on guided bone regenera-\ntion in supra-alveolar peri-implant defects in dogs. Int J Oral Max-\nillofac Implants. 1997;12:634–642.\n\t14.\t \u0007Hammack BL, Enneking WF. Comparative vascularization of \nautogenous and homogenous bone transplants. J Bone Joint Surg. \n1960;42A:811.\n\t15.\t \u0007Male AJ, Gasser J, Fonseca RJ, et al. Comparison of onlay autolo-\ngous and allogenic bone grafts to the maxilla in primates. J Oral \nMaxillofac Surg. 1983;42:487–499.\n\t16.\t \u0007Boyne PJ. Performance of bone grafts in reconstructive surgery. In: \nWilliams EF, ed. Biocompatibility of Tissue Analogs. Boca Raton, \nFla: CRC Press; 1985:(2).\n\t17.\t \u0007Burchardt H. Biology of bone transplantation. Orthop Clin North \nAm. 1987;18:187–195.\n\t18.\t \u0007Marx RE. Biology of bone grafts. Oral Maxillofac Surg Knowl \nUpdate. 1994;1:3–17.\n\t19.\t \u0007Cordaro L, Amade DS, Cordaro M. Clinical results of alveolar \nridge augmentation with mandibular block bone grafts in partially \nedentulous patients prior to implant placement. Clin Oral Implants \nRes. 2002;13:103–111.\n\t20.\t \u0007Misch CE. Use of mandibular ramus as a donor site for onlay bone \ngrafting. J Oral Implantol. 2000;26:42–49.\n\t21.\t \u0007Proussaefs P, Lozada J, Kleinman A, Roaher MD. The use of \nramus autogenous block grafts for vertical alveolar ridge augmenta-\ntion and implant placement: a pilot study. Int J Oral Maxillofac \nImplants. 2002;17:238–248.\n\t22.\t \u0007Proussaefs P, Lozada J. The use of intraorally harvested autogenous \nblock grafts for vertical alveolar ridge augmentation: a human \nstudy. Int J Periodontics Rest Dent. 2005;25:351–363.\n\t23.\t \u0007Proussaefs P. Clinical and histologic evaluation of the use of man-\ndibular tori as donor site for mandibular block autografts: report of \nthree cases. Int J Periodont Res Dent. 2006;26:43–51.\n\t24.\t \u0007Schwartz-Arad D, Levin L. Multitier technique for bone aug-\nmentation using intraoral autogenous bone blocks. Implant Dent. \n2007;16:5–12.\n\t25.\t \u0007Schwartz-Arad D, Levin L. Intraoral autogenous block onlay bone \ngrafting for extensive reconstruction of atrophic maxillary alveolar \nridges. J Periodontol. 2005;76:636–641.\n\t26.\t \u0007Schwartz-Arad D, Levin L, Sigal L. Surgical success of intra-oral \nautogenous block onlay bone grafting for alveolar ridge augmenta-\ntion. Implant Dent. 2005;14:131–138.\n\t27.\t \u0007Garg AK, Morales MJ, Navarro I, et al. Autogenous mandibular \nbone grafts in the treatment of the resorbed maxillary anterior \nalveolar ridge: rationale and approach. Implant Dent. 1998;7: \n167–176.\n\t28.\t \u0007Cranin AN, Katzap M, Demirdjan E, et al. Autogenous bone ridge \naugmentation using the mandibular symphysis as a donor. J Oral \nImplantol. 2001;27:43–47.\n\t29.\t \u0007Brånemark PI, Lindstrom J, Hallen O, et al. Reconstruction of the \ndefective mandible. Scand J Plast Reconstr Surg. 1975;9:116–128.\n\t30.\t \u0007Breine U, Brånemark PI. Reconstruction of alveolar jaw bone. \nScand J Plast Reconstr Surg. 1980;14:23–48.\n\t31.\t \u0007Keller EE, van Roekel NB, Desjardins RP, et al. Prosthetic-surgical \nreconstruction of the severely resorbed maxilla with iliac bone graft-\ning and tissue-integrated prostheses. Int J Oral Maxillofac Implants. \n1987;2:155–165.\n\t32.\t \u0007Listrom RD, Symington JM. Osseointegrated dental implants \nin conjunction with bone grafts. Int J Oral Maxillofac Surg. \n1988;17:116–118.\n\t33.\t \u0007Kahnberg KE, Nystrom L, Bartholdsson L. Combined use of bone \ngrafts and Brånemark fixtures in the treatment of severely resorbed \nmaxillae. Int J Oral Maxillofac Implants. 1989;4:297–304.\n\t34.\t \u0007Misch CE, Dietsh F. Endosteal implants and iliac crest grafts to \nrestore severely resorbed totally edentulous maxillae: a retrospective \nstudy. J Oral Implantol. 1994;20:100–110.\n\t35.\t \u0007Joshi A, Kostakis GC. An investigation of post-operative \nmorbidity following iliac crest graft harvesting. Br Dent J. \n2004;196:167–171.\n\t36.\t \u0007Sindet-Pedersen S, Enemark H. Reconstruction of alveolar clefts \nwith mandibular or iliac crest bone grafts: a compa-rative study. \nJ Oral Maxillofac Surg. 1990;48:554–558.\n\t37.\t \u0007Borstlap WA, Heidbuchel KLWM, Freihofer HPM, et al. Early \nsecondary bone grafting of alveolar cleft defects: a comparison \nbetween chin and rib grafts. J Cranio Max Fac Surg. 1990;18: \n201–205.\n\t38.\t \u0007Misch CM, Misch CE, Resnik R, et al. Reconstruction of maxil-\nlary alveolar defects with mandibular symphysis grafts for dental \nimplants: a preliminary procedural report. Int J Oral Maxillofac \nImplants. 1992;7:360–366."
  },
  {
    "page": 195,
    "content": "1085\nCHAPTER 38  Intraoral Autogenous Bone Grafting\n\t39.\t \u0007Jensen J, Sindet-Pedersen S. Autogenous mandibular bone grafts \nand osseointegrated implants for reconstruction of the severely \natrophied maxilla: a preliminary report. J Oral Maxillofac Surg. \n1991;49:1277–1287.\n\t40.\t \u0007Jensen J, Sindet-Pedersen S, Oliver AJ. Varying treatment strategies \nfor reconstruction of maxillary atrophy with implants: results in 98 \npatients. J Oral Maxillofac Surg. 1994;52:210–216.\n\t41.\t \u0007Misch CM, Misch CE. The repair of localized severe ridge defects \nfor implant placement using mandibular bone grafts. Implant Dent. \n1995;4:261–267.\n\t42.\t \u0007Misch CM. Ridge augmentation using mandibular ramus bone \ngrafts for the placement of dental implants: presentation of a tech-\nnique. Prac Periodont Aesth Dent. 1996;8:127–135.\n\t43.\t \u0007Aalam AA, Nowzari H. Mandibular cortical bone grafts part 1: \nanatomy, healing process, and influencing factors. Compend Contin \nEduc Dent. 2007;28:206–212.\n\t44.\t \u0007Misch CM. Comparison of intraoral donor sites for onlay graft-\ning prior to implant placement. Int J Oral Maxillofac Implants. \n1997;12:767–776.\n\t45.\t \u0007Misch CM. Enhance maxillary implant sites through symphysis \nbone graft. Dent Implant Update. 1991;2:101–104.\n\t46.\t \u0007Smith JD, Abramson M. Membranous vs. endochondral bone \nautografts. Arch Otolaryngol. 1974;99:203.\n\t47.\t \u0007Zins JE, Whitaker LA. Membranous vs endochondral bone auto-\ngrafts: implications for craniofacial reconstruction. Plast Reconstruct \nSurg. 1983;72:778.\n\t48.\t \u0007Kusiak JF, Zins JE, Whitaker LA. The early revascularization of \nmembranous bone. Plast Reconstr Surg. 1985;76:510–514.\n\t49.\t \u0007Lin KY, Bartlett SP, Yaremchuk MJ, et al. The effect of rigid fixa-\ntion on the survival of onlay bone grafts: an experimental study. \nPlast Reconstruct Surg. 1990;86:449–456.\n\t50.\t \u0007Rabie ABM, Dan Z, Samman N. Ultrastructural identification of \ncells involved in the healing of intramembranous and endochon-\ndral bones. Int J Oral Maxillofac Surg. 1996;25:383–388.\n\t51.\t \u0007Miller NA, Penaud J, Kohler C, et al. Regeneration of bone graft \ndonor sites. Clin Oral Implants Res. 1999;10:326–330.\n\t52.\t \u0007Avery JK. Development of cartilages and bones of the facial skel-\neton. In: Avery JK, ed. Oral Development and Histology. New York: \nThieme Medical Publishers; 1994.\n\t53.\t \u0007Marx RE. The science of reconstruction. In: Bell WH, ed. Modern \nPractice in Orthognathic and Reconstructive Surgery. Philadelphia: \nWB Saunders; 1992.\n\t54.\t \u0007Shirota T, Ohno K, Motohashi M, et al. Histologic and microra-\ndiologic comparison of block and particulate cancellous bone and \nmarrow grafts in reconstructed mandibles being considered for \ndental implant placement. J Oral Maxillofac Surg. 1996;54:15–20.\n\t55.\t \u0007Lu M, Rabie AB. Quantitative assessment of early healing of intra-\nmembranous and endochondral autogenous bone grafts using \nmicro-computed tomography and Q-win image analyzer. Int J Oral \nMaxillofac Surg. 2004;33:369–376.\n\t56.\t \u0007Lu M, Rabie AB. Macroarchitecture of rabbit mandibular defects \ngrafted with intramembranous or endochondral bone shown \nby micro-computed tomography. Br J Oral Maxillofac Surg. \n2003;41:385–391.\n\t57.\t \u0007Ozaki W, Buchman SR. Volume maintenance of onlay bone grafts \nin the craniofacial skeleton: micro-architecture versus embryologic \norigin. Plast Reconstr Surg. 1998;102:291–299.\n\t58.\t \u0007Glowacki J. In: discussion of Kusiak JF, Zins JE, Whitaker LA: \nThe early revascularization of membranous bone. Plast Reconstr Surg. \n1985;76:515.\n\t59.\t \u0007Rosenthal AH, Buchman SR. Volume maintenance of inlay \nbone grafts in the craniofacial skeleton. Plast Reconstr Surg. \n2003;112:802–811.\n\t60.\t \u0007Sharawy M, El-Shazly D, Um IW, et al. Fate of allogeneic cranial \nbone grafted to rabbit mandible (abstract 1015). J Dent Res. 1996:75.\n\t61.\t \u0007Takikawa S, Bauer TW, Kambic H, et al. Comparative evaluation \nof the osteoinductivity of two formulations of human demineral-\nized bone matrix. J Biomed Mater Res A. 2003;65:37–42.\n\t62.\t \u0007Martin GJ, Boden SD, Titus L, et al. New formulations of demin-\neralized bone matrix as a more effective bone graft alternative in \nexperimental posterior lateral lumbar spine arthrodesis. Spine. \n1999;24:637.\n\t63.\t \u0007Finkleman RD, Eason AL, Rakijian DR, et al. Elevated IGF-II and \nTGF-B concentrations in human calvarial bone: potential mech-\nanism for increased graft survival and resistance to osteoporosis. \nPlast Reconstr Surg. 1994;93:732–738.\n\t64.\t \u0007Hardesty RA, Marsh JL. Craniofacial onlay bone grafting: a pro-\nspective evaluation of graft morphology, orientation and embry-\nonic origin. Plast Reconstr Surg. 1990;85:5–14.\n\t65.\t \u0007Manson PN. Facial bone healing and bone grafts: a review of clini-\ncal physiology. Clin Plast Surg. 1994;21:331–348.\n\t66.\t \u0007Alberius P, Gordh M, Linberg L, et al. Influence of surrounding \nsoft tissues on onlay bone graft incor-poration. Oral Surg Oral Med \nOral Pathol. 1996;82:22–33.\n\t67.\t \u0007Lew D, Marino AA, Startzell JM, et al. A comparative study of \nosseointegration of titanium implants in corticocancellous block \nand corticocancellous chip grafts in canine ilium. J Oral Maxillofac \nSurg. 1994;52:952–958.\n\t68.\t \u0007Wong RW, Rabie AB. A quantitative assessment of the healing of \nintramembranous and endochondral autogenous bone grafts. Eur J \nOrthod. 1999;21:119–126.\n\t69.\t \u0007Buser D, Dula K, Belser UC, et al. Localized ridge augmentation \nusing guided bone regeneration. II. Surgical procedure in the man-\ndible. Int J Periodont Rest Dent. 1995;15:11–29.\n\t70.\t \u0007Roberts WE, Garetto LP, DeCastro RA. Remodeling of devital-\nized bone threatens periosteal margin integrity of endosseous tita-\nnium implants with threaded or smooth surfaces: indications for \nprovisional loading and axially directed occlusion. J Ind Dent Assoc. \n1989;68:19–24.\n\t71.\t \u0007Schenk RK. Bone regeneration: biologic basis. In: Buser D, Dahlin \nC, Schenk RK, eds. Guided Bone Regeneration in Implant Dentistry. \nChicago: Quintessence; 1994.\n\t72.\t \u0007Buser D, Dula K, Hirt HP, et  al. Lateral ridge augmenta-\ntion using autografts and barrier membranes: a clinical study \nwith 40 partially edentulous patients. J Oral Maxillofac Surg. \n1996;54:420–432.\n\t73.\t \u0007Misch CE. Density of bone: effect on treatment plans, surgical \napproach, healing and progressive bone loading. Int J Oral Implan-\ntol. 1990;6:23–31.\n\t74.\t \u0007Sennerby L, Thomsen P, Ericson LE. A morphometric and biome-\nchanic comparison of titanium implants inserted in rabbit cortical \nand cancellous bone. Int J Oral Maxillofac Implants. 1992;7:62–71.\n\t75.\t \u0007Bidez M, Misch CE. Issues in bone mechanics related to oral \nimplants. Implant Dent. 1992;1:289–294.\n\t76.\t \u0007Collins TA. Onlay bone grafting in combination with Brånemark \nimplants. Oral Maxillofac Surg Clin North Am. 1991;3:893–902.\n\t77.\t \u0007ten Bruggenkate CM, Kraaijenhagen HA, van der Kwast WA, et al. \nAutogenous maxillary bone grafts in conjunction with placement \nof I.T.I. endosseous implants: a preliminary report. Int J Oral Max-\nillofac Surg. 1992;21:81–84.\n\t78.\t \u0007Rosenquist JB, Nystrom E. Occlusion of the incisal canal with \nbone chips. Int J Oral Maxillfac Surg. 1992;21:210–211.\n\t79.\t \u0007Bahat O, Fontanesi RV, Preston J. Reconstruction of the hard and \nsoft tissues for optimal placement of osseointegrated implants. Int J \nPeriodont Rest Dent. 1993;13:255–275.\n\t80.\t \u0007Collins TA, Nunn W. Autogenous veneer grafting for improved \nesthetics with dental implants. Compend Contin Educ Dent. \n1994;15:370–376.\n\t81.\t \u0007Becker W, Becker BE, Polizzi G, et al. Autogenous bone grafting \nof bone defects adjacent to implants placed into immediate extrac-\ntion sockets in patients: a prospective study. Int J Oral Maxillofac \nImplants. 1994;9:389–396.\n\t82.\t \u0007Becker W, Becker BE, Caffesse R. A comparison of demin-\neralized freeze-dried bone and autologous bone to induce \nbone formation in human extraction sockets. J Periodontol. \n1994;65:1128–1133."
  },
  {
    "page": 196,
    "content": "1086\nPART VII    Soft and Hard Tissue Rehabilitation\n\t83.\t \u0007Raghoebar GM, Batenburg RHK, Vissink A, et al. Augmentation \nof localized defects of the anterior maxillary ridge with autog-\nenous bone before insertion of implants. J Oral Maxillofac Surg. \n1996;54:1180–1185.\n\t84.\t \u0007Friberg B. Bone augmentation at single-tooth implants using man-\ndibular grafts: a one-stage surgical procedure. Int J Periodont Rest \nDent. 1995;15:437–445.\n\t85.\t \u0007Lustmann J, Lewinstein I. Interpositional bone grafting technique \nto widen narrow maxillary ridge. Int J Oral Maxillofac Implants. \n1995;10:568–577.\n\t86.\t \u0007Lazzara R. Transplantation of a preosseointegrated implant from \nthe mental area to a maxillary sinus graft. Int J Periodont Rest Dent. \n1995;15:539–547.\n\t87.\t \u0007Williamson RA. Rehabilitation of the resorbed maxilla and man-\ndible using autogenous bone grafts and osseointegrated implants. \nInt J Oral Maxillofac Implants. 1996;11:476–488.\n\t88.\t \u0007Triplett RG, Schow S. Autologous bone grafts and endosseous \nimplants: complementary techniques. J Oral Maxillofac Surg. \n1996;54:486–494.\n\t89.\t \u0007Boyne PJ. Bone grafts: materials. In: Boyne PJ, ed. Osseous Recon-\nstruction of the Maxilla and the Mandible: Surgical Techniques Using \nTitanium Mesh and Bone Mineral. Chicago: Quintessence; 1996.\n\t90.\t \u0007von Arx T, Hardt N, Wallkamm B. The TIME technique: a \nnew method for localized alveolar ridge augmentation prior to \nplacement of dental implants. Int J Oral Maxillofac Implants. \n1996;11:387–394.\n\t91.\t \u0007Chiapasco M, Zaniboni M, Rimondini L. Autogenous onlay bone \ngrafts vs. alveolar distraction osteogenesis for the correction of ver-\ntically deficient edentulous ridges: a 2-4 year prospective study on \nhumans. Clin Oral Implant Res. 2007;18:432–440.\n\t92.\t \u0007Garber DA, Belser UC. Restoration-driven implant placement \nwith restoration-generated site development. Compend Contin Educ \nDent. 1995;16:796–804.\n\t93.\t \u0007Mecall RA, Rosenfeld AL. The influence of residual ridge resorp-\ntion patterns on fixture placement and tooth position in the partially \nedentulous patient. Part III. Presurgical assessment of ridge augmen-\ntation requirements. Int J Periodont Rest Dent. 1996;16:323–337.\n\t94.\t \u0007Rosenfeld AL, Mecall RA. The use of interactive computed tomogra-\nphy to predict the esthetic and functional demands of implant-sup-\nported prostheses. Compend Contin Educ Dent. 1996;17:1125–1144.\n\t95.\t \u0007Sarment DP, Misch CE. Scannographic templates for novel preim-\nplant planning methods. Int Mag Oral Implan. 2002;4:16–22.\n\t96.\t \u0007Albrektsson T. Repair of bone grafts: a vital microscopic and his-\ntologic investigation in the rabbit. Scand J Plast Reconstr Surg. \n1980;14:1–12.\n\t97.\t \u0007Cutright B, Quillopa N, Schubert W. An anthropometric study of \nthe key foramina for maxillofacial surgery. J Oral Maxillofac Surg. \n2003;61:354–357.\n\t98.\t \u0007Montazem A, Valauri DV, St-Hilaire H, et  al. The mandibular \nsymphysis as a donor site in maxillofacial bone grafting: a qualita-\ntive anatomic study. J Oral Maxillofac Surg. 2000;58:1368–1371.\n\t99.\t \u0007Gapski R, Wang HL, Misch CE. Management of incision design \nin symphysis graft procedures: a review of the literature. J Oral \nImplant. 2001;26. 13243-13142.\n\t100.\t \u0007Suer BT, Yaman Z. Harvesting mandibular ramus bone grafts using \nultrasonic surgical device: report of 20 cases. J Dent Oral Disord \nTher. 2014;2(1):5.\n\t101.\t \u0007Nelson Stanley J. Wheeler’s Dental Anatomy, Physiology and Occlu-\nsion-E-Book. Elsevier Health Sciences; 2014.\n\t102.\t \u0007Buhr W, Coulon JP. Limits of the mandibular symphysis as a \ndonor site for bone grafts in early secondary cleft palate osteoplasty. \nInt J Oral Maxillofac Surg. 1996;25:389–393.\n\t103.\t \u0007Kaufman E, Wang PD. Localized vertical maxillary ridge augmen-\ntation using symphyseal bone cores: a technique and case report. \nInt J Oral Maxillofac Implants. 2003;18:293–298.\n\t104.\t \u0007Rajchel J, Ellis E, Fonseca RJ. The anatomical location of the man-\ndibular canal: its relationship to the sagittal ramus osteotomy. Int J \nAdult Orthod Orthognath Surg. 1986;1:37.\n\t105.\t \u0007Smith BR, Rajchel JL. II. Anatomic considerations in mandibular \nramus osteotomies. In: Bell WH, ed. Modern Practice in Orthogna-\nthic and Reconstructive Surgery. Philadelphia: WB Saunders; 1992.\n\t106.\t \u0007Hall HD. Intraoral surgery. In: Bell WH, ed. Modern Practice in \nOrthognathic and Reconstructive Surgery. Philadelphia: WB Saun-\nders; 1992.\n\t107.\t \u0007Gungormus M, Yavuz MS. The ascending ramus of the mandible as \na donor site in maxillofacial bone grafting. J Oral Maxillofac Surg. \n2002;60:1316–1318.\n\t108.\t \u0007Wood RM, Moore DL. Grafting of the maxillary sinus with intra-\norally harvested autogenous bone prior to implant placement. Int J \nOral Maxillofac Implants. 1988;3:209–214.\n\t109.\t \u0007Wheeler S, Holmes RE, Calhoun CJ. Six-year clinical and his-\ntologic study of sinus-lift grafts. Int J Oral Maxillofac Implants. \n1996;11:26–34.\n\t110.\t \u0007Berry RL, Edwards RC, Paxton MC. Nasal augmentation using the \nmandibular coronoid as an autogenous graft: report of case. J Oral \nMaxillofac Surg. 1994;52:633–638.\n\t111.\t \u0007McLoughlin PM, Hopper C, Bowley NB. Hyperplasia of the man-\ndibular coronoid process: an analysis of 31 cases and a review of the \nliterature. J Oral Maxillofac Surg. 1995;53:250–255.\n\t112.\t \u0007Koury ME. Complications of mandibular fractures. In: Kaban LB, \nPogrel MA, Perrott DH, eds. Complications in Oral and Maxillofa-\ncial Surgery. Philadelphia: WB Saunders; 1997.\n\t113.\t \u0007Trauner R, Obwegeser H. The surgical correction of mandibular \nprognathism and retrognathia with consideration of genioplasty. \nPart I. Surgical procedures to correct mandibular prognathism and \nreshaping of the chin. Oral Surg. 1957;10:677.\n\t114.\t \u0007DalPont G. Retromolar osteotomy for correction of prognathism. \nJ Oral Surg. 1961;19:42.\n\t115.\t \u0007Hunsuck EE. Modified intraoral splitting technique for correction \nof mandibular prognathism. J Oral Surg. 1968;26:250.\n\t116.\t \u0007Epker BN. Modifications in the sagittal osteotomy of the mandible. \nJ Oral Surg. 1977;35:157.\n\t117.\t \u0007Bell WH, Schendel SA. Biologic basis for modification of the sagit-\ntal ramus split operation. J Oral Surg. 1977;34:362.\n\t118.\t \u0007Heggie AAC. The use of mandibular buccal cortical grafts in \nbimaxillary surgery. J Oral Maxillofac Surg. 1993;51:1282–1283.\n\t119.\t \u0007Jensen J, Reiche-Fischel O, Sindet-Pedersen S. Autogenous man-\ndibular bone grafts for molar augmentation. J Oral Maxillofac Surg. \n1995;53:88–90.\n\t120.\t \u0007Clavero J, Lundgren S. Ramus or chin grafts for maxillary sinus \ninlay and local onlay augmentation: Comparison of donor site mor-\nbidity and complications. Clin Implant Dent Relat Res. 2003;5:154.\n\t121.\t \u0007Whitaker LA. Biological boundaries: a concept in facial skeletal \nrestructuring. Clin Plast Surg. 1989;16:1.\n\t122.\t \u0007Nyman S, Lang NP, Buser D, et al. Bone regeneration adjacent to \ntitanium dental implants using guided tissue regeneration. A report \nof two cases. Int J Oral Maxillofac Implants. 1990;5:9–14.\n\t123.\t \u0007Marx RE, Snyder RM, Kline SN. Cellular survival of human mar-\nrow during placement of marrow cancellous bone grafts. J Oral \nSurg. 1979;37:712–718.\n\t124.\t \u0007Steiner M, Ramp WK. Short-term storage of freshly harvested \nbone. J Oral Maxillofac Surg. 1988;46:868–871.\n\t125.\t \u0007Thompson N, Casson JA. Experimental onlay bone grafts to the \njaws: a preliminary study in dogs. Plast Reconstr Surg. 1970;46: \n341–349.\n\t126.\t \u0007Knize D. The influence of periosteum and calcitonin on onlay bone \ngraft survival. Plast Reconstr Surg. 1974;53:190–199.\n\t127.\t \u0007Fonseca RJ, Clark PJ, Burkes EJ, et al. Revascularization and heal-\ning of onlay particulate autologous bone grafts in primates. J Oral \nSurg. 1980;38:572–577.\n\t128.\t \u0007Dado DV, Izquierdo R. Absorption of onlay bone grafts in imma-\nture rabbits: membranous versus endochondral bone and bone \nstruts versus paste. Ann Plast Surg. 1989;23:39–48.\n\t129.\t \u0007Chaushu G, Mardinger O, Peleg M. Analysis of complications fol-\nlowing augmentation with cancellous block allografts. J Periodon-\ntol. 2010;81(12):1759–1764."
  },
  {
    "page": 197,
    "content": "1087\nCHAPTER 38  Intraoral Autogenous Bone Grafting\n\t130.\t \u0007Gielkens PF, Bos RR, Raghoebar GM. Is there evidence that barrier \nmembranes prevent bone resorption in autologous bone grafts dur-\ning the healing period? A systematic review. Int J Oral Maxillofac \nImplants. 2007;22(3):390–398.\n\t131.\t \u0007Aloy-Prósper A, Peñarrocha-Oltra D, Peñarrocha-Diago MA, et al. \nThe outcome of intraoral onlay block bone grafts on alveolar ridge \naugmentations: a systematic review. Med Oral Patol Oral Cir Bucal. \n2015;20(2):e251.\n\t132.\t \u0007Gultekin BA, Bedeloglu E, Kose TE, et al. Comparison of bone \nresorption rates after intraoral block bone and guided bone regener-\nation augmentation for the reconstruction of horizontally deficient \nmaxillary alveolar ridges. BioMed Res Int. 2016.\n\t133.\t \u0007Yates DM, Brockhoff II HC, Finn R, Phillips C. Comparison of \nintraoral harvest sites for corticocancellous bone grafts. J Oral Max-\nillofac Surg. 2013;71(3):497–504.\n\t134.\t \u0007Jones JK, Triplett RG. The relationship of smoking to impaired \nintraoral wound healing. J Oral Maxillofac Surg. 1992;50: \n237–239.\n\t135.\t \u0007Misch CM. The extracted tooth pontic-provisional replacement \nduring bone graft and implant healing. Pract Periodont Aesth Dent. \n1998;10:711–718.\n\t136.\t \u0007Schnitman PA, Wohrle PS, Rubenstein JE. Immediate fixed interim \nprostheses supported by two-stage threaded implants. Methodol-\nogy and results. J Oral Implantol. 1990;16:96–105.\n\t137.\t \u0007Salama H, Rose LF, Salama M, et al. Immediate loading of bilat-\nerally splinted titanium root-form implants in fixed prosthodon-\ntics—a technique reexamined: two case reports. Int J Periodont Rest \nDent. 1995;15:345–361.\n\t138.\t \u0007Misch CM. Comparison of intraoral donor sites for onlay graft-\ning prior to implant placement. Int J Oral Maxillofac Implants. \n1997;12:767–776.\n\t139.\t \u0007Hoppenreijs TJM, Nijdam ES, Freihofer HPM. The chin as a donor \nsite in early secondary osteoplasty: a retrospective clinical and radio-\nlogical evaluation. J Cranio Maxillofac Surg. 1992;20(3):119–124.\n\t140.\t \u0007Borstlap WA, Stoelinga PJ, Hoppenreijs TJ, van’t Hof MA. Stabili-\nsation of sagittal split advancement osteotomies with miniplates: a \nprospective, multicentre study with two-year follow-up. Part I. Clin-\nical parameters. Int J Oral Maxillofac Surg. 2004;33(5):433–441.\n\t141.\t \u0007Miller RJ, Edwards WC, Boudet C, Cohen JH. Revised Maxillofa-\ncial Anatomy: the mandibular symphysis in 3D. Int J Dent Implants \nBiomaterials. 2009;2:1–7.\n\t142.\t \u0007Hendy CW, Smith KG, Robinson PP. Surgical anatomy of the \nbuccal nerve. Br J Oral Maxillofac Surg. 1996;34:457–460.\n\t143.\t \u0007Nkenke E, Radespiel-Troger M, Wiltfang J, et al. Morbidity of har-\nvesting of retromolar bone grafts: a prospective study. Clin Oral \nImplants Res. 2002;13:513–521.\n\t144.\t \u0007Silva FM, Cortez AL, Moreira RW, et al. Complications of intra-\noral donor site for bone grafting prior to implant placement. \nImplant Dent. 2006;15:420–426.\n\t145.\t \u0007Fontana F, Maschera E, Rocchietta I, Simion M. Clinical classifica-\ntion of complications in guided bone regeneration procedures by \nmeans of a nonresorbable membrane. Int J Periodontics Restorative \nDent. 2011;31(3):265–274.\n\t146.\t \u0007Koole R, Bosker H, Noorman van der Dussen F. Secondary autog-\nenous bone grafting in cleft patients comparing mandibular (ecto-\nmesenchymal) and iliac crest (mesenchymal) grafts. J Cranio Max \nFac Surg. 1989;17:28–30.\n\t147.\t \u0007Nystrom E, Kahnberg KE, Albrektsson T. Treatment of the severely \nresorbed maxillae with bone graft and titanium implants: histo-\nlogic review of autopsy specimens. Int J Oral Maxillofac Implants. \n1993;8:167–172.\n\t148.\t \u0007Buser D, Dula K, Belser U, et al. Localized ridge augmentation \nusing guided bone regeneration. I. Surgical procedure in the max-\nilla. Int J Periodont Rest Dent. 1993;13:29–45.\n\t149.\t \u0007Simion M, Dahlin C, Trisi P, et al. Qualitative and quantitative \ncomparative study on different filling materials used in bone tissue \nregeneration: a controlled clinical study. Int J Periodont Rest Dent. \n1994;14:199–215.\n\t150.\t \u0007Simion M, Fontana F. Autogenous and xenogeneic bone grafts \nfor the bone regeneration: a literature review. Minerva Stomatol. \n2004;53:191–206.\n\t151.\t \u0007Pansegrau KJ, Friedrich KL, Lew D, et al. A comparative study \nof osseointegration of titanium implants in autogenous and freeze-\ndried bone grafts. J Oral Maxillofac Surg. 1998;56:1067–1073.\n\t152.\t \u0007Roberts EW. Bone tissue interface. J Dent Educ. 1988;52: \n804–809.\n\t153.\t \u0007Chen J, Chen K, Garetto LP, et al. Mechanical response to func-\ntional and therapeutic loading of a retromolar endosseous implant \nused for orthodontic anchorage to mesially translate mandibular \nmolars. Implant Dent. 1995;4:246–258.\n\t154.\t \u0007Misch CE. Early crestal bone loss etiology and its effect on treat-\nment planning for implants. Postgrad Dent. 1995;2:3–16.\n\t155.\t \u0007Hall MB. Marginal bone loss around Brånemark fixtures in \nbone grafts used for augmentation. J Oral Maxillofac Surg. 1990; \n48:117.\n\t156.\t \u0007Ozkan Y, Ozcan M, Varol A, et al. Resonance frequency analy-\nsis assessment of implant stability in labial onlay grafted posterior \nmandibles: a pilot clinical study. Int J Oral Maxillofac Implants. \n2007;22:235–242.\n\t157.\t \u0007Sjostrom M, Lundgren S, Milson H, et al. Monitoring of implant \nstability in grafted bone using resonance frequency analysis. A clini-\ncal study from implant placement to 6 months of loading. Int J \nOral Maxillofac Surg. 2005;34:45–51.\n\t158.\t \u0007Sethi A, Kaus T. Ridge augmentation using mandibular block bone \ngrafts: preliminary results of an ongoing prospective study. Int J \nOral Maxillofac Implants. 2001;16:378–388."
  },
  {
    "page": 198,
    "content": "1088\n39\nExtraoral Bone Grafting for \nImplant Reconstruction\nDAVID J. DATTILO\nIntroduction\nThe pool of patients that are eligible for dental implant recon-\nstruction has expanded widely since Brånemark’s research first hit \nthe world of dentistry in the early 1980’s. Extensive research in \nbone biology, coupled with newer and proven bone grafting tech-\nniques, leaves almost no patient outside the boundaries of eligible \nrecipients. This includes patients with large bony defects resulting \nfrom trauma, resection from pathologic lesions, and congenital \ndeformities, which would be classified as division E in the Misch-\nJudy classification of available bone and prosthetic options.1,2 \nProcedures designed to provide large quantities of bone harvested \nfrom outside of the facial region that were previously used to only \nrestore continuity and primitive function now are expected to \nreproduce vertical and horizontal dimensions for ideal placement \nof implant fixtures for the support of multiple prosthetic designs.\nThese new demands on the implant surgeon make the evalu-\nation of the recipient defect, both dimensions and biologic envi-\nronment, as well as the appropriateness of the potential donor \nsite bone quality, of paramount importance. For instance, loss of \nbone from treatment of neoplastic or other pathologic processes \nrepresents far greater reconstructive challenges than loss of bone \nfrom trauma or infection. Other factors important to deciding \nthe type and quantity of bone graft required to be harvested for \nlarger defects is the presence of systemic diseases and the possible \nexposure to therapeutic doses of ionizing radiation. Success rates \nof bone grafts in irradiated jaws have been found to be lower by \nsignificant amounts, as well as complication rates of 81.3%.3 The \nrich cellular components that make autogenous grafts the “gold \nstandard” of implant-supported bone grafts, along with tech-\nniques such as hyperbaric oxygen treatment, platelet-rich plasma, \nand the use of engineered growth factors such as bone morpho-\ngenetic protein (BMP), all act to combat and hopefully overcome \nany hostile environment to provide a healthy osseous base for the \nplacement of dental implants.\nThe four major anatomic areas for harvesting of free autog-\nenous bone that will be discussed in this chapter include the cra-\nnium, the anterior and posterior iliac crest, and the tibial plateau. \nThe necessity required for the proverbial Mother of these inventive \ntechniques was primarily provided by the multiple facial injuries \nsustained by American and German soldiers during World War I \nand II. Surgeons from both countries, when faced with such large \ndeformities caused by the latest in wartime ballistics, searched the \nbody for the largest reservoirs of bone that could be used to fill \nthese functional and cosmetic defects. Surgical researchers Wolff, \nMoss, Tessier, Boyne, and Marx then took these procedures and \ninvestigated the details of bone graft healing and the interaction \nbetween the bone and the recipient soft tissue bed.7,8 These ini-\ntial autogenous bone grafts, however, were characterized by rapid \nand advanced bone resorption, which sometimes reached 30% to \n90% in the best of conditions.9,10 With the advent of endosteal \nimplants used in conjunction with autogenous grafts, research \nbegan reporting the maintenance of the grafted bone and the \nprevention of this rapid bone resorption.11,12 Surgeons placing \nextraoral autogenous bone grafts, when used in conjunction with \nendosteal implants, can now expect to maintain better than 90% \nof the initial grafted segment.\nAutogenous free bone grafts harvested from these four donor \nsites and their subsequent recipient sites have other unique bio-\nlogic qualities that contribute to their appropriate use for dental \nimplant support.  Calvarium and mandibular bone are of intra-\nmembranous origin formed through the progressive differentia-\ntion from primordial mesenchymal cells to stem cells to osteocytes, \nwhile the maxilla, anterior and posterior iliac crest and the tibia are \nformed through endochondral ossification through the transfor-\nmation and replacement of already formed cartilage.\nEarly studies comparing these two types of grafts on animal \nmodels revealed superiority of intramembranous bone grafts taken \nfrom the skull to endochondral bone grafts taken from the ilium \nor the rib.4,5 At one year, the intramembranous grafts appeared to \nmaintain the original grafted volume, whereas the endochondral \ngrafts were decreased in volume by 75%. These findings appeared \nto be counterintuitive because the higher cancellous bone content \nof the endochondral grafts would seem to welcome a much faster \nrevascularization than the more cortical intramembranous bone. \nFollow up studies actually showed a more rapid revascularization \nof these membranous grafts with complete ingrowth of vessels \nfrom the host bone and periosteum at 14 days whereas the endo-\nchondral bone still showed significant areas of necrotic bone and \nareas of resorption.6\nIronically, it appears the mechanism of revascularization of both \nthe intramembranous and endochondral grafts proceeds along \nthe same pathway borrowing similarities from both mechanisms \nwith the grafted bone acting as the matrix (osteoconduction) that"
  },
  {
    "page": 199,
    "content": "1089\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\nis subsequently replaced by osteoid generated by viable osteogenic \ncells (osteogenesis) with regulation from grafted growth factors \n(osteoinduction). \nEach of the four major donor sites for free autogenous grafts \nare unique in their ability to provide one or both of the essential \nstructural elements of bone, which include the strong and rigid \ncortical or the softer but more cellular and regenerative cancel-\nlous. These two bone types also differ in the process in which they \nregenerate new bone. The calvarial graft is predominantly corti-\ncal bone and used in areas in which maintenance of a particular \ndimension is essential for a longer term, bone grafts from the iliac \ncrest provide both cortical and cancellous bone in different quan-\ntities, and the tibial plateau is useful for obtaining quantities of \ncancellous bone only (Fig. 39.1).\nAll of these grafts can be augmented with a number of dif-\nferent supplemental materials, regenerated blood products, and \nexogenous growth factors, which may assist in turning these \ngrafted sites into the ideal bone quality to support future implant \nplacement.\nFinally, in spite of all of the positive science and technology \nsupporting the potential regenerative capacity of free autogenous \ngrafts, there will always be instances in which the size of the defect, \nor the lack of sufficient soft tissue cover and blood supply, or both, \nprevent the use of this technique. For the sake of completeness, \nthe end of this chapter will discuss the use of the vascularized \ncomposite bone grafts. Originally used to augment the largest \nof facial defects with less than optimum cosmetic and functional \nresults, this procedure also has progressed and improved along \nwith the rise in dental implant technology to refine the technique \nand provide more than an acceptable osseous base for an implant-\nsupported prosthesis. \nExtraoral Donor Bone Graft Sites\nCalvarial Graft\nThe prospect of having bone harvested from the skull (calvarial), \nwhich is an area so close to one of the most vital structures of \nthe human body, makes most patients cringe at the possibilities \nof such a dangerous procedure. The reality is quite the opposite. \nOf all of the extraoral bone grafting procedures discussed in this \nchapter, the split-thickness calvarial graft offers a very convenient \noption of unlimited bone with the least amount of postopera-\ntive morbidity. Access incisions are hidden inside the hairline and \npostoperative pain is minimal. For implant-guided reconstruc-\ntion, the donor site lies close to the recipient site, therefore the \nprocedure is not prolonged significantly more than an intraoral \ngrafting procedure. The cortical nature and volume of the outside \ntable with the intervening diploe of cancellous bone provide wide \npossibilities of shape, contour, and stability for reconstruction of \nany potential dental implant site. This bone is particularly useful \nfor onlay grafting to augment the atrophic mandible and maxilla \n(Fig. 39.2).\nTessier, in his landmark publication in 1982, first championed \nthe use of full- and split-thickness cranial grafts for the reconstruc-\ntion of congenital deformities in children and young adults.13 \nFor the purposes of site preparation for the placement of dental \nimplants, the use of the split-thickness graft will more than suffice. \nCranium\nMedical Illustration Drawing\nLarge area on\nbilateral parietal\nregions\nMinimal\nAnterior iliac crest\n3x5 cm Cortico-\ncancellous blocks\n50cc’s\nMorcilized bone\nPosterior iliac crest\n5x5 cm Cortico-\ncancellous blocks\n100–125cc’s\nMorcilized bone\nTibia\nNone\n24–40cc’s Cancellous bone\nFibula\nMaximum of 26cm in\nlength and 3cm in\nwidth of vascularized\nbicortical bone\nCortical\nSource\nCancellous\n• Fig. 39.1  Extraoral autogenous donor sites with the resultant quantity of cortical and cancellous bone."
  },
  {
    "page": 200,
    "content": "1090 PART VII    Soft and Hard Tissue Rehabilitation\nThe parietal bone, just above the insertion of the temporalis mus-\ncle, is the ideal spot for harvesting because of its thickness and its \nrelative isolation from vital structures both above and below the \ncranial vault. The thickness of the parietal bone can vary from 3 to \n12 mm, and any site less than 6 mm is a contraindication because \nof the possibility of dura exposure and possible tear. This procedure \nis also contraindicated in children less than 9 years of age because \nof the underdevelopment of the diploic space.14 It is also recom-\nmended that surgeons choose the nondominant hemisphere side \nof the cranium, although postharvest magnetic resonance imaging \n(MRI) studies of the underlying brain did not detect any abnor-\nmalities, even in cases when there was a full-thickness breach.15\nAnatomy and Technique\nIncision design and placement is dependent on the amount of \ngraft required for the reconstruction. For a large graft, a bicoronal \nincision is marked off in the hair bearing the scalp 4.0 cm poste-\nrior to the anterior hairline to hide the resultant scar and to expose \nas much of the parietal surface as possible. For smaller grafts, inci-\nsions may be made directly over the donor sight (Fig. 39.3).\nThe hair is washed and prepped, however, it is not shaved. Local \nanesthetic with vasoconstrictor is injected along the planned inci-\nsion site. It is imperative to wait the mandatory time (5–7 min-\nutes) to allow the anesthetic vasoconstriction in this very vascular \narea to be effective. Electrocautery may be used from the dermis \nlayer down to the bone so as to not disturb the hair follicles. Raney \nclips are then placed on both sides of the incision to help control \nfurther bleeding. Bone incisions are then outlined with a surgical \nmarker or electrocautery, making sure all boundaries are behind \nthe coronal suture and well away from the midline to avoid the \nsuperior sagittal sinus. The superior incision should be placed 2.0 \ncm lateral to the superior sagittal sinus, and the inferior extent of \nthe incision should be 2.0 cm above the squamoparietal suture \nto avoid the middle meningeal artery. This area, the middle to \nposterior region of the parietal bone, has been shown to exhibit \nthe thickest bone with the most developed diploic space.16 For the \npurposes of grafting for implant site preparation, ideal graft mea-\nsurements can be separated into 1 to 1.5 × 3 to 4 cm to prevent \nfracture of the graft during harvesting.\nWith presurgical data from computerized tomography (CT) or \ncone beam CT (CBCT) scans indicating the approximate thick-\nness of the skull, the initial osteotomies are initiated with a small \nSteiger bur or a Piezo saw down to the underlying diploe. Copious \nirrigation during the osteotomy is important so that the tempera-\nture of the bone is not increased this close to the cranial contents \nand to maintain the cellular vitality of the bone graft as best as pos-\nsible. The outer edge of the initial osteotomy is then beveled down \nwith an egg-shaped bur to provide a better access angle to allow \na curved osteotome into the appropriate plane of the underlying \ndiploe (Fig. 39.4). Beveling around additional sides of the initial \ngraft may be necessary to avoid breaching the internal table. Once \nthe initial graft of a multiple graft donor site is elevated cleanly, \nthe remaining segments can be lifted much easier having already \nestablished the appropriate plane and angle between the outer and \ninner table.\nAfter the grafts have been removed and placed in saline, \nhemostasis is obtained and the wound is closed in layers. Various \ncements, putties, and bone substitutes are available to reestablish \nthe contour of the cranium and obtain hemostasis from the cut \nedges of the bone. Closure of the periosteum and galea are per-\nformed with resorbable sutures, and the skin can be closed with \nstaples as long as attention is paid to eversion of the scalp margins. \nDrains are rarely necessary. \nComplications\n\t1.\t \u0007Alopecia along the incision line. This is caused by the use of elec-\ntrocautery and prolonged use of Raney clips, causing ischemic \nhair follicle injury. Scars caused by this can be minimized by \nusing a zigzag incision design.\n\t2.\t \u0007Bleeding from the harvest site. This can be controlled by the use \nof surgical hemostatic agents such as topical microfibrillar col-\nlagen (Avitine) and the use of bone wax or bone cement packed \nMiddle meningeal a.\nMiddle\nmeningeal a.\nDura mater\nSquamous suture\nSquamous \nsuture\nParietal bone\nCoronal suture\nSuperior sagittal sinus\nSagittal suture\nHarvest site\n• Fig. 39.2  Cranial bone harvest graft. Ideal location of graft harvest with underlying anatomic landmarks. \n(From Kademani D, Tiwana P, eds. Atlas of Oral & Maxillofacial Surgery. Philadelphia, PA: Elsevier; 2015.)"
  },
  {
    "page": 201,
    "content": "1091\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\nA\nB\nC\nD\n• Fig. 39.3  Calvarian graft incision. (A) Bicoronal incision design for large grafts. (B) access for harvesting \ngrafts from both sides of the parietal cranium. (C) Smaller incision design. (D) Bone graft harvest for single site.\nHarvest\nBeveling\n• Fig. 39.4  Calvarian osteotomy. Beveling the osteotomy to prevent perforation of inner table while raising \nouter table graft. (From Kademani D, Tiwana P, eds. Atlas of Oral & Maxillofacial Surgery. Philadelphia, PA: \nElsevier; 2015.)"
  },
  {
    "page": 202,
    "content": "PART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\n• Fig. 39.5  Clinical and radiographic images of patient with diffuse atrophic maxillary and mandibular bony areas \nfrom multiple congenitally missing teeth. (A) Left lateral image. (B) Right lateral image. (C) Panoramic image.\ninto the diploic spaces and along the base of the bed. If bone \ncement is used, make sure that the exogenic heat caused by the \nchemical setup of the material does not come into contact with \nthe bed until it has dissipated.\n\t3.\t \u0007Inner table perforations. Small inner table perforations with no \nevidence of a dural tear are of no consequence and can be cov-\nered with any selection of softer fillers. If a small tear exists, \nthen the tear will need to be sutured closed to prevent a cere-\nbrospinal fluid leak. If the tear is large and no immediate means \nof closure is at hand, then a neurosurgical consult is necessary.\n\t4.\t \u0007Bleeding from major vessels. These are very rare occasions, how-\never, if a misadventure would result in copious bleeding from \nthe central sagittal sinus and continuous pressure with surgical \npacking is indicated. Because this is venous blood, the hemo-\nstatic control should not result in any brain or scalp ischemia. If \nthe middle meningeal artery on the inferior border of the tem-\nporal border is cut, then an immediate neurosurgical consult is \nnecessary because this could result in an epidural hematoma. \nCase Study\nA 32-year-old male with a history of congenital absence of multiple \nmaxillary and mandibular teeth presents for implant reconstruc-\ntion. The patient had previous orthognathic surgery to correct a \nclass III maxillary atrophic deformity. CT scans revealed severe \nalveolar bone atrophy of all four quadrants (Fig. 39.5).\nThrough a bicoronal approach, split-thickness outer table \ngrafts were harvested from the parietal bone from the right and the \nleft cranium. The grafts were placed with two-point fixation in an \nonlay fashion throughout the maxilla and mandible. Additional \nparticulate bone pulverized from the unused grafts was used to fill \nin areas between the fixated grafts (Fig. 39.6).\nAt 6 months the grafted sites were exposed for removal of fixa-\ntion screws and placement of implant fixtures. Note the minimal \nchange and resorption of the original grafts that is emblematic \nof the high-density cortical grafts of the cranium. Surgical guide \nsplints were fabricated before the uncovering for implant place-\nment (Figs. 39.7 and 39.8; Boxes 39.1 and 39.2). \nIliac Crest Bone Graft\nThe ilium is historically the most popular donor site for facial \nbone grafting because of the high volume of cancellous and \ncortical bone. The corticocancellous block harvested from the \nilium provides the “best of both worlds” in bone grafting by \ncombining the high cellular transfer of the cancellous matrix \nwith the BMP-rich structural support of the cortical bone \n(Fig. 39.9).\nThe anterior ilium may yield up to 50 cc of bone for augmen-\ntation. This amount can reconstruct a 5.0-cm segmental defect \nof the mandible using the following equation: 1.0 cm requires \n10.0 cc of bone. For the purposes of implant site preparation, \nthis is usually sufficient; however, if larger division E deformi-\nties exist, then the posterior ilium may be used. The posterior \niliac crest can be harvested for donor bone when more signifi-\ncant volumes are necessary for the grafting of a facial defect. \nThe posterior iliac crest provides the same quality and ratio of \ncancellous and cortical bone but in quantities approaching 100 \nml of cancellous bone and a maximum of a 5 × 5-cm cortical \nblock.17\nThe success of endosseous implants placed in iliac crest grafted \nsites is well documented. In a retrospective study by Misch pub-\nlished in 1994 and updated in 1999, a total of 1364 implants \n1092"
  },
  {
    "page": 203,
    "content": "A\nC\nB\n• Fig. 39.6  (A) Cortical onlay grafts to maxilla. (B) Cortical onlay grafts to mandible. (C) Morselized cortical \nbone for augmenting areas between grafts.\nA\nB\nC\n• Fig. 39.7  (A) Uncovered grafts at 6 months. (B) Placement of maxillary implants. (C) Placement of man-\ndibular implants."
  },
  {
    "page": 204,
    "content": "1094\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\n• Fig. 39.8  (A) Final image, frontal at rest. (b) Final prosthesis.\nplaced in iliac crest bone grafts (940 maxillary and 424 mandibu-\nlar) in either an immediate or delayed fashion revealed an overall \nsurvival rate of 96.7%18 (Table 39.1).\nThe diversity of the iliac crest bone makes it useful not just in \nlarge segmental defects but also in routine C–w and C–h defects, \nwhich may benefit from the presence of the greater osteogenic \npotential of the autogenous bone, such as larger unilateral or \nbilateral sinus lift procedures. As with any bone graft, the success \ndepends on adherence to basic surgical principles that call for \nrigid immobilization with screw fixation of the blocks and a rigid \nbasket-type containment membrane (space maintenance) for all \ncancellous-only grafts, with minimal external pressure throughout \nthe healing period (Box 39.3).\nThe disadvantages of both the anterior and the posterior iliac \ncrest grafts include the use of a distant site from the oral cavity. \nThis may require the use of two surgical teams or an increased \nsurgical time for a single team with meticulous attention to \nmaintaining separate fields to prevent cross-contamination from \nthe oral cavity. In the case of the posterior iliac crest the surgi-\ncal time can be doubled because the patient needs to be turned \nto the prone position for harvest. Contraindications to the use \nof the anterior or posterior ilium would be the presence of a \nhip prosthesis to reduce any risk of hardware failure or infection \n(Box 39.4).\nAnatomy and Technique\nThe surgeon needs to first palpate the anatomic landmarks of the \niliac crest, which can be difficult in obese patients, but it is absolutely \nnecessary to prevent damage to local sensory nerves that overlay the \nanterior ilium. From posterior to anterior the landmarks include \nthe iliohypogastric, the subcostal, and the lateral femoral cutaneous \nnerves. The iliohypogastric nerve arises from the dorsal rami of L1 \nand L2 (lumbar vertebrae) and passes directly over the midcrest and \nis in most cases unavoidable. The subcostal nerve arises from the \ndorsal ramus of T12 over the edge of the anterior superior spine to \ninnervate the skin of the groin. The lateral femoral cutaneous nerve \nwill also sometimes deviate from its usual course under the inguinal \nligament in 2.5% of the population and also pass over the same area \nof the anterior ilium.19 Therefore the anterior superior iliac spine \n(ASIS) is first marked and the crest is then palpated to the widest \n\t1.\t \u0007Easy access with minimal postoperative pain or morbidity\n\t2.\t \u0007Onlay grafts of primarily cortical bone; can be morselized into particulate \ngraft\n\t3.\t \u0007For vertical and horizontal ridge augmentation of maxilla and mandible\n\t4.\t \u0007Large quantity of bone\n\t • BOX 39.1\t    \u0007Calvarian Graft: Indications and \nAdvantages\n\t1.\t \u0007Metabolic bone diseases such as osteopetrosis, osteogenesis \nimperfecta, Paget disease\n\t2.\t \u0007Radiation to the skull\n\t3.\t \u0007Children under 8 years old\n\t4.\t \u0007Male pattern baldness\n\t5.\t \u0007Previous skull trauma or surgery\n\t• BOX 39.2\t   \u0007Calvarian Graft: Contraindications and \nCautions\n• Fig. 39.9  Cross section of iliac crest showing inner and outer table of \ncortical bone with a large area of cellular-rich cancellous bone in between.\n  \u0007Iliac Crest Grafts Study (1984–2005)\nPatients\nArches\nMale patients\n36\n42\nFemale patients\n146\n179\nTotal\n182\n221\n   \nTABLE \n39.1"
  },
  {
    "page": 205,
    "content": "1095\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\n\t1.\t \u0007Cortical and cancellous bone in blocks and as free cancellous grafts\n\t2.\t \u0007Can reconstruct large alveolar defects up to 5cm (anterior) to 12 cm \n(posterior) in length\n\t3.\t \u0007Large sinus augmentations and horizontal and vertical ridge \naugmentation\n\t4.\t \u0007Alveolar cleft reconstruction\n\t• BOX 39.3\t   \u0007Ilium Graft: Advantages and Indications\n\t1.\t \u0007Second site harvest and postoperative pain\n\t2.\t \u0007Contraindicated in metabolic bone disease, previous fracture site or \nosteomyelitis, or previous hip prosthesis\n\t• BOX 39.4\t   \u0007Ilium Graft: Disadvantages and Cautions\nIliohypogastric n.\nIliacus m.\nGluteus medius m.\nGluteus maximus m.\nSubcostal n.\nAnterior iliac spine\nPosterior iliac crest\nInguinal ligament\nLateral femoral cutaneous n.\nTensor fascia lata\nSartorius m.\nB\nPsoas m.\nAnterior tubercle of the ilium\nAnterior superior iliac spine\nA\n• Fig. 39.10  (A) Lateral view demonstrating placement of a soft roll to elevate the anterior iliac crest. The \nincision (dashed line) is placed lateral to the crest and posterior to the anterior iliac spine. (B) Anterior view \nof the anterior iliac crest shows the relationships of the muscular and neural structures as they relate to the \nproposed incision (dashed line). Although not typically visualized during harvest, the iliohypogastric nerve \nmay be encountered with posterior extension of the incision. (From Kademani D, Tiwana P, eds. Atlas of \nOral & Maxillofacial Surgery. Philadelphia, PA: Elsevier; 2015.)\nportion to the iliac tubercle. The incision is then marked 2 cm lat-\neral to the iliac crest and 2 cm posterior to the ASIS to reduce injury \nto these two important sensory nerves19,20 (Fig. 39.10).\nThe subcutaneous tissue and the subperiosteal plane is then \ninfiltrated with local anesthesia and vasoconstrictor. After \nappropriate prepping and draping, the incision is made through \nskin down to the superficial abdominal facia or Camper and \nScarpa fascia. Once through this fascial layer, the crest is easily \npalpated and the fibers from the medial external oblique and \nthe lateral tensor fascia lata muscle are separated. A periosteal \nincision can now be made with electrocautery between these \ntwo muscles. Continuing to stay at least 1.5 cm posterior to the \nASIS, subperiosteal dissection is performed to obtain access to \nthe crest, as well as the medial wall under the iliacus muscle. \nFree cancellous bone can then be harvested through cortical \nwindows created through the crest and corticocancellous blocks \nobtained by further exposure down the medial wall elevating \nthe iliacus muscle. Blocks can be harvested via osteotomies"
  },
  {
    "page": 206,
    "content": "1096\nPART VII    Soft and Hard Tissue Rehabilitation\nthrough the medial wall down to the cancellous layer. A paral-\nlel incision is then made to the first cut at a desired distance no \nmore than 4 to 5 cm from the first cuts. Ninety-degree inci-\nsions are then made to connect these cuts on the inferior and \nsuperior margins. With the use of an osteotome the cortical \ncancellous blocks are lifted away carefully to not penetrate the \nposterior wall (Fig. 39.11).\nAfter the block graft has been elevated, additional cancellous \nbone for augmentation of the graft can be curettaged from the \nsides and the base of the graft bed. Closure of the periosteum and \nfascial layers is performed after hemostasis of the bone edges and \nany soft tissue adjacent to the donor site. Drains are not usually \nnecessary. The use of long-acting local anesthetics can be used \nto help in postoperative pain control and to encourage early \nambulation.\nThe technique for posterior iliac harvest differs from the ante-\nrior iliac in many ways; however, the most obvious way is the \nprone positioning of the patient. Either before or after exposure \nof the recipient site, all extraoral or intraoral wounds need to \nbe packed and isolated from contamination while the patient is \nturned and the graft harvested. Incisions should be first marked \nbeginning at least 1 cm lateral to the posterior superior iliac spine \nto avoid the sacroiliac ligament and then extended 5 to 6 cm lat-\nerally. After local and hemostatic infiltration, an incision is made \nthrough skin and taken down to the superior iliac spine. Unlike \nthe anterior technique, grafts are harvested from the lateral cortex \nby elevating the gluteal musculature with the superior cut being \njust below the crest of the ridge to avoid ilium fractures caused by \nweakening (Fig. 39.12).\nIn children both the anterior and posterior iliac crests act as \nossification sites and not true growth centers. The cartilaginous \ncrest should be kept intact, and any grafts, cortical or cancellous, \nshould be harvested from below this border. \nComplications\n\t1.\t \u0007Seroma. A common complication surrounding the incision \nsite usually caused by over activity in the early postoperative \ncourse. Initial aspiration and placement of drain if it continues \nto recur.\n\t2.\t \u0007Bleeding and hematoma. A stable hematoma can arise from \npersistent oozing from the harvest bone beds. Hematomas \ncan be prevented with fibrillary collagen packing or bone wax \nat the bone edges. Normally they will reabsorb. An expanding \nhematoma caused by an active bleeder is a much more seri-\nous situation and, as in pelvic fractures, could result in a large \namount of blood loss before its presence is identified. The \npatient should be treated for any signs of hypovolemic shock, \nand the wound should be reexplored to identify and control \nthe bleed.\n\t3.\t \u0007Postoperative paresthesia of the thigh. Also known as meralgia \nparesthetica, this is a temporary paresthesia of the distribution \nof the lateral femoral cutaneous nerve, which could be caused \nIliacus m.\nPsoas m.\nOsteotome to harvest block graft\nBone graft\n• Fig. 39.11  Harvesting of a corticocancellous block from the medial aspect of the anterior ilium after \nreflection of the iliacus muscle. An osteotome or saw can be used for the corticotomies in the suggested \ndesign. After retrieval of the block, the exposed underlying cancellous bone can be harvested using bone \ncurettes and gouges. (From Kademani D, Tiwana P, eds. Atlas of Oral & Maxillofacial Surgery. Philadelphia, \nPA: Elsevier; 2015.)"
  },
  {
    "page": 207,
    "content": "1097\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\nby pressure on the nerve from a hematoma of the iliacus muscle \nat the harvest site of the anterior table or pressure from retrac-\ntion of the anterior flap. Permanent anesthesia could be the \nresult of a poorly placed incision.\n\t4.\t \u0007Postoperative pain. This is helped by long-acting local anesthet-\nics with intravenous (IV) and analgesics by mouth (PO), and \naggressive physical therapy to get the patient up and walking.\n\t5.\t \u0007Abdominal perforation. This is a very rare occurrence of an \nanterior table harvest caused by the protection from sur-\nrounding musculature. Overweight patients may be at \nhigher risk because anatomy is unclear, and over aggres-\nsive use of rotary instruments for bone harvest may exist. \nAn immediate general surgery consult is indicated (see \nTable 39.1). \nCase Study 1: Corticocancellous Morcellized Graft\nA 28-year-old female with a history of basal cell nevus syndrome \npresented with right-sided swelling of her face. CT scan and Pan-\norex revealed a multilocular radiolucent lesion encompassing the \nbody and ascending ramus of the left mandible. Biopsy confirmed \nthe presence of a diffuse spread of an odontogenic keratocyst (Fig. \n39.13).\nThe patient was taken to the operating room for resection of \nthe lesion, which required disarticulation of the condyle and was \nimmediately reconstructed with an anterior iliac crest bone graft \nthrough an external facial incision. The corticocancellous blocks \nwere placed in a bone mill and collagen-soaked sponges of BMP \nwere placed into the rigidly fixated bone crib (Fig. 39.14).\nAt 20 weeks with the CT scan showing good consolidation \nof bone, the implant fixtures were placed. At 4 months the den-\ntal implants (Fig. 39.15) were uncovered and restored. At 5 years \nthe grafted area continued to show good consolidation, continued \nsupport for the implant fixtures, and no recurrence of the cystic \ntumor (Fig. 39.16). \nCase Study 2: Corticocancellous Block Grafts\nA 53-year-old female with an atrophic maxilla prefers a fixed \nprosthesis to articulate against a partially dentate mandible, very \nSuperior cluneal nn.\nMedial cluneal nn.\nA\nGluteus maximus m.\nThoracolumbar fascia\nGluteus maximus m.\nThoracolumbar fascia\nB\nPosterior iliac crest\n• Fig. 39.12  (A) Outline demonstrating incision design of posterior iliac crest harvest in relation to superior \ncluneal and medial cluneal nerves. (B) Outline of osteotomies. (From Kademani D, Tiwana P, eds. Atlas of \nOral & Maxillofacial Surgery. Philadelphia, PA: Elsevier; 2015.)"
  },
  {
    "page": 208,
    "content": "1098\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\n• Fig. 39.13  (A) Large keratocyst of left mandible. (B) Preresection occlu-\nsion.\nA\nB\nC\nD\n• Fig. 39.14  (A) Resected specimen. (B) Prefabricated reconstruction plate and condylar prosthesis in \nplace. (C) Morcellized corticocancellous bone in syringes. (D) Bone graft packed into retaining crib.\nA\nB\n• Fig. 39.15  (A) Computerized tomography of consolidated graft at 20 \nweeks. (B) Placement of implant fixtures."
  },
  {
    "page": 209,
    "content": "1099\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\nnarrow bone in the anterior, and low-lying sinus floors on the \nposterior bilaterally (Fig. 39.17).\nCorticocancellous strips were then harvested from the inner \ntable of the anterior iliac crest. Bilateral sinus lifts were performed \nusing cancellous bone from the residual harvest bed. The har-\nvested blocks were then cut appropriately and then rigidly fix-\nated as onlay grafts (Fig. 39.18). Additional cancellous bone was \nused to augment the rigidly fixated grafts, and the surgical site \nwas closed in a tension-free fashion. The bone grafts were allowed \nto heal and consolidate for 6 months. A full denture prosthesis \nwas fabricated for the patient for the interim period. The site was \nreopened, the fixating screw removed, and eight implant fixtures \nwere placed (Fig. 39.19). After integration of the implants a fixed \nhybrid prosthesis was fabricated. \nTibial Bone Graft\nThe proximal tibial metaphysis provides an excellent source of \ncancellous bone. The quantity that may be harvested is close to \nor equal to that of the anterior ilium. The tibial graft has a low \ncomplication rate and is technically easy to perform. Compari-\nson of tibial versus iliac crest grafts in secondary alveolar cleft \nreconstruction showed similar bone densities at 6 months.21 \nTibial bone grafts are most commonly used for maxillary sinus \nlift procedures and augmentation of existing bone for the place-\nment of implant fixtures.22 The rather low morbidity and easy \nsurgical access allows skeletally mature adults to have the surgery \ncompleted on an outpatient basis. Because of possible damage to \ndeveloping epiphyseal growth plates, this procedure is not recom-\nmended for children or adolescents; however, several authors have \nreported the safe and successful use of these grafts for alveolar cleft \ngrafting in children.23\nAs with the ilium grafting sites, it is recommended to avoid \nsites that have had previous surgery with orthopedic hardware or \nprosthetic joint replacements. It is also prudent to avoid using \nthis procedure on patients that apply large amounts of force to \nthe tibia on a repetitive basis, such as runners and other active \nathletes.\nAnatomy and Technique\nAfter placing support under the leg and rotating it to provide \nbetter access, the surgeon marks out a 2- to 3-cm incision site \nover the skin of the anterolateral aspect of the leg directly over \nthe Gerdy tubercle, which is lateral to the tuberosity. Catone and \ncolleagues24 described the incision as angled, with its cephalic \nlimit superior and medial to the tibialis anterior muscle origin and \nextending lateral to the patellar ligament. After incising through \nthe subcutaneous and fascial layers of the iliotibial tract, the peri-\nosteum is reflected to expose the cortex of the tibial metaphysis. \nWith the use of an end-cutting bur, a window is cut into the cor-\ntex approximately the size of a dime. This cortical layer is very \nthin and usually is of little use to the graft and is not replaced. \nBone curettes are then used to remove the cancellous bone in all \ndirections and down the shaft of the tibia. Careful attention in \nharvesting in the superior direction is taken so that the joint space \nis not entered. A thrombin-soaked collagen sponge can then be \nplaced in the donor site for hemostasis, and the wound is closed \nin layers with the iliotibial tract closed, followed by the skin and \nsubcutaneous tissue (Fig. 39.20).\nA\nB\n• Fig. 39.16  (A) Final restored occlusion. (B) Final Panorex of restored seg-\nment showing consolidated graft with implants.\nB\nA\n• Fig. 39.17  (A) Preoperative panoramic image. (B) Clinical photo of atrophic maxillary ridge."
  },
  {
    "page": 210,
    "content": "1100\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\nD\nE\nF\n• Fig. 39.18  (A and B) Full reflection of posterior maxilla, osteotomy, and bone grafting of the sinus floor. (C) \nBone block harvested from iliac crest. (D) Segmented bone blocks fixated to maxilla. (E) Cancellous bone \npacked around cortical grafts. (F) Final closure.\nAn alternative medial approach has been described25 with simi-\nlar soft tissue and bony osteotomies to harvest the donor graft. \nThis approach, however, does not transect the iliotibial tract, \nresulting in less soft tissue covering the bony donor site and creat-\ning the potential for wound breakdown after closure (Box 39.5).\nPostoperatively the patient can bear weight as tolerated with no \nvigorous physical activity for 6 weeks. Local wound care with peri-\nodic elevation of the site to prevent swelling is recommended. Rou-\ntine analgesia of hydrocodone or acetaminophen is usually adequate. \nComplications\n\t1.\t \u0007Ankle swelling. Swelling and ecchymosis is caused by the natu-\nral lymphatic drainage system of the lower leg. In most cases, \nthis will spontaneously resolve.\n\t2.\t \u0007Knee joint entrance or tibia fracture. This is caused by over \naggressive harvesting of bone in a superior direction. Initial \ntreatment would be splinting of the leg with staphylococcal \nantibiotic coverage, followed by orthopedic surgical consult \n(Box 39.6)."
  },
  {
    "page": 211,
    "content": "1101\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\nCase Study\nA 56-year-old female presented with large edentulous maxillary \nposterior space for implant reconstruction. A low-lying sinus floor \nprecluded implant placement without sinus grafting. The patient \nwas given an IV deep sedation, and the intraoral and right knee \nsites were prepped and draped and kept isolated from each other \nthroughout the procedure. A 4-cm incision was designed and \ninfiltrated with local anesthesia just blow the Gerdy tubercle on \nthe right leg (Fig. 39.21).\nA\nB\n• Fig. 39.19  (A) Panorex at 6 months before implant placement. (B) Final \nposition of implants.\nBone graft\nA\nIliotibial tract closed\nSkin closed\nB\n• Fig. 39.20  (A) Exposed osteotomy over the Gerdy tubercle and curet-\ntage of underlying bone. (B) Layered closure of incision (delete 123–1)\ncaption. (From Kademani D, Tiwana P, eds. Atlas of Oral & Maxillofacial \nSurgery. Philadelphia, PA: Elsevier; 2015.)\n\t1.\t \u0007Cancellous grafts of 25–40 cc\n\t2.\t \u0007Sinus grafts\n\t3.\t \u0007Socket grafts and ridge preservation\n\t4.\t \u0007Minimal postoperative pain\n\t5.\t \u0007Outpatient procedure.\n\t• BOX 39.5\t   \u0007Tibial Graft: Advantages and Indications\n\t1.\t \u0007Contraindicated in metabolic bone disease, history of knee surgery or \nosteomyelitis\n\t2.\t \u0007Caution in growing child, rheumatoid arthritis, or bisphosphonate history\n\t• BOX 39.6\t   \u0007Tibia Graft: Disadvantages and Cautions\nA\nB\n• Fig. 39.21  (A) Incision design over tubercle. (B) Exposure of underlying \ncortex."
  },
  {
    "page": 212,
    "content": "1102\nPART VII    Soft and Hard Tissue Rehabilitation\nB\nD\nA\nC\n• Fig. 39.22  (A) Outline of donor site. (B) Bone harvested from donor site. (C) Preparation of with platelet-\nrich plasma (PRP). (D) Donor bone mixed with PRP.\nThe anterior wall of the tibial plateau was exposed and hemo-\nstasis obtained. With the use of a small round bur a circular bone \nincision was made and the thin cortical cap removed. Then, 24 cc \nof cancellous bone was curetted out of the site and mixed with \nstrips of platelet-rich fibrin and packed into the sinus floor \nbed. Enough supportive bone was available to place immediate \nimplants at the time of surgery (Figs. 39.22 and 39.23). \nVascularized Composite Graft: The Fibula\nAs mentioned previously, when the bed for a bone graft is com-\npromised by radiation therapy, lack of blood supply, extensive \nlength of the defect, or just the compromised medical condition \nof the patient, a vascularized composite graft may be indicated. \nThese grafts differ from the free autogenous grafts because they \ndo not depend on the recipient’s local environment to aid in the \nregeneration and consolidation of new bone. These composite \ngrafts bring their own blood supply with them and maintain \nnormal physiologic function within all of the transferred tissues. \nThis will include a certain amount of soft tissue that helps to \ncover and protect these bone grafts in compromised receptor \nsites. The downside of these grafts is the increased procedure \ntime and the sometimes unavailable expertise of a microvascu-\nlar surgeon. Technical complications include larger defects at \nthe donor sites and the inability of the surgeon to construct a \nbony bed that is any different from the anatomic dimensions \nof the grafted bone. In the past, this bone stock, while provid-\ning excellent reconstruction of the continuity defect, did not \nalways provide the best base for an implant-supported prosthe-\nsis. As the reconstructive surgeon and implantologist worked \ntogether over the years and realized the limitations of both, most \nof these problems have been resolved. These advances in coop-\neration between the surgeon and the implantologist is no better \nevidenced than in the emergence of the computer-aided design \n(CAD)/computer-aided manufacturing (CAM) technology, pro-\nducing three-dimensional models for both the harvest and the \nimplant placement, which has decreased treatment time from \nmonths to days.\nSince the composite bone grafts were introduced in the late \n1970s many donor sites have been recommended. In 1989 \nHidalgo introduced the osteocutaneous fibula free flap for use \nin mandibular reconstruction, with 12 cases measuring defects \naveraging 13.5 cm.26 Since then the fibula free flap has become \nthe gold standard for reconstruction of large mandibular defects \nbecause of its consistency in size, its vascular pedicle length, and \nits ability to provide a reliable skin paddle with the bone flap. Its \nsegmental blood supply also allows for in situ osteotomies, which \naids in better anatomic reconstruction (Box 39.7).\nRegarding quality of bone for osseointegration, Frodel and \nMoscoso, in two separate studies, compared the bone stock and \nthickness as it relates to the placement of endosseous implants in \nthe four commonly used vascularized donor sites: the iliac crest, \nscapula, fibula, and radius. Although the iliac crest was found to \nhave greater amount of bone stock, the results did not achieve \nstatistical significance and the testing relied mostly on clinical \nobservation.27,28"
  },
  {
    "page": 213,
    "content": "1103\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\nThe first histologic study of the bone implant interface in a \nhuman vascularized graft was reported by Dattilo and colleagues \nin 1995.29 This study showed that although the implant had \nsuccessfully integrated into the iliac crest grafted bone and was \nclinically stable, the surrounding bone resembled the fine tra-\nbecular pattern of D4 density most commonly found in areas \nof the posterior maxilla (Fig. 39.24A). Sumi and coworkers in \n2001 published a similar study using fibula graft and found the \ninterface and surrounding bone to be more dense and cortical, \nresembling the D1 and D2 of the anterior native mandible30 \n(see Fig. 39.24B–C). This amount of bone density that has been \nshown to increase the stability and longevity of implants gives \nthe fibula another distinct advantage over the other composite \ngrafts (Box 39.8).\nAnatomy and Technique\nA detailed description of the surgical approach and harvest of \nthis graft is beyond the scope of this chapter. However, a basic \nknowledge of the anatomic contents and its harvest is important \nfor the implant surgeon to know, as well as the limitations and \nbenefits of its use. The graft is harvested via a lateral approach \nthrough the intermuscular septum of the peroneus longus and \nperoneus brevis muscles. Dissection is taken to the anterior \ncompartment for dissection of the vascular pedicle. The com-\nposite graft is based off the peroneal artery, which is a branch \nof the popliteal artery Fig. 39.26. During this dissection of the \nfeeding vasculature, the anterior tibial artery and the deep pero-\nneal nerve need to be identified and retracted medially to pre-\nvent injury. The diameter of the peroneal artery is 1 to 2.5 mm \nand matches well with the facial artery and vein, which are the \nmost common vessels used for anastomosis in the receptive bed \nB\nC\nA\n• Fig. 39.23  (A) Maxillary sinus prepared for graft. (B) Lateral wall sinus augmentation. (C) Final wound \nclosure.\n\t1.\t \u0007Reconstruction defects with poor tissue vascularity and questionable \nsoft tissue coverage\n\t2.\t \u0007Reconstruction of defects larger than 6 cm\n\t3.\t \u0007Postcancer reconstruction with provision of protective skin paddle\n\t4.\t \u0007Can withstand postsurgical radiation\n\t5.\t \u0007Failed large free bone grafted segments\n\t6.\t \u0007Can withstand immediate placement of dental implants\n\t• BOX 39.7\t   \u0007Vascularized Composite Graft: \nAdvantages and Indications"
  },
  {
    "page": 214,
    "content": "1104\nPART VII    Soft and Hard Tissue Rehabilitation\nB\nA\nbone \nmarrow\nC\ncortical \nbone\nbone \nmarrow\n• Fig. 39.24  (A) Implant interface with iliac crest composite graft with the fine trabecular pattern of pre-\ndominantly cancellous bone. (B) Implant interface with fibula graft with dense cortical bone on left cortex \nside and fine cortical interface on marrow side. (C) Closeup of cortical bone formation on marrow side with \nno intervening fibrous tissue. (A, From Dattilo D, et al. Interface analysis of hydroxyapatite-coated implants \nin a human vascularized iliac bone graft. Int J Oral Maxillofac Implants. 1995;10(4):405–409. B and C, \nFrom Sumi Y, Hasewaga T, Osamu M, et al. Interface analysis of titanium implants in a human vascularized \nfibula bone graft. J Oral Maxillofacial Surg. 2001;59(2):213–216.)\nregion. Of maximum importance is the careful dissection of the \neight perforating vessels along the fibula, which are most com-\nmonly located along the junction of the middle third and distal \nthird of the fibula. The vascularized bone is accompanied by por-\ntions of the peroneus longus, peroneus brevis, and the tibialis \nposterior muscle. The composition of the graft can change, how-\never, depending on the position of perforating vessels to the skin \nand musculature (Fig. 39.25). Dissection down to the fibula and \nsubsequent resection is performed while the vascular pedicle is \nstill intact. The available fibula can have a width between 1.0 and \n3.0 cm and a length of up to 26 cm; however, at least 5.0 to 8.0 \ncm is needed to be left on the superior and inferior portion to \nmaintain stability to the ankle and knee joint. It is at this point \nthat CAD/CAM-generated cutting guides can be used to per-\nform the initial resection and subsequent segmental osteotomies \nusing the rich blood supply to this graft.31 Custom-generated \nplates also can be placed at this time, as well as placement of \nendosseous dental implants, before separating the blood supply \n(Fig. 39.26).\nOnly after all of this is completed will the microvascular sur-\ngeon resect the peroneal artery and venous complex and reap-\nproximate it up to the receptor bed in the upper or lower jaw. A \nprefabricated plate, also generated from the custom CAD/CAM \nmodels, can now rigidly fixate the composite graft in place. \nComplications\n\t1.\t \u0007Thrombosis of the arterial (pale flap) and venous (blue flap). This \nwill result in necrosis of the flap if local measures or the reanas-\ntomosis procedure fails.\n\t2.\t \u0007Wound Infection. Treat this with antibiotics and local wound care.\n\t3.\t \u0007Compartment syndrome. This is rare but serious. It is caused \nby internal pressure on donor site tissue. Immediate surgical \nintervention is indicated. \nCase Study 1: Fibula Reconstruction with Immediate \nPlacement and Loading of Implants\nA 34-year-old male with a multiloculated lesion of the anterior \nmandible extending from #18 to #29 with tissue diagnosis of ame-\nloblastoma (Fig. 39.27). Virtual surgical planning (VSP) using \nCAD/CAM images to fabricate surgical cutting guides, custom \nrigid fixation plates, and custom models were used to determine \nimplant placement and positioning for immediate placement of \ninterim prosthesis. At surgery, custom cutting guides were used for \nresection of the tumor at predetermined positions (Fig. 39.28). At \nsurgery the pedicle flap was exposed through the lateral approach \nand the fibula was osteotomized at the specific length needed \nusing cutting cones provided by virtual planning models. Guides \nalso were provided by the virtual planning models (Fig. 39.29). \nBecause of the unique segmental blood supply of the fibula, sepa-\nrate osteotomies could be made to form the necessary curvature \nas dictated by the presurgical models. The implants are placed and \nthe custom plate is fastened to the graft before the in situ graft is \nreleased from the peroneal vascular blood supply. The peroneal \nvein and artery is then released and reanastomosed to the facial \nartery and vein near the reception site of the graft after the ante-\nrior segment is rigidly fixated to the right and left proximal seg-\nments of the mandible. The interim denture is then fixated to the \n\t1.\t \u0007Contraindicated if previous femoral artery graft in place\n\t2.\t \u0007Previous fracture\n\t3.\t \u0007Caution in metabolic bone disease\n\t• BOX 39.8\t   \u0007Vascularized Composite Graft: \nDisadvantages and Cautions"
  },
  {
    "page": 215,
    "content": "1105\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\nFlexor digitorum longus m.\nTibialis posterior m.\nTibialis posterior m.\nPosterior tibial a./v.\nTibia\nGastrocnemius m.\nSoleus m.\nSoleus m.\nTibial n.\nFibula\nFibula\nFlexor hallucis longus m.\nFlexor hallucis longus m.\nFlexor hallucis longus m.\nPeroneal v.\nPeroneal a.\nPeroneal v.\nPeroneal a.\nPeroneus brevis m.\nPeroneus longus m.\nTibialis posterior m.\nPeroneus brevis m.\nPeroneus longus m.\n• Fig. 39.25  Cross-sectional anatomy of the leg showing two possible sizes of osteocutaneous grafts. The \nupper smaller graft has septocutaneous vascular perforators running through the crural septum between \nthe peroneus longus and brevis muscles and gastrocnemius muscles. The larger graft is necessitated \nwhen the perforators are identified partially through the flexor hallucis longus muscle requiring harvesting of \nparts of this muscle. (From Kademani D, Tiwana P, eds. Atlas of Oral & Maxillofacial Surgery. Philadelphia, \nPA: Elsevier; 2015.)\ntransoral implants. Implants placed in the bicortical vascularized \ngraft routinely measure greater than 35 ncm of torque to allow \nplacement of immediate prostheses (Figs. 39.30–39.33). \nCase Study 2: Double-Barrel Fibula Graft with Immediate \nPlacement of Implants\nThe double-barrel technique is used to increase the height of the \nreconstructed mandible. This is a 52-year-old male with a patho-\nlogic fracture of the mandible caused by osteoradionecrosis (Fig. \n39.34). The wide excision of the necrotic bone was planned and \nthe guides were fabricated to complete the graft and the implants \nin one surgery.\nThe custom plate and the fibula models were used to first \nresect the bone at the proper dimension and also to osteotomize \nthe fibula in situ at the proper length. The dental implants were \nplaced with guides into the upper segment before detaching the \ngraft from the peroneal blood supply (Fig. 39.35). The graft is \nbrought up to the jaw and folded on itself, maintaining the blood \nsupply to double the height. The inferior segment is secured to the \ncustom plate to reapproximate the natural contour of the jaw, and \nthe upper segment has more freedom to be rotated and secured in \na position that is best suited for a good functional occlusion (Fig. \n39.36).\nFinally both segments are secured and covered with portions \nof the soft tissue pedicle to secure its survival. The implants are \nuncovered in 4 months and restored. Sometimes it is necessary \nto debulk thick intraoral soft tissue pedicles and perform grafted \nvestibuloplasties to create a more healthy, soft tissue environment \naround the implants (Fig. 39.37). \nSummary\nThe revolution in oral reconstruction brought about by the intro-\nduction of dental implants has revived the art and science of bone \nregeneration and grafting in dentistry. From the reconstruction of \nmajor jaw deformities to the augmentation of the smallest defect \naround a single tooth a bone graft is almost always considered to \nimprove the environment of an implant fixture and help ensure \nits longevity.\nThe autogenous bone from the donor sites described in this \nchapter provide the three major qualities of a successful graft: \nosteoconduction, osteoinduction, and osteogenesis. The trans-\nfer of viable primitive mesenchymal and osteoblastic cells, as \nwell as the growth factors (BMP) place the autogenous bone \ngraft well above any of the allografts yet developed. Pain, \ndeformity, and complications at the harvesting site are the"
  },
  {
    "page": 216,
    "content": "1106\nPART VII    Soft and Hard Tissue Rehabilitation\nPopliteal a.\nCommon peroneal n.\nDeep peroneal n.\nSuperficial peroneal n.\nAnterior tibial a.\nAnterior tibial a.\nPeroneal a.\nPerforating branch\nof peroneal a.\nNutrient a.\nPeriosteal supply\nA\nB\nInterosseous membrane\nTibia\nPosterior tibial a.\nTibial n.\nFibula\nC\n• Fig. 39.26  (A) Anterior view of left leg. The common peroneal nerve crosses the fibular neck, dividing into \nthe superficial and deep peroneal nerves. The anterior tibial vessel descends with the deep peroneal nerve \nalong the anterior medial aspect of the interosseous membrane. The distal aspect of the peroneal artery \npasses through the interosseous membrane into the anterior compartment. (B) Posterior view of left leg. \nThe popliteal artery branches into the anterior tibial artery, which branches into the anterior tibial artery and \nthe posterior tibial artery, which branches into the peroneal artery, which provides the blood supply to the \nfibula through a nutrient artery and numerous periosteal vessels. (C) Fibula illustrated with 6 cm marked \nfrom the fibular head and lateral malleolus. Peroneal nerve illustrated inferior to the fibular head. Perfora-\ntors marked in circles and a 4 × 9-cm skin paddle is drawn out (Courtesy of Fayette Williams DDS, MD.). \n(From Kademani D, Tiwana P, eds. Atlas of Oral & Maxillofacial Surgery. Philadelphia, PA: Elsevier; 2015.)\nusual arguments for using alloplastic or nonautogenous sub-\nstances as replacements. In a report published in 2005 a group \nof renowned craniofacial surgeons presented a survey of their \ncombined 25-year experience with cranial, tibial, crest, and rib \ngrafts. In 20,000 cases reviewed, less than 1% of complications \nwere noted in any one area of bone harvest. The authors’ con-\nclusions were that the often heard statement that an alloplastic \nmaterial was used to “spare the patient the added time and \ncomplications of harvesting and autogenous graft” is, in fact, \nnot a reasonable argument for a well-trained surgeon and may \nactually cause a failure or a compromised result at the recon-\nstructed site.32\nVSP will no doubt be a strong influence in the future of \nextraoral autogenous grafting for the implant patient. From the \nfabrication of custom cutting guides for resection, harvesting, \nand placement of larger grafts to the fabrication of immedi-\nate implant-borne prosthesis, these new computerized tech-\nnologies will continue to promote and maintain the extraoral \nautogenous bone graft as the gold standard of dental implant \nreconstruction."
  },
  {
    "page": 217,
    "content": "1107\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\n• Fig. 39.27  Panorex showing radiolucency involving anterior mandible and dentition. (Courtesy of Fayette \nWilliams DDS, MD.)\nA\nB\n• Fig. 39.28  (A) Computer-aided design (CAD)/computer-aided manufacturing (CAM) images of a cut-\nting guide for resection of tumor and (B) custom reconstruction plate and guide for implant placement.  \n(Courtesy of Fayette Williams DDS, MD.)\nB\nA\n• Fig. 39.29  (A and B) Computer-aided design (CAD)/computer-aided manufacturing (CAM) generated \nmodels for fabrication of immediate prosthesis. (Courtesy of Fayette Williams DDS, MD.)"
  },
  {
    "page": 218,
    "content": "• Fig. 39.30  Surgical specimen of anterior mandible. (Courtesy of Fayette Williams DDS, MD.)\n• Fig. 39.31  Incision designed on the lateral left leg over the intermuscular septum between the soleus and \nperoneus longus muscle. (Courtesy of Fayette Williams DDS, MD.)\nC\nB\nA\n• Fig. 39.32  (A) segmental osteotomies and dental implant placement of the graft in situ (Courtesy of Fayette Wil-\nliams DDS, MD). (B) Custom plate used to shape graft for placement (Courtesy of Fayette Williams DDS, MD). (C) \nGraft placed and fixated to mandible and reanastomosis of vessels begins (Courtesy of Fayette Williams DDS, MD)."
  },
  {
    "page": 219,
    "content": "1109\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\nA\nB\n• Fig. 39.33  (A) Prefabricated custom prosthesis from Computer-aided design (CAD)/computer-aided \nmanufacturing (CAM) models (Courtesy of Fayette Williams DDS, MD). (B) Final occlusion before leaving \nthe operating room (Courtesy of Fayette Williams DDS, MD).\n• Fig. 39.34  Panorex of pathologic fracture (Courtesy of Fayette Williams DDS, MD)."
  },
  {
    "page": 220,
    "content": "1110\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\n• Fig. 39.35  (A) Computerized tomographic image of lesion (Courtesy of Fayette Williams DDS, MD). (B) \nVirtual Surgical image of extent of resection and planned folded fibula graft (Courtesy of Fayette Williams \nDDS, MD). (C) Computer-aided design (CAD)/computer-aided manufacturing (CAM) (Courtesy of Fayette \nWilliams DDS, MD).\n• Fig. 39.36  Fibula graft osteotomized in half in situ with dental implants place in superior portion."
  },
  {
    "page": 221,
    "content": "1111\nCHAPTER 39  Extraoral Bone Grafting for Implant Reconstruction\nReferences\n\t 1.\t \u0007Misch CE. Divisions of available bone in implant dentistry. Int J \nOral Implantol. 1990;7:9–17.\n\t 2.\t \u0007Misch CE. Prosthetic options in implant dentistry. Int J Oal Implan-\ntol. 1991;7:17–21.\n\t 3.\t \u0007Shugaa-Addin B, Al-Shamiri HM, Al-Maweri S, Tarakji B. The \neffect of radiotherapy on survival of dental implants in head and \nneck cancer patients. J Clin Exp Dent. 2016;8(2):e194.\n\t 4.\t \u0007Smith JD, Abramson M. Membranous vs endochondral bone auto-\ngrafts. Arch Otolaryngol. 1974;99:203–205.\n\t 5.\t \u0007Zins JE, Whitaker LA. Membranous versus endochondral bone: \nImplications for craniofacial reconstruction. Plas Reconstr Surg. 1983.\n\t 6.\t \u0007Kusiak JF, Zins JE, Whitaker A. The early revascularization of mem-\nbranous bone. J Plas Reconstr Surg. 1985.\n\t 7.\t \u0007Oppenheimer AJ, Ton L, Buchman SR. Craniofacial bone grafting: \nwolff’s law revisited, craniomaxillofac. Trauma Reconstr. 2008;1:49.\n\t 8.\t \u0007Tessier P, Kawamoto H, Matthews D, et al. Autogenous bone grafts \nand bone substitutes: tools and techniques. A 20,000 case experience in \nmaxillofacial and craniofacial surgery. Plast Reconstr Surg. 2005;116:6s.\n\t 9.\t \u0007Wang J, Waite D, Steinhauser E. Ridge augmentation: and evalua-\ntion and follow-up report. J oral Surg. 1976;34:66–602.\n\t10.\t \u0007Curtis T, Ware W, Beirne OR, et al. Autogenous bone grafts for \natrophic edentulous mandibles, a final report. J Prosthet Dent. \n1987;57:73–78.\n\t11.\t \u0007Verhoeven JDW, Cune MS, Teriou M, et al. The combined use of end-\nosteal implants and iliac crest onlay grafts in the severely atrophic man-\ndible: a longitudinal study. Int J Oral Maxillofac Surg. 1997;26:351–357.\n\t12.\t \u0007MalchiodiL QA, D’Addona A, et al. Jaw reconstruction with grafted \nautologous bone:early insertion of osseointegrated implants and early \nprosthetic loading. J Oral Maxillofac Surg. 2006;64:1190–1198.\n\t13.\t \u0007Tessier P. Autogenous bone grafts taken from the calvarium for facial \nand cranial applications. Clin Plast Surg. 1882;9:531.\n\t14.\t \u0007Koenig WJ, Donovan JM, Pensler JM. Cranial bone grafting in chil-\ndren. Plast Reconstr Surg. 1995;95:1–4.\n\t15.\t \u0007Fearson JA. A magnetic resonance imaging investigation of poten-\ntial subclinical complications after in situ cranial bone graft harvest. \nPlast Reconstr Surg. 2000;105:1935–1939.\n\t16.\t \u0007Moreira-Gonzalez A, Papay FE, Zins JE. Calvarial thickness and its \nrelation to cranial bone harvest. Plast Reconstr Surg. 2006;117:1964.\n\t17.\t \u0007Zouhary KJ. Bone grafting from distant sites: concepts and tech-\nniques. Oral Maxillofac Surg Clin North Am. 2010;22:301.\n\t18.\t \u0007Misch CE. Extraoral autogenous donor bone grafts for endosteal \nimplants. In: Misch CE, ed. Contemporary Implant Dentistry. 2nd \ned. St Louis: Mosby; 1999.\n\t19.\t \u0007Mischkowski RA, Selbach I, Neugebauer J, et al. Lateral femoral \ncutaneous nerve and iliac crest bone grafts: anatomical and clinical \nconsiderations. Int J Oral Maxillofac Surg. 2006;35:366.\n\t20.\t \u0007Kademani D, Keller E. Iliac crest grafting for mandibular recon-\nstruction. Atlas Oral Maxillofac Surg Clin North Am. 2006;14:161.\n\t21.\t \u0007Sivarajasingam V, Fell G, Morse M, Shepaherd JP. Secondary bone \ngrafting of alvelarclefts: a densitometric comparison of iliac crest and \ntibial bone grafts. Cleft Palate Craniofac J. 2001;38:11–14.\n\t22.\t \u0007Peysakhov D, Ferneini EM, Bevilacqua RG. Maxillary sinus aug-\nmentation with autogenous tibial bone graft as an in office proce-\ndure. J Oral Implantol. 2012;38:50.\n\t23.\t \u0007Walker TW, Modayil PC, Cascarini L, et al. Retrospective review of \ndonor site complications after harvest of cancellous bone from the \nanteriomedial tibia. Br J Oral Maxillofac Surg. 2009;47:20.\n\t24.\t \u0007Catone GA, Reimer BL, McNeir D, Ray R. Tibial autogenous can-\ncellous bone as an alternative donor site in maxillofacial surgery: a \npreliminary report. J Oral Maxillofac Surg. 1992;50:1258.\n\t25.\t \u0007Herford AS, King BJ, Becktor J. Medial approach for tibial bone \ngraft: anatomic study and clinical technique. J Oral Maxillofac Surg. \n2003;61:358.\n\t26.\t \u0007Hidalgo DA. Fibula free flap: a new method of mandibular recon-\nstruction. Plast Reconstr Surg. 1989;84(1):71.\n\t27.\t \u0007Frodel JL, Funk GF, Capper DT, et al. Osseointegrated implants: a \ncomparative study of bone thickness in four vascularized bone flaps. \nPlast Recontruc Surg. 1993;92:449–455.\n\t28.\t \u0007Moscoso JF, Keller J, Genden E. Vascularized bone flaps in oro-\nmandibular reconstruction. Arch Otolaryngol Head Neck Surg. \n1994;120:36–43.\n\t29.\t \u0007Dattilo DJ, Misch CM, Arena S. Interface analysis of hydroxyapa-\ntite-coated implants in a human vascularized iliac bone graft. Int J \nOral Maxillofac Implants. 1995;10:405–409.\n\t30.\t \u0007Sumi Y, Hasegawa T, Miyaishi O, Ueda M. Interface analysis of \ntitanium implants in human vascularized fibula bone graft. J Oral \nMaxillofac Surg. 2001;59:213–216.\n\t31.\t \u0007Tepper O, Hirsch D, Levine J, Garfein E. The new age of three-\ndimensional virtual surgical planning in reconstructive plastic sur-\ngery plastic a reconstructive. Surgery. 2012.\n\t32.\t \u0007Tessier P, Kawamoto H, Posnick J, Raulo Y, Tulasne F, Wolfe SA. \nComplications of harvesting autogenous bone grafts: a group experi-\nence of 20,000 cases. Plast Reconsr Surg. 2005;116:5.\nA\nB\n• Fig. 39.37  (A) Double layered fibula secured with custom reconstruction plate and superior portion with \nsmaller position plates (Courtesy of Fayette Williams DDS, MD). (B) Six-week computerized tomography \nscan to check position. (Courtesy of Fayette Williams DDS, MD.)"
  },
  {
    "page": 222,
    "content": "1112\n40\nThe Use of Botox and \nDermal Fillers in Oral \nImplantology\nRANDOLPH R. RESNIK AND AMANDA M. SHEEHAN\nT\nhe field of oral implantology is constantly changing because \nof the advances in technology and science. With a better \nunderstanding of the dynamic relationships of the soft \ntissues surrounding the orofacial complex, the use of injectable \nbotulinum toxins (BTXs) and dermal fillers has become an inte-\ngral part of dentistry. With respect to oral implantology, dental \nimplant clinicians are in a unique position to evaluate and treat \npatients with these products. These pharmacologic agents may \nbe used to control parafunctional habits, help restore function, \nrelieve pain, and supplement facial esthetics in conjunction with \nimplant prosthetic procedures. Currently, the two most popular \ntreatments used in conjunction with oral implantology procedures \ninclude the use of injectable neurotoxins (BTX) and injectable \ndermal fillers (hyaluronic acid).\nInjectable Neurotoxin (Botulinum Toxin)\nBotulinum toxin, first used in humans in the 1970s, has become \nvery popular in dentistry. In 2002 Botox was approved in the \nUnited States for cosmetic treatment and for the treatment of \nexcessive forces from hyperfunctional muscle activity. There exist \neight different serotypes of BTX (i.e., designated as A to H), with \nsome being purified for therapeutic injections into hyperactive \nmuscles. Today, botulinum toxin type A (BTX-A; purified isolate \nfrom fermentation of the bacterium Clostridium botulinum) is the \nmost potent and widely used serotype in clinical practice. BTX-A \nis a stable compound that is present in a vacuum-dried powder \nthat currently is marketed under three different brand names: \nBotox, Dysport, and Xeomin. They all contain the same active \ningredient of BTX-A; however, they differ in their formulation: \nonabotulinum toxin A (Botox), abobotulinum toxin A (Dysport), \nand incobotulinumtoxin A (Xeomin).\nMechanism of Action\nIn general, BTX-A blocks the neuromuscular transmission by \ninhibiting the release of acetylcholine from motor nerve terminals, \nwhich results in a reduction of muscle contractions. Acetylcho-\nline is a neurotransmitter that is responsible for muscle contrac-\ntions. The muscle inhibition occurs in multiple steps (binding, \ninternalization, translocation, and cleavage) by BTX-A cleaving \nto a protein (SNAP-25), which is an integral part of acetylcho-\nline docking and release from vesicles in the nerve endings. When \ninjected intramuscularly, BTX-A produces a chemical denerva-\ntion of the muscle, which results in a reduction of muscle activity \n(Fig. 40.1).1\nThe effects of the botulinum neurotoxins are temporary because \nthe nerve terminals will recover back to their normal function. Ini-\ntially axonal sprouts arise from the affected nerve in response to \ngrowth factors from the inactive muscle. The axonal sprouts form \nnew immature synapses to the injected muscle, which allows neu-\nromuscular transmission to return to normal. \nHow Supplied and Preparation\nIn the United States BTX-A is manufactured as a purified neurotoxin \ncomplex supplied as a white powder in sterile glass vials. Each vial \ncontains either 50, 100, and 200 units (U) of BTX-A, with an \nexpiration date of 2 years when stored properly at −5°C to −20°C. \nThe BTX-A vial should always be refrigerated until use. Because \nof its powder form, the BTX-A must be reconstituted with 0.9% \nNaCl sterile saline solution. Most commonly, BTX-A is supplied in \na 100-U vial that is usually diluted with 2 or 4 mL of saline, which \nresults in a 5.0/2.5-U BTX-A per 0.1 mL solution. Commonly the \ndilution is dictated by the muscle or region being treated, or by the \nclinician’s preference. Usually a 1.0-mL tuberculin syringe with a \n26- to 30-gauge needle is used to draw up the required solution \nfor administration.2 Once opened and reconstituted, the solution \nmust be used within 24 hours because the BTX-A and diluent \ncontain no preservatives. The solution should be stored in a refrig-\nerator at 2°C to 8°C (36°F–46°F). If preservatives are used, the \nshelf-life is significantly increased. Hexsel et al.3 have shown that \nrefrigerated, reconstituted BXT-A can be used for up to 6 weeks \nwithout loss of efficacy (Table 40.1 and Fig. 40.2).\nGeneralized Botulinum Toxin Type A Injection Technique/\nDose\nIn general, injections should be made perpendicular to the skin sur-\nface and intramuscularly into the belly of the muscle. However, in \nsome situations a more customized injection pattern may be required."
  },
  {
    "page": 223,
    "content": "Acetylcholine\nSynaptobrevin\nSNAP-25\nSyntaxin\nAxon\nSynaptic cleft\nAcetylcholine receptor\nMuscle cell\nA\nSNARE\nComplex\nBTA receptor\nBTA light chain\nCleavage of SNARE proteins\nBTA\nB\nFrown Lines\nForehead\n    Lines\nBunny Lines\nGummy Smiles\nDimpled Chin\nPlatysmal Bands\nEyebrow Shaping\nCrows Feet\n Lip Lines\nMarionette Lines,\n      Sad Smile\n• Fig. 40.1  (A and B) Diagram depicting the action of botulinum toxin at the neuromuscular junction. (A) Normal acetylcholine release. Synaptobrevin and \nVAMP-2 (not shown) on the surface of the vesicle containing acetylcholine joins with SNAP-25 and syntaxin on the internal axonal surface. This forms a \ncomplex that allows fusion of the vesicle with the membrane to release acetylcholine into the synaptic cleft. Acetylcholine binds to its receptor on the sur-\nface of the muscle cell, opening voltage-gated sodium channels that result in membrane depolarization. (B) Action of botulinum toxin. Botulinum toxin type \nA (BTA) is internalized by the axon when bound by its receptor on the cell surface. The light chain of the toxin is taken up and cleaves the SNARE proteins \nbefore the acetylcholine vesicles can bind. The result is a lack of acetylcholine release into the synaptic cleft and subsequent paralysis of the muscle. (C) \nCommon facial anatomic areas for Botox injections. (A and B: From Miller J, Clarkson E. Botulinum toxin type a: review and its role in the dental office. \nDent Clin North Am. 2016;60:509-521.)"
  },
  {
    "page": 224,
    "content": "For muscle injections in the orofacial region, skin preparation should \nalways be completed using aseptic alcohol wipes and dry sterile gauze \nsponges. In most clinical situations the muscles should be injected \nbilaterally to minimize complications from asymmetry or unequal \nnerve involvement (i.e., number of units will vary depending on the \ntarget muscle). When considering the ideal dosing amount, the total \nnumber of units will depend on the area of interest, muscle mass, \nand strength and gender of the patient. In general, men will require \nmore units than women. Care should be taken when choosing the \ndilution being used because higher dilution may result in further \nmigration of the BTX-A and may result in unwanted effects. \nDuration of Action\nThe U.S. Drug Administration recommends an injection fre-\nquency of once every 3 months with the lowest effective dose. \nIn some patients multiple injections may over time result in the \ndevelopment of antibodies to BTX-A, which results in effect \nreduction and inactivating the toxin activity. However, in general \nthe length of efficacy varies among individuals and is dependent \non the patient’s metabolism of the toxin and the use or activity of \nthe muscle being treated. \nBotulinum Toxin Type A Uses in Implant \nDentistry\n\t1.\t \u0007Parafunctional habits\n\t2.\t \u0007Temporomandibular joint syndrome/temporomandibular dys-\nfunction (TMJ/TMD)\n\t3.\t \u0007Excessive tissue display (gummy smile)\nParafunctional Habits\nMasseter Muscle Hyperactivity\nA common sequela of patients with parafunction is masseter \nhypertrophy. The masseter muscle is one of the primary muscles \nof mastication. When the masseter muscle is hyperactive or over-\nused, the facial appearance often enlarges and results in a negative \ncosmetic impact with altered facial lines. Muscle function is also \naltered, which results in excessive force being placed on the teeth/\nimplants. Studies have shown a significant reduction in masseter \nmuscle volume with an average reduction in mass of 22% and up \nto approximately 35% reduction after the continued use of BTX-\nA4 (Figs. 40.3 and 40.4).\nAnatomy. The masseter muscle is a thick quadrilateral muscle \nthat consists of two heads: (1) superficial and (2) deep.\n   \nSuperficial: The larger superficial head arises by a thick aponeurosis \nfrom the maxillary process to the zygomatic bone and from \nthe anterior two-thirds of the inferior border of the zygomatic \narch. The fibers pass inferior and posterior, and are inserted in \nthe angle of the mandible and inferior half of the lateral surface \nof the mandibular ramus.\nDeep: The smaller deep head arises from the posterior third of the \nlower border and the medial surface of the zygomatic arch. Its \nfibers pass in a downward and forward direction to be inserted \ninto the upper half of the ramus as high as the coronoid process \nof the mandible. Anteriorly the superficial head conceals the \ndeep head and posteriorly is covered by the parotid gland. \nInnervation and Blood Supply. The masseter is innervated by \nthe anterior division of the mandibular division (V3) of the tri-\ngeminal nerve. The pathway of innervation is gyrus precentralis > \ngenu capsula interna > nucleus motorius nervi trigemini > nervus \ntrigeminus > nervus mandibularis > musculus masseter. The blood \nsupply to the masseter muscle is derived from three blood vessels: \nthe masseteric branch of the maxillary artery, the facial artery, and \nthe transverse facial branch of the superficial temporal artery. \nFunction. The primary function of the masseter muscle is ele-\nvation of the mandible. The masseter muscle parallels the medial \npterygoid muscle; however, it is significantly stronger and its \nsuperficial fibers can be responsible for protrusive movements.5 \nBotox Technique. Injection into the masseter muscle for the \ntreatment of masseter hypertrophy was first discussed by von \nLindern et al.6 They suggested injections into the zygomatic arch \nand mandibular angle. However, this method revealed a higher \nrisk for injection into the parotid gland, which led to significant \ncomplications. Hu et al.7 determined a safe zone for injection sites \ninto the masseter muscle. They recommended the safest entry \npoint to be in the central compartment of the masseter muscle \nas to avoid injections into the parotid gland and the mandibular \nbranch of the facial nerve. The parotid gland is located superfi-\ncial and at the posterior margin of the muscle. Branches of the \nfacial nerve also run superficial to the muscle. The delineation of \nthe “safe zone” is a line drawn from the lower ear to the angle of \nthe mouth (superior margin). The anterior extent is determined \nby palpation and the posterior extent is the posterior angle of the \nmandible (Fig. 40.4). The inferior border is delineated by the infe-\nrior border of the mandible.\nMapping Injection Sites. An outline of the muscle needs to be \ncompleted to determine the maximum areas of contraction and \ntension points of the masseter muscle. Initially a line is drawn with \na removable skin marker from the lateral commissure (corner of \nthe mouth) to the bottom of earlobe (small pointed eminence of \nthe external ear that projects over the meatus). The inferior border \nof the mandible is outlined, and the anterior and posterior borders \nof the muscle are marked. The patient is asked to clench his or her \nteeth, and the maximum contraction points are documented and \nmarked. Skin markings can easily be removed with alcohol swabs. \nInjection Technique. Two syringes of reconstituted 25 U of \nBTX-A are drawn up in into syringes and approximately 5 U is \ninjected deep into the belly of the muscle at each tension point. In \nmost cases the needle is inserted perpendicular to the skin surface \n(Fig. 40.5). \nStudies. Many studies have shown the successful reduction \nin masseter hypertrophy via BTX-A injections.7-10 With multi-\nple injections, concomitant reduction in gross masseter size has \nbeen shown to be up to 40%.8 Rafferty et al.11 showed masseter-\ninduced bite force reduction of up to 85% at week 3 after injec-\ntions and 65% less at week 7. However, clenching returned to \n  \u0007Dilution Table for Botulinum Toxin Type A\nBTX-A VIAL\nDiluent Added  \n(0.9% NaCl)\nResulting Dose \n(Units/0.1mL)\n50 units\n1.25 mL\n1.0 mL\n4.0 units\n5.0 units\n100 units\n2.50 mL\n2.0 mL\n4.0 units\n5.0 units\n200 units\n5.0 mL\n4.0 mL\n4.0 units\n5.0 units\n   \nTABLE \n40.1\n1114\nPART VII    Soft and Hard Tissue Rehabilitation"
  },
  {
    "page": 225,
    "content": "A\nB\nC\nD\nF\nE\nH\nG\n• Fig. 40.2  Reconstitution of Botulinum Toxin Type A (BTX-A).  (A)  0.9% Sodium Chloride Vial (B) Using an appropriate-size needle and syringe, draw \nup 1, 1.25 or 2.5 mL of 0.9% preservative sterile saline. (C) Invert needle and tap side to expel any air bubbles. (D) Insert the needle and slowly inject the \nsaline into the BTX-A. Vacuum must be present in the vial, which demonstrates that sterility of the vial is intact. (E) Remove the syringe, then gently mix \nthe vial with the saline by rotating the vial. Record the date and time of reconstitution on the label. (F) Using a small tuberculin syringe draw up the required \namount of solution; angle the needle into the bottom corner of the vial to allow for full extraction of solution. Do not completely invert the vial and expel any \nair bubbles in the syringe barrel. (G and H) Final syringes with BTX-A solution are ready for injection."
  },
  {
    "page": 226,
    "content": "1116\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nSuperficial head\nof masseter\nmuscle\nDeep head of\nmasseter muscle\nC\nD\nE\n• Fig. 40.3  Masseter Hypertrophy.  (A) Masseter muscle. (From Nanci A. Ten Cate’s Oral Histology: \nDevelopment, Structure, and Function. 9th ed. St. Louis, MO: Elsevier; 2018.) (B) Radiograph depicting \nlarge antegonial notch resulting from the excessive force on the angle of the mandible. (C) Enlarged \nfacial appearance from hypertrophied muscle. (D) Image of patient with missing dentition in lower left.  \n(E) Resultant hypertrophy of right masseter and atrophy of left masseter.\nAnterior\nMasseter\nBorder\nA\nB\nC\nPosterior\nMasseter\nBorder\nMandibular\nAngle\nSafety\nZone\nMandibular Border Line\nCommissure - Ear Lobe Line\n• Fig. 40.4  Masseter Muscle.  (A) Injection boundaries. (B) Masseter hypertrophy. (C) Reduction of \nmasetter mass after Botox injections."
  },
  {
    "page": 227,
    "content": "1117\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\nA\nC\nE\nF\nD\nB\n• Fig. 40.5  Masseter Mapping and Injection Technique.  (A) Skin Marker, (B) Commissure—ear lobe line \ndrawn. (C) Inferior border of mandible trajectory evaluated. (D)  Inferior border points marked. (E) Inferior \nborder and posterior border points connected. (F) Anterior masseter muscle border marked.\nbaseline values faster as the result of other muscles compensating. \nVan Zandijcke and Marchau12 described in 1990 the use of 100 \nU of BTX-A injections to the temporalis and masseter muscles \nin patients with brain injuries. The mean duration of response \nwas approximately 19 weeks and mean peak effect (abolishment \nof grinding) was approximately 3.5 weeks. In general the targeted \nmusculature usually adapts to the injections, and frequency of \ninjections usually decreases because of the atrophy of the muscles. \nComplications. Injections in the masseter muscle area are rela-\ntively safe with minimal side effects. Inaccurate injection location"
  },
  {
    "page": 228,
    "content": "1118\nPART VII    Soft and Hard Tissue Rehabilitation\nG\nI\nJ\nH\nFig. 40.5, cont’d  (G) Posterior masseter muscle border marked. (H) Tension points determined. (I and J) \nInjection of 5 units deep into the belly of the muscle at each point.\nor too high injection volume may lead to excessive swelling, bruis-\ning, facial muscle weakness, and xerostomia. Postoperatively, \npatients may report a “thicker” saliva and usually this is related \nto higher doses and injections into the parotid gland. Injections \nmade too far anteriorly may lead to BTX-A diffusion into adjacent \nmuscles, leading to smile alteration (Fig. 40.6). \nTemporalis Muscle\nThe temporalis muscle (also called the temporal muscle) is considered \na muscle of mastication and arises from the temporal fossa.\nAnatomy. The temporalis muscle is a broad, fan-shaped mus-\ncle of mastication on the lateral aspect of the skull. It arises \nfrom the temporal fossa, which is a large depression on the \nlateral aspect of the skull. A temporal fascia completely covers \nthe surface of the muscle. The muscle fibers converge as they \ndescend through a space between the zygomatic arch and end \nwith the temporalis tendon. The temporalis tendon is consid-\nered a very thick tendon that inserts at the coronoid process of \nthe mandible (Fig. 40.7). \nInnervation and Blood Supply. The third division of the man-\ndibular branch of the trigeminal nerve innervates the temporalis \nmuscle by the deep temporal nerves. The deep temporal branches \nof the maxillary artery, along with the middle temporal artery, \ncontribute to the blood supply of the muscle. \nFunction. The temporalis muscle is considered the strongest \nmuscle of mastication. It can be divided into two functional parts, \nthe anterior and posterior. The anterior temporalis runs vertically \nand is responsible for elevation of the mandible. The posterior \ntemporalis runs horizontally, and contraction results in retrusive \nmovements of the mandible.13 \nBotox Technique\nMapping Injection Sites. The anterior, posterior, and supe-\nrior extent of the temporalis muscle is marked with a skin \nmarker. As the patient clenches his or her teeth, the maximum \nareas of contraction and/or tension points are marked within \nthe boundaries. \nInjection Technique. The injection technique for the tempora-\nlis muscle usually consists of two injections, superficial and deep, \naccording to the location of the areas of maximum contraction. \nThe superficial injections are positioned into the thinner upper \nportions of the temporalis muscle in a fan shape. The deeper injec-\ntion involves the split of the superficial temporalis fascia, which is \nlocated approximately 1.5 mm superior to the zygomatic arch15 \n(Figs. 40.8 and 40.9). \nDuration. When BTX-A is injected for parafunctional habits \nin temporalis muscles, patients appear to require repeated injec-\ntions at approximately 5 months. Other studies have shown injec-\ntions to be repeated every 6 months.14"
  },
  {
    "page": 229,
    "content": "1119\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\nTemporomandibular Joint Syndrome (TMJ)/\nTemporomandibular Dysfunction (TMD) Pain\nThe use of BTX-A has been shown to treat TMJ or TMD com-\nplications, with the injection of the masseter and temporalis \nmuscles. Guarda-Nardini et al.16 demonstrated the use of Botox \nin the treatment of decreasing myofascial pain symptoms in \nbruxers, compared with saline injections. Baker et al.17 evaluated \nthe use of masseter and temporalis injections for patients exhib-\niting chronic masticatory myofascial pain dysfunction. Results \nshowed a decrease in overall pain and overall maximum volun-\ntary opening.\nSuccess rates are variable in the treatment of patients with TMJ. \nStudies have reported that BTXs used for the treatment of TMD \ndisorders may cause dysphagia18 or temporal drooling.19 However, \nin both of these reports greater than 100 U was administered.\nTemporomandibular Dysfunction/Temporomandibular \nJoint Technique\nThe TMD/TMJ BTX-A technique is very similar to the tra-\nditional masseter and temporalis muscle techniques, with the \nonly difference being dictated by myofascial trigger points. To \ndetermine the location of injections for TMD/TMJ technique, \nmyofascial trigger points must be located. Trigger points are \nhyperirritable areas within the fascia surrounding the muscle, \nwhich may differ from areas of maximum contraction. Usually in \nTMD/TMJ cases, one or more trigger points are generally pres-\nent, which on palpation will cause transmission of pain along the \nmuscle or neuronal tracks. Disruption of the trigger points have \nbeen reported to bring short- and long-term pain relief.20\n\t1.\t \u0007Palpate for two trigger points in the masseter and mark with a \nskin marker.\n\t2.\t \u0007Palpate for three trigger points in the temporalis and mark with \ntissue pen.\nB\nA\n• Fig. 40.6  Smile Alteration Complication: (A) Normal smile, (B) Smile \nalteration resulting from injection on the right side which was too medial, \nwhich inadvertently diffused and affected the Risorius muscle. Note the \nconstricted smile on the right side.\nTemporalis\nmuscle\n• Fig. 40.7  Temporalis Muscle. (From Nanci A. Ten Cate’s Oral Histology: \nDevelopment, Structure, and Function. 9th ed. St. Louis, MO: Elsevier; \n2018.)\n• Fig. 40.8  Temporalis Muscle Boundaries."
  },
  {
    "page": 230,
    "content": "1120\nPART VII    Soft and Hard Tissue Rehabilitation\n\t3.\t \u0007Clean injection areas with alcohol wipes.\n\t4.\t \u0007Using four tuberculin syringes, draw up (2) 20-U syringes and \n(2) 25-U syringes.\n\t5.\t \u0007Inject 10 U into each trigger point in the masseter.\n\t6.\t \u0007Inject 12.5 U into temporalis anterior fan, 7.5 U into the mid-\ndle, and 5 U into the temporalis posterior fan. (Fig. 40.10). \nExcessive Tissue Display (Gummy Smile)\nIn the rehabilitation of the dental implant patient, clinicians \nare often confronted with excessive display of maxillary gingi-\nval tissue on smiling. The “gummy smile” results in difficulty in \nrestoring patients because of nonideal esthetics and displeasure \nB\nC\nD\nA\nE\nG\nF\n• Fig. 40.9  Temporalis Technique.  (A) Maximum areas of contraction and/or trigger points evaluated \nwhile the patient clenches his teeth. (B) Trigger points are marked with skin marker. (C) Final tension points. \n(D) Anterior and superior borders are marked. (E) Final boundary outline and tension points. (F and G) Five \nunits of botulinum toxin type A per injection point."
  },
  {
    "page": 231,
    "content": "1121\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\nB\nC\nA\nD\nE\n• Fig. 40.10  Temporomandibular Dysfunction/Temporomandibular Joint Technique: Clean Injection \nAreas With Alcohol Wipes.  (A and B) Palpate for (A) two trigger points in the masseter and (B) three \ntrigger points in the temporalis, and mark with tissue pen. (C) Using four tuberculin syringes, draw up (2) \n20-U syringes and (2) 25-U syringes. (D) Inject 10 U into each trigger point in the masseter. (E) Inject 12.5 \nU into anterior fan, 7.5 U into the middle, and 5 U into the posterior fan of the temporalis muscle.\nin the prosthesis-tissue junction. Caution should be exercised \nwith the treatment of gummy smiles because vertical maxillary \nexcess is historically treated surgically by means of maxillary \nimpaction via a Le Fort 1 osteotomy procedure. For patients \nexhibiting delayed passive eruption, gingivectomies are the \nideal treatment. Botox can be used for correction of hyper-\nfunctional upper lip elevator muscles. Therefore, before treat-\nment, it is crucial that the etiology of the gummy smile be \nascertained.\nKokich et al.21 described an excessive gingival-to-lip distance \nof 4 mm or more, which they classified as “unattractive” by lay-\npeople and dental professionals. Excessive gingival display has \nbeen shown to have a prevalence rate of approximately 11% of the \npopulation, with more women displaying excessive gingiva than \nmen, with a 2:1 female:male ratio.22,23,24\nThere exist two types of smiles in the literature, the “social” and \nthe “enjoyment” smile. The social smile is a voluntary, unstrained \nand static facial expression that is usually used as a greeting. The \nlip component is due to the muscular contraction of the eleva-\ntor muscles of the lip. In contrast, the enjoyment smile is invol-\nuntary and usually results from laughter or pleasure. The upper \nand lower lip elevator and depressor muscles are responsible for \nthe full expansion of the lips, which show maximum anterior \ntooth display.25 A cosmetic smile has been defined as display-\ning less than 2 mm of the gum tissue. Any smile showing more \nthan 2 mm is classified as a gummy smile or excessive gingival \ndisplay.26 When treating these patients, it is imperative to have a \npreoperative photo of their enjoyment smile showing their maxi-\nmum lip movement, to properly assess the needs and outcome \nof the BTX-A treatment. In summary, a thorough intraoral and \nextraoral examination is imperative because the excessive gingi-\nval display may be treated with BTX-A only when it caused by \nhypermobility of the lip, not when the excessive gingival display \nis the result of the position of the maxilla (skeletal position) or a \nshort upper lip (Fig. 40.11).\nEtiology\nIn the production of a smile, many muscles are involved, includ-\ning orbicularis oris, levator labii superioris alaeque nasi (LLSAN), \nlevator labii superioris (LLS), zygomaticus major (ZM), and \ndepressor septi nasi muscle. In cases of true hyperfunctional \nupper lips, the primary muscle responsible for the hyperactiv-\nity with resultant excess display of gingiva is the LLSAN. The \nLLSAN is translated from the Latin as the “lifter of the upper \nlip and wing of the nose.” This muscle originates from the upper \nfrontal process of the maxilla and inserts into the skin of the \nlateral nostril and upper lip. Its main action involves elevation \nof the upper lip and is also involved in dilation of the nostrils \nand creation of associated deep nasolabial folds (Fig. 40.12 and \nBox 40.1). \nInjection Technique\nHwang et al.,27 at Yonsei University College of Dentistry, have \nproposed an injection point for the treatment of a gummy smile,"
  },
  {
    "page": 232,
    "content": "1122\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\n• Fig. 40.11  (A–C) Excess tissue “gummy smiles” examples.\nLayer 1\nLayer 2\nLayer 3\nLayer 4\n1. Depressor anguli oris\n4. Depressor labii inferioris\n5. Risorius\n6. Platysma\n7. Zygomaticus major\n9. Orbicularis oris\n10. Levator labii superioris \n11. Mentalis\n12. Levator anguli oris\n13. Buccinator\n8.Levator labii superioris\n   alaeque nasi\n2. Zygomaticus minor\n3. Orbicularis oculi\n3\n8\n10\n2\n7\n5\n1\n6\n4\n11\n9\n12\n13\n• Fig. 40.12  Image depicting the muscles of facial expression and injection site locations. (From Afifi AM, \nDjohan R. Anatomy of the head and neck. In: Neligan PC, ed. Plastic Surgery. Vol. 3: Craniofacial, Head \nand Neck Surgery. 3rd ed. London: Elsevier; 2013.)"
  },
  {
    "page": 233,
    "content": "1123\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\nwhich is named the Yonsei point. The Yonsei point is located at \nthe center of a triangle formed by LLS, LLSAN, and zygomaticus \nminor muscles. The merger of these muscles can be felt by palpat-\ning lateral to the nose while smiling and is roughly 1 cm lateral to \nthe ala of the nose and 3 cm superior from the lateral oral com-\nmissure. Hwang et al.27 have recommended a dose of 3 U at each \ninjection site (bilaterally).\nAchieving ideal outcomes for the treatment of excessive tissue \ndisplay is extremely technique sensitive, with excess treatment \noften occurring in transverse elongation and dysfunctional anima-\ntion of the maxillary lip. Therefore clinicians early on their learn-\ning curve should treat these areas cautiously and gradually, with \nmultiple low-dose treatments over a longer time period in lieu of a \nsingle bolus in one appointment.28 Ideally the lip at rest and high \nlip line should be documented with photographs by measuring \nfrom the gingival zenith to the inferior border of the upper lip. \nPatients with natural asymmetry to their smile may need different \namounts of BTX-A on each side to achieve an ideal smile level. \nThe asymmetry should be reevaluated at a 2-week interval, and \nmore BTX-A can be added to the hyperactive side (Figs. 40.13 \nto 40.15).\nFacial asymmetry corrected with Botox should be over a \n4-week period, with approximately 2 U administered bilaterally at \nthe initial visit and 1 U administered 2 weeks later. This technique \nusually will result in a more symmetric smile.\nDuration. The duration of action of BTX-A is not permanent, \nlasting on average for 6 months with a range of 4 to 8 months.29 \nIn most cases, BTX-A needs to be administered approximately \ntwo to three times a year, depending on how much muscle activity \nis present. The therapeutic effects will usually appear in 24 to \n72 hours and peak in 1 to 4 weeks, with a decline after 3 to 4 \nmonths.30 \nStudies. Polo22 showed favorable results with a mean gin-\ngival exposure reduction of 5.2 mm. Although the amount of \nOrbicularis Oris Muscle\nOrigin: maxilla and mandible\nInsertion: skin around the lip\nFunction: muscle encircling the mouth is a sphincter muscle and is \nresponsible for closing the mouth; it is known as the “kissing muscle,” \nbecause it is used to pucker the lips \nLevator Anguli Oris Muscle\nOrigin: maxilla inferior to the infraorbital foramen\nInsertion: modiolus\nFunction: lifts the upper lip \nZygomaticus Major Muscles\nOrigin: zygomatic bone\nInsertion: orbicularis at modiolus\nFunction: works with the risorius muscle to assist in laughing and smiling by \nlifting the corners of the mouth \nZygomaticus Minor Muscles\nOrigin: malar surface of the zygomatic bone\nInsertion: orbicularis oris\nFunction: draws the upper lip backward, upward, and outward and is used \nin smiling \nLevator Labii Superior Muscle\nOrigin: medial infraorbital margin\nInsertion: skin and muscle of the upper lip\nFunction: elevates the lip \nLevator Anguli Muscle\nOrigin: maxilla\nInsertion: modiolus\nFunction: elevates the angle of the mouth medially \nLevator Labii Superior Alaeque Nasi Muscle\nOrigin: nasal bone\nInsertion: nostril and upper lip\nFunction: dilates the nostril and elevates the upper lip and nose \nDepressor Anguli Oris Muscle\nOrigin: tubercle of mandible\nInsertion: modiolus of mouth\nFunction: depresses angle of mouth \nDepressor Labii Inferior Muscle\nOrigin: oblique line of mandible between symphysis and mental foramen\nInsertion: integument of the lower lip, orbicularis oris, modiolus\nFunction: depression of the lower lip \nRisorius Muscle\nOrigin: parotid fascia\nInsertion: modiolus\nFunction: retracts the angle of the mouth to produce a smile \nBuccinator Muscle\nOrigin: alveolar processes of maxilla and mandible\nInsertion: fibers of orbicularis oris\nFunction: compresses the cheeks against the teeth\n\t • BOX 40.1\t   \u0007Facial Muscles Anatomy and Function\nInjection Point\n• Fig. 40.13  Yonsei Point.  Is located 1 cm lateral to the ala of the nose \nand 3 cm superior to the oral commissure."
  },
  {
    "page": 234,
    "content": "1124\nPART VII    Soft and Hard Tissue Rehabilitation\ngingival display increased from 2 weeks to 24 weeks, the amount \nof original display had not returned at 24 weeks. Park et al.31 \nshowed a mean reduction in masseter thickness of up to 2.9 \nmm, measured at 3 months postoperatively. With multiple \ninjections, eventual atrophy of the masseter muscle resulted in \nrequiring less frequent doses, with a recommended recall of 4 \nto 6 months.\nComplications. In the treatment of the gummy smile, many \ncomplications may arise consisting of asymmetries, lip sagging, \nlip protrusion, exaggerated lip elongation, and interference \nwith speech. As stated, the clinician must be able to distinguish \nhyperfunctional upper lips from other causes of gummy smiles. \nFor instance, attempts to treat maxillary excess conditions with \nBTX-A may lead to unnatural results from the excessive loss \nof function needed to prevent gingival display. When short \nclinical crowns are present, tissue alteration in the form of a \ngingivoplasty should be completed to obtain esthetic crown \nlengthening. In general, vertical maxillary excess cases are usu-\nally treated with a maxillary impaction via Le Fort I osteotomy. \nGeneralized Botulinum Toxin Type A \nPostoperative Instructions\nPostoperative care is very important with BTX-A patients because \ndeviation from the following instructions may lead to increased \ncomplications:\n\t1.\t \u0007Patients should be instructed not to touch or massage the \ninjected areas for a minimum of 4 hours. This will prevent the \ndispersion of BTX-A into adjacent sites and allow the BTX-A \nto penetrate the targeted area for ideal effect.\n\t2.\t \u0007Patients should restrict physical activity for a minimum of 24 \nto 48 hours because this will minimize inflammation.\n\t3.\t \u0007Patients should avoid alcohol and smoking. Excessive perspi-\nration (e.g., exercise, sauna) should be avoided because tissue \nhealing may be affected.\n\t4.\t \u0007Patients should be instructed to refrain from lying down for at \nleast 4 hours after injections in the face because this may alter \nthe dispersion of the BTX-A.\n\t5.\t \u0007Patients should be educated on potential bruising, redness, and \nswelling, which are common after the injections. These side \neffects usually will resolve within 7 to 10 days.\n\t6.\t \u0007Patient education is important on expectations because results \nmay not be immediate. Usually changes will be seen as early as \n3 to 7 days, with maximum results after 14 days. \nGeneralized Contraindications to Botox\nGeneralized contraindications to Botox include32:\n • \u0007Psychologically unstable patients or patients who have ques-\ntionable motives and unrealistic expectations\n • \u0007Individuals who are dependent on intact facial movements and \nexpressions for their livelihood (e.g., actors, singers, musicians, \nand other media personalities)\n • \u0007Patients afflicted with a neuromuscular disorder (e.g., myas-\nthenia gravis, Eaton-Lambert syndrome, tardive dyskinesia, \nstroke)\n • \u0007Individuals who are allergic to any of the components of \nBTX-A or BTX-B (i.e., BTX, human albumin, saline, lactose, \nand sodium succinate) or eggs\n • \u0007Patients who are currently taking specific medications that \nmay interfere with neuromuscular impulse transmission and \nmay potentiate the side effects of BTX (e.g., aminoglycosides, \npenicillamine, quinine, and calcium blockers); drug classes \nthat have been shown to affect BTX-A include anticholinergic \ndrugs, muscle relaxants, other botulinum neurotoxin products, \ndopamine-blocking drugs, and some over-the-counter vita-\nmins such as vitamin E, fish oils, Omega 3 fatty acids, and \ncoenzyme Q10\n • \u0007Pregnant or lactating individuals (BTXs are classified as preg-\nnancy category C drugs)\n • \u0007Patients with presence of infection at the proposed injection \nsite \nGeneralized Complications to Botox\nGeneralized complications to Botox include:\n • \u0007Migration of BTX-A into associated muscles near the injection \nsite\n • \u0007Headache or flu-like symptoms\n • \u0007Discomfort or pain at injection site\nA\nB\n• Fig. 40.14  Gummy Smile Injection Points (Yonsei).   (A) Gummy smile, \n(B) Yonsei injection points."
  },
  {
    "page": 235,
    "content": "1125\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\n • \u0007Spread of BTX-A toxin effects, which spread to unwanted \nmuscle or anatomic areas; this is most likely a result of the \nincorrect injection site or too great a volume administered\n • \u0007Breathing or swallowing complications that may occur imme-\ndiately or weeks after injections\n • \u0007Swelling, rash, headache, local numbness, pain at injection site, \nbruising, respiratory problems, or allergic reactions\n • \u0007Antibiotics have been shown to shorten the length of duration \nof BTX-A \nInjectable Fillers\nAnother pharmacologic agent that is becoming increasingly popu-\nlar in implant dentistry is dermal fillers. In the past, injectable \nfillers such as liquid silicone and bovine collagen were used to \nreplace or enhance the volume of subcutaneous tissue. However, \nthese products exhibited a high incidence of allergic and foreign \nbody reactions. Today, many fillers without the side effects that \nwere associated with the earlier agents are on the market. These \nA\nB\nC\nD\nE\nF\n• Fig. 40.15  Gummy Smile Technique.  (A and B) Have patient smile as large as possible and document \nwith photos. (C) Injection site is cleaned with alcohol wipe. (D) Palpate for the levator labii superioris alaeque \nnasi muscle and mark with tissue pen bilaterally. (E) Have patient smile and verify vertical movement of \nmarked areas. (F) Draw up two separate tuberculin syringes with 1 to 2 U of BTX-A."
  },
  {
    "page": 236,
    "content": "1126\nPART VII    Soft and Hard Tissue Rehabilitation\nnewer filler products are classified as either “permanent” (e.g., \npolymethylmethacrylate [PMMA], calcium hydroxyl appetite, \nand expanded polytetrafluoroethylene) or “nonpermanent” (e.g., \ncollagen or hyaluronic acid). Currently, the most commonly used \nfillers in dentistry are hyaluronic acid products such as Juvéderm \n(Allergan) and Restylane (Medicis).33 These filler products have \nthe advantage of being supplied in various viscosities, are easy to \nhandle, have safe antigenicity, and effects can be reversed or dis-\nsolved using hyaluronidase (reversal agent) (Table 40.2).\nSignificant advances in the injectable dermal filler markets have \nled to a growing interest and increased usage. These minimally \ninvasive injectable procedures have been geared toward the treat-\nment of facial aging and facial enhancement; however, they are \nbecoming more popular in dental implant-related areas. Approx-\nimately 3 million soft tissue procedures were performed in the \nUnited States in 2016, of which the majority were of hyaluronic \nacid–based fillers.34\nWith respect to dental implant patients, many patients are at \nan advanced age, with associated facial aging symptoms. Therefore \nthe implant clinician must consider the benefits of rejuvenation \ntechniques for maximizing the cosmetic outcomes in association \nwith the implant procedures. In today’s implant practice, the stan-\ndard is for the implant dentist to consider the benefits of facial \nvolume restoration when performing implant surgery on patients \nwho may benefit from these products.\nHyaluronic acid fillers have become popular in the United \nStates and global markets because they are user friendly, are \nstable at room temperature, are available in single preloaded \nsyringes that require no preparation, are relatively inexpensive, \nand have the ability to be reversed with hyaluronidase. Addi-\ntional advantages include they exhibit longer duration of action \nin comparison with collagen preparations and require no allergy \ntesting.\nHyaluronic acid is an anionic, simple nonsulfated glycosamino-\nglycan widely found throughout connective, epithelial, and neural \ntissues. The natural hyaluronic acid contributes to tissue repair via \ncell hydration and lubrication. With age, the hyaluronic acid in \nthe skin decreases, which results in decreased dermal hydration. If \nthe skin is exposed to excessive ultraviolet B rays, cells within the \ndermis will induce the loss of hyaluronic acid from dermal tissue, \nresulting in photoaging.\nHyaluronic acid has a large particle size that leads to its inher-\nent hydrophilic nature, thus allowing it to retain large amounts of \nwater (can absorb up to 1000 times its molecular weight). When \ninjected under the skin the hyaluronic acid fillers attract and bind \nwater, thus providing volume to the skin. Because of its nonim-\nmunogenic nature, it is devoid of many of the allergenic collagen \nfillers that were prevalent in the past.\nThe modern hyaluronic acid–based fillers are created by cross-\nlinking the hyaluronic acid chains by conjugation with butanediol \nG\nH\nI\nFig. 40.15, cont’d  (G) Inject 1 to 2 units into levator labii superioris alaeque nasi muscle bilaterally by \ninserting needle halfway the depth of the needle. (H and I) After 2 weeks the patient should be evaluated \nfor symmetry and adjusted if needed."
  },
  {
    "page": 237,
    "content": "1127\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\ndiglycidyl ether. The cross-linked hyaluronic acid may be pro-\ncessed in various ways that yield homogeneous gels (the Juvé-\nderm family) or suspensions of particles in gel carriers (NASHA \nRestylane). Therefore, each type of hyaluronic acid filler contains \nvarying amounts of hyaluronic acid and through the various cross-\nlinking processes, different properties of gels and varying degrada-\ntion rates result (Fig. 40.16).\nMechanism of Action\nThe use of hyaluronic acid stimulates cell proliferation, migration, \nangiogenesis, and reepithelialization, and reduces collagen and \nscar formation.35 In comparison with collagen injections, hyal-\nuronic acid products do not require preinjection testing and pro-\nduce relatively reproducible, longer-lasting results.36 \nHow Supplied and Preparation\nCurrently, there are three major companies, Allergan, Medicis, \nand Merz, that have multiple hyaluronic acid fillers on the market. \nThere is no universal filler that is appropriate for every application \nor for every patient. It is important to understand the physical \nproperties of the fillers and how they interact for predictable clini-\ncal outcomes. Each of the major brands have multiple hyaluronic \nacid options in their lines that are specifically designed for differ-\nent treatment sites. It is important to properly understand and fol-\nlow the indications for usage for each hyaluronic acid filler being \nused. Some of the more common dermal fillers include:\n   \nRestylane (Sub-Q, Uppsala, Sweden) was the first hyaluronic acid \nproduct sold in the United States. Restylane is supplied as a gel \nwith a particle size of 400 μm. This product is most commonly \nused to treat nasolabial folds, the lips, and the oral commis-\nsures. It can also be used for cheek augmentation and to im-\nprove deformities of the chin and prejowl sulcus. However, it is \nnot generally used for the treatment of fine lines.\nPerlane (Sub-Q, Uppsala, Sweden) is a hyaluronic acid product of \nnonanimal origin. It has a large particle size (1000 μm) and is \nused to treat moderate-to-severe wrinkles and folds. This prod-\nuct contains 0.3% lidocaine to decrease injection discomfort.\nJuvéderm (Allergan Inc., Santa Barbara, Calif.) has many advan-\ntages over Restylane. It is usually softer and produces fewer \nlumps in the skin when injected close to the surface. Juvéderm \nis popular in correcting slight or moderate nasolabial folds in \npatients with fine skin. It is also used for lip enhancement and \nto treat minor defects in facial contours. Juvéderm has multiple \n• Fig. 40.16  Available Dermal Fillers (Allergan, Irvine, Calif.).\n  \u0007Available Dermal Fillers\nMaterial\nBrand Name\nDuration and Biodegradability\nAutologous fat\nTemporary and biodegradable\nHyaluronic acid\nRestylane®, Restylane Perlane®, Restylane Lipp®, Restylane Touch®, Restylane Vital® \nMacrolane® 20, 30\nJuvederm Ultra 1, 2, 3®, Juvederm Voluma® Hylaform®, Hylaform Plus®, Hylaform \nFineline® Others: Rofilan Forte®, Matridur®, Puragen®, Glytone®, Isogel®, \nPrevelle®, etc\nTemporary and biodegradable\nCollagen\nZyplast®/Zyderm® (bovine) Cosmoderm®/Cosmoplast® (human) Evolence®, \nPermacol®, Fibroquel® (porcine)\nTemporary and biodegradable\nCalcium hydroxylapatite\nRadiesse®\nSemipermanent and biodegradable\nPoly L-lactic acid\nSculptra®/New Fill®\nSemipermanent and biodegradable\nβ-Tricalcium phosphate \nwith hyaluronic acid\nAtlean®\nSemipermanent and biodegradable\nPolyacrylamide gel\nAquamid® Bio-Alcamid®\nPermanent and not biodegradable\nPolymethyl methacrylate\nArteplast®, Artecoll®, Artefill®\nSemipermanent and not biodegradable\nDermalive®/ Dermadeep®\nDimethylsiloxane polymers\nSilicone\nPermanent and not biodegradable\nFrom Carruthers A, Carruthers J. Botulinum Toxin: Procedures in Cosmetic Dermatology Series. St. Louis, MO: Elsevier; 2018.\n   \nTABLE \n40.2"
  },
  {
    "page": 238,
    "content": "1128\nPART VII    Soft and Hard Tissue Rehabilitation\nsublines of products with different viscosities. One of their re-\ncent products is Juvéderm Volbella, which is a soft, smooth gel \nused to increase lip fullness and correct perioral lines. Another \npopular Juvéderm product is Juvéderm Voluma, which is used \nfor the cheek area and for midfacial volume loss. Juvéderm Vol-\nlure is commonly used in nasolabial folds and perioral restora-\ntion.\nRestylane Lipp (Allergan Inc., Santa Barbara, Calif.) is a specific \nhyaluronic acid gel that is designed for lip augmentation. The \nbenefit of this material is that it lasts approximately 12 months; \nhowever, it must be homogenously distributed. Injecting exces-\nsive volume may lead to the inability of massage to redistribute \nthe material.\nBELOTERO ® (Merz) is a high-quality hyaluronic acid dermal fillers \nwith patented CPM® (Cohesive Polydensi ed Matrix) technol-\nogy that integrates easily to smooth various tissues. It is mainly \nused for wrinkles or fine lines as well as restoring facial volume.\nVersa (Revanesse) hyaluronic acid is for nasolabial folds in mid to \ndeep dermis. \nIndications\nThe main indication for the use of dermal fillers is for facial reju-\nvenation. Another popular area to use Dermal fillers are used \nto correct volume deficiencies to enhance facial contours. One \nof the most common areas is the nasolabial fold, which forms \na pronounced furrow as patients age. Specifically, in implant \ndentistry the use of dermal fillers for black triangles is becom-\ning increasingly popular. In addition, with respect to implant \nprosthetics, because of hard and soft tissue loss, dermal fillers are \nbeing used for lip augmentation, facial augmentation, and com-\nmissures for the treatment of angular cheilitis or a downturned \nsmile (Fig. 40.17). \nGeneral Technique\nA definite learning curve exists when injecting dermal fillers. It is \nimperative the clinician obtain adequate training and practice in \nperforming these procedures. Depending on the anatomic area, \nthere exists a variation in the amount of injected material, along \nwith the depth and angle of injection. In addition, the clinician \nmust understand the ideal dermal filling agent specific to the area \nof treatment. The viscosity of the material selected will dictate the \ngauge of needle used to deliver the dermal filler, with 30 gauge \nbeing the most commonly used. Lighter body materials often used \nin the lips may use a 32 gauge, while heavier bodied materials \nmay require a 27 gauge. Microcannulas have grown increasingly \npopular because they yield advantages such as fewer injection \npoints, leading to less trauma to the tissue and blood vessels. \nInjection Technique\nThere exist two general techniques for injecting dermal fillers into \ntissue:\n   \nRetrograde technique: Needle is advanced and syringe plunger is \ndepressed as the needle is withdrawn.\nAnterograde technique: Plunger is depressed as soon as needle is \nplaced subdermally so the filler elevates the subcutaneous tis-\nsues, which reduces the incidence of vascular perforation.\n   \nSpecifically, there are a number of detailed injecting techniques \nthat have been developed over the years.  Each of the following \ntechniques allow for a tailored approach which is specific for the \nanatomic location and clinical outcome expected. Some of the \nmore common techniques include linear threading, fanning, serial \npuncturing, or cross-hatching. A combination of multiple tech-\nniques is often used.\n\t1.\t \u0007Linear threading: The full length of the needle is inserted \ninto the tissue and the filler is injected as the syringe is \nslowly retracted. This technique results in the filler remain-\ning in the location of the injection, therefore not spreading \nor dissipating throughout the tissue. The linear threading or \n“tunneling” technique is ideal for straight, narrow lines and \nwrinkles.\n\t2.\t \u0007Serial puncture: Multiple injections are placed serially along the \nlength of the treatment so the filler will merge in a continuous \nline. This technique is usually indicated for small, fine lines and \nwrinkles.\n\t3.\t \u0007Fan technique: One line of the filler material is injected by the \nlinear threading technique; then the direction is changed and \ninjected along a new line.\n\t4.\t \u0007Cross-hatching: The linear threading technique is used at the \nperiphery of the treatment area; the needle is withdrawn and is \ninserted adjacent to the first site and the procedure is repeated. \nThis method is carried out continuously at right angles to the \noriginal line (Fig. 40.18). \nDuration of Action\nIn general, temporary dermal fillers usually last from 6 to 12 \nmonths; however much variation exists depending on the treat-\nment location, patient’s anatomy, and muscle use. Newer tempo-\nrary fillers are coming onto the market that have longer durations, \nranging from 18 months to 24 months. \nLateral Face\nLift created by\nDermal Filler\nMedial Face\nLight Source\nLateral Face\nShadow\nMedial Face\nLight Source\n• Fig. 40.17  Photo of general indications for dermal fillers. (From Aicken M. Dermal filler doses. Aesthetics. \n2017;4:41. © Aesthetics Media Ltd)"
  },
  {
    "page": 239,
    "content": "1129\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\nPermanent Fillers\nWith the scope of procedures increasing with soft tissue augmenta-\ntion, an increasing demand for permanent fillers is becoming more \nprevalent. The U.S. Food and Drug Administration defines perma-\nnent fillers as materials that are composed of nonabsorbable or per-\nmanent materials.9 Permanent fillers are advantageous in providing \nlong-term results; however, they carry the potential for irreversible \ncomplications. Therefore these agents require clinicians with experi-\nence and a higher level of expertise. Currently, in the United States, \nthe available permanent fillers are PMMA and liquid injectable sili-\ncone. The use of liquid injectable silicone and PMMA is advanta-\ngeous because they require no maintenance procedures that result \nin increased inconvenience, cost, and pain. The main disadvantage \nof permanent fillers is that they cannot be reversed or removed eas-\nily. The postoperative side effects associated with permanent fillers \ntend to be far greater than temporary fillers. A second disadvantage \nof permanent fillers is their lack of adaptability or modification as \nfacial tissues change shape.37 \nDermal Filler Use in Implant Dentistry\n\t1.\t \u0007Black triangle\n\t2.\t \u0007Lips\n\t3.\t \u0007Face/cheek augmentation because of midfacial volume loss\n\t4.\t \u0007Commissure (downturned smile and angular cheilitis)\nBlack Triangles\nThe soft tissues adjacent to a dental implant ideally need to be \nin harmony with adjacent teeth and/or implants. Unfortunately, \nespecially in the maxillary anterior region, it is not uncommon \nfor there to be a lack of papilla tissue (black triangle), resulting \nin non-ideal esthetic and functional issues. Papilla tissue may \nbe lost from trauma, tooth loss, lack of adjacent contact area, or \nassociated bone loss. The reconstruction of interdental papilla is \na complicated and difficult periodontal treatment. There exist \nvery limited options in the surgical treatment of this problem. To \nfurther complicate the situation, food particles often accumulate \nin the space and create esthetic issues (Fig. 40.19).\nEtiology\nIn anterior regions of the dentition, the interdental papilla is usu-\nally of a pyramidal form, whereas in the posterior regions the \npapillae are more flattened in the buccolingual direction. Tarnow \net al.38 have shown that the level of the bony crest to the con-\ntact area has a direct correlation between the presence or absence \nof interproximal papillae. Their results showed when there was \n5 mm or less from the contact area to the crestal bone, 100% of \nthe time papillae were present. When the distance was 6 mm or \ngreater than 7 mm, respectively, 56% or 27% of the time papil-\nlae were present. Other studies have shown papillae decrease with \nincreasing distance between adjacent roots and have become more \nprominent with increasing distance from the contact area to the \nalveolar crest.39\nTarnow, in a second study, showed increased crestal bone \nloss when the interimplant distance was less than 3 mm.40 \nTherefore papilla loss would occur when implants adjacent to \neach other are placed too close. However, many additional fac-\ntors are significant in determining whether papillae are present, \nwhich include tooth size and shape, implant/tooth position, \nperiodontal status, tissue biotype, and possible prosthesis \noverhang/misfit.\nNordland and Tarnow41 have proposed a classification using \nthree reference points that include the contact point, facial and \napical extent of cement-enamel junction (CEJ), and interproximal \nextent of CEJ. From these criteria a classification was reported \nwith four descriptions of papilla:\n   \nNormal: interdental papilla occupies embrasure space to the apical \npart of the interdental contact point\nClass I: tip of interdental papilla occupies space between the in-\nterdental contact point and the most coronal part of the CEJ\nClass II: tip of interdental papilla lies at or apical to the CEJ but \ncoronal to the apicalmost part of the CEJ on facial aspect\nClass III: tip of interdental papilla lies at level with or apical to the \nfacial CEJ\nInjection Technique. A hyaluronic gel is injected 2 to 3 mm \napical to the tip of the papilla. The tissue is entered with the needle \nuntil bone is contacted. The needle is slightly pulled back and \nmaterial is deposited to plump up the papilla. A gentle massage \nand molding of the filler is completed, ideally with a cotton swab. \nApproximately 0.1 to 0.15 ml of product is used routinely per \npapilla treated (Fig. 40.20). Usually, papillary injected need to be \nrepeated every 6 months. \n1\n2\n3\n4\n5\n6\n7\n8\n9\n1. Linear threading technique\n2. Serial puncture technique\n3. Fan technique\n4. Cross-hatching technique\n• Fig. 40.18  Dermal Filler Techniques.  (1) Linear threading; (2) serial \npuncture; (3) fan; and (4) cross-hatching.\n• Fig. 40.19  Black Triangle.  Maxillary anterior between #8 and #9 result-\ning in an unesthetic result."
  },
  {
    "page": 240,
    "content": "1130\nPART VII    Soft and Hard Tissue Rehabilitation\nLips\nWhen evaluating patients for comprehensive dental care involving \ndental implants, the lips are an often overlooked anatomic area. \nLips are an essential part of the facial symmetry of the patient and \nesthetics. In society today patients are more esthetically conscious \nand view lips as needing to be fuller and more pronounced. When \nthe vermilion lip is thin, facial harmony may be disrupted. With \nthe aging process, there becomes a less exposed vermilion, consist-\ning of increased loss of vermilion bulk and length.\nAnatomy\nThe lips are referred to as the “Labium superius oris” (upper) and \n“Labium inferius oris” (lower). The anatomy of the upper lip \nextends from the base of the nose superiorly to the nasolabial folds \nlaterally and inferiorly to the free edge of the vermilion border. \nA\nB\nC\nD\nE\n• Fig. 40.20   Black Triangles Technique.  (A) Obtain a photo of the black triangle area as a baseline. \nAnesthetize area to be treated via local infiltration. (B) Inject hyaluronic acid dermal filler into papilla with \nthe bevel of the needle down and angled in the direction that the papilla needs to be bulked. (C) Shape \npapilla using cotton-tip applicators. Often multiple appointments are needed to achieve ideal outcome. (D) \nImmediate post-operative view. (E) 2-week post-operative view after two treatments."
  },
  {
    "page": 241,
    "content": "1131\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\nThe vermilion border is defined as the junction of the lips and the \nskin, and the area with the borders is termed the vermilion zone.\nThe vermilion border of the upper lip is known as the \n“Cupid’s bow.” Along the upper vermilion/skin border, two \nelevations of the vermilion form the Cupid’s bow, which are \nraised vertical columns of tissue that form a midline depression \ncalled the philtrum.42 The fleshy protuberance in the center of \nthe upper lip is the tubercle, which is also known as the pro-\ncheilon (Fig. 40.21). \nMost Common Lip Issues\nThe most common patient complaint concerning the lips is a \ndeflating vermilion, mainly from insufficient volume. Usually \nfemale lips are fuller and bulge forward in comparison with male \nlips. The most ideal approach to lip augmentation depends on \nthe deficiency and the patient’s esthetic expectations. Most com-\nmonly the upper lip is treated more often than the lower. In gen-\neral, genetically thin lips are treated with a deeper-placed filler, \nfollowed by volume correction with a superficial filler arch. When \ncosmetic enhancement is required, a superficially placed filler for \nexpansion of the vermilion is ideal.42 \nInjection Technique\nJacono43 has postulated a classification of 15 anatomic lip zones \nthat is used to direct fillers for lip augmentation and to customize \nlip contour and size. This intended technique allows for better \ndirection of the filler placement to create more fullness and main-\ntain shape. He maintains five major zones within the lip region: \nvermilion/white roll, subvermilion, peristomal, philtral column, \nand commissural. The subvermilion corresponds to the dry muco-\nsal lip, and the peristomal at the junction of dry and wet muco-\nsal lip. The vermilion/white roll can be further subdivided in the \nupper lip to include lateral, Cupid’s bow apical, and central phil-\ntral zones, whereas the lower lip vermilion is divided into medial \nand lateral zones. The subvermilion is subdivided into medial and \nlateral zones, and the peristomal into medial and lateral zones \n(Fig. 40.22).\n\t1.\t \u0007Anesthesia is completed with an infraorbital block on the max-\nilla and a mental or inferior alveolar on the mandibular arch.\n\t2.\t \u0007Different techniques are advocated for lip filler placement. \nThe serial puncture and linear threading are usually used when \napplying the antegrade or retrograde method. The choice of one \ntechnique over another is usually personal preference of the cli-\nnician.\n\t3.\t \u0007Medium-depth fillers are usually used for lip augmentation, \nsuch as: (1) Restylane, (2) Juvéderm Ultra, and (3) Esthélis \nBasic with the use of a 30-gauge needle or a 27-gauge cannula \n(Fig. 40.23). \nLip Injection Complications Complications\nThe most common complications from lip filler injections include \npost-injection lumps and nodules. Improper technique or over-\naggressive injection may lead to irregularity or lumpiness, which \nusually occurs when overcorrection is completed. If the filler prod-\nuct is placed too superficial, beading can occur, leaving an unes-\nthetic result. If large nodules or lumps are present, hyaluronidase \ninjections may be used to dissolve the product. Herpetic labialis \nreactivation may be prevented with oral antivirals (acyclovir, fam-\nciclovir, or valaciclovir) (Fig. 40.24). \nFace\nThere are two common areas in the face that directly impact \nesthetics with dental implant patients. These include the nasola-\nbial folds and marionette lines, which become more prominent \nLower vermillion border\nOral commissure\nUpper vermillion border\nPhiltrum\n   ridges\nCutaneous upper lip\nCupid’s bow\nBody of the lips\nOral commissure\n• Fig. 40.21  Lip Anatomy.\nA\nB\n• Fig. 40.22  Lip Injection Anesthesia.  (A) Maxillary infraorbital injection. \n(B) Mandibular mental nerve block."
  },
  {
    "page": 242,
    "content": "1132\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\nD\nE\n• Fig. 40.23  Lip Technique.  The lip augmentation is initiated by anesthetizing the upper and lower lips \nwith bilateral Gordon Modified infraorbital blocks, mental blocks, (A) infiltration lateral to commissure of the \nmouth. (B, C, and D) Generally, begin by outlining the lips by injecting the subvermilion border starting at \nthe commissure by placing retrograde threads. (E) Massage the outline using Vaseline to smooth.\ncontinued"
  },
  {
    "page": 243,
    "content": "1133\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\nF\nG\nH\nI\nJ\nFig. 40.23, cont’d  (F). After the outline is completed, place two linear threads through the philtrum columns. \nMassage to smooth using cotton-tip applicator. (G- H) Assess for asymmetries and correct with threading \nor serial punctures. (I and J) Fill the lower and upper body of the lips to your liking. Massage well to smooth \nany irregularities."
  },
  {
    "page": 244,
    "content": "1134\nPART VII    Soft and Hard Tissue Rehabilitation\n• Fig. 40.24  Lip Complications: Edema and Ecchymosis.\nA\nB\n• Fig. 40.25  (A and B) Dermal filler sites within the facial area.\nwith the aging process and loss of teeth/bone. The problem with \nthese areas is the loss of volume and that they develop folds that \nbecome unesthetic. The darks lines associated with these areas are \nfrom a “shadow,” which results from an elevated lateral compo-\nnent and less elevated medial area (i.e., a step is present between \nthe two tissue areas)44 (Fig. 40.25).\nGoal of Facial Fillers\nBasically, the goal of facial fillers is reduction of the “steps,” which \nwill reduce the loss of the shadow and the appearance of the lines. \nNasolabial Folds/Nasolabial Crease\nAs patients age, the vertical lines at the corner of the mouth \nbecome more evident. The zygomatic retaining ligaments become \nlax and the malar soft tissue migrates downward along the direc-\ntion of the Zygomaticus Muscles (ZM), which results in bulging \nagainst the nasolabial crease. The skin lateral to the crease will \nstretch and become redundant, which results in the formation of \na prominent nasolabial fold.45 \nAnatomic Area. The nasolabial folds include two skin folds \nthat are located from the side of the nose to the corners of the \nmouth, which is made up of bulging fat pads. Basically this is the \narea that separates the cheek from the upper lip. The extent of the \nfold is at the junction of the nasal alar, the cheek, and the upper \nlip. As the fold progresses inferiorly, it will be in either a straight, \nconvex, or concave shape and ends below and lateral to the corner \nof the mouth.46 This anatomic area has been termed “smile” or \n“laugh” lines.47 When patients smile, multiple muscles are respon-\nsible for the accentuation of the fold. The ZM muscle will pull \nthe cheeks superior and laterally, and the orbicularis oris muscle \npulls the upper lip inferiorly and medially. The levator anguli oris \nwill contract, which results in the skin fold crease deepening and \nbecoming more prevalent. The nasolabial crease, or sulcus, is the \nfacial line between the upper lip and cheek, extending from the \nalae nasi to the lip commissure. \nInjection Technique. In the treatment of nasolabial folds, \nvolume of material is paramount to restoring contour.  Usually \na thicker dermal filler material is utilized deeper into the tissue \nspace.  If superficial placement of a thinner dermal filler is used, \nlack of contour will result with minimal longevity.  Most com-\nmonly, the retrograde linear threading technique is used along \nthe nasolabial fold.  Caution should always be exercised in stay-\ning medial to the fold while depositing the product.  If filler is \ninjected laterally, deepening of the fold will occur resulting in \nesthetic issues.\nComplication. Caution should be exercised in injecting in the \nsubcutaneous layer lateral to the ala because the angular artery \nis most commonly located and the risk for vascular occlusion is \nhigher (Fig. 40.26). \nMarionette Lines\nMarionette lines are associated with advancing age and are \ndependent on facial structure and anatomy. They are bilateral \nextensions of the nasolabial crease, which are directed inferiorly. \nAnatomic Area. The marionette lines are formed mainly from \nthe depressor anguli oris muscle and platysma muscle. \nInjection Technique. The filler is ideally placed inferiorly in the \nsubcutaneous layer and dermis in the oral commissure. To achieve \na tissue eversion, inject in a fanning direction, which forms a tent \npole effect. The use of the filler in the depressor anguli oris and \nmentalis and platysma below the mandibular margin allows the \nlateral oral commissure to elevate, restoring a more harmonious \nexpression. \nComplications. Injecting above or lateral to the lines will \nincrease the shadowing effect by increasing the step (Fig. 40.27)."
  },
  {
    "page": 245,
    "content": "1135\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\nAngular Cheilitis\nAngular cheilitis is diagnosed by the presence of redness, inflam-\nmation, maceration, and fissuring of the oral commissures. \nPatients usually describe a painful, burning area at the corners of \nthe mouth. In many cases mastication is impacted and range of \nopening is compromised. \nEtiology. The etiology of angular cheilitis is multifactorial \nand involves many conditions that promote a moist environment \nwithin the oral commissure area. Deficiencies in iron, riboflavin \n(B2), folate (B9), cobalamin (B12), or zinc have been associated \nwith this disorder. In addition, a decrease in vertical dimension \nfrom tooth loss, bone resorption, or inability to wear prostheses \nleads to the development of angular cheilitis. In almost all cases \nCandida albicans contributes to the pathophysiology of angular \ncheilitis. \nInjection Technique. Therapeutic use of dermal fillers in the lips \nand perioral structures has become increasingly popular in implant \ndentistry (Fig. 40.28). Treatment of the lips and perioral structures \nA\nB\nC\nD\nE\nF\n• Fig. 40.26  Nasolabial Fold.  (A) Nasolabial fold marked with skin marker. (B) Using the anterograde \nlinear threading technique, dermal fillers are extruded along the nasolabial fold. (C and D) Be sure to stay \nmedial to the fold while depositing product because extending laterally will result in deepening the fold. (E \nand F) Final medial injections."
  },
  {
    "page": 246,
    "content": "1136\nPART VII    Soft and Hard Tissue Rehabilitation\nA\nB\nC\nD\nF\nE\n• Fig. 40.27  Marionette lines follow the line down from the nasal labial fold, ensuring that you stay medial to \nthe fold again. (A) Fan across in an upward vector to lighten the marionette lines (B–D). Follow with fanning \nor cross-hatching above the marionette lines in an upward direction (E and F). Massage well to eliminate \nany bumps from the product.\nyields various practical dental improvements in orthognathic soft \ntissue profile, retention of removable prosthetics, proper phonet-\nics, asymmetric smiles, and loss of soft tissue profile due to missing \nteeth. In treating the oral commissures a significant decrease in \nangular cheilitis has been noted. Injection of dermal fillers has been \nshown to restore the commissure anatomy and decrease the sulcus \narea to minimize recurrence. However, the clinician must investi-\ngate all possible etiologies of the angular cheilitis and treat accord-\ningly.  Nutritional deficiencies and a collapsed vertical dimension \nof occlusion have been associated with angular cheilitis. Antican-\ndidal treatment may be used alone or in conjunction with der-\nmal filler treatment. The injection technique for angular cheilitis \nincludes having the patient opening wide, and injection of dermal \nfiller directly into the commissure with a linear thread technique. \nThe threading or fanning technique may be used also under the \nlower lip in an upward vector to increase elevation of the tissue. \nReversals for Dermal Fillers\nDermal fillers are advantageous because they exhibit reversibility \nwith an enzyme, hyaluronidase. Hyaluronidase is a naturally occur-\nring protein in the body and will catabolize hyaluronic acid usually \nwithin 24 hours through hydrolysis. This reversal agent is mainly \nused when overcorrection or misplacement of the dermal filler \noccurs. \nComplications With Dermal Fillers\nDermal fillers are associated with complications, some that can \nbe quite severe. A through medical history is advised before \ninjecting dermal fillers. A history of hypertrophic scars or \nkeloids may contraindicate the procedure. A history of herpes \nsimplex infections may require premedication with valacyclovir"
  },
  {
    "page": 247,
    "content": "1137\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\nor other antivirals before lip injections. Patients who take anti-\ncoagulant therapy or certain vitamins should be treated with \ncaution because of increased risks associated with bleeding and \nbruising.\nThe most common complication of dermal fillers includes \nan asymmetric appearance caused by too much material being \ninjected into a particular site. Clinicians should always attempt \nto undertreat specific areas because overtreatment is extremely dif-\nficult to remedy.\nMore common local complications appear as redness, inflam-\nmation, and bruising. This often occurs secondarily from trauma \ncaused by the injections. Erythema usually resolves within hours; \nhowever, edema may last for multiple days. Edema may be reduced \nby minimizing the number of injection sites, using epinephrine-\ncontaining anesthetics, and applying ice/cold compresses after \nthe procedure. It has been suggested that using a product such as \narnica (homeopathic herb) may reduce the effects of the trauma \nfrom the injections.\nInjection to the proper angle and depth is of utmost impor-\ntance; being too superficial may result in the “Tyndall effect,” \nwhere the skin appears bluish at the injection site. Tissue necrosis \nmay also occur if the filler occludes a blood vessel. In the event of \nsuspected tissue necrosis, immediate reversal with hyaluronidase is \nadvised and close postoperative care is imperative. \nComplications48\nEarly Onset (Immediate > 15 Days)\nDue to the procedure, not filler related\nErythema\nPain bruising\nSwelling at injection site\nInfection (viral or bacterial) can be related to filler due to biofilm\nDue to filler behavior and placement technique\nOvercorrection\nMisplacement\nHypersensitivity (type IV reaction)\nVascular occlusion\nGranuloma   \n   \nLate Onset (> 15 days)\nDue to the procedure, not filler related\nChronic infection\nItching\nDue to filler behavior and placement technique\nSkin discoloration\nNodules (product accumulation)\nHypertropic scarring\nHypersensitivity (type IV reaction)\nA\nB\nC\nD\n• Fig. 40.28  Angular Cheilitis.  (A) With the patient opening wide, inject directly into the commissure with a \nlinear thread. (B) Follow with linear thread in the lower lip line. Massage lip to smooth. (C) Optional fanning \nbelow to fill any depressions. (D) Often this treatment is done in combination with injecting the depressor \nanguli oris with botulinum toxin type A."
  },
  {
    "page": 248,
    "content": "1138\nPART VII    Soft and Hard Tissue Rehabilitation\nConclusion\nThe use of Botox and dermal fillers have been shown through the \nliterature to be valuable adjuncts in implant dentistry. These pharma-\ncologic agents are successful in treating many facial and maxillofacial \nmusculature dysfunctions as they provide an overall conservative, \nminimally invasive treatment approach.  Most notably, Botox may \nbe indicated for the treatment of parafunctional habits that may be \ndetrimental to the overall dental implant success.  In addition, the \nuse of Botox in the treatment of various temporomandibular joint \nsyndrome/temporomandibular dysfunction (TMJ/TMD) disorders \nand excessive tissue display (gummy smiles) have been shown to suc-\ncessful.   The use of dermal fillers have become popular for facial and \ncheek soft tissue augmentation as well as for the treatment of angular \ncheilitis.  With respect to dental implants, papilla loss leading to the \nformation of black triangles may be treated with dermal fillers lead-\ning to the reversal of the open spaces. Therefore, with the advances of \ntechnology and science, the use of Botox products as well as dermal \nfillers are becoming more popular and have become a mainstay in \nimplant dentistry.\nReferences\n\t 1.\t \u0007Binder WJ, Blitzer A, Brin MF. Treatment of hyperfunctional lines \nof the face with botulinum toxin A. Dermatol Surg. 1998;24:1198–\n1205.\n\t 2.\t \u0007Delcanho R. Botox injections. In: Selvaratnam P, Niere K, Zuluaga \nMaria, eds. Headache, Orofacial Pain and Bruxism. Churchill Living-\nstone; 2009:347–356.\n\t 3.\t \u0007Hexsel DM, De Almeida AT, Rutowitsch M, et  al. Multicenter, \ndouble blind study of the efficacy of injections with botulinum toxin \ntype A reconstituted up to six consecutive weeks before application. \nDermatol Surg. 2003;29:523–529.\n\t 4.\t \u0007Kim HJ, Yum KW, Lee SS, et al. Effects of botulinum toxin type \nA on bilateral masseteric hypertrophy evaluated with computed \ntomographic measurement. Dermatol Surg. 2003;29(5):484– \n489.\n\t 5.\t \u0007Fehrenbach M, Herring SW. Illustrated Anatomy of the Head and \nNeck. 4th ed. Philadelphia: Saunders; 2012:97.\n\t 6.\t \u0007von Lindern JJ, Niederhagen B, Apple T, et  al. Type A botuli-\nnum toxin for the treatment of hypertrophy of the masseter and \ntemporal muscles: an alternative treatment. Plast Reconstr Surg. \n2001;107:327–332.\n\t 7.\t \u0007Hu KS, Kim ST, Hur MS, et al. Topography of the masseter muscle \nin relation to treatment with botulinum toxin type A. Oral Surg Oral \nMed Oral Pathol Oral Radiol Endod. 2010;110:167–171.\n\t 8.\t \u0007Al-Ahmad HT, Al-Qudah MA. The treatment of masseter hyper-\ntrophy with botulinum toxin type A. Saudi Med J. 2006;27(3):397–\n400.\n\t 9.\t \u0007Clark GT. The management of oromandibular motor disorders and \nfacial spasms with injections of botulinum toxin. Phys Med Rehabil \nClin North Am. 2003;14(4):727–748.\n\t10.\t \u0007Rijsdijk BA, Van ESRJ, Zonneveld FW, et al. Botulinum toxin type \nA treatment of cosmetically disturbing masseteric hypertrophy. Ned \nTijdschr Geneeskd. 1998;142(10):529–532.\n\t11.\t \u0007Rafferty KL, Liu ZJ, Navarrete AL, et al. Botulinum toxin in mas-\nticatory muscles: short-and long-term effects on muscle, bone, and \ncraniofacial function in adult rabbits. Bone. 2012;50(3):651–662.\n\t12.\t \u0007Van Zandijcke M, Marchau MM. Treatment of bruxism with botuli-\nnum toxin injections. J Neurol Neurosurg Psychiatry. 1990;53(6):530.\n\t13.\t \u0007Scheid RC, Woelfel JB. Woelfel’s dental anatomy: its relevance to den-\ntistry. Philadelphia: Lippincott Williams & Wilkins; 2007:41.\n\t14.\t \u0007Bas B, Ozan B, Muglali M, Celebi N. Treatment of masseteric \nhypertrophy with botulinum toxin: a report of two cases. Med Oral \nPatol Oral Cir Bucal. 2010;15(4):649–652.\n\t15.\t \u0007Schwartz Marvin, Freund Brian. Treatment of temporomandibular \ndisorders with botulinum toxin. Clin J pain. 2002;18(6):S198–\nS203.\n\t16.\t \u0007Guarda-Nardini L, Manfredini D, Salamone M, et al. Efficacy of \nbotulinum toxin in treating myofascial pain in bruxers: a controlled \nplacebo pilot study. Cranio. 26:126–135.\n\t17.\t \u0007Baker, J. S., & Nolan, P. J. (2017). Effectiveness of botulinum toxin \ntype A for the treatment of chronic masticatory myofascial pain: A \ncase series. The Journal of the American Dental Association, 148(1), \n33–39.\n\t18.\t \u0007Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J \nAm Dent Assoc. 2000;131:211–216.\n\t19.\t \u0007Monroy PG, Da Fonseca MA. The use of botulinum toxin-a in the \ntreatment of severe bruxism in a patient with autism: a case report. \nSpec Care Dentist. 2006;26:37–39.\n\t20.\t \u0007Sinha Aditya, Hurakadli Megha, Yadav Pramod. Botox and derma fill-\ners: the twin face of cosmetic dentistry. Int J Contemp Dent Med Rev. \n2015.\n\t21.\t \u0007Kokich Vincent O, Asuman Kiyak H, Peter Shapiro A. Comparing \nthe perception of dentists and lay people to altered dental esthetics. \nJ Esthet Restor Dent. 1999;11(6):311–324.\n\t22.\t \u0007Polo M. Botulinum toxin type A (Botox) for the neuromuscular cor-\nrection of excessive gingival display on smiling (gummy smile). Am J \nOrthod Dentofacial Orthop. 2008;133(2):195–203. \n\t23.\t \u0007Peck S, Peck L. Selected aspects of the art and science of facial esthet-\nics. Sem Orthod. 1995;1(2):105–126.\n\t24.\t \u0007Al‐Jabrah, Osama, Raghda Al‐Shammout, Waddah El‐Naji, \nMahasen Al‐Ajarmeh, and Abdel‐Hakeem Al‐Quran. “Gender dif-\nferences in the amount of gingival display during smiling using two \nintraoral dental biometric measurements.” Journal of Prosthodontics: \nImplant, Esthetic and Reconstructive Dentistry 19, no. 4 (2010): 286–\n293.\n\t25.\t \u0007Ackerman MB, Ackerman JL. Smile analysis and design in the digi-\ntal era. J Clin Orthod. 2002;36(4):221–236.\n\t26.\t \u0007Nasr MW, Jabbour SF, Sidaoui JA, et al. Botulinum toxin for the \ntreatment of excessive gingival display: a systematic review. Aesthet \nSurg J. 2015;36(1):82–88.\n\t27.\t \u0007Hwang WS, Hur MS, Hu KS, et al. Surface anatomy of the lip ele-\nvator muscles for the treatment of gummy smile using botulinum \ntoxin. Angle Orthod. 2009;79(1):70–77.\n\t28.\t \u0007Miller J, Clarkson E. Botulinum toxin type A: review and its role in \nthe dental office. Dent Clin North Am. 2016;60(2):509–521.\n\t29.\t \u0007Grover S, Malik V, Kaushik A, et al. A future perspective of botox \nin dentofacial region. J Pharm Biomed Sci. 2014;04(05):525–\n531.\n\t30.\t \u0007Clark GT, Stiles A, Lockerman LZ, et al. A critical review of the \nuse of botulinum toxin in orofacial pain disorders. Dent Clin N Am. \n2007;51:245–261.\n\t31.\t \u0007Park NY, Ahn KY, Jung DS. Botulinum toxing type a treatment for \ncontouring of the lower face. Dermatol Surg. 2003;29(5):477–483.\n\t32.\t \u0007Patel D, Mehta F, Trivedi R, et al. Botulinum toxin and gummy \nsmile-A review. IOSR J Dent Med Sci. 2013;4(1):1–5.\n\t33.\t \u0007Freund B, Finkelstein I, Ko G. Review of the applications of botuli-\nnum toxin and tissue fillers in dental practice. Oral Health. 2014.\n\t34.\t \u0007https://www.plasticsurgery.org/documents/News/Statistics/2016/top-\nfive-cosmetic-plastic-surgery-procedures-2016.pdf.\n\t35.\t \u0007Chen J, Abatangelo G. Functions of hyaluronan in wound repair. \nWound Repair Regen. 1999;7(2):79–89.\n\t36.\t \u0007Rohrich RJ, Ghavami A, Crosby MA. The role of hyaluronic \nacid fillers (Restylane) in facial cosmetic surgery: review and \ntechnical considerations. Plast Reconstr Surg. 2007;120(suppl \n6):41S–54S.\n\t37.\t \u0007Carruthers J, Carruthers A. Soft tissue augmentation, fourth edition. \nProcedures in Cosmetic Dermatology Series. Elsevier; 2018.\n\t38.\t \u0007Tarnow D, Elian N, Fletcher P, et al. Vertical distance from the crest \nof bone to the height of the interproximal papilla between adjacent \nimplants. J Periodontol. 2003;74:1785–1788."
  },
  {
    "page": 249,
    "content": "1139\nCHAPTER 40  The Use of Botox and Dermal Fillers in Oral Implantology\n\t39.\t \u0007Cho HS, Jang HS, Kim DK, et al. The effects of interproximal dis-\ntance between roots on the existence of interdental papillae accord-\ning to the distance from the contact point to the alveolar crest. J \nPeriodontol. 2006;77:1651–1657.\n\t40.\t \u0007Tarnow, Dennis, Nicolas Elian, Paul Fletcher, Stuart Froum, Ann \nMagner, Sang‐Choon Cho, Maurice Salama, Henry Salama, and \nDavid A. Garber. “Vertical distance from the crest of bone to the \nheight of the interproximal papilla between adjacent implants.” Jour-\nnal of periodontology 74, no. 12 (2003): 1785–1788.\n\t41.\t \u0007Nordland WP, Tarnow DP. A classification system for loss of papil-\nlary height. J Periodontol. 1998;69:1124–1126.\n\t42.\t \u0007Luthra A. Shaping lips with fillers. J Cutan Aesthet Surg. \n2015;8(3):139.\n\t43.\t \u0007Jacono AA. A new classification of lip zones to customize injectable \nlip augmentation. Arch Facial Plast Surg. 2008;10(1):25–29.\n\t44.\t \u0007Guyuron B, Michelow B. The nasolabial fold: a challenge, a solu-\ntion. Plastic Reconstr Surg. 1994;93(3):522–529.\n\t45.\t \u0007Weinzweig J. Plastic Surgery Secrets Plus. Elsevier;2010. 498–505.\n\t46.\t \u0007Zufferey J. Anatomic variations of the nasolabial fold. Plastic Recon-\nstr Surg. 1992;89(2):225–231.\n\t47.\t \u0007Pogrel MA, Shariati S, Schmidt B, et al. The surgical anatomy of the \nnasolabial fold. Oral Surg Oral Med Oral Pathol, Oral Radiol Endod. \n1998;86(4):410–415.\n\t48.\t \u0007Carruthers A, Carruthers J. Botulinum Toxin: Procedures in Cosmetic \nDermatology Series. Elsevier; 2018."
  },
  {
    "page": 250,
    "content": "This page intentionally left blank"
  }
]